# SignalP-5.0	Organism: gram-	Timestamp: 20210212162708
# ID	Prediction	SP(Sec/SPI)	TAT(Tat/SPI)	LIPO(Sec/SPII)	OTHER	CS Position    sequence_length
NZ_CP027599.1_37	LIPO(Sec/SPII)	0.127358	0.009721	0.764608	0.098313	CS pos: 13-14. VVG-CL. Pr: 0.6879    18
NZ_CP027599.1_43	LIPO(Sec/SPII)	0.238365	0.124989	0.339605	0.297041	CS pos: ?. Probable protein fragment    16
NZ_CP027599.1_75	LIPO(Sec/SPII)	0.159318	0.011810	0.531393	0.297480	CS pos: 30-31. LTS-CS. Pr: 0.4848    34
NZ_CP027599.1_106	SP(Sec/SPI)	0.443698	0.046344	0.194801	0.315156	CS pos: ?. Probable protein fragment    23
NZ_CP027599.1_108	LIPO(Sec/SPII)	0.204880	0.019855	0.404773	0.370491	CS pos: 9-10. SFA-CD. Pr: 0.3810    20
NZ_CP027599.1_116	LIPO(Sec/SPII)	0.173599	0.006266	0.517752	0.302383	CS pos: 24-25. LQS-CR. Pr: 0.4946    32
NZ_CP027599.1_121	LIPO(Sec/SPII)	0.122767	0.009072	0.651565	0.216596	CS pos: 21-22. LTY-CN. Pr: 0.3397    37
NZ_CP027599.1_131	LIPO(Sec/SPII)	0.289351	0.039286	0.503312	0.168052	CS pos: 21-22. ANG-CR. Pr: 0.6188    34
NZ_CP027599.1_141	LIPO(Sec/SPII)	0.286541	0.043730	0.353327	0.316403	CS pos: ?. Probable protein fragment    15
NZ_CP027599.1_142	LIPO(Sec/SPII)	0.150646	0.018921	0.561355	0.269078	CS pos: 14-15. PAG-CS. Pr: 0.3676    16
NZ_CP027599.1_150	SP(Sec/SPI)	0.517895	0.037579	0.129214	0.315311	CS pos: 29-30. ASA-RQ. Pr: 0.4346    35
NZ_CP027599.1_165	LIPO(Sec/SPII)	0.246389	0.026952	0.369931	0.356728	CS pos: ?. Probable protein fragment    17
NZ_CP027599.1_211	SP(Sec/SPI)	0.383804	0.070867	0.163865	0.381463	CS pos: 15-16. RRA-AP. Pr: 0.1860    20
NZ_CP027599.1_214	LIPO(Sec/SPII)	0.225444	0.193194	0.310319	0.271042	CS pos: 21-22. SCL-CG. Pr: 0.0809    36
NZ_CP027599.1_217	LIPO(Sec/SPII)	0.165293	0.009061	0.553812	0.271834	CS pos: 22-23. LSL-CN. Pr: 0.2096    26
NZ_CP027599.1_243	SP(Sec/SPI)	0.564333	0.011983	0.268006	0.155678	CS pos: ?. Probable protein fragment    22
NZ_CP027599.1_248	LIPO(Sec/SPII)	0.153859	0.048990	0.684571	0.112580	CS pos: 18-19. PCG-CC. Pr: 0.4318    44
NZ_CP027599.1_249	LIPO(Sec/SPII)	0.284357	0.023494	0.444132	0.248017	CS pos: 12-13. TLT-CM. Pr: 0.0536    15
NZ_CP027599.1_271	LIPO(Sec/SPII)	0.217243	0.034922	0.419770	0.328065	CS pos: 17-18. AAR-CS. Pr: 0.1071    47
NZ_CP027599.1_287	LIPO(Sec/SPII)	0.324281	0.021305	0.331595	0.322818	CS pos: ?. Probable protein fragment    19
NZ_CP027599.1_298	SP(Sec/SPI)	0.431249	0.019114	0.217871	0.331766	CS pos: ?. Probable protein fragment    20
NZ_CP027599.1_307	LIPO(Sec/SPII)	0.193381	0.013700	0.423269	0.369649	CS pos: 16-17. IQY-CS. Pr: 0.3671    24
NZ_CP027599.1_377	SP(Sec/SPI)	0.586400	0.022529	0.099127	0.291943	CS pos: 21-22. ASA-PY. Pr: 0.1972    36
NZ_CP027599.1_380	SP(Sec/SPI)	0.516551	0.145584	0.017416	0.320449	CS pos: 38-39. AYA-GD. Pr: 0.6130    41
NZ_CP027599.1_427	LIPO(Sec/SPII)	0.172597	0.004689	0.529792	0.292922	CS pos: 21-22. CTA-CA. Pr: 0.3478    34
NZ_CP027599.1_452	LIPO(Sec/SPII)	0.055037	0.017740	0.546396	0.380827	CS pos: 16-17. GFA-CG. Pr: 0.2823    42
NZ_CP027599.1_455	LIPO(Sec/SPII)	0.164683	0.010221	0.527364	0.297733	CS pos: 12-13. GAP-CC. Pr: 0.2299    19
NZ_CP027599.1_456	LIPO(Sec/SPII)	0.265048	0.043904	0.383700	0.307347	CS pos: 21-22. GMR-CC. Pr: 0.0899    23
NZ_CP027599.1_469	LIPO(Sec/SPII)	0.193356	0.036927	0.394994	0.374723	CS pos: ?. Probable protein fragment    36
NZ_CP027599.1_470	SP(Sec/SPI)	0.496190	0.035366	0.157120	0.311325	CS pos: 21-22. AIA-QM. Pr: 0.2089    29
NZ_CP027599.1_491	SP(Sec/SPI)	0.402160	0.025395	0.373902	0.198542	CS pos: 15-16. VWA-AA. Pr: 0.2223    22
NZ_CP027599.1_511	SP(Sec/SPI)	0.670267	0.085159	0.150382	0.094192	CS pos: 26-27. VAA-SA. Pr: 0.2202    47
NZ_CP027599.1_550	SP(Sec/SPI)	0.383667	0.097820	0.143649	0.374864	CS pos: 14-15. AQA-TP. Pr: 0.2984    16
NZ_CP027599.1_557	LIPO(Sec/SPII)	0.267513	0.013296	0.482075	0.237117	CS pos: 14-15. HSV-CF. Pr: 0.1732    16
NZ_CP027599.1_568	LIPO(Sec/SPII)	0.233879	0.032411	0.372931	0.360778	CS pos: 12-13. LQM-CI. Pr: 0.0383    15
NZ_CP027599.1_586	SP(Sec/SPI)	0.501683	0.005377	0.047965	0.444975	CS pos: 13-14. THA-AP. Pr: 0.3236    46
NZ_CP027599.1_588	LIPO(Sec/SPII)	0.232139	0.018460	0.404501	0.344900	CS pos: 15-16. FVP-CL. Pr: 0.0328    18
NZ_CP027599.1_603	LIPO(Sec/SPII)	0.238407	0.150608	0.352940	0.258045	CS pos: 20-21. FQA-SS. Pr: 0.3701    39
NZ_CP027599.1_614	LIPO(Sec/SPII)	0.116963	0.036266	0.661045	0.185726	CS pos: 17-18. LSA-CS. Pr: 0.6630    45
NZ_CP027599.1_644	TAT(Tat/SPI)	0.047031	0.619005	0.056962	0.277002	CS pos: 27-28. SRS-AS. Pr: 0.0918    38
NZ_CP027599.1_656	LIPO(Sec/SPII)	0.114404	0.025399	0.701447	0.158750	CS pos: 12-13. VAS-CS. Pr: 0.6725    20
NZ_CP027599.1_669	LIPO(Sec/SPII)	0.093206	0.032561	0.667490	0.206742	CS pos: 14-15. SSS-CF. Pr: 0.6521    43
NZ_CP027599.1_694	TAT(Tat/SPI)	0.151947	0.303493	0.249404	0.295156	CS pos: ?. Probable protein fragment    15
NZ_CP027599.1_713	SP(Sec/SPI)	0.464873	0.049192	0.169201	0.316734	CS pos: 17-18. STA-LN. Pr: 0.2900    22
NZ_CP027599.1_733	LIPO(Sec/SPII)	0.115917	0.003263	0.781187	0.099633	CS pos: 17-18. LKG-CV. Pr: 0.7484    22
NZ_CP027599.1_764	SP(Sec/SPI)	0.425430	0.087496	0.144179	0.342896	CS pos: 18-19. IKA-KS. Pr: 0.3620    26
NZ_CP027599.1_804	LIPO(Sec/SPII)	0.206198	0.001569	0.726969	0.065264	CS pos: 17-18. LSF-CS. Pr: 0.5932    47
NZ_CP027599.1_814	LIPO(Sec/SPII)	0.314065	0.008195	0.408062	0.269677	CS pos: 13-14. CIY-CH. Pr: 0.0499    16
NZ_CP027599.1_835	LIPO(Sec/SPII)	0.186455	0.042650	0.435495	0.335400	CS pos: 30-31. CAS-CH. Pr: 0.2792    42
NZ_CP027599.1_849	LIPO(Sec/SPII)	0.100956	0.012076	0.726285	0.160684	CS pos: 17-18. ICS-CF. Pr: 0.6395    20
NZ_CP027599.1_897	SP(Sec/SPI)	0.508009	0.000741	0.119645	0.371604	CS pos: 21-22. ITS-SI. Pr: 0.1940    31
NZ_CP027599.1_905	LIPO(Sec/SPII)	0.207131	0.008722	0.481544	0.302603	CS pos: 16-17. ISF-CN. Pr: 0.2498    20
NZ_CP027599.1_942	LIPO(Sec/SPII)	0.024322	0.000094	0.947346	0.028237	CS pos: 14-15. VTG-CV. Pr: 0.7524    31
NZ_CP027599.1_948	LIPO(Sec/SPII)	0.259366	0.017082	0.434734	0.288819	CS pos: 15-16. FHV-CK. Pr: 0.0562    17
NZ_CP027599.1_968	LIPO(Sec/SPII)	0.256060	0.007966	0.380094	0.355879	CS pos: 12-13. CLA-CC. Pr: 0.1616    18
NZ_CP027599.1_998	LIPO(Sec/SPII)	0.096513	0.010736	0.517314	0.375437	CS pos: 18-19. ISA-CI. Pr: 0.4899    35
NZ_CP027599.1_1002	LIPO(Sec/SPII)	0.090999	0.015910	0.589667	0.303424	CS pos: 22-23. KVG-CD. Pr: 0.5736    28
NZ_CP027599.1_1010	LIPO(Sec/SPII)	0.208699	0.007917	0.446884	0.336500	CS pos: ?. Probable protein fragment    18
NZ_CP027599.1_1019	SP(Sec/SPI)	0.830168	0.001672	0.038305	0.129854	CS pos: 18-19. VRS-QP. Pr: 0.7704    44
NZ_CP027599.1_1034	LIPO(Sec/SPII)	0.209588	0.008158	0.473475	0.308780	CS pos: 16-17. TSG-CF. Pr: 0.2112    23
NZ_CP027599.1_1054	LIPO(Sec/SPII)	0.178366	0.019456	0.695651	0.106527	CS pos: 21-22. GSG-CF. Pr: 0.6927    37
NZ_CP027599.1_1073	SP(Sec/SPI)	0.541706	0.015820	0.083508	0.358966	CS pos: 18-19. NNA-SP. Pr: 0.3283    28
NZ_CP027599.1_1102	TAT(Tat/SPI)	0.353017	0.453466	0.039964	0.153553	CS pos: 33-34. ASA-GS. Pr: 0.4139    42
NZ_CP027599.1_1104	SP(Sec/SPI)	0.481308	0.036775	0.360082	0.121835	CS pos: 29-30. VAA-QP. Pr: 0.2401    43
NZ_CP027599.1_1107	TAT(Tat/SPI)	0.154104	0.464891	0.144791	0.236214	CS pos: 30-31. VSA-SF. Pr: 0.3182    47
NZ_CP027599.1_1112	SP(Sec/SPI)	0.423003	0.211262	0.070148	0.295587	CS pos: 24-25. ALA-TP. Pr: 0.3001    32
NZ_CP027599.1_1147	LIPO(Sec/SPII)	0.107051	0.003091	0.740682	0.149176	CS pos: 17-18. QGN-CS. Pr: 0.2934    28
NZ_CP027599.1_1176	LIPO(Sec/SPII)	0.186094	0.017503	0.564070	0.232333	CS pos: 21-22. SKS-CI. Pr: 0.4891    38
NZ_CP027599.1_1179	LIPO(Sec/SPII)	0.044397	0.001181	0.724787	0.229635	CS pos: 23-24. SGA-CY. Pr: 0.6480    44
NZ_CP027599.1_1181	LIPO(Sec/SPII)	0.222217	0.018827	0.386799	0.372157	CS pos: ?. Probable protein fragment    16
NZ_CP027599.1_1235	LIPO(Sec/SPII)	0.135792	0.034733	0.472178	0.357297	CS pos: 17-18. LAV-CS. Pr: 0.3876    23
NZ_CP027599.1_1244	LIPO(Sec/SPII)	0.096579	0.022086	0.453654	0.427681	CS pos: 18-19. IAN-CS. Pr: 0.4322    38
NZ_CP027599.1_1253	SP(Sec/SPI)	0.432885	0.102534	0.120402	0.344180	CS pos: 18-19. ARS-ST. Pr: 0.1386    28
NZ_CP027599.1_1258	SP(Sec/SPI)	0.407711	0.074115	0.214064	0.304110	CS pos: 16-17. TRA-NQ. Pr: 0.2273    21
NZ_CP027599.1_1262	LIPO(Sec/SPII)	0.165939	0.019896	0.585153	0.229013	CS pos: 21-22. AAS-CT. Pr: 0.4892    23
NZ_CP027599.1_1265	SP(Sec/SPI)	0.462404	0.269988	0.076225	0.191383	CS pos: 22-23. SGA-EE. Pr: 0.2502    37
NZ_CP027599.1_1288	SP(Sec/SPI)	0.393410	0.004640	0.381904	0.220046	CS pos: 23-24. CYV-SP. Pr: 0.0835    26
NZ_CP027599.1_1327	SP(Sec/SPI)	0.439147	0.033038	0.129157	0.398658	CS pos: 18-19. INS-DS. Pr: 0.0937    39
NZ_CP027599.1_1334	LIPO(Sec/SPII)	0.238573	0.004519	0.578129	0.178780	CS pos: 14-15. LVT-CH. Pr: 0.5123    23
NZ_CP027599.1_1351	LIPO(Sec/SPII)	0.176337	0.013637	0.634610	0.175416	CS pos: 14-15. APA-CS. Pr: 0.5787    24
NZ_CP027599.1_1404	LIPO(Sec/SPII)	0.175048	0.020443	0.424732	0.379777	CS pos: 17-18. MIT-CS. Pr: 0.2666    19
NZ_CP027599.1_1412	SP(Sec/SPI)	0.453603	0.081059	0.278099	0.187239	CS pos: 11-12. SYA-SS. Pr: 0.2727    31
NZ_CP027599.1_1449	SP(Sec/SPI)	0.547301	0.021595	0.169650	0.261454	CS pos: 16-17. VNA-MT. Pr: 0.3312    22
NZ_CP027599.1_1452	LIPO(Sec/SPII)	0.019273	0.000375	0.912752	0.067599	CS pos: 13-14. LWG-CL. Pr: 0.8994    20
NZ_CP027599.1_1504	LIPO(Sec/SPII)	0.166301	0.029483	0.438392	0.365824	CS pos: ?. Probable protein fragment    17
NZ_CP027599.1_1541	TAT(Tat/SPI)	0.127011	0.761264	0.026670	0.085055	CS pos: 25-26. AAA-ET. Pr: 0.5330    37
NZ_CP027599.1_1546	SP(Sec/SPI)	0.677484	0.076285	0.147170	0.099062	CS pos: 27-28. ASA-YP. Pr: 0.5735    41
NZ_CP027599.1_1562	LIPO(Sec/SPII)	0.245077	0.011068	0.409441	0.334413	CS pos: 15-16. PCA-IR. Pr: 0.0233    17
NZ_CP027599.1_1582	LIPO(Sec/SPII)	0.187150	0.003414	0.623187	0.186249	CS pos: ?. Probable protein fragment    17
NZ_CP027599.1_1605	LIPO(Sec/SPII)	0.396374	0.020353	0.548375	0.034898	CS pos: 24-25. LSA-AP. Pr: 0.4974    50
NZ_CP027599.1_1606	SP(Sec/SPI)	0.527907	0.066126	0.057529	0.348438	CS pos: 21-22. ASA-SI. Pr: 0.4431    26
NZ_CP027599.1_1613	SP(Sec/SPI)	0.732926	0.078264	0.049670	0.139139	CS pos: 24-25. AEA-MV. Pr: 0.4358    35
NZ_CP027599.1_1621	SP(Sec/SPI)	0.508655	0.030195	0.203578	0.257571	CS pos: 22-23. STA-IN. Pr: 0.3580    30
NZ_CP027599.1_1642	LIPO(Sec/SPII)	0.166324	0.080403	0.388879	0.364394	CS pos: 14-15. ATG-CV. Pr: 0.2848    17
NZ_CP027599.1_1661	LIPO(Sec/SPII)	0.148628	0.007286	0.780226	0.063860	CS pos: 22-23. AFA-CD. Pr: 0.8773    27
NZ_CP027599.1_1665	SP(Sec/SPI)	0.389643	0.174790	0.121801	0.313766	CS pos: 30-31. DDA-AF. Pr: 0.1717    50
NZ_CP027599.1_1670	SP(Sec/SPI)	0.403844	0.185853	0.055030	0.355273	CS pos: 18-19. ARG-AY. Pr: 0.2883    42
NZ_CP027599.1_1688	LIPO(Sec/SPII)	0.216798	0.005449	0.630930	0.146823	CS pos: 22-23. YSG-CL. Pr: 0.6059    29
NZ_CP027599.1_1701	LIPO(Sec/SPII)	0.047839	0.011216	0.579960	0.360985	CS pos: 16-17. VLA-CC. Pr: 0.3890    46
NZ_CP027599.1_1755	LIPO(Sec/SPII)	0.029406	0.013144	0.832094	0.125355	CS pos: 24-25. LFG-CV. Pr: 0.6204    50
NZ_CP027599.1_1777	LIPO(Sec/SPII)	0.327650	0.019670	0.341099	0.311581	CS pos: 15-16. CRA-FT. Pr: 0.0768    17
NZ_CP027599.1_1781	LIPO(Sec/SPII)	0.212613	0.022027	0.519986	0.245374	CS pos: ?. Probable protein fragment    16
NZ_CP027599.1_1803	SP(Sec/SPI)	0.457556	0.010332	0.112044	0.420069	CS pos: 25-26. VHS-WR. Pr: 0.3756    30
NZ_CP027599.1_1805	LIPO(Sec/SPII)	0.113331	0.008241	0.710863	0.167566	CS pos: 18-19. TDA-CA. Pr: 0.6467    29
NZ_CP027599.1_1843	SP(Sec/SPI)	0.553148	0.041887	0.104856	0.300109	CS pos: 22-23. TSA-HP. Pr: 0.3611    47
NZ_CP027599.1_1845	LIPO(Sec/SPII)	0.075067	0.002043	0.508160	0.414730	CS pos: 14-15. VFS-CG. Pr: 0.4813    35
NZ_CP027599.1_1846	SP(Sec/SPI)	0.354240	0.222219	0.216048	0.207492	CS pos: 27-28. VRA-GR. Pr: 0.3114    40
NZ_CP027599.1_1889	LIPO(Sec/SPII)	0.059457	0.003623	0.749716	0.187205	CS pos: 30-31. VIS-CC. Pr: 0.6175    42
NZ_CP027599.1_1921	LIPO(Sec/SPII)	0.203809	0.035331	0.384744	0.376116	CS pos: ?. Probable protein fragment    22
NZ_CP027599.1_1946	LIPO(Sec/SPII)	0.299453	0.015786	0.445228	0.239533	CS pos: ?. Probable protein fragment    15
NZ_CP027599.1_1979	SP(Sec/SPI)	0.501959	0.069130	0.030345	0.398565	CS pos: 28-29. LYA-SD. Pr: 0.5086    35
NZ_CP027599.1_1994	SP(Sec/SPI)	0.624637	0.039523	0.011308	0.324532	CS pos: 20-21. AFA-DF. Pr: 0.6057    41
NZ_CP027599.1_2029	LIPO(Sec/SPII)	0.304437	0.057139	0.337919	0.300506	CS pos: 13-14. FLS-CA. Pr: 0.1808    24
NZ_CP027599.1_2039	LIPO(Sec/SPII)	0.284599	0.020900	0.384736	0.309765	CS pos: ?. Probable protein fragment    16
NZ_CP027599.1_2043	SP(Sec/SPI)	0.762010	0.007747	0.079722	0.150520	CS pos: 18-19. AIA-MP. Pr: 0.6513    30
NZ_CP027599.1_2057	SP(Sec/SPI)	0.356269	0.254731	0.081628	0.307373	CS pos: 38-39. ASA-LT. Pr: 0.1912    49
NZ_CP027599.1_2091	LIPO(Sec/SPII)	0.197109	0.030859	0.446651	0.325381	CS pos: 11-12. ASG-CL. Pr: 0.3870    18
NZ_CP027599.1_2100	LIPO(Sec/SPII)	0.088729	0.020249	0.478306	0.412716	CS pos: 28-29. SSG-CL. Pr: 0.4220    37
NZ_CP027599.1_2110	SP(Sec/SPI)	0.608581	0.000815	0.027504	0.363101	CS pos: 17-18. LHG-DF. Pr: 0.5903    42
NZ_CP027599.1_2119	LIPO(Sec/SPII)	0.056834	0.011178	0.907993	0.023994	CS pos: 19-20. ISS-CP. Pr: 0.9045    34
NZ_CP027599.1_2123	SP(Sec/SPI)	0.836981	0.016065	0.118852	0.028102	CS pos: 21-22. VSS-AE. Pr: 0.4647    30
NZ_CP027599.1_2140	LIPO(Sec/SPII)	0.175550	0.101320	0.364465	0.358664	CS pos: 36-37. ALS-CC. Pr: 0.2440    41
NZ_CP027599.1_2148	SP(Sec/SPI)	0.548012	0.001740	0.298386	0.151862	CS pos: 17-18. CAA-NN. Pr: 0.4068    29
NZ_CP027599.1_2180	LIPO(Sec/SPII)	0.075097	0.006970	0.510958	0.406975	CS pos: 14-15. VTG-CG. Pr: 0.4880    32
NZ_CP027599.1_2181	LIPO(Sec/SPII)	0.152748	0.269034	0.300706	0.277512	CS pos: 16-17. AVS-CS. Pr: 0.2720    30
NZ_CP027599.1_2184	TAT(Tat/SPI)	0.178851	0.555941	0.045377	0.219832	CS pos: 26-27. RWC-SG. Pr: 0.0853    32
NZ_CP027599.1_2200	LIPO(Sec/SPII)	0.256312	0.024949	0.374282	0.344457	CS pos: ?. Probable protein fragment    16
NZ_CP027599.1_2210	SP(Sec/SPI)	0.452300	0.055666	0.166273	0.325761	CS pos: 20-21. AKM-AS. Pr: 0.0908    25
NZ_CP027599.1_2228	LIPO(Sec/SPII)	0.113640	0.008290	0.636534	0.241537	CS pos: 19-20. LSA-CC. Pr: 0.5313    24
NZ_CP027599.1_2246	LIPO(Sec/SPII)	0.255172	0.009612	0.437059	0.298156	CS pos: ?. Probable protein fragment    16
NZ_CP027599.1_2254	LIPO(Sec/SPII)	0.241295	0.013989	0.376919	0.367796	CS pos: 13-14. CFN-CA. Pr: 0.0984    15
NZ_CP027599.1_2260	LIPO(Sec/SPII)	0.235905	0.011521	0.483446	0.269128	CS pos: 13-14. WET-CA. Pr: 0.2474    20
NZ_CP027599.1_2266	SP(Sec/SPI)	0.585338	0.038663	0.217224	0.158775	CS pos: 16-17. AFA-ST. Pr: 0.4534    18
NZ_CP027599.1_2273	LIPO(Sec/SPII)	0.401575	0.013070	0.446987	0.138368	CS pos: 22-23. KQS-CY. Pr: 0.3331    39
NZ_CP027599.1_2286	SP(Sec/SPI)	0.658888	0.038781	0.163106	0.139225	CS pos: 18-19. ALT-SA. Pr: 0.2096    28
NZ_CP027599.1_2304	LIPO(Sec/SPII)	0.207470	0.016592	0.441858	0.334080	CS pos: 15-16. WQC-CW. Pr: 0.1179    18
NZ_CP027599.1_2307	LIPO(Sec/SPII)	0.048071	0.010716	0.822772	0.118442	CS pos: 16-17. IAG-CF. Pr: 0.8228    41
NZ_CP027599.1_2309	SP(Sec/SPI)	0.419859	0.113279	0.048263	0.418599	CS pos: 13-14. STA-AP. Pr: 0.2128    27
NZ_CP027599.1_2313	LIPO(Sec/SPII)	0.271212	0.023317	0.363491	0.341980	CS pos: 33-34. ITG-CA. Pr: 0.1956    35
NZ_CP027599.1_2316	LIPO(Sec/SPII)	0.181180	0.014784	0.488811	0.315226	CS pos: 14-15. MRG-CQ. Pr: 0.3404    18
NZ_CP027599.1_2343	LIPO(Sec/SPII)	0.100398	0.033912	0.656068	0.209623	CS pos: 19-20. CSS-CC. Pr: 0.5214    33
NZ_CP027599.1_2370	SP(Sec/SPI)	0.734042	0.058348	0.109062	0.098547	CS pos: 20-21. AEA-GR. Pr: 0.3378    36
NZ_CP027599.1_2390	LIPO(Sec/SPII)	0.139574	0.013914	0.462503	0.384010	CS pos: 18-19. CLG-CS. Pr: 0.3412    24
NZ_CP027599.1_2394	LIPO(Sec/SPII)	0.178497	0.026242	0.647192	0.148070	CS pos: 22-23. VST-CS. Pr: 0.6440    29
NZ_CP027599.1_2438	TAT(Tat/SPI)	0.132534	0.493151	0.011905	0.362410	CS pos: 41-42. GRC-AG. Pr: 0.1713    45
NZ_CP027599.1_2445	SP(Sec/SPI)	0.360050	0.030126	0.335752	0.274071	CS pos: 18-19. LLS-EG. Pr: 0.0438    20
NZ_CP027599.1_2449	LIPO(Sec/SPII)	0.051651	0.002103	0.693676	0.252570	CS pos: 13-14. LFQ-CN. Pr: 0.6808    30
NZ_CP027599.1_2459	LIPO(Sec/SPII)	0.093288	0.007757	0.719730	0.179225	CS pos: 17-18. IFA-CH. Pr: 0.6416    19
NZ_CP027599.1_2503	LIPO(Sec/SPII)	0.250328	0.027554	0.365446	0.356672	CS pos: ?. Probable protein fragment    15
NZ_CP027599.1_2511	SP(Sec/SPI)	0.652937	0.018441	0.193486	0.135136	CS pos: ?. Probable protein fragment    23
NZ_CP027599.1_2514	SP(Sec/SPI)	0.513749	0.000753	0.188814	0.296684	CS pos: 23-24. CRA-FG. Pr: 0.4553    38
NZ_CP027599.1_2521	LIPO(Sec/SPII)	0.041260	0.130626	0.629251	0.198862	CS pos: 18-19. LSG-CS. Pr: 0.6278    45
NZ_CP027599.1_2525	LIPO(Sec/SPII)	0.197289	0.035833	0.638707	0.128171	CS pos: 23-24. LYA-CL. Pr: 0.2638    37
NZ_CP027599.1_2532	SP(Sec/SPI)	0.382157	0.038321	0.222554	0.356968	CS pos: 18-19. AQG-KS. Pr: 0.1780    25
NZ_CP027599.1_2539	SP(Sec/SPI)	0.329940	0.058455	0.311591	0.300014	CS pos: 21-22. ACA-AL. Pr: 0.0642    30
NZ_CP027599.1_2594	LIPO(Sec/SPII)	0.165560	0.031598	0.406635	0.396207	CS pos: 10-11. GVS-CT. Pr: 0.3004    29
NZ_CP027599.1_2600	TAT(Tat/SPI)	0.079748	0.544218	0.021949	0.354086	CS pos: 30-31. AAG-HL. Pr: 0.1440    40
NZ_CP027599.1_2607	LIPO(Sec/SPII)	0.215163	0.010570	0.387219	0.387048	CS pos: 17-18. NTM-CF. Pr: 0.0426    22
NZ_CP027599.1_2612	LIPO(Sec/SPII)	0.332500	0.016636	0.338278	0.312586	CS pos: 22-23. MMA-PN. Pr: 0.1566    35
NZ_CP027599.1_2639	SP(Sec/SPI)	0.496881	0.181732	0.047120	0.274267	CS pos: 21-22. AFA-AV. Pr: 0.5079    28
NZ_CP027599.1_2651	LIPO(Sec/SPII)	0.234891	0.012456	0.379867	0.372786	CS pos: 14-15. FTG-VI. Pr: 0.0173    17
NZ_CP027599.1_2658	LIPO(Sec/SPII)	0.132638	0.009798	0.460073	0.397491	CS pos: ?. Probable protein fragment    18
NZ_CP027599.1_2710	SP(Sec/SPI)	0.551619	0.070795	0.092873	0.284713	CS pos: 20-21. PHA-NG. Pr: 0.1837    23
NZ_CP027599.1_2714	LIPO(Sec/SPII)	0.171689	0.063055	0.556442	0.208814	CS pos: 14-15. AFS-CS. Pr: 0.4915    18
NZ_CP027599.1_2744	SP(Sec/SPI)	0.471454	0.108639	0.063403	0.356503	CS pos: 26-27. ATA-TI. Pr: 0.3727    28
NZ_CP027599.1_2776	SP(Sec/SPI)	0.428701	0.219471	0.052292	0.299535	CS pos: 20-21. ATA-EP. Pr: 0.3399    35
NZ_CP027599.1_2794	LIPO(Sec/SPII)	0.141910	0.030768	0.432487	0.394836	CS pos: 13-14. QVA-CA. Pr: 0.3342    17
NZ_CP027599.1_2833	SP(Sec/SPI)	0.401712	0.127272	0.079048	0.391968	CS pos: 23-24. TWA-RS. Pr: 0.2206    44
NZ_CP027599.1_2835	LIPO(Sec/SPII)	0.256904	0.015566	0.492587	0.234943	CS pos: 17-18. ALC-CF. Pr: 0.2781    23
NZ_CP027599.1_2854	LIPO(Sec/SPII)	0.343236	0.008920	0.631713	0.016131	CS pos: 15-16. FCG-SI. Pr: 0.2880    41
NZ_CP027599.1_2855	SP(Sec/SPI)	0.356539	0.003581	0.309054	0.330826	CS pos: 18-19. RFA-TF. Pr: 0.1296    25
NZ_CP027599.1_2861	LIPO(Sec/SPII)	0.198034	0.051067	0.492323	0.258577	CS pos: 21-22. SSP-CS. Pr: 0.4167    27
NZ_CP027599.1_2865	SP(Sec/SPI)	0.624506	0.006819	0.158336	0.210339	CS pos: 32-33. LHG-TD. Pr: 0.5016    45
NZ_CP027599.1_2866	SP(Sec/SPI)	0.500548	0.007400	0.438537	0.053514	CS pos: 28-29. AFA-AC. Pr: 0.4471    31
NZ_CP027599.1_2879	LIPO(Sec/SPII)	0.174334	0.067175	0.392566	0.365925	CS pos: 23-24. VQS-CV. Pr: 0.3737    25
NZ_CP027599.1_2998	LIPO(Sec/SPII)	0.321237	0.004995	0.461706	0.212062	CS pos: 17-18. LSS-RN. Pr: 0.3409    35
NZ_CP027599.1_3005	LIPO(Sec/SPII)	0.186381	0.013776	0.506233	0.293610	CS pos: 16-17. RCG-CF. Pr: 0.3568    19
NZ_CP027599.1_3056	SP(Sec/SPI)	0.527621	0.004724	0.411673	0.055983	CS pos: 19-20. SGA-EE. Pr: 0.3500    23
NZ_CP027599.1_3084	TAT(Tat/SPI)	0.108944	0.454799	0.013111	0.423146	CS pos: 26-27. TRA-ES. Pr: 0.2501    33
NZ_CP027599.1_3095	TAT(Tat/SPI)	0.043665	0.924753	0.007108	0.024475	CS pos: 25-26. AYS-ES. Pr: 0.6238    37
NZ_CP027599.1_3098	SP(Sec/SPI)	0.382094	0.083089	0.269931	0.264887	CS pos: ?. Probable protein fragment    22
NZ_CP027599.1_3115	SP(Sec/SPI)	0.427583	0.063970	0.327927	0.180519	CS pos: 17-18. VAS-AP. Pr: 0.1376    48
NZ_CP027599.1_3150	LIPO(Sec/SPII)	0.163954	0.076805	0.469910	0.289331	CS pos: 15-16. CAS-CG. Pr: 0.3578    22
NZ_CP027599.1_3173	TAT(Tat/SPI)	0.100615	0.416936	0.076304	0.406146	CS pos: 22-23. ASA-EF. Pr: 0.0468    27
NZ_CP027599.1_3176	TAT(Tat/SPI)	0.075109	0.500710	0.013569	0.410612	CS pos: 33-34. ASA-KI. Pr: 0.3239    50
NZ_CP027599.1_3187	SP(Sec/SPI)	0.443632	0.023896	0.215979	0.316493	CS pos: 22-23. ARC-WE. Pr: 0.2277    30
NZ_CP027599.1_3193	SP(Sec/SPI)	0.409196	0.029910	0.199805	0.361088	CS pos: 14-15. SVA-GD. Pr: 0.1884    19
NZ_CP027599.1_3217	LIPO(Sec/SPII)	0.252271	0.025105	0.450516	0.272109	CS pos: ?. Probable protein fragment    19
NZ_CP027599.1_3229	LIPO(Sec/SPII)	0.226046	0.038483	0.581400	0.154071	CS pos: 15-16. VSS-CH. Pr: 0.5563    22
NZ_CP027599.1_3235	LIPO(Sec/SPII)	0.372871	0.020022	0.586842	0.020266	CS pos: 20-21. SSS-CI. Pr: 0.5692    30
NZ_CP027599.1_3248	SP(Sec/SPI)	0.472545	0.002128	0.079116	0.446212	CS pos: 19-20. GLA-PD. Pr: 0.3178    32
NZ_CP027599.1_3253	SP(Sec/SPI)	0.345124	0.019299	0.342262	0.293314	CS pos: 16-17. VFP-QA. Pr: 0.0493    18
NZ_CP027599.1_3260	LIPO(Sec/SPII)	0.241202	0.018978	0.388387	0.351433	CS pos: 22-23. TRS-CW. Pr: 0.3457    33
NZ_CP027599.1_3301	LIPO(Sec/SPII)	0.099966	0.009954	0.520394	0.369686	CS pos: 33-34. LAG-CN. Pr: 0.4786    48
NZ_CP027599.1_3311	LIPO(Sec/SPII)	0.169416	0.082507	0.405725	0.342352	CS pos: 18-19. SAG-CI. Pr: 0.2798    20
NZ_CP027599.1_3330	LIPO(Sec/SPII)	0.101770	0.034240	0.466859	0.397131	CS pos: 21-22. SAG-CQ. Pr: 0.4432    29
NZ_CP027599.1_3340	SP(Sec/SPI)	0.378897	0.016698	0.264655	0.339750	CS pos: 14-15. CWA-ND. Pr: 0.1189    18
NZ_CP027599.1_3357	LIPO(Sec/SPII)	0.060104	0.004664	0.557895	0.377337	CS pos: 22-23. IRA-CR. Pr: 0.4598    42
NZ_CP027599.1_3360	TAT(Tat/SPI)	0.233773	0.411783	0.009665	0.344779	CS pos: 26-27. AYS-GV. Pr: 0.4374    44
NZ_CP027599.1_3361	SP(Sec/SPI)	0.331466	0.036897	0.329980	0.301657	CS pos: ?. Probable protein fragment    15
NZ_CP027599.1_3372	LIPO(Sec/SPII)	0.057256	0.059422	0.750464	0.132858	CS pos: 26-27. AST-CT. Pr: 0.7338    43
NZ_CP027599.1_3381	LIPO(Sec/SPII)	0.018789	0.029738	0.796662	0.154810	CS pos: 18-19. LQA-CQ. Pr: 0.8168    43
NZ_CP027599.1_3404	LIPO(Sec/SPII)	0.313033	0.018529	0.515755	0.152682	CS pos: 18-19. LIS-TA. Pr: 0.2341    45
NZ_CP027599.1_3423	SP(Sec/SPI)	0.426630	0.087141	0.082621	0.403608	CS pos: 19-20. CSA-AP. Pr: 0.3249    39
NZ_CP027599.1_3424	LIPO(Sec/SPII)	0.107805	0.057763	0.537614	0.296818	CS pos: 15-16. ALN-CT. Pr: 0.4714    22
NZ_CP027599.1_3447	TAT(Tat/SPI)	0.275516	0.309984	0.117104	0.297397	CS pos: 27-28. LRP-VD. Pr: 0.0364    30
NZ_CP027599.1_3448	LIPO(Sec/SPII)	0.126939	0.042275	0.581077	0.249709	CS pos: 19-20. SIS-CW. Pr: 0.4775    46
NZ_CP027599.1_3449	SP(Sec/SPI)	0.409615	0.080406	0.156006	0.353973	CS pos: ?. Probable protein fragment    25
NZ_CP027599.1_3453	TAT(Tat/SPI)	0.133582	0.784323	0.056118	0.025977	CS pos: 22-23. SSA-WE. Pr: 0.5441    49
NZ_CP027599.1_3466	LIPO(Sec/SPII)	0.041660	0.008911	0.903945	0.045485	CS pos: 18-19. IAA-CA. Pr: 0.8917    39
NZ_CP027599.1_3471	SP(Sec/SPI)	0.417716	0.175386	0.051375	0.355524	CS pos: 18-19. AEA-AS. Pr: 0.1866    37
NZ_CP027599.1_3483	LIPO(Sec/SPII)	0.279334	0.112564	0.475251	0.132852	CS pos: 21-22. APS-CS. Pr: 0.3859    25
NZ_CP027599.1_3579	SP(Sec/SPI)	0.696044	0.044472	0.078600	0.180884	CS pos: 20-21. ASA-LA. Pr: 0.2254    24
NZ_CP027599.1_3604	SP(Sec/SPI)	0.476828	0.013546	0.377812	0.131815	CS pos: 19-20. VSA-WD. Pr: 0.3304    24
NZ_CP027599.1_3614	SP(Sec/SPI)	0.678064	0.016549	0.111927	0.193460	CS pos: 19-20. ANS-WP. Pr: 0.5260    23
NZ_CP027599.1_3620	LIPO(Sec/SPII)	0.018250	0.005745	0.941441	0.034563	CS pos: 19-20. ISA-CI. Pr: 0.9413    31
NZ_CP027599.1_3623	TAT(Tat/SPI)	0.091709	0.477644	0.038388	0.392259	CS pos: 29-30. LSA-RR. Pr: 0.1066    36
NZ_CP027599.1_3655	LIPO(Sec/SPII)	0.111162	0.051675	0.666445	0.170718	CS pos: 26-27. SLA-CA. Pr: 0.6095    32
NZ_CP027599.1_3661	LIPO(Sec/SPII)	0.095094	0.025080	0.488498	0.391328	CS pos: 21-22. TKT-CC. Pr: 0.2868    41
NZ_CP027599.1_3666	LIPO(Sec/SPII)	0.172131	0.009476	0.479683	0.338709	CS pos: 15-16. ATP-CR. Pr: 0.3552    18
NZ_CP027599.1_3711	TAT(Tat/SPI)	0.306853	0.347757	0.023017	0.322373	CS pos: 29-30. VRA-AP. Pr: 0.5254    36
NZ_CP027599.1_3713	LIPO(Sec/SPII)	0.268562	0.013873	0.429758	0.287808	CS pos: 17-18. TGG-CS. Pr: 0.0906    26
NZ_CP027599.1_3730	SP(Sec/SPI)	0.378850	0.060023	0.191412	0.369715	CS pos: 18-19. ASA-SG. Pr: 0.1966    21
NZ_CP027599.1_3753	LIPO(Sec/SPII)	0.366014	0.009445	0.452951	0.171590	CS pos: 10-11. LSG-CY. Pr: 0.2800    19
NZ_CP027599.1_3759	LIPO(Sec/SPII)	0.204176	0.044227	0.458913	0.292684	CS pos: 9-10. LTS-CS. Pr: 0.3094    15
NZ_CP027599.1_3776	SP(Sec/SPI)	0.472769	0.069323	0.164699	0.293209	CS pos: 26-27. PSA-GV. Pr: 0.1218    30
NZ_CP027599.1_3780	LIPO(Sec/SPII)	0.123448	0.016136	0.458249	0.402167	CS pos: 14-15. SCS-CG. Pr: 0.2897    25
NZ_CP027599.1_3798	LIPO(Sec/SPII)	0.187029	0.041479	0.630129	0.141363	CS pos: 20-21. VLA-CS. Pr: 0.6359    28
NZ_CP027599.1_3811	SP(Sec/SPI)	0.381783	0.056624	0.200677	0.360917	CS pos: ?. Probable protein fragment    19
NZ_CP027599.1_3839	LIPO(Sec/SPII)	0.244472	0.118020	0.326614	0.310894	CS pos: ?. Probable protein fragment    15
NZ_CP027599.1_3869	LIPO(Sec/SPII)	0.044677	0.062179	0.780925	0.112219	CS pos: 16-17. GAA-CS. Pr: 0.7774    35
NZ_CP027599.1_3905	SP(Sec/SPI)	0.363974	0.032166	0.333553	0.270308	CS pos: 15-16. CRG-HS. Pr: 0.0860    17
NZ_CP027599.1_3915	LIPO(Sec/SPII)	0.144073	0.031694	0.631181	0.193052	CS pos: 17-18. IPG-CR. Pr: 0.4983    19
NZ_CP027599.1_3927	LIPO(Sec/SPII)	0.036017	0.004710	0.703032	0.256241	CS pos: 19-20. IFA-CG. Pr: 0.6877    43
NZ_CP027599.1_3932	LIPO(Sec/SPII)	0.084505	0.011208	0.481206	0.423082	CS pos: 14-15. ATG-CC. Pr: 0.4278    28
NZ_CP027599.1_3939	LIPO(Sec/SPII)	0.030559	0.001035	0.961280	0.007126	CS pos: 17-18. VLA-CQ. Pr: 0.9654    25
NZ_CP027599.1_3988	LIPO(Sec/SPII)	0.239551	0.008426	0.386474	0.365549	CS pos: 19-20. GFC-YL. Pr: 0.0217    22
NZ_CP027599.1_4006	LIPO(Sec/SPII)	0.130400	0.013449	0.456902	0.399250	CS pos: 16-17. LNC-CW. Pr: 0.2827    24
NZ_CP027599.1_4013	LIPO(Sec/SPII)	0.037104	0.003002	0.747268	0.212626	CS pos: 20-21. LSS-CS. Pr: 0.7428    33
NZ_CP027599.1_4019	SP(Sec/SPI)	0.490788	0.011599	0.148058	0.349555	CS pos: 17-18. ADA-QG. Pr: 0.2468    27
NZ_CP027599.1_4020	LIPO(Sec/SPII)	0.313045	0.024746	0.367912	0.294298	CS pos: ?. Probable protein fragment    15
NZ_CP027599.1_4022	LIPO(Sec/SPII)	0.184713	0.025611	0.439058	0.350618	CS pos: 16-17. LYR-CF. Pr: 0.1365    18
NZ_CP027599.1_4033	SP(Sec/SPI)	0.421761	0.007138	0.333809	0.237293	CS pos: 21-22. CYA-KL. Pr: 0.3247    26
NZ_CP027599.1_4063	TAT(Tat/SPI)	0.332237	0.385024	0.031109	0.251630	CS pos: 26-27. AAA-SP. Pr: 0.5588    37
NZ_CP027599.1_4064	LIPO(Sec/SPII)	0.117326	0.014612	0.526649	0.341413	CS pos: 18-19. LTG-CR. Pr: 0.3095    33
NZ_CP027599.1_4072	SP(Sec/SPI)	0.454005	0.020072	0.107390	0.418533	CS pos: 20-21. GNC-AV. Pr: 0.3630    27
NZ_CP027599.1_4085	LIPO(Sec/SPII)	0.135621	0.070915	0.585868	0.207596	CS pos: 29-30. SAA-CG. Pr: 0.3141    35
NZ_CP027599.1_4086	LIPO(Sec/SPII)	0.210483	0.036694	0.433010	0.319812	CS pos: 12-13. PVA-CH. Pr: 0.3497    26
NZ_CP027599.1_4112	LIPO(Sec/SPII)	0.181865	0.070824	0.416734	0.330577	CS pos: 15-16. FFF-CS. Pr: 0.1192    18
NZ_CP027599.1_4116	LIPO(Sec/SPII)	0.250574	0.024574	0.443377	0.281475	CS pos: 20-21. NFS-CL. Pr: 0.3931    25
NZ_CP027599.1_4140	LIPO(Sec/SPII)	0.066993	0.004475	0.699931	0.228602	CS pos: 24-25. NAS-CK. Pr: 0.6750    37
NZ_CP027599.1_4218	LIPO(Sec/SPII)	0.163159	0.041647	0.487090	0.308104	CS pos: 13-14. VKS-CH. Pr: 0.2533    15
NZ_CP027599.1_4300	SP(Sec/SPI)	0.559515	0.008453	0.059495	0.372536	CS pos: 19-20. ALA-GV. Pr: 0.4511    35
NZ_CP027599.1_4312	SP(Sec/SPI)	0.497384	0.138299	0.039191	0.325126	CS pos: 21-22. ASA-SE. Pr: 0.5169    28
NZ_CP027599.1_4313	SP(Sec/SPI)	0.647764	0.090023	0.131491	0.130723	CS pos: 19-20. ATA-KP. Pr: 0.5656    32
NZ_CP027599.1_4319	TAT(Tat/SPI)	0.302018	0.368962	0.110114	0.218906	CS pos: 33-34. VLS-PT. Pr: 0.0309    36
NZ_CP027599.1_4333	LIPO(Sec/SPII)	0.244117	0.031205	0.644857	0.079822	CS pos: 21-22. KSS-CC. Pr: 0.3841    43
NZ_CP027599.1_4345	SP(Sec/SPI)	0.348598	0.012866	0.316263	0.322273	CS pos: ?. Probable protein fragment    21
NZ_CP027599.1_4347	LIPO(Sec/SPII)	0.229120	0.021901	0.581024	0.167955	CS pos: 21-22. ASV-CQ. Pr: 0.3651    23
NZ_CP027599.1_4360	TAT(Tat/SPI)	0.128834	0.427608	0.269507	0.174051	CS pos: ?. Probable protein fragment    20
NZ_CP027599.1_4364	SP(Sec/SPI)	0.397312	0.176632	0.115076	0.310980	CS pos: 31-32. ADA-GA. Pr: 0.3675    33
NZ_CP027599.1_4367	LIPO(Sec/SPII)	0.087761	0.014459	0.605545	0.292235	CS pos: 25-26. LHA-CW. Pr: 0.5846    32
NZ_CP027599.1_4368	SP(Sec/SPI)	0.506114	0.032204	0.254424	0.207259	CS pos: 27-28. ATA-SE. Pr: 0.1582    38
NZ_CP027599.1_4434	LIPO(Sec/SPII)	0.184608	0.040213	0.491679	0.283499	CS pos: 11-12. SAG-CC. Pr: 0.3579    15
NZ_CP027599.1_4455	LIPO(Sec/SPII)	0.270840	0.073475	0.340696	0.314988	CS pos: 17-18. CAG-RS. Pr: 0.1723    28
NZ_CP027599.1_4503	LIPO(Sec/SPII)	0.100702	0.008722	0.706273	0.184303	CS pos: ?. Probable protein fragment    19
NZ_CP027599.1_4505	LIPO(Sec/SPII)	0.336518	0.028306	0.348293	0.286883	CS pos: 15-16. LQS-AT. Pr: 0.2711    26
NZ_CP027599.1_4511	LIPO(Sec/SPII)	0.204788	0.026279	0.405507	0.363426	CS pos: 11-12. SIS-CN. Pr: 0.2826    18
NZ_CP027599.1_4595	SP(Sec/SPI)	0.537982	0.084979	0.085910	0.291130	CS pos: 17-18. AFA-GG. Pr: 0.4027    31
NZ_CP027599.1_4610	LIPO(Sec/SPII)	0.145207	0.004636	0.540791	0.309366	CS pos: 14-15. SKS-CA. Pr: 0.2983    24
NZ_CP027599.1_4656	SP(Sec/SPI)	0.385606	0.052505	0.187124	0.374764	CS pos: 22-23. SSA-AS. Pr: 0.1264    26
NZ_CP027599.1_4664	LIPO(Sec/SPII)	0.287927	0.007828	0.429758	0.274486	CS pos: 11-12. MTI-CT. Pr: 0.0589    18
NZ_CP027599.1_4680	LIPO(Sec/SPII)	0.223219	0.019274	0.437965	0.319542	CS pos: ?. Probable protein fragment    19
NZ_CP027599.1_4724	SP(Sec/SPI)	0.422763	0.032608	0.251976	0.292654	CS pos: 16-17. AHG-EC. Pr: 0.3022    19
NZ_CP027599.1_4773	LIPO(Sec/SPII)	0.158892	0.004611	0.785733	0.050764	CS pos: 26-27. SIG-CD. Pr: 0.7487    32
NZ_CP027599.1_4780	SP(Sec/SPI)	0.444074	0.018121	0.197857	0.339948	CS pos: 22-23. WFA-SS. Pr: 0.1034    27
NZ_CP027599.1_4788	SP(Sec/SPI)	0.368920	0.225774	0.041711	0.363595	CS pos: 22-23. AAA-WT. Pr: 0.1788    48
NZ_CP027599.1_4800	LIPO(Sec/SPII)	0.299931	0.031702	0.337731	0.330635	CS pos: ?. Probable protein fragment    15
NZ_CP027599.1_4812	SP(Sec/SPI)	0.389400	0.102997	0.155938	0.351664	CS pos: ?. Probable protein fragment    18
NZ_CP027599.1_4836	LIPO(Sec/SPII)	0.115850	0.015679	0.636223	0.232247	CS pos: 13-14. TCS-CG. Pr: 0.5159    20
NZ_CP027599.1_4843	SP(Sec/SPI)	0.435326	0.020653	0.206298	0.337723	CS pos: 15-16. TSG-DF. Pr: 0.2123    21
NZ_CP027599.1_4844	LIPO(Sec/SPII)	0.246222	0.045537	0.433909	0.274332	CS pos: ?. Probable protein fragment    15
NZ_CP027599.1_4854	LIPO(Sec/SPII)	0.207045	0.063922	0.378054	0.350979	CS pos: 15-16. HLA-CA. Pr: 0.3041    21
NZ_CP027599.1_4878	LIPO(Sec/SPII)	0.233316	0.025491	0.485140	0.256052	CS pos: 16-17. NAS-CP. Pr: 0.4236    20
NZ_CP027599.1_4881	SP(Sec/SPI)	0.444824	0.078570	0.081779	0.394827	CS pos: 25-26. SVA-NN. Pr: 0.0948    30
NZ_CP027599.1_4893	LIPO(Sec/SPII)	0.243106	0.014685	0.456497	0.285712	CS pos: ?. Probable protein fragment    16
NZ_CP027599.1_4935	SP(Sec/SPI)	0.562045	0.032569	0.137874	0.267512	CS pos: 18-19. VSA-NV. Pr: 0.5264    32
NZ_CP027599.1_4942	LIPO(Sec/SPII)	0.012771	0.004463	0.737356	0.245411	CS pos: 13-14. VAG-CR. Pr: 0.7423    48
NZ_CP027599.1_4945	SP(Sec/SPI)	0.562206	0.225846	0.082861	0.129088	CS pos: 27-28. ALA-TA. Pr: 0.4277    43
NZ_CP027599.1_4954	LIPO(Sec/SPII)	0.218490	0.034756	0.390968	0.355786	CS pos: 17-18. VAH-CW. Pr: 0.0691    27
NZ_CP027599.1_4957	LIPO(Sec/SPII)	0.190351	0.010632	0.510562	0.288455	CS pos: 18-19. VTF-CA. Pr: 0.2223    20
NZ_CP027599.1_4960	SP(Sec/SPI)	0.443273	0.047528	0.158212	0.350987	CS pos: 14-15. VVA-TT. Pr: 0.2479    23
NZ_CP027599.1_4965	LIPO(Sec/SPII)	0.215390	0.023762	0.550004	0.210844	CS pos: 19-20. AMA-CH. Pr: 0.6900    24
NZ_CP027599.1_4985	LIPO(Sec/SPII)	0.144090	0.029183	0.522115	0.304613	CS pos: 13-14. NAA-CV. Pr: 0.4007    15
NZ_CP027599.1_5018	LIPO(Sec/SPII)	0.200649	0.008362	0.542747	0.248242	CS pos: 13-14. YPA-CV. Pr: 0.2766    18
NZ_CP027599.1_5026	LIPO(Sec/SPII)	0.060520	0.021593	0.670146	0.247740	CS pos: 25-26. PKA-CW. Pr: 0.6127    46
NZ_CP027599.1_5031	LIPO(Sec/SPII)	0.118421	0.013668	0.788338	0.079573	CS pos: 18-19. CIS-CS. Pr: 0.7304    33
NZ_CP027599.1_5038	LIPO(Sec/SPII)	0.215321	0.066461	0.416086	0.302132	CS pos: ?. Probable protein fragment    18
NZ_CP027599.1_5044	SP(Sec/SPI)	0.444779	0.014960	0.111620	0.428641	CS pos: 16-17. TAA-FT. Pr: 0.1848    44
NZ_CP027599.1_5067	SP(Sec/SPI)	0.369732	0.033555	0.313071	0.283642	CS pos: ?. Probable protein fragment    21
NZ_CP027599.1_5071	SP(Sec/SPI)	0.336677	0.011389	0.319461	0.332473	CS pos: 20-21. IPA-TR. Pr: 0.1219    28
NZ_CP027599.1_5112	LIPO(Sec/SPII)	0.261540	0.063629	0.374896	0.299936	CS pos: ?. Probable protein fragment    15
NZ_CP027599.1_5130	LIPO(Sec/SPII)	0.196367	0.034172	0.405777	0.363683	CS pos: 14-15. VLS-CR. Pr: 0.2405    16
NZ_CP027599.1_5135	SP(Sec/SPI)	0.454671	0.292518	0.078604	0.174206	CS pos: 27-28. ATA-GA. Pr: 0.2754    33
NZ_CP027599.1_5140	LIPO(Sec/SPII)	0.308413	0.034501	0.386642	0.270444	CS pos: 23-24. TTG-AN. Pr: 0.1314    25
NZ_CP027599.1_5142	SP(Sec/SPI)	0.427883	0.006107	0.380561	0.185449	CS pos: ?. Probable protein fragment    20
NZ_CP027599.1_5146	LIPO(Sec/SPII)	0.065477	0.017358	0.669139	0.248026	CS pos: 17-18. MSG-CG. Pr: 0.6229    22
NZ_CP027599.1_5149	LIPO(Sec/SPII)	0.161508	0.058674	0.613337	0.166481	CS pos: 22-23. SIC-CR. Pr: 0.3403    37
NZ_CP027599.1_5150	LIPO(Sec/SPII)	0.020951	0.005244	0.804537	0.169268	CS pos: 13-14. LMG-CA. Pr: 0.8054    49
NZ_CP027599.1_5153	LIPO(Sec/SPII)	0.331946	0.041725	0.383990	0.242340	CS pos: 14-15. LCS-QE. Pr: 0.1829    48
NZ_CP027599.1_5158	SP(Sec/SPI)	0.691017	0.039535	0.092212	0.177237	CS pos: 30-31. TVA-KC. Pr: 0.4704    49
NZ_CP027599.1_5169	LIPO(Sec/SPII)	0.301835	0.008568	0.489904	0.199692	CS pos: 20-21. SLQ-CC. Pr: 0.2425    25
NZ_CP027599.1_5173	LIPO(Sec/SPII)	0.196837	0.049295	0.601913	0.151955	CS pos: 17-18. TVS-CT. Pr: 0.5257    29
NZ_CP027599.1_5225	LIPO(Sec/SPII)	0.127395	0.014117	0.445889	0.412599	CS pos: 15-16. TIT-CR. Pr: 0.3855    43
NZ_CP027599.1_5232	LIPO(Sec/SPII)	0.209736	0.083690	0.479697	0.226876	CS pos: 24-25. ATS-CL. Pr: 0.4560    38
NZ_CP027599.1_5234	LIPO(Sec/SPII)	0.295434	0.012808	0.404656	0.287103	CS pos: 17-18. LSS-LG. Pr: 0.0748    19
NZ_CP027599.1_5254	LIPO(Sec/SPII)	0.057328	0.068860	0.639687	0.234125	CS pos: 17-18. LAG-CA. Pr: 0.6339    39
NZ_CP027599.1_5257	LIPO(Sec/SPII)	0.192821	0.116920	0.390861	0.299398	CS pos: ?. Probable protein fragment    21
NZ_CP027599.1_5271	SP(Sec/SPI)	0.492152	0.149345	0.094281	0.264221	CS pos: 16-17. ISA-RV. Pr: 0.3084    43
NZ_CP027599.1_5276	LIPO(Sec/SPII)	0.126595	0.002898	0.774537	0.095970	CS pos: 13-14. LNA-CW. Pr: 0.7452    22
NZ_CP027599.1_5294	SP(Sec/SPI)	0.596463	0.119046	0.195475	0.089016	CS pos: 29-30. ISA-KA. Pr: 0.2930    41
NZ_CP027599.1_5301	LIPO(Sec/SPII)	0.017916	0.005494	0.968782	0.007807	CS pos: 30-31. VSG-CS. Pr: 0.9752    43
NZ_CP027599.1_5312	LIPO(Sec/SPII)	0.069435	0.004035	0.490471	0.436060	CS pos: 14-15. NFT-CD. Pr: 0.4570    45
NZ_CP027599.1_5313	LIPO(Sec/SPII)	0.070604	0.003612	0.710887	0.214897	CS pos: 20-21. WPG-CA. Pr: 0.6588    35
NZ_CP027599.1_5319	LIPO(Sec/SPII)	0.028059	0.001004	0.961288	0.009649	CS pos: 14-15. LIG-CP. Pr: 0.9583    34
NZ_CP027599.1_5342	SP(Sec/SPI)	0.439638	0.020767	0.219980	0.319615	CS pos: 14-15. AWS-AK. Pr: 0.1387    18
NZ_CP027599.1_5357	SP(Sec/SPI)	0.543319	0.098259	0.189305	0.169117	CS pos: 22-23. VWA-SG. Pr: 0.2577    38
NZ_CP027599.1_5376	LIPO(Sec/SPII)	0.207845	0.028715	0.449067	0.314373	CS pos: 12-13. APA-CV. Pr: 0.0484    16
NZ_CP027599.1_5412	SP(Sec/SPI)	0.561951	0.033813	0.040463	0.363773	CS pos: 21-22. ARA-SG. Pr: 0.4310    44
NZ_CP027599.1_5419	LIPO(Sec/SPII)	0.290082	0.010774	0.447194	0.251951	CS pos: 23-24. VAV-CA. Pr: 0.3677    33
NZ_CP027599.1_5423	SP(Sec/SPI)	0.455468	0.019271	0.365703	0.159558	CS pos: 19-20. VQT-VP. Pr: 0.2845    37
NZ_CP027599.1_5430	LIPO(Sec/SPII)	0.207696	0.016359	0.400082	0.375863	CS pos: 19-20. RVT-CR. Pr: 0.1305    30
NZ_CP027599.1_5433	LIPO(Sec/SPII)	0.203458	0.034301	0.506046	0.256195	CS pos: 13-14. AGG-CC. Pr: 0.3724    19
NZ_CP027599.1_5446	TAT(Tat/SPI)	0.115153	0.421304	0.086796	0.376747	CS pos: 21-22. CRL-SG. Pr: 0.0241    23
NZ_CP027599.1_5478	LIPO(Sec/SPII)	0.270276	0.031001	0.374007	0.324716	CS pos: 12-13. GIC-CT. Pr: 0.1659    17
NZ_CP027599.1_5513	SP(Sec/SPI)	0.410656	0.329492	0.066516	0.193335	CS pos: 43-44. ASA-SL. Pr: 0.5872    50
NZ_CP027599.1_5519	SP(Sec/SPI)	0.341490	0.022790	0.307743	0.327977	CS pos: 20-21. SAA-ST. Pr: 0.1396    22
NZ_CP027599.1_5525	LIPO(Sec/SPII)	0.206601	0.185801	0.358645	0.248953	CS pos: 14-15. GLR-CG. Pr: 0.1381    17
NZ_CP027599.1_5560	LIPO(Sec/SPII)	0.053037	0.024848	0.904292	0.017823	CS pos: 12-13. SIA-CS. Pr: 0.9022    49
NZ_CP027599.1_5593	LIPO(Sec/SPII)	0.239586	0.011515	0.462135	0.286763	CS pos: ?. Probable protein fragment    19
NZ_CP027599.1_5597	SP(Sec/SPI)	0.346121	0.028184	0.290124	0.335571	CS pos: 15-16. ARA-VV. Pr: 0.1556    24
NZ_CP027599.1_5606	SP(Sec/SPI)	0.426342	0.015027	0.269948	0.288683	CS pos: 29-30. AIC-SL. Pr: 0.2078    32
NZ_CP027599.1_5616	LIPO(Sec/SPII)	0.300117	0.031870	0.450654	0.217359	CS pos: 13-14. PVI-CQ. Pr: 0.1359    15
NZ_CP027599.1_5622	SP(Sec/SPI)	0.394353	0.011125	0.240162	0.354360	CS pos: 23-24. VNS-PL. Pr: 0.0605    40
NZ_CP027599.1_5623	SP(Sec/SPI)	0.447588	0.068528	0.139653	0.344232	CS pos: 19-20. LTA-DF. Pr: 0.2532    30
NZ_CP027599.1_5665	SP(Sec/SPI)	0.412081	0.078522	0.145441	0.363956	CS pos: 15-16. ARA-SV. Pr: 0.2502    17
NZ_CP027599.1_5669	LIPO(Sec/SPII)	0.193467	0.022366	0.520983	0.263184	CS pos: 15-16. VKS-CA. Pr: 0.3643    17
NZ_CP027599.1_5703	LIPO(Sec/SPII)	0.157891	0.031255	0.501903	0.308951	CS pos: 13-14. ATA-CS. Pr: 0.5165    27
NZ_CP027599.1_5705	SP(Sec/SPI)	0.534338	0.045753	0.220002	0.199906	CS pos: 20-21. LLG-DK. Pr: 0.2447    25
NZ_CP027599.1_5706	LIPO(Sec/SPII)	0.283046	0.015316	0.411968	0.289670	CS pos: ?. Probable protein fragment    17
NZ_CP027599.1_5738	SP(Sec/SPI)	0.396205	0.034119	0.174863	0.394813	CS pos: 21-22. SNA-VP. Pr: 0.0875    30
NZ_CP027599.1_5760	TAT(Tat/SPI)	0.285972	0.461544	0.089195	0.163290	CS pos: ?. Probable protein fragment    31
NZ_CP027599.1_5778	SP(Sec/SPI)	0.468184	0.016802	0.089614	0.425400	CS pos: 24-25. AAI-FP. Pr: 0.1661    44
NZ_CP027599.1_5780	SP(Sec/SPI)	0.416760	0.034672	0.142449	0.406119	CS pos: 21-22. AIC-ST. Pr: 0.2491    29
NZ_CP027599.1_5783	SP(Sec/SPI)	0.483820	0.170522	0.137835	0.207822	CS pos: 27-28. GNA-EA. Pr: 0.1574    29
NZ_CP027599.1_5793	LIPO(Sec/SPII)	0.005074	0.000297	0.914376	0.080253	CS pos: 19-20. IIG-CG. Pr: 0.8732    43
NZ_CP027599.1_5803	TAT(Tat/SPI)	0.345154	0.347738	0.046982	0.260126	CS pos: 20-21. ARA-AS. Pr: 0.4815    30
NZ_CP027599.1_5827	LIPO(Sec/SPII)	0.149135	0.034612	0.619371	0.196882	CS pos: 18-19. TTV-CG. Pr: 0.4918    31
NZ_CP027599.1_5834	LIPO(Sec/SPII)	0.229705	0.065914	0.502411	0.201969	CS pos: ?. Probable protein fragment    23
NZ_CP027599.1_5847	SP(Sec/SPI)	0.695360	0.021929	0.186334	0.096376	CS pos: 21-22. SVS-LP. Pr: 0.1983    32
NZ_CP027599.1_5886	LIPO(Sec/SPII)	0.383494	0.021951	0.578516	0.016039	CS pos: 14-15. ITG-CW. Pr: 0.5595    35
NZ_CP027599.1_5896	SP(Sec/SPI)	0.358473	0.235376	0.097986	0.308165	CS pos: 31-32. SAA-CA. Pr: 0.0872    36
NZ_CP027599.1_5916	LIPO(Sec/SPII)	0.236500	0.019104	0.390825	0.353571	CS pos: ?. Probable protein fragment    16
NZ_CP027599.1_5922	SP(Sec/SPI)	0.756950	0.056859	0.040964	0.145227	CS pos: 22-23. SMA-LT. Pr: 0.5637    34
NZ_CP027599.1_5932	TAT(Tat/SPI)	0.298862	0.392928	0.041128	0.267081	CS pos: 27-28. ASA-QR. Pr: 0.3997    43
NZ_CP027599.1_5947	SP(Sec/SPI)	0.361810	0.118203	0.176322	0.343664	CS pos: 21-22. FMA-SP. Pr: 0.0563    25
NZ_CP027599.1_5948	TAT(Tat/SPI)	0.121399	0.396565	0.087322	0.394715	CS pos: 30-31. SHS-VT. Pr: 0.1672    46
NZ_CP027599.1_5951	SP(Sec/SPI)	0.433555	0.187511	0.142244	0.236690	CS pos: 30-31. ASA-TA. Pr: 0.2545    36
NZ_CP027599.1_5953	SP(Sec/SPI)	0.658165	0.027927	0.149849	0.164059	CS pos: 23-24. VSG-TS. Pr: 0.4659    29
NZ_CP027599.1_5956	SP(Sec/SPI)	0.632940	0.050672	0.012459	0.303929	CS pos: 22-23. ASA-MT. Pr: 0.6145    43
NZ_CP027599.1_5976	LIPO(Sec/SPII)	0.099745	0.007332	0.651575	0.241348	CS pos: 18-19. TTG-CT. Pr: 0.6457    36
NZ_CP027599.1_5984	SP(Sec/SPI)	0.789128	0.005712	0.180492	0.024668	CS pos: 23-24. IGA-AL. Pr: 0.2417    41
NZ_CP027599.1_5989	LIPO(Sec/SPII)	0.224692	0.017869	0.465909	0.291530	CS pos: 17-18. LSG-VV. Pr: 0.3301    26
NZ_CP027599.1_5998	LIPO(Sec/SPII)	0.071700	0.020076	0.695688	0.212535	CS pos: 18-19. AMA-CG. Pr: 0.6783    33
NZ_CP027599.1_6002	SP(Sec/SPI)	0.532195	0.026355	0.119623	0.321827	CS pos: 13-14. AGA-YD. Pr: 0.2285    21
NZ_CP027599.1_6023	LIPO(Sec/SPII)	0.135220	0.017465	0.510632	0.336682	CS pos: 15-16. FFG-CQ. Pr: 0.5028    46
NZ_CP027599.1_6024	SP(Sec/SPI)	0.522378	0.032192	0.061841	0.383589	CS pos: 22-23. TSA-EF. Pr: 0.3995    37
NZ_CP027599.1_6028	SP(Sec/SPI)	0.702889	0.010169	0.077322	0.209620	CS pos: 16-17. SHA-DS. Pr: 0.6349    29
NZ_CP027599.1_6037	LIPO(Sec/SPII)	0.306952	0.022446	0.370969	0.299633	CS pos: 15-16. ISG-GI. Pr: 0.0613    17
NZ_CP027599.1_6038	LIPO(Sec/SPII)	0.184305	0.120789	0.392497	0.302410	CS pos: 18-19. SGS-CG. Pr: 0.3111    22
NZ_CP027599.1_6052	SP(Sec/SPI)	0.501583	0.012730	0.048180	0.437507	CS pos: 24-25. SYA-HF. Pr: 0.4549    32
NZ_CP027599.1_6055	TAT(Tat/SPI)	0.114734	0.506413	0.038533	0.340319	CS pos: 25-26. ATG-FL. Pr: 0.1679    34
NZ_CP027599.1_6069	LIPO(Sec/SPII)	0.176926	0.059744	0.570055	0.193275	CS pos: 25-26. SSA-CQ. Pr: 0.5379    28
NZ_CP027599.1_6110	LIPO(Sec/SPII)	0.138314	0.031092	0.456865	0.373729	CS pos: ?. Probable protein fragment    16
NZ_CP027599.1_6139	SP(Sec/SPI)	0.674047	0.021505	0.110137	0.194311	CS pos: 16-17. VPA-SL. Pr: 0.3758    33
NZ_CP027599.1_6163	LIPO(Sec/SPII)	0.031879	0.000617	0.950977	0.016526	CS pos: 22-23. LSA-CW. Pr: 0.9474    29
NZ_CP027599.1_6176	LIPO(Sec/SPII)	0.143256	0.012405	0.523322	0.321016	CS pos: 18-19. IPA-CT. Pr: 0.3916    22
NZ_CP027599.1_6192	LIPO(Sec/SPII)	0.165921	0.016268	0.588780	0.229031	CS pos: ?. Probable protein fragment    15
NZ_CP027599.1_6205	TAT(Tat/SPI)	0.223585	0.264417	0.258872	0.253127	CS pos: 30-31. VYA-RK. Pr: 0.3331    36
NZ_CP027599.1_6213	SP(Sec/SPI)	0.533997	0.112684	0.094335	0.258984	CS pos: 21-22. AAA-DA. Pr: 0.2093    31
NZ_CP027599.1_6239	LIPO(Sec/SPII)	0.243832	0.018617	0.384433	0.353117	CS pos: ?. Probable protein fragment    16
NZ_CP027599.1_6241	LIPO(Sec/SPII)	0.200017	0.067646	0.469407	0.262931	CS pos: 19-20. ARS-CR. Pr: 0.3339    22
NZ_CP027599.1_6244	SP(Sec/SPI)	0.476877	0.057560	0.091875	0.373687	CS pos: 19-20. AGG-DF. Pr: 0.3197    50
NZ_CP027599.1_6259	TAT(Tat/SPI)	0.295538	0.362352	0.068924	0.273186	CS pos: ?. Probable protein fragment    35
NZ_CP027599.1_6261	TAT(Tat/SPI)	0.021981	0.941206	0.007352	0.029461	CS pos: 31-32. LRA-GR. Pr: 0.2757    48
NZ_CP027599.1_6262	LIPO(Sec/SPII)	0.114890	0.060727	0.655114	0.169268	CS pos: 18-19. ARG-CW. Pr: 0.5871    26
NZ_CP027599.1_6285	LIPO(Sec/SPII)	0.185019	0.018091	0.665840	0.131050	CS pos: 13-14. AIA-CG. Pr: 0.6419    46
NZ_CP027599.1_6300	SP(Sec/SPI)	0.487872	0.129148	0.223877	0.159103	CS pos: 21-22. ANA-CG. Pr: 0.5349    32
NZ_CP027599.1_6312	SP(Sec/SPI)	0.380078	0.068086	0.200293	0.351544	CS pos: 22-23. PQA-TK. Pr: 0.0947    24
NZ_CP027599.1_6399	SP(Sec/SPI)	0.478104	0.034544	0.340611	0.146741	CS pos: ?. Probable protein fragment    22
NZ_CP027599.1_6452	LIPO(Sec/SPII)	0.119465	0.009826	0.613302	0.257407	CS pos: 18-19. LIS-CV. Pr: 0.5167    22
NZ_CP027599.1_6482	SP(Sec/SPI)	0.406960	0.048610	0.350381	0.194050	CS pos: 28-29. ILA-SP. Pr: 0.2604    41
NZ_CP027599.1_6523	TAT(Tat/SPI)	0.112883	0.605373	0.027579	0.254164	CS pos: 23-24. THA-LR. Pr: 0.3914    40
NZ_CP027599.1_6546	SP(Sec/SPI)	0.434103	0.075134	0.138424	0.352340	CS pos: 20-21. ARA-RW. Pr: 0.3659    33
NZ_CP027599.1_6550	LIPO(Sec/SPII)	0.203806	0.032562	0.453198	0.310434	CS pos: 17-18. STC-CA. Pr: 0.1513    33
NZ_CP027599.1_6562	SP(Sec/SPI)	0.512922	0.041889	0.231974	0.213215	CS pos: 18-19. STA-SP. Pr: 0.3356    40
NZ_CP027599.1_6578	SP(Sec/SPI)	0.442048	0.255959	0.257149	0.044844	CS pos: 20-21. ARS-TK. Pr: 0.2558    38
NZ_CP027599.1_6580	LIPO(Sec/SPII)	0.246167	0.003027	0.621244	0.129562	CS pos: 20-21. WFS-CF. Pr: 0.5062    29
NZ_CP027599.1_6592	LIPO(Sec/SPII)	0.237843	0.037506	0.411133	0.313519	CS pos: 17-18. ACC-CA. Pr: 0.0563    30
NZ_CP027599.1_6597	LIPO(Sec/SPII)	0.232709	0.047534	0.383008	0.336749	CS pos: 16-17. SCS-CA. Pr: 0.1773    20
NZ_CP027599.1_6600	LIPO(Sec/SPII)	0.274670	0.063133	0.436672	0.225525	CS pos: 14-15. SAA-CG. Pr: 0.3901    21
NZ_CP027599.1_6615	LIPO(Sec/SPII)	0.114895	0.008487	0.637413	0.239205	CS pos: 19-20. QSG-CS. Pr: 0.4040    25
NZ_CP027599.1_6616	SP(Sec/SPI)	0.577766	0.084779	0.089130	0.248325	CS pos: 20-21. VYS-RA. Pr: 0.3556    29
NZ_CP027599.1_6620	LIPO(Sec/SPII)	0.292024	0.023328	0.397882	0.286765	CS pos: 15-16. ISA-PL. Pr: 0.0272    18
NZ_CP027599.1_6623	LIPO(Sec/SPII)	0.227799	0.093714	0.483773	0.194713	CS pos: 22-23. AYS-CA. Pr: 0.4498    32
NZ_CP027599.1_6626	TAT(Tat/SPI)	0.275328	0.604006	0.018352	0.102314	CS pos: 38-39. ANA-AG. Pr: 0.6356    46
NZ_CP027599.1_6667	LIPO(Sec/SPII)	0.283257	0.028322	0.370318	0.318103	CS pos: ?. Probable protein fragment    17
NZ_CP027599.1_6730	LIPO(Sec/SPII)	0.277673	0.022505	0.420887	0.278935	CS pos: 14-15. WSC-CY. Pr: 0.2324    36
NZ_CP027599.1_6783	LIPO(Sec/SPII)	0.062888	0.007934	0.801085	0.128093	CS pos: 15-16. LVS-CR. Pr: 0.7789    24
NZ_CP027599.1_6797	LIPO(Sec/SPII)	0.176526	0.003480	0.725221	0.094774	CS pos: 22-23. GYS-CS. Pr: 0.7361    28
NZ_CP027599.1_6811	SP(Sec/SPI)	0.413179	0.021519	0.237222	0.328080	CS pos: 15-16. SKS-EE. Pr: 0.1203    17
NZ_CP027599.1_6899	LIPO(Sec/SPII)	0.049253	0.001593	0.647308	0.301845	CS pos: 14-15. TIS-CL. Pr: 0.6378    30
NZ_CP027599.1_6923	LIPO(Sec/SPII)	0.319539	0.019376	0.365548	0.295538	CS pos: 13-14. NAA-LW. Pr: 0.0432    15
NZ_CP027599.1_6930	LIPO(Sec/SPII)	0.286611	0.033424	0.378248	0.301717	CS pos: ?. Probable protein fragment    16
NZ_CP027599.1_6944	SP(Sec/SPI)	0.430508	0.024141	0.298908	0.246443	CS pos: ?. Probable protein fragment    19
NZ_CP027599.1_6946	LIPO(Sec/SPII)	0.066253	0.017487	0.706808	0.209451	CS pos: 25-26. SSG-CS. Pr: 0.5798    31
NZ_CP027599.1_6972	LIPO(Sec/SPII)	0.293201	0.021002	0.399344	0.286453	CS pos: ?. Probable protein fragment    19
NZ_CP027599.1_6989	SP(Sec/SPI)	0.349457	0.050081	0.251914	0.348548	CS pos: 19-20. AIS-SD. Pr: 0.2028    21
NZ_CP027599.1_7015	SP(Sec/SPI)	0.523358	0.081566	0.072512	0.322564	CS pos: 20-21. SMA-DM. Pr: 0.3804    37
NZ_CP027599.1_7024	SP(Sec/SPI)	0.470494	0.171809	0.156265	0.201432	CS pos: 21-22. ISA-SS. Pr: 0.1631    32
NZ_CP027599.1_7037	SP(Sec/SPI)	0.454464	0.077092	0.206221	0.262222	CS pos: ?. Probable protein fragment    31
NZ_CP027599.1_7040	LIPO(Sec/SPII)	0.213127	0.023935	0.444530	0.318407	CS pos: 21-22. QSN-CE. Pr: 0.3909    33
NZ_CP027599.1_7047	LIPO(Sec/SPII)	0.263570	0.041146	0.396352	0.298932	CS pos: 18-19. ISP-CG. Pr: 0.2552    43
NZ_CP027599.1_7051	SP(Sec/SPI)	0.564347	0.158752	0.024460	0.252441	CS pos: 25-26. AHS-ER. Pr: 0.3537    41
NZ_CP027599.1_7058	TAT(Tat/SPI)	0.260169	0.348867	0.049015	0.341949	CS pos: 27-28. GRS-GW. Pr: 0.2693    36
NZ_CP027599.1_7086	LIPO(Sec/SPII)	0.224754	0.140181	0.494820	0.140246	CS pos: 14-15. GKA-CG. Pr: 0.3122    29
NZ_CP027599.1_7099	LIPO(Sec/SPII)	0.219632	0.029949	0.404576	0.345843	CS pos: ?. Probable protein fragment    16
NZ_CP027599.1_7101	LIPO(Sec/SPII)	0.177900	0.012417	0.424583	0.385101	CS pos: 17-18. SRA-CD. Pr: 0.4746    28
NZ_CP027599.1_7115	LIPO(Sec/SPII)	0.213617	0.043246	0.528337	0.214799	CS pos: 18-19. LAR-CS. Pr: 0.4128    21
NZ_CP027599.1_7116	LIPO(Sec/SPII)	0.192059	0.057850	0.403199	0.346892	CS pos: 17-18. TVF-CL. Pr: 0.0703    20
NZ_CP027599.1_7126	LIPO(Sec/SPII)	0.192138	0.015230	0.426242	0.366390	CS pos: 12-13. HLG-CT. Pr: 0.2030    18
NZ_CP027599.1_7145	LIPO(Sec/SPII)	0.078873	0.118352	0.406584	0.396191	CS pos: 20-21. AIG-CA. Pr: 0.3780    45
NZ_CP027599.1_7161	LIPO(Sec/SPII)	0.248153	0.019830	0.377927	0.354090	CS pos: 10-11. VSS-CC. Pr: 0.0655    16
NZ_CP027599.1_7162	LIPO(Sec/SPII)	0.103914	0.010818	0.635526	0.249741	CS pos: 15-16. ILC-CQ. Pr: 0.4847    28
NZ_CP027599.1_7245	LIPO(Sec/SPII)	0.141396	0.017391	0.590369	0.250843	CS pos: 15-16. GLS-CQ. Pr: 0.5734    30
NZ_CP027599.1_7251	LIPO(Sec/SPII)	0.314725	0.012024	0.382357	0.290894	CS pos: 16-17. LTP-CR. Pr: 0.2475    21
NZ_CP027599.1_7261	TAT(Tat/SPI)	0.196651	0.531185	0.027281	0.244882	CS pos: 27-28. APA-QS. Pr: 0.1867    50
NZ_CP027599.1_7287	SP(Sec/SPI)	0.568807	0.042806	0.158063	0.230324	CS pos: 23-24. ANS-ET. Pr: 0.2760    28
NZ_CP027599.1_7302	SP(Sec/SPI)	0.710401	0.024157	0.048137	0.217305	CS pos: 21-22. VDA-SN. Pr: 0.4364    31
NZ_CP027599.1_7310	LIPO(Sec/SPII)	0.202303	0.054641	0.383275	0.359781	CS pos: 15-16. QSS-CC. Pr: 0.2532    25
NZ_CP027599.1_7337	LIPO(Sec/SPII)	0.098316	0.062305	0.642782	0.196597	CS pos: 18-19. ALS-CV. Pr: 0.6461    26
NZ_CP027599.1_7417	SP(Sec/SPI)	0.666071	0.072432	0.079284	0.182213	CS pos: 25-26. ASA-MA. Pr: 0.3417    43
NZ_CP027599.1_7418	SP(Sec/SPI)	0.747185	0.022234	0.143442	0.087139	CS pos: 21-22. PFA-LS. Pr: 0.1864    23
NZ_CP027599.1_7436	SP(Sec/SPI)	0.427959	0.153444	0.276337	0.142260	CS pos: 19-20. ALS-TG. Pr: 0.2791    42
NZ_CP027599.1_7448	SP(Sec/SPI)	0.671062	0.024140	0.181281	0.123517	CS pos: 19-20. STA-SV. Pr: 0.4559    48
NZ_CP027599.1_7453	LIPO(Sec/SPII)	0.238846	0.176656	0.487601	0.096897	CS pos: 14-15. LTG-CR. Pr: 0.4663    41
NZ_CP027599.1_7550	LIPO(Sec/SPII)	0.185518	0.003784	0.612880	0.197818	CS pos: 15-16. VLV-CF. Pr: 0.5356    34
NZ_CP027599.1_7574	LIPO(Sec/SPII)	0.107994	0.012726	0.773580	0.105700	CS pos: 15-16. IGG-CA. Pr: 0.6496    18
NZ_CP027599.1_7593	LIPO(Sec/SPII)	0.253164	0.021377	0.389661	0.335797	CS pos: 15-16. LSS-HG. Pr: 0.0345    17
NZ_CP027599.1_7630	LIPO(Sec/SPII)	0.078848	0.018592	0.608674	0.293887	CS pos: 23-24. AGA-CN. Pr: 0.5942    29
NZ_CP027599.1_7643	LIPO(Sec/SPII)	0.305520	0.009409	0.421918	0.263152	CS pos: 14-15. KMC-CA. Pr: 0.2040    20
NZ_CP027599.1_7654	LIPO(Sec/SPII)	0.015636	0.005836	0.895164	0.083365	CS pos: 31-32. ISS-CS. Pr: 0.8945    47
NZ_CP027599.1_7657	LIPO(Sec/SPII)	0.024385	0.005650	0.929002	0.040963	CS pos: 21-22. VTG-CS. Pr: 0.9178    24
NZ_CP027599.1_7661	SP(Sec/SPI)	0.397762	0.066431	0.156639	0.379168	CS pos: 18-19. AWS-SH. Pr: 0.2581    25
NZ_CP027599.1_7707	SP(Sec/SPI)	0.470965	0.152729	0.106777	0.269529	CS pos: 28-29. AHP-SG. Pr: 0.0854    37
NZ_CP027599.1_7721	SP(Sec/SPI)	0.361000	0.158846	0.124862	0.355292	CS pos: 21-22. RYA-GY. Pr: 0.4038    40
NZ_CP027599.1_7743	SP(Sec/SPI)	0.702335	0.010431	0.064582	0.222652	CS pos: 18-19. VAA-HM. Pr: 0.3628    35
NZ_CP027599.1_7793	SP(Sec/SPI)	0.664937	0.040570	0.052496	0.241997	CS pos: 21-22. TLG-FP. Pr: 0.2849    34
NZ_CP027599.1_7807	SP(Sec/SPI)	0.464460	0.021198	0.054803	0.459540	CS pos: 28-29. SWS-MH. Pr: 0.3097    33
NZ_CP027599.1_7834	SP(Sec/SPI)	0.342051	0.014202	0.311431	0.332317	CS pos: ?. Probable protein fragment    17
NZ_CP027599.1_7845	LIPO(Sec/SPII)	0.160277	0.016768	0.598532	0.224422	CS pos: 14-15. AAG-CL. Pr: 0.5139    19
NZ_CP027599.1_7880	LIPO(Sec/SPII)	0.260093	0.020074	0.363077	0.356755	CS pos: 15-16. ICP-CR. Pr: 0.1550    18
NZ_CP027599.1_7951	LIPO(Sec/SPII)	0.013580	0.002477	0.959765	0.024178	CS pos: 15-16. LAS-CW. Pr: 0.9594    35
NZ_CP027599.1_7994	LIPO(Sec/SPII)	0.336327	0.021518	0.415058	0.227096	CS pos: ?. Probable protein fragment    18
NZ_CP027599.1_8001	LIPO(Sec/SPII)	0.087961	0.027029	0.487889	0.397121	CS pos: 25-26. SGS-CT. Pr: 0.3879    39
NZ_CP027599.1_8002	LIPO(Sec/SPII)	0.294059	0.103268	0.437426	0.165247	CS pos: ?. Probable protein fragment    16
NZ_CP027599.1_8028	TAT(Tat/SPI)	0.353923	0.421798	0.024030	0.200250	CS pos: 25-26. ISA-IE. Pr: 0.6805    45
NZ_CP027599.1_8032	SP(Sec/SPI)	0.449367	0.085823	0.207443	0.257367	CS pos: 27-28. AAG-QA. Pr: 0.2187    36
NZ_CP027599.1_8040	SP(Sec/SPI)	0.494819	0.087893	0.190442	0.226846	CS pos: 17-18. SFA-SN. Pr: 0.3452    25
NZ_CP027599.1_8055	LIPO(Sec/SPII)	0.060422	0.018624	0.520304	0.400649	CS pos: 17-18. SVG-CW. Pr: 0.4834    31
NZ_CP027599.1_8067	LIPO(Sec/SPII)	0.145484	0.012852	0.665371	0.176294	CS pos: 13-14. FSA-CN. Pr: 0.5783    18
NZ_CP027599.1_8073	LIPO(Sec/SPII)	0.310681	0.037661	0.381971	0.269687	CS pos: 18-19. TSA-MS. Pr: 0.0676    21
NZ_CP027599.1_8081	LIPO(Sec/SPII)	0.251858	0.027746	0.382827	0.337570	CS pos: ?. Probable protein fragment    16
NZ_CP027599.1_8082	LIPO(Sec/SPII)	0.020928	0.001422	0.915271	0.062378	CS pos: 24-25. LVA-CA. Pr: 0.9048    36
NZ_CP027599.1_8085	LIPO(Sec/SPII)	0.249293	0.012549	0.398001	0.340157	CS pos: 19-20. LCS-VN. Pr: 0.0127    21
NZ_CP027599.1_8097	LIPO(Sec/SPII)	0.071668	0.003872	0.750664	0.173796	CS pos: 20-21. FHG-CR. Pr: 0.7256    36
NZ_CP027599.1_8108	LIPO(Sec/SPII)	0.261225	0.051053	0.392729	0.294994	CS pos: 14-15. LRC-CG. Pr: 0.1279    32
NZ_CP027599.1_8109	SP(Sec/SPI)	0.493332	0.089281	0.295064	0.122323	CS pos: 16-17. ASA-AT. Pr: 0.2639    38
NZ_CP027599.1_8110	SP(Sec/SPI)	0.397114	0.014080	0.276703	0.312103	CS pos: 20-21. VTA-NT. Pr: 0.1800    32
NZ_CP027599.1_8111	LIPO(Sec/SPII)	0.063075	0.005075	0.725992	0.205858	CS pos: 14-15. MSG-CW. Pr: 0.7050    27
NZ_CP027599.1_8117	LIPO(Sec/SPII)	0.259928	0.031184	0.357648	0.351240	CS pos: ?. Probable protein fragment    16
NZ_CP027599.1_8139	LIPO(Sec/SPII)	0.053775	0.002285	0.598852	0.345088	CS pos: 30-31. WCG-CR. Pr: 0.5833    37
NZ_CP027599.1_8144	LIPO(Sec/SPII)	0.236311	0.031385	0.371166	0.361138	CS pos: ?. Probable protein fragment    15
NZ_CP027599.1_8163	LIPO(Sec/SPII)	0.272485	0.008558	0.509177	0.209780	CS pos: 13-14. LCR-CA. Pr: 0.3997    21
NZ_CP027599.1_8173	LIPO(Sec/SPII)	0.179788	0.045417	0.399061	0.375735	CS pos: 26-27. FLG-CY. Pr: 0.3091    48
NZ_CP027599.1_8177	LIPO(Sec/SPII)	0.218671	0.006650	0.677279	0.097400	CS pos: 18-19. VCY-CS. Pr: 0.3006    35
NZ_CP027599.1_8180	LIPO(Sec/SPII)	0.193194	0.017852	0.588558	0.200395	CS pos: 12-13. SVG-CA. Pr: 0.5335    41
NZ_CP027599.1_8198	LIPO(Sec/SPII)	0.026448	0.011615	0.901762	0.060174	CS pos: 16-17. AAG-CH. Pr: 0.8023    35
NZ_CP027599.1_8199	SP(Sec/SPI)	0.450241	0.009426	0.118493	0.421841	CS pos: 20-21. QFA-DH. Pr: 0.0894    24
NZ_CP027599.1_8203	SP(Sec/SPI)	0.370975	0.232714	0.131952	0.264359	CS pos: 19-20. SGA-GG. Pr: 0.0830    33
NZ_CP027599.1_8206	SP(Sec/SPI)	0.422359	0.016029	0.299294	0.262318	CS pos: 19-20. VNA-GI. Pr: 0.3507    47
NZ_CP027599.1_8226	SP(Sec/SPI)	0.705622	0.002867	0.032355	0.259156	CS pos: 17-18. VFA-HK. Pr: 0.4789    49
NZ_CP027599.1_8232	SP(Sec/SPI)	0.450289	0.154495	0.148199	0.247017	CS pos: 27-28. GAA-LN. Pr: 0.3341    40
NZ_CP027599.1_8260	SP(Sec/SPI)	0.927974	0.023803	0.028754	0.019469	CS pos: 19-20. SHG-QP. Pr: 0.8572    36
NZ_CP027599.1_8261	LIPO(Sec/SPII)	0.158085	0.014251	0.708544	0.119120	CS pos: 12-13. VIA-CD. Pr: 0.6655    16
NZ_CP027599.1_8271	LIPO(Sec/SPII)	0.103157	0.242242	0.328392	0.326209	CS pos: 20-21. VAA-CA. Pr: 0.2994    43
NZ_CP027599.1_8290	LIPO(Sec/SPII)	0.286837	0.009640	0.451777	0.251746	CS pos: ?. Probable protein fragment    21
NZ_CP027599.1_8291	SP(Sec/SPI)	0.395116	0.067958	0.222966	0.313960	CS pos: 17-18. ASA-VR. Pr: 0.1921    20
NZ_CP027599.1_8306	SP(Sec/SPI)	0.870393	0.065326	0.013263	0.051019	CS pos: 19-20. VVA-AH. Pr: 0.5314    47
NZ_CP027599.1_8321	LIPO(Sec/SPII)	0.258223	0.012866	0.372594	0.356317	CS pos: ?. Probable protein fragment    21
NZ_CP027599.1_8338	LIPO(Sec/SPII)	0.111452	0.038498	0.538454	0.311597	CS pos: 22-23. IFS-CQ. Pr: 0.3977    25
NZ_CP027599.1_8345	SP(Sec/SPI)	0.602749	0.104290	0.106026	0.186936	CS pos: 14-15. ATA-GS. Pr: 0.2166    28
NZ_CP027599.1_8364	LIPO(Sec/SPII)	0.240398	0.111298	0.329675	0.318629	CS pos: 18-19. ALS-CR. Pr: 0.1182    20
NZ_CP027599.1_8375	SP(Sec/SPI)	0.501064	0.059627	0.037505	0.401803	CS pos: 10-11. AYA-DN. Pr: 0.3835    34
NZ_CP027599.1_8377	LIPO(Sec/SPII)	0.188723	0.017642	0.420556	0.373080	CS pos: 16-17. RLS-CK. Pr: 0.2486    18
NZ_CP027599.1_8409	LIPO(Sec/SPII)	0.091067	0.014895	0.620389	0.273649	CS pos: 22-23. ALG-CA. Pr: 0.5550    24
NZ_CP027599.1_8418	LIPO(Sec/SPII)	0.045184	0.006734	0.780100	0.167982	CS pos: 18-19. QLA-CQ. Pr: 0.7530    23
NZ_CP027599.1_8425	LIPO(Sec/SPII)	0.198086	0.129277	0.347420	0.325217	CS pos: 15-16. LSS-TV. Pr: 0.0236    18
NZ_CP027599.1_8433	SP(Sec/SPI)	0.353956	0.247528	0.196506	0.202010	CS pos: 22-23. ASA-VS. Pr: 0.3027    38
NZ_CP027599.1_8434	LIPO(Sec/SPII)	0.154254	0.041183	0.571504	0.233059	CS pos: 13-14. SSA-CC. Pr: 0.3941    18
NZ_CP027599.1_8435	LIPO(Sec/SPII)	0.083392	0.016800	0.559808	0.339999	CS pos: 21-22. IAS-CW. Pr: 0.3557    40
NZ_CP027599.1_8437	LIPO(Sec/SPII)	0.251319	0.035973	0.372456	0.340253	CS pos: ?. Probable protein fragment    17
NZ_CP027599.1_8445	LIPO(Sec/SPII)	0.018079	0.000493	0.974959	0.006469	CS pos: 17-18. SCS-CD. Pr: 0.4896    42
NZ_CP027599.1_8453	SP(Sec/SPI)	0.587429	0.011989	0.150332	0.250250	CS pos: 21-22. ILS-LS. Pr: 0.3112    36
NZ_CP027599.1_8466	TAT(Tat/SPI)	0.142135	0.511134	0.062487	0.284245	CS pos: 28-29. ALT-GP. Pr: 0.0158    30
NZ_CP027599.1_8468	LIPO(Sec/SPII)	0.154513	0.010661	0.474732	0.360094	CS pos: 25-26. HYA-CT. Pr: 0.4391    28
NZ_CP027599.1_8484	SP(Sec/SPI)	0.457027	0.034371	0.236716	0.271886	CS pos: 17-18. GSA-AS. Pr: 0.1458    24
NZ_CP027599.1_8490	LIPO(Sec/SPII)	0.018899	0.039298	0.926865	0.014938	CS pos: 26-27. WSG-CQ. Pr: 0.9154    38
NZ_CP027599.1_8491	LIPO(Sec/SPII)	0.165135	0.193481	0.490341	0.151043	CS pos: 29-30. SLT-CK. Pr: 0.4749    38
NZ_CP027599.1_8524	LIPO(Sec/SPII)	0.155345	0.037488	0.503278	0.303889	CS pos: 28-29. SAS-CR. Pr: 0.4220    31
NZ_CP027599.1_8534	LIPO(Sec/SPII)	0.222331	0.046458	0.423509	0.307702	CS pos: 16-17. GAV-CL. Pr: 0.3508    29
NZ_CP027599.1_8546	LIPO(Sec/SPII)	0.191284	0.007926	0.445061	0.355729	CS pos: 22-23. RNC-CH. Pr: 0.2810    27
NZ_CP027599.1_8583	LIPO(Sec/SPII)	0.276205	0.018907	0.381422	0.323467	CS pos: 15-16. VCG-SW. Pr: 0.0655    17
NZ_CP027599.1_8589	LIPO(Sec/SPII)	0.102862	0.005421	0.759812	0.131906	CS pos: 19-20. MAD-CS. Pr: 0.6417    25
NZ_CP027599.1_8600	LIPO(Sec/SPII)	0.149911	0.040892	0.495586	0.313611	CS pos: 13-14. FIS-CR. Pr: 0.4745    46
NZ_CP027599.1_8626	LIPO(Sec/SPII)	0.283094	0.031376	0.437230	0.248301	CS pos: ?. Probable protein fragment    15
NZ_CP027599.1_8627	LIPO(Sec/SPII)	0.173736	0.029884	0.642256	0.154124	CS pos: 15-16. TSS-CS. Pr: 0.5637    23
NZ_CP027599.1_8639	SP(Sec/SPI)	0.603319	0.089575	0.039719	0.267387	CS pos: 22-23. AQA-AI. Pr: 0.5673    32
NZ_CP027599.1_8657	LIPO(Sec/SPII)	0.176937	0.029543	0.440455	0.353065	CS pos: 13-14. IPA-CF. Pr: 0.3817    24
NZ_CP027599.1_8674	SP(Sec/SPI)	0.943682	0.019011	0.014765	0.022542	CS pos: 20-21. SYA-GQ. Pr: 0.8363    40
NZ_CP027599.1_8712	LIPO(Sec/SPII)	0.171435	0.044898	0.477663	0.306004	CS pos: 13-14. FVT-CS. Pr: 0.4557    33
NZ_CP027599.1_8755	LIPO(Sec/SPII)	0.032532	0.001501	0.857932	0.108036	CS pos: 15-16. LLA-CR. Pr: 0.7376    26
NZ_CP027599.1_8771	SP(Sec/SPI)	0.505781	0.013658	0.141034	0.339526	CS pos: 27-28. KVA-NG. Pr: 0.0948    31
NZ_CP027599.1_8794	LIPO(Sec/SPII)	0.191217	0.104611	0.378857	0.325315	CS pos: ?. Probable protein fragment    19
NZ_CP027599.1_8798	SP(Sec/SPI)	0.578554	0.052132	0.096213	0.273101	CS pos: 15-16. KYA-AK. Pr: 0.3420    28
NZ_CP027599.1_8805	LIPO(Sec/SPII)	0.034939	0.004057	0.937329	0.023675	CS pos: 17-18. FST-CG. Pr: 0.9354    33
NZ_CP027599.1_8834	LIPO(Sec/SPII)	0.232259	0.027352	0.377856	0.362534	CS pos: 17-18. GWA-CP. Pr: 0.3250    20
NZ_CP027599.1_8849	LIPO(Sec/SPII)	0.025826	0.007199	0.951427	0.015547	CS pos: 20-21. FVA-CS. Pr: 0.9501    43
NZ_CP027599.1_8854	LIPO(Sec/SPII)	0.009464	0.091779	0.877735	0.021022	CS pos: 22-23. ISS-CG. Pr: 0.8745    31
NZ_CP027599.1_8891	LIPO(Sec/SPII)	0.263303	0.019454	0.484052	0.233191	CS pos: ?. Probable protein fragment    16
NZ_CP027599.1_8909	LIPO(Sec/SPII)	0.110749	0.006019	0.651731	0.231502	CS pos: 14-15. AFC-CW. Pr: 0.4325    30
NZ_CP027599.1_8913	LIPO(Sec/SPII)	0.251425	0.023889	0.381284	0.343402	CS pos: ?. Probable protein fragment    17
NZ_CP027599.1_8922	LIPO(Sec/SPII)	0.119882	0.009027	0.470572	0.400519	CS pos: 24-25. VVC-CA. Pr: 0.1959    37
NZ_CP027599.1_8933	SP(Sec/SPI)	0.544536	0.213047	0.048307	0.194110	CS pos: 23-24. VKA-AQ. Pr: 0.4238    30
NZ_CP027599.1_8939	LIPO(Sec/SPII)	0.283703	0.011768	0.462771	0.241758	CS pos: 14-15. LKP-LF. Pr: 0.0249    16
NZ_CP027599.1_8968	LIPO(Sec/SPII)	0.124918	0.003773	0.821684	0.049625	CS pos: 19-20. SVV-CG. Pr: 0.5957    37
NZ_CP027599.1_8988	LIPO(Sec/SPII)	0.157814	0.021691	0.492334	0.328161	CS pos: 12-13. VMT-CN. Pr: 0.4455    35
NZ_CP027599.1_9006	LIPO(Sec/SPII)	0.183228	0.017159	0.507727	0.291886	CS pos: 10-11. AQG-CF. Pr: 0.2535    29
NZ_CP027599.1_9009	LIPO(Sec/SPII)	0.105352	0.010095	0.718256	0.166297	CS pos: 18-19. LAA-CW. Pr: 0.6084    42
NZ_CP027599.1_9010	LIPO(Sec/SPII)	0.251187	0.040210	0.369460	0.339142	CS pos: 14-15. TVT-CQ. Pr: 0.0597    17
NZ_CP027599.1_9015	SP(Sec/SPI)	0.456602	0.005237	0.237732	0.300429	CS pos: ?. Probable protein fragment    21
NZ_CP027599.1_9032	SP(Sec/SPI)	0.414392	0.004288	0.412239	0.169080	CS pos: 18-19. GKP-DQ. Pr: 0.1304    26
NZ_CP027599.1_9037	LIPO(Sec/SPII)	0.118266	0.007080	0.552428	0.322227	CS pos: 14-15. LSA-CC. Pr: 0.4982    26
NZ_CP027599.1_9076	SP(Sec/SPI)	0.406894	0.107411	0.096591	0.389104	CS pos: 18-19. FPA-GQ. Pr: 0.0640    37
NZ_CP027599.1_9093	SP(Sec/SPI)	0.372958	0.031891	0.344920	0.250232	CS pos: 23-24. CVA-AG. Pr: 0.1617    36
NZ_CP027599.1_9101	LIPO(Sec/SPII)	0.111384	0.025425	0.759725	0.103467	CS pos: 15-16. LSG-CQ. Pr: 0.7550    29
NZ_CP027599.1_9135	SP(Sec/SPI)	0.792897	0.056107	0.042286	0.108710	CS pos: 21-22. ARA-ES. Pr: 0.5780    36
NZ_CP027599.1_9157	LIPO(Sec/SPII)	0.149856	0.020715	0.490097	0.339333	CS pos: 16-17. WSS-CR. Pr: 0.4039    25
NZ_CP027599.1_9163	LIPO(Sec/SPII)	0.352247	0.032997	0.422532	0.192224	CS pos: 28-29. LPG-CL. Pr: 0.3960    44
NZ_CP027599.1_9169	LIPO(Sec/SPII)	0.150448	0.037675	0.438019	0.373858	CS pos: 20-21. IFA-CQ. Pr: 0.3414    22
NZ_CP027599.1_9195	LIPO(Sec/SPII)	0.243257	0.038390	0.368753	0.349600	CS pos: 16-17. MVA-VP. Pr: 0.0229    18
NZ_CP027599.1_9211	SP(Sec/SPI)	0.531386	0.015752	0.265323	0.187538	CS pos: ?. Probable protein fragment    23
NZ_CP027599.1_9213	LIPO(Sec/SPII)	0.119888	0.048138	0.619542	0.212432	CS pos: 19-20. TTN-CV. Pr: 0.3716    42
NZ_CP027599.1_9228	SP(Sec/SPI)	0.466117	0.084841	0.094069	0.354973	CS pos: 21-22. APS-AP. Pr: 0.1591    33
NZ_CP027599.1_9237	SP(Sec/SPI)	0.885584	0.011443	0.020065	0.082908	CS pos: 20-21. VGA-NP. Pr: 0.6000    41
NZ_CP027599.1_9263	LIPO(Sec/SPII)	0.243164	0.012307	0.380284	0.364245	CS pos: ?. Probable protein fragment    18
NZ_CP027599.1_9270	SP(Sec/SPI)	0.486054	0.099205	0.061817	0.352924	CS pos: 18-19. SDA-ST. Pr: 0.1567    23
NZ_CP027599.1_9296	SP(Sec/SPI)	0.835587	0.004421	0.024838	0.135153	CS pos: 26-27. AKA-DE. Pr: 0.8271    42
NZ_CP027599.1_9316	LIPO(Sec/SPII)	0.099592	0.038088	0.491766	0.370553	CS pos: 14-15. GCA-CC. Pr: 0.2558    43
NZ_CP027599.1_9336	LIPO(Sec/SPII)	0.239768	0.043028	0.369557	0.347647	CS pos: ?. Probable protein fragment    17
NZ_CP027599.1_9353	LIPO(Sec/SPII)	0.358015	0.026397	0.432154	0.183433	CS pos: 18-19. ATA-SV. Pr: 0.2231    36
NZ_CP027599.1_9360	SP(Sec/SPI)	0.513667	0.258029	0.059759	0.168546	CS pos: 19-20. SRA-AP. Pr: 0.3422    28
NZ_CP027599.1_9377	SP(Sec/SPI)	0.393745	0.086612	0.133728	0.385915	CS pos: 23-24. GLS-DP. Pr: 0.1393    41
NZ_CP027599.1_9379	SP(Sec/SPI)	0.924308	0.008452	0.026086	0.041155	CS pos: 21-22. SFA-QQ. Pr: 0.8182    33
NZ_CP027599.1_9385	SP(Sec/SPI)	0.362180	0.258489	0.064783	0.314548	CS pos: 20-21. SRA-LC. Pr: 0.1314    48
NZ_CP027599.1_9398	LIPO(Sec/SPII)	0.167931	0.008037	0.792163	0.031868	CS pos: 15-16. TSA-CN. Pr: 0.7881    34
NZ_CP027599.1_9409	TAT(Tat/SPI)	0.045240	0.949961	0.003187	0.001612	CS pos: 30-31. SQA-AA. Pr: 0.5379    38
NZ_CP027599.1_9424	SP(Sec/SPI)	0.324660	0.222561	0.221831	0.230947	CS pos: 37-38. SLA-TS. Pr: 0.1458    49
NZ_CP027599.1_9426	SP(Sec/SPI)	0.505587	0.003970	0.325070	0.165373	CS pos: 22-23. CGT-AP. Pr: 0.2500    30
NZ_CP027599.1_9442	SP(Sec/SPI)	0.527568	0.005703	0.284285	0.182443	CS pos: 17-18. VRC-FT. Pr: 0.4052    36
NZ_CP027599.1_9484	LIPO(Sec/SPII)	0.168199	0.004763	0.550167	0.276871	CS pos: 14-15. FTA-CF. Pr: 0.3886    20
NZ_CP027599.1_9512	SP(Sec/SPI)	0.537164	0.018237	0.061611	0.382987	CS pos: ?. Probable protein fragment    23
NZ_CP027599.1_9524	LIPO(Sec/SPII)	0.324620	0.007873	0.556519	0.110988	CS pos: ?. Probable protein fragment    17
NZ_CP027599.1_9590	LIPO(Sec/SPII)	0.343759	0.011647	0.361254	0.283340	CS pos: 16-17. LSS-AY. Pr: 0.1281    18
NZ_CP027599.1_9603	LIPO(Sec/SPII)	0.268224	0.008207	0.383194	0.340375	CS pos: 14-15. ALS-CL. Pr: 0.3730    50
NZ_CP027599.1_9654	SP(Sec/SPI)	0.669565	0.026578	0.033797	0.270060	CS pos: 21-22. VYA-DF. Pr: 0.6712    28
NZ_CP027599.1_9668	LIPO(Sec/SPII)	0.243224	0.030014	0.382734	0.344028	CS pos: 15-16. PSL-CW. Pr: 0.0613    17
NZ_CP027599.1_9676	SP(Sec/SPI)	0.497894	0.012103	0.021769	0.468234	CS pos: 25-26. CFA-GV. Pr: 0.4339    34
NZ_CP027599.1_9700	SP(Sec/SPI)	0.444347	0.072157	0.110093	0.373403	CS pos: ?. Probable protein fragment    22
NZ_CP027599.1_9722	SP(Sec/SPI)	0.782509	0.056418	0.053097	0.107976	CS pos: 24-25. TFA-AE. Pr: 0.7688    30
NZ_CP027599.1_9752	LIPO(Sec/SPII)	0.309219	0.068396	0.473376	0.149008	CS pos: 18-19. SRA-CR. Pr: 0.5452    33
NZ_CP027599.1_9777	LIPO(Sec/SPII)	0.305174	0.014345	0.469597	0.210884	CS pos: 13-14. MGR-CH. Pr: 0.1247    15
NZ_CP027599.1_9786	LIPO(Sec/SPII)	0.259893	0.027792	0.394783	0.317532	CS pos: 19-20. TSA-CR. Pr: 0.4703    38
NZ_CP027599.1_9790	SP(Sec/SPI)	0.557334	0.045369	0.238546	0.158751	CS pos: 19-20. ASS-AG. Pr: 0.1602    24
NZ_CP027599.1_9806	LIPO(Sec/SPII)	0.026803	0.000448	0.898900	0.073850	CS pos: 14-15. ILG-CT. Pr: 0.8878    27
NZ_CP027599.1_9829	LIPO(Sec/SPII)	0.228037	0.055843	0.401987	0.314133	CS pos: 19-20. GCL-CT. Pr: 0.0739    21
NZ_CP027599.1_9850	LIPO(Sec/SPII)	0.249798	0.037777	0.361106	0.351319	CS pos: ?. Probable protein fragment    15
NZ_CP027599.1_9870	LIPO(Sec/SPII)	0.277105	0.059637	0.421755	0.241502	CS pos: 18-19. GYG-CD. Pr: 0.3917    31
NZ_CP027599.1_9882	LIPO(Sec/SPII)	0.319187	0.022083	0.331940	0.326789	CS pos: ?. Probable protein fragment    16
NZ_CP027599.1_9940	TAT(Tat/SPI)	0.179966	0.461634	0.019487	0.338913	CS pos: 32-33. ARA-AA. Pr: 0.1783    49
NZ_CP027599.1_9969	SP(Sec/SPI)	0.532036	0.007960	0.088916	0.371088	CS pos: 22-23. QHS-LN. Pr: 0.2016    38
NZ_CP027599.1_9971	LIPO(Sec/SPII)	0.366327	0.005701	0.413987	0.213986	CS pos: 21-22. LNA-GE. Pr: 0.4121    31
NZ_CP027599.1_10047	SP(Sec/SPI)	0.339075	0.049089	0.275861	0.335976	CS pos: 21-22. RQG-CS. Pr: 0.1134    23
NZ_CP027599.1_10096	SP(Sec/SPI)	0.536174	0.054181	0.111495	0.298150	CS pos: 24-25. VAA-GY. Pr: 0.2577    48
NZ_CP027599.1_10110	SP(Sec/SPI)	0.650585	0.216830	0.041354	0.091231	CS pos: 21-22. TAA-HN. Pr: 0.5111    48
NZ_CP027599.1_10126	LIPO(Sec/SPII)	0.257124	0.048318	0.373742	0.320817	CS pos: 18-19. WCQ-CH. Pr: 0.1154    21
NZ_CP027599.1_10134	LIPO(Sec/SPII)	0.105938	0.015239	0.709765	0.169057	CS pos: 23-24. LAS-CR. Pr: 0.6821    31
NZ_CP027599.1_10143	SP(Sec/SPI)	0.507981	0.049182	0.122337	0.320500	CS pos: 20-21. VRS-VD. Pr: 0.2379    27
NZ_CP027599.1_10166	LIPO(Sec/SPII)	0.056794	0.005964	0.578947	0.358295	CS pos: 27-28. VTG-CG. Pr: 0.4206    40
NZ_CP027599.1_10174	LIPO(Sec/SPII)	0.290800	0.067680	0.521684	0.119836	CS pos: 19-20. AVA-CT. Pr: 0.4991    35
NZ_CP027599.1_10179	SP(Sec/SPI)	0.549795	0.029254	0.212768	0.208184	CS pos: 16-17. GAA-NE. Pr: 0.2340    25
NZ_CP027599.1_10184	SP(Sec/SPI)	0.811335	0.118883	0.049659	0.020124	CS pos: 32-33. AIA-SS. Pr: 0.7298    48
NZ_CP027599.1_10203	LIPO(Sec/SPII)	0.252611	0.016623	0.520722	0.210045	CS pos: 10-11. LSA-CR. Pr: 0.4942    38
NZ_CP027599.1_10221	LIPO(Sec/SPII)	0.140253	0.019835	0.649172	0.190740	CS pos: 15-16. LML-CS. Pr: 0.3607    27
NZ_CP027599.1_10231	SP(Sec/SPI)	0.617230	0.009031	0.069004	0.304735	CS pos: 21-22. VYA-TY. Pr: 0.5481    26
NZ_CP027599.1_10250	LIPO(Sec/SPII)	0.245218	0.030971	0.364817	0.358994	CS pos: 22-23. SNA-CN. Pr: 0.3436    24
NZ_CP027599.1_10253	SP(Sec/SPI)	0.635707	0.041325	0.076973	0.245995	CS pos: 21-22. LWA-SN. Pr: 0.5658    26
NZ_CP027599.1_10259	LIPO(Sec/SPII)	0.199679	0.033057	0.393879	0.373385	CS pos: 19-20. ASQ-CR. Pr: 0.1889    22
NZ_CP027599.1_10262	LIPO(Sec/SPII)	0.015809	0.006596	0.920866	0.056729	CS pos: 20-21. ASG-CG. Pr: 0.9239    40
NZ_CP027599.1_10268	SP(Sec/SPI)	0.628740	0.076690	0.164165	0.130406	CS pos: 25-26. SMP-TP. Pr: 0.1472    42
NZ_CP027599.1_10289	LIPO(Sec/SPII)	0.226968	0.027957	0.406255	0.338821	CS pos: ?. Probable protein fragment    18
NZ_CP027599.1_10304	SP(Sec/SPI)	0.380301	0.218584	0.170193	0.230922	CS pos: 27-28. ARP-VW. Pr: 0.0878    44
NZ_CP027599.1_10310	SP(Sec/SPI)	0.442400	0.017351	0.244734	0.295514	CS pos: 20-21. VLG-MT. Pr: 0.2836    22
NZ_CP027599.1_10313	LIPO(Sec/SPII)	0.302251	0.052524	0.468317	0.176908	CS pos: 24-25. WSA-CT. Pr: 0.4322    31
NZ_CP027599.1_10316	LIPO(Sec/SPII)	0.070397	0.063235	0.594142	0.272225	CS pos: 18-19. VSS-CS. Pr: 0.5787    32
NZ_CP027599.1_10317	LIPO(Sec/SPII)	0.063550	0.007089	0.837727	0.091634	CS pos: 23-24. FFS-CR. Pr: 0.7449    35
NZ_CP027599.1_10349	LIPO(Sec/SPII)	0.180119	0.019542	0.488553	0.311786	CS pos: 17-18. YSR-CA. Pr: 0.4395    37
NZ_CP027599.1_10355	LIPO(Sec/SPII)	0.158146	0.024023	0.450747	0.367084	CS pos: 17-18. MLA-CW. Pr: 0.3288    22
NZ_CP027599.1_10370	LIPO(Sec/SPII)	0.143670	0.028923	0.419240	0.408167	CS pos: 13-14. LSS-CA. Pr: 0.3680    25
NZ_CP027599.1_10461	SP(Sec/SPI)	0.529136	0.030318	0.023303	0.417243	CS pos: 13-14. AWS-DD. Pr: 0.4199    49
NZ_CP027599.1_10499	LIPO(Sec/SPII)	0.236835	0.031079	0.388410	0.343676	CS pos: ?. Probable protein fragment    17
NZ_CP027599.1_10510	LIPO(Sec/SPII)	0.312042	0.058727	0.354909	0.274322	CS pos: 14-15. VVA-SP. Pr: 0.0452    18
NZ_CP027599.1_10524	TAT(Tat/SPI)	0.114380	0.599560	0.251285	0.034775	CS pos: 30-31. SSS-SS. Pr: 0.0745    46
NZ_CP027599.1_10540	LIPO(Sec/SPII)	0.052249	0.006630	0.885343	0.055777	CS pos: 25-26. VPA-CQ. Pr: 0.8799    35
NZ_CP027599.1_10545	LIPO(Sec/SPII)	0.211571	0.258521	0.292058	0.237850	CS pos: 13-14. ALS-CC. Pr: 0.1075    17
NZ_CP027599.1_10550	SP(Sec/SPI)	0.422967	0.100180	0.172076	0.304777	CS pos: 21-22. CIA-AS. Pr: 0.2039    34
NZ_CP027599.1_10565	LIPO(Sec/SPII)	0.297746	0.017231	0.405014	0.280008	CS pos: 13-14. PQA-LD. Pr: 0.0634    15
NZ_CP027599.1_10590	LIPO(Sec/SPII)	0.171101	0.076064	0.389819	0.363015	CS pos: 27-28. LSG-CC. Pr: 0.2938    33
NZ_CP027599.1_10591	LIPO(Sec/SPII)	0.071955	0.019849	0.682606	0.225590	CS pos: 18-19. YLG-CR. Pr: 0.6485    31
NZ_CP027599.1_10592	TAT(Tat/SPI)	0.222483	0.384879	0.089431	0.303207	CS pos: 31-32. PRS-LP. Pr: 0.1396    40
NZ_CP027599.1_10596	LIPO(Sec/SPII)	0.058141	0.009051	0.554357	0.378451	CS pos: 27-28. RSG-CE. Pr: 0.5531    34
NZ_CP027599.1_10606	LIPO(Sec/SPII)	0.157811	0.007947	0.822321	0.011921	CS pos: 12-13. STA-CL. Pr: 0.4302    39
NZ_CP027599.1_10648	LIPO(Sec/SPII)	0.172172	0.027319	0.440328	0.360182	CS pos: 22-23. CTS-CS. Pr: 0.3687    26
NZ_CP027599.1_10649	LIPO(Sec/SPII)	0.344724	0.023484	0.400380	0.231412	CS pos: ?. Probable protein fragment    15
NZ_CP027599.1_10665	LIPO(Sec/SPII)	0.158663	0.089864	0.464224	0.287249	CS pos: 19-20. VSG-CR. Pr: 0.3724    31
NZ_CP027599.1_10667	SP(Sec/SPI)	0.362183	0.166673	0.141334	0.329810	CS pos: 18-19. SLS-LT. Pr: 0.1427    34
NZ_CP027599.1_10669	LIPO(Sec/SPII)	0.190577	0.009292	0.532578	0.267554	CS pos: 17-18. TFC-CI. Pr: 0.3578    23
NZ_CP027599.1_10670	LIPO(Sec/SPII)	0.236271	0.013069	0.458310	0.292349	CS pos: 14-15. FLR-CA. Pr: 0.2784    24
NZ_CP027599.1_10687	SP(Sec/SPI)	0.386609	0.043147	0.229882	0.340362	CS pos: 18-19. CLA-AT. Pr: 0.2216    24
NZ_CP027599.1_10701	LIPO(Sec/SPII)	0.177630	0.037756	0.571653	0.212961	CS pos: 17-18. LSG-CQ. Pr: 0.4630    21
NZ_CP027599.1_10709	SP(Sec/SPI)	0.491737	0.101897	0.086693	0.319673	CS pos: 19-20. ATA-AD. Pr: 0.4591    25
NZ_CP027599.1_10712	LIPO(Sec/SPII)	0.121309	0.030079	0.464762	0.383850	CS pos: 19-20. ICG-CV. Pr: 0.4006    30
NZ_CP027599.1_10715	SP(Sec/SPI)	0.544963	0.148772	0.093527	0.212738	CS pos: 26-27. ANA-QR. Pr: 0.3082    36
NZ_CP027599.1_10726	TAT(Tat/SPI)	0.094123	0.450180	0.026340	0.429357	CS pos: 26-27. AKA-VV. Pr: 0.2019    41
NZ_CP027599.1_10733	LIPO(Sec/SPII)	0.246469	0.033773	0.374641	0.345117	CS pos: ?. Probable protein fragment    19
NZ_CP027599.1_10762	LIPO(Sec/SPII)	0.239438	0.019615	0.522779	0.218168	CS pos: ?. Probable protein fragment    15
NZ_CP027599.1_10773	LIPO(Sec/SPII)	0.152053	0.013630	0.456216	0.378101	CS pos: 22-23. LSF-CK. Pr: 0.4038    27
NZ_CP027599.1_10778	SP(Sec/SPI)	0.559336	0.035054	0.036467	0.369143	CS pos: 21-22. VNA-AS. Pr: 0.4269    43
NZ_CP027599.1_10877	LIPO(Sec/SPII)	0.139945	0.009335	0.739436	0.111284	CS pos: 33-34. IAQ-CS. Pr: 0.7300    44
NZ_CP027599.1_10879	LIPO(Sec/SPII)	0.287826	0.009196	0.420025	0.282954	CS pos: ?. Probable protein fragment    16
NZ_CP027599.1_10889	LIPO(Sec/SPII)	0.083710	0.007462	0.570145	0.338682	CS pos: 21-22. IRS-CD. Pr: 0.5820    26
NZ_CP027599.1_10905	LIPO(Sec/SPII)	0.290297	0.024107	0.373179	0.312418	CS pos: ?. Probable protein fragment    17
NZ_CP027599.1_10937	LIPO(Sec/SPII)	0.170199	0.000744	0.512132	0.316925	CS pos: 18-19. IHF-CD. Pr: 0.4803    28
NZ_CP027599.1_10978	SP(Sec/SPI)	0.756896	0.041956	0.047588	0.153561	CS pos: 17-18. ADA-HV. Pr: 0.5806    33
NZ_CP027599.1_10992	LIPO(Sec/SPII)	0.193776	0.025122	0.633559	0.147543	CS pos: 19-20. GFA-CA. Pr: 0.3701    26
NZ_CP027599.1_10994	LIPO(Sec/SPII)	0.229795	0.027886	0.472691	0.269627	CS pos: ?. Probable protein fragment    16
NZ_CP027599.1_11009	LIPO(Sec/SPII)	0.218188	0.027381	0.614121	0.140309	CS pos: 13-14. AQS-CK. Pr: 0.5456    16
NZ_CP027599.1_11026	SP(Sec/SPI)	0.541498	0.005805	0.322742	0.129956	CS pos: 16-17. VVA-SN. Pr: 0.4164    28
NZ_CP027599.1_11027	LIPO(Sec/SPII)	0.078732	0.007321	0.460960	0.452987	CS pos: 26-27. RGG-CI. Pr: 0.4475    46
NZ_CP027599.1_11034	LIPO(Sec/SPII)	0.193941	0.048394	0.381629	0.376036	CS pos: 18-19. AQA-CL. Pr: 0.3687    20
NZ_CP027599.1_11038	TAT(Tat/SPI)	0.177278	0.442028	0.100294	0.280399	CS pos: 32-33. ARA-FC. Pr: 0.3971    49
NZ_CP027599.1_11072	LIPO(Sec/SPII)	0.245879	0.039787	0.516696	0.197638	CS pos: 19-20. SAT-CG. Pr: 0.4321    22
NZ_CP027599.1_11088	LIPO(Sec/SPII)	0.139016	0.019972	0.537200	0.303813	CS pos: 21-22. LAA-CM. Pr: 0.5068    36
NZ_CP027599.1_11096	LIPO(Sec/SPII)	0.164873	0.019118	0.648284	0.167725	CS pos: 23-24. VRA-CW. Pr: 0.5849    41
NZ_CP027599.1_11097	LIPO(Sec/SPII)	0.225549	0.091697	0.370134	0.312620	CS pos: 14-15. PMF-CR. Pr: 0.0463    16
NZ_CP027599.1_11103	TAT(Tat/SPI)	0.160938	0.370943	0.175337	0.292782	CS pos: ?. Probable protein fragment    16
NZ_CP027599.1_11137	LIPO(Sec/SPII)	0.110563	0.003866	0.723233	0.162337	CS pos: 11-12. MTG-CL. Pr: 0.7191    34
NZ_CP027599.1_11160	LIPO(Sec/SPII)	0.034583	0.030966	0.657844	0.276608	CS pos: 14-15. SVG-CR. Pr: 0.6652    48
NZ_CP027599.1_11217	LIPO(Sec/SPII)	0.276536	0.015100	0.426483	0.281880	CS pos: ?. Probable protein fragment    17
NZ_CP027599.1_11221	SP(Sec/SPI)	0.384948	0.178334	0.085281	0.351436	CS pos: 23-24. VIA-KS. Pr: 0.3514    41
NZ_CP027599.1_11231	LIPO(Sec/SPII)	0.223741	0.028244	0.501814	0.246200	CS pos: 13-14. SGS-CT. Pr: 0.1942    16
NZ_CP027599.1_11260	SP(Sec/SPI)	0.504906	0.006076	0.324330	0.164688	CS pos: 21-22. GKS-TQ. Pr: 0.1717    49
NZ_CP027599.1_11263	SP(Sec/SPI)	0.668827	0.072657	0.104494	0.154022	CS pos: 21-22. TQA-AP. Pr: 0.5205    25
NZ_CP027599.1_11270	LIPO(Sec/SPII)	0.251712	0.014953	0.462905	0.270430	CS pos: 12-13. LKS-CS. Pr: 0.4050    26
NZ_CP027599.1_11282	SP(Sec/SPI)	0.751850	0.028361	0.043925	0.175864	CS pos: 25-26. AQA-IK. Pr: 0.3900    50
NZ_CP027599.1_11284	SP(Sec/SPI)	0.440796	0.043067	0.114379	0.401758	CS pos: 19-20. AQA-GR. Pr: 0.3384    34
NZ_CP027599.1_11290	LIPO(Sec/SPII)	0.249678	0.016090	0.388466	0.345766	CS pos: 20-21. LRC-CH. Pr: 0.1534    25
NZ_CP027599.1_11316	LIPO(Sec/SPII)	0.115311	0.004888	0.485761	0.394040	CS pos: 25-26. FQA-CS. Pr: 0.4589    34
NZ_CP027599.1_11322	LIPO(Sec/SPII)	0.157236	0.171830	0.365645	0.305288	CS pos: 20-21. FSG-CR. Pr: 0.2895    36
NZ_CP027599.1_11337	LIPO(Sec/SPII)	0.093868	0.004888	0.855969	0.045276	CS pos: 18-19. AQS-CG. Pr: 0.8425    42
NZ_CP027599.1_11339	TAT(Tat/SPI)	0.288713	0.437385	0.022306	0.251597	CS pos: 23-24. ASA-KC. Pr: 0.6016    39
NZ_CP027599.1_11384	TAT(Tat/SPI)	0.216905	0.406141	0.050323	0.326630	CS pos: 24-25. AQP-AP. Pr: 0.1133    46
NZ_CP027599.1_11385	SP(Sec/SPI)	0.396826	0.023692	0.208861	0.370621	CS pos: 21-22. SKT-SE. Pr: 0.0722    26
NZ_CP027599.1_11392	LIPO(Sec/SPII)	0.288041	0.029572	0.494516	0.187872	CS pos: ?. Probable protein fragment    20
NZ_CP027599.1_11420	SP(Sec/SPI)	0.567955	0.117107	0.163054	0.151883	CS pos: 21-22. TSA-II. Pr: 0.2493    33
NZ_CP027599.1_11426	LIPO(Sec/SPII)	0.105386	0.015320	0.507861	0.371433	CS pos: 19-20. GVG-CF. Pr: 0.4440    28
NZ_CP027599.1_11429	LIPO(Sec/SPII)	0.078998	0.059365	0.759918	0.101719	CS pos: 20-21. LAG-CL. Pr: 0.7346    32
NZ_CP027599.1_11430	LIPO(Sec/SPII)	0.116853	0.004255	0.804638	0.074255	CS pos: 22-23. GVS-CP. Pr: 0.7676    33
NZ_CP027599.1_11458	LIPO(Sec/SPII)	0.123014	0.023383	0.437480	0.416123	CS pos: 19-20. LTG-KS. Pr: 0.4127    37
NZ_CP027599.1_11510	LIPO(Sec/SPII)	0.225626	0.005292	0.725174	0.043907	CS pos: 24-25. ATS-CR. Pr: 0.7020    26
NZ_CP027599.1_11513	LIPO(Sec/SPII)	0.141713	0.006788	0.750084	0.101415	CS pos: 18-19. IPA-CC. Pr: 0.3328    24
NZ_CP027599.1_11520	SP(Sec/SPI)	0.345343	0.164956	0.163149	0.326552	CS pos: ?. Probable protein fragment    22
NZ_CP027599.1_11539	LIPO(Sec/SPII)	0.291565	0.005664	0.576962	0.125808	CS pos: 26-27. AVN-CR. Pr: 0.4591    37
NZ_CP027599.1_11566	LIPO(Sec/SPII)	0.126623	0.005536	0.605062	0.262779	CS pos: 13-14. ASG-CW. Pr: 0.5731    21
NZ_CP027599.1_11581	SP(Sec/SPI)	0.552640	0.025261	0.142051	0.280048	CS pos: ?. Probable protein fragment    17
NZ_CP027599.1_11623	SP(Sec/SPI)	0.489022	0.016684	0.291686	0.202608	CS pos: 18-19. ALP-MP. Pr: 0.2384    30
NZ_CP027599.1_11629	LIPO(Sec/SPII)	0.276825	0.015991	0.412664	0.294521	CS pos: ?. Probable protein fragment    15
NZ_CP027599.1_11640	LIPO(Sec/SPII)	0.012976	0.002966	0.975734	0.008325	CS pos: 13-14. ILG-CP. Pr: 0.9760    41
NZ_CP027599.1_11641	LIPO(Sec/SPII)	0.221502	0.180907	0.378188	0.219402	CS pos: 16-17. LVG-CT. Pr: 0.2174    19
NZ_CP027599.1_11643	LIPO(Sec/SPII)	0.262290	0.009767	0.581111	0.146832	CS pos: 17-18. TNT-CS. Pr: 0.5092    21
NZ_CP027599.1_11673	LIPO(Sec/SPII)	0.220152	0.111167	0.365256	0.303425	CS pos: 13-14. ALV-CR. Pr: 0.1006    15
NZ_CP027599.1_11681	TAT(Tat/SPI)	0.115392	0.475914	0.134593	0.274100	CS pos: ?. Probable protein fragment    17
NZ_CP027599.1_11683	LIPO(Sec/SPII)	0.273064	0.018518	0.403706	0.304712	CS pos: 24-25. AAP-CT. Pr: 0.2043    44
NZ_CP027599.1_11687	TAT(Tat/SPI)	0.162942	0.433752	0.147863	0.255443	CS pos: ?. Probable protein fragment    17
NZ_CP027599.1_11712	SP(Sec/SPI)	0.420150	0.022943	0.153717	0.403189	CS pos: ?. Probable protein fragment    22
NZ_CP027599.1_11716	LIPO(Sec/SPII)	0.295238	0.007254	0.475998	0.221510	CS pos: 12-13. VCM-CQ. Pr: 0.0345    16
NZ_CP027599.1_11727	LIPO(Sec/SPII)	0.040721	0.001175	0.785345	0.172758	CS pos: 20-21. GAG-CR. Pr: 0.7738    33
NZ_CP027599.1_11732	LIPO(Sec/SPII)	0.379638	0.010541	0.461254	0.148567	CS pos: 23-24. SII-CR. Pr: 0.3335    46
NZ_CP027599.1_11747	TAT(Tat/SPI)	0.141949	0.609287	0.140722	0.108042	CS pos: ?. Probable protein fragment    21
NZ_CP027599.1_11782	LIPO(Sec/SPII)	0.041266	0.001909	0.709080	0.247745	CS pos: 22-23. LFS-CL. Pr: 0.6968    30
NZ_CP027599.1_11805	LIPO(Sec/SPII)	0.148640	0.031381	0.554211	0.265768	CS pos: 24-25. SIS-CR. Pr: 0.3657    34
NZ_CP027599.1_11827	SP(Sec/SPI)	0.461348	0.082161	0.140221	0.316270	CS pos: 20-21. GAA-RT. Pr: 0.1498    32
NZ_CP027599.1_11846	LIPO(Sec/SPII)	0.096120	0.003808	0.825654	0.074418	CS pos: 19-20. VTS-CR. Pr: 0.8022    26
NZ_CP027599.1_11858	LIPO(Sec/SPII)	0.163003	0.007814	0.650278	0.178905	CS pos: 19-20. WGG-CH. Pr: 0.5903    22
NZ_CP027599.1_11879	LIPO(Sec/SPII)	0.176525	0.012213	0.541579	0.269683	CS pos: ?. Probable protein fragment    19
NZ_CP027599.1_11896	LIPO(Sec/SPII)	0.285165	0.037914	0.564427	0.112494	CS pos: 20-21. TRS-CS. Pr: 0.5572    43
NZ_CP027599.1_11916	LIPO(Sec/SPII)	0.248661	0.048356	0.460461	0.242522	CS pos: ?. Probable protein fragment    16
NZ_CP027599.1_11960	LIPO(Sec/SPII)	0.186355	0.086835	0.400258	0.326552	CS pos: 23-24. VSR-CW. Pr: 0.3312    32
NZ_CP027599.1_11990	SP(Sec/SPI)	0.361966	0.034048	0.244857	0.359129	CS pos: 27-28. VTA-GI. Pr: 0.0564    36
NZ_CP027599.1_12001	LIPO(Sec/SPII)	0.166403	0.071242	0.395256	0.367098	CS pos: 10-11. SVA-CR. Pr: 0.3387    30
NZ_CP027599.1_12056	LIPO(Sec/SPII)	0.219380	0.089219	0.350314	0.341087	CS pos: 19-20. GAR-CG. Pr: 0.1649    25
NZ_CP027599.1_12063	LIPO(Sec/SPII)	0.295549	0.186104	0.344325	0.174022	CS pos: 18-19. VSS-CG. Pr: 0.3179    30
NZ_CP027599.1_12067	LIPO(Sec/SPII)	0.174828	0.017351	0.680994	0.126826	CS pos: 17-18. VTG-CA. Pr: 0.6249    22
NZ_CP027599.1_12070	SP(Sec/SPI)	0.419675	0.144927	0.099421	0.335977	CS pos: 30-31. ATG-AT. Pr: 0.2016    38
NZ_CP027599.1_12079	LIPO(Sec/SPII)	0.133141	0.004806	0.541655	0.320398	CS pos: 21-22. SVC-CC. Pr: 0.2292    28
NZ_CP027599.1_12092	LIPO(Sec/SPII)	0.100774	0.017642	0.684096	0.197487	CS pos: 28-29. MSS-CP. Pr: 0.6709    36
NZ_CP027599.1_12093	SP(Sec/SPI)	0.426828	0.070807	0.380243	0.122122	CS pos: 25-26. ASA-SD. Pr: 0.2893    44
NZ_CP027599.1_12130	LIPO(Sec/SPII)	0.200826	0.025913	0.389982	0.383278	CS pos: 16-17. GAG-CP. Pr: 0.2551    26
NZ_CP027599.1_12133	LIPO(Sec/SPII)	0.130952	0.015868	0.465438	0.387742	CS pos: 23-24. PGS-CF. Pr: 0.4183    31
NZ_CP027599.1_12155	LIPO(Sec/SPII)	0.332288	0.000839	0.386895	0.279978	CS pos: 16-17. ITV-CA. Pr: 0.3149    37
NZ_CP027599.1_12160	LIPO(Sec/SPII)	0.098848	0.024444	0.665820	0.210888	CS pos: 11-12. FAG-CK. Pr: 0.6260    25
NZ_CP027599.1_12166	LIPO(Sec/SPII)	0.200155	0.080473	0.411841	0.307532	CS pos: 23-24. AVP-CN. Pr: 0.2925    25
NZ_CP027599.1_12187	LIPO(Sec/SPII)	0.020462	0.000298	0.975288	0.003952	CS pos: 16-17. LAG-CC. Pr: 0.9655    26
NZ_CP027599.1_12191	TAT(Tat/SPI)	0.154637	0.330727	0.191347	0.323289	CS pos: ?. Probable protein fragment    15
NZ_CP027599.1_12202	LIPO(Sec/SPII)	0.129437	0.006635	0.676037	0.187891	CS pos: 18-19. WGA-CH. Pr: 0.6464    27
NZ_CP027599.1_12217	LIPO(Sec/SPII)	0.270229	0.008315	0.565430	0.156025	CS pos: 12-13. ISP-CF. Pr: 0.1445    15
NZ_CP027599.1_12234	LIPO(Sec/SPII)	0.139247	0.016976	0.638523	0.205253	CS pos: 14-15. GIA-CG. Pr: 0.5479    16
NZ_CP027599.1_12251	LIPO(Sec/SPII)	0.145274	0.007679	0.552598	0.294450	CS pos: ?. Probable protein fragment    21
NZ_CP027599.1_12253	LIPO(Sec/SPII)	0.034219	0.001301	0.957946	0.006533	CS pos: 24-25. AAG-CH. Pr: 0.9531    33
NZ_CP027599.1_12258	LIPO(Sec/SPII)	0.321071	0.011661	0.374023	0.293245	CS pos: 14-15. LAG-AT. Pr: 0.0419    16
NZ_CP027599.1_12275	LIPO(Sec/SPII)	0.237015	0.010693	0.376337	0.375955	CS pos: ?. Probable protein fragment    15
NZ_CP027599.1_12286	LIPO(Sec/SPII)	0.107018	0.050362	0.591454	0.251165	CS pos: 15-16. GYG-CM. Pr: 0.3121    34
NZ_CP027599.1_12298	LIPO(Sec/SPII)	0.053219	0.032490	0.803891	0.110399	CS pos: 18-19. GAG-CR. Pr: 0.7911    25
NZ_CP027599.1_12307	LIPO(Sec/SPII)	0.167422	0.031134	0.515587	0.285857	CS pos: 15-16. ISS-CE. Pr: 0.5007    22
NZ_CP027599.1_12343	LIPO(Sec/SPII)	0.082595	0.031843	0.637389	0.248174	CS pos: 16-17. LSA-CR. Pr: 0.5975    26
NZ_CP027599.1_12433	LIPO(Sec/SPII)	0.056741	0.020925	0.877633	0.044701	CS pos: 21-22. SVG-CA. Pr: 0.6930    37
NZ_CP027599.1_12452	LIPO(Sec/SPII)	0.162247	0.061816	0.526732	0.249205	CS pos: 15-16. SGA-CS. Pr: 0.5213    24
NZ_CP027599.1_12463	LIPO(Sec/SPII)	0.054467	0.003629	0.495994	0.445910	CS pos: 36-37. NTG-CR. Pr: 0.4807    41
NZ_CP027599.1_12465	SP(Sec/SPI)	0.474822	0.012686	0.245408	0.267083	CS pos: 17-18. TNS-TL. Pr: 0.1199    19
NZ_CP027599.1_12477	LIPO(Sec/SPII)	0.017503	0.000920	0.556338	0.425240	CS pos: 21-22. VFC-CV. Pr: 0.5049    32
NZ_CP027599.1_12487	SP(Sec/SPI)	0.435110	0.071296	0.082739	0.410855	CS pos: 18-19. YSG-AP. Pr: 0.0575    32
NZ_CP027599.1_12517	SP(Sec/SPI)	0.450468	0.030109	0.108787	0.410637	CS pos: 20-21. SLA-DR. Pr: 0.4082    25
NZ_CP027599.1_12569	LIPO(Sec/SPII)	0.124840	0.010068	0.490688	0.374404	CS pos: 18-19. GAG-CS. Pr: 0.4755    29
NZ_CP027599.1_12581	LIPO(Sec/SPII)	0.102331	0.011014	0.598867	0.287788	CS pos: 12-13. PAS-CN. Pr: 0.5610    20
NZ_CP027599.1_12608	LIPO(Sec/SPII)	0.232010	0.025518	0.471801	0.270671	CS pos: 14-15. FRT-CC. Pr: 0.1304    16
NZ_CP027599.1_12623	LIPO(Sec/SPII)	0.172807	0.007339	0.645219	0.174635	CS pos: 16-17. AVC-CT. Pr: 0.2317    20
NZ_CP027599.1_12630	LIPO(Sec/SPII)	0.245537	0.007066	0.545276	0.202121	CS pos: ?. Probable protein fragment    17
NZ_CP027599.1_12683	LIPO(Sec/SPII)	0.136773	0.015682	0.449524	0.398021	CS pos: 24-25. TAG-CK. Pr: 0.4086    45
NZ_CP027599.1_12686	LIPO(Sec/SPII)	0.306430	0.170024	0.338899	0.184647	CS pos: 22-23. VVL-CA. Pr: 0.1536    28
NZ_CP027599.1_12725	LIPO(Sec/SPII)	0.165990	0.023841	0.407013	0.403156	CS pos: 12-13. IVA-CW. Pr: 0.2601    15
NZ_CP027599.1_12730	LIPO(Sec/SPII)	0.056723	0.000695	0.930154	0.012429	CS pos: 16-17. MVT-CI. Pr: 0.8593    34
NZ_CP027599.1_12740	SP(Sec/SPI)	0.531011	0.042830	0.290098	0.136061	CS pos: 23-24. SWA-GG. Pr: 0.5124    31
NZ_CP027599.1_12751	LIPO(Sec/SPII)	0.369821	0.008755	0.403815	0.217609	CS pos: 16-17. LVA-VE. Pr: 0.0678    18
NZ_CP027599.1_12752	LIPO(Sec/SPII)	0.100351	0.013109	0.556910	0.329631	CS pos: 14-15. PSS-CG. Pr: 0.4857    24
NZ_CP027599.1_12770	LIPO(Sec/SPII)	0.198211	0.011430	0.602491	0.187868	CS pos: 20-21. GIQ-CA. Pr: 0.5011    31
NZ_CP027599.1_12771	SP(Sec/SPI)	0.551908	0.082019	0.044190	0.321883	CS pos: 15-16. ATA-EP. Pr: 0.2508    30
NZ_CP027599.1_12802	LIPO(Sec/SPII)	0.324418	0.018819	0.404280	0.252483	CS pos: 17-18. QQG-CA. Pr: 0.3055    20
NZ_CP027599.1_12805	LIPO(Sec/SPII)	0.240339	0.002182	0.591476	0.166002	CS pos: 17-18. LTT-CL. Pr: 0.3318    32
NZ_CP027599.1_12829	SP(Sec/SPI)	0.582247	0.050786	0.130425	0.236542	CS pos: 15-16. SSA-AV. Pr: 0.1583    28
NZ_CP027599.1_12840	SP(Sec/SPI)	0.391745	0.222346	0.226522	0.159386	CS pos: 24-25. AAA-CF. Pr: 0.4872    37
NZ_CP027599.1_12851	SP(Sec/SPI)	0.741991	0.026042	0.165663	0.066303	CS pos: 20-21. AMA-AS. Pr: 0.4383    36
NZ_CP027599.1_12863	SP(Sec/SPI)	0.389287	0.170367	0.076564	0.363781	CS pos: 17-18. AFG-AG. Pr: 0.0782    30
NZ_CP027599.1_12885	LIPO(Sec/SPII)	0.294792	0.022577	0.421413	0.261218	CS pos: 14-15. ALY-CA. Pr: 0.0664    16
NZ_CP027599.1_12940	LIPO(Sec/SPII)	0.272722	0.001646	0.718209	0.007423	CS pos: 13-14. FAG-CG. Pr: 0.7057    22
NZ_CP027599.1_12956	LIPO(Sec/SPII)	0.060338	0.049679	0.561421	0.328563	CS pos: 29-30. LSG-CP. Pr: 0.5460    48
NZ_CP027599.1_12958	LIPO(Sec/SPII)	0.212882	0.006523	0.501078	0.279518	CS pos: 18-19. FCG-SG. Pr: 0.2118    27
NZ_CP027599.1_12961	LIPO(Sec/SPII)	0.244842	0.017481	0.487624	0.250053	CS pos: 15-16. FCH-CG. Pr: 0.2060    18
NZ_CP027599.1_12971	LIPO(Sec/SPII)	0.046413	0.006327	0.842348	0.104912	CS pos: 22-23. LMG-CY. Pr: 0.8243    30
NZ_CP027599.1_12972	LIPO(Sec/SPII)	0.109562	0.014240	0.571021	0.305176	CS pos: 31-32. VPG-CD. Pr: 0.5095    35
NZ_CP027599.1_12974	LIPO(Sec/SPII)	0.131530	0.011316	0.523331	0.333822	CS pos: 22-23. AGG-CN. Pr: 0.4618    43
NZ_CP027599.1_12975	LIPO(Sec/SPII)	0.139089	0.081178	0.679969	0.099764	CS pos: 31-32. TSA-CA. Pr: 0.6307    47
NZ_CP027599.1_13000	SP(Sec/SPI)	0.639843	0.010994	0.023417	0.325746	CS pos: 26-27. TIA-AL. Pr: 0.4330    42
NZ_CP027599.1_13012	LIPO(Sec/SPII)	0.068067	0.006697	0.729335	0.195902	CS pos: 17-18. FYA-CR. Pr: 0.6690    19
NZ_CP027599.1_13020	LIPO(Sec/SPII)	0.196103	0.026713	0.392396	0.384787	CS pos: 22-23. ALP-CW. Pr: 0.3525    28
NZ_CP027599.1_13030	LIPO(Sec/SPII)	0.198761	0.003412	0.427744	0.370083	CS pos: 14-15. NSV-CS. Pr: 0.3603    24
NZ_CP027599.1_13041	LIPO(Sec/SPII)	0.022226	0.007101	0.922081	0.048593	CS pos: 17-18. FSS-CA. Pr: 0.9106    26
NZ_CP027599.1_13057	LIPO(Sec/SPII)	0.080161	0.075022	0.553351	0.291467	CS pos: 16-17. SAS-CS. Pr: 0.4842    29
NZ_CP027599.1_13133	LIPO(Sec/SPII)	0.288430	0.103089	0.461970	0.146511	CS pos: 15-16. TAS-CC. Pr: 0.2266    24
NZ_CP027599.1_13138	SP(Sec/SPI)	0.331225	0.306748	0.080805	0.281222	CS pos: 30-31. SWA-TA. Pr: 0.2476    33
NZ_CP027599.1_13141	SP(Sec/SPI)	0.608195	0.012914	0.215508	0.163384	CS pos: 17-18. LKA-GS. Pr: 0.3969    49
NZ_CP027599.1_13150	LIPO(Sec/SPII)	0.165097	0.012743	0.704303	0.117857	CS pos: 13-14. VVS-CR. Pr: 0.6405    20
NZ_CP027599.1_13194	LIPO(Sec/SPII)	0.263376	0.001191	0.714717	0.020716	CS pos: 14-15. MSV-CA. Pr: 0.6448    28
NZ_CP027599.1_13251	LIPO(Sec/SPII)	0.254317	0.021940	0.536659	0.187084	CS pos: 22-23. LAG-SS. Pr: 0.4487    35
NZ_CP027599.1_13277	SP(Sec/SPI)	0.756866	0.019178	0.068309	0.155647	CS pos: 18-19. ANA-HS. Pr: 0.3343    28
NZ_CP027599.1_13299	SP(Sec/SPI)	0.714475	0.018869	0.067316	0.199339	CS pos: 21-22. AEA-FQ. Pr: 0.5544    39
NZ_CP027599.1_13315	LIPO(Sec/SPII)	0.093470	0.010837	0.753977	0.141716	CS pos: 16-17. LTE-CS. Pr: 0.7081    21
NZ_CP027599.1_13323	TAT(Tat/SPI)	0.170067	0.631557	0.016958	0.181418	CS pos: 27-28. AQA-RC. Pr: 0.6351    40
NZ_CP027599.1_13346	LIPO(Sec/SPII)	0.106814	0.018798	0.451148	0.423240	CS pos: 25-26. LLH-CT. Pr: 0.4132    39
NZ_CP027599.1_13366	LIPO(Sec/SPII)	0.116918	0.008333	0.830435	0.044314	CS pos: 20-21. YLS-CS. Pr: 0.7054    35
NZ_CP027599.1_13370	TAT(Tat/SPI)	0.100491	0.597645	0.200335	0.101529	CS pos: 30-31. CWS-VL. Pr: 0.1263    49
NZ_CP027599.1_13371	LIPO(Sec/SPII)	0.237690	0.054076	0.370978	0.337257	CS pos: 12-13. ANG-CE. Pr: 0.2131    15
NZ_CP027599.1_13383	LIPO(Sec/SPII)	0.230804	0.047094	0.446975	0.275126	CS pos: 13-14. AAG-CL. Pr: 0.2880    15
NZ_CP027599.1_13399	LIPO(Sec/SPII)	0.258877	0.013986	0.387261	0.339876	CS pos: 13-14. ACI-CT. Pr: 0.1495    25
NZ_CP027599.1_13408	LIPO(Sec/SPII)	0.140280	0.027924	0.481141	0.350655	CS pos: 20-21. LTL-CS. Pr: 0.3425    23
NZ_CP027599.1_13420	TAT(Tat/SPI)	0.300977	0.397435	0.015490	0.286098	CS pos: 32-33. ASA-DA. Pr: 0.3737    46
NZ_CP027599.1_13428	LIPO(Sec/SPII)	0.223392	0.036566	0.416874	0.323169	CS pos: 20-21. VSS-AG. Pr: 0.2139    26
NZ_CP027599.1_13494	LIPO(Sec/SPII)	0.021405	0.000604	0.952831	0.025160	CS pos: 19-20. AFS-CT. Pr: 0.9539    43
NZ_CP027599.1_13503	SP(Sec/SPI)	0.630447	0.089573	0.090022	0.189958	CS pos: 17-18. ALA-ST. Pr: 0.3855    31
NZ_CP027599.1_13532	LIPO(Sec/SPII)	0.106773	0.011597	0.539189	0.342441	CS pos: 22-23. AWG-CN. Pr: 0.5674    33
NZ_CP027599.1_13549	LIPO(Sec/SPII)	0.145496	0.039676	0.553431	0.261397	CS pos: 23-24. SST-CS. Pr: 0.5245    42
NZ_CP027599.1_13550	LIPO(Sec/SPII)	0.058132	0.086319	0.533150	0.322399	CS pos: 22-23. AAG-CR. Pr: 0.5337    48
NZ_CP027599.1_13558	LIPO(Sec/SPII)	0.129266	0.045231	0.487645	0.337858	CS pos: 22-23. SNA-CS. Pr: 0.4565    39
NZ_CP027599.1_13578	SP(Sec/SPI)	0.510316	0.008389	0.279965	0.201330	CS pos: ?. Probable protein fragment    18
NZ_CP027599.1_13589	LIPO(Sec/SPII)	0.354657	0.011515	0.418789	0.215038	CS pos: ?. Probable protein fragment    17
NZ_CP027599.1_13612	SP(Sec/SPI)	0.707504	0.057530	0.076140	0.158826	CS pos: 17-18. GSA-AD. Pr: 0.3643    23
NZ_CP027599.1_13616	SP(Sec/SPI)	0.360560	0.094431	0.206933	0.338077	CS pos: 23-24. VAA-ST. Pr: 0.1654    28
NZ_CP027599.1_13685	LIPO(Sec/SPII)	0.259866	0.014487	0.456829	0.268818	CS pos: ?. Probable protein fragment    19
NZ_CP027599.1_13687	LIPO(Sec/SPII)	0.110546	0.046140	0.678729	0.164586	CS pos: 21-22. SAG-CT. Pr: 0.5877    25
NZ_CP027599.1_13695	SP(Sec/SPI)	0.371890	0.033810	0.320491	0.273809	CS pos: 20-21. RLA-NT. Pr: 0.1369    38
NZ_CP027599.1_13739	SP(Sec/SPI)	0.396734	0.232013	0.056783	0.314470	CS pos: 26-27. VSA-RV. Pr: 0.4312    42
NZ_CP027599.1_13756	SP(Sec/SPI)	0.686214	0.039312	0.152498	0.121976	CS pos: 16-17. ASA-QS. Pr: 0.3735    33
NZ_CP027599.1_13764	LIPO(Sec/SPII)	0.155768	0.006847	0.551859	0.285526	CS pos: 18-19. WAG-CR. Pr: 0.5278    44
NZ_CP027599.1_13774	SP(Sec/SPI)	0.378765	0.040922	0.231825	0.348488	CS pos: ?. Probable protein fragment    18
NZ_CP027599.1_13782	LIPO(Sec/SPII)	0.131054	0.006446	0.474963	0.387537	CS pos: 20-21. LPG-CV. Pr: 0.3744    28
NZ_CP027599.1_13783	LIPO(Sec/SPII)	0.163727	0.039849	0.479904	0.316519	CS pos: ?. Probable protein fragment    19
NZ_CP027599.1_13784	SP(Sec/SPI)	0.536193	0.043110	0.126960	0.293737	CS pos: 17-18. SVA-AE. Pr: 0.2226    23
NZ_CP027599.1_13816	LIPO(Sec/SPII)	0.212603	0.002207	0.414127	0.371063	CS pos: 29-30. SVC-CN. Pr: 0.1980    39
NZ_CP027599.1_13819	LIPO(Sec/SPII)	0.255821	0.019278	0.363734	0.361167	CS pos: ?. Probable protein fragment    15
NZ_CP027599.1_13828	LIPO(Sec/SPII)	0.266762	0.027013	0.456693	0.249533	CS pos: ?. Probable protein fragment    18
NZ_CP027599.1_13838	LIPO(Sec/SPII)	0.037274	0.001152	0.920041	0.041532	CS pos: 29-30. LTN-CT. Pr: 0.9144    44
NZ_CP027599.1_13852	LIPO(Sec/SPII)	0.137712	0.055024	0.506976	0.300288	CS pos: 12-13. GSG-CR. Pr: 0.4110    18
NZ_CP027599.1_13856	SP(Sec/SPI)	0.390427	0.119383	0.156344	0.333846	CS pos: 28-29. AHG-VA. Pr: 0.2123    42
NZ_CP027599.1_13858	SP(Sec/SPI)	0.476490	0.043781	0.046692	0.433038	CS pos: 16-17. VRA-AN. Pr: 0.3853    34
NZ_CP027599.1_13864	LIPO(Sec/SPII)	0.089871	0.022487	0.453266	0.434377	CS pos: 20-21. LSG-CR. Pr: 0.4227    27
NZ_CP027599.1_13867	LIPO(Sec/SPII)	0.226799	0.022685	0.426848	0.323668	CS pos: 13-14. SSA-CA. Pr: 0.3858    23
NZ_CP027599.1_13871	LIPO(Sec/SPII)	0.107153	0.005001	0.864245	0.023601	CS pos: 23-24. SNG-CS. Pr: 0.8223    34
NZ_CP027599.1_13937	SP(Sec/SPI)	0.466727	0.024949	0.138405	0.369919	CS pos: 24-25. VRA-RL. Pr: 0.3128    27
NZ_CP027599.1_13952	LIPO(Sec/SPII)	0.138627	0.017369	0.501642	0.342362	CS pos: 17-18. FVG-CL. Pr: 0.4117    21
NZ_CP027599.1_13969	LIPO(Sec/SPII)	0.226793	0.021809	0.481834	0.269564	CS pos: 15-16. SSN-CS. Pr: 0.2690    18
NZ_CP027599.1_14027	SP(Sec/SPI)	0.478342	0.006210	0.215278	0.300170	CS pos: 17-18. VSS-LQ. Pr: 0.3862    33
NZ_CP027599.1_14051	SP(Sec/SPI)	0.319103	0.266735	0.213562	0.200600	CS pos: 28-29. ATA-SS. Pr: 0.4070    32
NZ_CP027599.1_14104	SP(Sec/SPI)	0.280909	0.191614	0.266556	0.260921	CS pos: 23-24. TQG-AT. Pr: 0.1881    25
NZ_CP027599.1_14110	SP(Sec/SPI)	0.387184	0.069620	0.158595	0.384602	CS pos: 20-21. VPA-FP. Pr: 0.1389    27
NZ_CP027599.1_14129	SP(Sec/SPI)	0.450796	0.003199	0.135412	0.410593	CS pos: 21-22. LFS-KS. Pr: 0.2893    36
NZ_CP027599.1_14178	SP(Sec/SPI)	0.391985	0.121408	0.099730	0.386878	CS pos: 22-23. ISA-SR. Pr: 0.0809    46
NZ_CP027599.1_14208	LIPO(Sec/SPII)	0.021507	0.041821	0.924817	0.011855	CS pos: 23-24. FSG-CT. Pr: 0.9213    48
NZ_CP027599.1_14241	SP(Sec/SPI)	0.548051	0.122655	0.038777	0.290518	CS pos: 23-24. AAA-RV. Pr: 0.3006    38
NZ_CP027599.1_14319	SP(Sec/SPI)	0.391850	0.013118	0.320337	0.274695	CS pos: 12-13. MLA-AN. Pr: 0.1155    25
NZ_CP027599.1_14328	SP(Sec/SPI)	0.429403	0.047698	0.285711	0.237188	CS pos: 20-21. VGS-DV. Pr: 0.2583    35
NZ_CP027599.1_14341	SP(Sec/SPI)	0.754881	0.079041	0.122483	0.043595	CS pos: 22-23. NSA-QP. Pr: 0.3188    33
NZ_CP027599.1_14345	SP(Sec/SPI)	0.437163	0.065441	0.069509	0.427887	CS pos: 19-20. VRS-TK. Pr: 0.2026    47
NZ_CP027599.1_14357	TAT(Tat/SPI)	0.065729	0.681218	0.026424	0.226629	CS pos: 29-30. FSG-LF. Pr: 0.1507    45
NZ_CP027599.1_14359	SP(Sec/SPI)	0.471986	0.272759	0.041250	0.214006	CS pos: 30-31. AVA-AS. Pr: 0.1982    46
NZ_CP027599.1_14401	SP(Sec/SPI)	0.653032	0.025239	0.116635	0.205094	CS pos: 16-17. ALS-AF. Pr: 0.4155    32
NZ_CP027599.1_14416	LIPO(Sec/SPII)	0.197896	0.034667	0.444019	0.323418	CS pos: 13-14. FCA-CK. Pr: 0.2622    15
NZ_CP027599.1_14428	LIPO(Sec/SPII)	0.127633	0.001492	0.784535	0.086340	CS pos: 13-14. GLG-CF. Pr: 0.7497    38
NZ_CP027599.1_14457	LIPO(Sec/SPII)	0.288954	0.032505	0.347615	0.330926	CS pos: ?. Probable protein fragment    15
NZ_CP027599.1_14513	LIPO(Sec/SPII)	0.079412	0.004482	0.564745	0.351360	CS pos: 22-23. LTV-CN. Pr: 0.5289    27
NZ_CP027599.1_14515	LIPO(Sec/SPII)	0.264113	0.018743	0.430806	0.286338	CS pos: ?. Probable protein fragment    15
NZ_CP027599.1_14529	SP(Sec/SPI)	0.492260	0.007606	0.028572	0.471563	CS pos: 19-20. AGA-TD. Pr: 0.4560    48
NZ_CP027599.1_14553	LIPO(Sec/SPII)	0.133230	0.008624	0.665484	0.192662	CS pos: ?. Probable protein fragment    22
NZ_CP027599.1_14557	LIPO(Sec/SPII)	0.304673	0.020005	0.445878	0.229444	CS pos: 14-15. SHL-HP. Pr: 0.0240    16
NZ_CP027599.1_14562	SP(Sec/SPI)	0.461033	0.193202	0.021004	0.324762	CS pos: 29-30. MQA-LP. Pr: 0.4160    46
NZ_CP027599.1_14599	LIPO(Sec/SPII)	0.274303	0.016122	0.361606	0.347969	CS pos: 17-18. PMA-LF. Pr: 0.0228    19
NZ_CP027599.1_14602	SP(Sec/SPI)	0.414276	0.040814	0.155327	0.389583	CS pos: 16-17. TYS-AN. Pr: 0.1839    26
NZ_CP027599.1_14605	LIPO(Sec/SPII)	0.371784	0.005344	0.606068	0.016805	CS pos: 20-21. PIR-CS. Pr: 0.5498    38
NZ_CP027599.1_14620	LIPO(Sec/SPII)	0.234624	0.017192	0.449453	0.298732	CS pos: 18-19. IGP-CL. Pr: 0.1511    20
NZ_CP027599.1_14649	SP(Sec/SPI)	0.428044	0.013662	0.139500	0.418793	CS pos: 20-21. TWG-RV. Pr: 0.0904    31
NZ_CP027599.1_14672	SP(Sec/SPI)	0.599247	0.094300	0.063426	0.243027	CS pos: 23-24. SLA-IP. Pr: 0.3687    38
NZ_CP027599.1_14682	LIPO(Sec/SPII)	0.161630	0.010202	0.730717	0.097451	CS pos: 22-23. VTS-CP. Pr: 0.6167    25
NZ_CP027599.1_14697	SP(Sec/SPI)	0.331880	0.045749	0.291029	0.331342	CS pos: 16-17. CGA-DR. Pr: 0.1472    25
NZ_CP027599.1_14711	LIPO(Sec/SPII)	0.197128	0.020158	0.471169	0.311545	CS pos: 22-23. MTS-CA. Pr: 0.1692    27
NZ_CP027599.1_14737	LIPO(Sec/SPII)	0.238577	0.027128	0.466197	0.268098	CS pos: 17-18. LLS-CL. Pr: 0.1971    19
NZ_CP027599.1_14759	LIPO(Sec/SPII)	0.131289	0.013647	0.708377	0.146687	CS pos: 21-22. LSG-CR. Pr: 0.7097    38
NZ_CP027599.1_14813	SP(Sec/SPI)	0.420300	0.003152	0.336271	0.240277	CS pos: 21-22. GFK-VK. Pr: 0.0789    25
NZ_CP027599.1_14914	LIPO(Sec/SPII)	0.113085	0.001086	0.444003	0.441827	CS pos: 20-21. VIH-CK. Pr: 0.4120    37
NZ_CP027599.1_14928	LIPO(Sec/SPII)	0.223508	0.018061	0.474786	0.283646	CS pos: 15-16. ISK-CC. Pr: 0.2185    19
NZ_CP027599.1_14934	LIPO(Sec/SPII)	0.211051	0.018823	0.507692	0.262434	CS pos: 11-12. ILA-CS. Pr: 0.3798    16
NZ_CP027599.1_14948	LIPO(Sec/SPII)	0.245065	0.024395	0.381822	0.348718	CS pos: ?. Probable protein fragment    19
NZ_CP027599.1_14978	SP(Sec/SPI)	0.408137	0.002851	0.358726	0.230286	CS pos: 19-20. INC-HF. Pr: 0.2711    25
NZ_CP027599.1_15002	LIPO(Sec/SPII)	0.212915	0.023123	0.505017	0.258946	CS pos: 14-15. SLP-CT. Pr: 0.2577    34
NZ_CP027599.1_15009	LIPO(Sec/SPII)	0.122681	0.013232	0.480564	0.383523	CS pos: 17-18. FLQ-CK. Pr: 0.4008    22
NZ_CP027599.1_15012	LIPO(Sec/SPII)	0.022955	0.000989	0.942411	0.033644	CS pos: 13-14. FIA-CH. Pr: 0.9393    20
NZ_CP027599.1_15030	LIPO(Sec/SPII)	0.189795	0.022403	0.399672	0.388129	CS pos: ?. Probable protein fragment    16
NZ_CP027599.1_15061	LIPO(Sec/SPII)	0.113447	0.006412	0.682261	0.197880	CS pos: 12-13. SIA-CS. Pr: 0.6864    45
NZ_CP027599.1_15077	LIPO(Sec/SPII)	0.197914	0.018099	0.440718	0.343269	CS pos: 16-17. NLT-CQ. Pr: 0.3150    19
NZ_CP027599.1_15090	TAT(Tat/SPI)	0.216842	0.437747	0.038669	0.306741	CS pos: 41-42. ARS-HS. Pr: 0.2992    46
NZ_CP027599.1_15099	LIPO(Sec/SPII)	0.292068	0.039169	0.383031	0.285732	CS pos: 14-15. IFT-LH. Pr: 0.0168    16
NZ_CP027599.1_15136	LIPO(Sec/SPII)	0.167012	0.009733	0.696487	0.126768	CS pos: 22-23. SVC-CC. Pr: 0.3179    32
NZ_CP027599.1_15178	SP(Sec/SPI)	0.548973	0.004798	0.105101	0.341128	CS pos: 13-14. SQS-GN. Pr: 0.0999    24
NZ_CP027599.1_15182	LIPO(Sec/SPII)	0.179628	0.013409	0.405715	0.401248	CS pos: 18-19. FIF-CD. Pr: 0.1273    20
NZ_CP027599.1_15192	LIPO(Sec/SPII)	0.321427	0.004141	0.341922	0.332510	CS pos: 17-18. AHQ-CH. Pr: 0.3829    39
NZ_CP027599.1_15210	LIPO(Sec/SPII)	0.194840	0.022360	0.409224	0.373575	CS pos: ?. Probable protein fragment    20
NZ_CP027599.1_15252	LIPO(Sec/SPII)	0.325377	0.054743	0.368859	0.251021	CS pos: 15-16. GSG-CH. Pr: 0.3488    34
NZ_CP027599.1_15258	LIPO(Sec/SPII)	0.356231	0.016429	0.411936	0.215404	CS pos: 14-15. FCV-CS. Pr: 0.1743    18
NZ_CP027599.1_15264	SP(Sec/SPI)	0.584386	0.161457	0.059093	0.195064	CS pos: 23-24. AGA-ES. Pr: 0.3809    28
NZ_CP027599.1_15293	SP(Sec/SPI)	0.412325	0.185237	0.051695	0.350743	CS pos: 36-37. SQA-LG. Pr: 0.2395    46
NZ_CP027599.1_15351	LIPO(Sec/SPII)	0.252175	0.019982	0.403269	0.324574	CS pos: ?. Probable protein fragment    15
NZ_CP027599.1_15368	LIPO(Sec/SPII)	0.221826	0.105693	0.455316	0.217164	CS pos: 24-25. VPG-CS. Pr: 0.4252    37
NZ_CP027599.1_15384	SP(Sec/SPI)	0.467969	0.049055	0.123706	0.359270	CS pos: 20-21. CHA-GP. Pr: 0.3538    25
NZ_CP027599.1_15398	LIPO(Sec/SPII)	0.056572	0.080253	0.691948	0.171226	CS pos: 27-28. SSG-CY. Pr: 0.5918    42
NZ_CP027599.1_15412	LIPO(Sec/SPII)	0.089643	0.015886	0.621710	0.272760	CS pos: 15-16. PSS-CR. Pr: 0.5400    24
NZ_CP027599.1_15418	LIPO(Sec/SPII)	0.079384	0.005323	0.896816	0.018477	CS pos: 17-18. TAT-CS. Pr: 0.8743    22
NZ_CP027599.1_15430	SP(Sec/SPI)	0.376648	0.255208	0.068023	0.300122	CS pos: 24-25. ALA-SL. Pr: 0.5078    48
NZ_CP027599.1_15432	TAT(Tat/SPI)	0.207045	0.356857	0.167446	0.268652	CS pos: 23-24. GFA-LP. Pr: 0.1609    29
NZ_CP027599.1_15454	SP(Sec/SPI)	0.566018	0.023357	0.246857	0.163768	CS pos: 16-17. ATA-AY. Pr: 0.3781    18
NZ_CP027599.1_15471	LIPO(Sec/SPII)	0.115918	0.017332	0.740737	0.126013	CS pos: 21-22. LPS-CG. Pr: 0.6814    39
NZ_CP027599.1_15482	LIPO(Sec/SPII)	0.074748	0.014339	0.863582	0.047331	CS pos: 19-20. ASA-CS. Pr: 0.8243    22
NZ_CP027599.1_15487	TAT(Tat/SPI)	0.032240	0.704751	0.011850	0.251158	CS pos: 33-34. RRS-HE. Pr: 0.1167    46
NZ_CP027599.1_15490	LIPO(Sec/SPII)	0.257936	0.025638	0.387633	0.328793	CS pos: ?. Probable protein fragment    15
NZ_CP027599.1_15507	SP(Sec/SPI)	0.486029	0.059813	0.050936	0.403222	CS pos: 18-19. ADA-AG. Pr: 0.3347    25
NZ_CP027599.1_15528	TAT(Tat/SPI)	0.099747	0.579961	0.288788	0.031504	CS pos: 26-27. AGC-AI. Pr: 0.2961    35
NZ_CP027599.1_15530	LIPO(Sec/SPII)	0.245149	0.083371	0.373462	0.298018	CS pos: ?. Probable protein fragment    15
NZ_CP027599.1_15543	SP(Sec/SPI)	0.811805	0.057496	0.042166	0.088534	CS pos: 28-29. TRA-LP. Pr: 0.7667    36
NZ_CP027599.1_15547	LIPO(Sec/SPII)	0.127022	0.030916	0.805304	0.036758	CS pos: 16-17. ASA-CR. Pr: 0.8168    27
NZ_CP027599.1_15577	LIPO(Sec/SPII)	0.068881	0.017069	0.749924	0.164126	CS pos: 14-15. FAG-CK. Pr: 0.7021    30
NZ_CP027599.1_15610	LIPO(Sec/SPII)	0.239412	0.021993	0.424934	0.313661	CS pos: ?. Probable protein fragment    22
NZ_CP027599.1_15629	LIPO(Sec/SPII)	0.347918	0.006358	0.480551	0.165174	CS pos: 14-15. ITL-CS. Pr: 0.2896    24
NZ_CP027599.1_15652	LIPO(Sec/SPII)	0.238382	0.003296	0.657443	0.100879	CS pos: 14-15. CSG-CW. Pr: 0.4737    16
NZ_CP027599.1_15654	SP(Sec/SPI)	0.559154	0.005684	0.030248	0.404914	CS pos: 17-18. VHS-AL. Pr: 0.4721    27
NZ_CP027599.1_15659	LIPO(Sec/SPII)	0.115559	0.005316	0.497485	0.381640	CS pos: 15-16. WSI-CL. Pr: 0.4473    48
NZ_CP027599.1_15666	LIPO(Sec/SPII)	0.302301	0.011237	0.379907	0.306555	CS pos: ?. Probable protein fragment    17
NZ_CP027599.1_15707	TAT(Tat/SPI)	0.307017	0.352794	0.055042	0.285146	CS pos: 30-31. ARS-VP. Pr: 0.4137    41
NZ_CP027599.1_15761	SP(Sec/SPI)	0.446586	0.041095	0.247718	0.264601	CS pos: 20-21. AFS-SR. Pr: 0.2634    22
NZ_CP027599.1_15765	LIPO(Sec/SPII)	0.270656	0.014021	0.394584	0.320739	CS pos: 17-18. MMA-IS. Pr: 0.0491    19
NZ_CP027599.1_15766	LIPO(Sec/SPII)	0.097267	0.007686	0.517578	0.377469	CS pos: 27-28. LSA-CY. Pr: 0.3569    31
NZ_CP027599.1_15775	LIPO(Sec/SPII)	0.235575	0.011425	0.503218	0.249782	CS pos: 18-19. ISN-CR. Pr: 0.3784    20
NZ_CP027599.1_15821	LIPO(Sec/SPII)	0.327673	0.069397	0.556251	0.046679	CS pos: 18-19. TLA-CS. Pr: 0.5453    33
NZ_CP027599.1_15833	SP(Sec/SPI)	0.377406	0.258219	0.023802	0.340572	CS pos: 24-25. LEA-RS. Pr: 0.2982    32
NZ_CP027599.1_15836	SP(Sec/SPI)	0.482720	0.060576	0.328978	0.127727	CS pos: 15-16. SSA-SS. Pr: 0.0812    17
NZ_CP027599.1_15879	LIPO(Sec/SPII)	0.207078	0.001586	0.451608	0.339728	CS pos: 18-19. VTL-CD. Pr: 0.4517    37
NZ_CP027599.1_15888	LIPO(Sec/SPII)	0.219002	0.056317	0.362945	0.361736	CS pos: ?. Probable protein fragment    16
NZ_CP027599.1_15890	LIPO(Sec/SPII)	0.150927	0.017968	0.416062	0.415043	CS pos: 21-22. QTG-CQ. Pr: 0.3436    39
NZ_CP027599.1_15980	TAT(Tat/SPI)	0.112046	0.734469	0.029416	0.124068	CS pos: 29-30. SAA-II. Pr: 0.3873    43
NZ_CP027599.1_15987	LIPO(Sec/SPII)	0.030364	0.001380	0.750870	0.217386	CS pos: 14-15. TSS-CD. Pr: 0.7569    42
NZ_CP027599.1_16057	LIPO(Sec/SPII)	0.019308	0.001433	0.675695	0.303563	CS pos: 28-29. FLS-CS. Pr: 0.5897    43
NZ_CP027599.1_16061	LIPO(Sec/SPII)	0.220225	0.029433	0.402018	0.348323	CS pos: ?. Probable protein fragment    18
NZ_CP027599.1_16064	SP(Sec/SPI)	0.475482	0.017006	0.285472	0.222040	CS pos: ?. Probable protein fragment    24
NZ_CP027599.1_16074	SP(Sec/SPI)	0.449936	0.002735	0.129498	0.417831	CS pos: 24-25. ISP-AI. Pr: 0.1571    46
NZ_CP027599.1_16126	LIPO(Sec/SPII)	0.212277	0.015598	0.406985	0.365141	CS pos: 16-17. AIA-CA. Pr: 0.2841    27
NZ_CP027599.1_16166	SP(Sec/SPI)	0.526093	0.041910	0.224923	0.207074	CS pos: 30-31. IYS-SE. Pr: 0.1371    40
NZ_CP027599.1_16184	LIPO(Sec/SPII)	0.138979	0.037999	0.521402	0.301620	CS pos: 18-19. ASG-CQ. Pr: 0.5031    27
NZ_CP027599.1_16187	LIPO(Sec/SPII)	0.092697	0.017719	0.656340	0.233244	CS pos: 20-21. FTA-CV. Pr: 0.6276    29
NZ_CP027599.1_16188	LIPO(Sec/SPII)	0.050115	0.005770	0.484695	0.459420	CS pos: 18-19. FAG-CY. Pr: 0.4537    43
NZ_CP027599.1_16202	LIPO(Sec/SPII)	0.090132	0.003760	0.764346	0.141761	CS pos: 18-19. STS-CW. Pr: 0.7454    33
NZ_CP027599.1_16287	LIPO(Sec/SPII)	0.058161	0.260908	0.374809	0.306121	CS pos: 32-33. AAG-CA. Pr: 0.3878    49
NZ_CP027599.1_16296	SP(Sec/SPI)	0.729324	0.106377	0.038012	0.126287	CS pos: 21-22. ARA-SV. Pr: 0.7730    29
NZ_CP027599.1_16301	LIPO(Sec/SPII)	0.033481	0.004025	0.889561	0.072933	CS pos: 18-19. VFG-CG. Pr: 0.8748    22
NZ_CP027599.1_16311	LIPO(Sec/SPII)	0.113158	0.011055	0.664754	0.211033	CS pos: 13-14. KSA-CN. Pr: 0.6565    30
NZ_CP027599.1_16315	LIPO(Sec/SPII)	0.228080	0.015888	0.394438	0.361594	CS pos: 15-16. RAA-CG. Pr: 0.3158    21
NZ_CP027599.1_16341	LIPO(Sec/SPII)	0.232093	0.022608	0.393951	0.351348	CS pos: 13-14. MSG-FT. Pr: 0.0447    15
NZ_CP027599.1_16358	SP(Sec/SPI)	0.494637	0.041705	0.142890	0.320768	CS pos: 16-17. LHA-QL. Pr: 0.3287    19
NZ_CP027599.1_16409	SP(Sec/SPI)	0.474884	0.010437	0.263776	0.250903	CS pos: 25-26. ITA-KQ. Pr: 0.3848    29
NZ_CP027599.1_16413	LIPO(Sec/SPII)	0.272064	0.046682	0.493401	0.187854	CS pos: 15-16. HCS-LT. Pr: 0.0327    17
NZ_CP027599.1_16446	SP(Sec/SPI)	0.326678	0.193679	0.188310	0.291334	CS pos: 24-25. ILV-GK. Pr: 0.1385    34
NZ_CP027599.1_16448	SP(Sec/SPI)	0.423064	0.024347	0.159882	0.392706	CS pos: 24-25. AWC-GP. Pr: 0.2383    26
NZ_CP027599.1_16461	LIPO(Sec/SPII)	0.132413	0.019041	0.669665	0.178881	CS pos: 11-12. SLA-CG. Pr: 0.5905    20
NZ_CP027599.1_16465	LIPO(Sec/SPII)	0.222597	0.071095	0.419162	0.287146	CS pos: 21-22. ANA-CG. Pr: 0.3746    34
NZ_CP027599.1_16520	LIPO(Sec/SPII)	0.025112	0.009355	0.842660	0.122873	CS pos: 14-15. SGA-CS. Pr: 0.8335    35
NZ_CP027599.1_16584	LIPO(Sec/SPII)	0.055572	0.046195	0.744332	0.153900	CS pos: 25-26. FAG-CS. Pr: 0.7365    34
NZ_CP027599.1_16669	LIPO(Sec/SPII)	0.086472	0.021404	0.780194	0.111929	CS pos: 12-13. ATG-CR. Pr: 0.7492    19
NZ_CP027599.1_16698	LIPO(Sec/SPII)	0.124875	0.040996	0.495929	0.338201	CS pos: ?. Probable protein fragment    25
NZ_CP027599.1_16724	LIPO(Sec/SPII)	0.300054	0.024744	0.411423	0.263779	CS pos: ?. Probable protein fragment    16
NZ_CP027599.1_16737	LIPO(Sec/SPII)	0.111892	0.150944	0.506835	0.230328	CS pos: 24-25. VAA-CR. Pr: 0.5497    35
NZ_CP027599.1_16853	LIPO(Sec/SPII)	0.122261	0.099558	0.539748	0.238433	CS pos: 15-16. HTA-CV. Pr: 0.4989    25
NZ_CP027599.1_16880	SP(Sec/SPI)	0.365585	0.226557	0.072882	0.334976	CS pos: 27-28. TSA-IT. Pr: 0.3010    46
NZ_CP027599.1_16901	SP(Sec/SPI)	0.461189	0.056993	0.153694	0.328124	CS pos: 22-23. AQA-LR. Pr: 0.2830    29
NZ_CP027599.1_16903	SP(Sec/SPI)	0.420829	0.137994	0.131506	0.309671	CS pos: 26-27. VPA-AN. Pr: 0.2224    35
NZ_CP027599.1_16916	SP(Sec/SPI)	0.418070	0.202153	0.043286	0.336490	CS pos: 23-24. AWS-NP. Pr: 0.2287    38
NZ_CP027599.1_16943	LIPO(Sec/SPII)	0.098193	0.020562	0.856125	0.025120	CS pos: 25-26. AAS-CR. Pr: 0.8260    35
NZ_CP027599.1_16952	SP(Sec/SPI)	0.390972	0.159299	0.120901	0.328828	CS pos: 26-27. THS-AS. Pr: 0.1602    31
NZ_CP027599.1_16957	SP(Sec/SPI)	0.491761	0.031020	0.045882	0.431338	CS pos: 19-20. AIA-VW. Pr: 0.3815    32
NZ_CP027599.1_16966	TAT(Tat/SPI)	0.402193	0.516458	0.015920	0.065429	CS pos: 29-30. ARA-AS. Pr: 0.4605    47
NZ_CP027599.1_16973	LIPO(Sec/SPII)	0.153683	0.001932	0.834086	0.010300	CS pos: 18-19. SVS-CA. Pr: 0.8293    40
NZ_CP027599.1_16978	LIPO(Sec/SPII)	0.327905	0.043103	0.389348	0.239643	CS pos: 27-28. AVQ-CV. Pr: 0.3588    46
NZ_CP027599.1_17005	LIPO(Sec/SPII)	0.328569	0.053357	0.346691	0.271383	CS pos: 15-16. VFA-VR. Pr: 0.0511    18
NZ_CP027599.1_17007	LIPO(Sec/SPII)	0.200341	0.035325	0.546006	0.218328	CS pos: 18-19. VSP-CS. Pr: 0.4612    41
NZ_CP027599.1_17009	SP(Sec/SPI)	0.558883	0.229683	0.028295	0.183139	CS pos: 21-22. AHA-SD. Pr: 0.5364    26
NZ_CP027599.1_17016	LIPO(Sec/SPII)	0.207570	0.098948	0.664030	0.029452	CS pos: 19-20. ALC-CN. Pr: 0.3667    34
NZ_CP027599.1_17056	TAT(Tat/SPI)	0.338422	0.372669	0.055128	0.233781	CS pos: 27-28. VPA-SS. Pr: 0.3791    42
NZ_CP027599.1_17081	SP(Sec/SPI)	0.722077	0.035564	0.065755	0.176604	CS pos: 18-19. IAS-LP. Pr: 0.3756    32
NZ_CP027599.1_17090	LIPO(Sec/SPII)	0.215464	0.012621	0.732454	0.039460	CS pos: 18-19. TTP-CS. Pr: 0.6279    33
NZ_CP027599.1_17093	LIPO(Sec/SPII)	0.082313	0.016427	0.542398	0.358863	CS pos: 22-23. LSG-CS. Pr: 0.5054    40
NZ_CP027599.1_17095	SP(Sec/SPI)	0.408416	0.027985	0.208819	0.354781	CS pos: 22-23. VVS-KP. Pr: 0.1760    46
NZ_CP027599.1_17114	LIPO(Sec/SPII)	0.252778	0.030489	0.415111	0.301622	CS pos: ?. Probable protein fragment    17
NZ_CP027599.1_17117	TAT(Tat/SPI)	0.244503	0.494759	0.031989	0.228750	CS pos: 27-28. ALT-AT. Pr: 0.3743    50
NZ_CP027599.1_17122	LIPO(Sec/SPII)	0.215573	0.030202	0.430132	0.324093	CS pos: 15-16. GWA-CR. Pr: 0.2654    17
NZ_CP027599.1_17139	LIPO(Sec/SPII)	0.146379	0.047798	0.626409	0.179414	CS pos: 14-15. TSA-CS. Pr: 0.6164    17
NZ_CP027599.1_17144	LIPO(Sec/SPII)	0.121645	0.018328	0.434300	0.425726	CS pos: 20-21. ALS-CW. Pr: 0.3785    27
NZ_CP027599.1_17159	LIPO(Sec/SPII)	0.140573	0.023230	0.473341	0.362856	CS pos: 17-18. VAG-CR. Pr: 0.3349    28
NZ_CP027599.1_17163	LIPO(Sec/SPII)	0.266528	0.090314	0.376765	0.266393	CS pos: 16-17. CAI-CT. Pr: 0.0279    19
NZ_CP027599.1_17169	SP(Sec/SPI)	0.380830	0.126659	0.254603	0.237908	CS pos: 32-33. ALC-SS. Pr: 0.1141    41
NZ_CP027599.1_17183	SP(Sec/SPI)	0.327609	0.160193	0.215815	0.296384	CS pos: 31-32. AGA-EN. Pr: 0.1743    39
NZ_CP027599.1_17249	LIPO(Sec/SPII)	0.156745	0.026457	0.601603	0.215195	CS pos: 15-16. TVG-CT. Pr: 0.4741    18
NZ_CP027599.1_17304	SP(Sec/SPI)	0.399994	0.067150	0.295658	0.237198	CS pos: 24-25. ALS-AT. Pr: 0.0589    29
NZ_CP027599.1_17305	LIPO(Sec/SPII)	0.390070	0.012559	0.442838	0.154533	CS pos: ?. Probable protein fragment    17
NZ_CP027599.1_17317	LIPO(Sec/SPII)	0.170276	0.196509	0.492860	0.140354	CS pos: 19-20. CAG-CA. Pr: 0.4027    27
NZ_CP027599.1_17322	LIPO(Sec/SPII)	0.269270	0.021949	0.504687	0.204093	CS pos: 18-19. ASV-CG. Pr: 0.3084    20
NZ_CP027599.1_17327	LIPO(Sec/SPII)	0.228743	0.021625	0.448415	0.301217	CS pos: 15-16. LSG-SS. Pr: 0.1285    18
NZ_CP027599.1_17330	LIPO(Sec/SPII)	0.255390	0.017126	0.398415	0.329069	CS pos: ?. Probable protein fragment    18
NZ_CP027599.1_17345	LIPO(Sec/SPII)	0.114975	0.295876	0.303502	0.285647	CS pos: 18-19. TQV-CG. Pr: 0.2613    44
NZ_CP027599.1_17361	SP(Sec/SPI)	0.428124	0.044437	0.125732	0.401707	CS pos: 18-19. AWS-SS. Pr: 0.2048    26
NZ_CP027599.1_17366	LIPO(Sec/SPII)	0.080719	0.010868	0.726854	0.181559	CS pos: 16-17. YSA-CS. Pr: 0.6980    23
NZ_CP027599.1_17380	SP(Sec/SPI)	0.285075	0.278705	0.162565	0.273654	CS pos: 21-22. ITA-LC. Pr: 0.2564    39
NZ_CP027599.1_17382	LIPO(Sec/SPII)	0.131134	0.006510	0.768414	0.093942	CS pos: 22-23. MCA-CW. Pr: 0.5580    47
NZ_CP027599.1_17384	SP(Sec/SPI)	0.532094	0.134553	0.153347	0.180006	CS pos: 25-26. ISA-SS. Pr: 0.4118    38
NZ_CP027599.1_17390	LIPO(Sec/SPII)	0.188326	0.074642	0.526559	0.210473	CS pos: 27-28. NAT-CG. Pr: 0.4896    37
NZ_CP027599.1_17403	SP(Sec/SPI)	0.721354	0.136209	0.007594	0.134843	CS pos: 27-28. AFA-DT. Pr: 0.8082    42
NZ_CP027599.1_17417	SP(Sec/SPI)	0.515799	0.080940	0.133787	0.269474	CS pos: 18-19. AIS-AG. Pr: 0.1606    28
NZ_CP027599.1_17452	SP(Sec/SPI)	0.326851	0.322496	0.032569	0.318085	CS pos: 20-21. ASA-GS. Pr: 0.3378    50
NZ_CP027599.1_17481	LIPO(Sec/SPII)	0.340368	0.028529	0.365151	0.265952	CS pos: 28-29. GTV-CR. Pr: 0.1843    50
NZ_CP027599.1_17512	LIPO(Sec/SPII)	0.123551	0.022200	0.430999	0.423250	CS pos: 22-23. VGS-CG. Pr: 0.4010    33
NZ_CP027599.1_17524	LIPO(Sec/SPII)	0.183480	0.005177	0.720185	0.091158	CS pos: 23-24. TST-CS. Pr: 0.6337    27
NZ_CP027599.1_17527	LIPO(Sec/SPII)	0.180329	0.003573	0.779265	0.036832	CS pos: 18-19. VAQ-CV. Pr: 0.4933    38
NZ_CP027599.1_17529	LIPO(Sec/SPII)	0.277207	0.039007	0.348941	0.334845	CS pos: ?. Probable protein fragment    16
NZ_CP027599.1_17538	LIPO(Sec/SPII)	0.251703	0.016004	0.399569	0.332724	CS pos: ?. Probable protein fragment    19
NZ_CP027599.1_17552	LIPO(Sec/SPII)	0.131534	0.007197	0.577864	0.283406	CS pos: 18-19. VSQ-CE. Pr: 0.5615    30
NZ_CP027599.1_17554	SP(Sec/SPI)	0.425360	0.019052	0.240278	0.315310	CS pos: ?. Probable protein fragment    25
NZ_CP027599.1_17595	SP(Sec/SPI)	0.430135	0.029290	0.213551	0.327024	CS pos: 24-25. ATP-KS. Pr: 0.2098    41
NZ_CP027599.1_17607	LIPO(Sec/SPII)	0.118128	0.019286	0.690793	0.171793	CS pos: 18-19. MSG-CG. Pr: 0.6492    21
NZ_CP027599.1_17632	LIPO(Sec/SPII)	0.144049	0.017180	0.584679	0.254093	CS pos: 16-17. ASA-CR. Pr: 0.5361    21
NZ_CP027599.1_17646	SP(Sec/SPI)	0.610820	0.105038	0.064383	0.219760	CS pos: 16-17. SQA-LP. Pr: 0.4441    28
NZ_CP027599.1_17668	SP(Sec/SPI)	0.398523	0.056440	0.188790	0.356246	CS pos: 20-21. ALP-VP. Pr: 0.1174    37
NZ_CP027599.1_17671	SP(Sec/SPI)	0.421628	0.016506	0.218114	0.343752	CS pos: 21-22. LVA-GT. Pr: 0.1218    44
NZ_CP027599.1_17675	LIPO(Sec/SPII)	0.120490	0.048533	0.632967	0.198010	CS pos: 16-17. SRA-CC. Pr: 0.4865    35
NZ_CP027599.1_17683	SP(Sec/SPI)	0.547189	0.032820	0.113391	0.306600	CS pos: 21-22. SRA-AC. Pr: 0.5080    49
NZ_CP027599.1_17743	SP(Sec/SPI)	0.765995	0.030025	0.052356	0.151624	CS pos: 17-18. GSA-EN. Pr: 0.7055    42
NZ_CP027599.1_17748	LIPO(Sec/SPII)	0.133544	0.042260	0.536767	0.287428	CS pos: 13-14. MLS-CS. Pr: 0.5081    32
NZ_CP027599.1_17790	SP(Sec/SPI)	0.608216	0.071401	0.141433	0.178950	CS pos: 16-17. AYS-SS. Pr: 0.1904    25
NZ_CP027599.1_17798	SP(Sec/SPI)	0.440106	0.028529	0.144782	0.386584	CS pos: 29-30. LVA-RN. Pr: 0.0828    50
NZ_CP027599.1_17871	LIPO(Sec/SPII)	0.164642	0.062540	0.431208	0.341610	CS pos: ?. Probable protein fragment    20
NZ_CP027599.1_17900	TAT(Tat/SPI)	0.189046	0.383202	0.050811	0.376940	CS pos: 25-26. KHA-QN. Pr: 0.1695    38
NZ_CP027599.1_17918	LIPO(Sec/SPII)	0.270833	0.032840	0.382315	0.314012	CS pos: 17-18. SLA-TL. Pr: 0.0543    19
NZ_CP027599.1_17972	SP(Sec/SPI)	0.493304	0.044545	0.098849	0.363302	CS pos: 25-26. STA-SE. Pr: 0.2499    43
NZ_CP027599.1_18018	LIPO(Sec/SPII)	0.259759	0.007315	0.514361	0.218565	CS pos: ?. Probable protein fragment    15
NZ_CP027599.1_18025	LIPO(Sec/SPII)	0.249909	0.024582	0.473309	0.252200	CS pos: ?. Probable protein fragment    20
NZ_CP027599.1_18069	LIPO(Sec/SPII)	0.201160	0.005589	0.565451	0.227800	CS pos: 13-14. TMQ-CI. Pr: 0.2936    24
NZ_CP027599.1_18080	LIPO(Sec/SPII)	0.267935	0.018057	0.414102	0.299906	CS pos: ?. Probable protein fragment    19
NZ_CP027599.1_18107	LIPO(Sec/SPII)	0.183113	0.022118	0.411294	0.383475	CS pos: 19-20. VCS-CI. Pr: 0.2833    21
NZ_CP027599.1_18109	LIPO(Sec/SPII)	0.006641	0.000422	0.958936	0.034000	CS pos: 22-23. IQG-CA. Pr: 0.9596    39
NZ_CP027599.1_18167	LIPO(Sec/SPII)	0.113314	0.009704	0.489466	0.387515	CS pos: 13-14. VLS-CP. Pr: 0.3824    16
NZ_CP027599.1_18168	LIPO(Sec/SPII)	0.159996	0.001788	0.540348	0.297869	CS pos: ?. Probable protein fragment    20
NZ_CP027599.1_18179	LIPO(Sec/SPII)	0.128693	0.007828	0.794111	0.069368	CS pos: 11-12. ISS-CS. Pr: 0.7354    17
NZ_CP027599.1_18193	LIPO(Sec/SPII)	0.260710	0.042525	0.405353	0.291413	CS pos: 15-16. ALR-CA. Pr: 0.2769    26
NZ_CP027599.1_18195	SP(Sec/SPI)	0.585835	0.241416	0.032045	0.140704	CS pos: 32-33. THA-GY. Pr: 0.5556    40
NZ_CP027599.1_18212	LIPO(Sec/SPII)	0.112222	0.302372	0.548803	0.036603	CS pos: 20-21. VAS-CI. Pr: 0.5438    44
NZ_CP027599.1_18240	LIPO(Sec/SPII)	0.416565	0.001162	0.448385	0.133887	CS pos: 14-15. TSG-EV. Pr: 0.4733    27
NZ_CP027599.1_18282	LIPO(Sec/SPII)	0.124329	0.012035	0.542224	0.321412	CS pos: 13-14. AGA-CS. Pr: 0.5389    26
NZ_CP027599.1_18328	SP(Sec/SPI)	0.515505	0.081658	0.025231	0.377605	CS pos: 40-41. AQA-VP. Pr: 0.4545    45
NZ_CP027599.1_18347	TAT(Tat/SPI)	0.050256	0.620747	0.032577	0.296420	CS pos: 33-34. SRA-HV. Pr: 0.4105    45
NZ_CP027599.1_18370	LIPO(Sec/SPII)	0.042485	0.006151	0.776608	0.174755	CS pos: 23-24. LTN-CS. Pr: 0.7715    36
NZ_CP027599.1_18388	LIPO(Sec/SPII)	0.082445	0.109593	0.613298	0.194665	CS pos: 23-24. LVA-CA. Pr: 0.6072    32
NZ_CP027599.1_18414	LIPO(Sec/SPII)	0.113742	0.014746	0.588963	0.282550	CS pos: 24-25. ITA-CR. Pr: 0.5623    26
NZ_CP027599.1_18424	LIPO(Sec/SPII)	0.144106	0.009414	0.553836	0.292644	CS pos: 19-20. VAR-CG. Pr: 0.4702    22
NZ_CP027599.1_18436	LIPO(Sec/SPII)	0.298021	0.020182	0.342877	0.338920	CS pos: 15-16. AGF-CV. Pr: 0.0408    18
NZ_CP027599.1_18450	LIPO(Sec/SPII)	0.174464	0.011574	0.469266	0.344695	CS pos: ?. Probable protein fragment    16
NZ_CP027599.1_18465	LIPO(Sec/SPII)	0.182241	0.006388	0.459129	0.352242	CS pos: 16-17. SVC-CA. Pr: 0.3055    29
NZ_CP027599.1_18486	LIPO(Sec/SPII)	0.223126	0.019516	0.387272	0.370087	CS pos: 14-15. CWG-CM. Pr: 0.1868    16
NZ_CP027599.1_18499	TAT(Tat/SPI)	0.113995	0.428800	0.054925	0.402280	CS pos: 25-26. HRA-RE. Pr: 0.1689    35
NZ_CP027599.1_18537	SP(Sec/SPI)	0.657429	0.045235	0.116195	0.181141	CS pos: ?. Probable protein fragment    18
NZ_CP027599.1_18561	LIPO(Sec/SPII)	0.212866	0.026169	0.451854	0.309111	CS pos: ?. Probable protein fragment    19
NZ_CP027599.1_18571	TAT(Tat/SPI)	0.179580	0.418591	0.067085	0.334744	CS pos: 27-28. APQ-CG. Pr: 0.0567    49
NZ_CP027599.1_18632	SP(Sec/SPI)	0.420253	0.119661	0.087958	0.372128	CS pos: 21-22. VAA-DP. Pr: 0.2276    43
NZ_CP027599.1_18649	SP(Sec/SPI)	0.346909	0.006430	0.321126	0.325536	CS pos: 16-17. ATA-ET. Pr: 0.2827    18
NZ_CP027599.1_18676	LIPO(Sec/SPII)	0.138286	0.023235	0.509909	0.328571	CS pos: 17-18. PSG-CS. Pr: 0.4186    37
NZ_CP027599.1_18681	LIPO(Sec/SPII)	0.258508	0.056844	0.349127	0.335521	CS pos: ?. Probable protein fragment    15
NZ_CP027599.1_18685	SP(Sec/SPI)	0.457259	0.040740	0.129648	0.372352	CS pos: 31-32. ATA-SV. Pr: 0.3347    34
NZ_CP027599.1_18687	LIPO(Sec/SPII)	0.161015	0.015471	0.613761	0.209753	CS pos: 17-18. VPG-CG. Pr: 0.4778    19
NZ_CP027599.1_18724	LIPO(Sec/SPII)	0.166070	0.029209	0.443722	0.360998	CS pos: 26-27. ASF-CW. Pr: 0.3308    50
NZ_CP027599.1_18731	SP(Sec/SPI)	0.364664	0.033268	0.245295	0.356773	CS pos: 13-14. TGA-GR. Pr: 0.0547    20
NZ_CP027599.1_18760	LIPO(Sec/SPII)	0.010172	0.000848	0.837285	0.151696	CS pos: 15-16. LTG-CP. Pr: 0.8380    33
NZ_CP027599.1_18773	LIPO(Sec/SPII)	0.154401	0.007077	0.593871	0.244651	CS pos: 15-16. FFE-CD. Pr: 0.5048    18
NZ_CP027599.1_18847	LIPO(Sec/SPII)	0.036696	0.001843	0.731452	0.230009	CS pos: 17-18. ISG-CQ. Pr: 0.7263    29
NZ_CP027599.1_18861	LIPO(Sec/SPII)	0.281331	0.041969	0.452859	0.223841	CS pos: 24-25. SPS-CM. Pr: 0.3440    27
NZ_CP027599.1_18863	LIPO(Sec/SPII)	0.227676	0.022650	0.379475	0.370199	CS pos: ?. Probable protein fragment    15
NZ_CP027599.1_18869	LIPO(Sec/SPII)	0.299107	0.061908	0.373757	0.265229	CS pos: ?. Probable protein fragment    15
NZ_CP027599.1_18886	SP(Sec/SPI)	0.557848	0.044473	0.036406	0.361273	CS pos: 23-24. LPA-AD. Pr: 0.2408    33
NZ_CP027599.1_18916	LIPO(Sec/SPII)	0.269366	0.092682	0.401414	0.236538	CS pos: 16-17. SLP-IS. Pr: 0.0239    18
NZ_CP027599.1_18919	LIPO(Sec/SPII)	0.212287	0.036208	0.459329	0.292176	CS pos: 19-20. CWN-CV. Pr: 0.0250    25
NZ_CP027599.1_18922	SP(Sec/SPI)	0.524874	0.069276	0.028997	0.376853	CS pos: 24-25. SFA-GN. Pr: 0.5184    42
NZ_CP027599.1_18946	SP(Sec/SPI)	0.630154	0.024727	0.205646	0.139473	CS pos: 20-21. ISS-TP. Pr: 0.2483    39
NZ_CP027599.1_18975	SP(Sec/SPI)	0.361299	0.221672	0.113612	0.303417	CS pos: 21-22. ARS-AS. Pr: 0.2465    40
NZ_CP027599.1_18990	LIPO(Sec/SPII)	0.180503	0.029477	0.476506	0.313514	CS pos: ?. Probable protein fragment    17
NZ_CP027599.1_19039	LIPO(Sec/SPII)	0.145385	0.005410	0.766701	0.082503	CS pos: 14-15. LSN-CA. Pr: 0.6587    17
NZ_CP027599.1_19043	LIPO(Sec/SPII)	0.202861	0.021364	0.436959	0.338816	CS pos: 20-21. RTA-CT. Pr: 0.2535    24
NZ_CP027599.1_19074	LIPO(Sec/SPII)	0.164057	0.006630	0.458760	0.370553	CS pos: 13-14. LSV-CW. Pr: 0.3230    19
NZ_CP027599.1_19109	LIPO(Sec/SPII)	0.046036	0.000655	0.942762	0.010547	CS pos: 19-20. ASG-CN. Pr: 0.9486    21
NZ_CP027599.1_19116	LIPO(Sec/SPII)	0.112369	0.012232	0.626134	0.249265	CS pos: 17-18. HTS-CS. Pr: 0.5763    40
NZ_CP027599.1_19140	LIPO(Sec/SPII)	0.151229	0.031177	0.663482	0.154111	CS pos: 26-27. LAS-CR. Pr: 0.5952    39
NZ_CP027599.1_19159	LIPO(Sec/SPII)	0.238813	0.030590	0.409816	0.320780	CS pos: ?. Probable protein fragment    15
NZ_CP027599.1_19175	LIPO(Sec/SPII)	0.273121	0.026746	0.493147	0.206985	CS pos: ?. Probable protein fragment    15
NZ_CP027599.1_19198	LIPO(Sec/SPII)	0.149421	0.012644	0.594475	0.243459	CS pos: 17-18. LPS-CS. Pr: 0.3215    25
NZ_CP027599.1_19206	LIPO(Sec/SPII)	0.185573	0.054611	0.394352	0.365463	CS pos: 18-19. HCR-CT. Pr: 0.1726    29
NZ_CP027599.1_19243	LIPO(Sec/SPII)	0.135864	0.046264	0.550513	0.267359	CS pos: 32-33. TVS-CR. Pr: 0.5013    39
NZ_CP027599.1_19412	SP(Sec/SPI)	0.590997	0.030294	0.234614	0.144096	CS pos: 17-18. AAA-QA. Pr: 0.2766    44
NZ_CP027599.1_19423	SP(Sec/SPI)	0.722523	0.024163	0.058349	0.194965	CS pos: 18-19. CNA-DD. Pr: 0.6958    24
NZ_CP027599.1_19448	LIPO(Sec/SPII)	0.285284	0.016506	0.407933	0.290277	CS pos: 17-18. PSG-VR. Pr: 0.0438    19
NZ_CP027599.1_19467	SP(Sec/SPI)	0.598450	0.042437	0.020922	0.338190	CS pos: 37-38. VLA-DS. Pr: 0.5483    48
NZ_CP027599.1_19471	SP(Sec/SPI)	0.699646	0.111727	0.028905	0.159722	CS pos: 27-28. AMA-TS. Pr: 0.5997    43
NZ_CP027599.1_19491	TAT(Tat/SPI)	0.050640	0.547630	0.041552	0.360178	CS pos: 41-42. ARS-AD. Pr: 0.2827    49
NZ_CP027599.1_19498	SP(Sec/SPI)	0.442932	0.063223	0.065529	0.428316	CS pos: 19-20. SLS-AG. Pr: 0.1782    37
NZ_CP027599.1_19501	LIPO(Sec/SPII)	0.014470	0.000777	0.956182	0.028571	CS pos: 13-14. FCA-CD. Pr: 0.9600    48
NZ_CP027599.1_19508	LIPO(Sec/SPII)	0.121820	0.017766	0.512909	0.347505	CS pos: 21-22. SLS-CE. Pr: 0.4144    29
NZ_CP027599.1_19522	LIPO(Sec/SPII)	0.105792	0.008609	0.803601	0.081999	CS pos: 16-17. LKA-CK. Pr: 0.7717    19
NZ_CP027599.1_19527	SP(Sec/SPI)	0.544656	0.034339	0.131698	0.289306	CS pos: 11-12. VFA-AE. Pr: 0.3947    19
NZ_CP027599.1_19542	TAT(Tat/SPI)	0.142378	0.561839	0.252712	0.043071	CS pos: 25-26. AHA-FS. Pr: 0.6113    32
NZ_CP027599.1_19613	TAT(Tat/SPI)	0.181818	0.389753	0.189623	0.238806	CS pos: ?. Probable protein fragment    18
NZ_CP027599.1_19651	LIPO(Sec/SPII)	0.042374	0.025462	0.884312	0.047852	CS pos: 25-26. SSA-CC. Pr: 0.8042    43
NZ_CP027599.1_19667	LIPO(Sec/SPII)	0.204849	0.023650	0.397117	0.374385	CS pos: 18-19. FFR-CW. Pr: 0.1608    23
NZ_CP027599.1_19698	TAT(Tat/SPI)	0.363119	0.436350	0.027654	0.172878	CS pos: 20-21. AAA-DL. Pr: 0.4099    46
NZ_CP027599.1_19726	LIPO(Sec/SPII)	0.271265	0.040519	0.379153	0.309063	CS pos: ?. Probable protein fragment    16
NZ_CP027599.1_19755	LIPO(Sec/SPII)	0.153989	0.009902	0.447712	0.388397	CS pos: 18-19. LIQ-CI. Pr: 0.2940    20
NZ_CP027599.1_19758	SP(Sec/SPI)	0.659740	0.019968	0.139000	0.181292	CS pos: 20-21. ENA-AH. Pr: 0.1623    25
NZ_CP027599.1_19785	SP(Sec/SPI)	0.597381	0.050548	0.059913	0.292158	CS pos: 18-19. ARA-GW. Pr: 0.5616    34
NZ_CP027599.1_19788	SP(Sec/SPI)	0.806035	0.078836	0.049618	0.065511	CS pos: 24-25. SAA-SS. Pr: 0.4416    41
NZ_CP027599.1_19814	SP(Sec/SPI)	0.487914	0.056408	0.093814	0.361864	CS pos: 24-25. LFA-AE. Pr: 0.4025    26
NZ_CP027599.1_19829	TAT(Tat/SPI)	0.087568	0.449076	0.053266	0.410090	CS pos: 29-30. AFA-SS. Pr: 0.1343    36
NZ_CP027599.1_19832	LIPO(Sec/SPII)	0.313899	0.039069	0.408031	0.239001	CS pos: 18-19. GLQ-CS. Pr: 0.3372    33
NZ_CP027599.1_19833	LIPO(Sec/SPII)	0.032172	0.006395	0.726425	0.235009	CS pos: 19-20. FFS-CQ. Pr: 0.7164    48
NZ_CP027599.1_19862	LIPO(Sec/SPII)	0.226509	0.033573	0.417016	0.322902	CS pos: ?. Probable protein fragment    15
NZ_CP027599.1_19872	LIPO(Sec/SPII)	0.133640	0.012618	0.459037	0.394704	CS pos: 21-22. VSA-CH. Pr: 0.4645    40
NZ_CP027599.1_19908	LIPO(Sec/SPII)	0.033142	0.001379	0.631318	0.334161	CS pos: 23-24. VSA-CK. Pr: 0.2751    50
NZ_CP027599.1_19911	LIPO(Sec/SPII)	0.263105	0.010877	0.429663	0.296355	CS pos: ?. Probable protein fragment    17
NZ_CP027599.1_19916	LIPO(Sec/SPII)	0.240031	0.025869	0.373179	0.360921	CS pos: ?. Probable protein fragment    15
NZ_CP027599.1_19921	LIPO(Sec/SPII)	0.097308	0.011067	0.522349	0.369276	CS pos: 17-18. FIG-CI. Pr: 0.3303    35
NZ_CP027599.1_19923	LIPO(Sec/SPII)	0.266427	0.037345	0.390934	0.305293	CS pos: 17-18. LVL-CV. Pr: 0.2955    46
NZ_CP027599.1_19929	LIPO(Sec/SPII)	0.332155	0.000939	0.345097	0.321809	CS pos: 18-19. FTA-VN. Pr: 0.3172    30
NZ_CP027599.1_20000	LIPO(Sec/SPII)	0.141645	0.214356	0.571413	0.072587	CS pos: 15-16. LVG-CL. Pr: 0.5644    39
NZ_CP027599.1_20004	SP(Sec/SPI)	0.345589	0.030153	0.327598	0.296660	CS pos: 18-19. LVC-KP. Pr: 0.1549    32
NZ_CP027599.1_20015	LIPO(Sec/SPII)	0.268949	0.025468	0.372492	0.333091	CS pos: ?. Probable protein fragment    15
NZ_CP027599.1_20033	LIPO(Sec/SPII)	0.031645	0.005049	0.637673	0.325632	CS pos: 22-23. VTA-CW. Pr: 0.6428    45
NZ_CP027599.1_20070	SP(Sec/SPI)	0.494779	0.015921	0.213988	0.275312	CS pos: 18-19. SLA-RR. Pr: 0.3873    21
NZ_CP027599.1_20079	SP(Sec/SPI)	0.427366	0.057231	0.258717	0.256686	CS pos: 20-21. SWS-DS. Pr: 0.3963    25
NZ_CP027599.1_20088	SP(Sec/SPI)	0.346146	0.019611	0.321407	0.312836	CS pos: ?. Probable protein fragment    22
NZ_CP027599.1_20100	LIPO(Sec/SPII)	0.267174	0.029339	0.399996	0.303491	CS pos: ?. Probable protein fragment    16
NZ_CP027599.1_20108	LIPO(Sec/SPII)	0.238133	0.015371	0.544776	0.201721	CS pos: 13-14. TSI-CG. Pr: 0.2318    15
NZ_CP027599.1_20138	LIPO(Sec/SPII)	0.054386	0.009113	0.748588	0.187913	CS pos: 13-14. LAS-CH. Pr: 0.7218    45
NZ_CP027599.1_20156	LIPO(Sec/SPII)	0.223026	0.028119	0.379476	0.369379	CS pos: ?. Probable protein fragment    18
NZ_CP027599.1_20163	LIPO(Sec/SPII)	0.183292	0.032958	0.534563	0.249188	CS pos: 12-13. SGG-CS. Pr: 0.3747    16
NZ_CP027599.1_20193	SP(Sec/SPI)	0.627432	0.050921	0.064482	0.257165	CS pos: 19-20. GLA-SY. Pr: 0.2065    38
NZ_CP027599.1_20242	LIPO(Sec/SPII)	0.291073	0.016325	0.448776	0.243826	CS pos: ?. Probable protein fragment    15
NZ_CP027599.1_20258	LIPO(Sec/SPII)	0.068089	0.003140	0.744920	0.183850	CS pos: 19-20. LLN-CW. Pr: 0.7280    29
NZ_CP027599.1_20307	LIPO(Sec/SPII)	0.023718	0.000526	0.937025	0.038731	CS pos: 30-31. TYG-CC. Pr: 0.9255    40
NZ_CP027599.1_20312	LIPO(Sec/SPII)	0.212135	0.042777	0.376770	0.368317	CS pos: ?. Probable protein fragment    15
NZ_CP027599.1_20354	SP(Sec/SPI)	0.398863	0.109179	0.160603	0.331356	CS pos: 14-15. SLA-SN. Pr: 0.1291    19
NZ_CP027599.1_20365	SP(Sec/SPI)	0.337646	0.039700	0.312732	0.309923	CS pos: 17-18. SSG-YE. Pr: 0.2226    31
NZ_CP027599.1_20370	LIPO(Sec/SPII)	0.174092	0.008851	0.671703	0.145354	CS pos: 16-17. SFS-CR. Pr: 0.4638    18
NZ_CP027599.1_20372	TAT(Tat/SPI)	0.221847	0.527725	0.033931	0.216497	CS pos: 29-30. ARA-SS. Pr: 0.5528    34
NZ_CP027599.1_20373	LIPO(Sec/SPII)	0.142430	0.027026	0.496987	0.333557	CS pos: 26-27. IIS-CK. Pr: 0.4494    28
NZ_CP027599.1_20378	LIPO(Sec/SPII)	0.004169	0.000933	0.888052	0.106846	CS pos: 21-22. FNA-CQ. Pr: 0.8917    45
NZ_CP027599.1_20382	LIPO(Sec/SPII)	0.099046	0.010529	0.507471	0.382954	CS pos: 26-27. LSG-SG. Pr: 0.4328    30
NZ_CP027599.1_20416	SP(Sec/SPI)	0.473589	0.102312	0.081596	0.342502	CS pos: 22-23. VRA-VF. Pr: 0.4911    31
NZ_CP027599.1_20439	LIPO(Sec/SPII)	0.148232	0.007739	0.721671	0.122357	CS pos: 19-20. LST-CI. Pr: 0.6001    21
NZ_CP027599.1_20452	LIPO(Sec/SPII)	0.241297	0.026996	0.394571	0.337136	CS pos: ?. Probable protein fragment    15
NZ_CP027599.1_20461	SP(Sec/SPI)	0.434033	0.167168	0.038766	0.360033	CS pos: 22-23. IFA-NS. Pr: 0.2617    41
NZ_CP027599.1_20472	LIPO(Sec/SPII)	0.278766	0.009262	0.526404	0.185568	CS pos: 12-13. LIA-CP. Pr: 0.1563    18
NZ_CP027599.1_20490	LIPO(Sec/SPII)	0.050971	0.032923	0.537282	0.378824	CS pos: 16-17. VWS-CA. Pr: 0.5110    43
NZ_CP027599.1_20515	LIPO(Sec/SPII)	0.244191	0.025498	0.420308	0.310002	CS pos: ?. Probable protein fragment    17
NZ_CP027599.1_20616	LIPO(Sec/SPII)	0.321012	0.069530	0.343870	0.265589	CS pos: ?. Probable protein fragment    16
NZ_CP027599.1_20642	LIPO(Sec/SPII)	0.262633	0.014829	0.396130	0.326408	CS pos: 22-23. HWG-CG. Pr: 0.3253    33
NZ_CP027599.1_20716	LIPO(Sec/SPII)	0.147834	0.030494	0.596186	0.225485	CS pos: 18-19. AHG-CA. Pr: 0.5785    35
NZ_CP027599.1_20750	LIPO(Sec/SPII)	0.159741	0.018263	0.542209	0.279787	CS pos: ?. Probable protein fragment    17
NZ_CP027599.1_20768	LIPO(Sec/SPII)	0.290541	0.040115	0.523865	0.145479	CS pos: 20-21. SGV-CS. Pr: 0.4214    32
NZ_CP027599.1_20771	SP(Sec/SPI)	0.473862	0.030661	0.176795	0.318682	CS pos: 20-21. ADG-QT. Pr: 0.1907    26
NZ_CP027599.1_20774	LIPO(Sec/SPII)	0.127202	0.017013	0.657666	0.198119	CS pos: 14-15. ATA-CS. Pr: 0.5988    17
NZ_CP027599.1_20869	LIPO(Sec/SPII)	0.200180	0.016278	0.577440	0.206103	CS pos: 16-17. FPS-CT. Pr: 0.2846    18
NZ_CP027599.1_20871	SP(Sec/SPI)	0.844714	0.077011	0.010988	0.067286	CS pos: 33-34. AWA-NC. Pr: 0.8907    38
NZ_CP027599.1_20899	SP(Sec/SPI)	0.491033	0.081938	0.025708	0.401322	CS pos: 20-21. AEA-RR. Pr: 0.4835    44
NZ_CP027599.1_20901	SP(Sec/SPI)	0.440337	0.037644	0.386359	0.135659	CS pos: 21-22. ILC-AT. Pr: 0.3173    26
NZ_CP027599.1_20909	SP(Sec/SPI)	0.609360	0.054928	0.100092	0.235620	CS pos: 16-17. ARA-FG. Pr: 0.4622    20
NZ_CP027599.1_20935	LIPO(Sec/SPII)	0.230843	0.010791	0.470786	0.287580	CS pos: ?. Probable protein fragment    19
NZ_CP027599.1_20950	LIPO(Sec/SPII)	0.192120	0.085937	0.505099	0.216843	CS pos: 17-18. GTA-CC. Pr: 0.3276    19
NZ_CP027599.1_20960	TAT(Tat/SPI)	0.212566	0.482554	0.072250	0.232630	CS pos: ?. Probable protein fragment    33
NZ_CP027599.1_20983	SP(Sec/SPI)	0.471476	0.050959	0.028822	0.448743	CS pos: 24-25. VSA-ET. Pr: 0.3004    45
NZ_CP027599.1_21025	LIPO(Sec/SPII)	0.247021	0.003751	0.451764	0.297464	CS pos: 18-19. VIL-CK. Pr: 0.2651    42
NZ_CP027599.1_21034	SP(Sec/SPI)	0.585159	0.198533	0.084076	0.132232	CS pos: 34-35. TVA-AQ. Pr: 0.2572    43
NZ_CP027599.1_21035	LIPO(Sec/SPII)	0.055467	0.016582	0.767992	0.159958	CS pos: 14-15. PLS-CI. Pr: 0.7693    49
NZ_CP027599.1_21055	LIPO(Sec/SPII)	0.196609	0.035464	0.661159	0.106768	CS pos: 20-21. TTG-CA. Pr: 0.5753    23
NZ_CP027599.1_21058	LIPO(Sec/SPII)	0.150475	0.073640	0.482389	0.293496	CS pos: 18-19. VVH-CA. Pr: 0.3615    23
NZ_CP027599.1_21095	SP(Sec/SPI)	0.553649	0.013667	0.146666	0.286018	CS pos: 15-16. SYA-GT. Pr: 0.5074    30
NZ_CP027599.1_21111	LIPO(Sec/SPII)	0.128686	0.040834	0.429297	0.401183	CS pos: 14-15. GVA-CG. Pr: 0.3848    31
NZ_CP027599.1_21113	LIPO(Sec/SPII)	0.099227	0.019846	0.510391	0.370535	CS pos: 17-18. VLA-CL. Pr: 0.4613    29
NZ_CP027599.1_21129	LIPO(Sec/SPII)	0.285253	0.020062	0.382746	0.311939	CS pos: 17-18. ALA-CV. Pr: 0.1289    24
NZ_CP027599.1_21149	LIPO(Sec/SPII)	0.399441	0.016853	0.428824	0.154881	CS pos: 13-14. LIV-CW. Pr: 0.3022    37
NZ_CP027599.1_21161	LIPO(Sec/SPII)	0.187213	0.043024	0.406640	0.363123	CS pos: 13-14. KSA-CR. Pr: 0.2913    16
NZ_CP027599.1_21170	LIPO(Sec/SPII)	0.237651	0.008070	0.386247	0.368033	CS pos: ?. Probable protein fragment    18
NZ_CP027599.1_21183	LIPO(Sec/SPII)	0.287570	0.007170	0.513475	0.191785	CS pos: ?. Probable protein fragment    16
NZ_CP027599.1_21223	TAT(Tat/SPI)	0.069827	0.464521	0.122840	0.342813	CS pos: 32-33. ARG-SR. Pr: 0.1180    37
NZ_CP027599.1_21226	TAT(Tat/SPI)	0.183642	0.299932	0.247708	0.268718	CS pos: ?. Probable protein fragment    18
NZ_CP027599.1_21229	LIPO(Sec/SPII)	0.360241	0.001623	0.395565	0.242571	CS pos: 21-22. SLP-CT. Pr: 0.2150    49
NZ_CP027599.1_21235	LIPO(Sec/SPII)	0.107895	0.167389	0.628337	0.096379	CS pos: 18-19. MSA-CA. Pr: 0.5458    20
NZ_CP027599.1_21238	LIPO(Sec/SPII)	0.016653	0.004471	0.619022	0.359854	CS pos: 23-24. PAG-CF. Pr: 0.6116    44
NZ_CP027599.1_21239	SP(Sec/SPI)	0.383348	0.143716	0.209498	0.263438	CS pos: 22-23. SNA-VS. Pr: 0.2676    28
NZ_CP027599.1_21247	SP(Sec/SPI)	0.450939	0.239249	0.025989	0.283823	CS pos: 25-26. AGA-AD. Pr: 0.3407    37
NZ_CP027599.1_21258	LIPO(Sec/SPII)	0.090748	0.026775	0.462893	0.419584	CS pos: 20-21. PIS-CS. Pr: 0.3840    28
NZ_CP027599.1_21259	SP(Sec/SPI)	0.504797	0.116648	0.048144	0.330411	CS pos: 10-11. AQA-AD. Pr: 0.4690    19
NZ_CP027599.1_21266	SP(Sec/SPI)	0.425127	0.061495	0.258930	0.254448	CS pos: 16-17. VSA-LS. Pr: 0.2492    33
NZ_CP027599.1_21273	LIPO(Sec/SPII)	0.242295	0.020292	0.418385	0.319028	CS pos: 15-16. WRR-CG. Pr: 0.0542    17
NZ_CP027599.1_21282	LIPO(Sec/SPII)	0.296578	0.029290	0.438984	0.235149	CS pos: ?. Probable protein fragment    16
NZ_CP027599.1_21290	SP(Sec/SPI)	0.435787	0.030248	0.235793	0.298173	CS pos: 24-25. LRA-AC. Pr: 0.2611    39
NZ_CP027599.1_21299	LIPO(Sec/SPII)	0.300872	0.021228	0.365086	0.312814	CS pos: 18-19. ISA-SV. Pr: 0.2216    33
NZ_CP027599.1_21319	LIPO(Sec/SPII)	0.155516	0.027545	0.479032	0.337907	CS pos: 17-18. VTG-CM. Pr: 0.3406    19
NZ_CP027599.1_21328	LIPO(Sec/SPII)	0.324138	0.012816	0.369165	0.293881	CS pos: ?. Probable protein fragment    20
NZ_CP027599.1_21375	LIPO(Sec/SPII)	0.051689	0.011037	0.668508	0.268766	CS pos: 19-20. IQA-CR. Pr: 0.6607    38
NZ_CP027599.1_21378	LIPO(Sec/SPII)	0.063428	0.008584	0.576835	0.351153	CS pos: 18-19. APG-CD. Pr: 0.5729    40
NZ_CP027599.1_21380	TAT(Tat/SPI)	0.122214	0.384555	0.220914	0.272318	CS pos: 25-26. RTG-YR. Pr: 0.0459    43
NZ_CP027599.1_21382	LIPO(Sec/SPII)	0.143089	0.021763	0.742611	0.092537	CS pos: 23-24. ITL-CS. Pr: 0.6386    50
NZ_CP027599.1_21385	LIPO(Sec/SPII)	0.099777	0.017638	0.800320	0.082266	CS pos: 14-15. MSS-CD. Pr: 0.7847    24
NZ_CP027599.1_21394	SP(Sec/SPI)	0.567866	0.009266	0.029598	0.393269	CS pos: 20-21. FFA-DE. Pr: 0.5280    29
NZ_CP027599.1_21397	LIPO(Sec/SPII)	0.258018	0.017375	0.393652	0.330956	CS pos: ?. Probable protein fragment    15
NZ_CP027599.1_21410	LIPO(Sec/SPII)	0.255321	0.064512	0.375121	0.305046	CS pos: ?. Probable protein fragment    15
NZ_CP027599.1_21437	LIPO(Sec/SPII)	0.169632	0.004394	0.605023	0.220951	CS pos: 15-16. TSG-VN. Pr: 0.4011    44
NZ_CP027599.1_21438	SP(Sec/SPI)	0.494200	0.057183	0.094104	0.354513	CS pos: 18-19. VQG-KS. Pr: 0.3198    31
NZ_CP027599.1_21454	LIPO(Sec/SPII)	0.293996	0.064229	0.334797	0.306978	CS pos: 13-14. YGK-CS. Pr: 0.0546    16
NZ_CP027599.1_21485	LIPO(Sec/SPII)	0.076427	0.008396	0.552540	0.362637	CS pos: 16-17. TFS-CA. Pr: 0.5098    26
NZ_CP027599.1_21510	LIPO(Sec/SPII)	0.289492	0.015452	0.388144	0.306911	CS pos: 12-13. RIS-CV. Pr: 0.1015    19
NZ_CP027599.1_21522	LIPO(Sec/SPII)	0.222310	0.013807	0.406101	0.357782	CS pos: ?. Probable protein fragment    20
NZ_CP027599.1_21546	SP(Sec/SPI)	0.503483	0.024171	0.160275	0.312072	CS pos: 18-19. VFA-SS. Pr: 0.3686    21
NZ_CP027599.1_21550	LIPO(Sec/SPII)	0.285699	0.015777	0.505269	0.193256	CS pos: ?. Probable protein fragment    18
NZ_CP027599.1_21558	SP(Sec/SPI)	0.552004	0.078670	0.076967	0.292359	CS pos: 12-13. ATA-AT. Pr: 0.4261    32
NZ_CP027599.1_21564	LIPO(Sec/SPII)	0.183474	0.032203	0.543715	0.240609	CS pos: 17-18. VSA-CR. Pr: 0.4812    19
NZ_CP027599.1_21578	LIPO(Sec/SPII)	0.213469	0.011361	0.605427	0.169742	CS pos: 16-17. VAR-CS. Pr: 0.4776    19
NZ_CP027599.1_21598	LIPO(Sec/SPII)	0.320380	0.027329	0.384652	0.267639	CS pos: 17-18. NGL-CS. Pr: 0.2806    31
NZ_CP027599.1_21599	LIPO(Sec/SPII)	0.337107	0.015316	0.390112	0.257465	CS pos: ?. Probable protein fragment    18
NZ_CP027599.1_21604	LIPO(Sec/SPII)	0.200330	0.030310	0.475365	0.293995	CS pos: 11-12. LAS-CG. Pr: 0.2712    15
NZ_CP027599.1_21632	LIPO(Sec/SPII)	0.147706	0.003933	0.458934	0.389427	CS pos: 22-23. LLG-DF. Pr: 0.4047    28
NZ_CP027599.1_21639	LIPO(Sec/SPII)	0.231241	0.067999	0.369026	0.331734	CS pos: 12-13. GSG-CQ. Pr: 0.1511    15
NZ_CP027599.1_21675	LIPO(Sec/SPII)	0.321214	0.011755	0.402572	0.264459	CS pos: 16-17. IVS-TW. Pr: 0.0340    18
NZ_CP027599.1_21682	SP(Sec/SPI)	0.515523	0.028169	0.032704	0.423604	CS pos: 11-12. ISA-GY. Pr: 0.1868    45
NZ_CP027599.1_21693	LIPO(Sec/SPII)	0.136928	0.014143	0.549787	0.299142	CS pos: 16-17. FLA-CL. Pr: 0.3993    50
NZ_CP027599.1_21710	LIPO(Sec/SPII)	0.310399	0.010923	0.348051	0.330628	CS pos: 18-19. LVS-LN. Pr: 0.0664    21
NZ_CP027599.1_21722	LIPO(Sec/SPII)	0.101959	0.021757	0.645177	0.231108	CS pos: 18-19. SSS-CC. Pr: 0.5622    23
NZ_CP027599.1_21743	LIPO(Sec/SPII)	0.236199	0.010485	0.487958	0.265357	CS pos: 15-16. TKR-CS. Pr: 0.2027    17
NZ_CP027599.1_21745	LIPO(Sec/SPII)	0.260896	0.005522	0.549288	0.184293	CS pos: 15-16. CRG-CI. Pr: 0.4504    23
NZ_CP027599.1_21765	LIPO(Sec/SPII)	0.156466	0.003677	0.428993	0.410863	CS pos: 30-31. AIK-CV. Pr: 0.2651    34
NZ_CP027599.1_22077	LIPO(Sec/SPII)	0.190985	0.011699	0.617515	0.179801	CS pos: 21-22. VVR-CK. Pr: 0.5889    29
NZ_CP027599.1_22341	LIPO(Sec/SPII)	0.284111	0.006241	0.463148	0.246501	CS pos: 16-17. HYC-CP. Pr: 0.1037    18
NZ_CP027599.1_22349	LIPO(Sec/SPII)	0.100031	0.078959	0.598898	0.222111	CS pos: 25-26. GMA-CR. Pr: 0.5768    42
NZ_CP027599.1_22371	TAT(Tat/SPI)	0.305610	0.351773	0.021607	0.321010	CS pos: 29-30. SWA-AF. Pr: 0.5716    43
NZ_CP027599.1_22387	LIPO(Sec/SPII)	0.236680	0.016192	0.525616	0.221512	CS pos: ?. Probable protein fragment    15
NZ_CP027599.1_22451	LIPO(Sec/SPII)	0.219097	0.023456	0.380425	0.377022	CS pos: ?. Probable protein fragment    21
NZ_CP027599.1_22461	LIPO(Sec/SPII)	0.190692	0.006922	0.446690	0.355695	CS pos: 13-14. CAA-CC. Pr: 0.2066    22
NZ_CP027599.1_22462	SP(Sec/SPI)	0.504652	0.024109	0.113502	0.357737	CS pos: 20-21. AQS-LP. Pr: 0.2268    30
NZ_CP027599.1_22467	LIPO(Sec/SPII)	0.086126	0.001537	0.808460	0.103877	CS pos: 23-24. LMA-CR. Pr: 0.7539    26
NZ_CP027599.1_22507	SP(Sec/SPI)	0.517336	0.022900	0.367300	0.092464	CS pos: 20-21. AIA-SK. Pr: 0.3856    37
NZ_CP027599.1_22527	LIPO(Sec/SPII)	0.158239	0.022489	0.537088	0.282184	CS pos: ?. Probable protein fragment    17
NZ_CP027599.1_22570	LIPO(Sec/SPII)	0.168048	0.007940	0.446930	0.377082	CS pos: 31-32. VAG-QT. Pr: 0.3526    38
NZ_CP027599.1_22588	LIPO(Sec/SPII)	0.161083	0.010825	0.511415	0.316676	CS pos: 27-28. LTC-CV. Pr: 0.2788    37
NZ_CP027599.1_22590	LIPO(Sec/SPII)	0.215032	0.009690	0.504039	0.271240	CS pos: 18-19. SSQ-CD. Pr: 0.4785    35
NZ_CP027599.1_22591	LIPO(Sec/SPII)	0.342934	0.016223	0.374093	0.266749	CS pos: 21-22. LVG-HT. Pr: 0.2652    29
NZ_CP027599.1_22598	LIPO(Sec/SPII)	0.129205	0.280385	0.308269	0.282141	CS pos: 19-20. MLQ-CT. Pr: 0.2714    35
NZ_CP027599.1_22621	SP(Sec/SPI)	0.487531	0.099347	0.069565	0.343558	CS pos: 22-23. APA-LT. Pr: 0.0941    30
NZ_CP027599.1_22662	LIPO(Sec/SPII)	0.360055	0.055426	0.421782	0.162737	CS pos: 15-16. SHA-CI. Pr: 0.5400    32
NZ_CP027599.1_22664	LIPO(Sec/SPII)	0.348733	0.087247	0.351369	0.212651	CS pos: 15-16. LAS-VA. Pr: 0.1684    44
NZ_CP027599.1_22665	SP(Sec/SPI)	0.447406	0.108681	0.089002	0.354912	CS pos: 24-25. VAA-AR. Pr: 0.2421    33
NZ_CP027599.1_22692	TAT(Tat/SPI)	0.098068	0.535459	0.009120	0.357353	CS pos: 27-28. AAG-VH. Pr: 0.2789    43
NZ_CP027599.1_22697	LIPO(Sec/SPII)	0.023527	0.013454	0.890792	0.072227	CS pos: 18-19. GSS-CC. Pr: 0.8276    48
NZ_CP027599.1_22699	LIPO(Sec/SPII)	0.071733	0.010867	0.893670	0.023730	CS pos: 16-17. GIS-CA. Pr: 0.8644    40
NZ_CP027599.1_22753	LIPO(Sec/SPII)	0.232806	0.018214	0.515793	0.233188	CS pos: 17-18. LSA-CF. Pr: 0.3292    19
NZ_CP027599.1_22776	LIPO(Sec/SPII)	0.299339	0.147693	0.341723	0.211244	CS pos: 22-23. ASG-AG. Pr: 0.2486    44
NZ_CP027599.1_22798	LIPO(Sec/SPII)	0.009663	0.003072	0.837678	0.149587	CS pos: 17-18. LVA-CF. Pr: 0.8373    42
NZ_CP027599.1_22837	LIPO(Sec/SPII)	0.192044	0.061194	0.414602	0.332160	CS pos: 18-19. VPA-CG. Pr: 0.3908    27
NZ_CP027599.1_22841	TAT(Tat/SPI)	0.179744	0.450458	0.052671	0.317127	CS pos: 25-26. ASG-RG. Pr: 0.1882    36
NZ_CP027599.1_22861	SP(Sec/SPI)	0.468905	0.081421	0.086190	0.363485	CS pos: 24-25. GHC-ES. Pr: 0.1638    28
NZ_CP027599.1_22900	LIPO(Sec/SPII)	0.077762	0.170955	0.657910	0.093373	CS pos: 21-22. TPG-CT. Pr: 0.6150    27
NZ_CP027599.1_22915	SP(Sec/SPI)	0.655257	0.049406	0.277506	0.017831	CS pos: 20-21. ASA-GS. Pr: 0.4953    35
NZ_CP027599.1_22956	LIPO(Sec/SPII)	0.170833	0.012634	0.495177	0.321355	CS pos: 16-17. IGA-CF. Pr: 0.4532    20
NZ_CP027599.1_22958	SP(Sec/SPI)	0.746432	0.056805	0.024391	0.172372	CS pos: 27-28. VWA-DA. Pr: 0.7671    31
NZ_CP027599.1_22993	LIPO(Sec/SPII)	0.317931	0.015991	0.402842	0.263237	CS pos: 13-14. LPL-CK. Pr: 0.0376    16
NZ_CP027599.1_22994	SP(Sec/SPI)	0.520364	0.026678	0.053179	0.399779	CS pos: 25-26. AQA-VT. Pr: 0.3204    30
NZ_CP027599.1_23007	LIPO(Sec/SPII)	0.128265	0.053370	0.532864	0.285501	CS pos: 23-24. TVA-CQ. Pr: 0.5112    35
NZ_CP027599.1_23020	LIPO(Sec/SPII)	0.287624	0.142009	0.308977	0.261390	CS pos: 25-26. SAT-CT. Pr: 0.1600    28
NZ_CP027599.1_23040	SP(Sec/SPI)	0.435386	0.109748	0.181185	0.273680	CS pos: 15-16. ALA-VK. Pr: 0.2633    36
NZ_CP027599.1_23049	SP(Sec/SPI)	0.469750	0.146283	0.329679	0.054288	CS pos: 29-30. AIT-GM. Pr: 0.1275    50
NZ_CP027599.1_23068	LIPO(Sec/SPII)	0.050783	0.004965	0.657669	0.286583	CS pos: 18-19. GFA-CN. Pr: 0.6402    25
NZ_CP027599.1_23080	TAT(Tat/SPI)	0.158788	0.416546	0.031120	0.393547	CS pos: 32-33. ISA-MP. Pr: 0.1543    39
NZ_CP027599.1_23096	SP(Sec/SPI)	0.558072	0.030690	0.265216	0.146022	CS pos: 21-22. IAA-VC. Pr: 0.2283    33
NZ_CP027599.1_23108	LIPO(Sec/SPII)	0.104485	0.180934	0.358176	0.356404	CS pos: 23-24. STA-CA. Pr: 0.3601    48
NZ_CP027599.1_23111	LIPO(Sec/SPII)	0.081288	0.010602	0.516898	0.391212	CS pos: 20-21. RAG-CW. Pr: 0.5021    27
NZ_CP027599.1_23120	SP(Sec/SPI)	0.394848	0.015288	0.303530	0.286335	CS pos: ?. Probable protein fragment    15
NZ_CP027599.1_23124	LIPO(Sec/SPII)	0.118274	0.044580	0.508404	0.328742	CS pos: 17-18. LLC-CR. Pr: 0.3563    47
NZ_CP027599.1_23128	SP(Sec/SPI)	0.388088	0.011639	0.301359	0.298914	CS pos: ?. Probable protein fragment    21
NZ_CP027599.1_23135	SP(Sec/SPI)	0.502166	0.015366	0.230002	0.252466	CS pos: 14-15. ASA-VH. Pr: 0.2521    17
NZ_CP027599.1_23152	LIPO(Sec/SPII)	0.368019	0.095317	0.374204	0.162461	CS pos: 23-24. RAA-CL. Pr: 0.3396    38
NZ_CP027599.1_23165	LIPO(Sec/SPII)	0.049515	0.004986	0.532610	0.412888	CS pos: 16-17. VVA-CR. Pr: 0.5158    34
NZ_CP027599.1_23226	SP(Sec/SPI)	0.513390	0.009040	0.318009	0.159561	CS pos: 20-21. CRS-TV. Pr: 0.3220    30
NZ_CP027599.1_23271	LIPO(Sec/SPII)	0.187671	0.029900	0.634945	0.147484	CS pos: 17-18. LMA-CQ. Pr: 0.5098    24
NZ_CP027599.1_23286	LIPO(Sec/SPII)	0.222807	0.015504	0.381442	0.380247	CS pos: 18-19. VTK-CL. Pr: 0.1197    24
NZ_CP027599.1_23319	LIPO(Sec/SPII)	0.186122	0.042700	0.444094	0.327084	CS pos: 10-11. LSG-CR. Pr: 0.3733    17
NZ_CP027599.1_23334	LIPO(Sec/SPII)	0.026670	0.000829	0.530974	0.441527	CS pos: 15-16. ILA-CI. Pr: 0.5264    36
NZ_CP027599.1_23338	SP(Sec/SPI)	0.589347	0.005002	0.386887	0.018764	CS pos: 19-20. ASG-AN. Pr: 0.2556    47
NZ_CP027599.1_23339	LIPO(Sec/SPII)	0.071658	0.003199	0.747780	0.177364	CS pos: 17-18. IFC-CC. Pr: 0.3814    33
NZ_CP027599.1_23347	LIPO(Sec/SPII)	0.226598	0.012022	0.558702	0.202679	CS pos: 20-21. IIA-CA. Pr: 0.3777    24
NZ_CP027599.1_23362	LIPO(Sec/SPII)	0.429327	0.020250	0.478264	0.072159	CS pos: 17-18. LTV-CT. Pr: 0.3972    34
NZ_CP027599.1_23367	TAT(Tat/SPI)	0.080279	0.435750	0.055838	0.428133	CS pos: 32-33. SRA-SR. Pr: 0.2675    41
NZ_CP027599.1_23391	SP(Sec/SPI)	0.532991	0.098473	0.049704	0.318832	CS pos: 21-22. AWA-AL. Pr: 0.5395    23
NZ_CP027599.1_23432	LIPO(Sec/SPII)	0.157896	0.011645	0.681012	0.149447	CS pos: 18-19. YGG-CR. Pr: 0.5738    23
NZ_CP027599.1_23436	SP(Sec/SPI)	0.372991	0.014057	0.260718	0.352234	CS pos: 17-18. AYG-TS. Pr: 0.2364    26
NZ_CP027599.1_23444	LIPO(Sec/SPII)	0.226117	0.003574	0.662880	0.107428	CS pos: 12-13. LPA-CV. Pr: 0.4291    19
NZ_CP027599.1_23457	SP(Sec/SPI)	0.437233	0.032035	0.165618	0.365114	CS pos: 23-24. AWA-MC. Pr: 0.2866    25
NZ_CP027599.1_23465	LIPO(Sec/SPII)	0.244042	0.062986	0.426842	0.266129	CS pos: ?. Probable protein fragment    17
NZ_CP027599.1_23477	LIPO(Sec/SPII)	0.235912	0.011083	0.427314	0.325690	CS pos: ?. Probable protein fragment    17
NZ_CP027599.1_23485	LIPO(Sec/SPII)	0.223511	0.005705	0.526142	0.244641	CS pos: 25-26. VAG-CV. Pr: 0.2971    32
NZ_CP027599.1_23516	LIPO(Sec/SPII)	0.300638	0.008334	0.454880	0.236148	CS pos: ?. Probable protein fragment    15
NZ_CP027599.1_23532	SP(Sec/SPI)	0.536296	0.105528	0.062866	0.295311	CS pos: 22-23. SNA-LP. Pr: 0.3639    31
NZ_CP027599.1_23535	LIPO(Sec/SPII)	0.220831	0.055422	0.529903	0.193843	CS pos: 14-15. GSS-CM. Pr: 0.2511    29
NZ_CP027599.1_23539	SP(Sec/SPI)	0.380767	0.119467	0.211600	0.288165	CS pos: 18-19. AFS-EA. Pr: 0.1018    23
NZ_CP027599.1_23554	LIPO(Sec/SPII)	0.145304	0.274439	0.348227	0.232029	CS pos: ?. Probable protein fragment    16
NZ_CP027599.1_23566	LIPO(Sec/SPII)	0.058949	0.007006	0.630780	0.303265	CS pos: 15-16. SAA-CG. Pr: 0.6094    28
NZ_CP027599.1_23601	SP(Sec/SPI)	0.417246	0.087636	0.268420	0.226698	CS pos: 20-21. AAA-ST. Pr: 0.0548    27
NZ_CP027599.1_23602	LIPO(Sec/SPII)	0.321269	0.086523	0.458979	0.133228	CS pos: 18-19. AAA-CL. Pr: 0.4051    24
NZ_CP027599.1_23603	SP(Sec/SPI)	0.397462	0.293546	0.220866	0.088126	CS pos: 15-16. ASA-AA. Pr: 0.2770    40
NZ_CP027599.1_23611	LIPO(Sec/SPII)	0.194751	0.022478	0.453878	0.328893	CS pos: 20-21. VTS-CR. Pr: 0.3516    25
NZ_CP027599.1_23631	LIPO(Sec/SPII)	0.253547	0.012463	0.372195	0.361795	CS pos: 21-22. TCP-CC. Pr: 0.1077    28
NZ_CP027599.1_23701	LIPO(Sec/SPII)	0.114226	0.038611	0.506020	0.341142	CS pos: 25-26. VAF-CA. Pr: 0.3877    40
NZ_CP027599.1_23710	LIPO(Sec/SPII)	0.169912	0.057300	0.460584	0.312205	CS pos: 17-18. LSR-CG. Pr: 0.3421    20
NZ_CP027599.1_23713	SP(Sec/SPI)	0.540897	0.003183	0.246322	0.209598	CS pos: 21-22. DFA-ED. Pr: 0.2733    46
NZ_CP027599.1_23724	LIPO(Sec/SPII)	0.018710	0.000715	0.659332	0.321242	CS pos: 19-20. LQS-CA. Pr: 0.4921    45
NZ_CP027599.1_23733	LIPO(Sec/SPII)	0.040014	0.005423	0.905165	0.049398	CS pos: 16-17. FTG-CY. Pr: 0.8957    21
NZ_CP027599.1_23770	SP(Sec/SPI)	0.370631	0.108236	0.187664	0.333470	CS pos: 17-18. ASA-AG. Pr: 0.1697    22
NZ_CP027599.1_23772	LIPO(Sec/SPII)	0.140847	0.032965	0.493861	0.332327	CS pos: 19-20. STG-CY. Pr: 0.4519    26
NZ_CP027599.1_23780	SP(Sec/SPI)	0.463788	0.088861	0.024896	0.422455	CS pos: 20-21. LQA-AH. Pr: 0.3645    47
NZ_CP027599.1_23796	LIPO(Sec/SPII)	0.268803	0.022361	0.364385	0.344450	CS pos: ?. Probable protein fragment    16
NZ_CP027599.1_23798	LIPO(Sec/SPII)	0.329800	0.034063	0.347980	0.288157	CS pos: ?. Probable protein fragment    19
NZ_CP027599.1_23811	LIPO(Sec/SPII)	0.219675	0.025351	0.394249	0.360725	CS pos: ?. Probable protein fragment    16
NZ_CP027599.1_23841	SP(Sec/SPI)	0.504503	0.138961	0.176322	0.180213	CS pos: 22-23. ASA-ST. Pr: 0.3671    25
NZ_CP027599.1_23893	LIPO(Sec/SPII)	0.100763	0.017561	0.524060	0.357616	CS pos: 24-25. DGA-CS. Pr: 0.4939    34
NZ_CP027599.1_23916	SP(Sec/SPI)	0.380295	0.011062	0.286521	0.322122	CS pos: 16-17. CFA-RS. Pr: 0.1249    18
NZ_CP027599.1_23992	SP(Sec/SPI)	0.899463	0.017133	0.021884	0.061519	CS pos: 28-29. VFA-AQ. Pr: 0.8857    40
NZ_CP027599.1_24029	SP(Sec/SPI)	0.381085	0.028660	0.356962	0.233292	CS pos: 17-18. VRE-TG. Pr: 0.0625    22
NZ_CP027599.1_24076	LIPO(Sec/SPII)	0.160736	0.009019	0.527110	0.303135	CS pos: 17-18. LTC-CF. Pr: 0.3168    20
NZ_CP027599.1_24138	LIPO(Sec/SPII)	0.269218	0.009616	0.397971	0.323196	CS pos: ?. Probable protein fragment    18
NZ_CP027599.1_24145	LIPO(Sec/SPII)	0.185044	0.021437	0.465732	0.327787	CS pos: 15-16. VAP-CK. Pr: 0.2539    18
NZ_CP027599.1_24161	LIPO(Sec/SPII)	0.216956	0.034875	0.417662	0.330507	CS pos: 16-17. MGT-CS. Pr: 0.4042    37
NZ_CP027599.1_24182	SP(Sec/SPI)	0.416062	0.025813	0.237971	0.320154	CS pos: 13-14. AMC-SF. Pr: 0.0523    20
NZ_CP027599.1_24194	LIPO(Sec/SPII)	0.143780	0.017261	0.547078	0.291882	CS pos: 11-12. CVG-CK. Pr: 0.4830    17
NZ_CP027599.1_24198	SP(Sec/SPI)	0.481242	0.053254	0.254240	0.211264	CS pos: 15-16. SVA-SS. Pr: 0.1891    35
NZ_CP027599.1_24204	LIPO(Sec/SPII)	0.110872	0.012011	0.515874	0.361243	CS pos: 22-23. LFG-CS. Pr: 0.4445    25
NZ_CP027599.1_24220	SP(Sec/SPI)	0.592436	0.018294	0.172673	0.216597	CS pos: 17-18. SSA-LI. Pr: 0.2723    47
NZ_CP027599.1_24224	LIPO(Sec/SPII)	0.317777	0.013706	0.382389	0.286129	CS pos: 13-14. LHF-CS. Pr: 0.1884    18
NZ_CP027599.1_24236	SP(Sec/SPI)	0.409212	0.015576	0.179857	0.395355	CS pos: 15-16. TSG-YI. Pr: 0.1427    25
NZ_CP027599.1_24240	SP(Sec/SPI)	0.387189	0.011175	0.317603	0.284033	CS pos: 20-21. AFC-MT. Pr: 0.2463    43
NZ_CP027599.1_24247	LIPO(Sec/SPII)	0.079480	0.008855	0.700581	0.211084	CS pos: 17-18. CFS-CS. Pr: 0.6675    41
NZ_CP027599.1_24274	SP(Sec/SPI)	0.601135	0.101141	0.061615	0.236109	CS pos: 28-29. ASA-QC. Pr: 0.3543    32
NZ_CP027599.1_24320	SP(Sec/SPI)	0.434170	0.015717	0.197702	0.352412	CS pos: 17-18. IYA-ND. Pr: 0.3780    19
NZ_CP027599.1_24366	LIPO(Sec/SPII)	0.224865	0.054787	0.434654	0.285694	CS pos: 21-22. TGK-CV. Pr: 0.3449    32
NZ_CP027599.1_24406	LIPO(Sec/SPII)	0.016134	0.261086	0.718470	0.004310	CS pos: 21-22. TGG-CR. Pr: 0.7106    50
NZ_CP027599.1_24422	LIPO(Sec/SPII)	0.048633	0.016084	0.587506	0.347777	CS pos: 26-27. ISA-CR. Pr: 0.5379    32
NZ_CP027599.1_24478	SP(Sec/SPI)	0.730574	0.013570	0.017214	0.238642	CS pos: 19-20. AAA-AD. Pr: 0.4169    47
NZ_CP027599.1_24480	SP(Sec/SPI)	0.544316	0.052417	0.032661	0.370606	CS pos: 21-22. AEG-AD. Pr: 0.3835    49
NZ_CP027599.1_24516	LIPO(Sec/SPII)	0.213810	0.018404	0.593663	0.174124	CS pos: 15-16. LSA-CV. Pr: 0.5650    23
NZ_CP027599.1_24536	LIPO(Sec/SPII)	0.203924	0.037088	0.414702	0.344285	CS pos: 13-14. ISA-CT. Pr: 0.2537    20
NZ_CP027599.1_24552	LIPO(Sec/SPII)	0.161170	0.010532	0.665681	0.162618	CS pos: 19-20. SLA-CT. Pr: 0.7840    29
NZ_CP027599.1_24568	LIPO(Sec/SPII)	0.015056	0.004985	0.954525	0.025435	CS pos: 18-19. HQG-CI. Pr: 0.9542    39
NZ_CP027599.1_24613	SP(Sec/SPI)	0.491096	0.160762	0.179916	0.168226	CS pos: 21-22. ASA-QP. Pr: 0.2225    26
NZ_CP027599.1_24615	SP(Sec/SPI)	0.695723	0.226437	0.052948	0.024892	CS pos: 20-21. AYS-SP. Pr: 0.3301    46
NZ_CP027599.1_24618	SP(Sec/SPI)	0.412556	0.096843	0.122013	0.368588	CS pos: 22-23. VSS-AW. Pr: 0.1311    31
NZ_CP027599.1_24640	LIPO(Sec/SPII)	0.109554	0.175612	0.366191	0.348643	CS pos: 19-20. MVS-CC. Pr: 0.1611    32
NZ_CP027599.1_24651	LIPO(Sec/SPII)	0.134815	0.024890	0.706991	0.133304	CS pos: 24-25. APG-CS. Pr: 0.6098    36
NZ_CP027599.1_24657	LIPO(Sec/SPII)	0.012821	0.001468	0.882153	0.103558	CS pos: 19-20. WFS-CR. Pr: 0.8779    40
NZ_CP027599.1_24660	LIPO(Sec/SPII)	0.059922	0.013081	0.550507	0.376491	CS pos: 22-23. AEG-CS. Pr: 0.5384    37
NZ_CP027599.1_24683	SP(Sec/SPI)	0.510109	0.039941	0.078252	0.371699	CS pos: 16-17. TSA-ST. Pr: 0.3920    27
NZ_CP027599.1_24746	LIPO(Sec/SPII)	0.345229	0.011568	0.381139	0.262064	CS pos: ?. Probable protein fragment    18
NZ_CP027599.1_24759	LIPO(Sec/SPII)	0.079973	0.001168	0.529251	0.389609	CS pos: 26-27. IIT-CE. Pr: 0.4685    41
NZ_CP027599.1_24763	LIPO(Sec/SPII)	0.170361	0.007673	0.544099	0.277866	CS pos: 15-16. GIK-CQ. Pr: 0.5038    23
NZ_CP027599.1_24772	LIPO(Sec/SPII)	0.030527	0.007522	0.500954	0.460997	CS pos: 26-27. LQG-CC. Pr: 0.4276    40
NZ_CP027599.1_24783	LIPO(Sec/SPII)	0.367884	0.007989	0.518159	0.105968	CS pos: 17-18. CAS-CI. Pr: 0.4605    36
NZ_CP027599.1_24789	LIPO(Sec/SPII)	0.274753	0.018892	0.363444	0.342911	CS pos: ?. Probable protein fragment    17
NZ_CP027599.1_24821	SP(Sec/SPI)	0.406212	0.076777	0.232332	0.284679	CS pos: 21-22. ALS-AP. Pr: 0.1884    25
NZ_CP027599.1_24822	LIPO(Sec/SPII)	0.067278	0.004589	0.616754	0.311379	CS pos: 19-20. FSS-CI. Pr: 0.5470    36
NZ_CP027599.1_24842	SP(Sec/SPI)	0.591058	0.025808	0.189497	0.193637	CS pos: 19-20. AIG-AG. Pr: 0.2989    24
NZ_CP027599.1_24851	LIPO(Sec/SPII)	0.203011	0.016365	0.515147	0.265477	CS pos: 18-19. LIN-CL. Pr: 0.4961    50
NZ_CP027599.1_24862	LIPO(Sec/SPII)	0.241404	0.141864	0.313031	0.303701	CS pos: 27-28. LSA-SL. Pr: 0.2675    40
NZ_CP027599.1_24872	LIPO(Sec/SPII)	0.103691	0.045707	0.457412	0.393190	CS pos: 23-24. FVS-CG. Pr: 0.4297    31
NZ_CP027599.1_24878	LIPO(Sec/SPII)	0.271108	0.014727	0.403200	0.310965	CS pos: 25-26. LCC-CG. Pr: 0.1427    46
NZ_CP027599.1_24895	LIPO(Sec/SPII)	0.160352	0.001032	0.817602	0.021013	CS pos: 20-21. PEG-CR. Pr: 0.8096    45
NZ_CP027599.1_24945	SP(Sec/SPI)	0.463601	0.019254	0.202335	0.314809	CS pos: ?. Probable protein fragment    16
NZ_CP027599.1_24972	LIPO(Sec/SPII)	0.056393	0.002627	0.622068	0.318912	CS pos: 18-19. NTG-CI. Pr: 0.6035    32
NZ_CP027599.1_24978	SP(Sec/SPI)	0.731097	0.018801	0.106001	0.144101	CS pos: 21-22. SYG-SI. Pr: 0.5530    27
NZ_CP027599.1_24983	SP(Sec/SPI)	0.782467	0.015480	0.041632	0.160421	CS pos: 22-23. VHV-EP. Pr: 0.5378    40
NZ_CP027599.1_24984	LIPO(Sec/SPII)	0.046457	0.000464	0.952498	0.000581	CS pos: 20-21. LSA-CS. Pr: 0.9527    43
NZ_CP027599.1_24997	LIPO(Sec/SPII)	0.251819	0.016509	0.371561	0.360110	CS pos: ?. Probable protein fragment    15
NZ_CP027599.1_24999	LIPO(Sec/SPII)	0.334205	0.023502	0.343810	0.298482	CS pos: 9-10. VVS-CV. Pr: 0.1709    19
NZ_CP027599.1_25045	SP(Sec/SPI)	0.456350	0.007855	0.400097	0.135699	CS pos: 18-19. SGA-EC. Pr: 0.1079    20
NZ_CP027599.1_25063	LIPO(Sec/SPII)	0.060396	0.005566	0.488026	0.446012	CS pos: 13-14. PQG-CW. Pr: 0.4755    37
NZ_CP027599.1_25159	LIPO(Sec/SPII)	0.066712	0.011456	0.540142	0.381690	CS pos: 17-18. SSA-CH. Pr: 0.5174    29
NZ_CP027599.1_25210	LIPO(Sec/SPII)	0.278780	0.059326	0.346697	0.315196	CS pos: ?. Probable protein fragment    15
NZ_CP027599.1_25247	SP(Sec/SPI)	0.402275	0.264123	0.103331	0.230271	CS pos: 24-25. AFP-AK. Pr: 0.0693    30
NZ_CP027599.1_25273	LIPO(Sec/SPII)	0.238232	0.031847	0.412038	0.317883	CS pos: 17-18. LTA-CI. Pr: 0.0439    22
NZ_CP027599.1_25289	LIPO(Sec/SPII)	0.170886	0.009344	0.418813	0.400957	CS pos: 23-24. VAN-CI. Pr: 0.3324    50
NZ_CP027599.1_25297	SP(Sec/SPI)	0.465223	0.016775	0.143895	0.374107	CS pos: 16-17. SFT-KE. Pr: 0.2182    20
NZ_CP027599.1_25342	TAT(Tat/SPI)	0.094863	0.740273	0.053936	0.110928	CS pos: 29-30. AQS-EQ. Pr: 0.2277    40
NZ_CP027599.1_25364	LIPO(Sec/SPII)	0.186458	0.006659	0.467549	0.339335	CS pos: 15-16. ILN-CS. Pr: 0.2580    30
NZ_CP027599.1_25368	LIPO(Sec/SPII)	0.219222	0.002784	0.563377	0.214617	CS pos: 16-17. CWA-CS. Pr: 0.3937    22
NZ_CP027599.1_25377	LIPO(Sec/SPII)	0.245410	0.064512	0.504656	0.185422	CS pos: 15-16. SAT-CY. Pr: 0.4614    23
NZ_CP027599.1_25420	LIPO(Sec/SPII)	0.024880	0.001309	0.883600	0.090211	CS pos: 17-18. FLG-CT. Pr: 0.8546    23
NZ_CP027599.1_25453	LIPO(Sec/SPII)	0.034775	0.005530	0.935266	0.024429	CS pos: 22-23. LAS-CA. Pr: 0.9224    32
NZ_CP027599.1_25455	LIPO(Sec/SPII)	0.131945	0.009698	0.692201	0.166155	CS pos: 13-14. GCG-CQ. Pr: 0.5219    24
NZ_CP027599.1_25469	LIPO(Sec/SPII)	0.236519	0.026677	0.371412	0.365392	CS pos: 14-15. LGS-LF. Pr: 0.0207    16
NZ_CP027599.1_25498	SP(Sec/SPI)	0.472262	0.041484	0.020851	0.465403	CS pos: 28-29. AFG-KE. Pr: 0.4270    41
NZ_CP027599.1_25513	LIPO(Sec/SPII)	0.277343	0.022886	0.437226	0.262545	CS pos: 13-14. LFH-CQ. Pr: 0.0424    15
NZ_CP027599.1_25530	LIPO(Sec/SPII)	0.238717	0.029586	0.488476	0.243221	CS pos: 14-15. IAL-CS. Pr: 0.3190    22
NZ_CP027599.1_25541	SP(Sec/SPI)	0.462037	0.019150	0.171345	0.347468	CS pos: 14-15. VSA-LH. Pr: 0.2765    26
NZ_CP027599.1_25559	SP(Sec/SPI)	0.419595	0.042134	0.201717	0.336554	CS pos: 15-16. LYA-LS. Pr: 0.1913    22
NZ_CP027599.1_25572	LIPO(Sec/SPII)	0.092575	0.022454	0.542579	0.342392	CS pos: 19-20. FIG-CP. Pr: 0.5037    25
NZ_CP027599.1_25582	SP(Sec/SPI)	0.357209	0.104124	0.192835	0.345832	CS pos: 14-15. TAA-SQ. Pr: 0.0634    20
NZ_CP027599.1_25637	SP(Sec/SPI)	0.414748	0.022174	0.182775	0.380303	CS pos: ?. Probable protein fragment    19
NZ_CP027599.1_25651	SP(Sec/SPI)	0.466917	0.024619	0.119785	0.388679	CS pos: 22-23. VLT-AS. Pr: 0.2697    25
NZ_CP027599.1_25672	LIPO(Sec/SPII)	0.139035	0.031935	0.601945	0.227086	CS pos: 26-27. SSG-CS. Pr: 0.5013    50
NZ_CP027599.1_25695	LIPO(Sec/SPII)	0.297429	0.016313	0.418248	0.268010	CS pos: ?. Probable protein fragment    16
NZ_CP027599.1_25702	LIPO(Sec/SPII)	0.206161	0.021475	0.429087	0.343276	CS pos: 13-14. FNL-CG. Pr: 0.0408    15
NZ_CP027599.1_25704	LIPO(Sec/SPII)	0.154051	0.019043	0.445583	0.381322	CS pos: 11-12. YGG-CA. Pr: 0.3122    18
NZ_CP027599.1_25765	LIPO(Sec/SPII)	0.049654	0.007196	0.731567	0.211583	CS pos: 15-16. LVG-CC. Pr: 0.6572    39
NZ_CP027599.1_25828	LIPO(Sec/SPII)	0.182579	0.012998	0.421918	0.382506	CS pos: 18-19. QYA-CI. Pr: 0.3397    27
NZ_CP027599.1_25829	TAT(Tat/SPI)	0.179692	0.397130	0.214676	0.208502	CS pos: 19-20. MCG-QQ. Pr: 0.0516    21
NZ_CP027599.1_25832	LIPO(Sec/SPII)	0.089514	0.027510	0.612693	0.270284	CS pos: 20-21. LTT-CS. Pr: 0.5725    32
NZ_CP027599.1_25856	SP(Sec/SPI)	0.643266	0.049255	0.112385	0.195093	CS pos: 22-23. VRA-SD. Pr: 0.5861    25
NZ_CP027599.1_25880	SP(Sec/SPI)	0.398806	0.010167	0.393690	0.197337	CS pos: 24-25. VDS-CL. Pr: 0.4501    28
NZ_CP027599.1_25931	LIPO(Sec/SPII)	0.049420	0.000800	0.848791	0.100990	CS pos: 17-18. LDS-CE. Pr: 0.8022    27
NZ_CP027599.1_25947	SP(Sec/SPI)	0.547465	0.143937	0.018967	0.289631	CS pos: 21-22. SHA-HI. Pr: 0.5997    31
NZ_CP027599.1_25954	LIPO(Sec/SPII)	0.378075	0.007507	0.464697	0.149720	CS pos: 16-17. IAG-AG. Pr: 0.0722    18
NZ_CP027599.1_26015	LIPO(Sec/SPII)	0.190845	0.149449	0.344649	0.315057	CS pos: 20-21. GAG-CC. Pr: 0.2655    27
NZ_CP027599.1_26055	TAT(Tat/SPI)	0.291901	0.310916	0.138357	0.258825	CS pos: 26-27. ASG-HP. Pr: 0.1890    47
NZ_CP027599.1_26073	LIPO(Sec/SPII)	0.157924	0.035214	0.445636	0.361226	CS pos: 16-17. AVS-CS. Pr: 0.3123    18
NZ_CP027599.1_26125	LIPO(Sec/SPII)	0.162461	0.022359	0.500606	0.314574	CS pos: 11-12. CGG-CD. Pr: 0.4086    28
NZ_CP027599.1_26149	LIPO(Sec/SPII)	0.287552	0.038529	0.362475	0.311443	CS pos: ?. Probable protein fragment    15
NZ_CP027599.1_26151	LIPO(Sec/SPII)	0.246951	0.013979	0.374997	0.364073	CS pos: 15-16. AVV-CL. Pr: 0.0466    17
NZ_CP027599.1_26197	LIPO(Sec/SPII)	0.295642	0.008538	0.539978	0.155842	CS pos: 11-12. VAG-CV. Pr: 0.2915    19
NZ_CP027599.1_26295	LIPO(Sec/SPII)	0.288666	0.017013	0.349657	0.344663	CS pos: ?. Probable protein fragment    20
NZ_CP027599.1_26302	SP(Sec/SPI)	0.617642	0.023251	0.062596	0.296511	CS pos: 17-18. VRA-SP. Pr: 0.4003    45
NZ_CP027599.1_26309	LIPO(Sec/SPII)	0.173775	0.080894	0.411315	0.334016	CS pos: 16-17. SVT-CR. Pr: 0.2824    20
NZ_CP027599.1_26314	LIPO(Sec/SPII)	0.176867	0.019180	0.431462	0.372492	CS pos: 11-12. GVS-CQ. Pr: 0.3655    19
NZ_CP027599.1_26321	LIPO(Sec/SPII)	0.026345	0.001359	0.914228	0.058068	CS pos: 24-25. FSS-CS. Pr: 0.9084    37
NZ_CP027599.1_26322	SP(Sec/SPI)	0.637695	0.013758	0.225387	0.123160	CS pos: 17-18. VHS-AR. Pr: 0.2357    32
NZ_CP027599.1_26342	LIPO(Sec/SPII)	0.009510	0.000094	0.986676	0.003720	CS pos: 15-16. LYA-CC. Pr: 0.7853    31
NZ_CP027599.1_26376	SP(Sec/SPI)	0.429708	0.127250	0.040708	0.402335	CS pos: 27-28. LLA-NK. Pr: 0.4311    46
NZ_CP027599.1_26377	LIPO(Sec/SPII)	0.196159	0.006196	0.473967	0.323678	CS pos: 23-24. ISY-CS. Pr: 0.3294    26
NZ_CP027599.1_26392	LIPO(Sec/SPII)	0.016903	0.000854	0.948659	0.033584	CS pos: 18-19. VLG-CR. Pr: 0.9413    22
NZ_CP027599.1_26398	LIPO(Sec/SPII)	0.065949	0.005552	0.672437	0.256062	CS pos: 16-17. WVS-CA. Pr: 0.6297    22
NZ_CP027599.1_26415	LIPO(Sec/SPII)	0.111225	0.006261	0.573672	0.308842	CS pos: 21-22. AFS-CW. Pr: 0.5574    24
NZ_CP027599.1_26420	LIPO(Sec/SPII)	0.391915	0.011072	0.519025	0.077988	CS pos: 16-17. ANA-CP. Pr: 0.6542    18
NZ_CP027599.1_26436	LIPO(Sec/SPII)	0.075170	0.004328	0.476735	0.443767	CS pos: 31-32. HLG-CT. Pr: 0.4465    39
NZ_CP027599.1_26438	SP(Sec/SPI)	0.429034	0.074095	0.129379	0.367492	CS pos: 30-31. LTA-AC. Pr: 0.1841    45
NZ_CP027599.1_26442	LIPO(Sec/SPII)	0.201471	0.023505	0.410709	0.364315	CS pos: 24-25. SSL-CH. Pr: 0.3114    36
NZ_CP027599.1_26447	SP(Sec/SPI)	0.470150	0.082551	0.093316	0.353983	CS pos: 13-14. ALA-LP. Pr: 0.2078    26
NZ_CP027599.1_26454	LIPO(Sec/SPII)	0.134283	0.029689	0.502167	0.333862	CS pos: 22-23. RTC-CS. Pr: 0.2373    38
NZ_CP027599.1_26525	LIPO(Sec/SPII)	0.270876	0.027745	0.403033	0.298346	CS pos: ?. Probable protein fragment    16
NZ_CP027599.1_26528	SP(Sec/SPI)	0.458402	0.031900	0.083897	0.425800	CS pos: 25-26. TGA-GR. Pr: 0.1827    35
NZ_CP027599.1_26544	LIPO(Sec/SPII)	0.177398	0.008817	0.511676	0.302108	CS pos: 25-26. LTA-CY. Pr: 0.3459    35
NZ_CP027599.1_26578	LIPO(Sec/SPII)	0.025155	0.006927	0.488321	0.479596	CS pos: 33-34. SSG-CS. Pr: 0.4876    48
NZ_CP027599.1_26579	SP(Sec/SPI)	0.455728	0.014323	0.091925	0.438024	CS pos: 22-23. VLS-HS. Pr: 0.2093    25
NZ_CP027599.1_26589	SP(Sec/SPI)	0.517652	0.107693	0.107815	0.266840	CS pos: 22-23. AHR-AS. Pr: 0.1456    33
NZ_CP027599.1_26591	LIPO(Sec/SPII)	0.125592	0.035680	0.424270	0.414459	CS pos: 16-17. MNA-CW. Pr: 0.4011    26
NZ_CP027599.1_26600	LIPO(Sec/SPII)	0.182953	0.047231	0.462225	0.307591	CS pos: 14-15. ISG-CS. Pr: 0.3557    22
NZ_CP027599.1_26601	SP(Sec/SPI)	0.323626	0.069247	0.286383	0.320744	CS pos: 14-15. AAA-GG. Pr: 0.1032    17
NZ_CP027599.1_26623	SP(Sec/SPI)	0.637447	0.032774	0.100471	0.229308	CS pos: 17-18. VMP-AT. Pr: 0.2297    48
NZ_CP027599.1_26627	LIPO(Sec/SPII)	0.200243	0.080021	0.570478	0.149258	CS pos: 24-25. PAS-CA. Pr: 0.4032    36
NZ_CP027599.1_26630	LIPO(Sec/SPII)	0.161161	0.002472	0.531571	0.304796	CS pos: 22-23. LSP-CW. Pr: 0.4010    42
NZ_CP027599.1_26639	SP(Sec/SPI)	0.480745	0.072280	0.120839	0.326136	CS pos: 17-18. ARA-WV. Pr: 0.3999    23
NZ_CP027599.1_26641	LIPO(Sec/SPII)	0.275251	0.010613	0.432577	0.281558	CS pos: ?. Probable protein fragment    15
NZ_CP027599.1_26645	LIPO(Sec/SPII)	0.198628	0.108892	0.573807	0.118673	CS pos: 22-23. AGT-CA. Pr: 0.4941    34
NZ_CP027599.1_26648	LIPO(Sec/SPII)	0.176979	0.010474	0.467699	0.344848	CS pos: 12-13. MMS-CL. Pr: 0.2768    22
NZ_CP027599.1_26655	LIPO(Sec/SPII)	0.179205	0.054111	0.632049	0.134634	CS pos: 24-25. HCA-CG. Pr: 0.5427    37
NZ_CP027599.1_26659	SP(Sec/SPI)	0.435308	0.077408	0.137988	0.349296	CS pos: 18-19. SSA-GH. Pr: 0.1794    26
NZ_CP027599.1_26702	SP(Sec/SPI)	0.600492	0.099173	0.102714	0.197621	CS pos: 11-12. ASA-AP. Pr: 0.4603    17
NZ_CP027599.1_26715	LIPO(Sec/SPII)	0.181184	0.023002	0.435212	0.360603	CS pos: ?. Probable protein fragment    20
NZ_CP027599.1_26725	SP(Sec/SPI)	0.457764	0.068708	0.112996	0.360532	CS pos: 14-15. SAA-SD. Pr: 0.1757    24
NZ_CP027599.1_26749	LIPO(Sec/SPII)	0.295063	0.004483	0.465940	0.234514	CS pos: 16-17. THR-CV. Pr: 0.4409    44
NZ_CP027599.1_26750	LIPO(Sec/SPII)	0.227552	0.056865	0.546994	0.168589	CS pos: 12-13. SSS-CS. Pr: 0.3172    16
NZ_CP027599.1_26755	TAT(Tat/SPI)	0.149616	0.319138	0.303234	0.228011	CS pos: ?. Probable protein fragment    19
NZ_CP027599.1_26758	LIPO(Sec/SPII)	0.176951	0.070656	0.633925	0.118468	CS pos: 19-20. TTV-CR. Pr: 0.5143    38
NZ_CP027599.1_26765	LIPO(Sec/SPII)	0.254598	0.016795	0.446980	0.281627	CS pos: ?. Probable protein fragment    18
NZ_CP027599.1_26768	SP(Sec/SPI)	0.470636	0.099687	0.088293	0.341384	CS pos: 23-24. STA-SG. Pr: 0.3032    31
NZ_CP027599.1_26780	LIPO(Sec/SPII)	0.061055	0.005161	0.477270	0.456514	CS pos: 31-32. HVS-CV. Pr: 0.4640    44
NZ_CP027599.1_26782	LIPO(Sec/SPII)	0.258107	0.092632	0.431293	0.217968	CS pos: 13-14. VSP-CW. Pr: 0.2423    25
NZ_CP027599.1_26815	LIPO(Sec/SPII)	0.089695	0.011000	0.785984	0.113322	CS pos: 15-16. TLT-CQ. Pr: 0.7835    41
NZ_CP027599.1_26816	LIPO(Sec/SPII)	0.236596	0.022777	0.380676	0.359952	CS pos: 22-23. SVR-CA. Pr: 0.1942    26
NZ_CP027599.1_26853	LIPO(Sec/SPII)	0.139214	0.016173	0.636720	0.207892	CS pos: 19-20. RSG-CR. Pr: 0.4025    29
NZ_CP027599.1_26876	LIPO(Sec/SPII)	0.117609	0.242513	0.475632	0.164245	CS pos: 17-18. GGS-CF. Pr: 0.3532    21
NZ_CP027599.1_26878	SP(Sec/SPI)	0.469235	0.019187	0.363984	0.147593	CS pos: 19-20. SAA-TP. Pr: 0.2113    23
NZ_CP027599.1_26879	LIPO(Sec/SPII)	0.150351	0.003160	0.527611	0.318879	CS pos: 27-28. LCG-CL. Pr: 0.4849    32
NZ_CP027599.1_26885	SP(Sec/SPI)	0.468319	0.024884	0.169388	0.337410	CS pos: 22-23. QRS-DP. Pr: 0.1165    47
NZ_CP027599.1_26892	LIPO(Sec/SPII)	0.281649	0.002130	0.488464	0.227757	CS pos: 14-15. LTS-FS. Pr: 0.3791    21
NZ_CP027599.1_26899	LIPO(Sec/SPII)	0.136408	0.005229	0.741917	0.116446	CS pos: 22-23. PTS-CG. Pr: 0.4589    25
NZ_CP027599.1_26941	SP(Sec/SPI)	0.442144	0.005476	0.321981	0.230399	CS pos: 25-26. VAG-KR. Pr: 0.2414    40
NZ_CP027599.1_26953	SP(Sec/SPI)	0.390787	0.016732	0.226849	0.365632	CS pos: 20-21. SGG-RF. Pr: 0.0646    29
NZ_CP027599.1_26957	LIPO(Sec/SPII)	0.154077	0.051914	0.579914	0.214094	CS pos: 21-22. ASS-CN. Pr: 0.5499    28
NZ_CP027599.1_26986	LIPO(Sec/SPII)	0.065844	0.005108	0.747954	0.181095	CS pos: 24-25. FSG-CG. Pr: 0.7320    38
NZ_CP027599.1_26999	SP(Sec/SPI)	0.788470	0.004081	0.063788	0.143661	CS pos: 22-23. VQS-AD. Pr: 0.6355    48
NZ_CP027599.1_27006	LIPO(Sec/SPII)	0.120002	0.019300	0.743063	0.117635	CS pos: 23-24. VPG-CQ. Pr: 0.6644    29
NZ_CP027599.1_27014	SP(Sec/SPI)	0.398838	0.162808	0.220844	0.217510	CS pos: 23-24. TTA-GR. Pr: 0.2268    44
NZ_CP027599.1_27017	TAT(Tat/SPI)	0.215213	0.363312	0.080613	0.340861	CS pos: 23-24. GWC-RA. Pr: 0.2312    49
NZ_CP027599.1_27018	LIPO(Sec/SPII)	0.038247	0.011847	0.791216	0.158690	CS pos: 21-22. SFS-CG. Pr: 0.7843    34
NZ_CP027599.1_27034	LIPO(Sec/SPII)	0.025462	0.005947	0.922907	0.045684	CS pos: 16-17. FLA-CF. Pr: 0.8568    45
NZ_CP027599.1_27048	LIPO(Sec/SPII)	0.213009	0.116377	0.382627	0.287987	CS pos: 16-17. AGV-CG. Pr: 0.1798    39
NZ_CP027599.1_27056	LIPO(Sec/SPII)	0.270836	0.025289	0.365817	0.338057	CS pos: ?. Probable protein fragment    15
NZ_CP027599.1_27062	LIPO(Sec/SPII)	0.261566	0.007831	0.379339	0.351264	CS pos: ?. Probable protein fragment    15
NZ_CP027599.1_27073	LIPO(Sec/SPII)	0.224920	0.005216	0.680632	0.089233	CS pos: ?. Probable protein fragment    15
NZ_CP027599.1_27150	LIPO(Sec/SPII)	0.118208	0.018833	0.588852	0.274107	CS pos: 24-25. PLA-CV. Pr: 0.5361    27
NZ_CP027599.1_27158	LIPO(Sec/SPII)	0.273243	0.074540	0.384203	0.268015	CS pos: ?. Probable protein fragment    16
NZ_CP027599.1_27163	SP(Sec/SPI)	0.385860	0.229822	0.039960	0.344358	CS pos: 34-35. ANA-SA. Pr: 0.4113    41
NZ_CP027599.1_27170	SP(Sec/SPI)	0.538264	0.029638	0.209094	0.223004	CS pos: 23-24. AHT-AK. Pr: 0.2317    37
NZ_CP027599.1_27177	LIPO(Sec/SPII)	0.385548	0.038030	0.470591	0.105830	CS pos: 17-18. FAL-CS. Pr: 0.2416    41
NZ_CP027599.1_27179	LIPO(Sec/SPII)	0.025249	0.013998	0.883307	0.077446	CS pos: 18-19. STG-CR. Pr: 0.8792    35
NZ_CP027599.1_27181	LIPO(Sec/SPII)	0.210697	0.011895	0.711324	0.066084	CS pos: 18-19. STT-CR. Pr: 0.6282    29
NZ_CP027599.1_27186	SP(Sec/SPI)	0.646185	0.005998	0.110655	0.237161	CS pos: 19-20. NYA-RE. Pr: 0.4987    29
NZ_CP027599.1_27239	LIPO(Sec/SPII)	0.205218	0.216798	0.367833	0.210151	CS pos: 24-25. KLS-CW. Pr: 0.3463    39
NZ_CP027599.1_27270	SP(Sec/SPI)	0.438012	0.082065	0.337560	0.142363	CS pos: 16-17. SHT-AS. Pr: 0.1673    25
NZ_CP027599.1_27272	LIPO(Sec/SPII)	0.197814	0.014271	0.430701	0.357214	CS pos: 13-14. WTA-CR. Pr: 0.2785    15
NZ_CP027599.1_27274	LIPO(Sec/SPII)	0.325348	0.042656	0.577585	0.054410	CS pos: 14-15. LFT-CT. Pr: 0.5003    41
NZ_CP027599.1_27298	SP(Sec/SPI)	0.382843	0.108716	0.177363	0.331079	CS pos: 16-17. ALA-SR. Pr: 0.2740    24
NZ_CP027599.1_27301	LIPO(Sec/SPII)	0.072542	0.007657	0.720354	0.199447	CS pos: 31-32. LTG-CR. Pr: 0.7060    34
NZ_CP027599.1_27303	LIPO(Sec/SPII)	0.096186	0.011515	0.843507	0.048791	CS pos: 17-18. TCS-CS. Pr: 0.6811    24
NZ_CP027599.1_27309	SP(Sec/SPI)	0.480667	0.162439	0.136518	0.220375	CS pos: 39-40. VRG-WP. Pr: 0.3551    49
NZ_CP027599.1_27310	LIPO(Sec/SPII)	0.329285	0.024246	0.475731	0.170737	CS pos: 25-26. PAT-CA. Pr: 0.3508    27
NZ_CP027599.1_27329	SP(Sec/SPI)	0.503774	0.060372	0.160031	0.275823	CS pos: ?. Probable protein fragment    19
NZ_CP027599.1_27331	LIPO(Sec/SPII)	0.209074	0.011210	0.677989	0.101728	CS pos: 18-19. TAV-CS. Pr: 0.6040    28
NZ_CP027599.1_27339	SP(Sec/SPI)	0.565226	0.110619	0.199998	0.124158	CS pos: 22-23. IEA-KS. Pr: 0.4896    36
NZ_CP027599.1_27351	LIPO(Sec/SPII)	0.173674	0.012548	0.595009	0.218769	CS pos: 12-13. GIS-CC. Pr: 0.3797    15
NZ_CP027599.1_27370	LIPO(Sec/SPII)	0.028750	0.002368	0.743834	0.225049	CS pos: 27-28. IMG-CY. Pr: 0.7292    39
NZ_CP027599.1_27392	LIPO(Sec/SPII)	0.187091	0.037245	0.393454	0.382210	CS pos: 11-12. FAG-CS. Pr: 0.2129    17
NZ_CP027599.1_27398	LIPO(Sec/SPII)	0.110767	0.021738	0.687491	0.180004	CS pos: 18-19. FLG-CH. Pr: 0.6726    29
NZ_CP027599.1_27399	SP(Sec/SPI)	0.493180	0.031695	0.067571	0.407554	CS pos: 16-17. SWA-AM. Pr: 0.3482    30
NZ_CP027599.1_27407	LIPO(Sec/SPII)	0.207144	0.019728	0.413400	0.359728	CS pos: 15-16. CGM-CQ. Pr: 0.0403    19
NZ_CP027599.1_27414	LIPO(Sec/SPII)	0.236108	0.012323	0.395331	0.356238	CS pos: 27-28. VSP-CF. Pr: 0.2072    29
NZ_CP027599.1_27432	LIPO(Sec/SPII)	0.214850	0.036334	0.377095	0.371720	CS pos: 14-15. KAV-CS. Pr: 0.1655    17
NZ_CP027599.1_27437	SP(Sec/SPI)	0.389339	0.015595	0.376131	0.218934	CS pos: 21-22. CRA-EL. Pr: 0.2642    30
NZ_CP027599.1_27460	LIPO(Sec/SPII)	0.331927	0.013524	0.469195	0.185354	CS pos: ?. Probable protein fragment    17
NZ_CP027599.1_27485	LIPO(Sec/SPII)	0.063639	0.020743	0.551956	0.363662	CS pos: 21-22. IRG-CK. Pr: 0.5518    46
NZ_CP027599.1_27510	LIPO(Sec/SPII)	0.093398	0.014530	0.548874	0.343197	CS pos: 24-25. WSG-CY. Pr: 0.4920    29
NZ_CP027599.1_27514	TAT(Tat/SPI)	0.056449	0.668464	0.022056	0.253031	CS pos: 36-37. SAA-AT. Pr: 0.1376    40
NZ_CP027599.1_27524	LIPO(Sec/SPII)	0.251411	0.162572	0.314016	0.272001	CS pos: ?. Probable protein fragment    16
NZ_CP027599.1_27536	LIPO(Sec/SPII)	0.142741	0.008649	0.524940	0.323671	CS pos: 20-21. VKS-CI. Pr: 0.3644    23
NZ_CP027599.1_27539	SP(Sec/SPI)	0.636465	0.087231	0.033577	0.242726	CS pos: 25-26. AFS-EK. Pr: 0.4561    43
NZ_CP027599.1_27563	TAT(Tat/SPI)	0.217134	0.373216	0.124596	0.285053	CS pos: 21-22. RNA-CG. Pr: 0.1758    43
NZ_CP027599.1_27570	LIPO(Sec/SPII)	0.327820	0.115845	0.400339	0.155997	CS pos: 22-23. ARS-CT. Pr: 0.5760    32
NZ_CP027599.1_27585	SP(Sec/SPI)	0.832834	0.071050	0.037217	0.058900	CS pos: 21-22. AAA-EQ. Pr: 0.7618    26
NZ_CP027599.1_27630	LIPO(Sec/SPII)	0.385230	0.009028	0.442323	0.163419	CS pos: 16-17. VSG-AE. Pr: 0.2549    19
NZ_CP027599.1_27688	SP(Sec/SPI)	0.614469	0.031635	0.098758	0.255138	CS pos: 19-20. ATA-WL. Pr: 0.4828    28
NZ_CP027599.1_27693	LIPO(Sec/SPII)	0.266565	0.013534	0.405237	0.314665	CS pos: ?. Probable protein fragment    17
NZ_CP027599.1_27699	TAT(Tat/SPI)	0.190957	0.340308	0.193788	0.274947	CS pos: 21-22. SRS-MP. Pr: 0.1676    44
NZ_CP027599.1_27709	SP(Sec/SPI)	0.522237	0.207008	0.062211	0.208544	CS pos: 27-28. GKA-SV. Pr: 0.4597    49
NZ_CP027599.1_27733	LIPO(Sec/SPII)	0.293789	0.042417	0.422785	0.241009	CS pos: ?. Probable protein fragment    23
NZ_CP027599.1_27742	LIPO(Sec/SPII)	0.070194	0.025615	0.636055	0.268136	CS pos: 18-19. INA-CA. Pr: 0.6059    34
NZ_CP027599.1_27754	SP(Sec/SPI)	0.389827	0.181323	0.084042	0.344808	CS pos: 26-27. SSA-VT. Pr: 0.1489    35
NZ_CP027599.1_27764	LIPO(Sec/SPII)	0.264215	0.027745	0.363175	0.344865	CS pos: ?. Probable protein fragment    15
NZ_CP027599.1_27782	LIPO(Sec/SPII)	0.044895	0.007762	0.568852	0.378491	CS pos: 29-30. TSG-CT. Pr: 0.5646    42
NZ_CP027599.1_27796	LIPO(Sec/SPII)	0.024777	0.004251	0.812050	0.158923	CS pos: 22-23. TTS-CS. Pr: 0.7866    48
NZ_CP027599.1_27811	LIPO(Sec/SPII)	0.097757	0.011834	0.496177	0.394232	CS pos: 19-20. VAA-CV. Pr: 0.4866    47
NZ_CP027599.1_27823	LIPO(Sec/SPII)	0.296067	0.012858	0.515443	0.175632	CS pos: ?. Probable protein fragment    17
NZ_CP027599.1_27841	LIPO(Sec/SPII)	0.329302	0.032753	0.419867	0.218078	CS pos: 13-14. SPG-TG. Pr: 0.0309    15
NZ_CP027599.1_27856	LIPO(Sec/SPII)	0.041058	0.004466	0.882524	0.071952	CS pos: 16-17. IVS-CR. Pr: 0.8689    26
NZ_CP027599.1_27960	LIPO(Sec/SPII)	0.175178	0.029791	0.399248	0.395784	CS pos: 19-20. SST-CC. Pr: 0.1893    34
NZ_CP027599.1_27981	LIPO(Sec/SPII)	0.261924	0.018957	0.393272	0.325847	CS pos: ?. Probable protein fragment    16
NZ_CP027599.1_27983	LIPO(Sec/SPII)	0.280109	0.012237	0.440074	0.267580	CS pos: 14-15. ITA-IT. Pr: 0.0458    17
NZ_CP027599.1_28013	SP(Sec/SPI)	0.495567	0.032545	0.059241	0.412648	CS pos: 21-22. VSA-NE. Pr: 0.4315    46
NZ_CP027599.1_28045	LIPO(Sec/SPII)	0.038846	0.009054	0.515432	0.436668	CS pos: 20-21. CNS-CN. Pr: 0.4576    48
NZ_CP027599.1_28053	LIPO(Sec/SPII)	0.133256	0.053401	0.617137	0.196206	CS pos: 19-20. LAT-CT. Pr: 0.6038    31
NZ_CP027599.1_28070	LIPO(Sec/SPII)	0.189148	0.097067	0.420487	0.293298	CS pos: 21-22. ASR-CA. Pr: 0.3469    43
NZ_CP027599.1_28150	LIPO(Sec/SPII)	0.029751	0.006326	0.898833	0.065089	CS pos: 22-23. FSS-CL. Pr: 0.8818    26
NZ_CP027599.1_28160	LIPO(Sec/SPII)	0.181285	0.025480	0.475084	0.318150	CS pos: ?. Probable protein fragment    21
NZ_CP027599.1_28172	LIPO(Sec/SPII)	0.254889	0.023037	0.372415	0.349658	CS pos: 13-14. VIG-NV. Pr: 0.0392    15
NZ_CP027599.1_28202	LIPO(Sec/SPII)	0.145349	0.046102	0.566617	0.241931	CS pos: 21-22. PTT-CR. Pr: 0.3092    34
NZ_CP027599.1_28222	LIPO(Sec/SPII)	0.118558	0.001538	0.842822	0.037082	CS pos: 15-16. AFS-CG. Pr: 0.7260    17
NZ_CP027599.1_28237	LIPO(Sec/SPII)	0.163695	0.036069	0.413702	0.386534	CS pos: 19-20. KTS-CE. Pr: 0.3668    27
NZ_CP027599.1_28252	LIPO(Sec/SPII)	0.167049	0.028500	0.405215	0.399236	CS pos: 13-14. MFA-CF. Pr: 0.2802    15
NZ_CP027599.1_28277	LIPO(Sec/SPII)	0.188896	0.035138	0.401983	0.373982	CS pos: 18-19. VVS-CY. Pr: 0.3645    28
NZ_CP027599.1_28307	LIPO(Sec/SPII)	0.101092	0.029502	0.641525	0.227880	CS pos: 19-20. VQS-CT. Pr: 0.5923    24
NZ_CP027599.1_28329	LIPO(Sec/SPII)	0.315261	0.015067	0.409458	0.260213	CS pos: 17-18. ALN-CF. Pr: 0.2116    23
NZ_CP027599.1_28340	LIPO(Sec/SPII)	0.288283	0.016061	0.363228	0.332429	CS pos: 12-13. WYC-CG. Pr: 0.0968    15
NZ_CP027599.1_28342	LIPO(Sec/SPII)	0.010235	0.001767	0.745503	0.242495	CS pos: 27-28. SSG-CA. Pr: 0.7356    45
NZ_CP027599.1_28355	LIPO(Sec/SPII)	0.275905	0.011909	0.376411	0.335776	CS pos: 16-17. VVG-LL. Pr: 0.0264    19
NZ_CP027599.1_28362	LIPO(Sec/SPII)	0.117518	0.004543	0.836571	0.041368	CS pos: 14-15. SSA-CH. Pr: 0.8214    39
NZ_CP027599.1_28369	SP(Sec/SPI)	0.587593	0.040198	0.038390	0.333819	CS pos: 18-19. THA-LP. Pr: 0.3323    27
NZ_CP027599.1_28370	SP(Sec/SPI)	0.857456	0.047508	0.012707	0.082329	CS pos: 31-32. ILA-AS. Pr: 0.7868    45
NZ_CP027599.1_28386	LIPO(Sec/SPII)	0.244521	0.029171	0.364389	0.361919	CS pos: 15-16. CSS-LT. Pr: 0.0305    17
NZ_CP027599.1_28404	SP(Sec/SPI)	0.460807	0.073943	0.051072	0.414177	CS pos: 21-22. VRA-NG. Pr: 0.3558    32
NZ_CP027599.1_28432	LIPO(Sec/SPII)	0.272604	0.013370	0.418355	0.295671	CS pos: 15-16. SGI-CF. Pr: 0.0428    17
NZ_CP027599.1_28435	SP(Sec/SPI)	0.389435	0.055597	0.169984	0.384985	CS pos: ?. Probable protein fragment    21
NZ_CP027599.1_28455	SP(Sec/SPI)	0.658703	0.020234	0.042090	0.278974	CS pos: 18-19. TAG-YP. Pr: 0.4794    45
NZ_CP027599.1_28471	SP(Sec/SPI)	0.608968	0.066829	0.046416	0.277787	CS pos: 27-28. AAA-GF. Pr: 0.4315    35
NZ_CP027599.1_28528	LIPO(Sec/SPII)	0.336602	0.047341	0.440706	0.175351	CS pos: 18-19. RAS-CP. Pr: 0.3465    28
NZ_CP027599.1_28537	LIPO(Sec/SPII)	0.031456	0.006549	0.865363	0.096633	CS pos: 20-21. ISV-CL. Pr: 0.8292    39
NZ_CP027599.1_28554	LIPO(Sec/SPII)	0.224958	0.029672	0.413129	0.332241	CS pos: ?. Probable protein fragment    16
NZ_CP027599.1_28570	LIPO(Sec/SPII)	0.289100	0.017247	0.407601	0.286052	CS pos: 18-19. PSV-CL. Pr: 0.1763    22
NZ_CP027599.1_28600	LIPO(Sec/SPII)	0.166255	0.012750	0.493151	0.327845	CS pos: 32-33. ISG-CA. Pr: 0.4654    35
NZ_CP027599.1_28605	TAT(Tat/SPI)	0.175571	0.450119	0.058923	0.315388	CS pos: 37-38. ALA-AR. Pr: 0.3022    48
NZ_CP027599.1_28640	SP(Sec/SPI)	0.736165	0.013466	0.228781	0.021588	CS pos: 22-23. TGA-KE. Pr: 0.5143    41
NZ_CP027599.1_28642	LIPO(Sec/SPII)	0.158858	0.013889	0.458819	0.368433	CS pos: 16-17. TCS-CC. Pr: 0.1809    20
NZ_CP027599.1_28653	LIPO(Sec/SPII)	0.180679	0.196495	0.327324	0.295502	CS pos: 23-24. MPS-CR. Pr: 0.2798    46
NZ_CP027599.1_28698	LIPO(Sec/SPII)	0.250023	0.034318	0.378569	0.337090	CS pos: 20-21. VLL-CQ. Pr: 0.0677    22
NZ_CP027599.1_28751	LIPO(Sec/SPII)	0.070151	0.000538	0.861618	0.067692	CS pos: 25-26. DSG-CY. Pr: 0.5426    43
NZ_CP027599.1_28753	LIPO(Sec/SPII)	0.087997	0.006658	0.497894	0.407450	CS pos: 20-21. IYS-CL. Pr: 0.4668    24
NZ_CP027599.1_28755	LIPO(Sec/SPII)	0.038709	0.004647	0.730559	0.226086	CS pos: 16-17. IVG-CI. Pr: 0.7037    19
NZ_CP027599.1_28758	SP(Sec/SPI)	0.381139	0.028552	0.335522	0.254788	CS pos: ?. Probable protein fragment    19
NZ_CP027599.1_28766	LIPO(Sec/SPII)	0.187592	0.026516	0.407003	0.378888	CS pos: 20-21. TAE-CD. Pr: 0.3834    35
NZ_CP027599.1_28784	LIPO(Sec/SPII)	0.227565	0.010519	0.554138	0.207777	CS pos: 18-19. TGS-CY. Pr: 0.3910    21
NZ_CP027599.1_28793	LIPO(Sec/SPII)	0.281513	0.038426	0.353660	0.326400	CS pos: ?. Probable protein fragment    16
NZ_CP027599.1_28820	SP(Sec/SPI)	0.428911	0.092947	0.233669	0.244473	CS pos: 22-23. APA-GS. Pr: 0.1551    26
NZ_CP027599.1_28821	TAT(Tat/SPI)	0.156911	0.396901	0.174564	0.271623	CS pos: ?. Probable protein fragment    15
NZ_CP027599.1_28822	SP(Sec/SPI)	0.400902	0.024582	0.230193	0.344323	CS pos: 33-34. LRS-KV. Pr: 0.1323    46
NZ_CP027599.1_28826	LIPO(Sec/SPII)	0.069127	0.018506	0.524615	0.387753	CS pos: 21-22. LTG-CG. Pr: 0.4999    36
NZ_CP027599.1_28841	LIPO(Sec/SPII)	0.122676	0.048199	0.465888	0.363236	CS pos: 16-17. TFA-CR. Pr: 0.4027    20
NZ_CP027599.1_28871	SP(Sec/SPI)	0.537711	0.013667	0.104044	0.344577	CS pos: 21-22. VVA-GD. Pr: 0.3122    43
NZ_CP027599.1_28877	LIPO(Sec/SPII)	0.283972	0.033638	0.383051	0.299339	CS pos: 13-14. SFA-CS. Pr: 0.0900    16
NZ_CP027599.1_28903	SP(Sec/SPI)	0.419484	0.058792	0.238134	0.283590	CS pos: 27-28. VST-KS. Pr: 0.0770    30
NZ_CP027599.1_28931	SP(Sec/SPI)	0.453058	0.029995	0.094616	0.422331	CS pos: 21-22. AQG-GN. Pr: 0.2004    34
NZ_CP027599.1_28942	LIPO(Sec/SPII)	0.236657	0.043314	0.420243	0.299786	CS pos: 13-14. THS-CL. Pr: 0.0969    15
NZ_CP027599.1_28969	LIPO(Sec/SPII)	0.019092	0.003330	0.851069	0.126509	CS pos: 20-21. TTS-CS. Pr: 0.8500    42
NZ_CP027599.1_28971	LIPO(Sec/SPII)	0.215214	0.037590	0.409749	0.337447	CS pos: ?. Probable protein fragment    16
NZ_CP027599.1_28979	LIPO(Sec/SPII)	0.113631	0.007468	0.733332	0.145570	CS pos: 24-25. VYS-CD. Pr: 0.7667    36
NZ_CP027599.1_29004	LIPO(Sec/SPII)	0.202186	0.032437	0.619077	0.146300	CS pos: 19-20. AGA-CR. Pr: 0.6467    44
NZ_CP027599.1_29019	SP(Sec/SPI)	0.350425	0.219052	0.108530	0.321993	CS pos: 20-21. CRG-SF. Pr: 0.1726    40
NZ_CP027599.1_29027	TAT(Tat/SPI)	0.152358	0.620198	0.017691	0.209753	CS pos: 28-29. ADA-AD. Pr: 0.6911    35
NZ_CP027599.1_29030	LIPO(Sec/SPII)	0.087620	0.010542	0.642522	0.259316	CS pos: 22-23. VAS-CC. Pr: 0.5509    25
NZ_CP027599.1_29035	SP(Sec/SPI)	0.429721	0.071156	0.080357	0.418765	CS pos: 10-11. ADA-GD. Pr: 0.1819    21
NZ_CP027599.1_29037	LIPO(Sec/SPII)	0.083804	0.004769	0.869406	0.042020	CS pos: 23-24. PTA-CW. Pr: 0.8434    34
NZ_CP027599.1_29062	SP(Sec/SPI)	0.428045	0.101612	0.049269	0.421073	CS pos: 24-25. ARA-DY. Pr: 0.4287    28
NZ_CP027599.1_29087	SP(Sec/SPI)	0.452749	0.005611	0.106712	0.434929	CS pos: 20-21. ALM-ME. Pr: 0.1850    27
NZ_CP027599.1_29092	LIPO(Sec/SPII)	0.223054	0.033221	0.381873	0.361852	CS pos: 19-20. SHN-CG. Pr: 0.3211    49
NZ_CP027599.1_29096	TAT(Tat/SPI)	0.152067	0.416387	0.117348	0.314198	CS pos: ?. Probable protein fragment    22
NZ_CP027599.1_29102	LIPO(Sec/SPII)	0.159774	0.154491	0.559990	0.125745	CS pos: 19-20. LSG-KV. Pr: 0.4076    48
NZ_CP027599.1_29107	LIPO(Sec/SPII)	0.336772	0.030125	0.437816	0.195287	CS pos: 28-29. LVA-CG. Pr: 0.3510    40
NZ_CP027599.1_29132	LIPO(Sec/SPII)	0.104456	0.005175	0.835467	0.054902	CS pos: 17-18. AVA-CY. Pr: 0.8584    24
NZ_CP027599.1_29135	LIPO(Sec/SPII)	0.121118	0.018605	0.574735	0.285541	CS pos: 23-24. ATC-CW. Pr: 0.2453    33
NZ_CP027599.1_29138	LIPO(Sec/SPII)	0.180666	0.021852	0.624693	0.172789	CS pos: 13-14. GTA-CA. Pr: 0.4116    21
NZ_CP027599.1_29168	SP(Sec/SPI)	0.805185	0.009794	0.097952	0.087069	CS pos: 28-29. LHG-EN. Pr: 0.7123    42
NZ_CP027599.1_29184	SP(Sec/SPI)	0.434031	0.338405	0.034371	0.193192	CS pos: 21-22. SHA-RC. Pr: 0.5766    41
NZ_CP027599.1_29186	SP(Sec/SPI)	0.463358	0.071386	0.084520	0.380736	CS pos: 18-19. AGA-AG. Pr: 0.2753    25
NZ_CP027599.1_29190	SP(Sec/SPI)	0.732287	0.007664	0.130113	0.129935	CS pos: 20-21. AIA-HV. Pr: 0.5049    27
NZ_CP027599.1_29193	LIPO(Sec/SPII)	0.216255	0.014352	0.405861	0.363532	CS pos: 16-17. SVM-CA. Pr: 0.2050    18
NZ_CP027599.1_29198	SP(Sec/SPI)	0.550368	0.079998	0.042227	0.327407	CS pos: 25-26. GRA-DD. Pr: 0.5670    36
NZ_CP027599.1_29199	LIPO(Sec/SPII)	0.254782	0.006710	0.371653	0.366856	CS pos: ?. Probable protein fragment    17
NZ_CP027599.1_29215	SP(Sec/SPI)	0.363754	0.070973	0.309092	0.256181	CS pos: 12-13. ASA-AN. Pr: 0.2445    19
NZ_CP027599.1_29262	LIPO(Sec/SPII)	0.294174	0.035701	0.400533	0.269592	CS pos: ?. Probable protein fragment    15
NZ_CP027599.1_29278	LIPO(Sec/SPII)	0.339261	0.062729	0.366587	0.231423	CS pos: 17-18. SSF-CH. Pr: 0.2166    21
NZ_CP027599.1_29291	LIPO(Sec/SPII)	0.162059	0.017700	0.419432	0.400809	CS pos: 18-19. SVS-CP. Pr: 0.2068    22
NZ_CP027599.1_29309	SP(Sec/SPI)	0.637723	0.149334	0.145405	0.067537	CS pos: 24-25. AFS-YR. Pr: 0.4142    31
NZ_CP027599.1_29336	SP(Sec/SPI)	0.513478	0.031515	0.098648	0.356359	CS pos: 29-30. AQA-LQ. Pr: 0.4169    36
NZ_CP027599.1_29337	LIPO(Sec/SPII)	0.234618	0.020264	0.509469	0.235649	CS pos: ?. Probable protein fragment    17
NZ_CP027599.1_29359	LIPO(Sec/SPII)	0.063446	0.001753	0.562331	0.372470	CS pos: 22-23. TVS-CF. Pr: 0.5582    42
NZ_CP027599.1_29361	SP(Sec/SPI)	0.699928	0.071471	0.205947	0.022654	CS pos: 31-32. SFA-AV. Pr: 0.4217    40
NZ_CP027599.1_29363	LIPO(Sec/SPII)	0.063632	0.028127	0.673015	0.235226	CS pos: 22-23. FIG-CC. Pr: 0.5991    32
NZ_CP027599.1_29365	SP(Sec/SPI)	0.432945	0.010158	0.403858	0.153039	CS pos: ?. Probable protein fragment    16
NZ_CP027599.1_29376	LIPO(Sec/SPII)	0.091716	0.014686	0.529425	0.364173	CS pos: 24-25. WSG-CF. Pr: 0.5122    31
NZ_CP027599.1_29389	SP(Sec/SPI)	0.433869	0.011615	0.176379	0.378137	CS pos: 24-25. SLS-AA. Pr: 0.0989    29
NZ_CP027599.1_29432	SP(Sec/SPI)	0.674318	0.010893	0.262968	0.051820	CS pos: 18-19. VSA-GG. Pr: 0.5645    30
NZ_CP027599.1_29457	LIPO(Sec/SPII)	0.364268	0.009727	0.446143	0.179862	CS pos: 14-15. LAA-SD. Pr: 0.3375    19
NZ_CP027599.1_29463	LIPO(Sec/SPII)	0.286156	0.099497	0.431576	0.182770	CS pos: 12-13. SLT-CA. Pr: 0.3717    46
NZ_CP027599.1_29464	LIPO(Sec/SPII)	0.141590	0.010326	0.612937	0.235147	CS pos: 15-16. LEG-CY. Pr: 0.5733    17
NZ_CP027599.1_29466	SP(Sec/SPI)	0.361221	0.036816	0.305152	0.296812	CS pos: ?. Probable protein fragment    20
NZ_CP027599.1_29475	LIPO(Sec/SPII)	0.148172	0.064404	0.503520	0.283903	CS pos: 15-16. SLA-CW. Pr: 0.3827    19
NZ_CP027599.1_29483	LIPO(Sec/SPII)	0.131845	0.017878	0.677150	0.173127	CS pos: 12-13. LPG-CS. Pr: 0.5954    16
NZ_CP027599.1_29506	LIPO(Sec/SPII)	0.271087	0.028278	0.416849	0.283786	CS pos: 18-19. ITC-CS. Pr: 0.1641    29
NZ_CP027599.1_29531	LIPO(Sec/SPII)	0.285518	0.041555	0.410095	0.262832	CS pos: 12-13. PSA-CA. Pr: 0.1242    17
NZ_CP027599.1_29583	SP(Sec/SPI)	0.451353	0.020056	0.202003	0.326588	CS pos: 18-19. CIA-VE. Pr: 0.1650    27
NZ_CP027599.1_29590	SP(Sec/SPI)	0.378084	0.093521	0.151578	0.376818	CS pos: 15-16. ASG-QN. Pr: 0.1563    24
NZ_CP027599.1_29593	SP(Sec/SPI)	0.434231	0.015757	0.175445	0.374568	CS pos: ?. Probable protein fragment    22
NZ_CP027599.1_29599	LIPO(Sec/SPII)	0.060786	0.259903	0.390102	0.289209	CS pos: 25-26. ATG-CR. Pr: 0.3779    46
NZ_CP027599.1_29615	LIPO(Sec/SPII)	0.105297	0.002786	0.879131	0.012786	CS pos: 17-18. LTS-CL. Pr: 0.8152    25
NZ_CP027599.1_29677	LIPO(Sec/SPII)	0.284773	0.050895	0.341323	0.323009	CS pos: 14-15. VAG-SI. Pr: 0.1086    17
NZ_CP027599.1_29690	LIPO(Sec/SPII)	0.227069	0.011764	0.383347	0.377821	CS pos: 13-14. AMK-CE. Pr: 0.3300    23
NZ_CP027599.1_29693	SP(Sec/SPI)	0.558506	0.086628	0.033427	0.321438	CS pos: 16-17. ALA-DA. Pr: 0.5110    41
NZ_CP027599.1_29737	LIPO(Sec/SPII)	0.204170	0.012339	0.566216	0.217275	CS pos: ?. Probable protein fragment    24
NZ_CP027599.1_29741	LIPO(Sec/SPII)	0.423211	0.006151	0.448771	0.121867	CS pos: 18-19. QVP-CW. Pr: 0.3720    32
NZ_CP027599.1_29743	SP(Sec/SPI)	0.571653	0.013803	0.116876	0.297668	CS pos: 16-17. AHN-EQ. Pr: 0.2768    25
NZ_CP027599.1_29763	LIPO(Sec/SPII)	0.185082	0.014040	0.499119	0.301759	CS pos: 18-19. TLS-CS. Pr: 0.3861    20
NZ_CP027599.1_29801	LIPO(Sec/SPII)	0.101728	0.009728	0.622446	0.266098	CS pos: 17-18. LTG-CR. Pr: 0.5602    29
NZ_CP027599.1_29802	LIPO(Sec/SPII)	0.215469	0.021062	0.452497	0.310972	CS pos: ?. Probable protein fragment    19
NZ_CP027599.1_29804	SP(Sec/SPI)	0.474795	0.007201	0.069272	0.448732	CS pos: 18-19. KMA-QP. Pr: 0.2794    25
NZ_CP027599.1_29817	LIPO(Sec/SPII)	0.078573	0.003536	0.814853	0.103037	CS pos: 23-24. VAS-CS. Pr: 0.7938    33
NZ_CP027599.1_29838	LIPO(Sec/SPII)	0.323280	0.021050	0.407191	0.248479	CS pos: 16-17. AGG-NV. Pr: 0.0554    19
NZ_CP027599.1_29844	TAT(Tat/SPI)	0.267655	0.273025	0.220553	0.238767	CS pos: 29-30. SHA-LK. Pr: 0.3247    47
NZ_CP027599.1_29862	LIPO(Sec/SPII)	0.196182	0.017822	0.406309	0.379687	CS pos: 15-16. HFC-CQ. Pr: 0.1388    17
NZ_CP027599.1_29874	LIPO(Sec/SPII)	0.212942	0.041024	0.467587	0.278448	CS pos: ?. Probable protein fragment    19
NZ_CP027599.1_29875	LIPO(Sec/SPII)	0.112263	0.030762	0.628502	0.228472	CS pos: 14-15. FCG-CA. Pr: 0.4006    36
NZ_CP027599.1_29884	LIPO(Sec/SPII)	0.139617	0.010081	0.512573	0.337729	CS pos: 18-19. VSS-CL. Pr: 0.4385    25
NZ_CP027599.1_29920	SP(Sec/SPI)	0.582228	0.060292	0.012885	0.344595	CS pos: 20-21. ATA-LK. Pr: 0.6134    49
NZ_CP027599.1_29924	LIPO(Sec/SPII)	0.102804	0.024995	0.507675	0.364525	CS pos: 18-19. LVA-CR. Pr: 0.4584    22
NZ_CP027599.1_29932	LIPO(Sec/SPII)	0.189016	0.063231	0.413733	0.334020	CS pos: ?. Probable protein fragment    22
NZ_CP027599.1_29939	LIPO(Sec/SPII)	0.284822	0.010144	0.357617	0.347418	CS pos: ?. Probable protein fragment    15
NZ_CP027599.1_29943	SP(Sec/SPI)	0.487610	0.004352	0.365125	0.142913	CS pos: 22-23. TYC-RD. Pr: 0.3534    48
NZ_CP027599.1_29950	LIPO(Sec/SPII)	0.134665	0.029965	0.514526	0.320844	CS pos: 19-20. CMA-CV. Pr: 0.4168    24
NZ_CP027599.1_29953	SP(Sec/SPI)	0.346111	0.016860	0.313472	0.323557	CS pos: 18-19. TAA-TP. Pr: 0.0613    20
NZ_CP027599.1_29979	TAT(Tat/SPI)	0.199049	0.484737	0.208289	0.107925	CS pos: 24-25. NRA-DF. Pr: 0.3116    37
NZ_CP027599.1_29981	LIPO(Sec/SPII)	0.065105	0.004722	0.911276	0.018897	CS pos: 19-20. TAG-CN. Pr: 0.9042    26
NZ_CP027599.1_29983	SP(Sec/SPI)	0.769751	0.042233	0.062352	0.125664	CS pos: 25-26. SHA-FL. Pr: 0.5091    31
NZ_CP027599.1_29993	LIPO(Sec/SPII)	0.038717	0.010070	0.832155	0.119058	CS pos: 18-19. VAG-CD. Pr: 0.8290    28
NZ_CP027599.1_29997	SP(Sec/SPI)	0.431932	0.020986	0.212085	0.334997	CS pos: ?. Probable protein fragment    22
NZ_CP027599.1_30010	SP(Sec/SPI)	0.890820	0.020578	0.041655	0.046948	CS pos: 18-19. SDA-AN. Pr: 0.7347    31
NZ_CP027599.1_30016	LIPO(Sec/SPII)	0.116892	0.002974	0.529102	0.351032	CS pos: 18-19. AFC-CY. Pr: 0.3161    22
NZ_CP027599.1_30021	SP(Sec/SPI)	0.515606	0.020066	0.081237	0.383091	CS pos: 24-25. SNA-AG. Pr: 0.3371    50
NZ_CP027599.1_30078	SP(Sec/SPI)	0.472622	0.085527	0.098497	0.343355	CS pos: 18-19. SRA-KS. Pr: 0.3626    26
NZ_CP027599.1_30088	LIPO(Sec/SPII)	0.177635	0.043356	0.392096	0.386913	CS pos: ?. Probable protein fragment    21
NZ_CP027599.1_30095	TAT(Tat/SPI)	0.037161	0.717976	0.007854	0.237010	CS pos: 34-35. ALS-RW. Pr: 0.2544    48
NZ_CP027599.1_30104	LIPO(Sec/SPII)	0.106151	0.009658	0.851407	0.032784	CS pos: 19-20. TIS-CS. Pr: 0.8468    25
NZ_CP027599.1_30141	SP(Sec/SPI)	0.618505	0.023244	0.323317	0.034934	CS pos: 21-22. AFA-HP. Pr: 0.5347    28
NZ_CP027599.1_30198	LIPO(Sec/SPII)	0.073207	0.012618	0.788034	0.126141	CS pos: 23-24. ITQ-CA. Pr: 0.7684    33
NZ_CP027599.1_30202	SP(Sec/SPI)	0.418965	0.011482	0.274585	0.294968	CS pos: 15-16. LSA-WW. Pr: 0.1915    22
NZ_CP027599.1_30212	LIPO(Sec/SPII)	0.043204	0.003267	0.754682	0.198846	CS pos: 17-18. SIS-CD. Pr: 0.7548    29
NZ_CP027599.1_30240	SP(Sec/SPI)	0.458492	0.020134	0.105455	0.415920	CS pos: 23-24. ATC-LS. Pr: 0.1598    35
NZ_CP027599.1_30276	SP(Sec/SPI)	0.730965	0.008707	0.201006	0.059322	CS pos: 22-23. GGA-QP. Pr: 0.2913    43
NZ_CP027599.1_30291	LIPO(Sec/SPII)	0.123788	0.017542	0.666413	0.192257	CS pos: 15-16. PAA-CV. Pr: 0.6147    24
NZ_CP027599.1_30321	LIPO(Sec/SPII)	0.343874	0.020996	0.407843	0.227286	CS pos: 16-17. SAR-CS. Pr: 0.2356    32
NZ_CP027599.1_30328	SP(Sec/SPI)	0.441940	0.049356	0.106159	0.402545	CS pos: 21-22. VQS-KS. Pr: 0.1438    23
NZ_CP027599.1_30375	LIPO(Sec/SPII)	0.239716	0.019347	0.410391	0.330546	CS pos: ?. Probable protein fragment    15
NZ_CP027599.1_30383	LIPO(Sec/SPII)	0.216065	0.110609	0.362165	0.311161	CS pos: 21-22. RTG-CR. Pr: 0.2183    30
NZ_CP027599.1_30390	LIPO(Sec/SPII)	0.269469	0.022312	0.370470	0.337750	CS pos: 12-13. SLL-CL. Pr: 0.0134    16
NZ_CP027599.1_30401	LIPO(Sec/SPII)	0.246751	0.006396	0.510662	0.236191	CS pos: 16-17. LVS-CC. Pr: 0.2352    42
NZ_CP027599.1_30406	LIPO(Sec/SPII)	0.206247	0.155428	0.348825	0.289500	CS pos: ?. Probable protein fragment    17
NZ_CP027599.1_30409	LIPO(Sec/SPII)	0.021770	0.004079	0.921613	0.052537	CS pos: 21-22. LLT-CT. Pr: 0.9149    44
NZ_CP027599.1_30437	SP(Sec/SPI)	0.915394	0.021052	0.023796	0.039758	CS pos: 20-21. VDA-GN. Pr: 0.9013    38
NZ_CP027599.1_30456	LIPO(Sec/SPII)	0.236840	0.027929	0.372824	0.362407	CS pos: 13-14. FIC-CK. Pr: 0.1278    15
NZ_CP027599.1_30462	LIPO(Sec/SPII)	0.172355	0.044883	0.404617	0.378144	CS pos: ?. Probable protein fragment    25
NZ_CP027599.1_30467	LIPO(Sec/SPII)	0.087189	0.169118	0.595210	0.148484	CS pos: 22-23. APA-CE. Pr: 0.6815    45
NZ_CP027599.1_30471	SP(Sec/SPI)	0.823379	0.041368	0.045609	0.089643	CS pos: 22-23. VLA-AS. Pr: 0.7660    34
NZ_CP027599.1_30474	SP(Sec/SPI)	0.436286	0.045134	0.232326	0.286254	CS pos: 18-19. SMA-YN. Pr: 0.1939    20
NZ_CP027599.1_30511	LIPO(Sec/SPII)	0.314811	0.027051	0.331695	0.326443	CS pos: 17-18. INA-CP. Pr: 0.3399    19
NZ_CP027599.1_30518	SP(Sec/SPI)	0.466055	0.028454	0.294759	0.210732	CS pos: 24-25. CLA-VR. Pr: 0.3017    38
NZ_CP027599.1_30551	SP(Sec/SPI)	0.720819	0.039668	0.065385	0.174127	CS pos: 25-26. VQS-LG. Pr: 0.2915    45
NZ_CP027599.1_30564	LIPO(Sec/SPII)	0.207061	0.095170	0.415651	0.282118	CS pos: 21-22. LSS-CV. Pr: 0.3683    41
NZ_CP027599.1_30594	LIPO(Sec/SPII)	0.105092	0.005692	0.845874	0.043341	CS pos: 20-21. TTA-CA. Pr: 0.7899    39
NZ_CP027599.1_30604	LIPO(Sec/SPII)	0.186176	0.011341	0.583218	0.219265	CS pos: ?. Probable protein fragment    18
NZ_CP027599.1_30658	LIPO(Sec/SPII)	0.191358	0.009245	0.768863	0.030533	CS pos: 19-20. LAG-SS. Pr: 0.7286    38
NZ_CP027599.1_30693	LIPO(Sec/SPII)	0.066671	0.006604	0.623305	0.303420	CS pos: 29-30. ATA-CL. Pr: 0.6174    36
NZ_CP027599.1_30702	LIPO(Sec/SPII)	0.037612	0.007856	0.863124	0.091407	CS pos: 21-22. SGG-CR. Pr: 0.8524    36
NZ_CP027599.1_30706	LIPO(Sec/SPII)	0.213952	0.059554	0.404016	0.322478	CS pos: ?. Probable protein fragment    19
NZ_CP027599.1_30724	SP(Sec/SPI)	0.501410	0.048777	0.209946	0.239867	CS pos: 20-21. PTA-NN. Pr: 0.1177    24
NZ_CP027599.1_30745	SP(Sec/SPI)	0.357966	0.108778	0.182932	0.350324	CS pos: 21-22. STA-IT. Pr: 0.1764    35
NZ_CP027599.1_30811	LIPO(Sec/SPII)	0.225166	0.011563	0.588373	0.174898	CS pos: ?. Probable protein fragment    16
NZ_CP027599.1_30830	LIPO(Sec/SPII)	0.073596	0.007190	0.476306	0.442907	CS pos: 17-18. SCT-CR. Pr: 0.2774    33
NZ_CP027599.1_30874	LIPO(Sec/SPII)	0.214145	0.022526	0.448264	0.315065	CS pos: ?. Probable protein fragment    15
NZ_CP027599.1_30912	SP(Sec/SPI)	0.337805	0.011507	0.336032	0.314655	CS pos: ?. Probable protein fragment    18
NZ_CP027599.1_30934	LIPO(Sec/SPII)	0.102456	0.014557	0.468081	0.414905	CS pos: 25-26. GVG-CT. Pr: 0.4342    35
NZ_CP027599.1_31010	TAT(Tat/SPI)	0.266193	0.275891	0.232634	0.225282	CS pos: 21-22. SHS-IP. Pr: 0.0882    26
NZ_CP027599.1_31050	SP(Sec/SPI)	0.392726	0.120347	0.121742	0.365185	CS pos: 17-18. AGA-MD. Pr: 0.2597    26
NZ_CP027599.1_31059	SP(Sec/SPI)	0.395002	0.020065	0.235146	0.349787	CS pos: 15-16. ATA-VR. Pr: 0.3001    22
NZ_CP027599.1_31098	LIPO(Sec/SPII)	0.101680	0.002564	0.747453	0.148303	CS pos: 18-19. PLA-CW. Pr: 0.7313    32
NZ_CP027599.1_31129	LIPO(Sec/SPII)	0.232804	0.036462	0.428083	0.302650	CS pos: ?. Probable protein fragment    17
NZ_CP027599.1_31136	LIPO(Sec/SPII)	0.276466	0.021994	0.389929	0.311611	CS pos: ?. Probable protein fragment    16
NZ_CP027599.1_31187	SP(Sec/SPI)	0.667059	0.039311	0.023810	0.269820	CS pos: 29-30. TEA-IP. Pr: 0.6045    47
NZ_CP027599.1_31188	LIPO(Sec/SPII)	0.005361	0.000289	0.992684	0.001666	CS pos: 18-19. LAG-CC. Pr: 0.9653    39
NZ_CP027599.1_31206	LIPO(Sec/SPII)	0.127121	0.031839	0.448130	0.392910	CS pos: 13-14. SAS-CC. Pr: 0.2580    43
NZ_CP027599.1_31214	LIPO(Sec/SPII)	0.110096	0.032166	0.675727	0.182011	CS pos: 13-14. TSA-CK. Pr: 0.6752    28
NZ_CP027599.1_31217	LIPO(Sec/SPII)	0.284965	0.025023	0.401374	0.288638	CS pos: 11-12. SPA-CW. Pr: 0.1332    16
NZ_CP027599.1_31224	LIPO(Sec/SPII)	0.082859	0.046100	0.692330	0.178711	CS pos: 27-28. LNS-CN. Pr: 0.6425    37
NZ_CP027599.1_31249	SP(Sec/SPI)	0.462156	0.093427	0.145672	0.298745	CS pos: 19-20. SRA-MV. Pr: 0.3126    24
NZ_CP027599.1_31255	SP(Sec/SPI)	0.369020	0.365601	0.055409	0.209970	CS pos: 25-26. AAA-GT. Pr: 0.3360    38
NZ_CP027599.1_31265	TAT(Tat/SPI)	0.064760	0.719757	0.031830	0.183653	CS pos: 32-33. VYA-RW. Pr: 0.4791    36
NZ_CP027599.1_31266	SP(Sec/SPI)	0.409335	0.032273	0.179771	0.378622	CS pos: 23-24. TSS-SE. Pr: 0.1565    27
NZ_CP027599.1_31276	SP(Sec/SPI)	0.455099	0.066098	0.103168	0.375635	CS pos: 26-27. VLP-SA. Pr: 0.1378    36
NZ_CP027599.1_31278	LIPO(Sec/SPII)	0.054030	0.010634	0.908435	0.026900	CS pos: 19-20. IIA-CT. Pr: 0.8983    26
NZ_CP027599.1_31295	SP(Sec/SPI)	0.488971	0.117861	0.191539	0.201629	CS pos: 19-20. LFS-AP. Pr: 0.3430    37
NZ_CP027599.1_31302	TAT(Tat/SPI)	0.065088	0.745088	0.032779	0.157045	CS pos: 24-25. VRA-AR. Pr: 0.4130    26
NZ_CP027599.1_31307	SP(Sec/SPI)	0.512683	0.036891	0.127815	0.322611	CS pos: 29-30. CRA-AV. Pr: 0.2298    49
NZ_CP027599.1_31354	LIPO(Sec/SPII)	0.082949	0.011131	0.473406	0.432515	CS pos: 12-13. AAG-CF. Pr: 0.4479    22
NZ_CP027599.1_31367	LIPO(Sec/SPII)	0.100624	0.006851	0.568947	0.323578	CS pos: 16-17. VTV-CN. Pr: 0.3068    30
NZ_CP027599.1_31375	LIPO(Sec/SPII)	0.218081	0.051526	0.422881	0.307512	CS pos: 21-22. LYG-CD. Pr: 0.3440    24
NZ_CP027599.1_31379	LIPO(Sec/SPII)	0.093774	0.013681	0.617263	0.275282	CS pos: 19-20. TLC-CA. Pr: 0.3753    38
NZ_CP027599.1_31416	LIPO(Sec/SPII)	0.247849	0.023717	0.437758	0.290675	CS pos: 13-14. NVL-CQ. Pr: 0.0682    15
NZ_CP027599.1_31418	LIPO(Sec/SPII)	0.232870	0.258426	0.269723	0.238982	CS pos: 16-17. SAG-TS. Pr: 0.0475    18
NZ_CP027599.1_31468	SP(Sec/SPI)	0.444494	0.061885	0.140668	0.352953	CS pos: ?. Probable protein fragment    23
NZ_CP027599.1_31483	LIPO(Sec/SPII)	0.273271	0.016912	0.404681	0.305136	CS pos: ?. Probable protein fragment    15
NZ_CP027599.1_31494	TAT(Tat/SPI)	0.159729	0.362150	0.255385	0.222736	CS pos: ?. Probable protein fragment    15
NZ_CP027599.1_31506	LIPO(Sec/SPII)	0.226133	0.070664	0.419683	0.283520	CS pos: 26-27. PVS-CR. Pr: 0.2343    35
NZ_CP027599.1_31530	SP(Sec/SPI)	0.484416	0.356376	0.100755	0.058453	CS pos: 29-30. VTA-QT. Pr: 0.3116    41
NZ_CP027599.1_31599	LIPO(Sec/SPII)	0.058020	0.130923	0.519994	0.291062	CS pos: 28-29. QTA-CI. Pr: 0.5131    44
NZ_CP027599.1_31622	LIPO(Sec/SPII)	0.042500	0.002787	0.837014	0.117699	CS pos: 21-22. LMA-CR. Pr: 0.7772    25
NZ_CP027599.1_31645	TAT(Tat/SPI)	0.245719	0.403766	0.049138	0.301376	CS pos: 31-32. VKA-GK. Pr: 0.2817    41
NZ_CP027599.1_31650	LIPO(Sec/SPII)	0.315959	0.015717	0.382585	0.285740	CS pos: ?. Probable protein fragment    19
NZ_CP027599.1_31711	SP(Sec/SPI)	0.774217	0.024333	0.106054	0.095396	CS pos: 23-24. LRS-VP. Pr: 0.3286    37
NZ_CP027599.1_31716	LIPO(Sec/SPII)	0.151000	0.033868	0.475305	0.339827	CS pos: 25-26. FSA-CC. Pr: 0.3540    31
NZ_CP027599.1_31766	SP(Sec/SPI)	0.758354	0.028868	0.133234	0.079543	CS pos: 23-24. VFG-QR. Pr: 0.4442    36
NZ_CP027599.1_31785	SP(Sec/SPI)	0.382095	0.163191	0.122418	0.332296	CS pos: 24-25. KSA-TL. Pr: 0.1226    33
NZ_CP027599.1_31792	LIPO(Sec/SPII)	0.290822	0.013658	0.360233	0.335287	CS pos: 28-29. STS-CC. Pr: 0.2157    31
NZ_CP027599.1_31794	LIPO(Sec/SPII)	0.034332	0.011701	0.541597	0.412371	CS pos: 24-25. CYS-CC. Pr: 0.2409    42
NZ_CP027599.1_31802	LIPO(Sec/SPII)	0.467539	0.007374	0.504508	0.020579	CS pos: 18-19. APS-CA. Pr: 0.4795    36
NZ_CP027599.1_31824	SP(Sec/SPI)	0.657858	0.046295	0.198050	0.097797	CS pos: 17-18. ARG-ND. Pr: 0.3635    33
NZ_CP027599.1_31831	SP(Sec/SPI)	0.454386	0.049659	0.289779	0.206177	CS pos: 19-20. ALT-AP. Pr: 0.1462    26
NZ_CP027599.1_31833	LIPO(Sec/SPII)	0.287451	0.059730	0.374447	0.278372	CS pos: 12-13. NGS-CV. Pr: 0.1092    15
NZ_CP027599.1_31841	LIPO(Sec/SPII)	0.096868	0.011838	0.777924	0.113370	CS pos: 13-14. LTN-CA. Pr: 0.7260    29
NZ_CP027599.1_31874	LIPO(Sec/SPII)	0.068132	0.045378	0.776149	0.110341	CS pos: 21-22. AVA-CI. Pr: 0.8281    39
NZ_CP027599.1_31877	LIPO(Sec/SPII)	0.145255	0.017890	0.450026	0.386829	CS pos: 20-21. SAG-CS. Pr: 0.4301    27
NZ_CP027599.1_31900	LIPO(Sec/SPII)	0.151988	0.004469	0.717494	0.126049	CS pos: 14-15. SLS-CN. Pr: 0.5246    20
NZ_CP027599.1_31917	SP(Sec/SPI)	0.477432	0.015130	0.089181	0.418257	CS pos: 20-21. CYA-DC. Pr: 0.4549    33
NZ_CP027599.1_31923	LIPO(Sec/SPII)	0.225225	0.013625	0.442607	0.318543	CS pos: ?. Probable protein fragment    19
NZ_CP027599.1_31970	LIPO(Sec/SPII)	0.266561	0.023039	0.419173	0.291226	CS pos: 14-15. SVS-CS. Pr: 0.1243    18
NZ_CP027599.1_32014	LIPO(Sec/SPII)	0.226062	0.014267	0.459228	0.300443	CS pos: 13-14. LGR-LG. Pr: 0.0497    15
NZ_CP027599.1_32035	LIPO(Sec/SPII)	0.150448	0.012381	0.513277	0.323894	CS pos: 17-18. FYT-CW. Pr: 0.3145    35
NZ_CP027599.1_32049	LIPO(Sec/SPII)	0.154916	0.284525	0.351126	0.209433	CS pos: 19-20. RSS-CR. Pr: 0.2875    22
NZ_CP027599.1_32085	LIPO(Sec/SPII)	0.253323	0.029183	0.394411	0.323082	CS pos: 14-15. GVL-CW. Pr: 0.0928    16
NZ_CP027599.1_32131	LIPO(Sec/SPII)	0.070079	0.074361	0.465633	0.389927	CS pos: 33-34. RAG-CR. Pr: 0.4467    49
NZ_CP027599.1_32168	TAT(Tat/SPI)	0.069248	0.514979	0.047276	0.368497	CS pos: 25-26. PEA-GT. Pr: 0.1207    50
NZ_CP027599.1_32175	SP(Sec/SPI)	0.450937	0.198582	0.037705	0.312776	CS pos: 28-29. ARA-AM. Pr: 0.3361    48
NZ_CP027599.1_32187	TAT(Tat/SPI)	0.127145	0.601539	0.017707	0.253608	CS pos: 30-31. ARG-AT. Pr: 0.2291    50
NZ_CP027599.1_32226	SP(Sec/SPI)	0.536394	0.016624	0.223904	0.223078	CS pos: 19-20. IAA-DT. Pr: 0.2908    32
NZ_CP027599.1_32229	LIPO(Sec/SPII)	0.199936	0.031871	0.445792	0.322401	CS pos: 19-20. FSA-CA. Pr: 0.2611    23
NZ_CP027599.1_32239	LIPO(Sec/SPII)	0.291804	0.007132	0.542638	0.158425	CS pos: 11-12. SFS-CH. Pr: 0.3826    17
NZ_CP027599.1_32256	LIPO(Sec/SPII)	0.165455	0.086622	0.580438	0.167486	CS pos: 19-20. SAT-CR. Pr: 0.4995    29
NZ_CP027599.1_32360	LIPO(Sec/SPII)	0.212955	0.099668	0.387325	0.300052	CS pos: 18-19. GGS-CS. Pr: 0.1843    21
NZ_CP027599.1_32361	LIPO(Sec/SPII)	0.060093	0.007292	0.697379	0.235236	CS pos: 16-17. IAS-CR. Pr: 0.6611    33
NZ_CP027599.1_32368	LIPO(Sec/SPII)	0.157921	0.053404	0.498784	0.289891	CS pos: 23-24. WHS-CS. Pr: 0.2287    46
NZ_CP027599.1_32376	LIPO(Sec/SPII)	0.152628	0.015779	0.461063	0.370530	CS pos: 30-31. CWS-CK. Pr: 0.3753    46
NZ_CP027599.1_32385	SP(Sec/SPI)	0.482687	0.054723	0.152886	0.309704	CS pos: 13-14. AMS-NV. Pr: 0.0740    19
NZ_CP027599.1_32425	SP(Sec/SPI)	0.602978	0.004903	0.219973	0.172145	CS pos: 20-21. LHC-LT. Pr: 0.3246    35
NZ_CP027599.1_32620	LIPO(Sec/SPII)	0.152554	0.012955	0.645115	0.189375	CS pos: 15-16. MSS-CP. Pr: 0.4512    17
NZ_CP027599.1_32645	SP(Sec/SPI)	0.671056	0.093395	0.170274	0.065275	CS pos: 16-17. AAA-AV. Pr: 0.4009    32
NZ_CP027599.1_32746	SP(Sec/SPI)	0.481220	0.023949	0.113280	0.381551	CS pos: 23-24. VHS-DT. Pr: 0.4149    42
NZ_CP027599.1_32750	LIPO(Sec/SPII)	0.173075	0.047276	0.464905	0.314744	CS pos: 14-15. AVA-CK. Pr: 0.4525    22
NZ_CP027599.1_32788	LIPO(Sec/SPII)	0.324328	0.024840	0.337294	0.313539	CS pos: 14-15. SSG-TP. Pr: 0.0770    16
NZ_CP027599.1_32804	SP(Sec/SPI)	0.456279	0.010047	0.199736	0.333939	CS pos: 15-16. AES-SL. Pr: 0.3412    23
NZ_CP027599.1_32806	LIPO(Sec/SPII)	0.092238	0.014528	0.561891	0.331343	CS pos: 15-16. ISG-CR. Pr: 0.3759    25
NZ_CP027599.1_32885	LIPO(Sec/SPII)	0.038757	0.006108	0.544645	0.410491	CS pos: 13-14. ASA-CT. Pr: 0.5334    44
NZ_CP027599.1_32889	LIPO(Sec/SPII)	0.061327	0.010025	0.611664	0.316985	CS pos: 18-19. AIA-CW. Pr: 0.5855    27
NZ_CP027599.1_32900	LIPO(Sec/SPII)	0.050966	0.001636	0.895158	0.052240	CS pos: 16-17. LST-CV. Pr: 0.8885    31
NZ_CP027599.1_32908	LIPO(Sec/SPII)	0.278469	0.011016	0.424543	0.285972	CS pos: 14-15. IWR-CV. Pr: 0.0795    16
NZ_CP027599.1_32927	LIPO(Sec/SPII)	0.140609	0.042452	0.587339	0.229600	CS pos: 15-16. GNA-CA. Pr: 0.4422    18
NZ_CP027599.1_32939	LIPO(Sec/SPII)	0.093313	0.012202	0.636233	0.258252	CS pos: 20-21. QSG-CK. Pr: 0.5966    22
NZ_CP027599.1_32940	SP(Sec/SPI)	0.726628	0.028498	0.047765	0.197109	CS pos: 17-18. TWA-DS. Pr: 0.6929    25
NZ_CP027599.1_32953	SP(Sec/SPI)	0.415706	0.133955	0.064060	0.386279	CS pos: 13-14. AGA-NP. Pr: 0.1406    30
NZ_CP027599.1_32954	LIPO(Sec/SPII)	0.242797	0.022963	0.374378	0.359863	CS pos: 23-24. SPA-SV. Pr: 0.0268    25
NZ_CP027599.1_32959	LIPO(Sec/SPII)	0.287556	0.012586	0.416475	0.283382	CS pos: 17-18. GWG-LD. Pr: 0.0692    19
NZ_CP027599.1_32968	SP(Sec/SPI)	0.589179	0.214652	0.094265	0.101904	CS pos: 21-22. ARA-TK. Pr: 0.6678    29
NZ_CP027599.1_32969	LIPO(Sec/SPII)	0.228371	0.016118	0.514929	0.240582	CS pos: ?. Probable protein fragment    15
NZ_CP027599.1_32980	LIPO(Sec/SPII)	0.280699	0.025798	0.470359	0.223144	CS pos: 12-13. SSG-CP. Pr: 0.0906    17
NZ_CP027599.1_32986	SP(Sec/SPI)	0.397963	0.025493	0.247067	0.329477	CS pos: 17-18. FLC-SS. Pr: 0.1127    26
NZ_CP027599.1_32991	LIPO(Sec/SPII)	0.177948	0.004769	0.426533	0.390750	CS pos: 23-24. CVS-CA. Pr: 0.3163    25
NZ_CP027599.1_33036	LIPO(Sec/SPII)	0.128899	0.017391	0.483618	0.370093	CS pos: 14-15. CVS-CS. Pr: 0.4248    23
NZ_CP027599.1_33049	SP(Sec/SPI)	0.752265	0.047869	0.083108	0.116758	CS pos: 15-16. SNA-AP. Pr: 0.6963    26
NZ_CP027599.1_33162	LIPO(Sec/SPII)	0.177715	0.017947	0.556578	0.247760	CS pos: 20-21. SAA-CT. Pr: 0.4077    28
NZ_CP027599.1_33168	LIPO(Sec/SPII)	0.322100	0.015573	0.341806	0.320521	CS pos: ?. Probable protein fragment    17
NZ_CP027599.1_33196	SP(Sec/SPI)	0.447534	0.016779	0.329554	0.206133	CS pos: 15-16. SSA-WF. Pr: 0.1181    19
NZ_CP027599.1_33217	SP(Sec/SPI)	0.431739	0.215399	0.120444	0.232419	CS pos: 20-21. PRA-SN. Pr: 0.1653    28
NZ_CP027599.1_33244	SP(Sec/SPI)	0.414966	0.267185	0.062691	0.255158	CS pos: 28-29. ATA-AP. Pr: 0.1237    32
NZ_CP027599.1_33246	LIPO(Sec/SPII)	0.158921	0.142989	0.375026	0.323064	CS pos: 32-33. MTA-CR. Pr: 0.3262    37
NZ_CP027599.1_33253	LIPO(Sec/SPII)	0.237070	0.041926	0.416011	0.304993	CS pos: 15-16. ILS-CR. Pr: 0.3306    20
NZ_CP027599.1_33270	SP(Sec/SPI)	0.670844	0.108482	0.161640	0.059033	CS pos: 24-25. TAA-SW. Pr: 0.4890    42
NZ_CP027599.1_33285	LIPO(Sec/SPII)	0.071352	0.004009	0.525612	0.399027	CS pos: 17-18. GLT-CA. Pr: 0.4672    39
NZ_CP027599.1_33290	LIPO(Sec/SPII)	0.315920	0.027051	0.634138	0.022891	CS pos: 19-20. LPS-CG. Pr: 0.6222    37
NZ_CP027599.1_33306	SP(Sec/SPI)	0.348537	0.228533	0.255198	0.167732	CS pos: 20-21. SMA-SP. Pr: 0.2581    28
NZ_CP027599.1_33308	TAT(Tat/SPI)	0.236106	0.439310	0.049451	0.275133	CS pos: 37-38. ASA-GS. Pr: 0.2230    48
NZ_CP027599.1_33328	LIPO(Sec/SPII)	0.192885	0.028203	0.697091	0.081821	CS pos: 18-19. MTA-CC. Pr: 0.6543    27
NZ_CP027599.1_33340	LIPO(Sec/SPII)	0.297274	0.058563	0.409376	0.234787	CS pos: ?. Probable protein fragment    19
NZ_CP027599.1_33353	LIPO(Sec/SPII)	0.159707	0.131402	0.575472	0.133419	CS pos: 18-19. SCA-CH. Pr: 0.3850    36
NZ_CP027599.1_33363	LIPO(Sec/SPII)	0.106085	0.012430	0.457994	0.423491	CS pos: 25-26. PVS-CQ. Pr: 0.3723    28
NZ_CP027599.1_33394	LIPO(Sec/SPII)	0.173470	0.139314	0.662044	0.025171	CS pos: 19-20. SMA-CC. Pr: 0.5832    36
NZ_CP027599.1_33410	LIPO(Sec/SPII)	0.085567	0.006840	0.568763	0.338830	CS pos: 28-29. VMA-CS. Pr: 0.3315    42
NZ_CP027599.1_33424	SP(Sec/SPI)	0.381718	0.008839	0.256162	0.353280	CS pos: 18-19. VQP-ET. Pr: 0.1442    26
NZ_CP027599.1_33430	SP(Sec/SPI)	0.465502	0.009433	0.130651	0.394414	CS pos: 33-34. THS-AR. Pr: 0.3060    50
NZ_CP027599.1_33447	SP(Sec/SPI)	0.501481	0.033084	0.252159	0.213276	CS pos: 23-24. SMC-SK. Pr: 0.1248    41
NZ_CP027599.1_33448	SP(Sec/SPI)	0.476531	0.055455	0.041896	0.426117	CS pos: 25-26. CWA-AE. Pr: 0.3538    31
NZ_CP027599.1_33479	SP(Sec/SPI)	0.471867	0.108068	0.243158	0.176908	CS pos: 19-20. AVA-GA. Pr: 0.1831    40
NZ_CP027599.1_33503	SP(Sec/SPI)	0.346822	0.026473	0.316502	0.310204	CS pos: 13-14. IWG-LA. Pr: 0.0335    15
NZ_CP027599.1_33606	LIPO(Sec/SPII)	0.169400	0.052136	0.414196	0.364268	CS pos: 9-10. VSG-CI. Pr: 0.3391    20
NZ_CP027599.1_33609	SP(Sec/SPI)	0.571049	0.015873	0.345055	0.068024	CS pos: 17-18. ASA-SN. Pr: 0.3231    40
NZ_CP027599.1_33610	SP(Sec/SPI)	0.501981	0.192302	0.068964	0.236754	CS pos: 26-27. ALA-AG. Pr: 0.3937    36
NZ_CP027599.1_33613	TAT(Tat/SPI)	0.164106	0.415676	0.027956	0.392262	CS pos: 29-30. AGA-GG. Pr: 0.2640    46
NZ_CP027599.1_33622	TAT(Tat/SPI)	0.143279	0.354363	0.296776	0.205583	CS pos: ?. Probable protein fragment    17
NZ_CP027599.1_33649	LIPO(Sec/SPII)	0.037351	0.000751	0.639779	0.322119	CS pos: 21-22. SIM-CS. Pr: 0.6196    42
NZ_CP027599.1_33665	LIPO(Sec/SPII)	0.099811	0.016852	0.458473	0.424863	CS pos: 16-17. LPG-CM. Pr: 0.4386    35
NZ_CP027599.1_33689	SP(Sec/SPI)	0.493224	0.015699	0.219479	0.271598	CS pos: ?. Probable protein fragment    17
NZ_CP027599.1_33701	LIPO(Sec/SPII)	0.050531	0.005667	0.701675	0.242127	CS pos: 14-15. IAT-CL. Pr: 0.6787    29
NZ_CP027599.1_33702	SP(Sec/SPI)	0.515117	0.022459	0.194425	0.267999	CS pos: ?. Probable protein fragment    21
NZ_CP027599.1_33814	SP(Sec/SPI)	0.342293	0.120648	0.228420	0.308640	CS pos: 23-24. AIA-SH. Pr: 0.1643    33
NZ_CP027599.1_33839	TAT(Tat/SPI)	0.163147	0.327849	0.270685	0.238319	CS pos: 15-16. ALT-CG. Pr: 0.1113    17
NZ_CP027599.1_33853	LIPO(Sec/SPII)	0.200351	0.026309	0.398624	0.374716	CS pos: ?. Probable protein fragment    15
NZ_CP027599.1_33867	LIPO(Sec/SPII)	0.097793	0.011575	0.689485	0.201147	CS pos: 18-19. ELA-CR. Pr: 0.6507    28
NZ_CP027599.1_33880	SP(Sec/SPI)	0.370068	0.219916	0.062344	0.347672	CS pos: 22-23. AYA-PT. Pr: 0.3340    31
NZ_CP027599.1_33914	LIPO(Sec/SPII)	0.047698	0.001917	0.669939	0.280446	CS pos: 19-20. VLA-CC. Pr: 0.5264    25
NZ_CP027599.1_33919	LIPO(Sec/SPII)	0.199505	0.028969	0.447910	0.323616	CS pos: 20-21. KSS-CA. Pr: 0.3903    26
NZ_CP027599.1_33947	SP(Sec/SPI)	0.714401	0.017029	0.085016	0.183555	CS pos: 21-22. AWG-MD. Pr: 0.5617    36
NZ_CP027599.1_34006	LIPO(Sec/SPII)	0.074454	0.049634	0.505915	0.369997	CS pos: 14-15. MVG-CR. Pr: 0.4939    34
NZ_CP027599.1_34033	LIPO(Sec/SPII)	0.066623	0.006516	0.790117	0.136743	CS pos: 16-17. KQA-CS. Pr: 0.7761    27
NZ_CP027599.1_34034	LIPO(Sec/SPII)	0.091652	0.142986	0.418101	0.347260	CS pos: 24-25. VTS-CC. Pr: 0.3260    40
NZ_CP027599.1_34040	LIPO(Sec/SPII)	0.265270	0.013626	0.427427	0.293676	CS pos: ?. Probable protein fragment    16
NZ_CP027599.1_34041	LIPO(Sec/SPII)	0.185499	0.006944	0.611643	0.195915	CS pos: 13-14. VSN-CV. Pr: 0.4402    19
NZ_CP027599.1_34043	LIPO(Sec/SPII)	0.058929	0.009200	0.619481	0.312391	CS pos: 27-28. ILS-CA. Pr: 0.5814    38
NZ_CP027599.1_34073	LIPO(Sec/SPII)	0.208270	0.074882	0.361630	0.355219	CS pos: 15-16. QTA-CR. Pr: 0.1322    18
NZ_CP027599.1_34090	SP(Sec/SPI)	0.426642	0.142243	0.164228	0.266886	CS pos: 19-20. APA-GS. Pr: 0.1185    28
NZ_CP027599.1_34137	LIPO(Sec/SPII)	0.035245	0.007471	0.926428	0.030856	CS pos: 18-19. ATA-CR. Pr: 0.9245    27
NZ_CP027599.1_34141	LIPO(Sec/SPII)	0.182309	0.026808	0.399653	0.391230	CS pos: ?. Probable protein fragment    20
NZ_CP027599.1_34142	LIPO(Sec/SPII)	0.218303	0.009792	0.553795	0.218111	CS pos: 18-19. LAY-CS. Pr: 0.4234    25
NZ_CP027599.1_34154	LIPO(Sec/SPII)	0.227970	0.031871	0.423020	0.317139	CS pos: 16-17. ATC-CD. Pr: 0.1904    26
NZ_CP027599.1_34162	SP(Sec/SPI)	0.670202	0.036301	0.137317	0.156180	CS pos: ?. Probable protein fragment    26
NZ_CP027599.1_34170	LIPO(Sec/SPII)	0.074889	0.015850	0.766377	0.142884	CS pos: 19-20. FLS-CV. Pr: 0.7482    27
NZ_CP027599.1_34212	LIPO(Sec/SPII)	0.010956	0.000580	0.941208	0.047255	CS pos: 23-24. LSA-CH. Pr: 0.9354    41
NZ_CP027599.1_34232	LIPO(Sec/SPII)	0.119577	0.016483	0.449812	0.414128	CS pos: 21-22. FSS-CN. Pr: 0.4150    34
NZ_CP027599.1_34264	SP(Sec/SPI)	0.436590	0.044451	0.152043	0.366916	CS pos: ?. Probable protein fragment    23
NZ_CP027599.1_34279	TAT(Tat/SPI)	0.216539	0.300856	0.203595	0.279011	CS pos: 19-20. LSS-LS. Pr: 0.0794    23
NZ_CP027599.1_34322	SP(Sec/SPI)	0.395267	0.067030	0.152441	0.385262	CS pos: 14-15. AGA-GH. Pr: 0.1459    28
NZ_CP027599.1_34340	LIPO(Sec/SPII)	0.260546	0.021206	0.376664	0.341584	CS pos: ?. Probable protein fragment    17
NZ_CP027599.1_34342	LIPO(Sec/SPII)	0.309769	0.012162	0.398486	0.279583	CS pos: 13-14. LTG-RP. Pr: 0.2975    19
NZ_CP027599.1_34393	SP(Sec/SPI)	0.546991	0.130584	0.076839	0.245586	CS pos: 30-31. ASA-SF. Pr: 0.3403    40
NZ_CP027599.1_34463	LIPO(Sec/SPII)	0.151026	0.012448	0.471604	0.364923	CS pos: 24-25. LLS-CD. Pr: 0.4489    37
NZ_CP027599.1_34485	LIPO(Sec/SPII)	0.280368	0.023310	0.446144	0.250179	CS pos: 13-14. CAT-CQ. Pr: 0.0536    15
NZ_CP027599.1_34490	LIPO(Sec/SPII)	0.045384	0.030324	0.749462	0.174830	CS pos: 16-17. TPG-CQ. Pr: 0.7324    28
NZ_CP027599.1_34491	LIPO(Sec/SPII)	0.063093	0.003884	0.759395	0.173628	CS pos: 24-25. VTS-CF. Pr: 0.7299    26
NZ_CP027599.1_34497	LIPO(Sec/SPII)	0.118308	0.167326	0.599172	0.115194	CS pos: 15-16. STS-CP. Pr: 0.5516    23
NZ_CP027599.1_34502	SP(Sec/SPI)	0.440413	0.230184	0.023046	0.306357	CS pos: 29-30. AHA-AQ. Pr: 0.5877    49
NZ_CP027599.1_34543	LIPO(Sec/SPII)	0.184439	0.061227	0.589146	0.165189	CS pos: 23-24. LAG-LS. Pr: 0.4773    50
NZ_CP027599.1_34571	LIPO(Sec/SPII)	0.099708	0.042489	0.475934	0.381870	CS pos: 15-16. FRG-CY. Pr: 0.4719    43
NZ_CP027599.1_34579	SP(Sec/SPI)	0.548430	0.105630	0.141056	0.204883	CS pos: 22-23. SSA-NT. Pr: 0.3468    38
NZ_CP027599.1_34595	SP(Sec/SPI)	0.559069	0.049968	0.060491	0.330473	CS pos: 16-17. ASA-IR. Pr: 0.4785    36
NZ_CP027599.1_34610	LIPO(Sec/SPII)	0.020133	0.031172	0.916081	0.032613	CS pos: 24-25. LSG-CV. Pr: 0.9150    40
NZ_CP027599.1_34632	SP(Sec/SPI)	0.367833	0.027360	0.241464	0.363342	CS pos: 17-18. ASS-RD. Pr: 0.1190    49
NZ_CP027599.1_34640	LIPO(Sec/SPII)	0.176260	0.003091	0.676268	0.144380	CS pos: 20-21. DHG-CR. Pr: 0.3504    42
NZ_CP027599.1_34647	SP(Sec/SPI)	0.364365	0.148379	0.230738	0.256517	CS pos: 22-23. VSG-SP. Pr: 0.1129    37
NZ_CP027599.1_34651	LIPO(Sec/SPII)	0.295481	0.010927	0.363856	0.329736	CS pos: 11-12. LIC-VD. Pr: 0.0353    18
NZ_CP027599.1_34676	LIPO(Sec/SPII)	0.133558	0.016313	0.473925	0.376204	CS pos: 19-20. FTA-CP. Pr: 0.3592    31
NZ_CP027599.1_34704	LIPO(Sec/SPII)	0.248991	0.015397	0.408349	0.327263	CS pos: ?. Probable protein fragment    18
NZ_CP027599.1_34717	LIPO(Sec/SPII)	0.265855	0.017778	0.385175	0.331193	CS pos: 18-19. FRG-CC. Pr: 0.1566    20
NZ_CP027599.1_34724	SP(Sec/SPI)	0.588887	0.006260	0.116979	0.287874	CS pos: 27-28. SHS-KS. Pr: 0.2249    38
NZ_CP027599.1_34729	LIPO(Sec/SPII)	0.137567	0.042827	0.637954	0.181651	CS pos: 21-22. LTM-CR. Pr: 0.5560    30
NZ_CP027599.1_34732	LIPO(Sec/SPII)	0.264206	0.015677	0.390334	0.329783	CS pos: 19-20. LTG-QR. Pr: 0.3413    25
NZ_CP027599.1_34752	SP(Sec/SPI)	0.349492	0.043503	0.266361	0.340644	CS pos: 22-23. SNS-AV. Pr: 0.0500    24
NZ_CP027599.1_34812	LIPO(Sec/SPII)	0.262513	0.012312	0.378369	0.346806	CS pos: 13-14. LNL-CT. Pr: 0.0795    18
NZ_CP027599.1_34843	LIPO(Sec/SPII)	0.243399	0.016038	0.466122	0.274440	CS pos: 11-12. LLG-CL. Pr: 0.1115    15
NZ_CP027599.1_34858	LIPO(Sec/SPII)	0.043421	0.142230	0.434173	0.380175	CS pos: 26-27. STA-CW. Pr: 0.4199    50
NZ_CP027599.1_34862	SP(Sec/SPI)	0.429412	0.018950	0.200151	0.351487	CS pos: 23-24. SMA-LL. Pr: 0.1413    28
NZ_CP027599.1_34877	LIPO(Sec/SPII)	0.133361	0.030132	0.458049	0.378458	CS pos: 25-26. CAG-CL. Pr: 0.2781    30
NZ_CP027599.1_34883	LIPO(Sec/SPII)	0.075120	0.004459	0.747565	0.172856	CS pos: 25-26. ITC-CH. Pr: 0.4616    36
NZ_CP027599.1_34925	SP(Sec/SPI)	0.689111	0.011557	0.038517	0.260814	CS pos: 17-18. SNA-NY. Pr: 0.6256    35
NZ_CP027599.1_34932	LIPO(Sec/SPII)	0.131216	0.010293	0.762232	0.096258	CS pos: 16-17. PAS-CS. Pr: 0.7049    22
NZ_CP027599.1_34971	LIPO(Sec/SPII)	0.126364	0.024705	0.577163	0.271767	CS pos: 14-15. ASA-CW. Pr: 0.5586    17
NZ_CP027599.1_34975	LIPO(Sec/SPII)	0.097205	0.029675	0.439238	0.433882	CS pos: 21-22. SSI-CW. Pr: 0.1631    34
NZ_CP027599.1_34992	LIPO(Sec/SPII)	0.061991	0.003990	0.757022	0.176998	CS pos: 13-14. VLN-CQ. Pr: 0.7491    28
NZ_CP027599.1_34998	TAT(Tat/SPI)	0.253953	0.294956	0.181772	0.269319	CS pos: ?. Probable protein fragment    17
NZ_CP027599.1_35032	LIPO(Sec/SPII)	0.323058	0.009408	0.390494	0.277039	CS pos: 21-22. ATI-CN. Pr: 0.3015    24
NZ_CP027599.1_35079	SP(Sec/SPI)	0.394336	0.324106	0.183153	0.098405	CS pos: 23-24. AYG-AV. Pr: 0.5086    26
NZ_CP027599.1_35103	LIPO(Sec/SPII)	0.147721	0.155359	0.380013	0.316907	CS pos: 30-31. LAT-CL. Pr: 0.3655    46
NZ_CP027599.1_35123	SP(Sec/SPI)	0.628291	0.132350	0.125401	0.113959	CS pos: 18-19. LFA-AM. Pr: 0.2470    44
NZ_CP027599.1_35133	LIPO(Sec/SPII)	0.159624	0.029487	0.451342	0.359546	CS pos: 14-15. PQS-CL. Pr: 0.3853    34
NZ_CP027599.1_35134	TAT(Tat/SPI)	0.077229	0.739388	0.044495	0.138887	CS pos: 26-27. AKA-DG. Pr: 0.5964    41
NZ_CP027599.1_35138	LIPO(Sec/SPII)	0.122274	0.245936	0.468815	0.162975	CS pos: 15-16. AAA-CR. Pr: 0.3608    18
NZ_CP027599.1_35170	SP(Sec/SPI)	0.509326	0.083559	0.263825	0.143290	CS pos: 22-23. SHA-IS. Pr: 0.4167    27
NZ_CP027599.1_35187	SP(Sec/SPI)	0.442760	0.030672	0.114433	0.412136	CS pos: 17-18. LNA-GV. Pr: 0.1667    32
NZ_CP027599.1_35203	LIPO(Sec/SPII)	0.185979	0.049324	0.392293	0.372404	CS pos: 12-13. VAS-CR. Pr: 0.2978    16
NZ_CP027599.1_35208	SP(Sec/SPI)	0.458985	0.056479	0.141400	0.343136	CS pos: 21-22. SYA-SG. Pr: 0.3531    23
NZ_CP027599.1_35222	LIPO(Sec/SPII)	0.110634	0.018958	0.722015	0.148393	CS pos: 13-14. FTG-CA. Pr: 0.6739    23
NZ_CP027599.1_35275	SP(Sec/SPI)	0.379374	0.157886	0.149629	0.313111	CS pos: 19-20. VSS-TS. Pr: 0.1148    27
NZ_CP027599.1_35280	SP(Sec/SPI)	0.409769	0.022061	0.392111	0.176059	CS pos: ?. Probable protein fragment    16
NZ_CP027599.1_35287	SP(Sec/SPI)	0.423430	0.099223	0.061936	0.415410	CS pos: 19-20. TLA-SS. Pr: 0.3078    37
NZ_CP027599.1_35309	LIPO(Sec/SPII)	0.077473	0.006560	0.753049	0.162918	CS pos: 25-26. STA-CT. Pr: 0.7345    34
NZ_CP027599.1_35314	SP(Sec/SPI)	0.394634	0.327953	0.096103	0.181311	CS pos: 21-22. VSA-GR. Pr: 0.3941    32
NZ_CP027599.1_35321	LIPO(Sec/SPII)	0.121046	0.002252	0.841063	0.035639	CS pos: 16-17. AAG-CC. Pr: 0.8375    40
NZ_CP027599.1_35333	SP(Sec/SPI)	0.459377	0.055811	0.051838	0.432974	CS pos: 21-22. AAG-DS. Pr: 0.2379    31
NZ_CP027599.1_35341	SP(Sec/SPI)	0.446192	0.010018	0.344526	0.199263	CS pos: 20-21. ASS-TS. Pr: 0.1683    26
NZ_CP027599.1_35343	SP(Sec/SPI)	0.688125	0.022740	0.171160	0.117975	CS pos: 22-23. VNS-TH. Pr: 0.3447    35
NZ_CP027599.1_35372	SP(Sec/SPI)	0.643897	0.045320	0.069976	0.240807	CS pos: 13-14. ARA-AD. Pr: 0.6001    18
NZ_CP027599.1_35429	SP(Sec/SPI)	0.369803	0.006489	0.260995	0.362712	CS pos: 19-20. IRC-RI. Pr: 0.1155    36
NZ_CP027599.1_35430	SP(Sec/SPI)	0.400204	0.094308	0.186437	0.319051	CS pos: 21-22. SAA-SS. Pr: 0.0734    24
NZ_CP027599.1_35496	LIPO(Sec/SPII)	0.199771	0.022459	0.601464	0.176305	CS pos: 20-21. GAS-CA. Pr: 0.5134    28
NZ_CP027599.1_35498	LIPO(Sec/SPII)	0.011082	0.003284	0.969058	0.016577	CS pos: 13-14. MAG-CS. Pr: 0.9685    28
NZ_CP027599.1_35529	LIPO(Sec/SPII)	0.162842	0.003399	0.449706	0.384053	CS pos: 18-19. FSA-SK. Pr: 0.3109    27
NZ_CP027599.1_35589	SP(Sec/SPI)	0.583374	0.046715	0.100850	0.269060	CS pos: 21-22. TAA-SS. Pr: 0.3696    23
NZ_CP027599.1_35596	LIPO(Sec/SPII)	0.040383	0.004097	0.942818	0.012701	CS pos: 18-19. CAS-CN. Pr: 0.5409    38
NZ_CP027599.1_35598	LIPO(Sec/SPII)	0.270180	0.018827	0.464768	0.246224	CS pos: 18-19. SYV-CT. Pr: 0.1974    21
NZ_CP027599.1_35615	SP(Sec/SPI)	0.939195	0.010291	0.010981	0.039534	CS pos: 19-20. SSA-DT. Pr: 0.9003    48
NZ_CP027599.1_35622	SP(Sec/SPI)	0.373754	0.007105	0.253392	0.365749	CS pos: 28-29. ALA-SG. Pr: 0.0680    33
NZ_CP027599.1_35633	LIPO(Sec/SPII)	0.111297	0.002007	0.766590	0.120105	CS pos: 21-22. FSI-CE. Pr: 0.7510    43
NZ_CP027599.1_35642	LIPO(Sec/SPII)	0.112500	0.010081	0.644682	0.232737	CS pos: 16-17. IVN-CE. Pr: 0.6353    32
NZ_CP027599.1_35652	LIPO(Sec/SPII)	0.277897	0.017904	0.419892	0.284308	CS pos: ?. Probable protein fragment    15
NZ_CP027599.1_35705	SP(Sec/SPI)	0.492667	0.017114	0.225321	0.264899	CS pos: ?. Probable protein fragment    25
NZ_CP027599.1_35708	LIPO(Sec/SPII)	0.114258	0.003688	0.442038	0.440016	CS pos: 22-23. RSG-CV. Pr: 0.4110    35
NZ_CP027599.1_35731	LIPO(Sec/SPII)	0.208578	0.004742	0.606507	0.180174	CS pos: 17-18. ANG-CS. Pr: 0.6686    32
NZ_CP027599.1_35763	SP(Sec/SPI)	0.576075	0.038774	0.257395	0.127756	CS pos: 20-21. AWA-SD. Pr: 0.5830    29
NZ_CP027599.1_35774	LIPO(Sec/SPII)	0.113670	0.008811	0.692765	0.184755	CS pos: 15-16. AFS-CS. Pr: 0.6747    35
NZ_CP027599.1_35788	LIPO(Sec/SPII)	0.317482	0.010055	0.389538	0.282925	CS pos: ?. Probable protein fragment    16
NZ_CP027599.1_35837	LIPO(Sec/SPII)	0.222524	0.326763	0.419775	0.030938	CS pos: 22-23. LSK-CT. Pr: 0.4061    29
NZ_CP027599.1_35845	SP(Sec/SPI)	0.903047	0.057059	0.018500	0.021393	CS pos: 21-22. ASA-DK. Pr: 0.8161    49
NZ_CP027599.1_35868	LIPO(Sec/SPII)	0.291914	0.016901	0.455556	0.235629	CS pos: ?. Probable protein fragment    16
NZ_CP027599.1_35907	LIPO(Sec/SPII)	0.327824	0.005278	0.557881	0.109017	CS pos: 20-21. SSV-CA. Pr: 0.3676    28
NZ_CP027599.1_35973	LIPO(Sec/SPII)	0.269162	0.012707	0.413554	0.304576	CS pos: 13-14. WNA-VT. Pr: 0.0455    15
NZ_CP027599.1_35980	LIPO(Sec/SPII)	0.150429	0.019721	0.473162	0.356688	CS pos: 13-14. TTG-CG. Pr: 0.4392    37
NZ_CP027599.1_35996	LIPO(Sec/SPII)	0.263953	0.032268	0.387925	0.315854	CS pos: 17-18. VNT-CG. Pr: 0.1625    19
NZ_CP027599.1_36000	SP(Sec/SPI)	0.411869	0.014596	0.245235	0.328300	CS pos: 18-19. SWG-NN. Pr: 0.1895    27
NZ_CP027599.1_36002	LIPO(Sec/SPII)	0.255115	0.008589	0.621113	0.115182	CS pos: ?. Probable protein fragment    16
NZ_CP027599.1_36004	LIPO(Sec/SPII)	0.321308	0.001933	0.613022	0.063737	CS pos: 17-18. ALL-CD. Pr: 0.5454    32
NZ_CP027599.1_36013	SP(Sec/SPI)	0.627225	0.020878	0.050355	0.301542	CS pos: 18-19. AMA-VN. Pr: 0.5426    29
NZ_CP027599.1_36061	LIPO(Sec/SPII)	0.130567	0.027732	0.498237	0.343463	CS pos: 16-17. VPS-CS. Pr: 0.3956    20
NZ_CP027599.1_36073	LIPO(Sec/SPII)	0.287387	0.006571	0.433877	0.272166	CS pos: 16-17. LLR-CV. Pr: 0.1172    20
NZ_CP027599.1_36077	SP(Sec/SPI)	0.827658	0.010892	0.017610	0.143840	CS pos: 18-19. SQA-SD. Pr: 0.8080    34
NZ_CP027599.1_36097	LIPO(Sec/SPII)	0.231845	0.015612	0.401577	0.350966	CS pos: ?. Probable protein fragment    21
NZ_CP027599.1_36132	SP(Sec/SPI)	0.442053	0.060041	0.119200	0.378706	CS pos: 18-19. FFA-DR. Pr: 0.3978    23
NZ_CP027599.1_36150	SP(Sec/SPI)	0.624358	0.066859	0.076299	0.232485	CS pos: 24-25. IGA-SF. Pr: 0.2936    35
NZ_CP027599.1_36210	SP(Sec/SPI)	0.785412	0.001570	0.104739	0.108280	CS pos: 20-21. VWT-NS. Pr: 0.6251    40
NZ_CP027599.1_36221	LIPO(Sec/SPII)	0.190091	0.022171	0.584700	0.203038	CS pos: 19-20. TRA-CH. Pr: 0.6196    39
NZ_CP027599.1_36252	LIPO(Sec/SPII)	0.031537	0.004206	0.815777	0.148479	CS pos: 18-19. VTA-CR. Pr: 0.8069    32
NZ_CP027599.1_36290	SP(Sec/SPI)	0.593642	0.013454	0.168709	0.224195	CS pos: 19-20. VVS-RG. Pr: 0.2514    28
NZ_CP027599.1_36296	SP(Sec/SPI)	0.548432	0.008814	0.178295	0.264459	CS pos: 22-23. VLP-YN. Pr: 0.2360    50
NZ_CP027599.1_36300	TAT(Tat/SPI)	0.287353	0.342840	0.088182	0.281624	CS pos: 22-23. AGA-AI. Pr: 0.1854    37
NZ_CP027599.1_36303	LIPO(Sec/SPII)	0.217166	0.020275	0.476316	0.286242	CS pos: 34-35. TTS-CA. Pr: 0.2251    50
NZ_CP027599.1_36315	SP(Sec/SPI)	0.427364	0.084798	0.078286	0.409552	CS pos: 15-16. AAA-EI. Pr: 0.2945    33
NZ_CP027599.1_36345	LIPO(Sec/SPII)	0.024040	0.004041	0.907672	0.064247	CS pos: 17-18. FLG-CS. Pr: 0.9050    34
NZ_CP027599.1_36379	SP(Sec/SPI)	0.473802	0.028120	0.166211	0.331868	CS pos: 19-20. TLA-VS. Pr: 0.2140    25
NZ_CP027599.1_36381	SP(Sec/SPI)	0.595308	0.052652	0.067034	0.285006	CS pos: 17-18. SHG-LL. Pr: 0.4238    49
NZ_CP027599.1_36436	SP(Sec/SPI)	0.388174	0.012101	0.256276	0.343449	CS pos: 17-18. VRG-MN. Pr: 0.3055    28
NZ_CP027599.1_36481	LIPO(Sec/SPII)	0.179191	0.094206	0.485028	0.241574	CS pos: 19-20. SHC-CG. Pr: 0.3059    40
NZ_CP027599.1_36486	LIPO(Sec/SPII)	0.203044	0.005759	0.631057	0.160139	CS pos: 11-12. LCA-CR. Pr: 0.5559    42
NZ_CP027599.1_36498	TAT(Tat/SPI)	0.141847	0.533250	0.053297	0.271607	CS pos: 27-28. TDA-KN. Pr: 0.4377    39
NZ_CP027599.1_36502	LIPO(Sec/SPII)	0.198775	0.038753	0.389300	0.373172	CS pos: ?. Probable protein fragment    21
NZ_CP027599.1_36529	SP(Sec/SPI)	0.531587	0.078429	0.212504	0.177481	CS pos: 24-25. RYA-GT. Pr: 0.2701    32
NZ_CP027599.1_36532	LIPO(Sec/SPII)	0.305600	0.012719	0.498385	0.183296	CS pos: 14-15. RAA-CR. Pr: 0.2758    16
NZ_CP027599.1_36533	TAT(Tat/SPI)	0.112470	0.487957	0.358383	0.041191	CS pos: 27-28. VAA-ER. Pr: 0.3336    37
NZ_CP027599.1_36535	LIPO(Sec/SPII)	0.176896	0.029769	0.499954	0.293381	CS pos: 14-15. VTG-CP. Pr: 0.3216    16
NZ_CP027599.1_36696	LIPO(Sec/SPII)	0.013957	0.003661	0.636273	0.346109	CS pos: 21-22. SGG-CL. Pr: 0.6333    50
NZ_CP027599.1_36708	LIPO(Sec/SPII)	0.231482	0.021781	0.377754	0.368983	CS pos: ?. Probable protein fragment    18
NZ_CP027599.1_36710	SP(Sec/SPI)	0.504884	0.040847	0.244404	0.209865	CS pos: 21-22. AGA-YP. Pr: 0.2619    38
NZ_CP027599.1_36758	LIPO(Sec/SPII)	0.045566	0.003294	0.533511	0.417629	CS pos: 30-31. LSS-CA. Pr: 0.5354    49
NZ_CP027599.1_36760	TAT(Tat/SPI)	0.130262	0.416788	0.326839	0.126110	CS pos: 33-34. GLC-GK. Pr: 0.0614    38
NZ_CP027599.1_36776	LIPO(Sec/SPII)	0.297149	0.046665	0.334414	0.321772	CS pos: 16-17. FVS-CQ. Pr: 0.2701    33
NZ_CP027599.1_36779	LIPO(Sec/SPII)	0.208106	0.044020	0.459494	0.288380	CS pos: 14-15. GAA-CG. Pr: 0.3770    16
NZ_CP027599.1_36782	SP(Sec/SPI)	0.384039	0.330279	0.094361	0.191321	CS pos: 27-28. ARA-IT. Pr: 0.4803    35
NZ_CP027599.1_36842	LIPO(Sec/SPII)	0.235688	0.134736	0.352706	0.276870	CS pos: ?. Probable protein fragment    15
NZ_CP027599.1_36844	SP(Sec/SPI)	0.556045	0.017068	0.016450	0.410436	CS pos: 21-22. IFA-DY. Pr: 0.5269    45
NZ_CP027599.1_36874	LIPO(Sec/SPII)	0.235088	0.018153	0.377138	0.369621	CS pos: ?. Probable protein fragment    15
NZ_CP027599.1_36886	TAT(Tat/SPI)	0.106744	0.552945	0.073903	0.266408	CS pos: 19-20. AKA-PF. Pr: 0.0366    21
NZ_CP027599.1_36898	TAT(Tat/SPI)	0.226926	0.351564	0.120273	0.301237	CS pos: 24-25. STA-ET. Pr: 0.2215    39
NZ_CP027599.1_36899	LIPO(Sec/SPII)	0.222093	0.045336	0.443739	0.288832	CS pos: 18-19. VYS-CG. Pr: 0.3331    27
NZ_CP027599.1_36925	LIPO(Sec/SPII)	0.063918	0.005626	0.656074	0.274382	CS pos: 21-22. LSP-CG. Pr: 0.6314    44
NZ_CP027599.1_36931	SP(Sec/SPI)	0.484848	0.107443	0.142510	0.265199	CS pos: 18-19. AAA-IS. Pr: 0.2303    29
NZ_CP027599.1_36949	SP(Sec/SPI)	0.524915	0.071816	0.146298	0.256970	CS pos: 23-24. TRA-RV. Pr: 0.1873    48
NZ_CP027599.1_36961	LIPO(Sec/SPII)	0.240360	0.090353	0.368918	0.300369	CS pos: ?. Probable protein fragment    15
NZ_CP027599.1_36973	LIPO(Sec/SPII)	0.117472	0.009228	0.534604	0.338696	CS pos: 16-17. LAC-CF. Pr: 0.2712    24
NZ_CP027599.1_36999	SP(Sec/SPI)	0.419637	0.031656	0.177015	0.371692	CS pos: ?. Probable protein fragment    28
NZ_CP027599.1_37011	TAT(Tat/SPI)	0.098028	0.519343	0.034145	0.348484	CS pos: 35-36. SAA-SG. Pr: 0.1660    43
NZ_CP027599.1_37060	LIPO(Sec/SPII)	0.124721	0.013240	0.585246	0.276793	CS pos: 15-16. TST-CQ. Pr: 0.5295    20
NZ_CP027599.1_37067	LIPO(Sec/SPII)	0.214653	0.014669	0.429966	0.340713	CS pos: 19-20. RYA-CI. Pr: 0.2373    26
NZ_CP027599.1_37069	LIPO(Sec/SPII)	0.153707	0.019198	0.458370	0.368725	CS pos: 20-21. THA-CC. Pr: 0.3935    30
NZ_CP027599.1_37087	SP(Sec/SPI)	0.466428	0.091993	0.134210	0.307369	CS pos: 14-15. CRA-GG. Pr: 0.1118    44
NZ_CP027599.1_37106	LIPO(Sec/SPII)	0.134871	0.008582	0.610114	0.246433	CS pos: 17-18. CGS-CG. Pr: 0.5675    46
NZ_CP027599.1_37149	SP(Sec/SPI)	0.405467	0.014401	0.311814	0.268318	CS pos: ?. Probable protein fragment    18
NZ_CP027599.1_37165	LIPO(Sec/SPII)	0.225930	0.034354	0.394351	0.345365	CS pos: ?. Probable protein fragment    17
NZ_CP027599.1_37203	LIPO(Sec/SPII)	0.338206	0.004629	0.449709	0.207457	CS pos: 17-18. SMK-CN. Pr: 0.3856    30
NZ_CP027599.1_37208	LIPO(Sec/SPII)	0.088993	0.010590	0.547567	0.352850	CS pos: 17-18. LPA-CA. Pr: 0.5143    35
NZ_CP027599.1_37211	TAT(Tat/SPI)	0.260976	0.384756	0.103110	0.251157	CS pos: 23-24. ADC-VS. Pr: 0.0773    30
NZ_CP027599.1_37220	SP(Sec/SPI)	0.920677	0.047699	0.014936	0.016688	CS pos: 22-23. ATA-DG. Pr: 0.7888    37
NZ_CP027599.1_37234	LIPO(Sec/SPII)	0.155881	0.011755	0.611874	0.220490	CS pos: 32-33. ATG-CS. Pr: 0.5540    44
NZ_CP027599.1_37243	LIPO(Sec/SPII)	0.221607	0.025796	0.416417	0.336180	CS pos: 20-21. AEG-CQ. Pr: 0.5456    31
NZ_CP027599.1_37244	LIPO(Sec/SPII)	0.123899	0.032299	0.558426	0.285376	CS pos: 17-18. ASG-CY. Pr: 0.5262    20
NZ_CP027599.1_37268	SP(Sec/SPI)	0.506646	0.172205	0.034917	0.286232	CS pos: 27-28. AHA-NW. Pr: 0.4699    34
NZ_CP027599.1_37304	LIPO(Sec/SPII)	0.175086	0.043931	0.423679	0.357304	CS pos: 14-15. SFS-CS. Pr: 0.3383    19
NZ_CP027599.1_37310	SP(Sec/SPI)	0.851129	0.021481	0.018560	0.108830	CS pos: 19-20. VSA-GD. Pr: 0.7820    39
NZ_CP027599.1_37421	LIPO(Sec/SPII)	0.325329	0.006972	0.399537	0.268162	CS pos: 24-25. SGS-CQ. Pr: 0.4027    34
NZ_CP027599.1_37427	SP(Sec/SPI)	0.459742	0.092577	0.008975	0.438706	CS pos: 25-26. LSA-EY. Pr: 0.3692    49
NZ_CP027599.1_37433	SP(Sec/SPI)	0.355267	0.078904	0.341461	0.224367	CS pos: 18-19. VSG-ST. Pr: 0.2432    29
NZ_CP027599.1_37459	LIPO(Sec/SPII)	0.158575	0.060826	0.592997	0.187601	CS pos: 19-20. SCS-CC. Pr: 0.2955    39
NZ_CP027599.1_37466	LIPO(Sec/SPII)	0.236410	0.047522	0.412564	0.303504	CS pos: 15-16. VAS-CS. Pr: 0.3557    28
NZ_CP027599.1_37504	SP(Sec/SPI)	0.627801	0.033705	0.238911	0.099583	CS pos: 24-25. GQA-SY. Pr: 0.2777    41
NZ_CP027599.1_37521	SP(Sec/SPI)	0.455551	0.062071	0.040569	0.441809	CS pos: 19-20. VQG-LK. Pr: 0.2851    32
NZ_CP027599.1_37532	LIPO(Sec/SPII)	0.098699	0.009896	0.772669	0.118736	CS pos: 18-19. PFS-CP. Pr: 0.7236    36
NZ_CP027599.1_37538	LIPO(Sec/SPII)	0.152746	0.036712	0.417079	0.393463	CS pos: 12-13. VSG-CG. Pr: 0.2630    15
NZ_CP027599.1_37583	SP(Sec/SPI)	0.776897	0.045011	0.090020	0.088073	CS pos: 24-25. AAA-QV. Pr: 0.6315    29
NZ_CP027599.1_37658	LIPO(Sec/SPII)	0.119322	0.041557	0.535933	0.303188	CS pos: 21-22. RAG-CI. Pr: 0.4982    29
NZ_CP027599.1_37665	LIPO(Sec/SPII)	0.005243	0.001298	0.975459	0.017999	CS pos: 20-21. LQS-CG. Pr: 0.9754    34
NZ_CP027599.1_37677	LIPO(Sec/SPII)	0.298016	0.029974	0.368008	0.304002	CS pos: 18-19. ALI-CS. Pr: 0.1732    20
NZ_CP027599.1_37701	LIPO(Sec/SPII)	0.332053	0.018318	0.355878	0.293751	CS pos: ?. Probable protein fragment    16
NZ_CP027599.1_37702	LIPO(Sec/SPII)	0.245157	0.030878	0.395170	0.328795	CS pos: 13-14. CFS-CK. Pr: 0.1396    15
NZ_CP027599.1_37712	LIPO(Sec/SPII)	0.117932	0.008903	0.756667	0.116498	CS pos: 22-23. SNG-CN. Pr: 0.7440    33
NZ_CP027599.1_37716	SP(Sec/SPI)	0.473392	0.214204	0.049242	0.263162	CS pos: 21-22. AWA-RA. Pr: 0.3949    27
NZ_CP027599.1_37726	SP(Sec/SPI)	0.453835	0.031332	0.091308	0.423526	CS pos: 17-18. VIS-EE. Pr: 0.3584    26
NZ_CP027599.1_37738	SP(Sec/SPI)	0.457644	0.160549	0.302144	0.079662	CS pos: 18-19. ATA-SS. Pr: 0.2531    34
NZ_CP027599.1_37739	LIPO(Sec/SPII)	0.247323	0.016807	0.377395	0.358475	CS pos: 12-13. LSI-CS. Pr: 0.1652    17
NZ_CP027599.1_37743	SP(Sec/SPI)	0.691752	0.032343	0.099250	0.176655	CS pos: 24-25. TSA-SG. Pr: 0.3126    33
NZ_CP027599.1_37787	LIPO(Sec/SPII)	0.280295	0.057932	0.336053	0.325719	CS pos: 11-12. ARS-CT. Pr: 0.0679    17
NZ_CP027599.1_37796	LIPO(Sec/SPII)	0.155612	0.013001	0.465880	0.365507	CS pos: 22-23. LNC-CS. Pr: 0.2493    28
NZ_CP027599.1_37801	LIPO(Sec/SPII)	0.265758	0.014799	0.490606	0.228836	CS pos: ?. Probable protein fragment    15
NZ_CP027599.1_37815	LIPO(Sec/SPII)	0.323171	0.017180	0.344308	0.315341	CS pos: ?. Probable protein fragment    19
NZ_CP027599.1_37829	LIPO(Sec/SPII)	0.241672	0.082748	0.340834	0.334746	CS pos: ?. Probable protein fragment    15
NZ_CP027599.1_37867	SP(Sec/SPI)	0.463400	0.171741	0.092312	0.272546	CS pos: 19-20. GFA-VT. Pr: 0.2554    33
NZ_CP027599.1_37877	SP(Sec/SPI)	0.522892	0.006018	0.272794	0.198296	CS pos: 17-18. TAP-YP. Pr: 0.1099    45
NZ_CP027599.1_37888	SP(Sec/SPI)	0.499813	0.114041	0.022235	0.363911	CS pos: 21-22. ALA-ES. Pr: 0.5260    33
NZ_CP027599.1_37904	TAT(Tat/SPI)	0.284971	0.468702	0.056538	0.189788	CS pos: ?. Probable protein fragment    44
NZ_CP027599.1_37945	SP(Sec/SPI)	0.733788	0.134132	0.031814	0.100267	CS pos: 31-32. AHA-SS. Pr: 0.5446    44
NZ_CP027599.1_37999	SP(Sec/SPI)	0.469953	0.034854	0.256003	0.239191	CS pos: 23-24. GWA-AS. Pr: 0.1258    42
NZ_CP027599.1_38009	SP(Sec/SPI)	0.454525	0.018873	0.081795	0.444806	CS pos: 16-17. LLA-EV. Pr: 0.3801    26
NZ_CP027599.1_38017	LIPO(Sec/SPII)	0.048891	0.009122	0.563912	0.378075	CS pos: 20-21. WCA-CA. Pr: 0.5399    32
NZ_CP027599.1_38026	LIPO(Sec/SPII)	0.042388	0.015745	0.926224	0.015644	CS pos: 20-21. ATS-CI. Pr: 0.9158    42
NZ_CP027599.1_38085	SP(Sec/SPI)	0.622705	0.013370	0.190959	0.172967	CS pos: 19-20. GKS-ET. Pr: 0.3178    39
NZ_CP027599.1_38092	LIPO(Sec/SPII)	0.188984	0.002809	0.777239	0.030967	CS pos: 11-12. TAA-CS. Pr: 0.6613    17
NZ_CP027599.1_38093	LIPO(Sec/SPII)	0.080749	0.034704	0.532326	0.352221	CS pos: 23-24. LQS-CA. Pr: 0.4334    37
NZ_CP027599.1_38110	SP(Sec/SPI)	0.600192	0.021524	0.048343	0.329942	CS pos: 25-26. GQA-YG. Pr: 0.3463    31
NZ_CP027599.1_38116	LIPO(Sec/SPII)	0.123964	0.043541	0.624653	0.207843	CS pos: 27-28. IIC-CC. Pr: 0.3972    43
NZ_CP027599.1_38132	LIPO(Sec/SPII)	0.288922	0.017279	0.481258	0.212541	CS pos: ?. Probable protein fragment    15
NZ_CP027599.1_38154	SP(Sec/SPI)	0.528743	0.012752	0.228725	0.229779	CS pos: 24-25. LSA-AI. Pr: 0.2168    45
NZ_CP027599.1_38163	LIPO(Sec/SPII)	0.263876	0.023451	0.370914	0.341760	CS pos: 22-23. ALC-CG. Pr: 0.1508    25
NZ_CP027599.1_38173	LIPO(Sec/SPII)	0.268642	0.018124	0.366723	0.346511	CS pos: ?. Probable protein fragment    15
NZ_CP027599.1_38194	SP(Sec/SPI)	0.447601	0.052326	0.201447	0.298626	CS pos: 20-21. LQA-ER. Pr: 0.3956    26
NZ_CP027599.1_38204	LIPO(Sec/SPII)	0.174049	0.004679	0.673774	0.147498	CS pos: 13-14. MLS-CW. Pr: 0.5795    18
NZ_CP027599.1_38212	LIPO(Sec/SPII)	0.191874	0.008332	0.446939	0.352855	CS pos: 16-17. IGM-CK. Pr: 0.2914    18
NZ_CP027599.1_38234	SP(Sec/SPI)	0.588048	0.108692	0.076108	0.227152	CS pos: 19-20. MTA-ST. Pr: 0.1715    48
NZ_CP027599.1_38254	LIPO(Sec/SPII)	0.127981	0.021433	0.587396	0.263190	CS pos: 19-20. VSG-CR. Pr: 0.5327    23
NZ_CP027599.1_38255	LIPO(Sec/SPII)	0.252778	0.008308	0.516317	0.222596	CS pos: 15-16. IAQ-CG. Pr: 0.3533    22
NZ_CP027599.1_38266	TAT(Tat/SPI)	0.101540	0.397801	0.219134	0.281525	CS pos: 38-39. GSA-AG. Pr: 0.0656    41
NZ_CP027599.1_38276	LIPO(Sec/SPII)	0.217959	0.004955	0.416182	0.360904	CS pos: 9-10. MSG-CC. Pr: 0.2552    19
NZ_CP027599.1_38294	SP(Sec/SPI)	0.459846	0.007265	0.418123	0.114766	CS pos: 23-24. QYA-SP. Pr: 0.3090    29
NZ_CP027599.1_38298	TAT(Tat/SPI)	0.278071	0.376521	0.027916	0.317491	CS pos: 19-20. SQA-AQ. Pr: 0.4144    38
NZ_CP027599.1_38375	LIPO(Sec/SPII)	0.246610	0.012115	0.457332	0.283943	CS pos: 13-14. LTA-CF. Pr: 0.1649    19
NZ_CP027599.1_38391	SP(Sec/SPI)	0.784674	0.006569	0.069894	0.138862	CS pos: 23-24. NEA-FE. Pr: 0.6282    46
NZ_CP027599.1_38451	SP(Sec/SPI)	0.462757	0.033259	0.374842	0.129141	CS pos: 25-26. TNC-ES. Pr: 0.3379    50
NZ_CP027599.1_38515	LIPO(Sec/SPII)	0.025756	0.345740	0.609540	0.018964	CS pos: 21-22. LPA-CC. Pr: 0.4920    34
NZ_CP027599.1_38561	SP(Sec/SPI)	0.521361	0.117335	0.076236	0.285068	CS pos: 22-23. AQA-WG. Pr: 0.2922    40
NZ_CP027599.1_38598	LIPO(Sec/SPII)	0.092786	0.003264	0.805617	0.098333	CS pos: 14-15. AIS-CR. Pr: 0.6761    16
NZ_CP027599.1_38632	TAT(Tat/SPI)	0.133069	0.438701	0.057724	0.370506	CS pos: ?. Probable protein fragment    18
NZ_CP027599.1_38663	LIPO(Sec/SPII)	0.172560	0.019231	0.564281	0.243928	CS pos: 24-25. TGN-CD. Pr: 0.3891    43
NZ_CP027599.1_38698	LIPO(Sec/SPII)	0.288159	0.012115	0.481713	0.218013	CS pos: 16-17. CLN-CS. Pr: 0.3343    24
NZ_CP027599.1_38755	SP(Sec/SPI)	0.666670	0.008299	0.097750	0.227280	CS pos: 24-25. TIC-WI. Pr: 0.2717    34
NZ_CP027599.1_38759	LIPO(Sec/SPII)	0.240549	0.005331	0.552339	0.201780	CS pos: 16-17. AYT-CW. Pr: 0.5233    21
NZ_CP027599.1_38823	LIPO(Sec/SPII)	0.164244	0.014949	0.627854	0.192953	CS pos: 14-15. SKS-CN. Pr: 0.4199    16
NZ_CP027599.1_38852	LIPO(Sec/SPII)	0.209108	0.023615	0.421352	0.345925	CS pos: 17-18. AIN-CG. Pr: 0.3163    20
NZ_CP027599.1_38867	LIPO(Sec/SPII)	0.344514	0.017418	0.394806	0.243261	CS pos: 16-17. STA-SA. Pr: 0.0343    18
NZ_CP027599.1_38925	TAT(Tat/SPI)	0.047514	0.685100	0.011354	0.256032	CS pos: 35-36. TDA-RK. Pr: 0.5659    44
NZ_CP027599.1_38964	SP(Sec/SPI)	0.767963	0.022791	0.045428	0.163818	CS pos: 17-18. VFA-LN. Pr: 0.6920    35
NZ_CP027599.1_38985	LIPO(Sec/SPII)	0.226350	0.107151	0.356372	0.310127	CS pos: ?. Probable protein fragment    18
NZ_CP027599.1_39001	SP(Sec/SPI)	0.542331	0.007350	0.046883	0.403436	CS pos: 20-21. LYA-ES. Pr: 0.4320    26
NZ_CP027599.1_39019	LIPO(Sec/SPII)	0.230610	0.087175	0.367601	0.314614	CS pos: ?. Probable protein fragment    18
NZ_CP027599.1_39031	SP(Sec/SPI)	0.561701	0.027452	0.089093	0.321754	CS pos: 18-19. TNA-FS. Pr: 0.2769    36
NZ_CP027599.1_39032	SP(Sec/SPI)	0.537196	0.059733	0.145973	0.257097	CS pos: 17-18. IAA-YR. Pr: 0.1781    23
NZ_CP027599.1_39056	SP(Sec/SPI)	0.662550	0.006480	0.109608	0.221362	CS pos: 35-36. CLA-QK. Pr: 0.6282    42
NZ_CP027599.1_39078	LIPO(Sec/SPII)	0.030079	0.018916	0.486919	0.464086	CS pos: 22-23. LQS-CA. Pr: 0.4607    39
NZ_CP027599.1_39093	LIPO(Sec/SPII)	0.272712	0.022993	0.428040	0.276255	CS pos: ?. Probable protein fragment    15
NZ_CP027599.1_39111	TAT(Tat/SPI)	0.156271	0.328267	0.189437	0.326025	CS pos: 14-15. AHG-FR. Pr: 0.0501    16
NZ_CP027599.1_39120	LIPO(Sec/SPII)	0.260196	0.027491	0.412764	0.299548	CS pos: ?. Probable protein fragment    16
NZ_CP027599.1_39139	LIPO(Sec/SPII)	0.019974	0.001694	0.723489	0.254843	CS pos: 20-21. IIS-CF. Pr: 0.7175    31
NZ_CP027599.1_39150	LIPO(Sec/SPII)	0.093838	0.034535	0.855331	0.016297	CS pos: 25-26. AAA-CM. Pr: 0.8499    45
NZ_CP027599.1_39161	LIPO(Sec/SPII)	0.137284	0.014573	0.552682	0.295461	CS pos: ?. Probable protein fragment    23
NZ_CP027599.1_39171	LIPO(Sec/SPII)	0.232121	0.028214	0.486493	0.253172	CS pos: 19-20. VQA-CS. Pr: 0.5606    23
NZ_CP027599.1_39188	SP(Sec/SPI)	0.687334	0.058336	0.028089	0.226241	CS pos: 17-18. AHA-VK. Pr: 0.6798    31
NZ_CP027599.1_39212	TAT(Tat/SPI)	0.147775	0.660438	0.045304	0.146484	CS pos: 27-28. AHA-VS. Pr: 0.4807    30
NZ_CP027599.1_39216	LIPO(Sec/SPII)	0.296919	0.019207	0.434988	0.248885	CS pos: 14-15. SGR-CA. Pr: 0.1281    18
NZ_CP027599.1_39306	SP(Sec/SPI)	0.480092	0.035684	0.167606	0.316618	CS pos: 18-19. AFA-TC. Pr: 0.3278    50
NZ_CP027599.1_39352	LIPO(Sec/SPII)	0.173805	0.009185	0.544560	0.272449	CS pos: 12-13. ITA-CL. Pr: 0.4049    31
NZ_CP027599.1_39383	TAT(Tat/SPI)	0.131760	0.480256	0.017717	0.370266	CS pos: 32-33. KTA-VG. Pr: 0.0995    46
NZ_CP027599.1_39395	SP(Sec/SPI)	0.444646	0.002675	0.156727	0.395953	CS pos: 24-25. NFS-SC. Pr: 0.0674    30
NZ_CP027599.1_39442	SP(Sec/SPI)	0.357109	0.020771	0.329160	0.292960	CS pos: 19-20. ASA-KK. Pr: 0.2082    26
NZ_CP027599.1_39461	LIPO(Sec/SPII)	0.109029	0.025728	0.827354	0.037889	CS pos: 20-21. GST-CN. Pr: 0.7225    33
NZ_CP027599.1_39473	LIPO(Sec/SPII)	0.091922	0.145873	0.496791	0.265414	CS pos: 13-14. LAA-CS. Pr: 0.4951    44
NZ_CP027599.1_39529	SP(Sec/SPI)	0.678298	0.079515	0.066220	0.175967	CS pos: 17-18. ARG-MD. Pr: 0.5353    25
NZ_CP027599.1_39534	SP(Sec/SPI)	0.567575	0.045302	0.059652	0.327471	CS pos: 22-23. APA-YP. Pr: 0.3728    45
NZ_CP027599.1_39614	SP(Sec/SPI)	0.436382	0.066250	0.234303	0.263065	CS pos: ?. Probable protein fragment    19
NZ_CP027599.1_39630	LIPO(Sec/SPII)	0.284844	0.011944	0.383235	0.319976	CS pos: ?. Probable protein fragment    16
NZ_CP027599.1_39672	SP(Sec/SPI)	0.624153	0.015973	0.069623	0.290251	CS pos: 20-21. AKS-RV. Pr: 0.2002    34
NZ_CP027599.1_39675	LIPO(Sec/SPII)	0.024682	0.003293	0.664056	0.307970	CS pos: 21-22. LTA-CI. Pr: 0.6378    32
NZ_CP027599.1_39717	LIPO(Sec/SPII)	0.146282	0.083860	0.700289	0.069568	CS pos: 20-21. ASS-CV. Pr: 0.6514    50
NZ_CP027599.1_39739	SP(Sec/SPI)	0.490986	0.011520	0.134956	0.362538	CS pos: 26-27. VLS-RV. Pr: 0.2491    45
NZ_CP027599.1_39754	LIPO(Sec/SPII)	0.263902	0.057622	0.520139	0.158337	CS pos: 26-27. SST-CS. Pr: 0.4631    35
NZ_CP027599.1_39769	SP(Sec/SPI)	0.438529	0.147826	0.024957	0.388688	CS pos: 26-27. LVA-VD. Pr: 0.1791    50
NZ_CP027599.1_39802	SP(Sec/SPI)	0.376979	0.030218	0.335465	0.257338	CS pos: 15-16. THA-QA. Pr: 0.1119    34
NZ_CP027599.1_39815	SP(Sec/SPI)	0.502729	0.043390	0.043884	0.409998	CS pos: 14-15. AVA-RD. Pr: 0.4374    28
NZ_CP027599.1_39824	SP(Sec/SPI)	0.332218	0.043163	0.316303	0.308317	CS pos: 21-22. STA-KR. Pr: 0.1489    26
NZ_CP027599.1_39869	LIPO(Sec/SPII)	0.342906	0.033151	0.376489	0.247454	CS pos: 21-22. LTA-SV. Pr: 0.2848    43
NZ_CP027599.1_39886	LIPO(Sec/SPII)	0.063997	0.023264	0.808449	0.104289	CS pos: 16-17. SFA-CT. Pr: 0.8068    40
NZ_CP027599.1_39890	SP(Sec/SPI)	0.451562	0.033291	0.104983	0.410163	CS pos: 24-25. ANS-AD. Pr: 0.3100    29
NZ_CP027599.1_39893	LIPO(Sec/SPII)	0.326020	0.022848	0.416864	0.234268	CS pos: 16-17. SAF-CN. Pr: 0.2737    33
NZ_CP027599.1_39903	LIPO(Sec/SPII)	0.061862	0.002687	0.644099	0.291352	CS pos: 21-22. IGG-CV. Pr: 0.5774    38
NZ_CP027599.1_39934	LIPO(Sec/SPII)	0.073489	0.013587	0.883793	0.029131	CS pos: 16-17. ESG-CG. Pr: 0.8730    30
NZ_CP027599.1_39952	LIPO(Sec/SPII)	0.059131	0.005461	0.597380	0.338028	CS pos: 13-14. TTC-CA. Pr: 0.3522    35
NZ_CP027599.1_39998	LIPO(Sec/SPII)	0.225903	0.028957	0.445074	0.300065	CS pos: 16-17. LMC-CA. Pr: 0.1983    18
NZ_CP027599.1_40003	SP(Sec/SPI)	0.377915	0.180471	0.065600	0.376014	CS pos: 13-14. ATA-SV. Pr: 0.2431    30
NZ_CP027599.1_40034	SP(Sec/SPI)	0.467976	0.019396	0.065221	0.447407	CS pos: 19-20. IYA-DI. Pr: 0.3377    29
NZ_CP027599.1_40045	SP(Sec/SPI)	0.639280	0.032484	0.018886	0.309350	CS pos: 28-29. VFS-LD. Pr: 0.6283    42
NZ_CP027599.1_40061	LIPO(Sec/SPII)	0.110192	0.128657	0.416654	0.344497	CS pos: ?. Probable protein fragment    18
NZ_CP027599.1_40062	LIPO(Sec/SPII)	0.102756	0.006646	0.670186	0.220412	CS pos: 17-18. TNS-CN. Pr: 0.6593    26
NZ_CP027599.1_40068	SP(Sec/SPI)	0.615207	0.028846	0.118530	0.237417	CS pos: 21-22. INA-DS. Pr: 0.2905    30
NZ_CP027599.1_40079	SP(Sec/SPI)	0.491897	0.044164	0.077713	0.386226	CS pos: 16-17. SLA-KP. Pr: 0.3295    26
NZ_CP027599.1_40086	LIPO(Sec/SPII)	0.092221	0.007400	0.586776	0.313603	CS pos: 18-19. LTG-QR. Pr: 0.5498    31
NZ_CP027599.1_40095	TAT(Tat/SPI)	0.064516	0.413034	0.176576	0.345874	CS pos: 26-27. VSP-KV. Pr: 0.0673    44
NZ_CP027599.1_40101	SP(Sec/SPI)	0.340585	0.016430	0.309990	0.332995	CS pos: ?. Probable protein fragment    22
NZ_CP027599.1_40116	LIPO(Sec/SPII)	0.171568	0.006564	0.446865	0.375003	CS pos: 14-15. SAA-CA. Pr: 0.3861    27
NZ_CP027599.1_40126	SP(Sec/SPI)	0.460009	0.122731	0.034137	0.383123	CS pos: 14-15. ARA-AE. Pr: 0.3953    35
NZ_CP027599.1_40139	SP(Sec/SPI)	0.429803	0.090387	0.154085	0.325725	CS pos: 19-20. QSA-AP. Pr: 0.1544    25
NZ_CP027599.1_40142	SP(Sec/SPI)	0.465501	0.043613	0.096172	0.394714	CS pos: 23-24. LLA-RP. Pr: 0.4045    31
NZ_CP027599.1_40170	SP(Sec/SPI)	0.768235	0.068954	0.043935	0.118876	CS pos: 20-21. ASA-DA. Pr: 0.6254    24
NZ_CP027599.1_40194	LIPO(Sec/SPII)	0.226264	0.050490	0.373294	0.349952	CS pos: 15-16. FPA-HG. Pr: 0.0236    17
NZ_CP027599.1_40285	LIPO(Sec/SPII)	0.245253	0.060848	0.377400	0.316499	CS pos: ?. Probable protein fragment    19
NZ_CP027599.1_40286	LIPO(Sec/SPII)	0.204746	0.018688	0.413878	0.362688	CS pos: 15-16. LTL-CV. Pr: 0.2760    19
NZ_CP027599.1_40330	LIPO(Sec/SPII)	0.242036	0.006067	0.517613	0.234285	CS pos: 18-19. LAF-CY. Pr: 0.3857    26
NZ_CP027599.1_40334	LIPO(Sec/SPII)	0.142893	0.017296	0.621810	0.218000	CS pos: 17-18. GAG-CL. Pr: 0.5456    19
NZ_CP027599.1_40350	SP(Sec/SPI)	0.493424	0.087994	0.087073	0.331509	CS pos: 24-25. TKA-DV. Pr: 0.3217    45
NZ_CP027599.1_40358	LIPO(Sec/SPII)	0.158178	0.065131	0.705874	0.070817	CS pos: 21-22. AAG-CA. Pr: 0.6112    29
NZ_CP027599.1_40359	LIPO(Sec/SPII)	0.282255	0.007768	0.396896	0.313080	CS pos: 11-12. FAA-CA. Pr: 0.1925    26
NZ_CP027599.1_40361	LIPO(Sec/SPII)	0.191887	0.015805	0.472102	0.320206	CS pos: 15-16. ALC-CF. Pr: 0.2181    18
NZ_CP027599.1_40380	SP(Sec/SPI)	0.626856	0.112246	0.032359	0.228540	CS pos: 22-23. ASA-DE. Pr: 0.6578    25
NZ_CP027599.1_40398	LIPO(Sec/SPII)	0.294033	0.043940	0.344681	0.317347	CS pos: 16-17. RKS-CI. Pr: 0.2588    25
NZ_CP027599.1_40431	LIPO(Sec/SPII)	0.288206	0.013948	0.470379	0.227467	CS pos: 13-14. VYI-CE. Pr: 0.0971    16
NZ_CP027599.1_40476	LIPO(Sec/SPII)	0.150706	0.047881	0.519893	0.281520	CS pos: 14-15. INS-CD. Pr: 0.4801    31
NZ_CP027599.1_40481	LIPO(Sec/SPII)	0.347198	0.008785	0.377409	0.266607	CS pos: 24-25. LTK-CQ. Pr: 0.2315    27
NZ_CP027599.1_40505	LIPO(Sec/SPII)	0.186441	0.029663	0.466883	0.317013	CS pos: 12-13. LSS-CQ. Pr: 0.4049    20
NZ_CP027599.1_40529	SP(Sec/SPI)	0.414835	0.255357	0.025755	0.304054	CS pos: 31-32. VLA-MP. Pr: 0.5617    40
NZ_CP027599.1_40531	SP(Sec/SPI)	0.448290	0.216596	0.085402	0.249712	CS pos: 15-16. AQA-SA. Pr: 0.2412    37
NZ_CP027599.1_40550	SP(Sec/SPI)	0.422951	0.149455	0.033851	0.393742	CS pos: 25-26. AHS-AN. Pr: 0.2764    38
NZ_CP027599.1_40580	LIPO(Sec/SPII)	0.217745	0.014024	0.540512	0.227719	CS pos: 19-20. PLH-CA. Pr: 0.1745    22
NZ_CP027599.1_40588	SP(Sec/SPI)	0.503864	0.003921	0.195385	0.296830	CS pos: 19-20. VQS-IM. Pr: 0.4228    47
NZ_CP027599.1_40619	LIPO(Sec/SPII)	0.185752	0.011312	0.577183	0.225753	CS pos: 22-23. CPG-CG. Pr: 0.3795    24
NZ_CP027599.1_40626	LIPO(Sec/SPII)	0.256314	0.030824	0.369653	0.343209	CS pos: ?. Probable protein fragment    15
NZ_CP027599.1_40646	SP(Sec/SPI)	0.480092	0.036045	0.042670	0.441192	CS pos: 25-26. IAA-KS. Pr: 0.3042    39
NZ_CP027599.1_40651	SP(Sec/SPI)	0.551326	0.034276	0.137459	0.276940	CS pos: 23-24. AVS-DQ. Pr: 0.2212    27
NZ_CP027599.1_40728	SP(Sec/SPI)	0.360378	0.063111	0.334865	0.241646	CS pos: 16-17. SIS-SG. Pr: 0.0708    21
NZ_CP027599.1_40730	LIPO(Sec/SPII)	0.150165	0.017686	0.416768	0.415380	CS pos: 17-18. GSG-CF. Pr: 0.2590    36
NZ_CP027599.1_40749	LIPO(Sec/SPII)	0.152390	0.013569	0.496586	0.337454	CS pos: 15-16. IHS-CI. Pr: 0.4044    19
NZ_CP027599.1_40756	LIPO(Sec/SPII)	0.264883	0.035830	0.357823	0.341465	CS pos: ?. Probable protein fragment    15
NZ_CP027599.1_40759	LIPO(Sec/SPII)	0.200611	0.011775	0.627635	0.159979	CS pos: 17-18. LCA-CF. Pr: 0.4028    19
NZ_CP027599.1_40768	SP(Sec/SPI)	0.413532	0.095241	0.202205	0.289023	CS pos: 17-18. LRA-SS. Pr: 0.2583    29
NZ_CP027599.1_40785	LIPO(Sec/SPII)	0.041733	0.003567	0.874875	0.079824	CS pos: 14-15. ISG-CI. Pr: 0.8636    27
NZ_CP027599.1_40817	LIPO(Sec/SPII)	0.078306	0.004389	0.837412	0.079894	CS pos: 19-20. NAA-CD. Pr: 0.8349    27
NZ_CP027599.1_40826	LIPO(Sec/SPII)	0.077107	0.002716	0.750454	0.169723	CS pos: 13-14. FVT-CF. Pr: 0.6687    23
NZ_CP027599.1_40839	LIPO(Sec/SPII)	0.207640	0.015403	0.540587	0.236370	CS pos: 10-11. FSA-CC. Pr: 0.2995    18
NZ_CP027599.1_40841	LIPO(Sec/SPII)	0.068680	0.002948	0.851719	0.076652	CS pos: 18-19. FFC-CV. Pr: 0.7641    36
NZ_CP027599.1_40844	LIPO(Sec/SPII)	0.189865	0.025523	0.440340	0.344273	CS pos: 12-13. GRS-CL. Pr: 0.1917    15
NZ_CP027599.1_40856	LIPO(Sec/SPII)	0.031306	0.004016	0.952444	0.012235	CS pos: 18-19. MNA-CR. Pr: 0.9527    25
NZ_CP027599.1_40900	SP(Sec/SPI)	0.426631	0.023412	0.136908	0.413049	CS pos: 20-21. AHL-LC. Pr: 0.1302    26
NZ_CP027599.1_40922	TAT(Tat/SPI)	0.129890	0.379844	0.208722	0.281544	CS pos: ?. Probable protein fragment    16
NZ_CP027599.1_40929	LIPO(Sec/SPII)	0.170078	0.006839	0.480928	0.342155	CS pos: ?. Probable protein fragment    20
NZ_CP027599.1_40978	LIPO(Sec/SPII)	0.284196	0.019665	0.421350	0.274789	CS pos: ?. Probable protein fragment    15
NZ_CP027599.1_40993	LIPO(Sec/SPII)	0.149133	0.026301	0.487034	0.337533	CS pos: 22-23. VMS-CV. Pr: 0.3990    24
NZ_CP027599.1_41002	LIPO(Sec/SPII)	0.307702	0.006507	0.481081	0.204711	CS pos: 13-14. LLF-CT. Pr: 0.2424    40
NZ_CP027599.1_41005	SP(Sec/SPI)	0.509134	0.190194	0.040023	0.260649	CS pos: 32-33. THA-EK. Pr: 0.6071    50
NZ_CP027599.1_41253	SP(Sec/SPI)	0.345153	0.035517	0.274831	0.344500	CS pos: ?. Probable protein fragment    19
NZ_CP027599.1_41392	LIPO(Sec/SPII)	0.162609	0.008667	0.535721	0.293003	CS pos: 18-19. LTG-QE. Pr: 0.5151    22
NZ_CP027599.1_41426	LIPO(Sec/SPII)	0.148784	0.031685	0.416503	0.403027	CS pos: 24-25. SLI-CQ. Pr: 0.1972    26
NZ_CP027599.1_41429	LIPO(Sec/SPII)	0.238132	0.060969	0.397205	0.303694	CS pos: 11-12. FSA-CS. Pr: 0.1301    16
NZ_CP027599.1_41435	SP(Sec/SPI)	0.592590	0.006942	0.271845	0.128622	CS pos: 18-19. LFS-SS. Pr: 0.3278    44
NZ_CP027599.1_41438	LIPO(Sec/SPII)	0.070263	0.007625	0.523703	0.398410	CS pos: 17-18. YGG-CL. Pr: 0.4768    24
NZ_CP027599.1_41447	LIPO(Sec/SPII)	0.309288	0.015205	0.413717	0.261790	CS pos: 14-15. ITS-TS. Pr: 0.0332    16
NZ_CP027599.1_41450	LIPO(Sec/SPII)	0.066821	0.005230	0.506376	0.421573	CS pos: 17-18. IKS-CN. Pr: 0.4919    30
NZ_CP027599.1_41469	LIPO(Sec/SPII)	0.142748	0.016780	0.567998	0.272473	CS pos: 23-24. ITG-CG. Pr: 0.4038    37
NZ_CP027599.1_41490	LIPO(Sec/SPII)	0.170791	0.014654	0.446073	0.368482	CS pos: 15-16. IMP-CR. Pr: 0.2212    17
NZ_CP027599.1_41494	SP(Sec/SPI)	0.424841	0.011043	0.272711	0.291405	CS pos: 16-17. VNG-NQ. Pr: 0.2895    19
NZ_CP027599.1_41526	SP(Sec/SPI)	0.475125	0.010730	0.120575	0.393570	CS pos: 18-19. THS-SP. Pr: 0.1992    23
NZ_CP027599.1_41544	LIPO(Sec/SPII)	0.188718	0.030577	0.410641	0.370064	CS pos: 13-14. VNN-CS. Pr: 0.3232    19
NZ_CP027599.1_41560	LIPO(Sec/SPII)	0.052562	0.000479	0.532302	0.414657	CS pos: 25-26. EIT-CQ. Pr: 0.5231    47
NZ_CP027599.1_41616	SP(Sec/SPI)	0.471129	0.027065	0.094749	0.407057	CS pos: 19-20. ITA-SH. Pr: 0.2183    43
NZ_CP027599.1_41628	LIPO(Sec/SPII)	0.273497	0.000675	0.384233	0.341595	CS pos: 10-11. VLC-CG. Pr: 0.2170    28
NZ_CP027599.1_41631	LIPO(Sec/SPII)	0.236841	0.023824	0.562064	0.177271	CS pos: 25-26. LIC-CS. Pr: 0.4281    49
NZ_CP027599.1_41661	LIPO(Sec/SPII)	0.052473	0.007617	0.871700	0.068211	CS pos: 18-19. SCA-CS. Pr: 0.6525    35
NZ_CP027599.1_41676	SP(Sec/SPI)	0.564145	0.003829	0.092822	0.339204	CS pos: 21-22. SQA-KI. Pr: 0.4610    45
NZ_CP027599.1_41677	LIPO(Sec/SPII)	0.048315	0.012931	0.821184	0.117570	CS pos: 15-16. VGA-CN. Pr: 0.8223    31
NZ_CP027599.1_41687	LIPO(Sec/SPII)	0.306676	0.035760	0.634467	0.023096	CS pos: 17-18. SFC-CA. Pr: 0.3552    49
NZ_CP027599.1_41721	LIPO(Sec/SPII)	0.290974	0.013608	0.407486	0.287932	CS pos: ?. Probable protein fragment    15
NZ_CP027599.1_41723	LIPO(Sec/SPII)	0.058864	0.009619	0.515606	0.415911	CS pos: 29-30. FAS-CR. Pr: 0.4828    37
NZ_CP027599.1_41761	SP(Sec/SPI)	0.390658	0.116203	0.107952	0.385187	CS pos: 21-22. ALA-RI. Pr: 0.4034    39
NZ_CP027599.1_41779	SP(Sec/SPI)	0.817649	0.008974	0.125633	0.047744	CS pos: 21-22. SVA-SY. Pr: 0.2467    34
NZ_CP027599.1_41780	TAT(Tat/SPI)	0.138199	0.415498	0.036052	0.410252	CS pos: 29-30. AQA-RS. Pr: 0.2379    45
NZ_CP027599.1_41789	LIPO(Sec/SPII)	0.261235	0.022868	0.407732	0.308165	CS pos: ?. Probable protein fragment    17
NZ_CP027599.1_41790	SP(Sec/SPI)	0.565809	0.015844	0.109723	0.308624	CS pos: 19-20. SLT-DS. Pr: 0.1130    43
NZ_CP027599.1_41814	LIPO(Sec/SPII)	0.051381	0.013515	0.540713	0.394391	CS pos: 13-14. ATS-CQ. Pr: 0.5391    33
NZ_CP027599.1_41815	LIPO(Sec/SPII)	0.309960	0.015964	0.419891	0.254185	CS pos: 13-14. SLT-CV. Pr: 0.0571    20
NZ_CP027599.1_41864	LIPO(Sec/SPII)	0.200973	0.010345	0.503253	0.285430	CS pos: ?. Probable protein fragment    21
NZ_CP027599.1_41934	LIPO(Sec/SPII)	0.221034	0.083995	0.349148	0.345823	CS pos: 20-21. FCF-CL. Pr: 0.0480    22
NZ_CP027599.1_41943	LIPO(Sec/SPII)	0.134566	0.011562	0.531664	0.322207	CS pos: 13-14. CNS-CY. Pr: 0.5013    34
NZ_CP027599.1_41974	LIPO(Sec/SPII)	0.068115	0.008827	0.545769	0.377288	CS pos: 20-21. MTS-CY. Pr: 0.5368    30
NZ_CP027599.1_42000	LIPO(Sec/SPII)	0.311517	0.065594	0.313660	0.309228	CS pos: 19-20. RAS-CE. Pr: 0.2596    24
NZ_CP027599.1_42012	LIPO(Sec/SPII)	0.283107	0.004688	0.439603	0.272602	CS pos: 16-17. TLL-CR. Pr: 0.1906    21
NZ_CP027599.1_42037	TAT(Tat/SPI)	0.072221	0.621700	0.020795	0.285283	CS pos: 34-35. GSA-TI. Pr: 0.2827    48
NZ_CP027599.1_42038	SP(Sec/SPI)	0.601742	0.084611	0.065403	0.248244	CS pos: 20-21. IHA-VG. Pr: 0.4751    29
NZ_CP027599.1_42040	LIPO(Sec/SPII)	0.251632	0.023295	0.404399	0.320673	CS pos: ?. Probable protein fragment    15
NZ_CP027599.1_42055	LIPO(Sec/SPII)	0.203466	0.028796	0.476084	0.291653	CS pos: ?. Probable protein fragment    16
NZ_CP027599.1_42097	LIPO(Sec/SPII)	0.150894	0.091390	0.399849	0.357868	CS pos: 24-25. VSS-CS. Pr: 0.3728    42
NZ_CP027599.1_42181	LIPO(Sec/SPII)	0.296025	0.011993	0.544007	0.147974	CS pos: 11-12. LAG-CG. Pr: 0.4260    22
NZ_CP027599.1_42185	LIPO(Sec/SPII)	0.109936	0.021234	0.742366	0.126464	CS pos: 21-22. AIS-CW. Pr: 0.7329    41
NZ_CP027599.1_42220	LIPO(Sec/SPII)	0.131672	0.042156	0.469077	0.357095	CS pos: 16-17. QGG-CR. Pr: 0.3997    24
NZ_CP027599.1_42250	LIPO(Sec/SPII)	0.097424	0.097697	0.458242	0.346637	CS pos: 21-22. TTS-CR. Pr: 0.4353    39
NZ_CP027599.1_42281	TAT(Tat/SPI)	0.170740	0.489995	0.082449	0.256816	CS pos: ?. Probable protein fragment    27
NZ_CP027599.1_42283	SP(Sec/SPI)	0.376916	0.106204	0.164177	0.352703	CS pos: 17-18. AMA-GS. Pr: 0.1269    20
NZ_CP027599.1_42284	LIPO(Sec/SPII)	0.312849	0.024331	0.399167	0.263653	CS pos: ?. Probable protein fragment    15
NZ_CP027599.1_42294	LIPO(Sec/SPII)	0.190890	0.005512	0.773252	0.030346	CS pos: 24-25. TTA-CC. Pr: 0.7309    49
NZ_CP027599.1_42297	SP(Sec/SPI)	0.614953	0.191516	0.116342	0.077188	CS pos: 22-23. ATA-AT. Pr: 0.4727    34
NZ_CP027599.1_42336	LIPO(Sec/SPII)	0.315920	0.031215	0.336128	0.316737	CS pos: 17-18. SAG-QS. Pr: 0.0808    19
NZ_CP027599.1_42347	LIPO(Sec/SPII)	0.157518	0.010501	0.505649	0.326332	CS pos: 24-25. AVN-CR. Pr: 0.3502    32
NZ_CP027599.1_42377	LIPO(Sec/SPII)	0.073775	0.004213	0.910085	0.011927	CS pos: 16-17. GAA-CG. Pr: 0.9002    23
NZ_CP027599.1_42409	LIPO(Sec/SPII)	0.326471	0.023929	0.349395	0.300205	CS pos: ?. Probable protein fragment    20
NZ_CP027599.1_42410	SP(Sec/SPI)	0.359294	0.003291	0.338647	0.298767	CS pos: 22-23. VSG-DF. Pr: 0.4038    40
NZ_CP027599.1_42413	LIPO(Sec/SPII)	0.221235	0.107496	0.466146	0.205122	CS pos: ?. Probable protein fragment    19
NZ_CP027599.1_42417	LIPO(Sec/SPII)	0.256128	0.025692	0.534520	0.183660	CS pos: 20-21. WCR-CS. Pr: 0.4543    36
NZ_CP027599.1_42472	LIPO(Sec/SPII)	0.100118	0.031477	0.570767	0.297638	CS pos: 18-19. IVS-CQ. Pr: 0.5469    24
NZ_CP027599.1_42491	LIPO(Sec/SPII)	0.191951	0.092193	0.459244	0.256612	CS pos: 13-14. SCA-CK. Pr: 0.1859    26
NZ_CP027599.1_42519	LIPO(Sec/SPII)	0.205673	0.002023	0.596041	0.196262	CS pos: 24-25. VIF-CG. Pr: 0.4726    41
NZ_CP027599.1_42525	LIPO(Sec/SPII)	0.134314	0.017791	0.467718	0.380177	CS pos: 16-17. ISG-CQ. Pr: 0.4296    18
NZ_CP027599.1_42545	SP(Sec/SPI)	0.438767	0.112272	0.178755	0.270206	CS pos: 24-25. ARA-AI. Pr: 0.3549    44
NZ_CP027599.1_42546	LIPO(Sec/SPII)	0.044554	0.002562	0.774637	0.178247	CS pos: 20-21. LIA-CN. Pr: 0.7630    37
NZ_CP027599.1_42557	SP(Sec/SPI)	0.436183	0.027514	0.205913	0.330389	CS pos: 17-18. VYS-GQ. Pr: 0.2972    19
NZ_CP027599.1_42561	LIPO(Sec/SPII)	0.203422	0.037006	0.412547	0.347026	CS pos: 18-19. GAI-CV. Pr: 0.1136    20
NZ_CP027599.1_42567	SP(Sec/SPI)	0.546391	0.029454	0.123832	0.300323	CS pos: 17-18. SHA-SG. Pr: 0.4643    22
NZ_CP027599.1_42572	LIPO(Sec/SPII)	0.107171	0.003538	0.701865	0.187426	CS pos: 18-19. SRG-CL. Pr: 0.6809    27
NZ_CP027599.1_42573	LIPO(Sec/SPII)	0.242106	0.027847	0.404695	0.325353	CS pos: ?. Probable protein fragment    15
NZ_CP027599.1_42583	SP(Sec/SPI)	0.455955	0.047890	0.235671	0.260483	CS pos: 24-25. GLA-KT. Pr: 0.1807    34
NZ_CP027599.1_42621	LIPO(Sec/SPII)	0.273477	0.019643	0.360864	0.346016	CS pos: ?. Probable protein fragment    16
NZ_CP027599.1_42640	SP(Sec/SPI)	0.609928	0.007578	0.029305	0.353189	CS pos: 21-22. INA-AT. Pr: 0.5741    41
NZ_CP027599.1_42647	LIPO(Sec/SPII)	0.225167	0.023592	0.416716	0.334525	CS pos: 19-20. CMA-CF. Pr: 0.2709    24
NZ_CP027599.1_42658	LIPO(Sec/SPII)	0.328774	0.007017	0.379633	0.284577	CS pos: 20-21. VVS-CF. Pr: 0.3518    41
NZ_CP027599.1_42684	LIPO(Sec/SPII)	0.124233	0.008569	0.536748	0.330449	CS pos: 23-24. ALC-CM. Pr: 0.2812    26
NZ_CP027599.1_42688	LIPO(Sec/SPII)	0.257800	0.014816	0.479918	0.247467	CS pos: ?. Probable protein fragment    15
NZ_CP027599.1_42691	LIPO(Sec/SPII)	0.172705	0.013875	0.471098	0.342323	CS pos: 26-27. SPK-CS. Pr: 0.4363    40
NZ_CP027599.1_42705	LIPO(Sec/SPII)	0.135393	0.058280	0.516820	0.289507	CS pos: 27-28. LLP-CA. Pr: 0.4040    39
NZ_CP027599.1_42725	SP(Sec/SPI)	0.625653	0.031468	0.094136	0.248743	CS pos: 21-22. AKS-AP. Pr: 0.5095    33
NZ_CP027599.1_42756	SP(Sec/SPI)	0.419983	0.033666	0.169000	0.377351	CS pos: 21-22. SLS-AL. Pr: 0.1374    23
NZ_CP027599.1_42768	LIPO(Sec/SPII)	0.248655	0.038594	0.387756	0.324996	CS pos: 15-16. NAV-CN. Pr: 0.2393    17
NZ_CP027599.1_42787	TAT(Tat/SPI)	0.246065	0.475043	0.011010	0.267881	CS pos: 36-37. ARA-AP. Pr: 0.6462    48
NZ_CP027599.1_42809	LIPO(Sec/SPII)	0.267919	0.120679	0.307107	0.304295	CS pos: 19-20. IAA-IK. Pr: 0.2018    34
NZ_CP027599.1_42821	LIPO(Sec/SPII)	0.328795	0.020667	0.411985	0.238552	CS pos: 16-17. LST-QP. Pr: 0.0387    18
NZ_CP027599.1_42840	LIPO(Sec/SPII)	0.176487	0.168186	0.548238	0.107089	CS pos: 16-17. ASG-CQ. Pr: 0.4990    46
NZ_CP027599.1_42842	SP(Sec/SPI)	0.770919	0.117848	0.047908	0.063325	CS pos: 23-24. AKA-AV. Pr: 0.7047    33
NZ_CP027599.1_42875	SP(Sec/SPI)	0.528474	0.032647	0.121304	0.317575	CS pos: 18-19. AFA-ER. Pr: 0.4171    23
NZ_CP027599.1_42879	LIPO(Sec/SPII)	0.018265	0.005790	0.887095	0.088849	CS pos: 17-18. LKS-CA. Pr: 0.8892    47
NZ_CP027599.1_42889	LIPO(Sec/SPII)	0.009601	0.000282	0.964941	0.025176	CS pos: 19-20. TFS-CQ. Pr: 0.9646    31
NZ_CP027599.1_42953	SP(Sec/SPI)	0.383821	0.040242	0.222602	0.353335	CS pos: 22-23. TKS-TP. Pr: 0.0609    25
NZ_CP027599.1_42978	LIPO(Sec/SPII)	0.203174	0.028178	0.517104	0.251544	CS pos: 21-22. PSG-CC. Pr: 0.2682    24
NZ_CP027599.1_43003	SP(Sec/SPI)	0.661863	0.002776	0.098485	0.236876	CS pos: 18-19. INA-LN. Pr: 0.5810    49
NZ_CP027599.1_43053	SP(Sec/SPI)	0.422651	0.071328	0.171905	0.334116	CS pos: 17-18. STA-VV. Pr: 0.1254    27
NZ_CP027599.1_43162	SP(Sec/SPI)	0.566287	0.007827	0.133151	0.292735	CS pos: 20-21. KYA-AM. Pr: 0.3418    27
NZ_CP027599.1_43191	LIPO(Sec/SPII)	0.369810	0.004474	0.519844	0.105872	CS pos: ?. Probable protein fragment    15
NZ_CP027599.1_43218	LIPO(Sec/SPII)	0.200082	0.079539	0.398776	0.321603	CS pos: 26-27. GVA-CG. Pr: 0.3657    35
NZ_CP027599.1_43616	LIPO(Sec/SPII)	0.116860	0.003528	0.697240	0.182371	CS pos: 26-27. FAG-CC. Pr: 0.5823    30
NZ_CP027599.1_43629	LIPO(Sec/SPII)	0.238063	0.022042	0.385101	0.354794	CS pos: ?. Probable protein fragment    15
NZ_CP027599.1_43651	LIPO(Sec/SPII)	0.023569	0.001726	0.573370	0.401336	CS pos: 28-29. CSG-CI. Pr: 0.3425    34
NZ_CP027599.1_43658	SP(Sec/SPI)	0.418521	0.022346	0.176002	0.383131	CS pos: 24-25. NHA-LS. Pr: 0.2020    26
NZ_CP027599.1_43681	LIPO(Sec/SPII)	0.135717	0.009057	0.633683	0.221543	CS pos: 15-16. CST-CG. Pr: 0.4694    22
NZ_CP027599.1_43689	LIPO(Sec/SPII)	0.251752	0.004977	0.393936	0.349334	CS pos: 23-24. LGH-CI. Pr: 0.3385    48
NZ_CP027599.1_43691	LIPO(Sec/SPII)	0.074386	0.012775	0.732629	0.180210	CS pos: 18-19. TSG-CC. Pr: 0.6752    29
NZ_CP027599.1_43722	LIPO(Sec/SPII)	0.260249	0.048410	0.363312	0.328029	CS pos: 27-28. LAG-CF. Pr: 0.3439    45
NZ_CP027599.1_43723	SP(Sec/SPI)	0.550877	0.146671	0.221101	0.081350	CS pos: 21-22. AST-QS. Pr: 0.2683    32
NZ_CP027599.1_43733	SP(Sec/SPI)	0.614862	0.035667	0.153914	0.195556	CS pos: 13-14. SSA-AN. Pr: 0.2552    19
NZ_CP027599.1_43738	SP(Sec/SPI)	0.402633	0.011599	0.379215	0.206553	CS pos: ?. Probable protein fragment    16
NZ_CP027599.1_43762	LIPO(Sec/SPII)	0.353541	0.012266	0.601800	0.032393	CS pos: 12-13. PMA-CS. Pr: 0.3574    20
NZ_CP027599.1_43804	LIPO(Sec/SPII)	0.302254	0.014299	0.450978	0.232468	CS pos: 18-19. ILS-CL. Pr: 0.4377    42
NZ_CP027599.1_43829	SP(Sec/SPI)	0.369203	0.126408	0.311170	0.193219	CS pos: 21-22. SES-AG. Pr: 0.1930    32
NZ_CP027599.1_43855	SP(Sec/SPI)	0.679787	0.041908	0.077994	0.200311	CS pos: 29-30. LYA-AR. Pr: 0.4990    32
NZ_CP027599.1_43861	LIPO(Sec/SPII)	0.171269	0.019078	0.491550	0.318103	CS pos: 26-27. ATK-CV. Pr: 0.4204    40
NZ_CP027599.1_43880	SP(Sec/SPI)	0.935612	0.029678	0.020411	0.014299	CS pos: 26-27. VAP-AS. Pr: 0.3684    42
NZ_CP027599.1_43913	LIPO(Sec/SPII)	0.138322	0.010852	0.673896	0.176929	CS pos: 23-24. SAS-CA. Pr: 0.6390    27
NZ_CP027599.1_43924	LIPO(Sec/SPII)	0.223985	0.165594	0.404956	0.205465	CS pos: 17-18. TFS-CT. Pr: 0.3180    35
NZ_CP027599.1_43931	SP(Sec/SPI)	0.485112	0.044549	0.077531	0.392807	CS pos: 21-22. TTA-DQ. Pr: 0.3810    36
NZ_CP027599.1_43950	SP(Sec/SPI)	0.751055	0.019864	0.086212	0.142869	CS pos: 24-25. SLA-HQ. Pr: 0.7016    34
NZ_CP027599.1_43951	SP(Sec/SPI)	0.585763	0.026886	0.038663	0.348687	CS pos: 21-22. HWA-VP. Pr: 0.4108    35
NZ_CP027599.1_43960	SP(Sec/SPI)	0.274712	0.213874	0.267156	0.244258	CS pos: 13-14. SSA-GP. Pr: 0.0433    22
NZ_CP027599.1_43963	SP(Sec/SPI)	0.609566	0.007659	0.081096	0.301679	CS pos: 19-20. GWG-NG. Pr: 0.3656    41
NZ_CP027599.1_43985	SP(Sec/SPI)	0.491302	0.033402	0.087870	0.387426	CS pos: 21-22. ARA-SN. Pr: 0.4300    34
NZ_CP027599.1_44002	SP(Sec/SPI)	0.350349	0.101527	0.199814	0.348310	CS pos: 21-22. ASA-RH. Pr: 0.0849    34
NZ_CP027599.1_44011	SP(Sec/SPI)	0.432208	0.101722	0.072135	0.393935	CS pos: 21-22. TNA-ID. Pr: 0.3138    24
NZ_CP027599.1_44017	LIPO(Sec/SPII)	0.163821	0.071823	0.491933	0.272424	CS pos: 18-19. RAG-CC. Pr: 0.3947    24
NZ_CP027599.1_44021	SP(Sec/SPI)	0.396856	0.010041	0.225643	0.367461	CS pos: 14-15. AGA-TG. Pr: 0.1873    38
NZ_CP027599.1_44031	LIPO(Sec/SPII)	0.239911	0.015964	0.447102	0.297022	CS pos: 15-16. IIR-CS. Pr: 0.2205    18
NZ_CP027599.1_44034	LIPO(Sec/SPII)	0.042799	0.017473	0.701784	0.237944	CS pos: 21-22. LTA-CV. Pr: 0.6948    44
NZ_CP027599.1_44048	LIPO(Sec/SPII)	0.271545	0.023339	0.566163	0.138953	CS pos: 21-22. VTH-CA. Pr: 0.3505    34
NZ_CP027599.1_44065	SP(Sec/SPI)	0.626837	0.039314	0.063718	0.270130	CS pos: 30-31. VSS-GP. Pr: 0.4825    47
NZ_CP027599.1_44086	LIPO(Sec/SPII)	0.206287	0.035696	0.395400	0.362617	CS pos: ?. Probable protein fragment    23
NZ_CP027599.1_44100	LIPO(Sec/SPII)	0.247812	0.042220	0.355798	0.354170	CS pos: ?. Probable protein fragment    15
NZ_CP027599.1_44102	SP(Sec/SPI)	0.430685	0.097681	0.067904	0.403729	CS pos: 15-16. VYA-ES. Pr: 0.2407    30
NZ_CP027599.1_44114	LIPO(Sec/SPII)	0.086920	0.010879	0.772137	0.130064	CS pos: 13-14. FWG-CS. Pr: 0.7455    23
NZ_CP027599.1_44128	LIPO(Sec/SPII)	0.048430	0.003227	0.580138	0.368205	CS pos: 17-18. TTG-CT. Pr: 0.5787    44
NZ_CP027599.1_44135	LIPO(Sec/SPII)	0.172179	0.004903	0.540960	0.281957	CS pos: ?. Probable protein fragment    17
NZ_CP027599.1_44141	LIPO(Sec/SPII)	0.014552	0.000553	0.562915	0.421981	CS pos: 15-16. HSG-CS. Pr: 0.5531    43
NZ_CP027599.1_44174	SP(Sec/SPI)	0.374428	0.040365	0.255368	0.329839	CS pos: ?. Probable protein fragment    21
NZ_CP027599.1_44181	SP(Sec/SPI)	0.421305	0.043264	0.255841	0.279590	CS pos: 20-21. SSA-SG. Pr: 0.1380    22
NZ_CP027599.1_44192	SP(Sec/SPI)	0.695556	0.085386	0.150721	0.068337	CS pos: 24-25. AIS-SS. Pr: 0.1344    33
NZ_CP027599.1_44198	LIPO(Sec/SPII)	0.078857	0.007786	0.623137	0.290219	CS pos: 17-18. SQS-CH. Pr: 0.6131    36
NZ_CP027599.1_44217	SP(Sec/SPI)	0.348791	0.105371	0.218087	0.327750	CS pos: 21-22. AYG-AG. Pr: 0.2086    31
NZ_CP027599.1_44222	LIPO(Sec/SPII)	0.074407	0.070499	0.800427	0.054667	CS pos: 31-32. ICA-CA. Pr: 0.6917    45
NZ_CP027599.1_44233	LIPO(Sec/SPII)	0.208056	0.040449	0.432410	0.319086	CS pos: 23-24. ISS-CV. Pr: 0.3239    25
NZ_CP027599.1_44242	LIPO(Sec/SPII)	0.054538	0.047298	0.770555	0.127609	CS pos: 28-29. LVS-CR. Pr: 0.7570    41
NZ_CP027599.1_44272	LIPO(Sec/SPII)	0.209993	0.054449	0.417949	0.317608	CS pos: 16-17. SVA-CY. Pr: 0.2148    18
NZ_CP027599.1_44289	SP(Sec/SPI)	0.668594	0.020350	0.094715	0.216341	CS pos: 19-20. SSA-VT. Pr: 0.5165    42
NZ_CP027599.1_44291	SP(Sec/SPI)	0.362260	0.293754	0.074677	0.269308	CS pos: 17-18. AFA-AP. Pr: 0.1873    49
NZ_CP027599.1_44363	LIPO(Sec/SPII)	0.204702	0.027920	0.411581	0.355796	CS pos: 15-16. LTA-CV. Pr: 0.4427    29
NZ_CP027599.1_44377	LIPO(Sec/SPII)	0.052015	0.006080	0.779635	0.162270	CS pos: 21-22. FGG-CL. Pr: 0.4540    30
NZ_CP027599.1_44402	LIPO(Sec/SPII)	0.175735	0.007082	0.510573	0.306610	CS pos: 12-13. VFA-CL. Pr: 0.4872    23
NZ_CP027599.1_44415	LIPO(Sec/SPII)	0.111048	0.031487	0.472950	0.384515	CS pos: 14-15. ATA-CS. Pr: 0.4612    39
NZ_CP027599.1_44464	LIPO(Sec/SPII)	0.243044	0.018514	0.388717	0.349726	CS pos: 19-20. LVL-CW. Pr: 0.1235    23
NZ_CP027599.1_44553	LIPO(Sec/SPII)	0.075053	0.011773	0.767635	0.145538	CS pos: 19-20. HFS-CA. Pr: 0.7227    24
NZ_CP027599.1_44588	LIPO(Sec/SPII)	0.288549	0.016671	0.423002	0.271778	CS pos: ?. Probable protein fragment    21
NZ_CP027599.1_44611	TAT(Tat/SPI)	0.158917	0.645473	0.037634	0.157977	CS pos: 24-25. ATA-ES. Pr: 0.1789    33
NZ_CP027599.1_44612	TAT(Tat/SPI)	0.281974	0.532556	0.038787	0.146683	CS pos: 22-23. VLA-DD. Pr: 0.6326    24
NZ_CP027599.1_44616	LIPO(Sec/SPII)	0.128692	0.019340	0.750111	0.101858	CS pos: 12-13. LSA-CG. Pr: 0.6877    15
NZ_CP027599.1_44617	SP(Sec/SPI)	0.461125	0.048031	0.154051	0.336793	CS pos: 15-16. VRC-RR. Pr: 0.1104    32
NZ_CP027599.1_44650	LIPO(Sec/SPII)	0.150121	0.029061	0.425545	0.395273	CS pos: 12-13. PAG-CY. Pr: 0.3657    20
NZ_CP027599.1_44651	LIPO(Sec/SPII)	0.198924	0.010238	0.415112	0.375726	CS pos: 22-23. VSR-CS. Pr: 0.1993    26
NZ_CP027599.1_44666	LIPO(Sec/SPII)	0.072188	0.001788	0.814325	0.111699	CS pos: 29-30. ISG-CR. Pr: 0.7801    32
NZ_CP027599.1_44673	SP(Sec/SPI)	0.468160	0.057120	0.043341	0.431379	CS pos: 12-13. VFA-AP. Pr: 0.3421    35
NZ_CP027599.1_44714	SP(Sec/SPI)	0.408142	0.008674	0.276981	0.306202	CS pos: ?. Probable protein fragment    19
NZ_CP027599.1_44717	LIPO(Sec/SPII)	0.199025	0.036617	0.395331	0.369027	CS pos: ?. Probable protein fragment    17
NZ_CP027599.1_44728	SP(Sec/SPI)	0.397114	0.048055	0.169348	0.385483	CS pos: 23-24. VVA-AP. Pr: 0.2030    27
NZ_CP027599.1_44745	LIPO(Sec/SPII)	0.051567	0.001018	0.927397	0.020017	CS pos: 16-17. ATG-CW. Pr: 0.9274    34
NZ_CP027599.1_44747	LIPO(Sec/SPII)	0.023219	0.002515	0.582437	0.391829	CS pos: 26-27. IWG-CW. Pr: 0.5823    40
NZ_CP027599.1_44777	LIPO(Sec/SPII)	0.293788	0.040243	0.340948	0.325021	CS pos: 14-15. ISS-SV. Pr: 0.0337    18
NZ_CP027599.1_44797	LIPO(Sec/SPII)	0.051063	0.017376	0.606302	0.325259	CS pos: 29-30. SAS-CQ. Pr: 0.5848    50
NZ_CP027599.1_44840	LIPO(Sec/SPII)	0.372244	0.012390	0.602172	0.013194	CS pos: 17-18. TMV-CG. Pr: 0.4924    40
NZ_CP027599.1_44859	LIPO(Sec/SPII)	0.279989	0.014292	0.391699	0.314020	CS pos: ?. Probable protein fragment    17
NZ_CP027599.1_44918	SP(Sec/SPI)	0.470727	0.092784	0.089506	0.346983	CS pos: 15-16. ADG-AG. Pr: 0.1175    28
NZ_CP027599.1_44920	SP(Sec/SPI)	0.393301	0.118607	0.293622	0.194471	CS pos: 24-25. ALS-QP. Pr: 0.1679    50
NZ_CP027599.1_44932	LIPO(Sec/SPII)	0.319152	0.041394	0.414217	0.225237	CS pos: ?. Probable protein fragment    20
NZ_CP027599.1_44997	TAT(Tat/SPI)	0.150340	0.382552	0.124718	0.342390	CS pos: 15-16. KRA-ST. Pr: 0.0511    17
NZ_CP027599.1_45014	LIPO(Sec/SPII)	0.282695	0.018794	0.475301	0.223211	CS pos: 16-17. LSG-CY. Pr: 0.2718    28
NZ_CP027599.1_45015	TAT(Tat/SPI)	0.390946	0.472414	0.028787	0.107853	CS pos: 24-25. SFA-VG. Pr: 0.6602    35
NZ_CP027599.1_45020	SP(Sec/SPI)	0.860085	0.126962	0.002970	0.009983	CS pos: 29-30. SFA-DV. Pr: 0.9624    50
NZ_CP027599.1_45046	LIPO(Sec/SPII)	0.050293	0.008527	0.797664	0.143516	CS pos: 14-15. TFS-CD. Pr: 0.5534    48
NZ_CP027599.1_45065	SP(Sec/SPI)	0.485406	0.082124	0.185047	0.247423	CS pos: 19-20. FRA-SS. Pr: 0.2314    34
NZ_CP027599.1_45107	SP(Sec/SPI)	0.370871	0.016591	0.366603	0.245935	CS pos: 21-22. CFG-AS. Pr: 0.1545    33
NZ_CP027599.1_45113	LIPO(Sec/SPII)	0.020950	0.007572	0.933505	0.037972	CS pos: 16-17. FSS-CQ. Pr: 0.9315    31
NZ_CP027599.1_45114	SP(Sec/SPI)	0.451105	0.073165	0.212778	0.262952	CS pos: 15-16. TFA-DR. Pr: 0.3347    18
NZ_CP027599.1_45136	LIPO(Sec/SPII)	0.141403	0.002354	0.726131	0.130111	CS pos: 14-15. FLT-CT. Pr: 0.6243    18
NZ_CP027599.1_45152	LIPO(Sec/SPII)	0.253435	0.025854	0.380469	0.340243	CS pos: 15-16. LAA-FN. Pr: 0.0337    18
NZ_CP027599.1_45185	LIPO(Sec/SPII)	0.091131	0.008769	0.760420	0.139680	CS pos: 23-24. ISG-CG. Pr: 0.7556    28
NZ_CP027599.1_45201	LIPO(Sec/SPII)	0.156644	0.004065	0.675914	0.163376	CS pos: 14-15. CLS-CR. Pr: 0.5027    16
NZ_CP027599.1_45228	LIPO(Sec/SPII)	0.167086	0.199640	0.329307	0.303966	CS pos: 18-19. MTG-CR. Pr: 0.2848    33
NZ_CP027599.1_45236	LIPO(Sec/SPII)	0.206266	0.013084	0.631737	0.148913	CS pos: ?. Probable protein fragment    18
NZ_CP027599.1_45237	SP(Sec/SPI)	0.426570	0.249691	0.050732	0.273007	CS pos: 23-24. SRA-VQ. Pr: 0.5119    33
NZ_CP027599.1_45286	SP(Sec/SPI)	0.558514	0.055340	0.119710	0.266436	CS pos: 19-20. ASA-DV. Pr: 0.4489    43
NZ_CP027599.1_45296	LIPO(Sec/SPII)	0.227318	0.057317	0.538876	0.176490	CS pos: 18-19. SAS-CP. Pr: 0.4585    28
NZ_CP027599.1_45306	LIPO(Sec/SPII)	0.171588	0.073967	0.479081	0.275364	CS pos: 20-21. LSS-CW. Pr: 0.4622    44
NZ_CP027599.1_45329	LIPO(Sec/SPII)	0.074113	0.006439	0.892232	0.027216	CS pos: 20-21. LSS-CC. Pr: 0.4914    27
NZ_CP027599.1_45350	LIPO(Sec/SPII)	0.040981	0.009689	0.917465	0.031864	CS pos: 16-17. MTS-CC. Pr: 0.8306    45
NZ_CP027599.1_45366	LIPO(Sec/SPII)	0.177427	0.001961	0.783221	0.037391	CS pos: 16-17. LSG-QA. Pr: 0.7614    27
NZ_CP027599.1_45367	LIPO(Sec/SPII)	0.208403	0.029007	0.541045	0.221544	CS pos: ?. Probable protein fragment    15
NZ_CP027599.1_45401	SP(Sec/SPI)	0.398331	0.016501	0.207267	0.377901	CS pos: 21-22. STS-LF. Pr: 0.0611    24
NZ_CP027599.1_45429	LIPO(Sec/SPII)	0.157302	0.014184	0.574945	0.253569	CS pos: 23-24. ASL-CS. Pr: 0.4508    30
NZ_CP027599.1_45444	SP(Sec/SPI)	0.439196	0.004037	0.199809	0.356959	CS pos: 21-22. TVS-WW. Pr: 0.1366    35
NZ_CP027599.1_45464	LIPO(Sec/SPII)	0.228820	0.033806	0.436668	0.300706	CS pos: 18-19. WMS-CS. Pr: 0.1871    36
NZ_CP027599.1_45477	LIPO(Sec/SPII)	0.011984	0.011503	0.906221	0.070291	CS pos: 24-25. FSS-CS. Pr: 0.9084    41
NZ_CP027599.1_45505	LIPO(Sec/SPII)	0.049671	0.035287	0.826731	0.088311	CS pos: 24-25. FSS-CT. Pr: 0.4336    43
NZ_CP027599.1_45538	SP(Sec/SPI)	0.634588	0.021616	0.142634	0.201163	CS pos: 15-16. AEA-ST. Pr: 0.5212    19
NZ_CP027599.1_45543	LIPO(Sec/SPII)	0.077577	0.014203	0.781049	0.127170	CS pos: 11-12. ISG-CR. Pr: 0.7548    24
NZ_CP027599.1_45565	LIPO(Sec/SPII)	0.207872	0.017833	0.399484	0.374811	CS pos: ?. Probable protein fragment    18
NZ_CP027599.1_45568	LIPO(Sec/SPII)	0.173003	0.004134	0.437473	0.385389	CS pos: 17-18. CAF-CV. Pr: 0.2379    20
NZ_CP027599.1_45575	LIPO(Sec/SPII)	0.439593	0.008330	0.496601	0.055476	CS pos: 15-16. TVI-CF. Pr: 0.2571    31
NZ_CP027599.1_45580	SP(Sec/SPI)	0.392874	0.064272	0.150507	0.392347	CS pos: 25-26. SFA-NV. Pr: 0.2411    35
NZ_CP027599.1_45609	SP(Sec/SPI)	0.337339	0.066230	0.270757	0.325674	CS pos: 21-22. SRA-FT. Pr: 0.1966    28
NZ_CP027599.1_45612	LIPO(Sec/SPII)	0.167310	0.015637	0.415991	0.401062	CS pos: 17-18. SCT-CT. Pr: 0.1792    23
NZ_CP027599.1_45636	SP(Sec/SPI)	0.434677	0.017030	0.335837	0.212457	CS pos: 19-20. ASS-SL. Pr: 0.1924    21
NZ_CP027599.1_45638	LIPO(Sec/SPII)	0.206414	0.011821	0.568381	0.213384	CS pos: 15-16. ITC-CN. Pr: 0.2802    18
NZ_CP027599.1_45668	LIPO(Sec/SPII)	0.025631	0.004429	0.906858	0.063082	CS pos: 17-18. STA-CA. Pr: 0.9014    48
NZ_CP027599.1_45673	LIPO(Sec/SPII)	0.317592	0.011948	0.512323	0.158137	CS pos: ?. Probable protein fragment    15
NZ_CP027599.1_45682	LIPO(Sec/SPII)	0.054383	0.006604	0.782847	0.156166	CS pos: 23-24. CTA-CW. Pr: 0.4669    38
NZ_CP027599.1_45704	SP(Sec/SPI)	0.794150	0.010280	0.039725	0.155845	CS pos: 21-22. ANA-LT. Pr: 0.7266    26
NZ_CP027599.1_45713	LIPO(Sec/SPII)	0.166727	0.014671	0.438797	0.379805	CS pos: 21-22. VVH-CS. Pr: 0.3703    25
NZ_CP027599.1_45732	SP(Sec/SPI)	0.472975	0.027945	0.058014	0.441067	CS pos: 17-18. NKA-AE. Pr: 0.2670    23
NZ_CP027599.1_45738	LIPO(Sec/SPII)	0.034203	0.018279	0.734720	0.212799	CS pos: 16-17. FLS-CN. Pr: 0.7351    43
NZ_CP027599.1_45755	SP(Sec/SPI)	0.548144	0.012193	0.071187	0.368476	CS pos: 15-16. TKA-GG. Pr: 0.2262    46
NZ_CP027599.1_45774	LIPO(Sec/SPII)	0.215680	0.095299	0.366575	0.322445	CS pos: ?. Probable protein fragment    18
NZ_CP027599.1_45788	SP(Sec/SPI)	0.420278	0.004575	0.218663	0.356483	CS pos: 15-16. LQT-ID. Pr: 0.2274    30
NZ_CP027599.1_45793	LIPO(Sec/SPII)	0.053097	0.003219	0.762817	0.180867	CS pos: 13-14. VVA-CI. Pr: 0.7352    20
NZ_CP027599.1_45806	SP(Sec/SPI)	0.870770	0.062244	0.027575	0.039411	CS pos: 26-27. AHS-DF. Pr: 0.6021    41
NZ_CP027599.1_45812	LIPO(Sec/SPII)	0.150187	0.008644	0.562445	0.278725	CS pos: 23-24. LTS-CC. Pr: 0.4835    33
NZ_CP027599.1_45813	SP(Sec/SPI)	0.363345	0.079982	0.254760	0.301913	CS pos: ?. Probable protein fragment    19
NZ_CP027599.1_45825	LIPO(Sec/SPII)	0.256006	0.040760	0.371161	0.332073	CS pos: ?. Probable protein fragment    16
NZ_CP027599.1_45852	LIPO(Sec/SPII)	0.230510	0.011324	0.426238	0.331928	CS pos: 15-16. LTG-VG. Pr: 0.0798    17
NZ_CP027599.1_45885	LIPO(Sec/SPII)	0.276900	0.019353	0.376820	0.326928	CS pos: 13-14. GIH-CI. Pr: 0.0679    17
NZ_CP027599.1_45903	SP(Sec/SPI)	0.627443	0.054802	0.131898	0.185857	CS pos: 17-18. ALT-RT. Pr: 0.4268    33
NZ_CP027599.1_45911	LIPO(Sec/SPII)	0.173616	0.008075	0.543202	0.275107	CS pos: 18-19. CVT-CS. Pr: 0.4272    27
NZ_CP027599.1_45947	SP(Sec/SPI)	0.427169	0.014687	0.181697	0.376447	CS pos: ?. Probable protein fragment    25
NZ_CP027599.1_45963	SP(Sec/SPI)	0.411497	0.013404	0.381924	0.193174	CS pos: 21-22. AKS-NK. Pr: 0.2454    33
NZ_CP027599.1_46037	LIPO(Sec/SPII)	0.309887	0.043433	0.536414	0.110266	CS pos: 18-19. LSA-ST. Pr: 0.3687    43
NZ_CP027599.1_46132	SP(Sec/SPI)	0.686053	0.144683	0.035127	0.134137	CS pos: 21-22. ASA-SP. Pr: 0.5837    33
NZ_CP027599.1_46148	SP(Sec/SPI)	0.462109	0.017978	0.266023	0.253889	CS pos: 20-21. CFS-QA. Pr: 0.1890    24
NZ_CP027599.1_46162	LIPO(Sec/SPII)	0.061026	0.090388	0.563943	0.284643	CS pos: 19-20. STS-CC. Pr: 0.4322    42
NZ_CP027599.1_46175	SP(Sec/SPI)	0.744833	0.021281	0.123269	0.110617	CS pos: 20-21. VRS-SV. Pr: 0.4939    29
NZ_CP027599.1_46181	SP(Sec/SPI)	0.407375	0.049979	0.158227	0.384418	CS pos: 16-17. ALA-LS. Pr: 0.1965    21
NZ_CP027599.1_46248	LIPO(Sec/SPII)	0.278700	0.041576	0.595865	0.083859	CS pos: 18-19. AAG-CE. Pr: 0.5998    27
NZ_CP027599.1_46255	SP(Sec/SPI)	0.529279	0.194582	0.087700	0.188438	CS pos: 17-18. VHA-TR. Pr: 0.4246    29
NZ_CP027599.1_46288	SP(Sec/SPI)	0.548019	0.009614	0.348318	0.094049	CS pos: 22-23. VQP-AS. Pr: 0.2581    48
NZ_CP027599.1_46344	LIPO(Sec/SPII)	0.173698	0.015809	0.449570	0.360922	CS pos: 19-20. ICY-CT. Pr: 0.2722    25
NZ_CP027599.1_46359	LIPO(Sec/SPII)	0.201728	0.007945	0.461632	0.328695	CS pos: ?. Probable protein fragment    26
NZ_CP027599.1_46373	SP(Sec/SPI)	0.447012	0.017580	0.302137	0.233272	CS pos: 18-19. IRG-KQ. Pr: 0.1111    21
NZ_CP027599.1_46374	LIPO(Sec/SPII)	0.184260	0.025013	0.416392	0.374335	CS pos: 17-18. TYT-CL. Pr: 0.1552    26
NZ_CP027599.1_46401	SP(Sec/SPI)	0.519660	0.005909	0.263052	0.211379	CS pos: 17-18. AHV-RG. Pr: 0.0787    19
NZ_CP027599.1_46439	SP(Sec/SPI)	0.542970	0.045921	0.120212	0.290896	CS pos: 17-18. NQA-SL. Pr: 0.2992    27
NZ_CP027599.1_46472	LIPO(Sec/SPII)	0.262881	0.022645	0.375744	0.338730	CS pos: ?. Probable protein fragment    16
NZ_CP027599.1_46481	SP(Sec/SPI)	0.930777	0.023457	0.014455	0.031311	CS pos: 27-28. ANA-EI. Pr: 0.6522    38
NZ_CP027599.1_46516	LIPO(Sec/SPII)	0.242876	0.015812	0.409602	0.331710	CS pos: ?. Probable protein fragment    15
NZ_CP027599.1_46521	LIPO(Sec/SPII)	0.106188	0.004683	0.805993	0.083135	CS pos: 20-21. ATA-CY. Pr: 0.8524    44
NZ_CP027599.1_46604	LIPO(Sec/SPII)	0.062717	0.019459	0.881777	0.036047	CS pos: 18-19. LSA-CA. Pr: 0.8696    29
NZ_CP027599.1_46647	LIPO(Sec/SPII)	0.147564	0.022365	0.485623	0.344448	CS pos: 15-16. ACS-CN. Pr: 0.2868    23
NZ_CP027599.1_46648	SP(Sec/SPI)	0.482302	0.088348	0.236951	0.192399	CS pos: 21-22. TSS-HT. Pr: 0.1839    35
NZ_CP027599.1_46703	LIPO(Sec/SPII)	0.071694	0.010044	0.792432	0.125830	CS pos: 20-21. TTF-CS. Pr: 0.7562    33
NZ_CP027599.1_46710	LIPO(Sec/SPII)	0.103936	0.008968	0.621365	0.265731	CS pos: 19-20. LTG-CL. Pr: 0.5575    23
NZ_CP027599.1_46733	SP(Sec/SPI)	0.519608	0.059506	0.062950	0.357936	CS pos: 14-15. ADA-AV. Pr: 0.4743    22
NZ_CP027599.1_46794	TAT(Tat/SPI)	0.022895	0.908128	0.020303	0.048674	CS pos: 30-31. IRC-IQ. Pr: 0.4887    47
NZ_CP027599.1_46809	LIPO(Sec/SPII)	0.215981	0.014179	0.740846	0.028995	CS pos: 22-23. ASS-CA. Pr: 0.6951    27
NZ_CP027599.1_46817	TAT(Tat/SPI)	0.088135	0.589702	0.049536	0.272627	CS pos: 28-29. RRA-DN. Pr: 0.3635    50
NZ_CP027599.1_46819	LIPO(Sec/SPII)	0.198933	0.070142	0.637534	0.093392	CS pos: 20-21. LLS-CS. Pr: 0.4825    33
NZ_CP027599.1_46823	LIPO(Sec/SPII)	0.118141	0.025529	0.740036	0.116294	CS pos: 13-14. ISA-CS. Pr: 0.7198    23
NZ_CP027599.1_46845	LIPO(Sec/SPII)	0.107774	0.034372	0.749976	0.107879	CS pos: 16-17. TSS-CC. Pr: 0.5354    19
NZ_CP027599.1_46846	LIPO(Sec/SPII)	0.289991	0.025821	0.525311	0.158876	CS pos: 15-16. VSA-CS. Pr: 0.2462    20
NZ_CP027599.1_46847	LIPO(Sec/SPII)	0.082378	0.005849	0.539140	0.372634	CS pos: 18-19. CSS-CC. Pr: 0.3076    30
NZ_CP027599.1_46865	LIPO(Sec/SPII)	0.295914	0.015434	0.369889	0.318763	CS pos: ?. Probable protein fragment    17
NZ_CP027599.1_46867	SP(Sec/SPI)	0.799905	0.029725	0.036567	0.133803	CS pos: 17-18. AVA-AE. Pr: 0.6354    29
NZ_CP027599.1_46879	SP(Sec/SPI)	0.420740	0.013628	0.283176	0.282456	CS pos: 19-20. ILS-AR. Pr: 0.2715    21
NZ_CP027599.1_46894	TAT(Tat/SPI)	0.230565	0.494050	0.028727	0.246657	CS pos: 29-30. ASA-QT. Pr: 0.5034    43
NZ_CP027599.1_46901	LIPO(Sec/SPII)	0.119778	0.035618	0.513071	0.331533	CS pos: 23-24. TFA-CF. Pr: 0.5114    45
NZ_CP027599.1_46911	LIPO(Sec/SPII)	0.150982	0.024414	0.600613	0.223992	CS pos: 15-16. AHG-CC. Pr: 0.5515    48
NZ_CP027599.1_46930	SP(Sec/SPI)	0.491166	0.062066	0.163418	0.283349	CS pos: 18-19. SSA-SS. Pr: 0.2477    22
NZ_CP027599.1_46953	LIPO(Sec/SPII)	0.337327	0.032470	0.537505	0.092699	CS pos: 22-23. SYS-CS. Pr: 0.5287    29
NZ_CP027599.1_46956	TAT(Tat/SPI)	0.109703	0.357649	0.185100	0.347549	CS pos: 30-31. RYA-AS. Pr: 0.2069    42
NZ_CP027599.1_46967	LIPO(Sec/SPII)	0.262461	0.066892	0.394436	0.276211	CS pos: ?. Probable protein fragment    16
NZ_CP027599.1_47029	LIPO(Sec/SPII)	0.239206	0.023261	0.407212	0.330321	CS pos: ?. Probable protein fragment    15
NZ_CP027599.1_47139	LIPO(Sec/SPII)	0.087674	0.004728	0.708442	0.199156	CS pos: 20-21. YTS-CN. Pr: 0.7107    44
NZ_CP027599.1_47143	LIPO(Sec/SPII)	0.037745	0.002373	0.819130	0.140753	CS pos: 18-19. ALA-CQ. Pr: 0.6795    27
NZ_CP027599.1_47149	LIPO(Sec/SPII)	0.192737	0.046901	0.382631	0.377731	CS pos: ?. Probable protein fragment    26
NZ_CP027599.1_47158	LIPO(Sec/SPII)	0.156166	0.040226	0.510683	0.292926	CS pos: 15-16. SAS-CS. Pr: 0.4050    17
NZ_CP027599.1_47173	LIPO(Sec/SPII)	0.124154	0.032322	0.597024	0.246500	CS pos: 19-20. PAG-CW. Pr: 0.5764    34
NZ_CP027599.1_47185	LIPO(Sec/SPII)	0.071565	0.007849	0.486352	0.434234	CS pos: 26-27. TIA-CF. Pr: 0.4334    34
NZ_CP027599.1_47190	SP(Sec/SPI)	0.501778	0.010721	0.086140	0.401361	CS pos: 17-18. ADS-LK. Pr: 0.2975    24
NZ_CP027599.1_47219	LIPO(Sec/SPII)	0.263475	0.009975	0.531255	0.195294	CS pos: 14-15. SSN-CF. Pr: 0.2327    16
NZ_CP027599.1_47227	LIPO(Sec/SPII)	0.345202	0.014440	0.412593	0.227765	CS pos: 13-14. LTS-MS. Pr: 0.0502    18
NZ_CP027599.1_47293	LIPO(Sec/SPII)	0.043958	0.006075	0.905910	0.044057	CS pos: 21-22. YVA-CS. Pr: 0.8882    32
NZ_CP027599.1_47302	LIPO(Sec/SPII)	0.019244	0.001890	0.921765	0.057101	CS pos: 18-19. LSG-CT. Pr: 0.9224    38
NZ_CP027599.1_47324	LIPO(Sec/SPII)	0.189104	0.097186	0.440706	0.273004	CS pos: 16-17. AIP-CS. Pr: 0.3371    23
NZ_CP027599.1_47407	LIPO(Sec/SPII)	0.231196	0.018463	0.399475	0.350866	CS pos: ?. Probable protein fragment    16
NZ_CP027599.1_47439	LIPO(Sec/SPII)	0.129736	0.002509	0.845508	0.022247	CS pos: 20-21. AAS-CK. Pr: 0.8312    30
NZ_CP027599.1_47453	LIPO(Sec/SPII)	0.280023	0.023919	0.398524	0.297533	CS pos: 31-32. LAA-SS. Pr: 0.1698    45
NZ_CP027599.1_47507	SP(Sec/SPI)	0.377997	0.194423	0.152101	0.275479	CS pos: 17-18. VTA-DT. Pr: 0.3248    34
NZ_CP027599.1_47523	TAT(Tat/SPI)	0.193075	0.627087	0.064775	0.115063	CS pos: 28-29. VGA-RM. Pr: 0.2714    31
NZ_CP027599.1_47598	SP(Sec/SPI)	0.942619	0.010841	0.034482	0.012059	CS pos: 17-18. ANA-LT. Pr: 0.7811    30
NZ_CP027599.1_47630	SP(Sec/SPI)	0.470472	0.112498	0.269690	0.147340	CS pos: 20-21. ATA-IP. Pr: 0.3388    35
NZ_CP027599.1_47631	SP(Sec/SPI)	0.644556	0.027882	0.053406	0.274156	CS pos: 15-16. VNA-DN. Pr: 0.6066    19
NZ_CP027599.1_47633	SP(Sec/SPI)	0.383960	0.029868	0.227230	0.358943	CS pos: 13-14. SDA-SH. Pr: 0.0882    19
NZ_CP027599.1_47649	SP(Sec/SPI)	0.560734	0.022752	0.015223	0.401291	CS pos: 18-19. SYA-TV. Pr: 0.5052    38
NZ_CP027599.1_47672	SP(Sec/SPI)	0.424513	0.150730	0.047591	0.377166	CS pos: 19-20. LWS-YP. Pr: 0.2157    42
NZ_CP027599.1_47706	LIPO(Sec/SPII)	0.113638	0.017763	0.564968	0.303631	CS pos: 16-17. FLS-CQ. Pr: 0.5195    32
NZ_CP027599.1_47707	LIPO(Sec/SPII)	0.234009	0.020830	0.388180	0.356981	CS pos: ?. Probable protein fragment    15
NZ_CP027599.1_47712	LIPO(Sec/SPII)	0.193550	0.062212	0.389674	0.354565	CS pos: 15-16. WSA-CH. Pr: 0.3490    25
NZ_CP027599.1_47725	LIPO(Sec/SPII)	0.406016	0.014541	0.564505	0.014938	CS pos: 16-17. GVA-SS. Pr: 0.2031    42
NZ_CP027599.1_47745	SP(Sec/SPI)	0.505287	0.209276	0.091889	0.193547	CS pos: 16-17. ALA-PA. Pr: 0.1769    26
NZ_CP027599.1_47759	LIPO(Sec/SPII)	0.170631	0.017068	0.429553	0.382747	CS pos: 17-18. RYG-CS. Pr: 0.2310    24
NZ_CP027599.1_47760	SP(Sec/SPI)	0.383572	0.093382	0.153888	0.369158	CS pos: 12-13. TDA-AS. Pr: 0.1080    25
NZ_CP027599.1_47766	SP(Sec/SPI)	0.462027	0.028594	0.143577	0.365802	CS pos: 19-20. IQS-FE. Pr: 0.1446    27
NZ_CP027599.1_47770	LIPO(Sec/SPII)	0.134812	0.012490	0.504410	0.348289	CS pos: 21-22. GFT-CA. Pr: 0.1748    36
NZ_CP027599.1_47775	LIPO(Sec/SPII)	0.333470	0.009247	0.469063	0.188220	CS pos: 14-15. LSA-SS. Pr: 0.2092    25
NZ_CP027599.1_47779	LIPO(Sec/SPII)	0.029887	0.004394	0.827304	0.138415	CS pos: 17-18. ASS-CD. Pr: 0.8270    27
NZ_CP027599.1_47805	LIPO(Sec/SPII)	0.215318	0.033932	0.378924	0.371825	CS pos: ?. Probable protein fragment    17
NZ_CP027599.1_47807	LIPO(Sec/SPII)	0.113565	0.010709	0.563980	0.311746	CS pos: 17-18. VSP-CC. Pr: 0.3650    35
NZ_CP027599.1_47899	LIPO(Sec/SPII)	0.272489	0.012795	0.401027	0.313688	CS pos: ?. Probable protein fragment    16
NZ_CP027599.1_47907	LIPO(Sec/SPII)	0.157539	0.008975	0.467984	0.365502	CS pos: ?. Probable protein fragment    18
NZ_CP027599.1_47911	LIPO(Sec/SPII)	0.213992	0.005863	0.620302	0.159843	CS pos: 18-19. LSI-CH. Pr: 0.5724    25
NZ_CP027599.1_47961	LIPO(Sec/SPII)	0.086101	0.003558	0.516887	0.393453	CS pos: 10-11. PFS-CN. Pr: 0.4943    35
NZ_CP027599.1_47982	LIPO(Sec/SPII)	0.071266	0.011732	0.468745	0.448257	CS pos: 16-17. CAS-CI. Pr: 0.4470    38
NZ_CP027599.1_48010	SP(Sec/SPI)	0.360495	0.216729	0.140195	0.282581	CS pos: 16-17. GSA-AG. Pr: 0.1113    35
NZ_CP027599.1_48048	LIPO(Sec/SPII)	0.176369	0.012583	0.561164	0.249885	CS pos: 12-13. LTH-CE. Pr: 0.5089    18
NZ_CP027599.1_48051	LIPO(Sec/SPII)	0.024307	0.001985	0.682531	0.291177	CS pos: 39-40. LNG-CA. Pr: 0.6842    47
NZ_CP027599.1_48082	SP(Sec/SPI)	0.771852	0.059522	0.119684	0.048942	CS pos: 21-22. VSA-SP. Pr: 0.3069    24
NZ_CP027599.1_48089	LIPO(Sec/SPII)	0.100195	0.021868	0.559148	0.318790	CS pos: 20-21. STG-CP. Pr: 0.5358    38
NZ_CP027599.1_48095	SP(Sec/SPI)	0.411490	0.348539	0.038355	0.201615	CS pos: 20-21. VSA-VA. Pr: 0.3283    45
NZ_CP027599.1_48145	SP(Sec/SPI)	0.438440	0.162531	0.138465	0.260564	CS pos: 23-24. YNA-AP. Pr: 0.2780    35
NZ_CP027599.1_48146	LIPO(Sec/SPII)	0.206491	0.060473	0.419624	0.313412	CS pos: 18-19. AVA-CP. Pr: 0.3661    24
NZ_CP027599.1_48175	SP(Sec/SPI)	0.387567	0.145445	0.126080	0.340909	CS pos: 25-26. RWG-QQ. Pr: 0.1392    31
NZ_CP027599.1_48176	LIPO(Sec/SPII)	0.053923	0.081226	0.818396	0.046455	CS pos: 20-21. TAS-CR. Pr: 0.8013    44
NZ_CP027599.1_48181	TAT(Tat/SPI)	0.254631	0.328383	0.143207	0.273779	CS pos: 22-23. AAA-RP. Pr: 0.1997    31
NZ_CP027599.1_48187	SP(Sec/SPI)	0.393692	0.089555	0.192066	0.324686	CS pos: 19-20. SAA-TP. Pr: 0.1862    29
NZ_CP027599.1_48196	TAT(Tat/SPI)	0.100969	0.509266	0.022476	0.367289	CS pos: 31-32. SRA-FT. Pr: 0.3281    39
NZ_CP027599.1_48201	LIPO(Sec/SPII)	0.160551	0.041399	0.654669	0.143381	CS pos: 17-18. MIS-CS. Pr: 0.4986    21
NZ_CP027599.1_48216	LIPO(Sec/SPII)	0.281794	0.150361	0.362024	0.205821	CS pos: 14-15. AGS-CA. Pr: 0.3091    27
NZ_CP027599.1_48254	TAT(Tat/SPI)	0.292323	0.365912	0.030980	0.310785	CS pos: 33-34. AQA-EI. Pr: 0.4331    46
NZ_CP027599.1_48256	TAT(Tat/SPI)	0.323362	0.400592	0.033078	0.242968	CS pos: 22-23. ASA-QV. Pr: 0.5458    45
NZ_CP027599.1_48259	LIPO(Sec/SPII)	0.161902	0.113049	0.459474	0.265576	CS pos: 15-16. TGG-CL. Pr: 0.2795    17
NZ_CP027599.1_48268	LIPO(Sec/SPII)	0.201195	0.010510	0.472214	0.316081	CS pos: 17-18. EMS-CR. Pr: 0.2696    22
NZ_CP027599.1_48277	TAT(Tat/SPI)	0.167403	0.468055	0.061625	0.302917	CS pos: 23-24. SSS-VR. Pr: 0.1891    37
NZ_CP027599.1_48310	LIPO(Sec/SPII)	0.249881	0.022941	0.465172	0.262006	CS pos: 11-12. PVS-CL. Pr: 0.0946    15
NZ_CP027599.1_48327	SP(Sec/SPI)	0.551855	0.233010	0.187038	0.028098	CS pos: 29-30. VFA-IS. Pr: 0.6432    40
NZ_CP027599.1_48350	SP(Sec/SPI)	0.699413	0.020563	0.167399	0.112625	CS pos: 18-19. AQA-VP. Pr: 0.5703    20
NZ_CP027599.1_48353	LIPO(Sec/SPII)	0.211608	0.048901	0.389944	0.349546	CS pos: 11-12. PAS-CS. Pr: 0.1459    17
NZ_CP027599.1_48355	LIPO(Sec/SPII)	0.260012	0.019947	0.404918	0.315123	CS pos: 22-23. PLS-CG. Pr: 0.2910    24
NZ_CP027599.1_48371	TAT(Tat/SPI)	0.127668	0.702256	0.130924	0.039152	CS pos: 32-33. SNC-SC. Pr: 0.1953    38
NZ_CP027599.1_48394	TAT(Tat/SPI)	0.028244	0.895808	0.029904	0.046044	CS pos: 28-29. SNC-NP. Pr: 0.3294    48
NZ_CP027599.1_48407	SP(Sec/SPI)	0.462103	0.065094	0.132582	0.340220	CS pos: 16-17. TFS-AR. Pr: 0.1144    43
NZ_CP027599.1_48421	SP(Sec/SPI)	0.631748	0.037538	0.070691	0.260023	CS pos: 23-24. SFA-MT. Pr: 0.5215    28
NZ_CP027599.1_48443	SP(Sec/SPI)	0.348943	0.008852	0.348600	0.293605	CS pos: 21-22. SDS-SE. Pr: 0.1362    25
NZ_CP027599.1_48477	LIPO(Sec/SPII)	0.174771	0.038790	0.586949	0.199489	CS pos: 22-23. LTS-CH. Pr: 0.5741    38
NZ_CP027599.1_48501	SP(Sec/SPI)	0.603774	0.031587	0.154078	0.210561	CS pos: 16-17. ATA-GI. Pr: 0.5011    25
NZ_CP027599.1_48531	SP(Sec/SPI)	0.428094	0.011324	0.356845	0.203738	CS pos: 17-18. PWC-CP. Pr: 0.1831    22
NZ_CP027599.1_48598	LIPO(Sec/SPII)	0.259423	0.058391	0.496990	0.185196	CS pos: 13-14. SAS-CI. Pr: 0.4788    25
NZ_CP027599.1_48601	LIPO(Sec/SPII)	0.258247	0.151443	0.363917	0.226392	CS pos: 19-20. AGH-CS. Pr: 0.2585    34
NZ_CP027599.1_48603	LIPO(Sec/SPII)	0.201559	0.017887	0.745569	0.034985	CS pos: 17-18. FTI-CS. Pr: 0.6799    36
NZ_CP027599.1_48604	LIPO(Sec/SPII)	0.154637	0.052705	0.422414	0.370244	CS pos: 22-23. LLK-CT. Pr: 0.1778    25
NZ_CP027599.1_48736	LIPO(Sec/SPII)	0.308828	0.003551	0.382721	0.304899	CS pos: 19-20. LVS-QE. Pr: 0.3775    48
NZ_CP027599.1_48739	LIPO(Sec/SPII)	0.210446	0.020789	0.421947	0.346818	CS pos: 17-18. RIS-CY. Pr: 0.3049    22
NZ_CP027599.1_48778	SP(Sec/SPI)	0.370021	0.021603	0.277616	0.330759	CS pos: 20-21. ATA-IP. Pr: 0.1803    22
NZ_CP027599.1_48795	LIPO(Sec/SPII)	0.102982	0.014195	0.729798	0.153025	CS pos: 14-15. IMS-CS. Pr: 0.6942    21
NZ_CP027599.1_48834	LIPO(Sec/SPII)	0.197085	0.037413	0.553695	0.211808	CS pos: 23-24. WCS-CP. Pr: 0.2684    37
NZ_CP027599.1_48840	SP(Sec/SPI)	0.527600	0.080383	0.119765	0.272252	CS pos: 15-16. LLA-AQ. Pr: 0.1858    28
NZ_CP027599.1_48885	LIPO(Sec/SPII)	0.243980	0.041054	0.461139	0.253827	CS pos: 13-14. TLA-CV. Pr: 0.1538    19
NZ_CP027599.1_48886	SP(Sec/SPI)	0.408832	0.017040	0.239993	0.334135	CS pos: 19-20. VFG-SV. Pr: 0.2127    23
NZ_CP027599.1_48949	LIPO(Sec/SPII)	0.151158	0.002217	0.473252	0.373374	CS pos: 19-20. LVF-CS. Pr: 0.2207    32
NZ_CP027599.1_48996	SP(Sec/SPI)	0.769774	0.041439	0.040331	0.148456	CS pos: 26-27. SMS-RD. Pr: 0.6362    45
NZ_CP027599.1_49020	LIPO(Sec/SPII)	0.215074	0.023591	0.421312	0.340023	CS pos: 16-17. VAV-CG. Pr: 0.0872    18
NZ_CP027599.1_49021	LIPO(Sec/SPII)	0.240314	0.011285	0.462074	0.286327	CS pos: ?. Probable protein fragment    18
NZ_CP027599.1_49030	LIPO(Sec/SPII)	0.344397	0.031185	0.347568	0.276850	CS pos: 21-22. HSG-CR. Pr: 0.2739    34
NZ_CP027599.1_49050	SP(Sec/SPI)	0.563777	0.137921	0.063969	0.234332	CS pos: 26-27. VAA-ER. Pr: 0.3273    40
NZ_CP027599.1_49116	SP(Sec/SPI)	0.572729	0.051031	0.088500	0.287739	CS pos: 21-22. CYA-AK. Pr: 0.4849    36
NZ_CP027599.1_49155	SP(Sec/SPI)	0.381625	0.228631	0.083293	0.306451	CS pos: 12-13. AAA-TP. Pr: 0.1848    38
NZ_CP027599.1_49161	SP(Sec/SPI)	0.465532	0.041213	0.052812	0.440443	CS pos: 15-16. TMA-LN. Pr: 0.3109    33
NZ_CP027599.1_49174	SP(Sec/SPI)	0.551486	0.138452	0.063366	0.246697	CS pos: 31-32. SLA-ET. Pr: 0.0991    44
NZ_CP027599.1_49178	SP(Sec/SPI)	0.432784	0.037032	0.257171	0.273014	CS pos: 15-16. CNA-IK. Pr: 0.2078    32
NZ_CP027599.1_49187	LIPO(Sec/SPII)	0.269787	0.104416	0.330386	0.295411	CS pos: 29-30. RSA-CC. Pr: 0.2982    43
NZ_CP027599.1_49206	LIPO(Sec/SPII)	0.150608	0.010465	0.462384	0.376543	CS pos: 13-14. VVK-CT. Pr: 0.2922    17
NZ_CP027599.1_49221	LIPO(Sec/SPII)	0.248828	0.035103	0.362759	0.353310	CS pos: ?. Probable protein fragment    15
NZ_CP027599.1_49231	SP(Sec/SPI)	0.345068	0.014257	0.311358	0.329317	CS pos: 14-15. SYS-SR. Pr: 0.0735    16
NZ_CP027599.1_49251	LIPO(Sec/SPII)	0.012384	0.001650	0.966379	0.019587	CS pos: 17-18. PLA-CT. Pr: 0.9574    35
NZ_CP027599.1_49331	SP(Sec/SPI)	0.776244	0.024156	0.096660	0.102940	CS pos: 17-18. SQA-LN. Pr: 0.6296    25
NZ_CP027599.1_49439	SP(Sec/SPI)	0.623980	0.084937	0.154384	0.136698	CS pos: 16-17. ASA-SY. Pr: 0.3691    23
NZ_CP027599.1_49444	LIPO(Sec/SPII)	0.252383	0.017608	0.494345	0.235665	CS pos: 17-18. AAV-CR. Pr: 0.2197    19
NZ_CP027599.1_49470	SP(Sec/SPI)	0.362144	0.161695	0.239751	0.236410	CS pos: 24-25. CGA-DG. Pr: 0.1861    43
NZ_CP027599.1_49481	SP(Sec/SPI)	0.352677	0.122798	0.280539	0.243985	CS pos: 32-33. CFG-AS. Pr: 0.1163    44
NZ_CP027599.1_49555	LIPO(Sec/SPII)	0.260075	0.005511	0.461200	0.273214	CS pos: 17-18. LSA-ML. Pr: 0.1162    21
NZ_CP027599.1_49557	LIPO(Sec/SPII)	0.205115	0.111493	0.379217	0.304174	CS pos: 22-23. LLA-CA. Pr: 0.4256    43
NZ_CP027599.1_49566	LIPO(Sec/SPII)	0.325348	0.014470	0.447722	0.212460	CS pos: 24-25. VCS-CH. Pr: 0.2985    30
NZ_CP027599.1_49574	LIPO(Sec/SPII)	0.172026	0.003402	0.453678	0.370894	CS pos: 27-28. CTA-CY. Pr: 0.1833    32
NZ_CP027599.1_49583	LIPO(Sec/SPII)	0.194502	0.033798	0.431554	0.340146	CS pos: 16-17. LTA-CG. Pr: 0.3507    18
NZ_CP027599.1_49602	LIPO(Sec/SPII)	0.090935	0.182703	0.369003	0.357359	CS pos: 20-21. AYS-CF. Pr: 0.3376    47
NZ_CP027599.1_49622	LIPO(Sec/SPII)	0.295139	0.010266	0.422778	0.271817	CS pos: ?. Probable protein fragment    16
NZ_CP027599.1_49653	LIPO(Sec/SPII)	0.140092	0.012334	0.426039	0.421535	CS pos: 21-22. VTA-CG. Pr: 0.3075    30
NZ_CP027599.1_49666	SP(Sec/SPI)	0.392972	0.007405	0.311487	0.288137	CS pos: 18-19. IIS-LI. Pr: 0.0803    29
NZ_CP027599.1_49694	TAT(Tat/SPI)	0.219829	0.288836	0.213785	0.277550	CS pos: ?. Probable protein fragment    16
NZ_CP027599.1_49705	TAT(Tat/SPI)	0.157062	0.685629	0.029162	0.128147	CS pos: 35-36. VQA-EV. Pr: 0.5734    37
NZ_CP027599.1_49735	LIPO(Sec/SPII)	0.092527	0.004978	0.838161	0.064334	CS pos: 26-27. HTG-CV. Pr: 0.7714    49
NZ_CP027599.1_49746	TAT(Tat/SPI)	0.123573	0.432371	0.109785	0.334272	CS pos: 30-31. VSA-VV. Pr: 0.3053    42
NZ_CP027599.1_49766	LIPO(Sec/SPII)	0.195348	0.015997	0.400765	0.387890	CS pos: 25-26. ARS-CW. Pr: 0.3535    32
NZ_CP027599.1_49768	LIPO(Sec/SPII)	0.242637	0.041547	0.463252	0.252564	CS pos: ?. Probable protein fragment    24
NZ_CP027599.1_49788	SP(Sec/SPI)	0.402901	0.041879	0.304034	0.251186	CS pos: ?. Probable protein fragment    16
NZ_CP027599.1_49791	LIPO(Sec/SPII)	0.062481	0.041248	0.568073	0.328197	CS pos: 15-16. TAA-CG. Pr: 0.5521    46
NZ_CP027599.1_49796	LIPO(Sec/SPII)	0.177205	0.011032	0.579654	0.232109	CS pos: 20-21. SLS-CC. Pr: 0.2028    26
NZ_CP027599.1_49797	LIPO(Sec/SPII)	0.133826	0.011150	0.519392	0.335633	CS pos: 14-15. WGS-CW. Pr: 0.4361    27
NZ_CP027599.1_49798	LIPO(Sec/SPII)	0.037263	0.004111	0.896011	0.062616	CS pos: 22-23. LKA-CS. Pr: 0.8734    36
NZ_CP027599.1_49810	TAT(Tat/SPI)	0.088626	0.491764	0.031193	0.388416	CS pos: 31-32. LRA-SY. Pr: 0.4038    41
NZ_CP027599.1_49816	SP(Sec/SPI)	0.500409	0.019875	0.026643	0.453073	CS pos: 17-18. VYA-SE. Pr: 0.4328    33
NZ_CP027599.1_49830	LIPO(Sec/SPII)	0.219806	0.112586	0.400076	0.267532	CS pos: 14-15. GLC-CC. Pr: 0.0470    16
NZ_CP027599.1_49890	SP(Sec/SPI)	0.507021	0.183896	0.049154	0.259930	CS pos: 32-33. SAA-DP. Pr: 0.4160    35
NZ_CP027599.1_49908	LIPO(Sec/SPII)	0.152604	0.008927	0.714809	0.123660	CS pos: 17-18. FIA-CC. Pr: 0.4297    33
NZ_CP027599.1_49935	SP(Sec/SPI)	0.391391	0.098165	0.169997	0.340446	CS pos: 26-27. QLA-GR. Pr: 0.2019    45
NZ_CP027599.1_49936	LIPO(Sec/SPII)	0.219670	0.010452	0.634063	0.135816	CS pos: 14-15. FLS-CT. Pr: 0.3580    21
NZ_CP027599.1_49950	LIPO(Sec/SPII)	0.279242	0.023950	0.407390	0.289418	CS pos: 12-13. PTM-CW. Pr: 0.1015    15
NZ_CP027599.1_49982	SP(Sec/SPI)	0.411785	0.012290	0.202466	0.373460	CS pos: 26-27. AST-KY. Pr: 0.1028    44
NZ_CP027599.1_50030	LIPO(Sec/SPII)	0.233117	0.069902	0.584313	0.112667	CS pos: 15-16. ALS-CG. Pr: 0.5553    28
NZ_CP027599.1_50038	LIPO(Sec/SPII)	0.232557	0.049796	0.396358	0.321288	CS pos: ?. Probable protein fragment    16
NZ_CP027599.1_50040	LIPO(Sec/SPII)	0.211913	0.070691	0.372790	0.344605	CS pos: ?. Probable protein fragment    22
NZ_CP027599.1_50043	SP(Sec/SPI)	0.709581	0.017809	0.130112	0.142498	CS pos: 23-24. ASG-LS. Pr: 0.3558    36
NZ_CP027599.1_50054	SP(Sec/SPI)	0.406445	0.040305	0.180859	0.372391	CS pos: 43-44. AKA-MC. Pr: 0.1752    47
NZ_CP027599.1_50111	LIPO(Sec/SPII)	0.279845	0.017130	0.373660	0.329364	CS pos: ?. Probable protein fragment    17
NZ_CP027599.1_50144	LIPO(Sec/SPII)	0.166459	0.020825	0.661726	0.150990	CS pos: ?. Probable protein fragment    17
NZ_CP027599.1_50162	LIPO(Sec/SPII)	0.096613	0.006620	0.805077	0.091691	CS pos: 16-17. SCA-CR. Pr: 0.4105    19
NZ_CP027599.1_50176	LIPO(Sec/SPII)	0.262942	0.032582	0.403778	0.300698	CS pos: ?. Probable protein fragment    15
NZ_CP027599.1_50185	LIPO(Sec/SPII)	0.146552	0.032823	0.704473	0.116152	CS pos: 17-18. VIN-CS. Pr: 0.6855    36
NZ_CP027599.1_50223	LIPO(Sec/SPII)	0.098613	0.028646	0.588347	0.284393	CS pos: 18-19. SSG-CH. Pr: 0.5825    31
NZ_CP027599.1_50230	LIPO(Sec/SPII)	0.200204	0.014946	0.397323	0.387527	CS pos: ?. Probable protein fragment    16
NZ_CP027599.1_50232	SP(Sec/SPI)	0.503249	0.057470	0.033063	0.406218	CS pos: 22-23. SAA-GI. Pr: 0.1744    49
NZ_CP027599.1_50279	SP(Sec/SPI)	0.707965	0.015480	0.168180	0.108374	CS pos: 26-27. SRA-GD. Pr: 0.6515    29
NZ_CP027599.1_50313	SP(Sec/SPI)	0.397633	0.022697	0.284937	0.294733	CS pos: 19-20. SLS-ST. Pr: 0.0532    23
NZ_CP027599.1_50334	LIPO(Sec/SPII)	0.282052	0.028746	0.418153	0.271049	CS pos: ?. Probable protein fragment    16
NZ_CP027599.1_50371	LIPO(Sec/SPII)	0.092890	0.012994	0.452749	0.441367	CS pos: 15-16. NSG-CS. Pr: 0.4234    29
NZ_CP027599.1_50397	LIPO(Sec/SPII)	0.275821	0.025221	0.420107	0.278851	CS pos: 24-25. ATA-CL. Pr: 0.3935    30
NZ_CP027599.1_50409	LIPO(Sec/SPII)	0.283811	0.000854	0.597542	0.117793	CS pos: 16-17. LSK-LS. Pr: 0.2329    28
NZ_CP027599.1_50427	TAT(Tat/SPI)	0.066299	0.852765	0.001454	0.079483	CS pos: 32-33. AAA-QA. Pr: 0.5759    50
NZ_CP027599.1_50435	LIPO(Sec/SPII)	0.186578	0.023979	0.420509	0.368933	CS pos: 21-22. RAG-CS. Pr: 0.3704    24
NZ_CP027599.1_50442	SP(Sec/SPI)	0.572773	0.022516	0.094552	0.310159	CS pos: 24-25. SSS-KR. Pr: 0.2394    32
NZ_CP027599.1_50484	LIPO(Sec/SPII)	0.201452	0.032407	0.488299	0.277842	CS pos: ?. Probable protein fragment    17
NZ_CP027599.1_50485	LIPO(Sec/SPII)	0.384360	0.002349	0.562493	0.050799	CS pos: 14-15. CYS-CH. Pr: 0.5257    28
NZ_CP027599.1_50499	LIPO(Sec/SPII)	0.261377	0.019729	0.498171	0.220722	CS pos: 12-13. SVS-CL. Pr: 0.3760    21
NZ_CP027599.1_50534	LIPO(Sec/SPII)	0.060307	0.015193	0.488712	0.435789	CS pos: 15-16. LNT-CS. Pr: 0.4598    44
NZ_CP027599.1_50545	LIPO(Sec/SPII)	0.113229	0.177333	0.365331	0.344107	CS pos: 16-17. SSG-CL. Pr: 0.2972    24
NZ_CP027599.1_50548	SP(Sec/SPI)	0.523439	0.114212	0.175675	0.186674	CS pos: 13-14. SMA-GV. Pr: 0.2194    25
NZ_CP027599.1_50566	TAT(Tat/SPI)	0.039895	0.785760	0.017210	0.157136	CS pos: 39-40. TLS-AG. Pr: 0.2193    46
NZ_CP027599.1_50568	LIPO(Sec/SPII)	0.083550	0.025510	0.567540	0.323400	CS pos: 15-16. LPG-CC. Pr: 0.4428    28
NZ_CP027599.1_50569	LIPO(Sec/SPII)	0.127579	0.083628	0.496560	0.292233	CS pos: 26-27. TTG-IS. Pr: 0.2341    42
NZ_CP027599.1_50581	LIPO(Sec/SPII)	0.171567	0.004781	0.769412	0.054240	CS pos: 23-24. SSV-CR. Pr: 0.3754    46
NZ_CP027599.1_50586	LIPO(Sec/SPII)	0.064280	0.030126	0.858700	0.046894	CS pos: 23-24. STA-CN. Pr: 0.8549    37
NZ_CP027599.1_50606	LIPO(Sec/SPII)	0.243873	0.019992	0.453881	0.282254	CS pos: ?. Probable protein fragment    15
NZ_CP027599.1_50610	SP(Sec/SPI)	0.539594	0.012114	0.048255	0.400037	CS pos: 30-31. LPA-GL. Pr: 0.2128    49
NZ_CP027599.1_50615	LIPO(Sec/SPII)	0.126342	0.068319	0.525575	0.279764	CS pos: 16-17. LSG-CG. Pr: 0.5018    25
NZ_CP027599.1_50623	LIPO(Sec/SPII)	0.222081	0.015777	0.551012	0.211130	CS pos: ?. Probable protein fragment    18
NZ_CP027599.1_50626	LIPO(Sec/SPII)	0.258961	0.019369	0.437727	0.283942	CS pos: 12-13. LSM-CS. Pr: 0.2313    19
NZ_CP027599.1_50633	SP(Sec/SPI)	0.458733	0.050085	0.437064	0.054119	CS pos: 28-29. CSA-AS. Pr: 0.3251    44
NZ_CP027599.1_50655	LIPO(Sec/SPII)	0.156779	0.066400	0.515235	0.261586	CS pos: 14-15. CSS-CC. Pr: 0.2398    39
NZ_CP027599.1_50664	LIPO(Sec/SPII)	0.180268	0.027696	0.493378	0.298658	CS pos: 16-17. CSG-CF. Pr: 0.3173    18
NZ_CP027599.1_50675	LIPO(Sec/SPII)	0.202827	0.059207	0.498937	0.239029	CS pos: 14-15. AST-CP. Pr: 0.4565    34
NZ_CP027599.1_50691	LIPO(Sec/SPII)	0.103233	0.010347	0.481820	0.404600	CS pos: 23-24. SIS-CL. Pr: 0.4318    28
NZ_CP027599.1_50705	LIPO(Sec/SPII)	0.280543	0.005224	0.371961	0.342272	CS pos: 19-20. FVS-DS. Pr: 0.2338    24
NZ_CP027599.1_50710	SP(Sec/SPI)	0.440953	0.121854	0.122937	0.314256	CS pos: 19-20. AAA-LR. Pr: 0.3571    21
NZ_CP027599.1_50748	SP(Sec/SPI)	0.830192	0.051039	0.039908	0.078862	CS pos: 22-23. VSA-LP. Pr: 0.6473    50
NZ_CP027599.1_50768	LIPO(Sec/SPII)	0.253937	0.009478	0.569552	0.167033	CS pos: 12-13. PVS-CS. Pr: 0.2215    16
NZ_CP027599.1_50774	LIPO(Sec/SPII)	0.240236	0.011096	0.517469	0.231198	CS pos: 18-19. SFC-CV. Pr: 0.4426    29
NZ_CP027599.1_50785	LIPO(Sec/SPII)	0.218184	0.032307	0.415001	0.334509	CS pos: 14-15. PVR-CN. Pr: 0.1921    16
NZ_CP027599.1_50786	LIPO(Sec/SPII)	0.252636	0.008428	0.459665	0.279271	CS pos: 19-20. CQP-CA. Pr: 0.3066    29
NZ_CP027599.1_50805	LIPO(Sec/SPII)	0.068940	0.001627	0.895759	0.033674	CS pos: 20-21. ATT-CM. Pr: 0.8786    44
NZ_CP027599.1_50849	LIPO(Sec/SPII)	0.275849	0.014330	0.441171	0.268650	CS pos: 13-14. LSF-CP. Pr: 0.1052    16
NZ_CP027599.1_50853	LIPO(Sec/SPII)	0.314565	0.038888	0.441707	0.204839	CS pos: 26-27. SVS-CS. Pr: 0.3515    32
NZ_CP027599.1_50862	SP(Sec/SPI)	0.427568	0.016803	0.358003	0.197626	CS pos: 17-18. SLA-EC. Pr: 0.3252    22
NZ_CP027599.1_50863	LIPO(Sec/SPII)	0.353280	0.006155	0.570650	0.069915	CS pos: 20-21. SGR-CC. Pr: 0.2990    34
NZ_CP027599.1_50874	LIPO(Sec/SPII)	0.236506	0.008855	0.470694	0.283944	CS pos: 20-21. SIK-CV. Pr: 0.3645    25
NZ_CP027599.1_50887	LIPO(Sec/SPII)	0.276569	0.015859	0.386703	0.320869	CS pos: ?. Probable protein fragment    15
NZ_CP027599.1_50987	LIPO(Sec/SPII)	0.109803	0.028150	0.690079	0.171968	CS pos: 15-16. VSS-CT. Pr: 0.6345    18
NZ_CP027599.1_50991	SP(Sec/SPI)	0.399746	0.031562	0.198376	0.370316	CS pos: 14-15. GLA-QQ. Pr: 0.2205    16
NZ_CP027599.1_50993	LIPO(Sec/SPII)	0.067467	0.009235	0.534305	0.388992	CS pos: 18-19. LSR-CC. Pr: 0.1331    27
NZ_CP027599.1_50996	LIPO(Sec/SPII)	0.133574	0.003314	0.700577	0.162535	CS pos: 18-19. LRA-CW. Pr: 0.6260    20
NZ_CP027599.1_51007	LIPO(Sec/SPII)	0.209552	0.010581	0.464040	0.315827	CS pos: 35-36. STA-CG. Pr: 0.4364    49
NZ_CP027599.1_51014	TAT(Tat/SPI)	0.093853	0.635588	0.047062	0.223496	CS pos: 27-28. LRA-EK. Pr: 0.4281    37
NZ_CP027599.1_51021	SP(Sec/SPI)	0.465969	0.030049	0.090205	0.413778	CS pos: 19-20. ILA-AP. Pr: 0.3660    26
NZ_CP027599.1_51035	TAT(Tat/SPI)	0.224827	0.520472	0.031303	0.223398	CS pos: 31-32. ADA-AS. Pr: 0.4260    44
NZ_CP027599.1_51083	LIPO(Sec/SPII)	0.223858	0.019143	0.420867	0.336133	CS pos: ?. Probable protein fragment    15
NZ_CP027599.1_51118	LIPO(Sec/SPII)	0.132063	0.025734	0.460133	0.382069	CS pos: 16-17. ISS-CR. Pr: 0.4222    23
NZ_CP027599.1_51133	SP(Sec/SPI)	0.374637	0.123989	0.204935	0.296439	CS pos: 21-22. SSA-SS. Pr: 0.2381    24
NZ_CP027599.1_51135	TAT(Tat/SPI)	0.115393	0.426258	0.144078	0.314272	CS pos: ?. Probable protein fragment    16
NZ_CP027599.1_51144	LIPO(Sec/SPII)	0.073929	0.132313	0.628763	0.164995	CS pos: 20-21. AGS-CD. Pr: 0.6276    40
NZ_CP027599.1_51145	LIPO(Sec/SPII)	0.180663	0.030729	0.402288	0.386319	CS pos: ?. Probable protein fragment    18
NZ_CP027599.1_51196	LIPO(Sec/SPII)	0.068770	0.004137	0.835059	0.092034	CS pos: 20-21. GYG-CT. Pr: 0.8132    32
NZ_CP027599.1_51213	SP(Sec/SPI)	0.593246	0.032306	0.032576	0.341871	CS pos: 19-20. ARG-ES. Pr: 0.4786    45
NZ_CP027599.1_51217	SP(Sec/SPI)	0.658314	0.224462	0.060057	0.057166	CS pos: 26-27. MYS-AT. Pr: 0.1868    34
NZ_CP027599.1_51231	LIPO(Sec/SPII)	0.299026	0.059752	0.328790	0.312432	CS pos: 19-20. AGA-CS. Pr: 0.2150    21
NZ_CP027599.1_51254	SP(Sec/SPI)	0.722948	0.026335	0.078443	0.172274	CS pos: 20-21. GVA-IA. Pr: 0.1808    30
NZ_CP027599.1_51264	TAT(Tat/SPI)	0.121235	0.451620	0.023245	0.403900	CS pos: 26-27. ISA-SR. Pr: 0.1998    34
NZ_CP027599.1_51280	SP(Sec/SPI)	0.950456	0.020969	0.021996	0.006579	CS pos: 21-22. VQA-EA. Pr: 0.5010    46
NZ_CP027599.1_51284	LIPO(Sec/SPII)	0.055348	0.014391	0.720653	0.209608	CS pos: 18-19. VAA-CS. Pr: 0.7128    26
NZ_CP027599.1_51335	SP(Sec/SPI)	0.502121	0.240176	0.217759	0.039945	CS pos: 21-22. VTA-TL. Pr: 0.4883    32
NZ_CP027599.1_51345	SP(Sec/SPI)	0.456355	0.029438	0.222364	0.291844	CS pos: ?. Probable protein fragment    19
NZ_CP027599.1_51349	SP(Sec/SPI)	0.487617	0.095619	0.021547	0.395216	CS pos: 29-30. ISA-EK. Pr: 0.2852    34
NZ_CP027599.1_51382	TAT(Tat/SPI)	0.153458	0.411358	0.068776	0.366409	CS pos: 31-32. AIS-GV. Pr: 0.1330    49
NZ_CP027599.1_51390	SP(Sec/SPI)	0.517897	0.175121	0.065169	0.241813	CS pos: 24-25. AFA-NN. Pr: 0.5541    46
NZ_CP027599.1_51422	LIPO(Sec/SPII)	0.134194	0.004293	0.435298	0.426215	CS pos: 23-24. KMC-CV. Pr: 0.2501    45
NZ_CP027599.1_51427	SP(Sec/SPI)	0.597426	0.033550	0.217821	0.151203	CS pos: 23-24. ASA-NL. Pr: 0.4670    32
NZ_CP027599.1_51436	LIPO(Sec/SPII)	0.109489	0.005966	0.722039	0.162507	CS pos: 24-25. ALA-CW. Pr: 0.6993    32
NZ_CP027599.1_51439	LIPO(Sec/SPII)	0.084100	0.010374	0.578836	0.326690	CS pos: 20-21. LAP-CV. Pr: 0.5291    33
NZ_CP027599.1_51456	LIPO(Sec/SPII)	0.359040	0.027264	0.385906	0.227790	CS pos: 20-21. TVA-CR. Pr: 0.2962    33
NZ_CP027599.1_51463	LIPO(Sec/SPII)	0.241106	0.107029	0.354328	0.297537	CS pos: ?. Probable protein fragment    16
NZ_CP027599.1_51468	LIPO(Sec/SPII)	0.287255	0.054715	0.425754	0.232275	CS pos: ?. Probable protein fragment    22
NZ_CP027599.1_51483	LIPO(Sec/SPII)	0.284563	0.005225	0.626904	0.083308	CS pos: 22-23. TTA-CD. Pr: 0.5872    50
NZ_CP027599.1_51487	SP(Sec/SPI)	0.419946	0.020384	0.232733	0.326937	CS pos: ?. Probable protein fragment    21
NZ_CP027599.1_51519	LIPO(Sec/SPII)	0.190646	0.018905	0.506644	0.283806	CS pos: 16-17. SES-CA. Pr: 0.4383    30
NZ_CP027599.1_51524	SP(Sec/SPI)	0.399121	0.099159	0.156049	0.345671	CS pos: 16-17. AFA-FS. Pr: 0.1470    39
NZ_CP027599.1_51545	LIPO(Sec/SPII)	0.131419	0.011464	0.464605	0.392511	CS pos: 28-29. TFS-CN. Pr: 0.4609    48
NZ_CP027599.1_51547	LIPO(Sec/SPII)	0.112640	0.030814	0.472670	0.383876	CS pos: 17-18. GTG-CA. Pr: 0.2341    46
NZ_CP027599.1_51561	SP(Sec/SPI)	0.592372	0.019355	0.232938	0.155335	CS pos: 29-30. VLA-IH. Pr: 0.4188    42
NZ_CP027599.1_51562	SP(Sec/SPI)	0.531053	0.093042	0.046388	0.329516	CS pos: 17-18. AEA-RD. Pr: 0.4963    26
NZ_CP027599.1_51567	LIPO(Sec/SPII)	0.084254	0.042976	0.473092	0.399679	CS pos: 26-27. LAG-CS. Pr: 0.4461    37
NZ_CP027599.1_51588	SP(Sec/SPI)	0.399043	0.019378	0.272129	0.309450	CS pos: ?. Probable protein fragment    20
NZ_CP027599.1_51609	LIPO(Sec/SPII)	0.067969	0.002788	0.581096	0.348147	CS pos: 24-25. PLA-CA. Pr: 0.5468    35
NZ_CP027599.1_51644	SP(Sec/SPI)	0.558063	0.091262	0.114279	0.236395	CS pos: 19-20. VSA-KP. Pr: 0.1699    50
NZ_CP027599.1_51649	LIPO(Sec/SPII)	0.204848	0.042294	0.430259	0.322600	CS pos: 28-29. STA-CS. Pr: 0.2959    37
NZ_CP027599.1_51656	LIPO(Sec/SPII)	0.352769	0.009597	0.553212	0.084422	CS pos: 22-23. VAS-CV. Pr: 0.5261    28
NZ_CP027599.1_51672	SP(Sec/SPI)	0.463538	0.046176	0.137467	0.352819	CS pos: 14-15. AFP-AS. Pr: 0.1040    25
NZ_CP027599.1_51697	LIPO(Sec/SPII)	0.075560	0.027458	0.520083	0.376899	CS pos: 17-18. HAG-CT. Pr: 0.5135    38
NZ_CP027599.1_51698	LIPO(Sec/SPII)	0.043617	0.006140	0.734440	0.215803	CS pos: 18-19. LNG-CM. Pr: 0.7226    27
NZ_CP027599.1_51726	LIPO(Sec/SPII)	0.053233	0.012250	0.894121	0.040397	CS pos: 15-16. LTS-CA. Pr: 0.8939    35
NZ_CP027599.1_51734	LIPO(Sec/SPII)	0.128298	0.006673	0.611630	0.253398	CS pos: 16-17. TKA-CS. Pr: 0.6819    35
NZ_CP027599.1_51754	LIPO(Sec/SPII)	0.143082	0.016582	0.446053	0.394283	CS pos: 19-20. FLG-CI. Pr: 0.3726    25
NZ_CP027599.1_51780	TAT(Tat/SPI)	0.113362	0.459677	0.025737	0.401224	CS pos: 25-26. TLA-HR. Pr: 0.3608    42
NZ_CP027599.1_51797	LIPO(Sec/SPII)	0.158554	0.096466	0.652206	0.092775	CS pos: 21-22. SAA-CR. Pr: 0.6483    32
NZ_CP027599.1_51800	LIPO(Sec/SPII)	0.114609	0.019801	0.817860	0.047730	CS pos: 21-22. MPS-CA. Pr: 0.7725    36
NZ_CP027599.1_51826	SP(Sec/SPI)	0.622114	0.025691	0.161122	0.191073	CS pos: 18-19. PTA-DC. Pr: 0.2038    24
NZ_CP027599.1_51873	LIPO(Sec/SPII)	0.240478	0.009179	0.398627	0.351716	CS pos: 13-14. TTV-CA. Pr: 0.2244    22
NZ_CP027599.1_51874	LIPO(Sec/SPII)	0.244958	0.015410	0.435691	0.303941	CS pos: 14-15. SLS-CS. Pr: 0.3083    23
NZ_CP027599.1_51882	SP(Sec/SPI)	0.500751	0.031001	0.250023	0.218225	CS pos: 20-21. TLP-LP. Pr: 0.1444    36
NZ_CP027599.1_51982	SP(Sec/SPI)	0.824191	0.032984	0.075637	0.067187	CS pos: 16-17. AAA-VL. Pr: 0.2802    38
NZ_CP027599.1_51987	LIPO(Sec/SPII)	0.365570	0.025336	0.490438	0.118656	CS pos: 14-15. LPS-CA. Pr: 0.3599    28
NZ_CP027599.1_52022	SP(Sec/SPI)	0.504510	0.021913	0.094846	0.378731	CS pos: 22-23. THA-YF. Pr: 0.4305    37
NZ_CP027599.1_52027	LIPO(Sec/SPII)	0.138462	0.004555	0.667344	0.189639	CS pos: 14-15. MVN-CS. Pr: 0.5664    16
NZ_CP027599.1_52036	LIPO(Sec/SPII)	0.042125	0.007892	0.872574	0.077409	CS pos: 23-24. TSA-CW. Pr: 0.8745    40
NZ_CP027599.1_52040	LIPO(Sec/SPII)	0.141036	0.017261	0.519521	0.322182	CS pos: 26-27. LIS-CS. Pr: 0.4421    29
NZ_CP027599.1_52075	LIPO(Sec/SPII)	0.250264	0.012093	0.406203	0.331440	CS pos: 13-14. ATV-CI. Pr: 0.1598    15
NZ_CP027599.1_52172	LIPO(Sec/SPII)	0.082435	0.038525	0.440637	0.438403	CS pos: 22-23. SSS-CV. Pr: 0.4092    34
NZ_CP027599.1_52183	SP(Sec/SPI)	0.600437	0.021754	0.055140	0.322670	CS pos: 17-18. AVA-RL. Pr: 0.5012    49
NZ_CP027599.1_52199	SP(Sec/SPI)	0.870488	0.061522	0.043953	0.024037	CS pos: 17-18. ASA-GT. Pr: 0.7742    28
NZ_CP027599.1_52205	SP(Sec/SPI)	0.516790	0.051798	0.140384	0.291028	CS pos: 23-24. TLS-FN. Pr: 0.2273    26
NZ_CP027599.1_52218	LIPO(Sec/SPII)	0.162451	0.030932	0.511921	0.294696	CS pos: 16-17. ICA-CS. Pr: 0.4129    19
NZ_CP027599.1_52221	SP(Sec/SPI)	0.805758	0.082780	0.031581	0.079882	CS pos: 25-26. ASA-AA. Pr: 0.4496    39
NZ_CP027599.1_52228	SP(Sec/SPI)	0.571111	0.037869	0.187223	0.203797	CS pos: 20-21. VSS-SV. Pr: 0.2925    25
NZ_CP027599.1_52263	LIPO(Sec/SPII)	0.204650	0.030199	0.490479	0.274672	CS pos: 14-15. LTT-CQ. Pr: 0.4595    34
NZ_CP027599.1_52390	LIPO(Sec/SPII)	0.356640	0.107887	0.483451	0.052022	CS pos: 19-20. AAS-CD. Pr: 0.4746    30
NZ_CP027599.1_52391	LIPO(Sec/SPII)	0.286665	0.037874	0.356192	0.319269	CS pos: ?. Probable protein fragment    16
NZ_CP027599.1_52394	TAT(Tat/SPI)	0.094884	0.429696	0.067338	0.408082	CS pos: 35-36. SSA-SL. Pr: 0.2159    50
NZ_CP027599.1_52408	LIPO(Sec/SPII)	0.268218	0.028677	0.404853	0.298252	CS pos: ?. Probable protein fragment    15
NZ_CP027599.1_52412	SP(Sec/SPI)	0.342289	0.070087	0.255316	0.332309	CS pos: 19-20. IES-SQ. Pr: 0.1122    24
NZ_CP027599.1_52417	TAT(Tat/SPI)	0.163721	0.528195	0.041164	0.266920	CS pos: 25-26. SPA-QP. Pr: 0.2629    47
NZ_CP027599.1_52425	LIPO(Sec/SPII)	0.115739	0.040236	0.680692	0.163333	CS pos: 14-15. SSA-CS. Pr: 0.6639    31
NZ_CP027599.1_52446	LIPO(Sec/SPII)	0.087037	0.023632	0.471465	0.417867	CS pos: 21-22. NTG-CI. Pr: 0.4550    32
NZ_CP027599.1_52471	LIPO(Sec/SPII)	0.369435	0.047461	0.381653	0.201451	CS pos: ?. Probable protein fragment    15
NZ_CP027599.1_52496	SP(Sec/SPI)	0.443453	0.094917	0.038133	0.423497	CS pos: 23-24. SYA-AG. Pr: 0.3318    33
NZ_CP027599.1_52514	LIPO(Sec/SPII)	0.125854	0.012479	0.690165	0.171502	CS pos: 16-17. LST-CK. Pr: 0.5491    18
NZ_CP027599.1_52521	LIPO(Sec/SPII)	0.228450	0.038795	0.375429	0.357326	CS pos: ?. Probable protein fragment    15
NZ_CP027599.1_52561	SP(Sec/SPI)	0.643395	0.015933	0.143330	0.197342	CS pos: 18-19. VPG-GP. Pr: 0.1905    36
NZ_CP027599.1_52593	SP(Sec/SPI)	0.512432	0.068594	0.091523	0.327451	CS pos: 22-23. ISA-TP. Pr: 0.3570    31
NZ_CP027599.1_52618	SP(Sec/SPI)	0.517715	0.082318	0.089171	0.310795	CS pos: 20-21. LSA-GT. Pr: 0.2843    40
NZ_CP027599.1_52637	LIPO(Sec/SPII)	0.266170	0.013585	0.387352	0.332893	CS pos: 16-17. LIS-NT. Pr: 0.0568    19
NZ_CP027599.1_52641	LIPO(Sec/SPII)	0.243189	0.001206	0.519683	0.235922	CS pos: 21-22. FGI-CH. Pr: 0.4814    46
NZ_CP027599.1_52646	SP(Sec/SPI)	0.707662	0.017225	0.080581	0.194531	CS pos: 24-25. GNA-AN. Pr: 0.5398    29
NZ_CP027599.1_52648	LIPO(Sec/SPII)	0.331125	0.030603	0.398606	0.239666	CS pos: 14-15. LLS-LP. Pr: 0.0209    16
NZ_CP027599.1_52651	LIPO(Sec/SPII)	0.039383	0.006224	0.497558	0.456835	CS pos: 21-22. SAG-CF. Pr: 0.4989    49
NZ_CP027599.1_52674	TAT(Tat/SPI)	0.267278	0.447397	0.034002	0.251323	CS pos: 27-28. IHA-KS. Pr: 0.4414    39
NZ_CP027599.1_52721	LIPO(Sec/SPII)	0.046343	0.007971	0.764326	0.181360	CS pos: 15-16. LVS-CR. Pr: 0.7519    26
NZ_CP027599.1_52735	LIPO(Sec/SPII)	0.048665	0.005517	0.555689	0.390129	CS pos: 21-22. SIS-CH. Pr: 0.5503    40
NZ_CP027599.1_52736	LIPO(Sec/SPII)	0.246405	0.006554	0.430911	0.316130	CS pos: 24-25. ISS-CL. Pr: 0.3498    32
NZ_CP027599.1_52789	LIPO(Sec/SPII)	0.158268	0.006378	0.506581	0.328772	CS pos: 12-13. VLS-CR. Pr: 0.3449    16
NZ_CP027599.1_52800	LIPO(Sec/SPII)	0.032432	0.011716	0.769272	0.186581	CS pos: 28-29. LSA-CR. Pr: 0.7426    45
NZ_CP027599.1_52812	LIPO(Sec/SPII)	0.122399	0.023566	0.639340	0.214695	CS pos: 15-16. GLG-CG. Pr: 0.5805    30
NZ_CP027599.1_52814	LIPO(Sec/SPII)	0.264562	0.028487	0.423154	0.283798	CS pos: ?. Probable protein fragment    19
NZ_CP027599.1_52829	LIPO(Sec/SPII)	0.247652	0.042345	0.380377	0.329627	CS pos: ?. Probable protein fragment    15
NZ_CP027599.1_52852	SP(Sec/SPI)	0.352553	0.023402	0.344685	0.279360	CS pos: ?. Probable protein fragment    19
NZ_CP027599.1_52939	LIPO(Sec/SPII)	0.122403	0.149086	0.376610	0.351902	CS pos: 30-31. QTA-CQ. Pr: 0.3595    48
NZ_CP027599.1_52967	LIPO(Sec/SPII)	0.156152	0.018927	0.626959	0.197961	CS pos: 16-17. LLA-CS. Pr: 0.4651    19
NZ_CP027599.1_52979	SP(Sec/SPI)	0.475582	0.031766	0.107524	0.385128	CS pos: 21-22. KWA-DG. Pr: 0.3362    23
NZ_CP027599.1_52981	LIPO(Sec/SPII)	0.316717	0.003917	0.603606	0.075759	CS pos: 13-14. GLC-CL. Pr: 0.4078    21
NZ_CP027599.1_52995	SP(Sec/SPI)	0.437998	0.254684	0.132041	0.175277	CS pos: 21-22. IWA-CP. Pr: 0.7023    26
NZ_CP027599.1_53003	LIPO(Sec/SPII)	0.112917	0.004007	0.687862	0.195214	CS pos: 16-17. MAA-CS. Pr: 0.6579    32
NZ_CP027599.1_53020	LIPO(Sec/SPII)	0.101580	0.024092	0.705197	0.169131	CS pos: 20-21. VSG-CA. Pr: 0.6555    27
NZ_CP027599.1_53023	SP(Sec/SPI)	0.418119	0.183195	0.077296	0.321389	CS pos: 24-25. IKS-AP. Pr: 0.2665    27
NZ_CP027599.1_53037	TAT(Tat/SPI)	0.284604	0.315007	0.115396	0.284994	CS pos: 28-29. ASA-RP. Pr: 0.2129    33
NZ_CP027599.1_53057	LIPO(Sec/SPII)	0.239094	0.016816	0.383138	0.360951	CS pos: 15-16. IFS-VP. Pr: 0.0206    17
NZ_CP027599.1_53077	LIPO(Sec/SPII)	0.106846	0.039114	0.701935	0.152106	CS pos: 15-16. LAG-CQ. Pr: 0.6893    26
NZ_CP027599.1_53126	LIPO(Sec/SPII)	0.148954	0.039501	0.537904	0.273641	CS pos: 14-15. LTS-CA. Pr: 0.4931    37
NZ_CP027599.1_53133	LIPO(Sec/SPII)	0.002612	0.000099	0.997113	0.000176	CS pos: 20-21. LSG-CG. Pr: 0.9975    42
NZ_CP027599.1_53203	TAT(Tat/SPI)	0.212734	0.411657	0.052469	0.323139	CS pos: 32-33. SIA-FS. Pr: 0.0795    34
NZ_CP027599.1_53216	SP(Sec/SPI)	0.520423	0.015835	0.167015	0.296726	CS pos: 20-21. VLS-NL. Pr: 0.3971    43
NZ_CP027599.1_53285	SP(Sec/SPI)	0.395890	0.009636	0.328587	0.265887	CS pos: 16-17. VRS-AI. Pr: 0.1370    18
NZ_CP027599.1_53288	SP(Sec/SPI)	0.441803	0.195344	0.102930	0.259923	CS pos: 26-27. VPA-DP. Pr: 0.1012    46
NZ_CP027599.1_53291	LIPO(Sec/SPII)	0.215514	0.025621	0.480367	0.278498	CS pos: 16-17. YPT-CF. Pr: 0.0850    18
NZ_CP027599.1_53356	LIPO(Sec/SPII)	0.017818	0.060369	0.796450	0.125363	CS pos: 22-23. GTG-CA. Pr: 0.7978    50
NZ_CP027599.1_53364	SP(Sec/SPI)	0.489596	0.042990	0.039241	0.428174	CS pos: 25-26. TQA-WQ. Pr: 0.2136    41
NZ_CP027599.1_53385	SP(Sec/SPI)	0.437855	0.011876	0.183901	0.366368	CS pos: 17-18. AYP-GL. Pr: 0.1821    21
NZ_CP027599.1_53402	TAT(Tat/SPI)	0.188518	0.461114	0.035925	0.314444	CS pos: 21-22. SLS-DL. Pr: 0.0453    23
NZ_CP027599.1_53445	LIPO(Sec/SPII)	0.075744	0.002844	0.874870	0.046543	CS pos: 19-20. FLQ-CK. Pr: 0.8615    33
NZ_CP027599.1_53480	SP(Sec/SPI)	0.794635	0.010516	0.053125	0.141725	CS pos: 23-24. MNA-GN. Pr: 0.6044    43
NZ_CP027599.1_53486	SP(Sec/SPI)	0.470662	0.003806	0.267847	0.257685	CS pos: 17-18. VDS-HY. Pr: 0.2826    36
NZ_CP027599.1_53494	SP(Sec/SPI)	0.608918	0.031326	0.053986	0.305770	CS pos: 23-24. TLA-AG. Pr: 0.4057    37
NZ_CP027599.1_53575	LIPO(Sec/SPII)	0.039505	0.005929	0.821781	0.132785	CS pos: 18-19. AAA-CY. Pr: 0.8183    30
NZ_CP027599.1_53577	LIPO(Sec/SPII)	0.060629	0.005719	0.470797	0.462854	CS pos: 17-18. IAA-CL. Pr: 0.4651    28
NZ_CP027599.1_53620	LIPO(Sec/SPII)	0.154719	0.154138	0.661910	0.029234	CS pos: 26-27. IAA-CC. Pr: 0.6222    34
NZ_CP027599.1_53625	SP(Sec/SPI)	0.636187	0.007813	0.058617	0.297383	CS pos: 19-20. VDA-AD. Pr: 0.5879    30
NZ_CP027599.1_53628	SP(Sec/SPI)	0.873396	0.035477	0.067162	0.023964	CS pos: 18-19. SPA-AP. Pr: 0.5791    42
NZ_CP027599.1_53653	SP(Sec/SPI)	0.369893	0.044643	0.243526	0.341938	CS pos: 22-23. RLA-AP. Pr: 0.0435    38
NZ_CP027599.1_53678	LIPO(Sec/SPII)	0.112347	0.010028	0.471810	0.405815	CS pos: 20-21. FCG-CT. Pr: 0.4336    26
NZ_CP027599.1_53685	TAT(Tat/SPI)	0.221072	0.299462	0.197554	0.281912	CS pos: 28-29. RGA-DV. Pr: 0.1648    44
NZ_CP027599.1_53710	TAT(Tat/SPI)	0.192810	0.370286	0.087090	0.349814	CS pos: 40-41. ARA-VP. Pr: 0.2190    44
NZ_CP027599.1_53717	LIPO(Sec/SPII)	0.254345	0.063855	0.341623	0.340177	CS pos: 14-15. GAA-CG. Pr: 0.0992    20
NZ_CP027599.1_53732	TAT(Tat/SPI)	0.092042	0.646417	0.026711	0.234831	CS pos: 25-26. RNA-FN. Pr: 0.2453    49
NZ_CP027599.1_53736	LIPO(Sec/SPII)	0.096109	0.128825	0.477888	0.297177	CS pos: 23-24. LAS-CA. Pr: 0.4073    34
NZ_CP027599.1_53751	LIPO(Sec/SPII)	0.268706	0.013475	0.371947	0.345873	CS pos: 15-16. LMC-CL. Pr: 0.1139    18
NZ_CP027599.1_53770	LIPO(Sec/SPII)	0.268876	0.110525	0.345386	0.275213	CS pos: 17-18. VSG-SL. Pr: 0.2305    27
NZ_CP027599.1_53776	TAT(Tat/SPI)	0.115762	0.627852	0.064396	0.191989	CS pos: 21-22. LDG-GP. Pr: 0.1446    42
NZ_CP027599.1_53779	LIPO(Sec/SPII)	0.077000	0.005843	0.691968	0.225189	CS pos: 16-17. LPA-CY. Pr: 0.6746    29
NZ_CP027599.1_53795	SP(Sec/SPI)	0.402550	0.060065	0.173796	0.363588	CS pos: 21-22. VIS-VP. Pr: 0.0842    30
NZ_CP027599.1_53802	LIPO(Sec/SPII)	0.334421	0.041320	0.363056	0.261202	CS pos: 17-18. SPC-CW. Pr: 0.1719    27
NZ_CP027599.1_53815	LIPO(Sec/SPII)	0.018812	0.002655	0.818793	0.159740	CS pos: 21-22. ISG-CE. Pr: 0.8248    33
NZ_CP027599.1_53819	LIPO(Sec/SPII)	0.184776	0.008027	0.589403	0.217795	CS pos: 18-19. SST-CK. Pr: 0.4661    23
NZ_CP027599.1_53900	LIPO(Sec/SPII)	0.016030	0.000556	0.659875	0.323539	CS pos: 27-28. FVG-CW. Pr: 0.6463    37
NZ_CP027599.1_53983	SP(Sec/SPI)	0.761489	0.044946	0.036949	0.156615	CS pos: 30-31. VKA-DL. Pr: 0.7488    33
NZ_CP027599.1_54007	LIPO(Sec/SPII)	0.137363	0.009316	0.845294	0.008028	CS pos: 17-18. ATA-CS. Pr: 0.8461    42
NZ_CP027599.1_54020	LIPO(Sec/SPII)	0.333466	0.009175	0.474303	0.183056	CS pos: ?. Probable protein fragment    16
NZ_CP027599.1_54040	LIPO(Sec/SPII)	0.115859	0.019541	0.695055	0.169546	CS pos: 12-13. FQA-CF. Pr: 0.5699    15
NZ_CP027599.1_54054	TAT(Tat/SPI)	0.159196	0.343849	0.169963	0.326992	CS pos: ?. Probable protein fragment    15
NZ_CP027599.1_54075	SP(Sec/SPI)	0.463614	0.030037	0.154345	0.352004	CS pos: 18-19. ATR-EH. Pr: 0.1037    31
NZ_CP027599.1_54088	SP(Sec/SPI)	0.444590	0.081451	0.118329	0.355630	CS pos: 22-23. AAA-HQ. Pr: 0.2030    27
NZ_CP027599.1_54133	SP(Sec/SPI)	0.521633	0.015766	0.385080	0.077521	CS pos: 25-26. IMA-MP. Pr: 0.3997    31
NZ_CP027599.1_54190	LIPO(Sec/SPII)	0.244914	0.026853	0.558163	0.170070	CS pos: 25-26. LTS-CH. Pr: 0.5362    37
NZ_CP027599.1_54419	SP(Sec/SPI)	0.430473	0.122653	0.087289	0.359585	CS pos: 12-13. SFA-AN. Pr: 0.2593    24
NZ_CP027599.1_54519	SP(Sec/SPI)	0.437645	0.103374	0.103618	0.355364	CS pos: 17-18. ASA-MN. Pr: 0.3836    24
NZ_CP027599.1_54532	TAT(Tat/SPI)	0.115698	0.378968	0.216051	0.289283	CS pos: ?. Probable protein fragment    43
NZ_CP027599.1_54554	LIPO(Sec/SPII)	0.092081	0.008557	0.486898	0.412465	CS pos: 15-16. VTG-CA. Pr: 0.4495    32
NZ_CP027599.1_54565	SP(Sec/SPI)	0.449673	0.037681	0.086566	0.426080	CS pos: 15-16. VLA-TG. Pr: 0.2950    25
NZ_CP027599.1_54568	SP(Sec/SPI)	0.501854	0.036797	0.142904	0.318445	CS pos: 20-21. ALS-MV. Pr: 0.3461    23
NZ_CP027599.1_54587	LIPO(Sec/SPII)	0.086759	0.028615	0.534968	0.349659	CS pos: 19-20. GMP-CT. Pr: 0.4807    32
NZ_CP027599.1_54588	SP(Sec/SPI)	0.428870	0.016482	0.187559	0.367089	CS pos: 22-23. VLS-RP. Pr: 0.2459    26
NZ_CP027599.1_54616	LIPO(Sec/SPII)	0.151297	0.006846	0.634157	0.207700	CS pos: 14-15. VSP-CF. Pr: 0.5542    18
NZ_CP027599.1_54628	SP(Sec/SPI)	0.546327	0.023050	0.028701	0.401922	CS pos: 21-22. TSA-EV. Pr: 0.3205    39
NZ_CP027599.1_54658	SP(Sec/SPI)	0.447522	0.029284	0.248471	0.274723	CS pos: 16-17. ASS-DE. Pr: 0.1797    18
NZ_CP027599.1_54732	SP(Sec/SPI)	0.395284	0.061100	0.154036	0.389580	CS pos: 29-30. GYA-LI. Pr: 0.2026    37
NZ_CP027599.1_54763	LIPO(Sec/SPII)	0.204936	0.116608	0.390851	0.287604	CS pos: 12-13. STC-CI. Pr: 0.0830    15
NZ_CP027599.1_54781	SP(Sec/SPI)	0.415308	0.049420	0.187254	0.348017	CS pos: ?. Probable protein fragment    21
NZ_CP027599.1_54805	TAT(Tat/SPI)	0.203443	0.486520	0.059677	0.250360	CS pos: 29-30. TTA-TQ. Pr: 0.0801    39
NZ_CP027599.1_54828	LIPO(Sec/SPII)	0.264171	0.093489	0.574245	0.068095	CS pos: 30-31. VTC-CH. Pr: 0.3468    45
NZ_CP027599.1_54847	LIPO(Sec/SPII)	0.197547	0.065827	0.370754	0.365872	CS pos: ?. Probable protein fragment    16
NZ_CP027599.1_54860	LIPO(Sec/SPII)	0.282674	0.050838	0.427943	0.238546	CS pos: 20-21. LTS-SG. Pr: 0.2840    40
NZ_CP027599.1_54874	SP(Sec/SPI)	0.484185	0.050986	0.046434	0.418395	CS pos: 28-29. SAA-QY. Pr: 0.4418    32
NZ_CP027599.1_54889	SP(Sec/SPI)	0.525591	0.034889	0.141674	0.297846	CS pos: 16-17. VYS-AS. Pr: 0.4265    47
NZ_CP027599.1_54905	LIPO(Sec/SPII)	0.246201	0.046042	0.447012	0.260745	CS pos: ?. Probable protein fragment    15
NZ_CP027599.1_54911	LIPO(Sec/SPII)	0.062543	0.004030	0.854981	0.078445	CS pos: 18-19. FCA-CT. Pr: 0.8326    25
NZ_CP027599.1_54955	LIPO(Sec/SPII)	0.205147	0.019626	0.637133	0.138094	CS pos: 21-22. ASA-CC. Pr: 0.6745    29
NZ_CP027599.1_54980	LIPO(Sec/SPII)	0.280659	0.024303	0.351442	0.343596	CS pos: ?. Probable protein fragment    16
NZ_CP027599.1_55032	SP(Sec/SPI)	0.426535	0.190274	0.090837	0.292354	CS pos: 21-22. SRS-AP. Pr: 0.2596    45
NZ_CP027599.1_55051	SP(Sec/SPI)	0.381490	0.033133	0.376595	0.208781	CS pos: 14-15. ASA-SH. Pr: 0.0754    16
NZ_CP027599.1_55072	TAT(Tat/SPI)	0.068792	0.463728	0.439882	0.027598	CS pos: 26-27. CSA-AG. Pr: 0.0859    40
NZ_CP027599.1_55111	SP(Sec/SPI)	0.828052	0.022384	0.146408	0.003157	CS pos: 18-19. AAA-TT. Pr: 0.4095    32
NZ_CP027599.1_55170	LIPO(Sec/SPII)	0.276191	0.007034	0.371676	0.345099	CS pos: ?. Probable protein fragment    17
NZ_CP027599.1_55227	LIPO(Sec/SPII)	0.133092	0.022378	0.707768	0.136762	CS pos: 18-19. FTT-CL. Pr: 0.6827    47
NZ_CP027599.1_55243	SP(Sec/SPI)	0.341049	0.338158	0.044150	0.276643	CS pos: 17-18. SKA-FS. Pr: 0.2128    32
NZ_CP027599.1_55252	TAT(Tat/SPI)	0.333721	0.434167	0.020810	0.211301	CS pos: 41-42. PSA-LP. Pr: 0.2183    50
NZ_CP027599.1_55260	SP(Sec/SPI)	0.535699	0.049047	0.188960	0.226293	CS pos: 24-25. AAP-AS. Pr: 0.1401    36
NZ_CP027599.1_55275	SP(Sec/SPI)	0.829043	0.058799	0.068396	0.043762	CS pos: 24-25. VYS-AP. Pr: 0.7804    28
NZ_CP027599.1_55280	SP(Sec/SPI)	0.543702	0.050580	0.061894	0.343824	CS pos: 21-22. SHG-QP. Pr: 0.4044    36
NZ_CP027599.1_55284	SP(Sec/SPI)	0.563510	0.056255	0.168118	0.212117	CS pos: 16-17. TRA-AV. Pr: 0.3473    45
NZ_CP027599.1_55305	SP(Sec/SPI)	0.324436	0.130952	0.236588	0.308024	CS pos: 19-20. SLA-AS. Pr: 0.0846    27
NZ_CP027599.1_55308	TAT(Tat/SPI)	0.236798	0.521981	0.039886	0.201335	CS pos: ?. Probable protein fragment    41
NZ_CP027599.1_55331	TAT(Tat/SPI)	0.195069	0.348977	0.165874	0.290080	CS pos: 20-21. ASS-QD. Pr: 0.1165    26
NZ_CP027599.1_55338	TAT(Tat/SPI)	0.139264	0.643045	0.029623	0.188067	CS pos: 32-33. FHA-RN. Pr: 0.3705    43
NZ_CP027599.1_55340	LIPO(Sec/SPII)	0.038750	0.014900	0.578065	0.368286	CS pos: 27-28. FFS-CH. Pr: 0.5621    45
NZ_CP027599.1_55341	LIPO(Sec/SPII)	0.079259	0.299821	0.503559	0.117361	CS pos: 27-28. FST-CS. Pr: 0.4496    48
NZ_CP027599.1_55407	LIPO(Sec/SPII)	0.194949	0.065338	0.398667	0.341047	CS pos: 13-14. ITS-CY. Pr: 0.2627    15
NZ_CP027599.1_55474	LIPO(Sec/SPII)	0.078078	0.007951	0.649478	0.264493	CS pos: 19-20. VSA-CL. Pr: 0.5517    26
NZ_CP027599.1_55506	LIPO(Sec/SPII)	0.105254	0.002606	0.546381	0.345758	CS pos: 20-21. CCP-CP. Pr: 0.2787    38
NZ_CP027599.1_55535	LIPO(Sec/SPII)	0.244447	0.073225	0.390644	0.291684	CS pos: 37-38. GAS-CS. Pr: 0.3339    40
NZ_CP027599.1_55540	TAT(Tat/SPI)	0.134997	0.531079	0.031506	0.302418	CS pos: 28-29. AVA-RD. Pr: 0.4546    44
NZ_CP027599.1_55542	SP(Sec/SPI)	0.436729	0.008913	0.211977	0.342380	CS pos: ?. Probable protein fragment    19
NZ_CP027599.1_55546	LIPO(Sec/SPII)	0.131253	0.059883	0.657979	0.150885	CS pos: 20-21. WCS-CL. Pr: 0.6116    34
NZ_CP027599.1_55550	SP(Sec/SPI)	0.484610	0.059183	0.043673	0.412535	CS pos: 14-15. SIA-SD. Pr: 0.3672    38
NZ_CP027599.1_55559	SP(Sec/SPI)	0.629458	0.015681	0.065041	0.289820	CS pos: 23-24. ALS-AL. Pr: 0.2665    39
NZ_CP027599.1_55593	LIPO(Sec/SPII)	0.162915	0.025637	0.795036	0.016412	CS pos: 25-26. ASG-CS. Pr: 0.7077    44
NZ_CP027599.1_55603	SP(Sec/SPI)	0.437825	0.108207	0.108572	0.345396	CS pos: 15-16. IPA-TP. Pr: 0.1542    50
NZ_CP027599.1_55618	SP(Sec/SPI)	0.424583	0.088038	0.147837	0.339542	CS pos: 19-20. VSP-SQ. Pr: 0.1059    28
NZ_CP027599.1_55628	SP(Sec/SPI)	0.668502	0.024728	0.084008	0.222761	CS pos: 26-27. ARA-AH. Pr: 0.5867    28
NZ_CP027599.1_55631	SP(Sec/SPI)	0.552411	0.011876	0.321637	0.114076	CS pos: 26-27. CRA-TT. Pr: 0.1845    37
NZ_CP027599.1_55647	LIPO(Sec/SPII)	0.097782	0.007980	0.645899	0.248339	CS pos: 18-19. VFT-CK. Pr: 0.5838    22
NZ_CP027599.1_55673	SP(Sec/SPI)	0.416289	0.002890	0.284064	0.296758	CS pos: 21-22. CIS-VR. Pr: 0.1075    24
NZ_CP027599.1_55682	SP(Sec/SPI)	0.569546	0.010777	0.058642	0.361036	CS pos: 20-21. VHS-GL. Pr: 0.4857    46
NZ_CP027599.1_55702	LIPO(Sec/SPII)	0.113023	0.000739	0.705765	0.180473	CS pos: 14-15. WTC-CK. Pr: 0.5897    39
NZ_CP027599.1_55768	LIPO(Sec/SPII)	0.198373	0.004431	0.766020	0.031176	CS pos: 19-20. LCI-CA. Pr: 0.6775    47
NZ_CP027599.1_55772	SP(Sec/SPI)	0.376616	0.017557	0.273239	0.332588	CS pos: ?. Probable protein fragment    19
NZ_CP027599.1_55776	TAT(Tat/SPI)	0.150362	0.626926	0.061491	0.161220	CS pos: ?. Probable protein fragment    26
NZ_CP027599.1_55784	SP(Sec/SPI)	0.795954	0.062683	0.048874	0.092489	CS pos: 16-17. SYA-LN. Pr: 0.7115    37
NZ_CP027599.1_55789	LIPO(Sec/SPII)	0.240243	0.022011	0.374887	0.362859	CS pos: ?. Probable protein fragment    18
NZ_CP027599.1_55819	LIPO(Sec/SPII)	0.068186	0.016096	0.789518	0.126200	CS pos: 14-15. FVA-CP. Pr: 0.7740    25
NZ_CP027599.1_55843	LIPO(Sec/SPII)	0.219519	0.007732	0.760049	0.012700	CS pos: 19-20. QAS-CD. Pr: 0.7470    26
NZ_CP027599.1_55846	SP(Sec/SPI)	0.620287	0.010584	0.318689	0.050440	CS pos: ?. Probable protein fragment    22
NZ_CP027599.1_55856	LIPO(Sec/SPII)	0.186793	0.013780	0.473395	0.326033	CS pos: ?. Probable protein fragment    19
NZ_CP027599.1_55875	SP(Sec/SPI)	0.546386	0.017863	0.109550	0.326201	CS pos: 16-17. VNA-MQ. Pr: 0.3928    25
NZ_CP027599.1_55903	LIPO(Sec/SPII)	0.011023	0.000472	0.951882	0.036622	CS pos: 30-31. VTG-CT. Pr: 0.9507    43
NZ_CP027599.1_55943	LIPO(Sec/SPII)	0.137404	0.020722	0.556964	0.284910	CS pos: 14-15. LST-CA. Pr: 0.4634    22
NZ_CP027599.1_55953	SP(Sec/SPI)	0.465881	0.131983	0.305189	0.096946	CS pos: 23-24. VWC-IR. Pr: 0.3399    47
NZ_CP027599.1_55954	SP(Sec/SPI)	0.474697	0.070240	0.062553	0.392511	CS pos: 34-35. VDA-AE. Pr: 0.3684    39
NZ_CP027599.1_55967	LIPO(Sec/SPII)	0.321160	0.036052	0.401341	0.241448	CS pos: ?. Probable protein fragment    15
NZ_CP027599.1_55989	SP(Sec/SPI)	0.540392	0.052940	0.039673	0.366996	CS pos: 21-22. GWE-AT. Pr: 0.2254    41
NZ_CP027599.1_55996	LIPO(Sec/SPII)	0.333557	0.036234	0.493669	0.136540	CS pos: 34-35. STG-CS. Pr: 0.3977    40
NZ_CP027599.1_56007	SP(Sec/SPI)	0.478936	0.076351	0.056099	0.388615	CS pos: 15-16. PHA-SL. Pr: 0.1460    43
NZ_CP027599.1_56042	SP(Sec/SPI)	0.357954	0.074069	0.336253	0.231724	CS pos: 17-18. SFA-SR. Pr: 0.1474    34
NZ_CP027599.1_56043	LIPO(Sec/SPII)	0.273468	0.038132	0.639900	0.048500	CS pos: 25-26. TAG-CL. Pr: 0.5914    34
NZ_CP027599.1_56048	LIPO(Sec/SPII)	0.348154	0.036707	0.415945	0.199194	CS pos: 13-14. ITS-CL. Pr: 0.3349    33
NZ_CP027599.1_56054	SP(Sec/SPI)	0.344263	0.050208	0.315220	0.290309	CS pos: ?. Probable protein fragment    16
NZ_CP027599.1_56100	SP(Sec/SPI)	0.490496	0.008376	0.300637	0.200492	CS pos: 23-24. PSA-QK. Pr: 0.1648    35
NZ_CP027599.1_56117	LIPO(Sec/SPII)	0.221211	0.043162	0.377499	0.358128	CS pos: ?. Probable protein fragment    18
NZ_CP027599.1_56162	LIPO(Sec/SPII)	0.084471	0.008968	0.642750	0.263812	CS pos: 18-19. LLS-CA. Pr: 0.5998    37
NZ_CP027599.1_56174	SP(Sec/SPI)	0.526084	0.022551	0.100493	0.350872	CS pos: 17-18. VSG-GT. Pr: 0.3062    25
NZ_CP027599.1_56202	LIPO(Sec/SPII)	0.194134	0.006238	0.541154	0.258474	CS pos: 16-17. LYP-CC. Pr: 0.3246    20
NZ_CP027599.1_56218	SP(Sec/SPI)	0.422655	0.009494	0.370925	0.196927	CS pos: 17-18. VAS-NE. Pr: 0.2597    36
NZ_CP027599.1_56225	LIPO(Sec/SPII)	0.100975	0.021081	0.705139	0.172805	CS pos: 20-21. LSG-CL. Pr: 0.3789    36
NZ_CP027599.1_56226	SP(Sec/SPI)	0.839267	0.011012	0.048522	0.101199	CS pos: 20-21. TGA-NP. Pr: 0.4420    50
NZ_CP027599.1_56234	SP(Sec/SPI)	0.531903	0.024300	0.119373	0.324424	CS pos: 21-22. SPA-KR. Pr: 0.1193    26
NZ_CP027599.1_56250	LIPO(Sec/SPII)	0.264529	0.014237	0.560404	0.160830	CS pos: 13-14. AHQ-CT. Pr: 0.2502    15
NZ_CP027599.1_56258	SP(Sec/SPI)	0.683432	0.059858	0.004445	0.252264	CS pos: 17-18. AHA-DE. Pr: 0.7185    44
NZ_CP027599.1_56282	LIPO(Sec/SPII)	0.235397	0.080816	0.358768	0.325020	CS pos: ?. Probable protein fragment    18
NZ_CP027599.1_56285	LIPO(Sec/SPII)	0.235551	0.040563	0.371076	0.352811	CS pos: 14-15. CPG-CR. Pr: 0.1027    17
NZ_CP027599.1_56288	LIPO(Sec/SPII)	0.145660	0.108805	0.392227	0.353309	CS pos: 18-19. FTA-CT. Pr: 0.3286    25
NZ_CP027599.1_56300	LIPO(Sec/SPII)	0.142979	0.019542	0.449106	0.388372	CS pos: 19-20. IAG-GN. Pr: 0.2315    26
NZ_CP027599.1_56342	LIPO(Sec/SPII)	0.324039	0.022694	0.475322	0.177945	CS pos: 23-24. SAN-CN. Pr: 0.2524    47
NZ_CP027599.1_56353	LIPO(Sec/SPII)	0.315416	0.018048	0.364293	0.302243	CS pos: 12-13. TVF-CA. Pr: 0.2091    26
NZ_CP027599.1_56413	LIPO(Sec/SPII)	0.185590	0.055517	0.389577	0.369316	CS pos: 22-23. CLW-CS. Pr: 0.0215    24
NZ_CP027599.1_56436	LIPO(Sec/SPII)	0.212358	0.056928	0.548411	0.182304	CS pos: 12-13. CVS-CS. Pr: 0.4850    41
NZ_CP027599.1_56437	LIPO(Sec/SPII)	0.282878	0.013504	0.359498	0.344121	CS pos: ?. Probable protein fragment    21
NZ_CP027599.1_56457	LIPO(Sec/SPII)	0.052739	0.015027	0.495668	0.436566	CS pos: 27-28. ISS-CR. Pr: 0.4793    36
NZ_CP027599.1_56508	SP(Sec/SPI)	0.441813	0.213536	0.052106	0.292545	CS pos: 27-28. AMA-GS. Pr: 0.4966    46
NZ_CP027599.1_56514	LIPO(Sec/SPII)	0.156263	0.100792	0.458660	0.284286	CS pos: 13-14. SGS-CG. Pr: 0.3898    23
NZ_CP027599.1_56530	TAT(Tat/SPI)	0.160434	0.526941	0.076320	0.236304	CS pos: 28-29. LSA-RT. Pr: 0.0834    48
NZ_CP027599.1_56538	SP(Sec/SPI)	0.674916	0.042886	0.148188	0.134010	CS pos: 20-21. TLS-SN. Pr: 0.3187    30
NZ_CP027599.1_56543	SP(Sec/SPI)	0.465296	0.099523	0.043045	0.392136	CS pos: 12-13. AHA-AS. Pr: 0.3494    36
NZ_CP027599.1_56549	TAT(Tat/SPI)	0.269064	0.512730	0.044615	0.173591	CS pos: 19-20. ARA-SF. Pr: 0.3241    48
NZ_CP027599.1_56550	SP(Sec/SPI)	0.350803	0.088092	0.234511	0.326594	CS pos: 17-18. SRA-IS. Pr: 0.1467    29
NZ_CP027599.1_56557	TAT(Tat/SPI)	0.158413	0.422064	0.075035	0.344488	CS pos: 29-30. TRA-WR. Pr: 0.3067    49
NZ_CP027599.1_56568	TAT(Tat/SPI)	0.077740	0.504165	0.054587	0.363507	CS pos: 25-26. VSS-SS. Pr: 0.1242    45
NZ_CP027599.1_56573	LIPO(Sec/SPII)	0.205367	0.026477	0.418168	0.349988	CS pos: 13-14. TCA-CT. Pr: 0.2662    18
NZ_CP027599.1_56574	LIPO(Sec/SPII)	0.148893	0.069965	0.459131	0.322011	CS pos: 15-16. KSA-CA. Pr: 0.3833    23
NZ_CP027599.1_56585	LIPO(Sec/SPII)	0.169994	0.059707	0.402728	0.367571	CS pos: 14-15. IPA-CT. Pr: 0.2512    16
NZ_CP027599.1_56589	LIPO(Sec/SPII)	0.140440	0.016932	0.768352	0.074277	CS pos: 18-19. SAA-CF. Pr: 0.7621    34
NZ_CP027599.1_56591	TAT(Tat/SPI)	0.135100	0.497598	0.084418	0.282884	CS pos: 19-20. ASS-TR. Pr: 0.1754    49
NZ_CP027599.1_56615	TAT(Tat/SPI)	0.207430	0.416088	0.168388	0.208094	CS pos: 23-24. VRA-GA. Pr: 0.2933    50
NZ_CP027599.1_56619	LIPO(Sec/SPII)	0.135524	0.016042	0.680582	0.167852	CS pos: 12-13. FPG-CH. Pr: 0.6375    25
NZ_CP027599.1_56628	SP(Sec/SPI)	0.447081	0.048080	0.285644	0.219194	CS pos: 24-25. LNA-HF. Pr: 0.2233    37
NZ_CP027599.1_56640	SP(Sec/SPI)	0.375482	0.110070	0.271746	0.242702	CS pos: 18-19. ASS-RN. Pr: 0.1282    21
NZ_CP027599.1_56643	LIPO(Sec/SPII)	0.038111	0.003066	0.889745	0.069078	CS pos: 14-15. MPS-CN. Pr: 0.8837    48
NZ_CP027599.1_56649	LIPO(Sec/SPII)	0.099590	0.063848	0.740562	0.096000	CS pos: 25-26. ASV-CE. Pr: 0.7096    44
NZ_CP027599.1_56656	LIPO(Sec/SPII)	0.115296	0.023374	0.580220	0.281110	CS pos: 21-22. VSI-CS. Pr: 0.5468    38
NZ_CP027599.1_56662	SP(Sec/SPI)	0.577510	0.075084	0.088320	0.259085	CS pos: 15-16. AHA-LA. Pr: 0.2411    32
NZ_CP027599.1_56665	LIPO(Sec/SPII)	0.266398	0.023231	0.371024	0.339348	CS pos: 14-15. TSG-CC. Pr: 0.3005    37
NZ_CP027599.1_56675	LIPO(Sec/SPII)	0.114857	0.016594	0.710081	0.158469	CS pos: 16-17. AHG-CT. Pr: 0.6808    27
NZ_CP027599.1_56708	LIPO(Sec/SPII)	0.210717	0.012729	0.404091	0.372464	CS pos: ?. Probable protein fragment    21
NZ_CP027599.1_56714	LIPO(Sec/SPII)	0.302148	0.070233	0.493233	0.134386	CS pos: 19-20. IIS-CC. Pr: 0.4275    33
NZ_CP027599.1_56728	SP(Sec/SPI)	0.769060	0.029816	0.018182	0.182943	CS pos: 20-21. VHA-GY. Pr: 0.7668    26
NZ_CP027599.1_56732	LIPO(Sec/SPII)	0.093904	0.021642	0.517749	0.366705	CS pos: 17-18. QTA-CG. Pr: 0.4870    38
NZ_CP027599.1_56734	LIPO(Sec/SPII)	0.093107	0.017160	0.461569	0.428164	CS pos: 13-14. AVS-CS. Pr: 0.4552    26
NZ_CP027599.1_56735	LIPO(Sec/SPII)	0.099315	0.009286	0.858180	0.033220	CS pos: 14-15. IAS-CV. Pr: 0.8570    44
NZ_CP027599.1_56755	LIPO(Sec/SPII)	0.208031	0.020400	0.518650	0.252918	CS pos: 14-15. MPS-CR. Pr: 0.3576    20
NZ_CP027599.1_56786	LIPO(Sec/SPII)	0.297396	0.011544	0.427239	0.263822	CS pos: ?. Probable protein fragment    16
NZ_CP027599.1_56792	SP(Sec/SPI)	0.523216	0.007310	0.040343	0.429131	CS pos: 23-24. QWS-SP. Pr: 0.2845    35
NZ_CP027599.1_56810	LIPO(Sec/SPII)	0.281224	0.046833	0.342337	0.329606	CS pos: ?. Probable protein fragment    15
NZ_CP027599.1_56865	LIPO(Sec/SPII)	0.070828	0.007668	0.636326	0.285178	CS pos: 19-20. CVS-CW. Pr: 0.5578    38
NZ_CP027599.1_56872	LIPO(Sec/SPII)	0.178459	0.158544	0.333524	0.329474	CS pos: ?. Probable protein fragment    16
NZ_CP027599.1_56880	LIPO(Sec/SPII)	0.231116	0.010363	0.603659	0.154862	CS pos: 25-26. SQT-CL. Pr: 0.4467    27
NZ_CP027599.1_56883	LIPO(Sec/SPII)	0.319557	0.016543	0.416811	0.247089	CS pos: 12-13. AVV-CW. Pr: 0.0396    16
NZ_CP027599.1_56885	LIPO(Sec/SPII)	0.119470	0.027682	0.492152	0.360696	CS pos: 15-16. ING-CR. Pr: 0.4182    20
NZ_CP027599.1_56890	SP(Sec/SPI)	0.357548	0.289284	0.035161	0.318007	CS pos: 30-31. TLA-TS. Pr: 0.5110    47
NZ_CP027599.1_56895	LIPO(Sec/SPII)	0.275011	0.038405	0.386340	0.300245	CS pos: 20-21. ALR-CT. Pr: 0.3291    26
NZ_CP027599.1_56907	LIPO(Sec/SPII)	0.264380	0.044940	0.366322	0.324358	CS pos: ?. Probable protein fragment    15
NZ_CP027599.1_56926	LIPO(Sec/SPII)	0.225299	0.033112	0.506481	0.235109	CS pos: 16-17. LNL-CN. Pr: 0.2199    18
NZ_CP027599.1_57020	SP(Sec/SPI)	0.610048	0.064967	0.036026	0.288959	CS pos: 16-17. AKA-AR. Pr: 0.5399    37
NZ_CP027599.1_57047	TAT(Tat/SPI)	0.132786	0.451444	0.092893	0.322877	CS pos: 20-21. AFS-AL. Pr: 0.0809    42
NZ_CP027599.1_57066	LIPO(Sec/SPII)	0.247003	0.024744	0.368143	0.360110	CS pos: ?. Probable protein fragment    15
NZ_CP027599.1_57080	SP(Sec/SPI)	0.531573	0.127539	0.059848	0.281040	CS pos: 20-21. SRA-SL. Pr: 0.1862    50
NZ_CP027599.1_57109	LIPO(Sec/SPII)	0.220451	0.029694	0.473552	0.276302	CS pos: ?. Probable protein fragment    18
NZ_CP027599.1_57156	LIPO(Sec/SPII)	0.188147	0.025470	0.395485	0.390898	CS pos: ?. Probable protein fragment    15
NZ_CP027599.1_57163	LIPO(Sec/SPII)	0.277797	0.024381	0.590778	0.107044	CS pos: 19-20. TTG-CC. Pr: 0.5419    32
NZ_CP027599.1_57165	LIPO(Sec/SPII)	0.209901	0.011906	0.459708	0.318484	CS pos: 19-20. TAG-CA. Pr: 0.3714    27
NZ_CP027599.1_57179	SP(Sec/SPI)	0.873797	0.025837	0.034564	0.065802	CS pos: 22-23. TTA-DN. Pr: 0.8072    50
NZ_CP027599.1_57194	SP(Sec/SPI)	0.330733	0.030954	0.323945	0.314367	CS pos: 32-33. LLS-DP. Pr: 0.1743    50
NZ_CP027599.1_57214	LIPO(Sec/SPII)	0.207586	0.015843	0.459598	0.316973	CS pos: 20-21. TLL-CK. Pr: 0.1543    22
NZ_CP027599.1_57217	SP(Sec/SPI)	0.407424	0.091105	0.132109	0.369361	CS pos: 18-19. AVA-DC. Pr: 0.2522    26
NZ_CP027599.1_57219	SP(Sec/SPI)	0.503191	0.026322	0.071238	0.399249	CS pos: 19-20. VYG-AG. Pr: 0.1305    28
NZ_CP027599.1_57239	TAT(Tat/SPI)	0.066798	0.665814	0.019687	0.247701	CS pos: 33-34. TGA-LS. Pr: 0.1692    47
NZ_CP027599.1_57246	SP(Sec/SPI)	0.389319	0.031181	0.244330	0.335169	CS pos: ?. Probable protein fragment    17
NZ_CP027599.1_57281	LIPO(Sec/SPII)	0.277993	0.015891	0.361312	0.344805	CS pos: 19-20. APR-CH. Pr: 0.2254    22
NZ_CP027599.1_57298	SP(Sec/SPI)	0.413492	0.049767	0.288818	0.247923	CS pos: 17-18. SMA-LS. Pr: 0.0797    19
NZ_CP027599.1_57302	SP(Sec/SPI)	0.466571	0.075580	0.166091	0.291758	CS pos: ?. Probable protein fragment    19
NZ_CP027599.1_57344	LIPO(Sec/SPII)	0.153412	0.096572	0.412839	0.337177	CS pos: 17-18. THG-CF. Pr: 0.3415    31
NZ_CP027599.1_57355	LIPO(Sec/SPII)	0.277485	0.061540	0.347651	0.313324	CS pos: 11-12. TST-CS. Pr: 0.1206    17
NZ_CP027599.1_57367	SP(Sec/SPI)	0.552960	0.010676	0.426355	0.010009	CS pos: 21-22. SVA-AV. Pr: 0.2608    38
NZ_CP027599.1_57382	LIPO(Sec/SPII)	0.351999	0.058380	0.377901	0.211720	CS pos: 12-13. ATA-CA. Pr: 0.3242    24
NZ_CP027599.1_57399	LIPO(Sec/SPII)	0.258728	0.043728	0.355556	0.341988	CS pos: 12-13. CAF-CL. Pr: 0.0244    15
NZ_CP027599.1_57413	LIPO(Sec/SPII)	0.170659	0.011651	0.532036	0.285655	CS pos: 19-20. ALH-CQ. Pr: 0.4584    24
NZ_CP027599.1_57433	LIPO(Sec/SPII)	0.081257	0.011640	0.490364	0.416740	CS pos: 23-24. SSS-CC. Pr: 0.3746    30
NZ_CP027599.1_57437	LIPO(Sec/SPII)	0.266872	0.025051	0.376290	0.331786	CS pos: ?. Probable protein fragment    15
NZ_CP027599.1_57445	LIPO(Sec/SPII)	0.259798	0.021767	0.377526	0.340909	CS pos: 10-11. VFS-CA. Pr: 0.0882    15
NZ_CP027599.1_57476	SP(Sec/SPI)	0.950474	0.023680	0.021689	0.004157	CS pos: 21-22. ASA-TT. Pr: 0.4845    35
NZ_CP027599.1_57489	LIPO(Sec/SPII)	0.070073	0.002008	0.737622	0.190297	CS pos: 20-21. LAN-CW. Pr: 0.7114    27
NZ_CP027599.1_57503	LIPO(Sec/SPII)	0.254998	0.015222	0.442602	0.287178	CS pos: ?. Probable protein fragment    21
NZ_CP027599.1_57520	SP(Sec/SPI)	0.628952	0.069350	0.077286	0.224412	CS pos: 26-27. ADA-AM. Pr: 0.5679    29
NZ_CP027599.1_57551	LIPO(Sec/SPII)	0.305448	0.012153	0.341935	0.340463	CS pos: 14-15. AIF-CG. Pr: 0.1427    20
NZ_CP027599.1_57571	LIPO(Sec/SPII)	0.093190	0.008131	0.540156	0.358524	CS pos: 26-27. LQQ-CF. Pr: 0.5219    41
NZ_CP027599.1_57599	SP(Sec/SPI)	0.512692	0.008936	0.124843	0.353528	CS pos: 21-22. SIA-IR. Pr: 0.3671    30
NZ_CP027599.1_57606	LIPO(Sec/SPII)	0.139642	0.004525	0.819141	0.036692	CS pos: 14-15. AAA-CC. Pr: 0.7044    31
NZ_CP027599.1_57620	LIPO(Sec/SPII)	0.193366	0.043468	0.394942	0.368224	CS pos: 20-21. TLS-CS. Pr: 0.3585    31
NZ_CP027599.1_57624	LIPO(Sec/SPII)	0.270430	0.003911	0.487106	0.238553	CS pos: 21-22. PRS-CC. Pr: 0.3146    23
NZ_CP027599.1_57626	LIPO(Sec/SPII)	0.320347	0.027714	0.478254	0.173684	CS pos: ?. Probable protein fragment    19
NZ_CP027599.1_57636	LIPO(Sec/SPII)	0.172093	0.061535	0.489808	0.276564	CS pos: ?. Probable protein fragment    16
NZ_CP027599.1_57645	SP(Sec/SPI)	0.497740	0.060446	0.046334	0.395480	CS pos: 22-23. ILA-FQ. Pr: 0.4526    32
NZ_CP027599.1_57679	LIPO(Sec/SPII)	0.193669	0.008123	0.566276	0.231932	CS pos: 12-13. AMS-CT. Pr: 0.5252    42
NZ_CP027599.1_57739	LIPO(Sec/SPII)	0.115671	0.028411	0.749898	0.106020	CS pos: 16-17. ATA-CS. Pr: 0.7499    29
NZ_CP027599.1_57783	LIPO(Sec/SPII)	0.062321	0.023087	0.730316	0.184277	CS pos: 22-23. LCA-CK. Pr: 0.6986    27
NZ_CP027599.1_57801	LIPO(Sec/SPII)	0.312482	0.004987	0.528901	0.153629	CS pos: 22-23. FSA-SG. Pr: 0.2723    42
NZ_CP027599.1_57804	SP(Sec/SPI)	0.423519	0.023235	0.174533	0.378713	CS pos: 19-20. AWK-AG. Pr: 0.1943    29
NZ_CP027599.1_57818	LIPO(Sec/SPII)	0.177913	0.005432	0.593887	0.222768	CS pos: 17-18. LMY-CE. Pr: 0.3019    19
NZ_CP027599.1_57832	LIPO(Sec/SPII)	0.172390	0.022694	0.589632	0.215284	CS pos: 13-14. VAT-CE. Pr: 0.4621    16
NZ_CP027599.1_57860	LIPO(Sec/SPII)	0.260995	0.018084	0.399321	0.321601	CS pos: ?. Probable protein fragment    17
NZ_CP027599.1_57867	LIPO(Sec/SPII)	0.229988	0.011195	0.510230	0.248586	CS pos: ?. Probable protein fragment    19
NZ_CP027599.1_57868	SP(Sec/SPI)	0.675414	0.024676	0.163783	0.136127	CS pos: 24-25. ATA-AS. Pr: 0.5225    27
NZ_CP027599.1_57875	TAT(Tat/SPI)	0.164484	0.390055	0.171058	0.274403	CS pos: 33-34. SLC-SP. Pr: 0.1878    40
NZ_CP027599.1_57900	LIPO(Sec/SPII)	0.201789	0.034367	0.414845	0.348999	CS pos: 13-14. GIA-CG. Pr: 0.2600    19
NZ_CP027599.1_57911	SP(Sec/SPI)	0.461180	0.020856	0.090276	0.427689	CS pos: 20-21. ATP-FS. Pr: 0.1131    30
NZ_CP027599.1_57927	LIPO(Sec/SPII)	0.152147	0.010004	0.538968	0.298882	CS pos: 16-17. LSS-CH. Pr: 0.4898    31
NZ_CP027599.1_57937	SP(Sec/SPI)	0.447871	0.134177	0.126765	0.291187	CS pos: 16-17. SSA-LP. Pr: 0.1209    26
NZ_CP027599.1_57943	LIPO(Sec/SPII)	0.102409	0.004590	0.806134	0.086868	CS pos: 18-19. FAS-CC. Pr: 0.6100    42
NZ_CP027599.1_57971	SP(Sec/SPI)	0.382363	0.092100	0.187465	0.338072	CS pos: 13-14. AAA-QS. Pr: 0.2109    16
NZ_CP027599.1_57973	TAT(Tat/SPI)	0.419020	0.453064	0.093143	0.034772	CS pos: 26-27. AGA-AQ. Pr: 0.3513    50
NZ_CP027599.1_57991	LIPO(Sec/SPII)	0.046761	0.009298	0.483768	0.460172	CS pos: 37-38. ITT-CQ. Pr: 0.4792    46
NZ_CP027599.1_57993	SP(Sec/SPI)	0.354682	0.024043	0.287591	0.333684	CS pos: 20-21. CAA-TW. Pr: 0.1430    22
NZ_CP027599.1_57995	SP(Sec/SPI)	0.556186	0.008479	0.345343	0.089992	CS pos: 17-18. VLA-ST. Pr: 0.2739    23
NZ_CP027599.1_58118	SP(Sec/SPI)	0.428964	0.082212	0.091297	0.397526	CS pos: 18-19. NRA-GS. Pr: 0.1888    48
NZ_CP027599.1_58132	LIPO(Sec/SPII)	0.088462	0.009071	0.794426	0.108041	CS pos: 21-22. SVA-CS. Pr: 0.7751    23
NZ_CP027599.1_58191	SP(Sec/SPI)	0.485922	0.143214	0.148888	0.221976	CS pos: 19-20. ATA-KS. Pr: 0.4142    30
NZ_CP027599.1_58196	LIPO(Sec/SPII)	0.303197	0.138117	0.319110	0.239576	CS pos: 12-13. SAA-CC. Pr: 0.1933    23
NZ_CP027599.1_58197	LIPO(Sec/SPII)	0.095766	0.011201	0.712385	0.180648	CS pos: 21-22. ALS-CW. Pr: 0.7065    37
NZ_CP027599.1_58215	LIPO(Sec/SPII)	0.142132	0.007682	0.679483	0.170703	CS pos: 15-16. CGA-CI. Pr: 0.5012    27
NZ_CP027599.1_58216	SP(Sec/SPI)	0.533096	0.082510	0.125514	0.258880	CS pos: 12-13. AHA-FS. Pr: 0.3365    34
NZ_CP027599.1_58257	LIPO(Sec/SPII)	0.102618	0.009623	0.793595	0.094164	CS pos: 22-23. TSA-CV. Pr: 0.7922    28
NZ_CP027599.1_58274	SP(Sec/SPI)	0.394948	0.204478	0.125932	0.274643	CS pos: 37-38. AAA-SP. Pr: 0.4616    40
NZ_CP027599.1_58280	LIPO(Sec/SPII)	0.209683	0.066984	0.446332	0.277002	CS pos: 20-21. ASN-CS. Pr: 0.3202    25
NZ_CP027599.1_58286	LIPO(Sec/SPII)	0.149532	0.008490	0.681329	0.160649	CS pos: 17-18. TAK-CG. Pr: 0.6263    25
NZ_CP027599.1_58291	LIPO(Sec/SPII)	0.097080	0.023137	0.450735	0.429048	CS pos: 16-17. FTS-CT. Pr: 0.4245    30
NZ_CP027599.1_58335	LIPO(Sec/SPII)	0.066525	0.002953	0.879969	0.050553	CS pos: 18-19. LAS-CS. Pr: 0.8297    20
NZ_CP027599.1_58348	SP(Sec/SPI)	0.488793	0.086778	0.065990	0.358439	CS pos: 32-33. CRA-AY. Pr: 0.3998    42
NZ_CP027599.1_58374	LIPO(Sec/SPII)	0.041732	0.013320	0.840627	0.104321	CS pos: 20-21. LMS-CS. Pr: 0.8366    34
NZ_CP027599.1_58407	LIPO(Sec/SPII)	0.165126	0.003885	0.668220	0.162769	CS pos: 14-15. MMN-CH. Pr: 0.6007    18
NZ_CP027599.1_58421	LIPO(Sec/SPII)	0.233071	0.028849	0.397471	0.340609	CS pos: ?. Probable protein fragment    18
NZ_CP027599.1_58462	TAT(Tat/SPI)	0.139298	0.415691	0.040121	0.404890	CS pos: 25-26. GNA-IP. Pr: 0.2693    40
NZ_CP027599.1_58474	LIPO(Sec/SPII)	0.296990	0.035719	0.335984	0.331308	CS pos: 13-14. STG-RS. Pr: 0.0677    17
NZ_CP027599.1_58484	SP(Sec/SPI)	0.450978	0.043298	0.169373	0.336351	CS pos: 12-13. LSG-DP. Pr: 0.0866    30
NZ_CP027599.1_58497	LIPO(Sec/SPII)	0.321044	0.032699	0.327745	0.318513	CS pos: 15-16. LRG-KS. Pr: 0.2810    40
NZ_CP027599.1_58523	LIPO(Sec/SPII)	0.262595	0.007590	0.415723	0.314092	CS pos: ?. Probable protein fragment    18
NZ_CP027599.1_58554	TAT(Tat/SPI)	0.253398	0.323018	0.126794	0.296791	CS pos: 28-29. IES-SI. Pr: 0.3495    37
NZ_CP027599.1_58583	LIPO(Sec/SPII)	0.118831	0.027104	0.557694	0.296371	CS pos: 16-17. SIN-CT. Pr: 0.5055    40
NZ_CP027599.1_58592	LIPO(Sec/SPII)	0.065552	0.017649	0.647733	0.269066	CS pos: 24-25. GYA-CV. Pr: 0.5944    29
NZ_CP027599.1_58596	LIPO(Sec/SPII)	0.061705	0.004604	0.806994	0.126697	CS pos: 17-18. LVS-CV. Pr: 0.7932    33
NZ_CP027599.1_58601	LIPO(Sec/SPII)	0.148820	0.056651	0.665465	0.129064	CS pos: 24-25. IFS-CS. Pr: 0.6055    44
NZ_CP027599.1_58613	TAT(Tat/SPI)	0.129377	0.531016	0.183130	0.156477	CS pos: 29-30. SKS-QL. Pr: 0.2135    46
NZ_CP027599.1_58650	SP(Sec/SPI)	0.475439	0.017277	0.206825	0.300459	CS pos: 20-21. TFA-RV. Pr: 0.3349    23
NZ_CP027599.1_58679	SP(Sec/SPI)	0.385747	0.010044	0.298037	0.306171	CS pos: 21-22. GLA-KI. Pr: 0.1764    27
NZ_CP027599.1_58709	LIPO(Sec/SPII)	0.201478	0.285882	0.301330	0.211310	CS pos: 21-22. SSL-CS. Pr: 0.2338    46
NZ_CP027599.1_58756	SP(Sec/SPI)	0.495453	0.026790	0.121617	0.356139	CS pos: 25-26. ASA-LT. Pr: 0.1564    46
NZ_CP027599.1_58765	SP(Sec/SPI)	0.401513	0.037833	0.231691	0.328964	CS pos: 16-17. AYA-VG. Pr: 0.2009    26
NZ_CP027599.1_58776	LIPO(Sec/SPII)	0.145357	0.002252	0.848367	0.004023	CS pos: 19-20. PAS-CG. Pr: 0.8426    39
NZ_CP027599.1_58784	LIPO(Sec/SPII)	0.096889	0.002575	0.798478	0.102059	CS pos: 23-24. FSA-CR. Pr: 0.7564    30
NZ_CP027599.1_58788	LIPO(Sec/SPII)	0.182998	0.010173	0.671717	0.135113	CS pos: 15-16. CKA-CS. Pr: 0.6437    27
NZ_CP027599.1_58792	LIPO(Sec/SPII)	0.263921	0.021018	0.384866	0.330195	CS pos: 13-14. LMC-CC. Pr: 0.1206    15
NZ_CP027599.1_58804	LIPO(Sec/SPII)	0.289429	0.006959	0.433247	0.270365	CS pos: 13-14. VCG-RY. Pr: 0.0503    16
NZ_CP027599.1_58820	LIPO(Sec/SPII)	0.340423	0.080439	0.341374	0.237764	CS pos: 14-15. SSA-TR. Pr: 0.0927    17
NZ_CP027599.1_58822	LIPO(Sec/SPII)	0.300638	0.005232	0.432691	0.261439	CS pos: 26-27. FAG-CI. Pr: 0.2378    32
NZ_CP027599.1_58839	LIPO(Sec/SPII)	0.296022	0.020764	0.357677	0.325538	CS pos: 14-15. AIV-CT. Pr: 0.1377    18
NZ_CP027599.1_58845	SP(Sec/SPI)	0.494105	0.006808	0.356851	0.142236	CS pos: 15-16. AIA-AS. Pr: 0.2003    24
NZ_CP027599.1_58901	SP(Sec/SPI)	0.537165	0.226707	0.013528	0.222600	CS pos: 20-21. SNA-AS. Pr: 0.5962    37
NZ_CP027599.1_58916	LIPO(Sec/SPII)	0.374889	0.011471	0.425572	0.188068	CS pos: ?. Probable protein fragment    15
NZ_CP027599.1_58926	LIPO(Sec/SPII)	0.024839	0.008219	0.802313	0.164630	CS pos: 17-18. TAS-CY. Pr: 0.7814    29
NZ_CP027599.1_58931	LIPO(Sec/SPII)	0.146004	0.012566	0.659999	0.181432	CS pos: 15-16. SLS-CY. Pr: 0.6455    26
NZ_CP027599.1_58985	LIPO(Sec/SPII)	0.015415	0.001847	0.906232	0.076506	CS pos: 18-19. LLA-CL. Pr: 0.8947    28
NZ_CP027599.1_58991	LIPO(Sec/SPII)	0.078717	0.020675	0.733100	0.167508	CS pos: 16-17. THG-CY. Pr: 0.7421    33
NZ_CP027599.1_58997	LIPO(Sec/SPII)	0.061550	0.009191	0.905692	0.023567	CS pos: 21-22. ASS-CR. Pr: 0.8860    28
NZ_CP027599.1_59011	LIPO(Sec/SPII)	0.219043	0.041195	0.467974	0.271787	CS pos: ?. Probable protein fragment    21
NZ_CP027599.1_59151	SP(Sec/SPI)	0.637750	0.069581	0.107454	0.185215	CS pos: 26-27. GLP-AT. Pr: 0.1746    50
NZ_CP027599.1_59162	SP(Sec/SPI)	0.345624	0.288305	0.042534	0.323537	CS pos: 20-21. TTA-LP. Pr: 0.3246    35
NZ_CP027599.1_59256	LIPO(Sec/SPII)	0.136493	0.033203	0.554849	0.275455	CS pos: 17-18. FIS-CG. Pr: 0.3903    28
NZ_CP027599.1_59262	SP(Sec/SPI)	0.423205	0.329396	0.128523	0.118876	CS pos: 26-27. VRS-SV. Pr: 0.1989    40
NZ_CP027599.1_59274	SP(Sec/SPI)	0.468987	0.010813	0.422008	0.098192	CS pos: 18-19. VSS-PE. Pr: 0.0575    21
NZ_CP027599.1_59337	LIPO(Sec/SPII)	0.195692	0.059415	0.380450	0.364443	CS pos: 13-14. LPA-CD. Pr: 0.3743    42
NZ_CP027599.1_59376	LIPO(Sec/SPII)	0.048065	0.002442	0.546284	0.403209	CS pos: 28-29. LFS-CC. Pr: 0.3606    36
NZ_CP027599.1_59377	SP(Sec/SPI)	0.439329	0.060716	0.198235	0.301719	CS pos: ?. Probable protein fragment    27
NZ_CP027599.1_59417	SP(Sec/SPI)	0.367668	0.031334	0.327952	0.273047	CS pos: 11-12. AHA-AG. Pr: 0.0952    16
NZ_CP027599.1_59464	SP(Sec/SPI)	0.452323	0.125772	0.234500	0.187405	CS pos: 17-18. ATA-IP. Pr: 0.2338    36
NZ_CP027599.1_59502	SP(Sec/SPI)	0.575071	0.015811	0.100967	0.308150	CS pos: 19-20. VQL-SR. Pr: 0.2341    27
NZ_CP027599.1_59521	LIPO(Sec/SPII)	0.215760	0.020640	0.443800	0.319801	CS pos: 13-14. FPS-CP. Pr: 0.2059    16
NZ_CP027599.1_59572	SP(Sec/SPI)	0.512344	0.424165	0.016096	0.047395	CS pos: 33-34. TNA-AP. Pr: 0.8542    50
NZ_CP027599.1_59704	LIPO(Sec/SPII)	0.244664	0.027421	0.371380	0.356535	CS pos: 14-15. LSG-YQ. Pr: 0.1043    16
NZ_CP027599.1_59722	SP(Sec/SPI)	0.478445	0.157253	0.022778	0.341524	CS pos: 27-28. ATA-KS. Pr: 0.5239    37
NZ_CP027599.1_59725	LIPO(Sec/SPII)	0.276900	0.019932	0.431551	0.271617	CS pos: 18-19. AQW-CS. Pr: 0.3188    27
NZ_CP027599.1_59748	SP(Sec/SPI)	0.412411	0.059912	0.122511	0.405165	CS pos: 24-25. SLA-EV. Pr: 0.2407    27
NZ_CP027599.1_59756	LIPO(Sec/SPII)	0.227480	0.031388	0.668679	0.072453	CS pos: 14-15. ATS-CG. Pr: 0.6773    33
NZ_CP027599.1_59764	TAT(Tat/SPI)	0.165325	0.463706	0.110777	0.260193	CS pos: 19-20. AAG-NV. Pr: 0.0868    26
NZ_CP027599.1_59805	TAT(Tat/SPI)	0.279450	0.431115	0.085084	0.204351	CS pos: 31-32. SRS-LP. Pr: 0.3052    46
NZ_CP027599.1_59830	LIPO(Sec/SPII)	0.287983	0.010209	0.436514	0.265295	CS pos: 17-18. STR-CH. Pr: 0.3592    23
NZ_CP027599.1_59835	LIPO(Sec/SPII)	0.189037	0.044025	0.546427	0.220511	CS pos: 14-15. AGS-CA. Pr: 0.4636    18
NZ_CP027599.1_59839	LIPO(Sec/SPII)	0.300532	0.035168	0.478738	0.185562	CS pos: 18-19. STT-CV. Pr: 0.3504    26
NZ_CP027599.1_59846	SP(Sec/SPI)	0.461100	0.076934	0.108913	0.353053	CS pos: 33-34. VQA-WR. Pr: 0.4949    42
NZ_CP027599.1_59851	SP(Sec/SPI)	0.351539	0.036277	0.327617	0.284567	CS pos: ?. Probable protein fragment    19
NZ_CP027599.1_59852	SP(Sec/SPI)	0.444472	0.094535	0.114354	0.346639	CS pos: 19-20. SHG-FI. Pr: 0.1818    36
NZ_CP027599.1_59865	SP(Sec/SPI)	0.544554	0.015263	0.133159	0.307024	CS pos: 16-17. ATG-YS. Pr: 0.3163    42
NZ_CP027599.1_59909	LIPO(Sec/SPII)	0.028932	0.002461	0.901788	0.066818	CS pos: 28-29. LSS-CR. Pr: 0.8968    38
NZ_CP027599.1_59965	LIPO(Sec/SPII)	0.033337	0.006226	0.743889	0.216548	CS pos: 19-20. ITS-CR. Pr: 0.5864    39
NZ_CP027599.1_59993	SP(Sec/SPI)	0.596234	0.019054	0.265823	0.118890	CS pos: 22-23. QRA-SR. Pr: 0.2235    26
NZ_CP027599.1_60053	LIPO(Sec/SPII)	0.017008	0.003266	0.844305	0.135421	CS pos: 17-18. FVG-CP. Pr: 0.8466    37
NZ_CP027599.1_60108	SP(Sec/SPI)	0.702630	0.122167	0.045382	0.129820	CS pos: 20-21. ASA-VG. Pr: 0.4451    30
NZ_CP027599.1_60127	SP(Sec/SPI)	0.499897	0.123570	0.018263	0.358270	CS pos: 28-29. AVA-DE. Pr: 0.5600    35
NZ_CP027599.1_60144	LIPO(Sec/SPII)	0.173441	0.015947	0.573808	0.236803	CS pos: 13-14. LFG-CL. Pr: 0.4038    15
NZ_CP027599.1_60189	SP(Sec/SPI)	0.363355	0.138698	0.201754	0.296193	CS pos: 22-23. SIA-AS. Pr: 0.1681    33
NZ_CP027599.1_60225	LIPO(Sec/SPII)	0.103574	0.070165	0.795460	0.030801	CS pos: 17-18. AAS-CS. Pr: 0.7834    41
NZ_CP027599.1_60229	SP(Sec/SPI)	0.472097	0.016137	0.100045	0.411721	CS pos: 18-19. VLA-DY. Pr: 0.3709    28
NZ_CP027599.1_60230	SP(Sec/SPI)	0.692319	0.030819	0.093486	0.183376	CS pos: 19-20. SFA-GE. Pr: 0.6280    21
NZ_CP027599.1_60247	TAT(Tat/SPI)	0.320619	0.323517	0.060814	0.295050	CS pos: 25-26. IAA-IT. Pr: 0.1888    33
NZ_CP027599.1_60318	LIPO(Sec/SPII)	0.121264	0.035819	0.457561	0.385355	CS pos: 16-17. APA-CQ. Pr: 0.4264    28
NZ_CP027599.1_60327	LIPO(Sec/SPII)	0.251536	0.097593	0.361668	0.289203	CS pos: 23-24. LLG-SS. Pr: 0.1634    44
NZ_CP027599.1_60333	LIPO(Sec/SPII)	0.356705	0.003504	0.461133	0.178658	CS pos: 21-22. VSG-SE. Pr: 0.5136    27
NZ_CP027599.1_60402	SP(Sec/SPI)	0.410896	0.044765	0.231594	0.312746	CS pos: 27-28. TGA-KC. Pr: 0.0953    33
NZ_CP027599.1_60411	LIPO(Sec/SPII)	0.138233	0.012412	0.663100	0.186255	CS pos: 17-18. LST-CA. Pr: 0.5784    19
NZ_CP027599.1_60441	SP(Sec/SPI)	0.754768	0.122274	0.029473	0.093485	CS pos: 23-24. AAA-GA. Pr: 0.3726    47
NZ_CP027599.1_60469	SP(Sec/SPI)	0.543980	0.055016	0.035091	0.365912	CS pos: 12-13. ATA-NP. Pr: 0.3448    37
NZ_CP027599.1_60482	SP(Sec/SPI)	0.420529	0.038052	0.328618	0.212801	CS pos: 19-20. VVC-GS. Pr: 0.1784    31
NZ_CP027599.1_60495	LIPO(Sec/SPII)	0.183194	0.011148	0.563648	0.242010	CS pos: 13-14. TIG-CP. Pr: 0.3633    27
NZ_CP027599.1_60509	SP(Sec/SPI)	0.514813	0.106227	0.025810	0.353149	CS pos: 26-27. VQS-AR. Pr: 0.4506    45
NZ_CP027599.1_60525	LIPO(Sec/SPII)	0.059287	0.005198	0.736907	0.198608	CS pos: 13-14. LIS-CS. Pr: 0.7158    27
NZ_CP027599.1_60530	LIPO(Sec/SPII)	0.205525	0.025171	0.464347	0.304956	CS pos: 26-27. FTA-CV. Pr: 0.3790    30
NZ_CP027599.1_60553	LIPO(Sec/SPII)	0.224901	0.015749	0.505045	0.254304	CS pos: 17-18. CQA-CK. Pr: 0.2948    43
NZ_CP027599.1_60559	SP(Sec/SPI)	0.614802	0.023698	0.317530	0.043970	CS pos: 19-20. TLA-TK. Pr: 0.4168    43
NZ_CP027599.1_60598	LIPO(Sec/SPII)	0.100756	0.038322	0.536425	0.324496	CS pos: 18-19. INS-CN. Pr: 0.5022    25
NZ_CP027599.1_60623	SP(Sec/SPI)	0.723024	0.002626	0.028280	0.246070	CS pos: 19-20. IMS-DT. Pr: 0.6373    43
NZ_CP027599.1_60686	LIPO(Sec/SPII)	0.078901	0.001498	0.794375	0.125227	CS pos: 25-26. HSS-CN. Pr: 0.7540    27
NZ_CP027599.1_60689	TAT(Tat/SPI)	0.081072	0.498580	0.037144	0.383204	CS pos: 35-36. AGA-AD. Pr: 0.3609    37
NZ_CP027599.1_60692	LIPO(Sec/SPII)	0.173253	0.005972	0.675635	0.145140	CS pos: 24-25. HSS-CR. Pr: 0.4620    33
NZ_CP027599.1_60705	LIPO(Sec/SPII)	0.288312	0.008790	0.500855	0.202044	CS pos: 15-16. WCR-CG. Pr: 0.1858    17
NZ_CP027599.1_60707	LIPO(Sec/SPII)	0.295539	0.006688	0.429812	0.267962	CS pos: ?. Probable protein fragment    17
NZ_CP027599.1_60739	LIPO(Sec/SPII)	0.028815	0.002532	0.598416	0.370237	CS pos: 22-23. WVG-CW. Pr: 0.5773    36
NZ_CP027599.1_60761	LIPO(Sec/SPII)	0.069986	0.009771	0.663320	0.256923	CS pos: 26-27. FGG-CY. Pr: 0.6376    30
NZ_CP027599.1_60781	LIPO(Sec/SPII)	0.180874	0.009234	0.774969	0.034923	CS pos: 18-19. SAT-CA. Pr: 0.7272    26
NZ_CP027599.1_60784	SP(Sec/SPI)	0.427565	0.074358	0.243606	0.254471	CS pos: 18-19. LYA-AT. Pr: 0.4188    29
NZ_CP027599.1_60802	LIPO(Sec/SPII)	0.100624	0.025253	0.486531	0.387591	CS pos: 11-12. HSS-CM. Pr: 0.3964    19
NZ_CP027599.1_60844	LIPO(Sec/SPII)	0.226871	0.071310	0.422156	0.279663	CS pos: 25-26. LAR-CI. Pr: 0.1819    45
NZ_CP027599.1_60860	LIPO(Sec/SPII)	0.165107	0.032302	0.762699	0.039892	CS pos: 17-18. LFS-CT. Pr: 0.7522    41
NZ_CP027599.1_60875	SP(Sec/SPI)	0.469582	0.017500	0.247682	0.265236	CS pos: 18-19. VLA-EY. Pr: 0.4358    27
NZ_CP027599.1_60895	TAT(Tat/SPI)	0.127472	0.484145	0.121386	0.266996	CS pos: ?. Probable protein fragment    15
NZ_CP027599.1_60916	SP(Sec/SPI)	0.434111	0.161627	0.054631	0.349631	CS pos: 16-17. AIA-AK. Pr: 0.4250    29
NZ_CP027599.1_60977	LIPO(Sec/SPII)	0.224276	0.050487	0.431588	0.293649	CS pos: 15-16. IVG-CD. Pr: 0.3310    24
NZ_CP027599.1_60987	SP(Sec/SPI)	0.643142	0.012768	0.293446	0.050644	CS pos: 20-21. SLS-SR. Pr: 0.3683    39
NZ_CP027599.1_61008	SP(Sec/SPI)	0.644713	0.007102	0.307756	0.040429	CS pos: 23-24. SSA-TE. Pr: 0.3256    29
NZ_CP027599.1_61031	LIPO(Sec/SPII)	0.124636	0.005887	0.794168	0.075309	CS pos: 20-21. SIS-CV. Pr: 0.7971    30
NZ_CP027599.1_61042	SP(Sec/SPI)	0.471169	0.252931	0.054103	0.221796	CS pos: 21-22. ANA-GT. Pr: 0.4776    33
NZ_CP027599.1_61043	LIPO(Sec/SPII)	0.288989	0.014891	0.585607	0.110513	CS pos: 13-14. SAN-CA. Pr: 0.4465    16
NZ_CP027599.1_61067	LIPO(Sec/SPII)	0.219055	0.022171	0.476350	0.282424	CS pos: 20-21. QLS-CV. Pr: 0.3904    30
NZ_CP027599.1_61074	LIPO(Sec/SPII)	0.124808	0.003959	0.737366	0.133866	CS pos: 20-21. TVS-CM. Pr: 0.7203    26
NZ_CP027599.1_61111	SP(Sec/SPI)	0.723803	0.075751	0.149885	0.050560	CS pos: 21-22. TSA-SP. Pr: 0.6645    45
NZ_CP027599.1_61114	LIPO(Sec/SPII)	0.208616	0.031161	0.387929	0.372294	CS pos: 25-26. SSA-CH. Pr: 0.2254    38
NZ_CP027599.1_61130	LIPO(Sec/SPII)	0.276298	0.041238	0.417599	0.264865	CS pos: 21-22. LSQ-CL. Pr: 0.3618    29
NZ_CP027599.1_61137	SP(Sec/SPI)	0.478991	0.208961	0.063927	0.248121	CS pos: 23-24. SIA-AT. Pr: 0.2651    29
NZ_CP027599.1_61191	SP(Sec/SPI)	0.328059	0.089667	0.269602	0.312673	CS pos: 14-15. ANA-CA. Pr: 0.3673    38
NZ_CP027599.1_61215	SP(Sec/SPI)	0.631456	0.007158	0.116124	0.245262	CS pos: 21-22. SPA-DK. Pr: 0.2312    30
NZ_CP027599.1_61255	LIPO(Sec/SPII)	0.275496	0.015933	0.416089	0.292481	CS pos: 19-20. LSS-RR. Pr: 0.1804    21
NZ_CP027599.1_61302	LIPO(Sec/SPII)	0.026793	0.001235	0.856286	0.115685	CS pos: 19-20. STA-CL. Pr: 0.8492    41
NZ_CP027599.1_61308	SP(Sec/SPI)	0.464095	0.045056	0.229142	0.261708	CS pos: 13-14. VNA-AS. Pr: 0.1869    41
NZ_CP027599.1_61331	TAT(Tat/SPI)	0.208688	0.607093	0.137446	0.046772	CS pos: 29-30. SSA-SS. Pr: 0.2404    42
NZ_CP027599.1_61406	LIPO(Sec/SPII)	0.095971	0.016376	0.616182	0.271470	CS pos: 25-26. QTS-CI. Pr: 0.5928    30
NZ_CP027599.1_61413	LIPO(Sec/SPII)	0.023973	0.001880	0.934705	0.039443	CS pos: 21-22. ASS-CH. Pr: 0.9332    43
NZ_CP027599.1_61423	SP(Sec/SPI)	0.819829	0.009518	0.012845	0.157808	CS pos: 25-26. TWA-TY. Pr: 0.8030    34
NZ_CP027599.1_61429	LIPO(Sec/SPII)	0.193026	0.091090	0.413679	0.302205	CS pos: 22-23. GGS-CG. Pr: 0.3773    34
NZ_CP027599.1_61433	SP(Sec/SPI)	0.487900	0.022103	0.166133	0.323864	CS pos: 16-17. VLT-MK. Pr: 0.1176    27
NZ_CP027599.1_61448	SP(Sec/SPI)	0.547952	0.051097	0.244007	0.156944	CS pos: 20-21. TSA-SR. Pr: 0.3949    26
NZ_CP027599.1_61467	LIPO(Sec/SPII)	0.134999	0.003616	0.763653	0.097732	CS pos: 17-18. IAA-CR. Pr: 0.6234    19
NZ_CP027599.1_61472	LIPO(Sec/SPII)	0.251097	0.023790	0.413086	0.312027	CS pos: ?. Probable protein fragment    15
NZ_CP027599.1_61497	SP(Sec/SPI)	0.566677	0.022686	0.317397	0.093240	CS pos: 23-24. SLA-QR. Pr: 0.4781    31
NZ_CP027599.1_61513	LIPO(Sec/SPII)	0.270029	0.027976	0.390406	0.311589	CS pos: ?. Probable protein fragment    20
NZ_CP027599.1_61516	LIPO(Sec/SPII)	0.135332	0.060244	0.489816	0.314607	CS pos: 18-19. FSG-CR. Pr: 0.4257    21
NZ_CP027599.1_61532	TAT(Tat/SPI)	0.213321	0.421738	0.087708	0.277233	CS pos: ?. Probable protein fragment    25
NZ_CP027599.1_61556	LIPO(Sec/SPII)	0.327679	0.023935	0.371746	0.276640	CS pos: ?. Probable protein fragment    15
NZ_CP027599.1_61647	SP(Sec/SPI)	0.739163	0.142407	0.027299	0.091131	CS pos: 20-21. AAA-MV. Pr: 0.6048    31
NZ_CP027599.1_61655	SP(Sec/SPI)	0.470726	0.035947	0.105131	0.388195	CS pos: 16-17. FHA-RP. Pr: 0.2004    23
NZ_CP027599.1_61679	SP(Sec/SPI)	0.666580	0.075519	0.041726	0.216175	CS pos: 23-24. ALA-KT. Pr: 0.6430    31
NZ_CP027599.1_61695	LIPO(Sec/SPII)	0.091833	0.006214	0.722398	0.179555	CS pos: 18-19. SVA-CY. Pr: 0.6319    21
NZ_CP027599.1_61704	SP(Sec/SPI)	0.589667	0.012050	0.102461	0.295822	CS pos: 16-17. VHA-DH. Pr: 0.5450    23
NZ_CP027599.1_61721	LIPO(Sec/SPII)	0.106128	0.001851	0.888902	0.003120	CS pos: 19-20. AVC-CT. Pr: 0.5749    50
NZ_CP027599.1_61736	SP(Sec/SPI)	0.560916	0.047423	0.104590	0.287071	CS pos: 22-23. VNG-AV. Pr: 0.4248    33
NZ_CP027599.1_61765	LIPO(Sec/SPII)	0.098641	0.010419	0.588819	0.302121	CS pos: 16-17. FDG-CN. Pr: 0.5479    18
NZ_CP027599.1_61785	SP(Sec/SPI)	0.497224	0.179520	0.172353	0.150904	CS pos: 27-28. RWS-AT. Pr: 0.3593    37
NZ_CP027599.1_61804	SP(Sec/SPI)	0.415176	0.067675	0.109976	0.407173	CS pos: 16-17. ALA-RP. Pr: 0.3374    19
NZ_CP027599.1_61823	LIPO(Sec/SPII)	0.045977	0.331756	0.442779	0.179488	CS pos: 21-22. GAG-CT. Pr: 0.4409    47
NZ_CP027599.1_61825	LIPO(Sec/SPII)	0.236324	0.077434	0.607885	0.078357	CS pos: 19-20. AAA-CC. Pr: 0.4714    36
NZ_CP027599.1_61830	SP(Sec/SPI)	0.641649	0.181888	0.053177	0.123287	CS pos: 19-20. ASA-QP. Pr: 0.5494    47
NZ_CP027599.1_61832	SP(Sec/SPI)	0.530615	0.127137	0.072400	0.269848	CS pos: 16-17. AHA-VK. Pr: 0.5431    25
NZ_CP027599.1_61837	LIPO(Sec/SPII)	0.047624	0.012690	0.727223	0.212463	CS pos: 24-25. VIT-CS. Pr: 0.6956    31
NZ_CP027599.1_61845	SP(Sec/SPI)	0.390577	0.092167	0.141213	0.376042	CS pos: 18-19. ARC-AL. Pr: 0.2270    26
NZ_CP027599.1_61852	SP(Sec/SPI)	0.495087	0.054344	0.134438	0.316132	CS pos: 20-21. SVA-GK. Pr: 0.2888    27
NZ_CP027599.1_61887	LIPO(Sec/SPII)	0.150837	0.060167	0.536076	0.252920	CS pos: 20-21. SSA-CS. Pr: 0.5363    31
NZ_CP027599.1_61904	SP(Sec/SPI)	0.519829	0.016402	0.185999	0.277770	CS pos: 25-26. SYS-ST. Pr: 0.3258    27
NZ_CP027599.1_61915	SP(Sec/SPI)	0.775062	0.063200	0.023561	0.138177	CS pos: 23-24. ASA-AT. Pr: 0.7013    45
NZ_CP027599.1_61939	LIPO(Sec/SPII)	0.157875	0.028362	0.407997	0.405766	CS pos: 11-12. LVT-CT. Pr: 0.3280    19
NZ_CP027599.1_61961	LIPO(Sec/SPII)	0.221721	0.003091	0.419243	0.355945	CS pos: ?. Probable protein fragment    19
NZ_CP027599.1_61962	LIPO(Sec/SPII)	0.049870	0.012439	0.509799	0.427891	CS pos: 18-19. ISS-CQ. Pr: 0.5053    35
NZ_CP027599.1_62010	TAT(Tat/SPI)	0.153776	0.667560	0.042430	0.136234	CS pos: 25-26. ISA-GG. Pr: 0.1275    29
NZ_CP027599.1_62038	TAT(Tat/SPI)	0.132157	0.416435	0.060798	0.390610	CS pos: 35-36. RSA-AR. Pr: 0.0532    38
NZ_CP027599.1_62059	SP(Sec/SPI)	0.447087	0.191594	0.061530	0.299789	CS pos: 22-23. VSA-NS. Pr: 0.3946    25
NZ_CP027599.1_62060	SP(Sec/SPI)	0.594150	0.028760	0.165409	0.211681	CS pos: 17-18. SVA-KG. Pr: 0.2448    22
NZ_CP027599.1_62065	LIPO(Sec/SPII)	0.164228	0.209914	0.399354	0.226504	CS pos: 17-18. APS-CA. Pr: 0.4041    43
NZ_CP027599.1_62066	SP(Sec/SPI)	0.421214	0.090693	0.092810	0.395283	CS pos: 25-26. GQT-AR. Pr: 0.1099    39
NZ_CP027599.1_62080	LIPO(Sec/SPII)	0.315592	0.018452	0.375381	0.290575	CS pos: 11-12. ALC-CG. Pr: 0.0237    15
NZ_CP027599.1_62081	SP(Sec/SPI)	0.445432	0.098583	0.113007	0.342978	CS pos: 26-27. ASA-TH. Pr: 0.2554    36
NZ_CP027599.1_62092	SP(Sec/SPI)	0.439985	0.062233	0.143025	0.354758	CS pos: 25-26. VSG-KS. Pr: 0.1541    29
NZ_CP027599.1_62116	LIPO(Sec/SPII)	0.131950	0.015776	0.552409	0.299865	CS pos: 10-11. ASG-CG. Pr: 0.4972    20
NZ_CP027599.1_62130	SP(Sec/SPI)	0.438912	0.077730	0.107873	0.375486	CS pos: 16-17. AAA-SG. Pr: 0.2163    33
NZ_CP027599.1_62150	LIPO(Sec/SPII)	0.126482	0.007531	0.593659	0.272328	CS pos: 22-23. FLG-CT. Pr: 0.4322    25
NZ_CP027599.1_62163	LIPO(Sec/SPII)	0.283581	0.045931	0.616829	0.053660	CS pos: 19-20. WSG-CS. Pr: 0.5286    31
NZ_CP027599.1_62165	LIPO(Sec/SPII)	0.119728	0.007835	0.639380	0.233056	CS pos: 17-18. IPG-CC. Pr: 0.5234    19
NZ_CP027599.1_62169	LIPO(Sec/SPII)	0.245985	0.090098	0.344316	0.319601	CS pos: ?. Probable protein fragment    16
NZ_CP027599.1_62180	SP(Sec/SPI)	0.393935	0.010246	0.330647	0.265172	CS pos: 14-15. LDA-IA. Pr: 0.0473    16
NZ_CP027599.1_62186	LIPO(Sec/SPII)	0.109136	0.007628	0.676823	0.206413	CS pos: 16-17. FVN-CS. Pr: 0.6232    21
NZ_CP027599.1_62189	SP(Sec/SPI)	0.421178	0.276518	0.116221	0.186083	CS pos: 23-24. LRS-IP. Pr: 0.1682    40
NZ_CP027599.1_62190	SP(Sec/SPI)	0.340754	0.041020	0.315897	0.302329	CS pos: 16-17. AMS-SE. Pr: 0.1000    18
NZ_CP027599.1_62217	SP(Sec/SPI)	0.595335	0.058434	0.059501	0.286730	CS pos: 19-20. VQA-TV. Pr: 0.5746    31
NZ_CP027599.1_62219	LIPO(Sec/SPII)	0.024576	0.008170	0.950068	0.017185	CS pos: 19-20. VTA-CS. Pr: 0.9397    44
NZ_CP027599.1_62236	LIPO(Sec/SPII)	0.345445	0.038589	0.515186	0.100780	CS pos: 14-15. FAA-CS. Pr: 0.4732    29
NZ_CP027599.1_62242	LIPO(Sec/SPII)	0.272327	0.009965	0.643372	0.074336	CS pos: 19-20. SVS-CA. Pr: 0.5593    23
NZ_CP027599.1_62270	LIPO(Sec/SPII)	0.037354	0.127972	0.751297	0.083376	CS pos: 20-21. GAG-CS. Pr: 0.7509    29
NZ_CP027599.1_62272	SP(Sec/SPI)	0.398211	0.010721	0.299747	0.291322	CS pos: 17-18. LIA-EI. Pr: 0.2487    20
NZ_CP027599.1_62276	LIPO(Sec/SPII)	0.240137	0.014400	0.520574	0.224889	CS pos: ?. Probable protein fragment    17
NZ_CP027599.1_62286	SP(Sec/SPI)	0.400477	0.043544	0.358190	0.197789	CS pos: 18-19. GSG-LQ. Pr: 0.1195    23
NZ_CP027599.1_62295	LIPO(Sec/SPII)	0.304081	0.013716	0.506616	0.175587	CS pos: 16-17. ITG-AR. Pr: 0.2897    19
NZ_CP027599.1_62312	LIPO(Sec/SPII)	0.246439	0.039522	0.363417	0.350623	CS pos: ?. Probable protein fragment    16
NZ_CP027599.1_62350	LIPO(Sec/SPII)	0.243951	0.021757	0.369626	0.364666	CS pos: 15-16. GVR-CF. Pr: 0.1530    17
NZ_CP027599.1_62365	SP(Sec/SPI)	0.409044	0.007705	0.338753	0.244497	CS pos: 26-27. VHG-FG. Pr: 0.1220    40
NZ_CP027599.1_62388	SP(Sec/SPI)	0.550559	0.217041	0.055283	0.177116	CS pos: 15-16. ASA-AV. Pr: 0.6002    47
NZ_CP027599.1_62403	SP(Sec/SPI)	0.596967	0.160047	0.061048	0.181938	CS pos: 18-19. ARA-IK. Pr: 0.5581    28
NZ_CP027599.1_62407	SP(Sec/SPI)	0.420030	0.118775	0.068180	0.393014	CS pos: 23-24. SFA-DN. Pr: 0.0873    27
NZ_CP027599.1_62416	SP(Sec/SPI)	0.578309	0.085712	0.099805	0.236175	CS pos: 27-28. ATA-DD. Pr: 0.5300    36
NZ_CP027599.1_62452	LIPO(Sec/SPII)	0.071886	0.007313	0.759993	0.160808	CS pos: 23-24. TCG-CT. Pr: 0.5798    30
NZ_CP027599.1_62453	LIPO(Sec/SPII)	0.287994	0.013495	0.433541	0.264970	CS pos: ?. Probable protein fragment    15
NZ_CP027599.1_62474	LIPO(Sec/SPII)	0.163355	0.004549	0.818816	0.013281	CS pos: 15-16. AAA-CR. Pr: 0.8124    36
NZ_CP027599.1_62476	LIPO(Sec/SPII)	0.275206	0.016732	0.495099	0.212963	CS pos: 28-29. VNS-CF. Pr: 0.3411    37
NZ_CP027599.1_62478	LIPO(Sec/SPII)	0.303323	0.023892	0.472801	0.199985	CS pos: ?. Probable protein fragment    16
NZ_CP027599.1_62497	LIPO(Sec/SPII)	0.189967	0.010930	0.518888	0.280214	CS pos: 15-16. ALS-CG. Pr: 0.3609    21
NZ_CP027599.1_62500	LIPO(Sec/SPII)	0.338392	0.064088	0.346771	0.250749	CS pos: 17-18. RAK-CC. Pr: 0.1853    30
NZ_CP027599.1_62517	LIPO(Sec/SPII)	0.301160	0.011187	0.421986	0.265667	CS pos: ?. Probable protein fragment    20
NZ_CP027599.1_62520	TAT(Tat/SPI)	0.168885	0.350366	0.178570	0.302179	CS pos: 35-36. ADA-AS. Pr: 0.2760    44
NZ_CP027599.1_62559	SP(Sec/SPI)	0.561817	0.072238	0.069364	0.296581	CS pos: 15-16. VNA-GP. Pr: 0.4291    21
NZ_CP027599.1_62571	SP(Sec/SPI)	0.499946	0.015311	0.182781	0.301962	CS pos: 16-17. AHR-FC. Pr: 0.1802    24
NZ_CP027599.1_62575	SP(Sec/SPI)	0.390339	0.232563	0.014987	0.362111	CS pos: 18-19. ARA-TN. Pr: 0.5380    40
NZ_CP027599.1_62580	LIPO(Sec/SPII)	0.181421	0.067546	0.400625	0.350408	CS pos: 29-30. TWS-CS. Pr: 0.3683    35
NZ_CP027599.1_62597	LIPO(Sec/SPII)	0.109414	0.159518	0.593506	0.137563	CS pos: 19-20. SAA-CR. Pr: 0.5262    21
NZ_CP027599.1_62634	LIPO(Sec/SPII)	0.203816	0.041591	0.380829	0.373763	CS pos: ?. Probable protein fragment    15
NZ_CP027599.1_62650	SP(Sec/SPI)	0.611799	0.124387	0.101722	0.162092	CS pos: 23-24. SSA-GP. Pr: 0.5122    43
NZ_CP027599.1_62670	SP(Sec/SPI)	0.450122	0.006923	0.314655	0.228299	CS pos: ?. Probable protein fragment    19
NZ_CP027599.1_62672	SP(Sec/SPI)	0.770617	0.017518	0.095000	0.116865	CS pos: 21-22. GYA-AL. Pr: 0.6026    26
NZ_CP027599.1_62678	LIPO(Sec/SPII)	0.263058	0.017649	0.384264	0.335029	CS pos: ?. Probable protein fragment    17
NZ_CP027599.1_62704	LIPO(Sec/SPII)	0.180433	0.025257	0.403725	0.390584	CS pos: 13-14. LTC-CY. Pr: 0.1722    43
NZ_CP027599.1_62712	LIPO(Sec/SPII)	0.090015	0.004267	0.669362	0.236356	CS pos: 18-19. GRG-CC. Pr: 0.5405    24
NZ_CP027599.1_62734	LIPO(Sec/SPII)	0.163829	0.108406	0.528622	0.199142	CS pos: 31-32. LSA-CV. Pr: 0.4274    36
NZ_CP027599.1_62869	LIPO(Sec/SPII)	0.174653	0.009146	0.578889	0.237313	CS pos: 19-20. QMC-CW. Pr: 0.3172    24
NZ_CP027599.1_62892	LIPO(Sec/SPII)	0.202547	0.012485	0.551415	0.233552	CS pos: 21-22. VPA-CF. Pr: 0.6061    37
NZ_CP027599.1_62951	LIPO(Sec/SPII)	0.215470	0.093881	0.568799	0.121849	CS pos: 19-20. APA-CF. Pr: 0.5253    28
NZ_CP027599.1_62965	SP(Sec/SPI)	0.484756	0.057431	0.172102	0.285711	CS pos: 27-28. GSA-IP. Pr: 0.0898    36
NZ_CP027599.1_63068	LIPO(Sec/SPII)	0.081042	0.045342	0.684434	0.189182	CS pos: 12-13. TAS-CT. Pr: 0.6811    38
NZ_CP027599.1_63084	LIPO(Sec/SPII)	0.157065	0.070519	0.465867	0.306548	CS pos: 14-15. SSS-CR. Pr: 0.4185    38
NZ_CP027599.1_63145	LIPO(Sec/SPII)	0.050424	0.002548	0.489790	0.457237	CS pos: 22-23. PSS-CF. Pr: 0.4268    35
NZ_CP027599.1_63149	TAT(Tat/SPI)	0.178258	0.456581	0.037718	0.327443	CS pos: 37-38. SSA-AT. Pr: 0.1205    41
NZ_CP027599.1_63151	SP(Sec/SPI)	0.446596	0.019741	0.117528	0.416136	CS pos: 17-18. SLA-FL. Pr: 0.2241    24
NZ_CP027599.1_63190	SP(Sec/SPI)	0.512886	0.009860	0.265424	0.211831	CS pos: ?. Probable protein fragment    20
NZ_CP027599.1_63207	LIPO(Sec/SPII)	0.144473	0.009199	0.686976	0.159352	CS pos: 18-19. LQL-CP. Pr: 0.6579    41
NZ_CP027599.1_63220	SP(Sec/SPI)	0.441288	0.192447	0.044249	0.322017	CS pos: 29-30. AHS-FA. Pr: 0.2102    45
NZ_CP027599.1_63224	SP(Sec/SPI)	0.333196	0.213605	0.148130	0.305069	CS pos: 20-21. CRA-AA. Pr: 0.2260    29
NZ_CP027599.1_63247	SP(Sec/SPI)	0.360541	0.013023	0.354530	0.271906	CS pos: 21-22. SRC-TI. Pr: 0.1674    25
NZ_CP027599.1_63274	LIPO(Sec/SPII)	0.240003	0.013534	0.392695	0.353768	CS pos: 16-17. YSA-NT. Pr: 0.1345    18
NZ_CP027599.1_63306	LIPO(Sec/SPII)	0.104645	0.003765	0.649469	0.242121	CS pos: 19-20. GSG-CI. Pr: 0.6247    28
NZ_CP027599.1_63366	SP(Sec/SPI)	0.399776	0.136224	0.088224	0.375776	CS pos: 23-24. TWG-LF. Pr: 0.2626    41
NZ_CP027599.1_63378	SP(Sec/SPI)	0.427477	0.094424	0.140117	0.337982	CS pos: 24-25. VSA-AY. Pr: 0.2782    32
NZ_CP027599.1_63438	LIPO(Sec/SPII)	0.335618	0.004630	0.420393	0.239359	CS pos: 13-14. STI-CT. Pr: 0.3560    31
NZ_CP027599.1_63550	SP(Sec/SPI)	0.605304	0.022468	0.108169	0.264059	CS pos: 15-16. VRA-SG. Pr: 0.4339    20
NZ_CP027599.1_63551	LIPO(Sec/SPII)	0.126197	0.063012	0.688348	0.122443	CS pos: 13-14. SSA-CA. Pr: 0.6246    37
NZ_CP027599.1_63572	LIPO(Sec/SPII)	0.234973	0.040508	0.385724	0.338795	CS pos: ?. Probable protein fragment    16
NZ_CP027599.1_63579	SP(Sec/SPI)	0.540099	0.088995	0.042570	0.328336	CS pos: 34-35. SKA-ES. Pr: 0.4712    42
NZ_CP027599.1_63580	LIPO(Sec/SPII)	0.230599	0.011338	0.407411	0.350653	CS pos: 13-14. LFP-CY. Pr: 0.1849    37
NZ_CP027599.1_63583	LIPO(Sec/SPII)	0.070573	0.020062	0.886042	0.023323	CS pos: 17-18. PIS-CS. Pr: 0.8714    31
NZ_CP027599.1_63595	SP(Sec/SPI)	0.391832	0.075285	0.257337	0.275546	CS pos: 22-23. ASA-SL. Pr: 0.3353    39
NZ_CP027599.1_63610	SP(Sec/SPI)	0.429993	0.161972	0.104897	0.303137	CS pos: 16-17. GYG-ST. Pr: 0.1603    36
NZ_CP027599.1_63618	TAT(Tat/SPI)	0.306113	0.454943	0.090779	0.148165	CS pos: 26-27. SSA-RC. Pr: 0.2140    35
NZ_CP027599.1_63636	SP(Sec/SPI)	0.496100	0.072319	0.413837	0.017744	CS pos: 21-22. SFA-QP. Pr: 0.4518    48
NZ_CP027599.1_63679	LIPO(Sec/SPII)	0.310842	0.016260	0.394390	0.278508	CS pos: 15-16. TQR-VV. Pr: 0.0295    17
NZ_CP027599.1_63690	LIPO(Sec/SPII)	0.207527	0.017452	0.587293	0.187729	CS pos: 20-21. LPC-CA. Pr: 0.2380    27
NZ_CP027599.1_63707	SP(Sec/SPI)	0.365117	0.009088	0.295853	0.329941	CS pos: ?. Probable protein fragment    18
NZ_CP027599.1_63722	SP(Sec/SPI)	0.412636	0.113417	0.075369	0.398579	CS pos: 23-24. VAA-TI. Pr: 0.1240    40
NZ_CP027599.1_63767	LIPO(Sec/SPII)	0.230913	0.009384	0.422657	0.337046	CS pos: 13-14. FCC-CT. Pr: 0.0852    17
NZ_CP027599.1_63802	SP(Sec/SPI)	0.327394	0.021955	0.325631	0.325020	CS pos: 13-14. CRA-GI. Pr: 0.0865    16
NZ_CP027599.1_63833	LIPO(Sec/SPII)	0.180248	0.064187	0.417410	0.338155	CS pos: 13-14. NAS-CT. Pr: 0.3328    16
NZ_CP027599.1_63854	LIPO(Sec/SPII)	0.125666	0.171120	0.374389	0.328825	CS pos: 23-24. GVN-CC. Pr: 0.1709    41
NZ_CP027599.1_63869	LIPO(Sec/SPII)	0.145775	0.041380	0.543020	0.269825	CS pos: 19-20. VRS-CS. Pr: 0.4972    30
NZ_CP027599.1_63884	SP(Sec/SPI)	0.547969	0.023249	0.194658	0.234125	CS pos: 17-18. SSA-GE. Pr: 0.3681    20
NZ_CP027599.1_63893	SP(Sec/SPI)	0.729354	0.065346	0.124184	0.081116	CS pos: 18-19. SKA-QC. Pr: 0.7002    27
NZ_CP027599.1_63917	LIPO(Sec/SPII)	0.232349	0.020336	0.477842	0.269472	CS pos: ?. Probable protein fragment    15
NZ_CP027599.1_63924	LIPO(Sec/SPII)	0.217383	0.016244	0.430668	0.335706	CS pos: ?. Probable protein fragment    17
NZ_CP027599.1_63974	SP(Sec/SPI)	0.479587	0.059405	0.106388	0.354619	CS pos: 20-21. AVT-ST. Pr: 0.1197    35
NZ_CP027599.1_63982	TAT(Tat/SPI)	0.242878	0.378331	0.072630	0.306161	CS pos: 22-23. RHA-IP. Pr: 0.1248    30
NZ_CP027599.1_63995	SP(Sec/SPI)	0.438969	0.236367	0.054771	0.269894	CS pos: 16-17. VRS-AE. Pr: 0.3218    48
NZ_CP027599.1_64001	SP(Sec/SPI)	0.425288	0.267529	0.106906	0.200276	CS pos: 41-42. ANC-AT. Pr: 0.3651    48
NZ_CP027599.1_64007	TAT(Tat/SPI)	0.271293	0.392571	0.028118	0.308019	CS pos: 29-30. SRA-GS. Pr: 0.4519    46
NZ_CP027599.1_64015	TAT(Tat/SPI)	0.202813	0.381976	0.043949	0.371262	CS pos: 24-25. ASA-AL. Pr: 0.1418    29
NZ_CP027599.1_64016	SP(Sec/SPI)	0.644600	0.058491	0.123581	0.173329	CS pos: 14-15. ANA-AP. Pr: 0.6212    26
NZ_CP027599.1_64017	SP(Sec/SPI)	0.368313	0.082635	0.302905	0.246147	CS pos: 24-25. SHS-KP. Pr: 0.1986    45
NZ_CP027599.1_64036	LIPO(Sec/SPII)	0.219043	0.019410	0.564254	0.197293	CS pos: 16-17. STV-CS. Pr: 0.3310    18
NZ_CP027599.1_64065	TAT(Tat/SPI)	0.051183	0.564358	0.010592	0.373867	CS pos: 36-37. ARA-SK. Pr: 0.4550    47
NZ_CP027599.1_64076	LIPO(Sec/SPII)	0.349807	0.041966	0.375026	0.233201	CS pos: 15-16. AVC-CW. Pr: 0.2515    35
NZ_CP027599.1_64086	SP(Sec/SPI)	0.570741	0.020614	0.108519	0.300127	CS pos: 22-23. VRA-TP. Pr: 0.4683    28
NZ_CP027599.1_64092	SP(Sec/SPI)	0.429528	0.075723	0.186821	0.307929	CS pos: 17-18. ASA-VR. Pr: 0.2798    26
NZ_CP027599.1_64099	LIPO(Sec/SPII)	0.223783	0.055948	0.446112	0.274157	CS pos: 13-14. PHG-CL. Pr: 0.2464    17
NZ_CP027599.1_64107	SP(Sec/SPI)	0.667598	0.071276	0.077744	0.183381	CS pos: 21-22. SVA-SS. Pr: 0.3033    31
NZ_CP027599.1_64120	LIPO(Sec/SPII)	0.164766	0.056942	0.490816	0.287475	CS pos: 16-17. TSG-CV. Pr: 0.3276    20
NZ_CP027599.1_64125	LIPO(Sec/SPII)	0.153656	0.034661	0.584024	0.227659	CS pos: 19-20. ASS-CC. Pr: 0.3804    21
NZ_CP027599.1_64135	LIPO(Sec/SPII)	0.197637	0.112440	0.350390	0.339533	CS pos: 26-27. VCC-CA. Pr: 0.0670    28
NZ_CP027599.1_64157	LIPO(Sec/SPII)	0.108310	0.008289	0.644223	0.239178	CS pos: 16-17. FTA-CQ. Pr: 0.5735    48
NZ_CP027599.1_64162	LIPO(Sec/SPII)	0.106205	0.000828	0.870657	0.022310	CS pos: 13-14. LVA-CF. Pr: 0.3909    31
NZ_CP027599.1_64169	LIPO(Sec/SPII)	0.338737	0.025581	0.346962	0.288720	CS pos: 17-18. PPV-CS. Pr: 0.1265    27
NZ_CP027599.1_64195	LIPO(Sec/SPII)	0.196639	0.021463	0.578100	0.203798	CS pos: 14-15. TGS-CE. Pr: 0.4775    16
NZ_CP027599.1_64198	LIPO(Sec/SPII)	0.165387	0.008243	0.681633	0.144738	CS pos: 16-17. SVC-CS. Pr: 0.4070    19
NZ_CP027599.1_64210	SP(Sec/SPI)	0.506903	0.158962	0.045424	0.288711	CS pos: 23-24. ANA-TP. Pr: 0.5072    36
NZ_CP027599.1_64230	LIPO(Sec/SPII)	0.176239	0.019694	0.538299	0.265769	CS pos: 13-14. VSG-CA. Pr: 0.5361    34
NZ_CP027599.1_64234	SP(Sec/SPI)	0.524443	0.023025	0.257649	0.194883	CS pos: 16-17. IWG-SP. Pr: 0.1905    21
NZ_CP027599.1_64235	LIPO(Sec/SPII)	0.125731	0.010313	0.457755	0.406201	CS pos: 19-20. LAS-CL. Pr: 0.3636    29
NZ_CP027599.1_64259	SP(Sec/SPI)	0.601895	0.088117	0.046714	0.263274	CS pos: 16-17. IHA-AD. Pr: 0.5778    28
NZ_CP027599.1_64269	SP(Sec/SPI)	0.722095	0.105588	0.025336	0.146980	CS pos: 24-25. TQA-AL. Pr: 0.6024    34
NZ_CP027599.1_64274	LIPO(Sec/SPII)	0.274291	0.022153	0.423350	0.280206	CS pos: ?. Probable protein fragment    15
NZ_CP027599.1_64287	SP(Sec/SPI)	0.702065	0.049060	0.083334	0.165542	CS pos: 19-20. SFS-DT. Pr: 0.5607    25
NZ_CP027599.1_64288	SP(Sec/SPI)	0.577283	0.092571	0.051704	0.278442	CS pos: 15-16. AEA-SS. Pr: 0.5466    26
NZ_CP027599.1_64301	SP(Sec/SPI)	0.382011	0.185367	0.067666	0.364956	CS pos: 29-30. ASA-SL. Pr: 0.3111    32
NZ_CP027599.1_64305	LIPO(Sec/SPII)	0.103704	0.014423	0.811313	0.070559	CS pos: 12-13. ASA-CG. Pr: 0.7973    30
NZ_CP027599.1_64345	SP(Sec/SPI)	0.676942	0.044006	0.199642	0.079411	CS pos: 21-22. GLA-SS. Pr: 0.3103    32
NZ_CP027599.1_64350	SP(Sec/SPI)	0.548832	0.156442	0.037122	0.257604	CS pos: 23-24. VEP-FN. Pr: 0.1439    43
NZ_CP027599.1_64352	LIPO(Sec/SPII)	0.234516	0.067014	0.569344	0.129126	CS pos: 21-22. KAT-CS. Pr: 0.5254    30
NZ_CP027599.1_64378	SP(Sec/SPI)	0.463884	0.045211	0.116083	0.374823	CS pos: 21-22. EFA-TY. Pr: 0.1775    34
NZ_CP027599.1_64389	SP(Sec/SPI)	0.390558	0.071468	0.157186	0.380788	CS pos: 10-11. GLA-GG. Pr: 0.0866    23
NZ_CP027599.1_64404	LIPO(Sec/SPII)	0.143258	0.016391	0.668858	0.171494	CS pos: 22-23. TLG-CS. Pr: 0.5960    40
NZ_CP027599.1_64408	LIPO(Sec/SPII)	0.103272	0.085913	0.411942	0.398873	CS pos: 23-24. QAG-CE. Pr: 0.3881    34
NZ_CP027599.1_64424	LIPO(Sec/SPII)	0.301689	0.025333	0.363028	0.309949	CS pos: 14-15. TSG-LA. Pr: 0.0485    16
NZ_CP027599.1_64427	LIPO(Sec/SPII)	0.229174	0.010289	0.423109	0.337429	CS pos: ?. Probable protein fragment    30
NZ_CP027599.1_64481	LIPO(Sec/SPII)	0.263957	0.058906	0.357387	0.319750	CS pos: 21-22. STR-CV. Pr: 0.1878    25
NZ_CP027599.1_64488	LIPO(Sec/SPII)	0.177890	0.016598	0.515812	0.289701	CS pos: 25-26. ICS-CR. Pr: 0.3688    32
NZ_CP027599.1_64492	LIPO(Sec/SPII)	0.079379	0.080462	0.747067	0.093091	CS pos: 21-22. LTA-CS. Pr: 0.7321    33
NZ_CP027599.1_64494	LIPO(Sec/SPII)	0.154188	0.026306	0.479518	0.339989	CS pos: 17-18. APS-CQ. Pr: 0.3984    26
NZ_CP027599.1_64506	LIPO(Sec/SPII)	0.175814	0.033371	0.533884	0.256932	CS pos: 18-19. GRG-CP. Pr: 0.4383    37
NZ_CP027599.1_64510	LIPO(Sec/SPII)	0.220837	0.061375	0.383763	0.334025	CS pos: ?. Probable protein fragment    15
NZ_CP027599.1_64561	LIPO(Sec/SPII)	0.139591	0.010440	0.499739	0.350231	CS pos: 22-23. IIG-CR. Pr: 0.4022    41
NZ_CP027599.1_64564	SP(Sec/SPI)	0.410080	0.041176	0.148757	0.399987	CS pos: 13-14. TAA-YF. Pr: 0.0746    18
NZ_CP027599.1_64569	LIPO(Sec/SPII)	0.092726	0.018921	0.476108	0.412245	CS pos: 15-16. GSG-CR. Pr: 0.4046    22
NZ_CP027599.1_64602	LIPO(Sec/SPII)	0.087704	0.005847	0.460719	0.445730	CS pos: 23-24. TLA-CC. Pr: 0.3058    50
NZ_CP027599.1_64610	LIPO(Sec/SPII)	0.082525	0.007616	0.509543	0.400315	CS pos: 38-39. LTS-CR. Pr: 0.2836    40
NZ_CP027599.1_64614	LIPO(Sec/SPII)	0.151264	0.017637	0.503788	0.327310	CS pos: 29-30. RTA-CW. Pr: 0.4960    39
NZ_CP027599.1_64618	SP(Sec/SPI)	0.782787	0.043488	0.034639	0.139086	CS pos: 13-14. VHA-DQ. Pr: 0.7676    24
NZ_CP027599.1_64619	LIPO(Sec/SPII)	0.086260	0.021402	0.641983	0.250355	CS pos: 18-19. LSS-CT. Pr: 0.6254    22
NZ_CP027599.1_64631	SP(Sec/SPI)	0.540365	0.092039	0.040911	0.326686	CS pos: 18-19. AIA-TS. Pr: 0.4443    42
NZ_CP027599.1_64658	SP(Sec/SPI)	0.335700	0.125222	0.272474	0.266604	CS pos: 17-18. SSA-AS. Pr: 0.0943    21
NZ_CP027599.1_64659	LIPO(Sec/SPII)	0.290035	0.030573	0.376736	0.302656	CS pos: ?. Probable protein fragment    15
NZ_CP027599.1_64660	SP(Sec/SPI)	0.567343	0.024521	0.131167	0.276970	CS pos: 21-22. VSA-ER. Pr: 0.4237    36
NZ_CP027599.1_64717	LIPO(Sec/SPII)	0.336023	0.014573	0.464093	0.185311	CS pos: ?. Probable protein fragment    15
NZ_CP027599.1_64753	SP(Sec/SPI)	0.409175	0.074677	0.176709	0.339438	CS pos: 20-21. TSS-ND. Pr: 0.2243    27
NZ_CP027599.1_64761	LIPO(Sec/SPII)	0.242395	0.049470	0.357035	0.351100	CS pos: 14-15. FLF-CS. Pr: 0.0418    16
NZ_CP027599.1_64766	LIPO(Sec/SPII)	0.286891	0.048405	0.478447	0.186258	CS pos: 21-22. CLT-CS. Pr: 0.2294    34
NZ_CP027599.1_64782	TAT(Tat/SPI)	0.066629	0.670336	0.012210	0.250825	CS pos: 33-34. CAA-RS. Pr: 0.4315    45
NZ_CP027599.1_64791	SP(Sec/SPI)	0.554199	0.031691	0.098894	0.315216	CS pos: 19-20. FSA-LR. Pr: 0.2107    28
NZ_CP027599.1_64798	LIPO(Sec/SPII)	0.241840	0.077941	0.464320	0.215899	CS pos: 14-15. HGT-CT. Pr: 0.1265    20
NZ_CP027599.1_64821	LIPO(Sec/SPII)	0.151575	0.022209	0.584615	0.241601	CS pos: 12-13. FFA-CS. Pr: 0.4990    18
NZ_CP027599.1_64837	SP(Sec/SPI)	0.417722	0.101296	0.074968	0.406015	CS pos: 21-22. VLP-EQ. Pr: 0.1887    39
NZ_CP027599.1_64877	LIPO(Sec/SPII)	0.099140	0.073148	0.687885	0.139828	CS pos: 15-16. AVG-CS. Pr: 0.6689    23
NZ_CP027599.1_64884	SP(Sec/SPI)	0.949991	0.013009	0.023785	0.013216	CS pos: 27-28. AWA-QP. Pr: 0.8961    47
NZ_CP027599.1_64930	LIPO(Sec/SPII)	0.160521	0.025349	0.437205	0.376924	CS pos: 17-18. ITA-CS. Pr: 0.2877    19
NZ_CP027599.1_64933	SP(Sec/SPI)	0.387720	0.048257	0.309087	0.254936	CS pos: 24-25. LHG-HD. Pr: 0.3272    33
NZ_CP027599.1_64935	SP(Sec/SPI)	0.357380	0.020806	0.323634	0.298180	CS pos: 19-20. ATA-TR. Pr: 0.1560    24
NZ_CP027599.1_64946	LIPO(Sec/SPII)	0.145809	0.015828	0.477764	0.360599	CS pos: 20-21. CAS-CT. Pr: 0.3280    22
NZ_CP027599.1_64948	LIPO(Sec/SPII)	0.146315	0.019133	0.445249	0.389303	CS pos: 14-15. VTG-CG. Pr: 0.3493    21
NZ_CP027599.1_64950	LIPO(Sec/SPII)	0.088472	0.002612	0.552113	0.356803	CS pos: 19-20. ALC-CC. Pr: 0.2926    33
NZ_CP027599.1_64958	LIPO(Sec/SPII)	0.185216	0.058595	0.499916	0.256273	CS pos: 18-19. RAS-CS. Pr: 0.4259    31
NZ_CP027599.1_64974	TAT(Tat/SPI)	0.282311	0.492194	0.039375	0.186120	CS pos: 30-31. LSA-TP. Pr: 0.5836    36
NZ_CP027599.1_65004	LIPO(Sec/SPII)	0.246664	0.036293	0.403807	0.313236	CS pos: 18-19. LVA-NH. Pr: 0.1216    20
NZ_CP027599.1_65005	LIPO(Sec/SPII)	0.261947	0.013166	0.459001	0.265886	CS pos: 21-22. NLG-CT. Pr: 0.3503    27
NZ_CP027599.1_65007	SP(Sec/SPI)	0.469549	0.071454	0.035164	0.423834	CS pos: 20-21. AHA-SD. Pr: 0.4184    33
NZ_CP027599.1_65023	LIPO(Sec/SPII)	0.131496	0.038774	0.497252	0.332477	CS pos: 12-13. MTA-CK. Pr: 0.4474    27
NZ_CP027599.1_65041	SP(Sec/SPI)	0.411530	0.081447	0.135339	0.371683	CS pos: 40-41. AMA-TW. Pr: 0.1720    49
NZ_CP027599.1_65048	LIPO(Sec/SPII)	0.041829	0.004109	0.899339	0.054723	CS pos: 13-14. SVG-CG. Pr: 0.8702    19
NZ_CP027599.1_65056	LIPO(Sec/SPII)	0.168044	0.053869	0.453987	0.324100	CS pos: 13-14. TSA-CT. Pr: 0.4590    16
NZ_CP027599.1_65065	TAT(Tat/SPI)	0.261315	0.350346	0.049394	0.338944	CS pos: 27-28. TRA-DS. Pr: 0.3925    31
NZ_CP027599.1_65104	LIPO(Sec/SPII)	0.226985	0.025638	0.412077	0.335301	CS pos: 21-22. VTM-CW. Pr: 0.3257    28
NZ_CP027599.1_65119	LIPO(Sec/SPII)	0.251806	0.050253	0.445929	0.252011	CS pos: 10-11. VAA-CN. Pr: 0.4288    15
NZ_CP027599.1_65147	SP(Sec/SPI)	0.659132	0.047348	0.179037	0.114483	CS pos: 19-20. VLP-AG. Pr: 0.2109    35
NZ_CP027599.1_65165	LIPO(Sec/SPII)	0.143879	0.014844	0.566588	0.274689	CS pos: 30-31. MPA-CC. Pr: 0.4829    34
NZ_CP027599.1_65167	SP(Sec/SPI)	0.448900	0.156046	0.128987	0.266068	CS pos: 19-20. TRA-TP. Pr: 0.1483    34
NZ_CP027599.1_65169	LIPO(Sec/SPII)	0.180783	0.045947	0.422313	0.350956	CS pos: 18-19. TSA-CG. Pr: 0.2473    26
NZ_CP027599.1_65172	LIPO(Sec/SPII)	0.141921	0.038191	0.639970	0.179919	CS pos: 12-13. LAP-CN. Pr: 0.6105    32
NZ_CP027599.1_65198	LIPO(Sec/SPII)	0.300284	0.008129	0.444705	0.246881	CS pos: 11-12. LCG-CA. Pr: 0.1305    18
NZ_CP027599.1_65208	LIPO(Sec/SPII)	0.164871	0.042206	0.402732	0.390191	CS pos: 21-22. HAG-CG. Pr: 0.3974    39
NZ_CP027599.1_65210	LIPO(Sec/SPII)	0.166696	0.048952	0.643440	0.140911	CS pos: 12-13. TSS-CS. Pr: 0.4954    38
NZ_CP027599.1_65230	LIPO(Sec/SPII)	0.280249	0.014726	0.618109	0.086916	CS pos: 13-14. VYS-CA. Pr: 0.5214    21
NZ_CP027599.1_65245	SP(Sec/SPI)	0.505131	0.075506	0.045257	0.374106	CS pos: 17-18. AFA-HW. Pr: 0.5030    26
NZ_CP027599.1_65260	SP(Sec/SPI)	0.400568	0.062065	0.189853	0.347514	CS pos: 22-23. AFG-SP. Pr: 0.0684    31
NZ_CP027599.1_65274	SP(Sec/SPI)	0.314883	0.304826	0.094656	0.285635	CS pos: 23-24. AFA-AS. Pr: 0.3120    42
NZ_CP027599.1_65296	LIPO(Sec/SPII)	0.073905	0.042729	0.561788	0.321578	CS pos: 22-23. FST-CQ. Pr: 0.2636    43
NZ_CP027599.1_65305	SP(Sec/SPI)	0.543301	0.130217	0.165788	0.160694	CS pos: 19-20. VSA-AT. Pr: 0.4068    45
NZ_CP027599.1_65312	LIPO(Sec/SPII)	0.303087	0.051099	0.349150	0.296663	CS pos: 20-21. TPG-CC. Pr: 0.1562    22
NZ_CP027599.1_65342	LIPO(Sec/SPII)	0.208394	0.025053	0.402084	0.364469	CS pos: 12-13. ALA-CS. Pr: 0.3923    25
NZ_CP027599.1_65382	TAT(Tat/SPI)	0.308707	0.418186	0.182390	0.090717	CS pos: 23-24. LNS-AP. Pr: 0.2995    41
NZ_CP027599.1_65432	SP(Sec/SPI)	0.540545	0.127233	0.055446	0.276775	CS pos: 14-15. AWA-DC. Pr: 0.4507    39
NZ_CP027599.1_65439	LIPO(Sec/SPII)	0.104431	0.069929	0.551193	0.274448	CS pos: 16-17. ATG-CS. Pr: 0.5376    30
NZ_CP027599.1_65453	LIPO(Sec/SPII)	0.125703	0.006385	0.666751	0.201162	CS pos: 23-24. LWA-CS. Pr: 0.6357    31
NZ_CP027599.1_65466	LIPO(Sec/SPII)	0.099121	0.053334	0.732390	0.115154	CS pos: 24-25. FSA-CP. Pr: 0.7219    30
NZ_CP027599.1_65485	TAT(Tat/SPI)	0.136486	0.359650	0.174147	0.329718	CS pos: 21-22. AAC-FQ. Pr: 0.0227    25
NZ_CP027599.1_65486	SP(Sec/SPI)	0.341138	0.011626	0.325812	0.321424	CS pos: 17-18. VLA-RQ. Pr: 0.1341    19
NZ_CP027599.1_65498	LIPO(Sec/SPII)	0.225792	0.012620	0.383529	0.378060	CS pos: 13-14. LQQ-CT. Pr: 0.2499    20
NZ_CP027599.1_65548	SP(Sec/SPI)	0.421780	0.140182	0.061754	0.376284	CS pos: 19-20. ASA-YV. Pr: 0.4110    29
NZ_CP027599.1_65552	SP(Sec/SPI)	0.446418	0.128351	0.128414	0.296817	CS pos: 23-24. RWA-MT. Pr: 0.1660    42
NZ_CP027599.1_65573	LIPO(Sec/SPII)	0.155267	0.015939	0.488463	0.340331	CS pos: 24-25. FLS-CK. Pr: 0.4427    29
NZ_CP027599.1_65584	LIPO(Sec/SPII)	0.070369	0.002873	0.907699	0.019060	CS pos: 14-15. LAA-CG. Pr: 0.8945    23
NZ_CP027599.1_65590	LIPO(Sec/SPII)	0.405762	0.002780	0.588075	0.003382	CS pos: 21-22. LAY-CR. Pr: 0.5791    46
NZ_CP027599.1_65594	LIPO(Sec/SPII)	0.030146	0.036594	0.913514	0.019745	CS pos: 16-17. VAS-CN. Pr: 0.9135    39
NZ_CP027599.1_65606	SP(Sec/SPI)	0.605128	0.123176	0.129939	0.141758	CS pos: 20-21. SYS-AP. Pr: 0.3798    24
NZ_CP027599.1_65616	SP(Sec/SPI)	0.467417	0.030948	0.112306	0.389329	CS pos: 12-13. ALS-AE. Pr: 0.2315    30
NZ_CP027599.1_65632	LIPO(Sec/SPII)	0.099000	0.001341	0.848031	0.051628	CS pos: 15-16. FIA-TT. Pr: 0.7476    46
NZ_CP027599.1_65640	SP(Sec/SPI)	0.606300	0.001833	0.152369	0.239498	CS pos: 30-31. AIA-EP. Pr: 0.5216    40
NZ_CP027599.1_65660	SP(Sec/SPI)	0.337559	0.329962	0.054581	0.277898	CS pos: 28-29. TLA-TS. Pr: 0.3349    42
NZ_CP027599.1_65675	SP(Sec/SPI)	0.406987	0.038474	0.298763	0.255775	CS pos: 16-17. ISA-IP. Pr: 0.2217    25
NZ_CP027599.1_65680	LIPO(Sec/SPII)	0.143396	0.025744	0.524323	0.306537	CS pos: 15-16. GAG-CR. Pr: 0.4479    17
NZ_CP027599.1_65688	LIPO(Sec/SPII)	0.252039	0.020455	0.374612	0.352894	CS pos: ?. Probable protein fragment    18
NZ_CP027599.1_65696	SP(Sec/SPI)	0.526580	0.057101	0.026616	0.389702	CS pos: 18-19. ARA-TL. Pr: 0.4893    39
NZ_CP027599.1_65798	LIPO(Sec/SPII)	0.290505	0.016769	0.570688	0.122039	CS pos: 19-20. AVC-CA. Pr: 0.4180    33
NZ_CP027599.1_65810	LIPO(Sec/SPII)	0.114293	0.024613	0.602938	0.258156	CS pos: 12-13. SFG-CQ. Pr: 0.5409    18
NZ_CP027599.1_65833	SP(Sec/SPI)	0.355953	0.058610	0.324144	0.261293	CS pos: 24-25. IFS-IP. Pr: 0.0990    47
NZ_CP027599.1_65839	SP(Sec/SPI)	0.584830	0.037454	0.212393	0.165323	CS pos: 29-30. VSS-AV. Pr: 0.3190    37
NZ_CP027599.1_65879	LIPO(Sec/SPII)	0.043584	0.003310	0.775467	0.177639	CS pos: 15-16. VAG-CW. Pr: 0.7598    19
NZ_CP027599.1_65927	LIPO(Sec/SPII)	0.108435	0.094068	0.678940	0.118558	CS pos: 20-21. ATS-CR. Pr: 0.5901    23
NZ_CP027599.1_65929	LIPO(Sec/SPII)	0.344455	0.020381	0.376480	0.258685	CS pos: 23-24. ASL-CR. Pr: 0.2483    28
NZ_CP027599.1_65941	LIPO(Sec/SPII)	0.238843	0.056724	0.518943	0.185490	CS pos: 16-17. SLS-CL. Pr: 0.2386    37
NZ_CP027599.1_65943	SP(Sec/SPI)	0.471003	0.206764	0.260069	0.062165	CS pos: 23-24. ALS-NC. Pr: 0.5628    40
NZ_CP027599.1_65968	SP(Sec/SPI)	0.452375	0.171902	0.143657	0.232067	CS pos: 22-23. AAA-SI. Pr: 0.2871    34
NZ_CP027599.1_66005	SP(Sec/SPI)	0.322251	0.266979	0.102320	0.308449	CS pos: 26-27. AFA-SS. Pr: 0.0764    32
NZ_CP027599.1_66008	LIPO(Sec/SPII)	0.372394	0.056698	0.564385	0.006523	CS pos: 12-13. MTA-CA. Pr: 0.4604    49
NZ_CP027599.1_66009	LIPO(Sec/SPII)	0.161813	0.088491	0.611682	0.138014	CS pos: 31-32. STS-CA. Pr: 0.5876    46
NZ_CP027599.1_66019	SP(Sec/SPI)	0.578298	0.049133	0.084312	0.288258	CS pos: 15-16. AHA-AA. Pr: 0.3131    25
NZ_CP027599.1_66020	LIPO(Sec/SPII)	0.184061	0.189566	0.383739	0.242634	CS pos: 23-24. RIF-CG. Pr: 0.1391    45
NZ_CP027599.1_66031	LIPO(Sec/SPII)	0.231993	0.002007	0.644509	0.121491	CS pos: 11-12. MSG-CC. Pr: 0.5374    40
NZ_CP027599.1_66060	LIPO(Sec/SPII)	0.098905	0.020149	0.515747	0.365199	CS pos: 17-18. WTA-CC. Pr: 0.3664    26
NZ_CP027599.1_66078	LIPO(Sec/SPII)	0.285118	0.021267	0.358382	0.335233	CS pos: 19-20. MVC-CC. Pr: 0.0701    21
NZ_CP027599.1_66082	SP(Sec/SPI)	0.424240	0.070047	0.116596	0.389117	CS pos: 16-17. VHA-VR. Pr: 0.3683    26
NZ_CP027599.1_66096	SP(Sec/SPI)	0.620597	0.016757	0.031229	0.331417	CS pos: 23-24. SQA-FF. Pr: 0.4950    36
NZ_CP027599.1_66102	LIPO(Sec/SPII)	0.218794	0.020616	0.691207	0.069384	CS pos: 21-22. ICH-CQ. Pr: 0.4599    43
NZ_CP027599.1_66103	SP(Sec/SPI)	0.570022	0.133515	0.100322	0.196141	CS pos: 16-17. TSA-AT. Pr: 0.3522    22
NZ_CP027599.1_66130	LIPO(Sec/SPII)	0.292216	0.045721	0.546535	0.115528	CS pos: 16-17. LTV-CA. Pr: 0.4871    24
NZ_CP027599.1_66136	SP(Sec/SPI)	0.475000	0.212761	0.028514	0.283725	CS pos: 17-18. IRA-AD. Pr: 0.5206    29
NZ_CP027599.1_66168	TAT(Tat/SPI)	0.061199	0.444212	0.335493	0.159097	CS pos: ?. Probable protein fragment    23
NZ_CP027599.1_66169	SP(Sec/SPI)	0.333422	0.044567	0.290640	0.331371	CS pos: 19-20. VLA-IT. Pr: 0.0691    27
NZ_CP027599.1_66179	SP(Sec/SPI)	0.512771	0.174261	0.052643	0.260326	CS pos: 22-23. ARA-AT. Pr: 0.5504    38
NZ_CP027599.1_66183	SP(Sec/SPI)	0.883515	0.027849	0.060598	0.028038	CS pos: 28-29. SVA-SE. Pr: 0.4830    38
NZ_CP027599.1_66227	SP(Sec/SPI)	0.359553	0.095834	0.277390	0.267223	CS pos: ?. Probable protein fragment    25
NZ_CP027599.1_66238	SP(Sec/SPI)	0.391065	0.202335	0.040171	0.366429	CS pos: 12-13. ASA-ET. Pr: 0.2352    38
NZ_CP027599.1_66299	LIPO(Sec/SPII)	0.107891	0.018941	0.770339	0.102829	CS pos: 21-22. LVT-CW. Pr: 0.6010    50
NZ_CP027599.1_66321	LIPO(Sec/SPII)	0.241709	0.008828	0.412270	0.337192	CS pos: 14-15. WIL-CT. Pr: 0.0099    19
NZ_CP027599.1_66325	TAT(Tat/SPI)	0.060122	0.747814	0.119434	0.072630	CS pos: 28-29. ACA-AS. Pr: 0.3511    34
NZ_CP027599.1_66326	TAT(Tat/SPI)	0.301390	0.371856	0.037825	0.288929	CS pos: 29-30. NTA-NE. Pr: 0.1953    37
NZ_CP027599.1_66331	LIPO(Sec/SPII)	0.300887	0.006489	0.431971	0.260652	CS pos: 18-19. ATR-CQ. Pr: 0.3954    45
NZ_CP027599.1_66389	SP(Sec/SPI)	0.679346	0.149772	0.014934	0.155949	CS pos: 19-20. ATA-AN. Pr: 0.6900    33
NZ_CP027599.1_66399	LIPO(Sec/SPII)	0.196028	0.008246	0.461798	0.333928	CS pos: 18-19. INV-CQ. Pr: 0.3207    20
NZ_CP027599.1_66424	LIPO(Sec/SPII)	0.223852	0.038934	0.377249	0.359965	CS pos: 19-20. ISA-AG. Pr: 0.1908    45
NZ_CP027599.1_66429	LIPO(Sec/SPII)	0.010260	0.013663	0.908879	0.067197	CS pos: 24-25. IAA-CA. Pr: 0.8900    39
NZ_CP027599.1_66516	SP(Sec/SPI)	0.418023	0.120925	0.077908	0.383143	CS pos: 27-28. APA-AS. Pr: 0.0563    44
NZ_CP027599.1_66573	SP(Sec/SPI)	0.390057	0.023026	0.205692	0.381225	CS pos: 19-20. VLA-AS. Pr: 0.2947    29
NZ_CP027599.1_66579	LIPO(Sec/SPII)	0.418906	0.004248	0.424520	0.152326	CS pos: 10-11. LIS-CF. Pr: 0.2277    24
NZ_CP027599.1_66602	LIPO(Sec/SPII)	0.118376	0.009153	0.709533	0.162938	CS pos: 19-20. SYS-CF. Pr: 0.6361    22
NZ_CP027599.1_66611	LIPO(Sec/SPII)	0.148017	0.005317	0.745703	0.100964	CS pos: 21-22. TCA-CG. Pr: 0.6075    23
NZ_CP027599.1_66613	SP(Sec/SPI)	0.520552	0.045210	0.104970	0.329268	CS pos: 26-27. SEA-VN. Pr: 0.3231    32
NZ_CP027599.1_66633	SP(Sec/SPI)	0.503091	0.148422	0.253836	0.094650	CS pos: 27-28. VRA-PK. Pr: 0.2767    42
NZ_CP027599.1_66638	SP(Sec/SPI)	0.650012	0.107378	0.104064	0.138546	CS pos: 22-23. SRS-AR. Pr: 0.2573    47
NZ_CP027599.1_66652	SP(Sec/SPI)	0.578103	0.041855	0.181063	0.198980	CS pos: 17-18. AQS-RR. Pr: 0.1776    49
NZ_CP027599.1_66656	LIPO(Sec/SPII)	0.118024	0.009082	0.529824	0.343070	CS pos: 16-17. SNT-CA. Pr: 0.4648    30
NZ_CP027599.1_66657	SP(Sec/SPI)	0.747305	0.012876	0.152960	0.086858	CS pos: 24-25. SQS-LI. Pr: 0.3766    49
NZ_CP027599.1_66662	LIPO(Sec/SPII)	0.245368	0.021735	0.422090	0.310806	CS pos: 16-17. VIT-CS. Pr: 0.0506    20
NZ_CP027599.1_66708	TAT(Tat/SPI)	0.197547	0.413200	0.056224	0.333028	CS pos: 28-29. TFS-LP. Pr: 0.2592    31
NZ_CP027599.1_66717	TAT(Tat/SPI)	0.155417	0.435659	0.120548	0.288375	CS pos: ?. Probable protein fragment    18
NZ_CP027599.1_66740	LIPO(Sec/SPII)	0.066220	0.005237	0.625700	0.302843	CS pos: 17-18. ESA-CI. Pr: 0.5949    22
NZ_CP027599.1_66751	TAT(Tat/SPI)	0.302128	0.346675	0.106663	0.244534	CS pos: ?. Probable protein fragment    31
NZ_CP027599.1_66772	SP(Sec/SPI)	0.652220	0.008765	0.128917	0.210098	CS pos: 21-22. SAA-HQ. Pr: 0.2841    38
NZ_CP027599.1_66798	SP(Sec/SPI)	0.431889	0.063114	0.094449	0.410547	CS pos: 28-29. PSA-SY. Pr: 0.0959    35
NZ_CP027599.1_66803	SP(Sec/SPI)	0.558461	0.041749	0.116004	0.283786	CS pos: 18-19. THA-NE. Pr: 0.4389    20
NZ_CP027599.1_66850	LIPO(Sec/SPII)	0.298829	0.045559	0.340595	0.315017	CS pos: 20-21. ASG-CT. Pr: 0.2822    23
NZ_CP027599.1_66904	LIPO(Sec/SPII)	0.038149	0.022351	0.765242	0.174258	CS pos: 17-18. LVS-CG. Pr: 0.7638    43
NZ_CP027599.1_66961	LIPO(Sec/SPII)	0.126646	0.004166	0.727791	0.141397	CS pos: 24-25. AIN-CS. Pr: 0.6392    28
NZ_CP027599.1_66976	LIPO(Sec/SPII)	0.015035	0.001862	0.897580	0.085523	CS pos: 22-23. YSS-CS. Pr: 0.8947    44
NZ_CP027599.1_67027	SP(Sec/SPI)	0.392976	0.295378	0.110728	0.200918	CS pos: 21-22. ARS-AG. Pr: 0.3076    29
NZ_CP027599.1_67029	SP(Sec/SPI)	0.403530	0.025558	0.281438	0.289475	CS pos: 16-17. AGA-TH. Pr: 0.1013    23
NZ_CP027599.1_67076	TAT(Tat/SPI)	0.306898	0.328608	0.091479	0.273015	CS pos: 25-26. TSG-SV. Pr: 0.0313    27
NZ_CP027599.1_67091	SP(Sec/SPI)	0.542833	0.003141	0.268539	0.185487	CS pos: 24-25. SQG-LA. Pr: 0.1960    28
NZ_CP027599.1_67119	LIPO(Sec/SPII)	0.185895	0.002888	0.443534	0.367683	CS pos: 20-21. VPL-CY. Pr: 0.3612    29
NZ_CP027599.1_67156	TAT(Tat/SPI)	0.224150	0.363422	0.078648	0.333780	CS pos: 25-26. AGA-GT. Pr: 0.0211    30
NZ_CP027599.1_67160	LIPO(Sec/SPII)	0.348111	0.016431	0.380806	0.254652	CS pos: 21-22. AAS-CS. Pr: 0.2943    23
NZ_CP027599.1_67166	LIPO(Sec/SPII)	0.040832	0.250998	0.695950	0.012219	CS pos: 22-23. SSA-CA. Pr: 0.6964    47
NZ_CP027599.1_67187	LIPO(Sec/SPII)	0.308142	0.017339	0.351028	0.323492	CS pos: ?. Probable protein fragment    17
NZ_CP027599.1_67191	LIPO(Sec/SPII)	0.207074	0.021761	0.641309	0.129856	CS pos: 15-16. SCT-CT. Pr: 0.2620    18
NZ_CP027599.1_67210	LIPO(Sec/SPII)	0.067338	0.016278	0.541809	0.374574	CS pos: 21-22. QLS-CP. Pr: 0.5161    33
NZ_CP027599.1_67242	TAT(Tat/SPI)	0.142253	0.399115	0.084666	0.373965	CS pos: 25-26. VNA-QL. Pr: 0.3334    32
NZ_CP027599.1_67245	LIPO(Sec/SPII)	0.006763	0.000789	0.949397	0.043050	CS pos: 22-23. TTG-CV. Pr: 0.9457    32
NZ_CP027599.1_67261	LIPO(Sec/SPII)	0.256416	0.035796	0.386521	0.321267	CS pos: ?. Probable protein fragment    15
NZ_CP027599.1_67305	LIPO(Sec/SPII)	0.103555	0.056926	0.479621	0.359899	CS pos: 20-21. AFA-CY. Pr: 0.5334    36
NZ_CP027599.1_67310	LIPO(Sec/SPII)	0.357494	0.011205	0.383554	0.247748	CS pos: 12-13. SPA-CG. Pr: 0.2203    23
NZ_CP027599.1_67327	SP(Sec/SPI)	0.816672	0.107666	0.018119	0.057543	CS pos: 29-30. ANA-AA. Pr: 0.5311    39
NZ_CP027599.1_67341	SP(Sec/SPI)	0.543776	0.187787	0.024002	0.244435	CS pos: 19-20. AAA-DT. Pr: 0.2815    39
NZ_CP027599.1_67379	LIPO(Sec/SPII)	0.138876	0.029903	0.518169	0.313053	CS pos: 19-20. LIA-CC. Pr: 0.4077    37
NZ_CP027599.1_67384	SP(Sec/SPI)	0.450571	0.074144	0.038896	0.436389	CS pos: 26-27. VSA-HQ. Pr: 0.3626    43
NZ_CP027599.1_67432	SP(Sec/SPI)	0.631934	0.025376	0.122931	0.219759	CS pos: 17-18. LQA-RT. Pr: 0.4373    33
NZ_CP027599.1_67459	LIPO(Sec/SPII)	0.191061	0.013025	0.404802	0.391112	CS pos: ?. Probable protein fragment    19
NZ_CP027599.1_67520	LIPO(Sec/SPII)	0.071129	0.001733	0.816262	0.110876	CS pos: 22-23. FHA-CF. Pr: 0.8192    40
NZ_CP027599.1_67535	LIPO(Sec/SPII)	0.229156	0.030995	0.472928	0.266921	CS pos: ?. Probable protein fragment    15
NZ_CP027599.1_67536	LIPO(Sec/SPII)	0.241404	0.008643	0.378723	0.371231	CS pos: 18-19. ICC-CA. Pr: 0.1002    26
NZ_CP027599.1_67582	LIPO(Sec/SPII)	0.238855	0.017080	0.516456	0.227608	CS pos: 16-17. WAR-CM. Pr: 0.4755    41
NZ_CP027599.1_67590	LIPO(Sec/SPII)	0.012238	0.000520	0.973820	0.013422	CS pos: 16-17. IAG-CD. Pr: 0.9734    27
NZ_CP027599.1_67592	TAT(Tat/SPI)	0.303911	0.368642	0.055878	0.271570	CS pos: 27-28. ALS-NR. Pr: 0.4583    32
NZ_CP027599.1_67616	LIPO(Sec/SPII)	0.085301	0.011814	0.599405	0.303480	CS pos: 23-24. CHG-CS. Pr: 0.5125    34
NZ_CP027599.1_67625	LIPO(Sec/SPII)	0.176936	0.009910	0.462402	0.350752	CS pos: 15-16. SLS-CV. Pr: 0.4015    22
NZ_CP027599.1_67626	SP(Sec/SPI)	0.736499	0.007809	0.143255	0.112437	CS pos: 24-25. VTC-NT. Pr: 0.3805    35
NZ_CP027599.1_67646	LIPO(Sec/SPII)	0.203845	0.286967	0.297188	0.212000	CS pos: 17-18. CCC-CS. Pr: 0.0733    34
NZ_CP027599.1_67679	SP(Sec/SPI)	0.574884	0.016972	0.139570	0.268574	CS pos: 16-17. VSS-DS. Pr: 0.3493    44
NZ_CP027599.1_67703	LIPO(Sec/SPII)	0.153223	0.011690	0.625549	0.209538	CS pos: 17-18. TSG-CT. Pr: 0.5016    24
NZ_CP027599.1_67704	TAT(Tat/SPI)	0.263728	0.518423	0.035322	0.182527	CS pos: 33-34. PHA-DQ. Pr: 0.1684    49
NZ_CP027599.1_67716	LIPO(Sec/SPII)	0.283919	0.022911	0.350858	0.342312	CS pos: 29-30. SAG-CQ. Pr: 0.2596    41
NZ_CP027599.1_67746	SP(Sec/SPI)	0.346228	0.066311	0.243810	0.343651	CS pos: 14-15. SPA-AT. Pr: 0.0769    17
NZ_CP027599.1_67749	LIPO(Sec/SPII)	0.257978	0.012292	0.473077	0.256653	CS pos: 22-23. SFS-CG. Pr: 0.2643    29
NZ_CP027599.1_67754	TAT(Tat/SPI)	0.216291	0.368186	0.049408	0.366115	CS pos: 40-41. VSA-AA. Pr: 0.0908    42
NZ_CP027599.1_67756	TAT(Tat/SPI)	0.087198	0.576873	0.033529	0.302399	CS pos: 33-34. LAS-YN. Pr: 0.1598    36
NZ_CP027599.1_67757	LIPO(Sec/SPII)	0.247142	0.021032	0.418869	0.312957	CS pos: 17-18. RPA-CW. Pr: 0.3060    34
NZ_CP027599.1_67774	LIPO(Sec/SPII)	0.187663	0.006300	0.658843	0.147194	CS pos: 20-21. LQV-CR. Pr: 0.6090    41
NZ_CP027599.1_67787	LIPO(Sec/SPII)	0.181183	0.011600	0.487287	0.319930	CS pos: 13-14. SIP-CK. Pr: 0.4134    18
NZ_CP027599.1_67804	LIPO(Sec/SPII)	0.156102	0.009220	0.474764	0.359914	CS pos: 10-11. LIA-CK. Pr: 0.4601    37
NZ_CP027599.1_67845	LIPO(Sec/SPII)	0.041800	0.012889	0.892410	0.052901	CS pos: 14-15. PLS-CT. Pr: 0.8721    29
NZ_CP027599.1_67847	LIPO(Sec/SPII)	0.299626	0.008269	0.356109	0.335997	CS pos: 17-18. TLL-CW. Pr: 0.1526    24
NZ_CP027599.1_67854	SP(Sec/SPI)	0.629978	0.128003	0.032530	0.209490	CS pos: 24-25. SRA-SY. Pr: 0.2762    37
NZ_CP027599.1_67859	LIPO(Sec/SPII)	0.219846	0.069133	0.375532	0.335488	CS pos: ?. Probable protein fragment    24
NZ_CP027599.1_67863	LIPO(Sec/SPII)	0.236883	0.003112	0.711941	0.048064	CS pos: 17-18. SST-CA. Pr: 0.6688    24
NZ_CP027599.1_67869	LIPO(Sec/SPII)	0.051040	0.032061	0.809915	0.106984	CS pos: 18-19. LSA-CC. Pr: 0.7318    32
NZ_CP027599.1_67887	LIPO(Sec/SPII)	0.305997	0.004132	0.500165	0.189706	CS pos: 20-21. VFA-CL. Pr: 0.7605    39
NZ_CP027599.1_67893	SP(Sec/SPI)	0.908964	0.036488	0.028225	0.026322	CS pos: 22-23. SRA-LS. Pr: 0.8048    39
NZ_CP027599.1_67901	LIPO(Sec/SPII)	0.308265	0.045641	0.453402	0.192692	CS pos: 11-12. VAG-CG. Pr: 0.2373    35
NZ_CP027599.1_67905	LIPO(Sec/SPII)	0.191599	0.059645	0.410474	0.338281	CS pos: 24-25. APS-CA. Pr: 0.3577    27
NZ_CP027599.1_67918	LIPO(Sec/SPII)	0.129925	0.010044	0.785893	0.074138	CS pos: 15-16. PSS-CS. Pr: 0.7448    28
NZ_CP027599.1_67925	SP(Sec/SPI)	0.335867	0.030244	0.318514	0.315375	CS pos: ?. Probable protein fragment    21
NZ_CP027599.1_67933	SP(Sec/SPI)	0.522747	0.087663	0.063780	0.325810	CS pos: 14-15. AYA-KQ. Pr: 0.5264    24
NZ_CP027599.1_67954	SP(Sec/SPI)	0.394527	0.030055	0.303173	0.272245	CS pos: 25-26. VSG-SA. Pr: 0.1390    27
NZ_CP027599.1_67957	LIPO(Sec/SPII)	0.237408	0.027883	0.416958	0.317751	CS pos: 16-17. KSG-CT. Pr: 0.1906    24
NZ_CP027599.1_67965	SP(Sec/SPI)	0.711114	0.087898	0.134601	0.066387	CS pos: 21-22. CRA-ET. Pr: 0.4994    29
NZ_CP027599.1_67979	LIPO(Sec/SPII)	0.268634	0.029903	0.456948	0.244515	CS pos: ?. Probable protein fragment    17
NZ_CP027599.1_67984	SP(Sec/SPI)	0.598855	0.126058	0.133027	0.142060	CS pos: 20-21. ATA-RL. Pr: 0.2478    30
NZ_CP027599.1_67998	SP(Sec/SPI)	0.517339	0.032672	0.031318	0.418671	CS pos: 10-11. AYG-DS. Pr: 0.2497    43
NZ_CP027599.1_68012	SP(Sec/SPI)	0.540933	0.174422	0.065833	0.218812	CS pos: 20-21. ARA-QS. Pr: 0.5488    36
NZ_CP027599.1_68019	TAT(Tat/SPI)	0.187520	0.400133	0.021657	0.390690	CS pos: 27-28. AEA-IH. Pr: 0.4387    32
NZ_CP027599.1_68027	SP(Sec/SPI)	0.624056	0.138033	0.113977	0.123934	CS pos: 27-28. APA-TA. Pr: 0.0785    42
NZ_CP027599.1_68029	LIPO(Sec/SPII)	0.098900	0.006269	0.887098	0.007733	CS pos: 14-15. SSG-CA. Pr: 0.8465    34
NZ_CP027599.1_68034	TAT(Tat/SPI)	0.371338	0.442745	0.020073	0.165845	CS pos: 21-22. AVA-EF. Pr: 0.6931    34
NZ_CP027599.1_68037	TAT(Tat/SPI)	0.029188	0.660790	0.084344	0.225678	CS pos: 31-32. TSS-FW. Pr: 0.0683    44
NZ_CP027599.1_68041	LIPO(Sec/SPII)	0.350865	0.056495	0.405578	0.187062	CS pos: 14-15. LIC-CQ. Pr: 0.1513    21
NZ_CP027599.1_68059	LIPO(Sec/SPII)	0.283872	0.031158	0.367388	0.317582	CS pos: ?. Probable protein fragment    19
NZ_CP027599.1_68072	LIPO(Sec/SPII)	0.268996	0.017677	0.375319	0.338008	CS pos: 16-17. SAM-CT. Pr: 0.0987    20
NZ_CP027599.1_68086	LIPO(Sec/SPII)	0.287725	0.012127	0.370566	0.329582	CS pos: ?. Probable protein fragment    18
NZ_CP027599.1_68087	LIPO(Sec/SPII)	0.092590	0.016228	0.618113	0.273069	CS pos: 20-21. GFA-CT. Pr: 0.5925    32
NZ_CP027599.1_68094	LIPO(Sec/SPII)	0.272929	0.023893	0.430110	0.273068	CS pos: ?. Probable protein fragment    15
NZ_CP027599.1_68126	LIPO(Sec/SPII)	0.036088	0.007108	0.889434	0.067370	CS pos: 18-19. LSA-CT. Pr: 0.8852    30
NZ_CP027599.1_68140	LIPO(Sec/SPII)	0.160473	0.039014	0.504570	0.295943	CS pos: 20-21. ILA-CR. Pr: 0.3974    23
NZ_CP027599.1_68152	LIPO(Sec/SPII)	0.026255	0.002059	0.606477	0.365209	CS pos: 19-20. LRS-CI. Pr: 0.5912    34
NZ_CP027599.1_68158	LIPO(Sec/SPII)	0.121291	0.020717	0.562670	0.295322	CS pos: 24-25. MQG-CL. Pr: 0.4685    43
NZ_CP027599.1_68205	LIPO(Sec/SPII)	0.067372	0.015774	0.662116	0.254737	CS pos: 19-20. VLA-CV. Pr: 0.6388    31
NZ_CP027599.1_68214	LIPO(Sec/SPII)	0.184218	0.025640	0.399175	0.390968	CS pos: 22-23. SRA-CK. Pr: 0.3335    24
NZ_CP027599.1_68253	LIPO(Sec/SPII)	0.191989	0.023900	0.597237	0.186875	CS pos: 18-19. SLA-CC. Pr: 0.4192    25
NZ_CP027599.1_68293	SP(Sec/SPI)	0.370515	0.198203	0.308759	0.122524	CS pos: 20-21. GIA-DG. Pr: 0.2321    25
NZ_CP027599.1_68331	SP(Sec/SPI)	0.729726	0.004992	0.164076	0.101207	CS pos: 18-19. SLA-SI. Pr: 0.5469    25
NZ_CP027599.1_68339	LIPO(Sec/SPII)	0.091079	0.007098	0.792380	0.109444	CS pos: 18-19. IGT-CN. Pr: 0.7195    31
NZ_CP027599.1_68382	LIPO(Sec/SPII)	0.116730	0.016243	0.533077	0.333950	CS pos: 20-21. IST-CC. Pr: 0.3060    31
NZ_CP027599.1_68400	SP(Sec/SPI)	0.531977	0.257892	0.079725	0.130406	CS pos: 21-22. TRA-DR. Pr: 0.5906    44
NZ_CP027599.1_68403	SP(Sec/SPI)	0.649429	0.064688	0.098318	0.187565	CS pos: 22-23. SRA-LQ. Pr: 0.5468    33
NZ_CP027599.1_68405	LIPO(Sec/SPII)	0.095644	0.010572	0.699171	0.194612	CS pos: 11-12. ALS-CW. Pr: 0.4009    34
NZ_CP027599.1_68411	LIPO(Sec/SPII)	0.118753	0.017841	0.498688	0.364719	CS pos: 19-20. VAA-CC. Pr: 0.2617    40
NZ_CP027599.1_68412	LIPO(Sec/SPII)	0.110383	0.032364	0.796229	0.061025	CS pos: 25-26. YTA-CC. Pr: 0.7520    34
NZ_CP027599.1_68419	LIPO(Sec/SPII)	0.273805	0.028159	0.350732	0.347305	CS pos: ?. Probable protein fragment    16
NZ_CP027599.1_68428	TAT(Tat/SPI)	0.097467	0.722126	0.073180	0.107228	CS pos: ?. Probable protein fragment    25
NZ_CP027599.1_68443	TAT(Tat/SPI)	0.241459	0.419563	0.048769	0.290209	CS pos: 31-32. VPA-AV. Pr: 0.1318    49
NZ_CP027599.1_68452	LIPO(Sec/SPII)	0.134006	0.011395	0.812578	0.042021	CS pos: 19-20. GGG-CA. Pr: 0.7877    26
NZ_CP027599.1_68456	SP(Sec/SPI)	0.380245	0.251177	0.022887	0.345691	CS pos: 18-19. ALA-EH. Pr: 0.4944    50
NZ_CP027599.1_68457	SP(Sec/SPI)	0.379723	0.095158	0.186181	0.338938	CS pos: 32-33. GAA-SG. Pr: 0.1146    44
NZ_CP027599.1_68459	LIPO(Sec/SPII)	0.230766	0.064277	0.456734	0.248224	CS pos: 15-16. STG-CC. Pr: 0.2826    23
NZ_CP027599.1_68466	LIPO(Sec/SPII)	0.260450	0.034641	0.370537	0.334373	CS pos: 20-21. IAV-CG. Pr: 0.1410    28
NZ_CP027599.1_68472	SP(Sec/SPI)	0.468366	0.055567	0.142447	0.333620	CS pos: 21-22. AWA-DG. Pr: 0.3681    23
NZ_CP027599.1_68482	LIPO(Sec/SPII)	0.262790	0.016332	0.523582	0.197296	CS pos: 13-14. TSI-CV. Pr: 0.1115    17
NZ_CP027599.1_68483	LIPO(Sec/SPII)	0.133774	0.034696	0.426023	0.405507	CS pos: 26-27. ATA-CK. Pr: 0.4662    31
NZ_CP027599.1_68487	LIPO(Sec/SPII)	0.267414	0.074428	0.334129	0.324030	CS pos: ?. Probable protein fragment    17
NZ_CP027599.1_68492	LIPO(Sec/SPII)	0.233640	0.023430	0.423340	0.319589	CS pos: ?. Probable protein fragment    16
NZ_CP027599.1_68499	LIPO(Sec/SPII)	0.171281	0.040102	0.600717	0.187900	CS pos: 18-19. LTT-CA. Pr: 0.5470    26
NZ_CP027599.1_68500	TAT(Tat/SPI)	0.262487	0.320675	0.207188	0.209649	CS pos: 23-24. SSA-CS. Pr: 0.2695    29
NZ_CP027599.1_68552	SP(Sec/SPI)	0.365378	0.001665	0.307122	0.325835	CS pos: 18-19. VLA-SF. Pr: 0.2068    31
NZ_CP027599.1_68613	LIPO(Sec/SPII)	0.059208	0.006731	0.658420	0.275641	CS pos: 24-25. VVG-CL. Pr: 0.6356    39
NZ_CP027599.1_68690	SP(Sec/SPI)	0.472049	0.025880	0.091617	0.410455	CS pos: 23-24. IRA-IT. Pr: 0.3001    32
NZ_CP027599.1_68694	SP(Sec/SPI)	0.400311	0.025549	0.341564	0.232576	CS pos: ?. Probable protein fragment    20
NZ_CP027599.1_68721	LIPO(Sec/SPII)	0.069290	0.027066	0.777386	0.126258	CS pos: 22-23. APG-CD. Pr: 0.7674    36
NZ_CP027599.1_68728	LIPO(Sec/SPII)	0.294269	0.059454	0.362518	0.283759	CS pos: 14-15. SFA-CA. Pr: 0.3539    20
NZ_CP027599.1_68730	LIPO(Sec/SPII)	0.086036	0.016458	0.496949	0.400557	CS pos: 24-25. AQC-CV. Pr: 0.2868    38
NZ_CP027599.1_68782	LIPO(Sec/SPII)	0.315845	0.070354	0.342943	0.270858	CS pos: 17-18. INA-CT. Pr: 0.2977    44
NZ_CP027599.1_68787	LIPO(Sec/SPII)	0.059386	0.011483	0.542504	0.386626	CS pos: 14-15. FSS-CD. Pr: 0.5258    29
NZ_CP027599.1_68806	SP(Sec/SPI)	0.495814	0.118222	0.111630	0.274334	CS pos: 19-20. VSG-IR. Pr: 0.2412    34
NZ_CP027599.1_68852	LIPO(Sec/SPII)	0.104610	0.005879	0.566623	0.322888	CS pos: 19-20. TGA-CP. Pr: 0.5340    32
NZ_CP027599.1_68857	LIPO(Sec/SPII)	0.237637	0.042346	0.381748	0.338269	CS pos: ?. Probable protein fragment    21
NZ_CP027599.1_68863	LIPO(Sec/SPII)	0.151377	0.053987	0.698771	0.095866	CS pos: 22-23. VTT-CV. Pr: 0.6045    41
NZ_CP027599.1_68882	SP(Sec/SPI)	0.626481	0.028700	0.108860	0.235960	CS pos: 27-28. ATA-RN. Pr: 0.2133    30
NZ_CP027599.1_68923	LIPO(Sec/SPII)	0.276993	0.012851	0.387668	0.322488	CS pos: ?. Probable protein fragment    17
NZ_CP027599.1_68924	SP(Sec/SPI)	0.765324	0.006797	0.098703	0.129177	CS pos: 20-21. NHA-IT. Pr: 0.2856    31
NZ_CP027599.1_68928	LIPO(Sec/SPII)	0.035958	0.021886	0.766693	0.175464	CS pos: 18-19. FAS-CS. Pr: 0.7621    36
NZ_CP027599.1_68946	SP(Sec/SPI)	0.473035	0.017068	0.118560	0.391338	CS pos: 20-21. ATA-QW. Pr: 0.4193    27
NZ_CP027599.1_68953	LIPO(Sec/SPII)	0.176551	0.027458	0.446472	0.349519	CS pos: 16-17. CAS-CT. Pr: 0.4066    46
NZ_CP027599.1_68959	SP(Sec/SPI)	0.422637	0.271326	0.062803	0.243234	CS pos: 24-25. TAA-RP. Pr: 0.3546    28
NZ_CP027599.1_68976	TAT(Tat/SPI)	0.129353	0.462233	0.165839	0.242574	CS pos: 32-33. CSS-IP. Pr: 0.1516    47
NZ_CP027599.1_68998	TAT(Tat/SPI)	0.058848	0.831283	0.003207	0.106662	CS pos: 42-43. MDA-QP. Pr: 0.7003    50
NZ_CP027599.1_69000	SP(Sec/SPI)	0.469904	0.111323	0.066933	0.351840	CS pos: 16-17. IAS-AP. Pr: 0.1891    47
NZ_CP027599.1_69005	TAT(Tat/SPI)	0.303652	0.337784	0.116919	0.241645	CS pos: 24-25. AYA-RS. Pr: 0.2893    39
NZ_CP027599.1_69008	LIPO(Sec/SPII)	0.067735	0.029747	0.648429	0.254089	CS pos: 17-18. AIG-CS. Pr: 0.6311    31
NZ_CP027599.1_69023	TAT(Tat/SPI)	0.154008	0.644731	0.106593	0.094668	CS pos: 22-23. AST-HP. Pr: 0.3451    42
NZ_CP027599.1_69031	LIPO(Sec/SPII)	0.051266	0.057113	0.707391	0.184231	CS pos: 21-22. VAA-CR. Pr: 0.7180    47
NZ_CP027599.1_69050	SP(Sec/SPI)	0.405334	0.382684	0.020388	0.191595	CS pos: 23-24. AAA-FF. Pr: 0.4993    38
NZ_CP027599.1_69067	TAT(Tat/SPI)	0.057320	0.471941	0.010845	0.459894	CS pos: 38-39. NKA-GV. Pr: 0.2641    49
NZ_CP027599.1_69088	LIPO(Sec/SPII)	0.056970	0.354242	0.476705	0.112083	CS pos: 30-31. LLG-CS. Pr: 0.5215    37
NZ_CP027599.1_69104	LIPO(Sec/SPII)	0.249661	0.021022	0.530790	0.198527	CS pos: 12-13. GTG-CP. Pr: 0.1752    15
NZ_CP027599.1_69128	LIPO(Sec/SPII)	0.361902	0.047582	0.493897	0.096619	CS pos: 28-29. LVS-CS. Pr: 0.4425    49
NZ_CP027599.1_69173	LIPO(Sec/SPII)	0.124939	0.011454	0.441456	0.422151	CS pos: 26-27. ASS-CI. Pr: 0.4036    39
NZ_CP027599.1_69188	LIPO(Sec/SPII)	0.042323	0.003134	0.813717	0.140826	CS pos: 13-14. SSA-CE. Pr: 0.8209    31
NZ_CP027599.1_69221	TAT(Tat/SPI)	0.229541	0.649753	0.013837	0.106869	CS pos: 32-33. AFA-RP. Pr: 0.6435    48
NZ_CP027599.1_69272	LIPO(Sec/SPII)	0.198495	0.107875	0.355303	0.338327	CS pos: 19-20. ALG-CK. Pr: 0.2849    26
NZ_CP027599.1_69292	LIPO(Sec/SPII)	0.203489	0.085847	0.494051	0.216614	CS pos: ?. Probable protein fragment    15
NZ_CP027599.1_69300	LIPO(Sec/SPII)	0.126940	0.031360	0.522991	0.318709	CS pos: 12-13. ITS-CS. Pr: 0.4476    20
NZ_CP027599.1_69339	TAT(Tat/SPI)	0.162871	0.413531	0.189671	0.233928	CS pos: 27-28. ASS-LA. Pr: 0.1510    45
NZ_CP027599.1_69404	LIPO(Sec/SPII)	0.269683	0.048757	0.404836	0.276723	CS pos: ?. Probable protein fragment    19
NZ_CP027599.1_69410	LIPO(Sec/SPII)	0.291396	0.021730	0.368432	0.318442	CS pos: 21-22. TAS-QM. Pr: 0.0552    23
NZ_CP027599.1_69411	LIPO(Sec/SPII)	0.282386	0.018976	0.467864	0.230774	CS pos: 17-18. QAR-CD. Pr: 0.3548    20
NZ_CP027599.1_69481	LIPO(Sec/SPII)	0.197607	0.045801	0.594972	0.161620	CS pos: 26-27. LAA-CS. Pr: 0.5478    37
NZ_CP027599.1_69488	TAT(Tat/SPI)	0.174615	0.409127	0.111800	0.304458	CS pos: ?. Probable protein fragment    23
NZ_CP027599.1_69497	TAT(Tat/SPI)	0.346975	0.352700	0.032937	0.267388	CS pos: 23-24. ADA-AP. Pr: 0.2088    37
NZ_CP027599.1_69524	SP(Sec/SPI)	0.381913	0.068770	0.188525	0.360791	CS pos: 18-19. SSA-EV. Pr: 0.1660    40
NZ_CP027599.1_69526	LIPO(Sec/SPII)	0.218806	0.050404	0.444147	0.286642	CS pos: 17-18. GGS-CC. Pr: 0.3015    21
NZ_CP027599.1_69576	LIPO(Sec/SPII)	0.232790	0.025269	0.530770	0.211170	CS pos: 19-20. YAA-CA. Pr: 0.3809    31
NZ_CP027599.1_69589	LIPO(Sec/SPII)	0.134329	0.234474	0.567338	0.063858	CS pos: 20-21. LAP-CT. Pr: 0.5348    37
NZ_CP027599.1_69603	SP(Sec/SPI)	0.544076	0.178762	0.086223	0.190939	CS pos: 27-28. SNA-IG. Pr: 0.4647    34
NZ_CP027599.1_69604	TAT(Tat/SPI)	0.152496	0.517195	0.046517	0.283792	CS pos: 27-28. LSA-SP. Pr: 0.2845    39
NZ_CP027599.1_69611	SP(Sec/SPI)	0.376511	0.061278	0.223760	0.338451	CS pos: 11-12. ATA-SS. Pr: 0.1016    15
NZ_CP027599.1_69613	LIPO(Sec/SPII)	0.396449	0.018874	0.441625	0.143053	CS pos: 13-14. SGR-CP. Pr: 0.1096    16
NZ_CP027599.1_69691	LIPO(Sec/SPII)	0.254134	0.008357	0.397701	0.339809	CS pos: 14-15. GNG-CR. Pr: 0.2223    20
NZ_CP027599.1_69694	LIPO(Sec/SPII)	0.209767	0.042162	0.441840	0.306231	CS pos: ?. Probable protein fragment    15
NZ_CP027599.1_69717	SP(Sec/SPI)	0.388793	0.012083	0.358453	0.240672	CS pos: ?. Probable protein fragment    19
NZ_CP027599.1_69724	SP(Sec/SPI)	0.507539	0.011699	0.071239	0.409523	CS pos: 20-21. AQS-GH. Pr: 0.2812    48
NZ_CP027599.1_69726	LIPO(Sec/SPII)	0.182069	0.009728	0.492912	0.315291	CS pos: ?. Probable protein fragment    17
NZ_CP027599.1_69739	LIPO(Sec/SPII)	0.342379	0.017537	0.385200	0.254883	CS pos: ?. Probable protein fragment    18
NZ_CP027599.1_69801	LIPO(Sec/SPII)	0.064224	0.016159	0.590255	0.329363	CS pos: 21-22. LTQ-CS. Pr: 0.5756    43
NZ_CP027599.1_69820	LIPO(Sec/SPII)	0.146945	0.003445	0.756201	0.093409	CS pos: 19-20. ITT-CR. Pr: 0.6180    21
NZ_CP027599.1_69825	LIPO(Sec/SPII)	0.240720	0.005320	0.395454	0.358506	CS pos: 22-23. LPC-CL. Pr: 0.0398    25
NZ_CP027599.1_69861	LIPO(Sec/SPII)	0.185715	0.033941	0.633960	0.146383	CS pos: 14-15. SIS-CA. Pr: 0.5436    19
NZ_CP027599.1_69872	SP(Sec/SPI)	0.456580	0.124304	0.292611	0.126505	CS pos: 17-18. TAA-TK. Pr: 0.1943    29
NZ_CP027599.1_69893	LIPO(Sec/SPII)	0.289179	0.011427	0.468681	0.230713	CS pos: 14-15. PGS-VW. Pr: 0.0243    16
NZ_CP027599.1_69935	LIPO(Sec/SPII)	0.022799	0.002861	0.968752	0.005588	CS pos: 17-18. TSA-CL. Pr: 0.9675    35
NZ_CP027599.1_69976	LIPO(Sec/SPII)	0.194479	0.124619	0.353952	0.326949	CS pos: 15-16. PGS-CS. Pr: 0.2424    29
NZ_CP027599.1_69986	SP(Sec/SPI)	0.651638	0.134852	0.047028	0.166482	CS pos: 21-22. LKS-AK. Pr: 0.2600    29
NZ_CP027599.1_70009	LIPO(Sec/SPII)	0.101313	0.021820	0.731941	0.144927	CS pos: 22-23. STT-CS. Pr: 0.6961    30
NZ_CP027599.1_70019	LIPO(Sec/SPII)	0.223111	0.036119	0.431927	0.308844	CS pos: ?. Probable protein fragment    15
NZ_CP027599.1_70025	SP(Sec/SPI)	0.552412	0.067703	0.147914	0.231971	CS pos: 16-17. SSA-SI. Pr: 0.1817    20
NZ_CP027599.1_70051	LIPO(Sec/SPII)	0.002520	0.001507	0.992850	0.003123	CS pos: 17-18. IAG-CS. Pr: 0.9933    35
NZ_CP027599.1_70058	SP(Sec/SPI)	0.566479	0.009971	0.178033	0.245517	CS pos: 19-20. ARQ-WS. Pr: 0.1990    30
NZ_CP027599.1_70101	SP(Sec/SPI)	0.327363	0.250517	0.122932	0.299188	CS pos: 15-16. SLA-GS. Pr: 0.0858    23
NZ_CP027599.1_70104	SP(Sec/SPI)	0.715791	0.054479	0.123736	0.105995	CS pos: 20-21. SAA-SP. Pr: 0.5293    24
NZ_CP027599.1_70107	LIPO(Sec/SPII)	0.357723	0.005110	0.519097	0.118070	CS pos: 11-12. LVS-CA. Pr: 0.1951    18
NZ_CP027599.1_70109	SP(Sec/SPI)	0.552817	0.121278	0.087967	0.237937	CS pos: 18-19. TSA-AV. Pr: 0.2670    41
NZ_CP027599.1_70118	SP(Sec/SPI)	0.405617	0.259904	0.037944	0.296535	CS pos: 18-19. ASA-SS. Pr: 0.4643    25
NZ_CP027599.1_70147	LIPO(Sec/SPII)	0.145685	0.019771	0.492359	0.342184	CS pos: 21-22. RFS-CH. Pr: 0.4074    24
NZ_CP027599.1_70155	LIPO(Sec/SPII)	0.051544	0.015127	0.533333	0.399996	CS pos: 17-18. AVC-CL. Pr: 0.4182    40
NZ_CP027599.1_70159	LIPO(Sec/SPII)	0.042363	0.002968	0.645491	0.309177	CS pos: 15-16. GSA-CC. Pr: 0.4832    23
NZ_CP027599.1_70188	LIPO(Sec/SPII)	0.062283	0.006476	0.604710	0.326531	CS pos: 20-21. VTS-CW. Pr: 0.6043    32
NZ_CP027599.1_70211	LIPO(Sec/SPII)	0.051934	0.004831	0.504488	0.438747	CS pos: 15-16. MES-CW. Pr: 0.4893    27
NZ_CP027599.1_70212	LIPO(Sec/SPII)	0.064105	0.035964	0.788747	0.111184	CS pos: 25-26. LAG-CQ. Pr: 0.7757    41
NZ_CP027599.1_70233	SP(Sec/SPI)	0.422491	0.005834	0.362987	0.208688	CS pos: 17-18. CRS-LP. Pr: 0.1721    31
NZ_CP027599.1_70235	LIPO(Sec/SPII)	0.221108	0.014535	0.393855	0.370502	CS pos: 11-12. GAG-CW. Pr: 0.1984    21
NZ_CP027599.1_70273	LIPO(Sec/SPII)	0.077932	0.015041	0.702260	0.204767	CS pos: 17-18. TFG-CI. Pr: 0.6723    28
NZ_CP027599.1_70275	LIPO(Sec/SPII)	0.220736	0.024621	0.402034	0.352609	CS pos: 13-14. PTC-CA. Pr: 0.1306    15
NZ_CP027599.1_70309	LIPO(Sec/SPII)	0.338760	0.012652	0.624495	0.024093	CS pos: 24-25. TSA-CQ. Pr: 0.6007    48
NZ_CP027599.1_70324	LIPO(Sec/SPII)	0.275715	0.028747	0.445631	0.249907	CS pos: 13-14. VLA-CP. Pr: 0.0619    17
NZ_CP027599.1_70334	LIPO(Sec/SPII)	0.090885	0.005469	0.817246	0.086400	CS pos: 19-20. NFA-CG. Pr: 0.7814    25
NZ_CP027599.1_70340	SP(Sec/SPI)	0.483740	0.313611	0.099829	0.102820	CS pos: 34-35. KLA-AT. Pr: 0.2301    45
NZ_CP027599.1_70353	SP(Sec/SPI)	0.423270	0.002146	0.222264	0.352319	CS pos: 20-21. TYP-TE. Pr: 0.1935    31
NZ_CP027599.1_70355	SP(Sec/SPI)	0.405455	0.024593	0.339124	0.230827	CS pos: 16-17. TLA-TG. Pr: 0.1014    31
NZ_CP027599.1_70356	SP(Sec/SPI)	0.403304	0.196920	0.059776	0.340000	CS pos: 14-15. SHA-AG. Pr: 0.2234    31
NZ_CP027599.1_70423	LIPO(Sec/SPII)	0.017580	0.003478	0.962414	0.016528	CS pos: 16-17. TIG-CR. Pr: 0.9362    40
NZ_CP027599.1_70426	SP(Sec/SPI)	0.430844	0.040497	0.112693	0.415966	CS pos: 18-19. AMA-MP. Pr: 0.3335    20
NZ_CP027599.1_70469	SP(Sec/SPI)	0.561936	0.077484	0.346862	0.013718	CS pos: 25-26. SAA-SC. Pr: 0.3078    43
NZ_CP027599.1_70470	SP(Sec/SPI)	0.441371	0.063113	0.102362	0.393154	CS pos: 17-18. AHR-HD. Pr: 0.1916    36
NZ_CP027599.1_70490	LIPO(Sec/SPII)	0.095436	0.057463	0.489690	0.357412	CS pos: 18-19. QSS-CC. Pr: 0.3885    37
NZ_CP027599.1_70509	SP(Sec/SPI)	0.321437	0.082082	0.285086	0.311395	CS pos: 23-24. ASS-AS. Pr: 0.1427    31
NZ_CP027599.1_70517	TAT(Tat/SPI)	0.026678	0.630941	0.011521	0.330860	CS pos: 27-28. LLA-NP. Pr: 0.1743    43
NZ_CP027599.1_70536	LIPO(Sec/SPII)	0.249217	0.153304	0.316623	0.280856	CS pos: 31-32. AIA-CG. Pr: 0.2872    40
NZ_CP027599.1_70591	SP(Sec/SPI)	0.546243	0.018051	0.280494	0.155212	CS pos: ?. Probable protein fragment    21
NZ_CP027599.1_70631	LIPO(Sec/SPII)	0.169458	0.271295	0.438241	0.121006	CS pos: 31-32. SSS-CG. Pr: 0.3890    33
NZ_CP027599.1_70644	SP(Sec/SPI)	0.433219	0.080926	0.119918	0.365937	CS pos: 18-19. VTS-TT. Pr: 0.0983    39
NZ_CP027599.1_70672	LIPO(Sec/SPII)	0.084564	0.050294	0.724571	0.140571	CS pos: 21-22. TAG-CD. Pr: 0.7285    27
NZ_CP027599.1_70687	SP(Sec/SPI)	0.642270	0.034713	0.025649	0.297368	CS pos: 26-27. TGA-EL. Pr: 0.3861    46
NZ_CP027599.1_70693	LIPO(Sec/SPII)	0.295535	0.020817	0.418149	0.265499	CS pos: ?. Probable protein fragment    16
NZ_CP027599.1_70695	LIPO(Sec/SPII)	0.333155	0.028099	0.342364	0.296383	CS pos: 16-17. PPQ-CT. Pr: 0.2427    29
NZ_CP027599.1_70706	SP(Sec/SPI)	0.722494	0.206533	0.036098	0.034875	CS pos: 28-29. ASA-WP. Pr: 0.6825    44
NZ_CP027599.1_70714	LIPO(Sec/SPII)	0.423472	0.004911	0.452062	0.119556	CS pos: 19-20. ATF-CL. Pr: 0.2104    25
NZ_CP027599.1_70728	SP(Sec/SPI)	0.440738	0.140581	0.026950	0.391731	CS pos: 29-30. AQA-AP. Pr: 0.5035    44
NZ_CP027599.1_70734	LIPO(Sec/SPII)	0.113888	0.044960	0.513968	0.327183	CS pos: 21-22. NGA-CL. Pr: 0.3336    30
NZ_CP027599.1_70740	SP(Sec/SPI)	0.562943	0.043506	0.093999	0.299553	CS pos: 22-23. ANS-QT. Pr: 0.4080    28
NZ_CP027599.1_70743	LIPO(Sec/SPII)	0.073499	0.002609	0.910942	0.012950	CS pos: 17-18. TTS-CC. Pr: 0.8177    20
NZ_CP027599.1_70777	LIPO(Sec/SPII)	0.133460	0.005810	0.840822	0.019908	CS pos: 21-22. LLV-CN. Pr: 0.6736    48
NZ_CP027599.1_70789	SP(Sec/SPI)	0.393168	0.058153	0.166904	0.381775	CS pos: 30-31. IAG-RI. Pr: 0.1081    38
NZ_CP027599.1_70791	LIPO(Sec/SPII)	0.203580	0.037127	0.405717	0.353576	CS pos: 19-20. TSN-CG. Pr: 0.3115    36
NZ_CP027599.1_70797	LIPO(Sec/SPII)	0.132928	0.033676	0.542564	0.290833	CS pos: 16-17. STG-CH. Pr: 0.4731    39
NZ_CP027599.1_70798	TAT(Tat/SPI)	0.142214	0.380792	0.261985	0.215010	CS pos: ?. Probable protein fragment    17
NZ_CP027599.1_70810	SP(Sec/SPI)	0.388103	0.221573	0.092802	0.297522	CS pos: 23-24. AGA-KI. Pr: 0.0911    41
NZ_CP027599.1_70817	LIPO(Sec/SPII)	0.049248	0.003268	0.896411	0.051073	CS pos: 22-23. LSA-CH. Pr: 0.8538    30
NZ_CP027599.1_70874	SP(Sec/SPI)	0.488719	0.046005	0.075209	0.390067	CS pos: 18-19. AHS-LT. Pr: 0.2751    22
NZ_CP027599.1_70888	LIPO(Sec/SPII)	0.375501	0.014666	0.527934	0.081900	CS pos: 16-17. ASI-CM. Pr: 0.4502    36
NZ_CP027599.1_70890	LIPO(Sec/SPII)	0.047896	0.008683	0.772596	0.170825	CS pos: 29-30. WCG-CT. Pr: 0.7440    42
NZ_CP027599.1_70891	TAT(Tat/SPI)	0.076356	0.683170	0.025738	0.214737	CS pos: 37-38. DHA-QQ. Pr: 0.2857    48
NZ_CP027599.1_70915	SP(Sec/SPI)	0.407869	0.243162	0.101345	0.247624	CS pos: 28-29. ANA-AG. Pr: 0.3551    30
NZ_CP027599.1_70918	LIPO(Sec/SPII)	0.301526	0.024070	0.355418	0.318986	CS pos: ?. Probable protein fragment    18
NZ_CP027599.1_70934	LIPO(Sec/SPII)	0.109918	0.029140	0.567177	0.293765	CS pos: 18-19. IKA-CT. Pr: 0.5237    27
NZ_CP027599.1_70944	SP(Sec/SPI)	0.674302	0.033056	0.081402	0.211241	CS pos: 25-26. VKS-AT. Pr: 0.1998    29
NZ_CP027599.1_70946	TAT(Tat/SPI)	0.147972	0.566824	0.028619	0.256585	CS pos: 31-32. AIS-GV. Pr: 0.2128    44
NZ_CP027599.1_70980	SP(Sec/SPI)	0.309623	0.268037	0.140242	0.282098	CS pos: 19-20. ARS-EP. Pr: 0.2159    24
NZ_CP027599.1_70981	LIPO(Sec/SPII)	0.245502	0.019917	0.394380	0.340201	CS pos: 13-14. WMP-CV. Pr: 0.0217    15
NZ_CP027599.1_71006	LIPO(Sec/SPII)	0.167100	0.011180	0.570871	0.250850	CS pos: ?. Probable protein fragment    21
NZ_CP027599.1_71008	SP(Sec/SPI)	0.479763	0.147400	0.065610	0.307227	CS pos: 27-28. SQA-AN. Pr: 0.3427    48
NZ_CP027599.1_71009	SP(Sec/SPI)	0.813693	0.134633	0.047815	0.003859	CS pos: 19-20. LQA-SS. Pr: 0.7195    38
NZ_CP027599.1_71089	LIPO(Sec/SPII)	0.110901	0.004969	0.610454	0.273676	CS pos: 17-18. TLC-CK. Pr: 0.2263    22
NZ_CP027599.1_71102	LIPO(Sec/SPII)	0.105727	0.003061	0.843709	0.047504	CS pos: 21-22. SLC-CK. Pr: 0.4887    30
NZ_CP027599.1_71150	SP(Sec/SPI)	0.661215	0.204457	0.027630	0.106698	CS pos: 19-20. AMA-SS. Pr: 0.7179    34
NZ_CP027599.1_71159	SP(Sec/SPI)	0.458925	0.054149	0.200484	0.286443	CS pos: 24-25. AMS-LN. Pr: 0.3359    26
NZ_CP027599.1_71170	LIPO(Sec/SPII)	0.179836	0.026865	0.476551	0.316749	CS pos: 15-16. LST-CQ. Pr: 0.3926    19
NZ_CP027599.1_71182	LIPO(Sec/SPII)	0.273704	0.040822	0.354500	0.330974	CS pos: 12-13. VLA-CS. Pr: 0.2659    22
NZ_CP027599.1_71188	SP(Sec/SPI)	0.603521	0.027292	0.220866	0.148322	CS pos: 28-29. ANA-TE. Pr: 0.3137    49
NZ_CP027599.1_71210	LIPO(Sec/SPII)	0.177372	0.014942	0.524586	0.283100	CS pos: 17-18. TAG-CC. Pr: 0.4829    35
NZ_CP027599.1_71220	SP(Sec/SPI)	0.731587	0.010623	0.177342	0.080448	CS pos: 21-22. CDA-LA. Pr: 0.5170    50
NZ_CP027599.1_71225	SP(Sec/SPI)	0.494707	0.009401	0.173235	0.322657	CS pos: 17-18. VLA-SL. Pr: 0.3056    26
NZ_CP027599.1_71236	TAT(Tat/SPI)	0.197167	0.366890	0.096801	0.339143	CS pos: ?. Probable protein fragment    23
NZ_CP027599.1_71261	LIPO(Sec/SPII)	0.245315	0.098136	0.357582	0.298967	CS pos: 15-16. LTA-CS. Pr: 0.2973    44
NZ_CP027599.1_71265	SP(Sec/SPI)	0.369905	0.144953	0.135740	0.349401	CS pos: 16-17. LKA-AS. Pr: 0.1325    30
NZ_CP027599.1_71269	LIPO(Sec/SPII)	0.272052	0.016317	0.442111	0.269520	CS pos: 15-16. VTL-CC. Pr: 0.1307    17
NZ_CP027599.1_71280	SP(Sec/SPI)	0.405327	0.016570	0.307573	0.270530	CS pos: 24-25. AAP-TP. Pr: 0.0933    30
NZ_CP027599.1_71342	SP(Sec/SPI)	0.678100	0.210452	0.047611	0.063837	CS pos: 25-26. SLG-KT. Pr: 0.6048    39
NZ_CP027599.1_71365	SP(Sec/SPI)	0.509049	0.041179	0.242246	0.207526	CS pos: 27-28. ASA-FS. Pr: 0.2867    42
NZ_CP027599.1_71404	SP(Sec/SPI)	0.414314	0.030546	0.319409	0.235731	CS pos: 14-15. ASA-SS. Pr: 0.1781    16
NZ_CP027599.1_71423	SP(Sec/SPI)	0.479100	0.198138	0.048199	0.274563	CS pos: 21-22. ASA-VP. Pr: 0.4679    31
NZ_CP027599.1_71424	LIPO(Sec/SPII)	0.294537	0.017565	0.438015	0.249883	CS pos: ?. Probable protein fragment    17
NZ_CP027599.1_71448	SP(Sec/SPI)	0.406187	0.078095	0.295584	0.220134	CS pos: 23-24. SSA-GS. Pr: 0.0790    33
NZ_CP027599.1_71470	SP(Sec/SPI)	0.333276	0.103426	0.283302	0.279996	CS pos: 20-21. AQS-GS. Pr: 0.1032    37
NZ_CP027599.1_71473	LIPO(Sec/SPII)	0.035394	0.019159	0.670902	0.274545	CS pos: 19-20. ITS-CG. Pr: 0.6654    34
NZ_CP027599.1_71484	LIPO(Sec/SPII)	0.295754	0.050701	0.457914	0.195631	CS pos: 14-15. PFS-CS. Pr: 0.4253    34
NZ_CP027599.1_71493	LIPO(Sec/SPII)	0.074200	0.034073	0.539238	0.352489	CS pos: 24-25. RYG-CD. Pr: 0.5467    39
NZ_CP027599.1_71530	LIPO(Sec/SPII)	0.197190	0.009691	0.489334	0.303785	CS pos: 17-18. IRS-CK. Pr: 0.2726    19
NZ_CP027599.1_71611	TAT(Tat/SPI)	0.238884	0.353206	0.073008	0.334902	CS pos: 26-27. REA-ID. Pr: 0.2851    32
NZ_CP027599.1_71655	LIPO(Sec/SPII)	0.130148	0.014894	0.737437	0.117520	CS pos: 18-19. AYG-CC. Pr: 0.6097    42
NZ_CP027599.1_71665	SP(Sec/SPI)	0.629340	0.040414	0.273680	0.056566	CS pos: 24-25. ALP-AD. Pr: 0.2938    36
NZ_CP027599.1_71691	SP(Sec/SPI)	0.715469	0.034303	0.161401	0.088827	CS pos: 19-20. INA-AS. Pr: 0.5577    30
NZ_CP027599.1_71714	SP(Sec/SPI)	0.357362	0.226932	0.098025	0.317681	CS pos: 29-30. LNA-AT. Pr: 0.0975    44
NZ_CP027599.1_71719	LIPO(Sec/SPII)	0.104455	0.275186	0.451735	0.168623	CS pos: 20-21. AAG-CA. Pr: 0.4358    27
NZ_CP027599.1_71726	TAT(Tat/SPI)	0.115834	0.570141	0.040963	0.273062	CS pos: 28-29. QPA-SS. Pr: 0.1304    46
NZ_CP027599.1_71742	LIPO(Sec/SPII)	0.102098	0.083194	0.518040	0.296668	CS pos: 18-19. YQS-CG. Pr: 0.4595    23
NZ_CP027599.1_71744	SP(Sec/SPI)	0.347842	0.030752	0.334705	0.286701	CS pos: 24-25. GSC-RG. Pr: 0.0833    29
NZ_CP027599.1_71752	SP(Sec/SPI)	0.625955	0.025934	0.189024	0.159088	CS pos: 21-22. APS-LP. Pr: 0.2678    36
NZ_CP027599.1_71754	SP(Sec/SPI)	0.366638	0.178792	0.108785	0.345785	CS pos: 19-20. SSA-AP. Pr: 0.3165    22
NZ_CP027599.1_71761	TAT(Tat/SPI)	0.110380	0.490945	0.020482	0.378193	CS pos: 39-40. FNA-AL. Pr: 0.1851    49
NZ_CP027599.1_71778	SP(Sec/SPI)	0.332091	0.043761	0.298813	0.325336	CS pos: ?. Probable protein fragment    19
NZ_CP027599.1_71846	LIPO(Sec/SPII)	0.182206	0.008413	0.585723	0.223659	CS pos: 11-12. FVG-CC. Pr: 0.3999    18
NZ_CP027599.1_71853	LIPO(Sec/SPII)	0.055312	0.008803	0.629804	0.306081	CS pos: 16-17. STS-CN. Pr: 0.6376    48
NZ_CP027599.1_71860	LIPO(Sec/SPII)	0.263686	0.015843	0.383279	0.337191	CS pos: ?. Probable protein fragment    16
NZ_CP027599.1_71865	LIPO(Sec/SPII)	0.213147	0.018692	0.530193	0.237968	CS pos: 19-20. LLC-CC. Pr: 0.2384    21
NZ_CP027599.1_71881	SP(Sec/SPI)	0.371677	0.157505	0.113523	0.357296	CS pos: 12-13. CRA-AS. Pr: 0.1668    34
NZ_CP027599.1_71937	LIPO(Sec/SPII)	0.167346	0.041448	0.580411	0.210795	CS pos: 16-17. LMA-CQ. Pr: 0.5432    20
NZ_CP027599.1_71986	LIPO(Sec/SPII)	0.156017	0.071322	0.584300	0.188361	CS pos: 16-17. AVA-CG. Pr: 0.5485    24
NZ_CP027599.1_72006	SP(Sec/SPI)	0.631053	0.023847	0.222416	0.122684	CS pos: 18-19. SYS-SP. Pr: 0.2291    28
NZ_CP027599.1_72055	SP(Sec/SPI)	0.385688	0.015514	0.370125	0.228673	CS pos: 20-21. LHT-SQ. Pr: 0.2048    35
NZ_CP027599.1_72075	SP(Sec/SPI)	0.537965	0.038005	0.020953	0.403077	CS pos: 10-11. ASA-AD. Pr: 0.4719    36
NZ_CP027599.1_72126	SP(Sec/SPI)	0.497816	0.026893	0.350848	0.124443	CS pos: 21-22. AFA-AS. Pr: 0.4483    38
NZ_CP027599.1_72132	SP(Sec/SPI)	0.544385	0.220198	0.047211	0.188206	CS pos: 25-26. ARA-SE. Pr: 0.5175    29
NZ_CP027599.1_72146	LIPO(Sec/SPII)	0.082712	0.007173	0.762934	0.147181	CS pos: 18-19. LLA-CR. Pr: 0.7025    21
NZ_CP027599.1_72174	LIPO(Sec/SPII)	0.282376	0.062206	0.415041	0.240376	CS pos: ?. Probable protein fragment    16
NZ_CP027599.1_72195	LIPO(Sec/SPII)	0.076880	0.045324	0.732687	0.145108	CS pos: 19-20. VAG-CR. Pr: 0.7253    35
NZ_CP027599.1_72198	SP(Sec/SPI)	0.344656	0.036358	0.283251	0.335734	CS pos: 36-37. TFA-GR. Pr: 0.0256    45
NZ_CP027599.1_72218	TAT(Tat/SPI)	0.138184	0.681113	0.014704	0.165999	CS pos: 35-36. VFA-AP. Pr: 0.6110    50
NZ_CP027599.1_72264	SP(Sec/SPI)	0.466975	0.022702	0.153121	0.357202	CS pos: 14-15. TSS-EI. Pr: 0.1878    21
NZ_CP027599.1_72275	SP(Sec/SPI)	0.428021	0.039448	0.200789	0.331742	CS pos: 18-19. AWA-RC. Pr: 0.3553    23
NZ_CP027599.1_72279	LIPO(Sec/SPII)	0.160710	0.114904	0.391576	0.332810	CS pos: 31-32. GVS-CS. Pr: 0.3625    34
NZ_CP027599.1_72289	LIPO(Sec/SPII)	0.114962	0.020575	0.775826	0.088638	CS pos: 21-22. AAA-CA. Pr: 0.7409    34
NZ_CP027599.1_72290	LIPO(Sec/SPII)	0.275630	0.044040	0.379270	0.301059	CS pos: 15-16. SSG-KT. Pr: 0.0709    20
NZ_CP027599.1_72293	LIPO(Sec/SPII)	0.045622	0.000345	0.944534	0.009499	CS pos: 19-20. VAS-CC. Pr: 0.8725    24
NZ_CP027599.1_72295	SP(Sec/SPI)	0.658522	0.063282	0.139033	0.139163	CS pos: 20-21. PFA-EN. Pr: 0.3476    46
NZ_CP027599.1_72299	LIPO(Sec/SPII)	0.169742	0.011686	0.660464	0.158108	CS pos: 13-14. AAS-CE. Pr: 0.5407    16
NZ_CP027599.1_72328	LIPO(Sec/SPII)	0.137438	0.032981	0.556059	0.273522	CS pos: 12-13. AAG-CW. Pr: 0.2739    27
NZ_CP027599.1_72334	LIPO(Sec/SPII)	0.025653	0.015482	0.900633	0.058232	CS pos: 26-27. LTG-CA. Pr: 0.8988    43
NZ_CP027599.1_72364	LIPO(Sec/SPII)	0.087692	0.002213	0.896093	0.014002	CS pos: 15-16. AYS-CC. Pr: 0.7037    27
NZ_CP027599.1_72366	LIPO(Sec/SPII)	0.062012	0.007710	0.588414	0.341864	CS pos: 20-21. STA-CV. Pr: 0.5974    33
NZ_CP027599.1_72380	LIPO(Sec/SPII)	0.326810	0.013487	0.406738	0.252965	CS pos: 12-13. ALI-CM. Pr: 0.0259    15
NZ_CP027599.1_72396	SP(Sec/SPI)	0.387030	0.250776	0.060702	0.301493	CS pos: 22-23. LVS-QE. Pr: 0.1181    45
NZ_CP027599.1_72404	LIPO(Sec/SPII)	0.301007	0.020741	0.345216	0.333036	CS pos: ?. Probable protein fragment    15
NZ_CP027599.1_72423	LIPO(Sec/SPII)	0.009685	0.000830	0.772804	0.216681	CS pos: 24-25. VTA-CW. Pr: 0.7727    43
NZ_CP027599.1_72427	LIPO(Sec/SPII)	0.228012	0.011640	0.411388	0.348959	CS pos: 21-22. VKM-CS. Pr: 0.1215    23
NZ_CP027599.1_72434	LIPO(Sec/SPII)	0.166627	0.069454	0.388940	0.374979	CS pos: 22-23. FVA-TS. Pr: 0.2493    31
NZ_CP027599.1_72491	LIPO(Sec/SPII)	0.236419	0.037568	0.587122	0.138891	CS pos: 27-28. LTS-CR. Pr: 0.5363    33
NZ_CP027599.1_72497	SP(Sec/SPI)	0.408526	0.106920	0.211994	0.272561	CS pos: ?. Probable protein fragment    21
NZ_CP027599.1_72527	LIPO(Sec/SPII)	0.159758	0.041922	0.479575	0.318746	CS pos: 12-13. ISG-CS. Pr: 0.3572    15
NZ_CP027599.1_72536	LIPO(Sec/SPII)	0.084711	0.011524	0.595751	0.308013	CS pos: 18-19. KTG-CH. Pr: 0.5766    33
NZ_CP027599.1_72557	LIPO(Sec/SPII)	0.234862	0.040098	0.441038	0.284002	CS pos: 16-17. FLS-CS. Pr: 0.1008    20
NZ_CP027599.1_72562	LIPO(Sec/SPII)	0.175839	0.011001	0.634390	0.178770	CS pos: 17-18. GLA-CA. Pr: 0.5027    31
NZ_CP027599.1_72567	LIPO(Sec/SPII)	0.306138	0.033969	0.335720	0.324173	CS pos: ?. Probable protein fragment    17
NZ_CP027599.1_72570	TAT(Tat/SPI)	0.357995	0.394244	0.038824	0.208936	CS pos: 26-27. TTA-DV. Pr: 0.1794    36
NZ_CP027599.1_72571	SP(Sec/SPI)	0.626809	0.253822	0.057303	0.062066	CS pos: 22-23. AAA-AD. Pr: 0.3140    32
NZ_CP027599.1_72572	SP(Sec/SPI)	0.421541	0.076516	0.178534	0.323410	CS pos: 28-29. AYG-AN. Pr: 0.1026    38
NZ_CP027599.1_72579	SP(Sec/SPI)	0.434592	0.061369	0.126788	0.377251	CS pos: 15-16. AHC-DK. Pr: 0.3957    22
NZ_CP027599.1_72634	LIPO(Sec/SPII)	0.229619	0.056507	0.444275	0.269599	CS pos: 22-23. CVP-CR. Pr: 0.1998    35
NZ_CP027599.1_72652	SP(Sec/SPI)	0.390955	0.119241	0.104443	0.385361	CS pos: 24-25. ATA-KA. Pr: 0.2010    31
NZ_CP027599.1_72656	LIPO(Sec/SPII)	0.184755	0.076481	0.420950	0.317814	CS pos: 18-19. AAA-CI. Pr: 0.3569    38
NZ_CP027599.1_72692	SP(Sec/SPI)	0.387803	0.115873	0.117464	0.378860	CS pos: 20-21. SSA-FP. Pr: 0.1980    26
NZ_CP027599.1_72699	LIPO(Sec/SPII)	0.073067	0.080388	0.432120	0.414426	CS pos: 28-29. PSA-CW. Pr: 0.4144    41
NZ_CP027599.1_72706	LIPO(Sec/SPII)	0.191990	0.116935	0.350189	0.340886	CS pos: ?. Probable protein fragment    19
NZ_CP027599.1_72709	TAT(Tat/SPI)	0.278318	0.349278	0.078566	0.293838	CS pos: 25-26. AWS-GT. Pr: 0.1967    42
NZ_CP027599.1_72736	LIPO(Sec/SPII)	0.086969	0.035878	0.472464	0.404689	CS pos: 14-15. VTN-CM. Pr: 0.4566    43
NZ_CP027599.1_72739	LIPO(Sec/SPII)	0.349721	0.014029	0.395159	0.241092	CS pos: 28-29. IST-CW. Pr: 0.2047    33
NZ_CP027599.1_72743	SP(Sec/SPI)	0.458926	0.053789	0.284365	0.202920	CS pos: 18-19. IMS-RS. Pr: 0.1797    20
NZ_CP027599.1_72755	LIPO(Sec/SPII)	0.087609	0.006121	0.659497	0.246773	CS pos: 27-28. LYA-CV. Pr: 0.6372    49
NZ_CP027599.1_72766	SP(Sec/SPI)	0.430501	0.020395	0.204219	0.344885	CS pos: 20-21. VTA-HL. Pr: 0.2045    25
NZ_CP027599.1_72782	LIPO(Sec/SPII)	0.279032	0.019011	0.499175	0.202783	CS pos: 23-24. SVF-CS. Pr: 0.3975    30
NZ_CP027599.1_72784	LIPO(Sec/SPII)	0.330301	0.003147	0.542314	0.124239	CS pos: 16-17. CRT-CW. Pr: 0.2659    24
NZ_CP027599.1_72810	LIPO(Sec/SPII)	0.170192	0.149036	0.399531	0.281241	CS pos: 16-17. SAS-CC. Pr: 0.2718    22
NZ_CP027599.1_72850	SP(Sec/SPI)	0.735873	0.011135	0.183866	0.069127	CS pos: 27-28. AGA-QP. Pr: 0.6396    34
NZ_CP027599.1_72866	LIPO(Sec/SPII)	0.313297	0.022163	0.374165	0.290376	CS pos: 26-27. SPG-CC. Pr: 0.2017    29
NZ_CP027599.1_72887	SP(Sec/SPI)	0.325268	0.073999	0.284147	0.316586	CS pos: 27-28. CLA-RR. Pr: 0.2967    39
NZ_CP027599.1_72938	LIPO(Sec/SPII)	0.013421	0.002738	0.924623	0.059218	CS pos: 20-21. SCG-CG. Pr: 0.6181    33
NZ_CP027599.1_72973	LIPO(Sec/SPII)	0.222062	0.012172	0.421140	0.344626	CS pos: 17-18. FSF-CM. Pr: 0.3283    26
NZ_CP027599.1_72975	LIPO(Sec/SPII)	0.097051	0.012332	0.451412	0.439204	CS pos: 17-18. SKG-CI. Pr: 0.3967    30
NZ_CP027599.1_72979	SP(Sec/SPI)	0.572634	0.069570	0.035742	0.322054	CS pos: 6-7. ASA-AD. Pr: 0.3227    31
NZ_CP027599.1_73002	LIPO(Sec/SPII)	0.103275	0.037197	0.605204	0.254324	CS pos: 18-19. LSG-CH. Pr: 0.5545    20
NZ_CP027599.1_73020	SP(Sec/SPI)	0.525909	0.155427	0.047775	0.270890	CS pos: 19-20. VWP-RQ. Pr: 0.2886    49
NZ_CP027599.1_73021	LIPO(Sec/SPII)	0.114028	0.025544	0.676860	0.183568	CS pos: 24-25. MSR-CR. Pr: 0.5750    36
NZ_CP027599.1_73022	LIPO(Sec/SPII)	0.089651	0.004506	0.485816	0.420027	CS pos: 24-25. LAY-CW. Pr: 0.4303    31
NZ_CP027599.1_73023	LIPO(Sec/SPII)	0.055155	0.003259	0.936069	0.005517	CS pos: 23-24. AIG-CS. Pr: 0.9340    33
NZ_CP027599.1_73031	LIPO(Sec/SPII)	0.122987	0.050891	0.622468	0.203654	CS pos: 17-18. AVA-CR. Pr: 0.5141    22
NZ_CP027599.1_73034	TAT(Tat/SPI)	0.238338	0.550421	0.052100	0.159141	CS pos: 23-24. ANS-DH. Pr: 0.5624    34
NZ_CP027599.1_73046	SP(Sec/SPI)	0.377133	0.010829	0.332385	0.279653	CS pos: 18-19. IYG-NG. Pr: 0.1417    20
NZ_CP027599.1_73064	SP(Sec/SPI)	0.546339	0.119922	0.043595	0.290145	CS pos: 19-20. ANA-QP. Pr: 0.5573    32
NZ_CP027599.1_73084	SP(Sec/SPI)	0.422720	0.013456	0.184382	0.379442	CS pos: 20-21. GFS-AL. Pr: 0.1825    25
NZ_CP027599.1_73087	LIPO(Sec/SPII)	0.215511	0.008169	0.727371	0.048950	CS pos: 12-13. LSS-CN. Pr: 0.7276    40
NZ_CP027599.1_73099	LIPO(Sec/SPII)	0.068322	0.002361	0.643870	0.285448	CS pos: 21-22. LLS-CL. Pr: 0.6158    40
NZ_CP027599.1_73118	SP(Sec/SPI)	0.598777	0.030052	0.165500	0.205670	CS pos: 19-20. AVA-LL. Pr: 0.3463    31
NZ_CP027599.1_73124	LIPO(Sec/SPII)	0.184008	0.129842	0.483140	0.203010	CS pos: 15-16. AFV-CA. Pr: 0.2321    28
NZ_CP027599.1_73128	SP(Sec/SPI)	0.422638	0.092899	0.397540	0.086924	CS pos: 19-20. SLA-TR. Pr: 0.2610    40
NZ_CP027599.1_73136	LIPO(Sec/SPII)	0.262779	0.023318	0.368705	0.345198	CS pos: 13-14. MLT-CW. Pr: 0.1055    16
NZ_CP027599.1_73147	TAT(Tat/SPI)	0.130290	0.429546	0.126754	0.313410	CS pos: ?. Probable protein fragment    15
NZ_CP027599.1_73149	LIPO(Sec/SPII)	0.227628	0.034343	0.423045	0.314985	CS pos: 12-13. LPG-CR. Pr: 0.3642    29
NZ_CP027599.1_73155	LIPO(Sec/SPII)	0.191695	0.000566	0.789611	0.018128	CS pos: 15-16. LCT-CH. Pr: 0.7538    30
NZ_CP027599.1_73195	SP(Sec/SPI)	0.798869	0.010689	0.126389	0.064053	CS pos: 22-23. TLS-SG. Pr: 0.4070    29
NZ_CP027599.1_73202	SP(Sec/SPI)	0.540596	0.075970	0.179023	0.204411	CS pos: 33-34. LEA-SS. Pr: 0.1416    42
NZ_CP027599.1_73212	SP(Sec/SPI)	0.461263	0.067265	0.326447	0.145024	CS pos: 19-20. SMA-LP. Pr: 0.3673    28
NZ_CP027599.1_73215	TAT(Tat/SPI)	0.185173	0.428734	0.093075	0.293018	CS pos: 28-29. ASS-RR. Pr: 0.1511    38
NZ_CP027599.1_73230	LIPO(Sec/SPII)	0.292805	0.022118	0.345033	0.340044	CS pos: 19-20. TIH-CI. Pr: 0.3071    41
NZ_CP027599.1_73232	TAT(Tat/SPI)	0.107561	0.437525	0.071978	0.382937	CS pos: 26-27. AYG-TG. Pr: 0.2627    41
NZ_CP027599.1_73243	LIPO(Sec/SPII)	0.297018	0.023918	0.398062	0.281002	CS pos: 14-15. AAN-CS. Pr: 0.2539    18
NZ_CP027599.1_73248	SP(Sec/SPI)	0.430934	0.007065	0.334384	0.227617	CS pos: ?. Probable protein fragment    18
NZ_CP027599.1_73281	LIPO(Sec/SPII)	0.022356	0.003239	0.878311	0.096094	CS pos: 15-16. LSS-CS. Pr: 0.8673    29
NZ_CP027599.1_73287	LIPO(Sec/SPII)	0.221730	0.008649	0.620778	0.148843	CS pos: 18-19. TGT-CV. Pr: 0.4986    25
NZ_CP027599.1_73299	SP(Sec/SPI)	0.701385	0.082290	0.110460	0.105865	CS pos: 23-24. ALT-ST. Pr: 0.5342    39
NZ_CP027599.1_73321	LIPO(Sec/SPII)	0.024089	0.008160	0.821375	0.146376	CS pos: 19-20. VFS-CR. Pr: 0.8161    35
NZ_CP027599.1_73355	LIPO(Sec/SPII)	0.248850	0.014697	0.416618	0.319834	CS pos: ?. Probable protein fragment    15
NZ_CP027599.1_73363	SP(Sec/SPI)	0.646097	0.010716	0.262980	0.080207	CS pos: 25-26. VSA-IM. Pr: 0.3221    29
NZ_CP027599.1_73366	SP(Sec/SPI)	0.458069	0.037319	0.274800	0.229812	CS pos: 14-15. GVA-SP. Pr: 0.0948    18
NZ_CP027599.1_73439	LIPO(Sec/SPII)	0.271701	0.014644	0.376420	0.337235	CS pos: 15-16. AFR-HH. Pr: 0.0294    17
NZ_CP027599.1_73440	LIPO(Sec/SPII)	0.007440	0.000780	0.980653	0.011127	CS pos: 18-19. FSS-CD. Pr: 0.9800    28
NZ_CP027599.1_73454	SP(Sec/SPI)	0.541393	0.004965	0.307785	0.145857	CS pos: 31-32. SNG-VT. Pr: 0.3573    47
NZ_CP027599.1_73465	SP(Sec/SPI)	0.828956	0.005105	0.028228	0.137710	CS pos: 21-22. RMA-KD. Pr: 0.7749    39
NZ_CP027599.1_73484	LIPO(Sec/SPII)	0.165034	0.022260	0.481605	0.331101	CS pos: 15-16. YVS-CD. Pr: 0.4740    36
NZ_CP027599.1_73830	SP(Sec/SPI)	0.542646	0.004070	0.337876	0.115408	CS pos: 18-19. VHC-TE. Pr: 0.3188    22
NZ_CP027599.1_73831	LIPO(Sec/SPII)	0.069542	0.002465	0.843692	0.084301	CS pos: 17-18. SDS-CS. Pr: 0.8319    45
NZ_CP027599.1_73834	TAT(Tat/SPI)	0.080295	0.447370	0.032028	0.440307	CS pos: 25-26. LQG-HI. Pr: 0.0719    33
NZ_CP027599.1_73840	TAT(Tat/SPI)	0.168143	0.600398	0.034334	0.197125	CS pos: 38-39. SRA-AR. Pr: 0.4192    43
NZ_CP027599.1_73852	LIPO(Sec/SPII)	0.223020	0.085447	0.378396	0.313136	CS pos: ?. Probable protein fragment    21
NZ_CP027599.1_73858	LIPO(Sec/SPII)	0.203101	0.010235	0.435066	0.351598	CS pos: 16-17. IIY-CS. Pr: 0.1867    18
NZ_CP027599.1_73872	SP(Sec/SPI)	0.416660	0.065281	0.128697	0.389362	CS pos: 21-22. AGA-LH. Pr: 0.1623    26
NZ_CP027599.1_73876	LIPO(Sec/SPII)	0.081613	0.003362	0.796368	0.118657	CS pos: 13-14. IGG-CP. Pr: 0.7448    39
NZ_CP027599.1_73910	LIPO(Sec/SPII)	0.277665	0.046468	0.385453	0.290414	CS pos: ?. Probable protein fragment    16
NZ_CP027599.1_73979	LIPO(Sec/SPII)	0.139227	0.013965	0.675884	0.170924	CS pos: 15-16. FQG-CF. Pr: 0.5389    17
NZ_CP027599.1_73999	SP(Sec/SPI)	0.511127	0.045893	0.140555	0.302425	CS pos: 17-18. SSA-ER. Pr: 0.2577    46
NZ_CP027599.1_74022	SP(Sec/SPI)	0.395193	0.129938	0.088298	0.386570	CS pos: 19-20. PHA-AM. Pr: 0.2452    25
NZ_CP027599.1_74025	LIPO(Sec/SPII)	0.145912	0.034124	0.443543	0.376421	CS pos: 22-23. STG-CF. Pr: 0.4419    31
NZ_CP027599.1_74027	LIPO(Sec/SPII)	0.094569	0.066990	0.481382	0.357058	CS pos: 13-14. ASS-CS. Pr: 0.4831    44
NZ_CP027599.1_74057	LIPO(Sec/SPII)	0.234691	0.002506	0.435682	0.327122	CS pos: 14-15. VFS-YE. Pr: 0.3327    45
NZ_CP027599.1_74083	SP(Sec/SPI)	0.424122	0.002852	0.195990	0.377036	CS pos: 18-19. VRM-TH. Pr: 0.1068    26
NZ_CP027599.1_74128	LIPO(Sec/SPII)	0.252880	0.031467	0.412459	0.303194	CS pos: 13-14. ARA-CC. Pr: 0.2172    21
NZ_CP027599.1_74151	LIPO(Sec/SPII)	0.203450	0.017488	0.565932	0.213130	CS pos: 15-16. SNS-CM. Pr: 0.3973    17
NZ_CP027599.1_74154	SP(Sec/SPI)	0.492966	0.013712	0.065786	0.427537	CS pos: 25-26. FPA-TP. Pr: 0.1563    38
NZ_CP027599.1_74194	TAT(Tat/SPI)	0.045214	0.529633	0.106275	0.318878	CS pos: 33-34. RNA-VR. Pr: 0.1408    37
NZ_CP027599.1_74289	LIPO(Sec/SPII)	0.072080	0.012696	0.478560	0.436664	CS pos: 15-16. CLS-CS. Pr: 0.3108    40
NZ_CP027599.1_74309	SP(Sec/SPI)	0.531739	0.086256	0.099950	0.282055	CS pos: 19-20. ASA-SL. Pr: 0.4913    25
NZ_CP027599.1_74313	LIPO(Sec/SPII)	0.243193	0.009919	0.482985	0.263904	CS pos: 18-19. IPI-CR. Pr: 0.1017    20
NZ_CP027599.1_74326	LIPO(Sec/SPII)	0.163690	0.006414	0.708941	0.120955	CS pos: 17-18. LMS-CV. Pr: 0.6392    20
NZ_CP027599.1_74365	TAT(Tat/SPI)	0.184217	0.496007	0.044948	0.274827	CS pos: 32-33. SSA-RP. Pr: 0.0748    49
NZ_CP027599.1_74399	SP(Sec/SPI)	0.514443	0.055169	0.139404	0.290984	CS pos: 25-26. CLA-DE. Pr: 0.4976    34
NZ_CP027599.1_74410	LIPO(Sec/SPII)	0.200144	0.115327	0.353581	0.330948	CS pos: ?. Probable protein fragment    16
NZ_CP027599.1_74411	LIPO(Sec/SPII)	0.019804	0.033242	0.703275	0.243679	CS pos: 20-21. VSA-CS. Pr: 0.7106    50
NZ_CP027599.1_74439	LIPO(Sec/SPII)	0.207640	0.027357	0.474557	0.290446	CS pos: 12-13. VTS-CG. Pr: 0.3527    20
NZ_CP027599.1_74464	SP(Sec/SPI)	0.461123	0.011668	0.157573	0.369637	CS pos: 24-25. SFA-YT. Pr: 0.3529    34
NZ_CP027599.1_74493	SP(Sec/SPI)	0.838820	0.113898	0.020802	0.026481	CS pos: 23-24. ARA-MS. Pr: 0.8089    47
NZ_CP027599.1_74497	LIPO(Sec/SPII)	0.185152	0.071351	0.435243	0.308254	CS pos: 27-28. LMS-CR. Pr: 0.3593    43
NZ_CP027599.1_74507	LIPO(Sec/SPII)	0.045905	0.006403	0.657285	0.290408	CS pos: 15-16. MYG-CR. Pr: 0.6444    36
NZ_CP027599.1_74523	LIPO(Sec/SPII)	0.226016	0.006502	0.442559	0.324924	CS pos: 14-15. FLD-CL. Pr: 0.2238    17
NZ_CP027599.1_74548	SP(Sec/SPI)	0.448792	0.331503	0.064789	0.154916	CS pos: 25-26. GLA-RP. Pr: 0.4017    46
NZ_CP027599.1_74555	LIPO(Sec/SPII)	0.098262	0.004506	0.765105	0.132127	CS pos: 18-19. AVT-CA. Pr: 0.6394    35
NZ_CP027599.1_74576	SP(Sec/SPI)	0.410660	0.039731	0.241088	0.308521	CS pos: 19-20. AKS-GS. Pr: 0.1244    22
NZ_CP027599.1_74596	SP(Sec/SPI)	0.384103	0.023960	0.287410	0.304527	CS pos: ?. Probable protein fragment    17
NZ_CP027599.1_74681	LIPO(Sec/SPII)	0.106900	0.021159	0.714328	0.157614	CS pos: 16-17. ISA-CR. Pr: 0.6737    21
NZ_CP027599.1_74698	LIPO(Sec/SPII)	0.100591	0.007135	0.503600	0.388674	CS pos: 15-16. NAS-CR. Pr: 0.4289    29
NZ_CP027599.1_74704	LIPO(Sec/SPII)	0.193573	0.071459	0.404675	0.330293	CS pos: ?. Probable protein fragment    16
NZ_CP027599.1_74708	SP(Sec/SPI)	0.439423	0.113244	0.114347	0.332986	CS pos: 27-28. GFA-RR. Pr: 0.3385    29
NZ_CP027599.1_74711	LIPO(Sec/SPII)	0.145586	0.020593	0.606512	0.227308	CS pos: 14-15. STG-CA. Pr: 0.4922    19
NZ_CP027599.1_74744	LIPO(Sec/SPII)	0.136769	0.102101	0.522663	0.238467	CS pos: 17-18. SSA-CG. Pr: 0.5126    35
NZ_CP027599.1_74747	LIPO(Sec/SPII)	0.284262	0.024878	0.364367	0.326494	CS pos: 15-16. LVA-YV. Pr: 0.0254    17
NZ_CP027599.1_74763	SP(Sec/SPI)	0.872977	0.057982	0.037756	0.031285	CS pos: 17-18. ALA-AP. Pr: 0.8520    39
NZ_CP027599.1_74769	SP(Sec/SPI)	0.842103	0.031238	0.105026	0.021632	CS pos: 22-23. SFA-SF. Pr: 0.6706    29
NZ_CP027599.1_74805	SP(Sec/SPI)	0.635353	0.014085	0.073142	0.277420	CS pos: 19-20. SHC-LI. Pr: 0.4999    49
NZ_CP027599.1_74819	LIPO(Sec/SPII)	0.404393	0.003902	0.578409	0.013296	CS pos: 13-14. LTA-TS. Pr: 0.5216    41
NZ_CP027599.1_74826	LIPO(Sec/SPII)	0.178354	0.053138	0.487198	0.281310	CS pos: 22-23. AAS-CS. Pr: 0.4008    34
NZ_CP027599.1_74841	SP(Sec/SPI)	0.635584	0.097399	0.247864	0.019153	CS pos: 23-24. ATA-ST. Pr: 0.5822    41
NZ_CP027599.1_74853	LIPO(Sec/SPII)	0.144521	0.016148	0.609443	0.229887	CS pos: 21-22. LLC-CR. Pr: 0.3959    24
NZ_CP027599.1_74932	LIPO(Sec/SPII)	0.296022	0.008507	0.540033	0.155439	CS pos: ?. Probable protein fragment    15
NZ_CP027599.1_74940	LIPO(Sec/SPII)	0.234280	0.022445	0.395163	0.348112	CS pos: ?. Probable protein fragment    16
NZ_CP027599.1_74983	LIPO(Sec/SPII)	0.040428	0.008320	0.836930	0.114323	CS pos: 25-26. TSG-CE. Pr: 0.8366    39
NZ_CP027599.1_74995	LIPO(Sec/SPII)	0.299087	0.033543	0.336128	0.331242	CS pos: ?. Probable protein fragment    15
NZ_CP027599.1_75034	LIPO(Sec/SPII)	0.285107	0.008985	0.498319	0.207589	CS pos: ?. Probable protein fragment    20
NZ_CP027599.1_75044	LIPO(Sec/SPII)	0.062375	0.056997	0.820882	0.059745	CS pos: 21-22. FTA-CS. Pr: 0.8032    34
NZ_CP027599.1_75045	LIPO(Sec/SPII)	0.203372	0.024800	0.623028	0.148800	CS pos: 17-18. ASA-CT. Pr: 0.5809    33
NZ_CP027599.1_75055	SP(Sec/SPI)	0.362592	0.102023	0.214490	0.320895	CS pos: 23-24. SRA-TT. Pr: 0.3499    31
NZ_CP027599.1_75058	LIPO(Sec/SPII)	0.117798	0.011685	0.723441	0.147076	CS pos: 19-20. STS-CW. Pr: 0.6831    21
NZ_CP027599.1_75081	SP(Sec/SPI)	0.354235	0.075445	0.225041	0.345279	CS pos: 16-17. AVS-QI. Pr: 0.0978    46
NZ_CP027599.1_75084	SP(Sec/SPI)	0.499672	0.068307	0.028620	0.403401	CS pos: 14-15. ASA-DG. Pr: 0.3658    39
NZ_CP027599.1_75094	LIPO(Sec/SPII)	0.135665	0.021420	0.440693	0.402222	CS pos: 15-16. IKG-CP. Pr: 0.3518    17
NZ_CP027599.1_75096	LIPO(Sec/SPII)	0.215478	0.029317	0.429724	0.325481	CS pos: ?. Probable protein fragment    18
NZ_CP027599.1_75111	SP(Sec/SPI)	0.430737	0.015822	0.146947	0.406494	CS pos: 19-20. VMT-AV. Pr: 0.2100    24
NZ_CP027599.1_75122	SP(Sec/SPI)	0.380390	0.022891	0.345814	0.250905	CS pos: ?. Probable protein fragment    17
NZ_CP027599.1_75147	LIPO(Sec/SPII)	0.025042	0.001987	0.869647	0.103324	CS pos: 14-15. MTG-CR. Pr: 0.8618    36
NZ_CP027599.1_75151	SP(Sec/SPI)	0.682659	0.024204	0.263250	0.029887	CS pos: 22-23. ATA-NS. Pr: 0.4635    32
NZ_CP027599.1_75154	LIPO(Sec/SPII)	0.122102	0.022798	0.538815	0.316285	CS pos: 16-17. PAG-CG. Pr: 0.4959    25
NZ_CP027599.1_75155	LIPO(Sec/SPII)	0.197645	0.259571	0.331434	0.211350	CS pos: ?. Probable protein fragment    24
NZ_CP027599.1_75158	LIPO(Sec/SPII)	0.158603	0.028183	0.449223	0.363991	CS pos: 18-19. ASK-CR. Pr: 0.2896    21
NZ_CP027599.1_75173	SP(Sec/SPI)	0.555835	0.128835	0.062344	0.252985	CS pos: 26-27. VSA-RG. Pr: 0.4540    31
NZ_CP027599.1_75177	SP(Sec/SPI)	0.509800	0.021442	0.070352	0.398407	CS pos: 18-19. VFA-RR. Pr: 0.3081    36
NZ_CP027599.1_75189	LIPO(Sec/SPII)	0.214109	0.061841	0.401379	0.322671	CS pos: ?. Probable protein fragment    17
NZ_CP027599.1_75207	SP(Sec/SPI)	0.808142	0.019914	0.082631	0.089313	CS pos: 20-21. AFS-QP. Pr: 0.7405    34
NZ_CP027599.1_75236	LIPO(Sec/SPII)	0.272623	0.016641	0.463593	0.247142	CS pos: 26-27. SAS-CC. Pr: 0.4146    28
NZ_CP027599.1_75315	SP(Sec/SPI)	0.559487	0.120140	0.268750	0.051623	CS pos: 29-30. SWA-SF. Pr: 0.3065    38
NZ_CP027599.1_75316	SP(Sec/SPI)	0.495978	0.046683	0.158106	0.299233	CS pos: 25-26. VFS-SY. Pr: 0.2639    46
NZ_CP027599.1_75318	LIPO(Sec/SPII)	0.066288	0.066734	0.466975	0.400004	CS pos: 23-24. YTG-CH. Pr: 0.4547    47
NZ_CP027599.1_75322	TAT(Tat/SPI)	0.329158	0.404465	0.038451	0.227926	CS pos: 24-25. AFA-TS. Pr: 0.2734    44
NZ_CP027599.1_75371	SP(Sec/SPI)	0.754207	0.015413	0.081170	0.149210	CS pos: 17-18. ALA-NK. Pr: 0.6490    24
NZ_CP027599.1_75377	LIPO(Sec/SPII)	0.257882	0.041971	0.365126	0.335022	CS pos: ?. Probable protein fragment    15
NZ_CP027599.1_75393	LIPO(Sec/SPII)	0.198124	0.050748	0.479372	0.271756	CS pos: 14-15. GTG-CL. Pr: 0.3801    21
NZ_CP027599.1_75436	SP(Sec/SPI)	0.425386	0.032825	0.254684	0.287105	CS pos: 14-15. AAA-VN. Pr: 0.2837    45
NZ_CP027599.1_75453	SP(Sec/SPI)	0.625876	0.035463	0.128225	0.210435	CS pos: 24-25. VTA-MD. Pr: 0.3110    27
NZ_CP027599.1_75481	LIPO(Sec/SPII)	0.142817	0.026218	0.465055	0.365910	CS pos: 23-24. IQS-CT. Pr: 0.4443    27
NZ_CP027599.1_75504	TAT(Tat/SPI)	0.288718	0.395130	0.069498	0.246654	CS pos: 21-22. GSA-IS. Pr: 0.2350    42
NZ_CP027599.1_75524	LIPO(Sec/SPII)	0.384157	0.008248	0.427737	0.179858	CS pos: 17-18. SIF-CS. Pr: 0.2898    39
NZ_CP027599.1_75551	SP(Sec/SPI)	0.445098	0.045463	0.077375	0.432064	CS pos: 21-22. ALA-DA. Pr: 0.2436    26
NZ_CP027599.1_75554	SP(Sec/SPI)	0.456873	0.023723	0.084864	0.434540	CS pos: 22-23. VFA-IN. Pr: 0.3802    28
NZ_CP027599.1_75569	TAT(Tat/SPI)	0.123421	0.566494	0.130170	0.179915	CS pos: 32-33. AHV-IR. Pr: 0.1685    36
NZ_CP027599.1_75587	LIPO(Sec/SPII)	0.242501	0.018339	0.448906	0.290254	CS pos: 14-15. STF-CT. Pr: 0.2803    18
NZ_CP027599.1_75595	SP(Sec/SPI)	0.380858	0.340751	0.075806	0.202584	CS pos: 17-18. ASA-SP. Pr: 0.3413    26
NZ_CP027599.1_75632	LIPO(Sec/SPII)	0.167163	0.036470	0.480658	0.315709	CS pos: 20-21. PTT-CN. Pr: 0.4087    36
NZ_CP027599.1_75655	LIPO(Sec/SPII)	0.265329	0.243856	0.352638	0.138178	CS pos: 28-29. VSS-CC. Pr: 0.2553    37
NZ_CP027599.1_75657	LIPO(Sec/SPII)	0.372626	0.016640	0.455709	0.155026	CS pos: ?. Probable protein fragment    15
NZ_CP027599.1_75660	LIPO(Sec/SPII)	0.057457	0.079184	0.556898	0.306461	CS pos: 21-22. ASA-CS. Pr: 0.5587    46
NZ_CP027599.1_75667	LIPO(Sec/SPII)	0.415423	0.008225	0.535662	0.040691	CS pos: 19-20. VAP-CG. Pr: 0.4479    30
NZ_CP027599.1_75720	LIPO(Sec/SPII)	0.228146	0.049906	0.411266	0.310682	CS pos: 14-15. STA-CE. Pr: 0.2868    16
NZ_CP027599.1_75751	LIPO(Sec/SPII)	0.366490	0.012637	0.402864	0.218010	CS pos: 22-23. LAG-SG. Pr: 0.3375    38
NZ_CP027599.1_75764	LIPO(Sec/SPII)	0.140556	0.012119	0.673096	0.174228	CS pos: 16-17. LST-CL. Pr: 0.6265    22
NZ_CP027599.1_75784	TAT(Tat/SPI)	0.298765	0.362945	0.062220	0.276071	CS pos: 26-27. GNA-ET. Pr: 0.0882    31
NZ_CP027599.1_75788	LIPO(Sec/SPII)	0.253907	0.017869	0.556495	0.171729	CS pos: 13-14. PLT-CA. Pr: 0.1009    16
NZ_CP027599.1_75793	SP(Sec/SPI)	0.365374	0.027684	0.295658	0.311284	CS pos: 22-23. ANV-FP. Pr: 0.1409    30
NZ_CP027599.1_75795	SP(Sec/SPI)	0.352240	0.027853	0.333537	0.286370	CS pos: 15-16. AAA-TT. Pr: 0.0861    25
NZ_CP027599.1_75797	LIPO(Sec/SPII)	0.125684	0.005172	0.731827	0.137317	CS pos: ?. Probable protein fragment    24
NZ_CP027599.1_75883	LIPO(Sec/SPII)	0.300033	0.101281	0.407428	0.191257	CS pos: 17-18. SSA-CA. Pr: 0.3380    40
NZ_CP027599.1_75905	LIPO(Sec/SPII)	0.225476	0.168787	0.322505	0.283233	CS pos: 17-18. AYS-CS. Pr: 0.2281    19
NZ_CP027599.1_75912	LIPO(Sec/SPII)	0.300581	0.016167	0.418983	0.264269	CS pos: 19-20. LEG-KS. Pr: 0.3212    22
NZ_CP027599.1_75917	LIPO(Sec/SPII)	0.065283	0.012943	0.779700	0.142074	CS pos: 16-17. LAA-CM. Pr: 0.7656    46
NZ_CP027599.1_75934	SP(Sec/SPI)	0.436497	0.019003	0.122864	0.421636	CS pos: 21-22. GNT-AM. Pr: 0.0690    46
NZ_CP027599.1_75936	SP(Sec/SPI)	0.450553	0.040246	0.235971	0.273230	CS pos: 27-28. VVS-EC. Pr: 0.2345    29
NZ_CP027599.1_75952	SP(Sec/SPI)	0.497034	0.028087	0.256350	0.218529	CS pos: 15-16. ASA-DS. Pr: 0.3620    35
NZ_CP027599.1_75965	SP(Sec/SPI)	0.412399	0.066113	0.265580	0.255908	CS pos: 24-25. AFC-YV. Pr: 0.2435    27
NZ_CP027599.1_75981	LIPO(Sec/SPII)	0.242260	0.008645	0.481363	0.267732	CS pos: ?. Probable protein fragment    22
NZ_CP027599.1_76026	LIPO(Sec/SPII)	0.090751	0.004154	0.599068	0.306028	CS pos: 14-15. SVS-CE. Pr: 0.5986    44
NZ_CP027599.1_76039	LIPO(Sec/SPII)	0.305730	0.007569	0.414941	0.271759	CS pos: 17-18. LVF-CR. Pr: 0.2048    30
NZ_CP027599.1_76043	LIPO(Sec/SPII)	0.295020	0.010126	0.439043	0.255810	CS pos: 14-15. MAS-LL. Pr: 0.0595    16
NZ_CP027599.1_76069	LIPO(Sec/SPII)	0.317667	0.012797	0.421418	0.248119	CS pos: ?. Probable protein fragment    16
NZ_CP027599.1_76071	SP(Sec/SPI)	0.337314	0.013835	0.324017	0.324833	CS pos: ?. Probable protein fragment    19
NZ_CP027599.1_76094	LIPO(Sec/SPII)	0.131070	0.001675	0.745821	0.121434	CS pos: 18-19. LLC-CT. Pr: 0.6158    28
NZ_CP027599.1_76128	SP(Sec/SPI)	0.598457	0.052221	0.086447	0.262875	CS pos: 25-26. SYA-AS. Pr: 0.4745    45
NZ_CP027599.1_76143	LIPO(Sec/SPII)	0.185130	0.029616	0.492003	0.293251	CS pos: 13-14. TLA-CQ. Pr: 0.3027    15
NZ_CP027599.1_76148	SP(Sec/SPI)	0.499135	0.034863	0.319516	0.146486	CS pos: 21-22. VLA-VT. Pr: 0.4757    34
NZ_CP027599.1_76164	SP(Sec/SPI)	0.437886	0.137916	0.263699	0.160499	CS pos: 24-25. RHG-SS. Pr: 0.0988    44
NZ_CP027599.1_76208	LIPO(Sec/SPII)	0.210681	0.030202	0.399044	0.360073	CS pos: 13-14. LSF-CK. Pr: 0.0280    15
NZ_CP027599.1_76213	LIPO(Sec/SPII)	0.158292	0.004354	0.626515	0.210839	CS pos: 14-15. VVP-CW. Pr: 0.6087    22
NZ_CP027599.1_76229	LIPO(Sec/SPII)	0.244481	0.016745	0.380391	0.358382	CS pos: 19-20. TIM-CL. Pr: 0.0659    21
NZ_CP027599.1_76234	LIPO(Sec/SPII)	0.198753	0.017972	0.541860	0.241414	CS pos: 14-15. FLG-CF. Pr: 0.3141    16
NZ_CP027599.1_76366	LIPO(Sec/SPII)	0.239889	0.020844	0.384947	0.354320	CS pos: ?. Probable protein fragment    17
NZ_CP027599.1_76397	SP(Sec/SPI)	0.468813	0.012138	0.060002	0.459047	CS pos: 15-16. FPA-TN. Pr: 0.0894    35
NZ_CP027599.1_76437	SP(Sec/SPI)	0.409888	0.080564	0.197261	0.312287	CS pos: 27-28. CRC-AQ. Pr: 0.2564    40
NZ_CP027599.1_76511	LIPO(Sec/SPII)	0.134338	0.016617	0.579135	0.269910	CS pos: 11-12. MSS-CL. Pr: 0.5254    17
NZ_CP027599.1_76519	TAT(Tat/SPI)	0.275165	0.355380	0.053944	0.315512	CS pos: 25-26. SLC-RV. Pr: 0.1190    32
NZ_CP027599.1_76527	LIPO(Sec/SPII)	0.170546	0.004673	0.753319	0.071462	CS pos: 14-15. AFC-CS. Pr: 0.3570    36
NZ_CP027599.1_76582	SP(Sec/SPI)	0.398852	0.013732	0.253566	0.333850	CS pos: 17-18. TKS-SP. Pr: 0.0641    24
NZ_CP027599.1_76597	LIPO(Sec/SPII)	0.220619	0.020974	0.507650	0.250757	CS pos: ?. Probable protein fragment    15
NZ_CP027599.1_76602	LIPO(Sec/SPII)	0.187979	0.036278	0.393977	0.381766	CS pos: 25-26. IAP-CC. Pr: 0.2002    28
NZ_CP027599.1_76603	LIPO(Sec/SPII)	0.230652	0.010984	0.478466	0.279898	CS pos: ?. Probable protein fragment    17
NZ_CP027599.1_76617	LIPO(Sec/SPII)	0.053101	0.005274	0.522694	0.418931	CS pos: 12-13. LIS-CG. Pr: 0.4751    33
NZ_CP027599.1_76648	LIPO(Sec/SPII)	0.259272	0.017376	0.367981	0.355371	CS pos: 19-20. LCL-CR. Pr: 0.1755    24
NZ_CP027599.1_76655	SP(Sec/SPI)	0.293947	0.217375	0.227740	0.260938	CS pos: 28-29. ASS-SG. Pr: 0.0830    43
NZ_CP027599.1_76665	LIPO(Sec/SPII)	0.282306	0.034054	0.630868	0.052771	CS pos: 17-18. LTA-LS. Pr: 0.5825    39
NZ_CP027599.1_76700	LIPO(Sec/SPII)	0.146969	0.057266	0.480973	0.314793	CS pos: ?. Probable protein fragment    23
NZ_CP027599.1_76767	SP(Sec/SPI)	0.377653	0.015078	0.277041	0.330228	CS pos: ?. Probable protein fragment    19
NZ_CP027599.1_76773	LIPO(Sec/SPII)	0.131027	0.017712	0.670496	0.180765	CS pos: 14-15. SGS-CP. Pr: 0.5824    30
NZ_CP027599.1_76779	SP(Sec/SPI)	0.489040	0.013429	0.466627	0.030904	CS pos: 23-24. GRS-DV. Pr: 0.2868    36
NZ_CP027599.1_76809	LIPO(Sec/SPII)	0.304548	0.006650	0.528496	0.160306	CS pos: ?. Probable protein fragment    15
NZ_CP027599.1_76812	SP(Sec/SPI)	0.611650	0.007010	0.054860	0.326479	CS pos: 18-19. AES-FS. Pr: 0.4272    34
NZ_CP027599.1_76832	LIPO(Sec/SPII)	0.078591	0.023679	0.656034	0.241696	CS pos: 17-18. MSS-CE. Pr: 0.6138    22
NZ_CP027599.1_77050	LIPO(Sec/SPII)	0.164577	0.014932	0.439964	0.380527	CS pos: 23-24. IFQ-CA. Pr: 0.3765    49
NZ_CP027599.1_77067	SP(Sec/SPI)	0.421469	0.052151	0.196446	0.329934	CS pos: 19-20. AEC-KT. Pr: 0.2515    29
NZ_CP027599.1_77102	LIPO(Sec/SPII)	0.250388	0.023862	0.514103	0.211647	CS pos: 11-12. ITS-CI. Pr: 0.1694    15
NZ_CP027599.1_77111	SP(Sec/SPI)	0.456396	0.009344	0.274170	0.260091	CS pos: 18-19. SAA-IN. Pr: 0.2884    20
NZ_CP027599.1_77154	LIPO(Sec/SPII)	0.023840	0.000526	0.969041	0.006593	CS pos: 20-21. ISS-CA. Pr: 0.9618    27
NZ_CP027599.1_77204	LIPO(Sec/SPII)	0.003958	0.002217	0.980776	0.013049	CS pos: 29-30. LTS-CT. Pr: 0.9824    44
NZ_CP027599.1_77209	LIPO(Sec/SPII)	0.128801	0.028725	0.458046	0.384429	CS pos: 20-21. TSG-CR. Pr: 0.4001    24
NZ_CP027599.1_77219	LIPO(Sec/SPII)	0.261943	0.016534	0.364930	0.356592	CS pos: ?. Probable protein fragment    19
NZ_CP027599.1_77226	LIPO(Sec/SPII)	0.013798	0.000417	0.983422	0.002363	CS pos: 15-16. LAT-CK. Pr: 0.9807    26
NZ_CP027599.1_77233	LIPO(Sec/SPII)	0.048032	0.008131	0.789689	0.154149	CS pos: 22-23. MLS-CI. Pr: 0.7755    29
NZ_CP027599.1_77240	SP(Sec/SPI)	0.486120	0.038925	0.138494	0.336460	CS pos: 24-25. SSG-MI. Pr: 0.1440    46
NZ_CP027599.1_77245	SP(Sec/SPI)	0.515158	0.008185	0.089256	0.387401	CS pos: 25-26. SYS-TG. Pr: 0.3762    45
NZ_CP027599.1_77299	LIPO(Sec/SPII)	0.252186	0.014088	0.471690	0.262036	CS pos: ?. Probable protein fragment    17
NZ_CP027599.1_77300	LIPO(Sec/SPII)	0.183783	0.009937	0.658804	0.147475	CS pos: 24-25. LSG-CG. Pr: 0.5590    39
NZ_CP027599.1_77321	LIPO(Sec/SPII)	0.114683	0.080354	0.482944	0.322019	CS pos: 11-12. AGA-CT. Pr: 0.4619    28
NZ_CP027599.1_77361	SP(Sec/SPI)	0.605319	0.075788	0.216446	0.102447	CS pos: 28-29. ARC-EG. Pr: 0.3111    37
NZ_CP027599.1_77388	SP(Sec/SPI)	0.441961	0.029317	0.118768	0.409955	CS pos: 18-19. QWG-YS. Pr: 0.0572    25
NZ_CP027599.1_77408	LIPO(Sec/SPII)	0.088374	0.200691	0.620729	0.090207	CS pos: 19-20. LSG-QS. Pr: 0.5866    39
NZ_CP027599.1_77411	SP(Sec/SPI)	0.343996	0.052507	0.284704	0.318794	CS pos: 24-25. AST-RP. Pr: 0.0821    27
NZ_CP027599.1_77426	LIPO(Sec/SPII)	0.283968	0.062550	0.370579	0.282903	CS pos: 14-15. SMA-TF. Pr: 0.0197    17
NZ_CP027599.1_77442	SP(Sec/SPI)	0.449260	0.026382	0.113848	0.410510	CS pos: 22-23. SNA-GV. Pr: 0.2624    24
NZ_CP027599.1_77455	LIPO(Sec/SPII)	0.247396	0.013190	0.391247	0.348168	CS pos: ?. Probable protein fragment    16
NZ_CP027599.1_77462	SP(Sec/SPI)	0.498315	0.043890	0.182347	0.275449	CS pos: 19-20. STA-GA. Pr: 0.1910    23
NZ_CP027599.1_77468	SP(Sec/SPI)	0.364479	0.096049	0.178092	0.361380	CS pos: 11-12. ANA-MT. Pr: 0.3091    31
NZ_CP027599.1_77490	LIPO(Sec/SPII)	0.085187	0.186609	0.504050	0.224155	CS pos: 31-32. ATS-CV. Pr: 0.4921    41
NZ_CP027599.1_77493	SP(Sec/SPI)	0.455220	0.188547	0.212448	0.143785	CS pos: 15-16. AFA-SG. Pr: 0.1429    25
NZ_CP027599.1_77502	LIPO(Sec/SPII)	0.339802	0.006527	0.386203	0.267468	CS pos: ?. Probable protein fragment    17
NZ_CP027599.1_77503	LIPO(Sec/SPII)	0.111790	0.038993	0.647297	0.201919	CS pos: 15-16. SFS-CK. Pr: 0.6106    30
NZ_CP027599.1_77550	LIPO(Sec/SPII)	0.253592	0.047376	0.474730	0.224302	CS pos: 21-22. PLT-CA. Pr: 0.2206    23
NZ_CP027599.1_77586	LIPO(Sec/SPII)	0.097465	0.039344	0.454610	0.408581	CS pos: 25-26. ITA-CT. Pr: 0.4247    47
NZ_CP027599.1_77588	SP(Sec/SPI)	0.497985	0.012304	0.236905	0.252806	CS pos: 15-16. ATA-LP. Pr: 0.1394    21
NZ_CP027599.1_77604	SP(Sec/SPI)	0.344975	0.174949	0.262861	0.217215	CS pos: 31-32. AKA-AP. Pr: 0.1399    44
NZ_CP027599.1_77606	SP(Sec/SPI)	0.674552	0.052906	0.067772	0.204770	CS pos: 18-19. SPA-DS. Pr: 0.2951    29
NZ_CP027599.1_77623	TAT(Tat/SPI)	0.209486	0.394741	0.035806	0.359966	CS pos: 24-25. VQA-GS. Pr: 0.0747    44
NZ_CP027599.1_77626	TAT(Tat/SPI)	0.066613	0.462492	0.030229	0.440665	CS pos: 27-28. RRA-LR. Pr: 0.1720    29
NZ_CP027599.1_77659	SP(Sec/SPI)	0.388854	0.072606	0.225482	0.313058	CS pos: 29-30. AYS-SP. Pr: 0.0655    33
NZ_CP027599.1_77667	TAT(Tat/SPI)	0.240588	0.515381	0.101210	0.142821	CS pos: 24-25. CWA-LS. Pr: 0.5533    36
NZ_CP027599.1_77684	TAT(Tat/SPI)	0.149625	0.400661	0.278908	0.170806	CS pos: 25-26. ANC-RI. Pr: 0.1350    42
NZ_CP027599.1_77695	LIPO(Sec/SPII)	0.167422	0.008955	0.690186	0.133437	CS pos: 18-19. TSG-CT. Pr: 0.7182    24
NZ_CP027599.1_77696	TAT(Tat/SPI)	0.016044	0.970018	0.002617	0.011322	CS pos: 38-39. GFA-GD. Pr: 0.3646    50
NZ_CP027599.1_77708	LIPO(Sec/SPII)	0.096597	0.010022	0.482621	0.410759	CS pos: 21-22. PLA-CR. Pr: 0.4189    26
NZ_CP027599.1_77715	SP(Sec/SPI)	0.470942	0.029090	0.086683	0.413285	CS pos: 13-14. AWA-GT. Pr: 0.2803    50
NZ_CP027599.1_77717	LIPO(Sec/SPII)	0.210766	0.017636	0.580049	0.191549	CS pos: 24-25. FVL-CA. Pr: 0.4854    42
NZ_CP027599.1_77743	SP(Sec/SPI)	0.384790	0.106762	0.153113	0.355335	CS pos: 20-21. LYA-AR. Pr: 0.1417    33
NZ_CP027599.1_77754	LIPO(Sec/SPII)	0.189638	0.007259	0.430076	0.373027	CS pos: 25-26. ISI-CG. Pr: 0.1421    27
NZ_CP027599.1_77820	TAT(Tat/SPI)	0.126249	0.399864	0.123097	0.350790	CS pos: 23-24. ITA-KS. Pr: 0.1547    41
NZ_CP027599.1_77828	SP(Sec/SPI)	0.582837	0.016512	0.257284	0.143368	CS pos: 25-26. AHR-LQ. Pr: 0.3309    37
NZ_CP027599.1_77875	LIPO(Sec/SPII)	0.215919	0.003674	0.436540	0.343867	CS pos: 14-15. AVC-CA. Pr: 0.2156    18
NZ_CP027599.1_77890	LIPO(Sec/SPII)	0.189927	0.023389	0.510093	0.276591	CS pos: 19-20. ILS-CN. Pr: 0.4497    22
NZ_CP027599.1_77898	LIPO(Sec/SPII)	0.233489	0.026243	0.595660	0.144607	CS pos: 24-25. LAN-CQ. Pr: 0.2913    30
NZ_CP027599.1_77930	LIPO(Sec/SPII)	0.172852	0.024024	0.578648	0.224477	CS pos: 14-15. APA-CS. Pr: 0.4595    18
NZ_CP027599.1_77936	SP(Sec/SPI)	0.432236	0.152488	0.128841	0.286435	CS pos: 20-21. LTA-AS. Pr: 0.2346    39
NZ_CP027599.1_77941	LIPO(Sec/SPII)	0.114447	0.011989	0.629675	0.243889	CS pos: 17-18. TEA-CF. Pr: 0.6609    28
NZ_CP027599.1_77946	SP(Sec/SPI)	0.633008	0.095158	0.103625	0.168210	CS pos: 17-18. AFA-SK. Pr: 0.4408    19
NZ_CP027599.1_77954	LIPO(Sec/SPII)	0.281306	0.048191	0.411397	0.259106	CS pos: 23-24. AAV-CS. Pr: 0.3289    26
NZ_CP027599.1_77960	LIPO(Sec/SPII)	0.150620	0.037790	0.596412	0.215177	CS pos: 13-14. ITA-CS. Pr: 0.5033    18
NZ_CP027599.1_78042	LIPO(Sec/SPII)	0.336133	0.006891	0.364576	0.292400	CS pos: ?. Probable protein fragment    18
NZ_CP027599.1_78045	LIPO(Sec/SPII)	0.226620	0.019150	0.399533	0.354697	CS pos: ?. Probable protein fragment    17
NZ_CP027599.1_78055	LIPO(Sec/SPII)	0.327540	0.031381	0.444256	0.196823	CS pos: ?. Probable protein fragment    21
NZ_CP027599.1_78061	SP(Sec/SPI)	0.420857	0.143095	0.074996	0.361052	CS pos: 17-18. AAA-DL. Pr: 0.3359    26
NZ_CP027599.1_78062	SP(Sec/SPI)	0.421971	0.094570	0.176131	0.307328	CS pos: 21-22. AHG-AS. Pr: 0.2470    27
NZ_CP027599.1_78071	LIPO(Sec/SPII)	0.268839	0.013846	0.503256	0.214058	CS pos: ?. Probable protein fragment    15
NZ_CP027599.1_78096	LIPO(Sec/SPII)	0.088163	0.006724	0.723450	0.181663	CS pos: 25-26. QQA-CA. Pr: 0.7023    32
NZ_CP027599.1_78122	LIPO(Sec/SPII)	0.148700	0.016055	0.542802	0.292444	CS pos: 19-20. RNA-CS. Pr: 0.5533    38
NZ_CP027599.1_78181	SP(Sec/SPI)	0.396782	0.043834	0.305164	0.254220	CS pos: 18-19. GIA-AT. Pr: 0.0529    26
NZ_CP027599.1_78251	LIPO(Sec/SPII)	0.286482	0.009468	0.437506	0.266544	CS pos: ?. Probable protein fragment    16
NZ_CP027599.1_78255	LIPO(Sec/SPII)	0.226428	0.006989	0.462576	0.304006	CS pos: 13-14. MVR-CA. Pr: 0.3821    25
NZ_CP027599.1_78267	LIPO(Sec/SPII)	0.263101	0.049166	0.387828	0.299905	CS pos: ?. Probable protein fragment    16
NZ_CP027599.1_78268	SP(Sec/SPI)	0.572861	0.268907	0.102320	0.055911	CS pos: 27-28. STA-AT. Pr: 0.3979    39
NZ_CP027599.1_78269	SP(Sec/SPI)	0.412877	0.276524	0.096075	0.214524	CS pos: 18-19. ASA-SS. Pr: 0.3893    31
NZ_CP027599.1_78283	LIPO(Sec/SPII)	0.202003	0.195324	0.397988	0.204686	CS pos: 15-16. ACS-CG. Pr: 0.1897    23
NZ_CP027599.1_78289	TAT(Tat/SPI)	0.212140	0.348616	0.216852	0.222392	CS pos: ?. Probable protein fragment    16
NZ_CP027599.1_78343	SP(Sec/SPI)	0.545405	0.074626	0.140966	0.239004	CS pos: 22-23. LWA-FS. Pr: 0.3153    26
NZ_CP027599.1_78390	SP(Sec/SPI)	0.467236	0.013143	0.295252	0.224370	CS pos: 21-22. SFT-LP. Pr: 0.1739    46
NZ_CP027599.1_78419	LIPO(Sec/SPII)	0.228208	0.011926	0.481825	0.278040	CS pos: ?. Probable protein fragment    18
NZ_CP027599.1_78427	LIPO(Sec/SPII)	0.126628	0.052859	0.562041	0.258472	CS pos: 18-19. ITG-CT. Pr: 0.5043    21
NZ_CP027599.1_78437	SP(Sec/SPI)	0.359971	0.126225	0.224095	0.289710	CS pos: ?. Probable protein fragment    30
NZ_CP027599.1_78438	LIPO(Sec/SPII)	0.143747	0.026891	0.694489	0.134872	CS pos: 20-21. TSG-CC. Pr: 0.5781    33
NZ_CP027599.1_78453	SP(Sec/SPI)	0.318313	0.138988	0.281728	0.260972	CS pos: 26-27. ARA-KR. Pr: 0.3226    38
NZ_CP027599.1_78499	LIPO(Sec/SPII)	0.232803	0.034745	0.415464	0.316989	CS pos: ?. Probable protein fragment    15
NZ_CP027599.1_78550	LIPO(Sec/SPII)	0.123730	0.005499	0.769144	0.101628	CS pos: 15-16. LPS-CS. Pr: 0.6532    19
NZ_CP027599.1_78558	LIPO(Sec/SPII)	0.096734	0.023307	0.443956	0.436003	CS pos: 21-22. LTG-GD. Pr: 0.3347    48
NZ_CP027599.1_78568	SP(Sec/SPI)	0.491583	0.074718	0.072678	0.361021	CS pos: 34-35. ITA-NS. Pr: 0.3360    47
NZ_CP027599.1_78636	LIPO(Sec/SPII)	0.308904	0.007318	0.508703	0.175075	CS pos: 20-21. TGS-CT. Pr: 0.3141    30
NZ_CP027599.1_78640	SP(Sec/SPI)	0.538501	0.008731	0.179307	0.273460	CS pos: 19-20. LNA-AL. Pr: 0.3424    34
NZ_CP027599.1_78645	SP(Sec/SPI)	0.613990	0.108670	0.130471	0.146869	CS pos: 20-21. ASA-VS. Pr: 0.5099    28
NZ_CP027599.1_78651	SP(Sec/SPI)	0.574666	0.027279	0.082751	0.315304	CS pos: 22-23. TKA-GY. Pr: 0.2171    27
NZ_CP027599.1_78680	SP(Sec/SPI)	0.388848	0.017459	0.331884	0.261809	CS pos: 24-25. SAA-SE. Pr: 0.2058    32
NZ_CP027599.1_78688	SP(Sec/SPI)	0.547589	0.229061	0.063449	0.159900	CS pos: 25-26. ADA-ML. Pr: 0.6017    34
NZ_CP027599.1_78718	SP(Sec/SPI)	0.386102	0.087613	0.167218	0.359067	CS pos: 20-21. SFS-SG. Pr: 0.1176    47
NZ_CP027599.1_78727	LIPO(Sec/SPII)	0.129116	0.010276	0.609985	0.250623	CS pos: 18-19. LQR-CE. Pr: 0.5317    24
NZ_CP027599.1_78744	LIPO(Sec/SPII)	0.256631	0.023483	0.361374	0.358511	CS pos: ?. Probable protein fragment    15
NZ_CP027599.1_78745	LIPO(Sec/SPII)	0.293961	0.031893	0.368438	0.305708	CS pos: ?. Probable protein fragment    15
NZ_CP027599.1_78781	LIPO(Sec/SPII)	0.189625	0.043447	0.412898	0.354031	CS pos: ?. Probable protein fragment    25
NZ_CP027599.1_78836	LIPO(Sec/SPII)	0.103157	0.054331	0.743217	0.099295	CS pos: 18-19. SAA-CL. Pr: 0.7456    46
NZ_CP027599.1_78850	LIPO(Sec/SPII)	0.261262	0.037994	0.361836	0.338909	CS pos: ?. Probable protein fragment    15
NZ_CP027599.1_78864	SP(Sec/SPI)	0.641067	0.004385	0.302602	0.051946	CS pos: 18-19. ATS-PE. Pr: 0.1499    20
NZ_CP027599.1_78880	LIPO(Sec/SPII)	0.044543	0.002634	0.639152	0.313671	CS pos: 19-20. WAA-CW. Pr: 0.6157    29
NZ_CP027599.1_78904	TAT(Tat/SPI)	0.247819	0.634757	0.007188	0.110236	CS pos: 29-30. TWA-RQ. Pr: 0.5272    43
NZ_CP027599.1_78907	SP(Sec/SPI)	0.435044	0.056273	0.122764	0.385919	CS pos: 16-17. AAA-KS. Pr: 0.1470    27
NZ_CP027599.1_78914	LIPO(Sec/SPII)	0.045541	0.003980	0.541881	0.408598	CS pos: 21-22. YAG-CG. Pr: 0.5358    42
NZ_CP027599.1_78936	SP(Sec/SPI)	0.556782	0.226593	0.054569	0.162057	CS pos: 32-33. ANG-QT. Pr: 0.4391    36
NZ_CP027599.1_78951	LIPO(Sec/SPII)	0.147817	0.005676	0.578318	0.268189	CS pos: 19-20. IPA-CF. Pr: 0.5860    35
NZ_CP027599.1_78960	SP(Sec/SPI)	0.470694	0.232206	0.086069	0.211031	CS pos: 21-22. VTA-NA. Pr: 0.2466    25
NZ_CP027599.1_78963	LIPO(Sec/SPII)	0.346093	0.016140	0.408842	0.228925	CS pos: ?. Probable protein fragment    16
NZ_CP027599.1_78966	LIPO(Sec/SPII)	0.292327	0.049561	0.432547	0.225564	CS pos: 11-12. STS-CT. Pr: 0.2485    22
NZ_CP027599.1_79039	LIPO(Sec/SPII)	0.044084	0.001028	0.511853	0.443035	CS pos: 12-13. MHA-CL. Pr: 0.5047    49
NZ_CP027599.1_79068	LIPO(Sec/SPII)	0.127960	0.044049	0.565936	0.262055	CS pos: 21-22. QRS-CS. Pr: 0.5347    28
NZ_CP027599.1_79069	LIPO(Sec/SPII)	0.064831	0.002486	0.911417	0.021267	CS pos: 16-17. QSA-CS. Pr: 0.8082    33
NZ_CP027599.1_79094	SP(Sec/SPI)	0.576405	0.005561	0.137305	0.280729	CS pos: 34-35. SLA-GS. Pr: 0.5155    45
NZ_CP027599.1_79103	LIPO(Sec/SPII)	0.289752	0.034164	0.434477	0.241607	CS pos: 11-12. VTA-CL. Pr: 0.2637    20
NZ_CP027599.1_79119	LIPO(Sec/SPII)	0.289273	0.030587	0.418465	0.261675	CS pos: ?. Probable protein fragment    16
NZ_CP027599.1_79133	LIPO(Sec/SPII)	0.142921	0.011060	0.429835	0.416184	CS pos: 16-17. AYG-CA. Pr: 0.3736    22
NZ_CP027599.1_79134	LIPO(Sec/SPII)	0.034612	0.000377	0.882495	0.082515	CS pos: 21-22. WVG-CW. Pr: 0.8670    33
NZ_CP027599.1_79253	SP(Sec/SPI)	0.403215	0.067263	0.261243	0.268278	CS pos: 24-25. VIA-SL. Pr: 0.2089    39
NZ_CP027599.1_79268	SP(Sec/SPI)	0.488228	0.062886	0.142077	0.306809	CS pos: 14-15. SSA-AR. Pr: 0.2022    26
NZ_CP027599.1_79269	SP(Sec/SPI)	0.403575	0.043327	0.249350	0.303748	CS pos: 18-19. SRS-EI. Pr: 0.2905    44
NZ_CP027599.1_79295	SP(Sec/SPI)	0.509946	0.126268	0.252577	0.111210	CS pos: 22-23. VTA-NQ. Pr: 0.5046    41
NZ_CP027599.1_79301	LIPO(Sec/SPII)	0.300497	0.024568	0.376775	0.298160	CS pos: 14-15. TLR-CN. Pr: 0.2191    19
NZ_CP027599.1_79322	LIPO(Sec/SPII)	0.306230	0.008962	0.458719	0.226089	CS pos: 18-19. VES-CS. Pr: 0.6201    20
NZ_CP027599.1_79329	LIPO(Sec/SPII)	0.003232	0.001084	0.987583	0.008100	CS pos: 18-19. STA-CS. Pr: 0.9889    42
NZ_CP027599.1_79353	SP(Sec/SPI)	0.537457	0.137802	0.056780	0.267961	CS pos: 26-27. AWA-RV. Pr: 0.4052    34
NZ_CP027599.1_79362	LIPO(Sec/SPII)	0.125889	0.028556	0.733561	0.111994	CS pos: 19-20. YIS-CP. Pr: 0.6571    22
NZ_CP027599.1_79435	SP(Sec/SPI)	0.465241	0.052162	0.134472	0.348126	CS pos: 25-26. LLS-AP. Pr: 0.1676    34
NZ_CP027599.1_79466	LIPO(Sec/SPII)	0.205132	0.014612	0.561263	0.218993	CS pos: 14-15. LTP-CR. Pr: 0.3632    26
NZ_CP027599.1_79468	TAT(Tat/SPI)	0.120226	0.432747	0.072202	0.374824	CS pos: 27-28. SPS-NT. Pr: 0.0536    31
NZ_CP027599.1_79475	SP(Sec/SPI)	0.410069	0.106499	0.283898	0.199533	CS pos: 26-27. QFA-TV. Pr: 0.1237    44
NZ_CP027599.1_79517	LIPO(Sec/SPII)	0.325468	0.040563	0.327699	0.306269	CS pos: 13-14. VSA-WR. Pr: 0.0294    15
NZ_CP027599.1_79535	LIPO(Sec/SPII)	0.118138	0.018388	0.467311	0.396162	CS pos: 14-15. ASS-CS. Pr: 0.4534    35
NZ_CP027599.1_79552	LIPO(Sec/SPII)	0.115626	0.016328	0.706076	0.161969	CS pos: 21-22. SAA-CY. Pr: 0.6887    28
NZ_CP027599.1_79591	LIPO(Sec/SPII)	0.194995	0.021550	0.606023	0.177432	CS pos: 17-18. AAT-CS. Pr: 0.5112    21
NZ_CP027599.1_79620	TAT(Tat/SPI)	0.226255	0.487143	0.032512	0.254090	CS pos: 24-25. FRA-EP. Pr: 0.3064    38
NZ_CP027599.1_79622	SP(Sec/SPI)	0.393678	0.066497	0.214978	0.324847	CS pos: 18-19. VAA-TT. Pr: 0.1354    26
NZ_CP027599.1_79625	SP(Sec/SPI)	0.411655	0.392028	0.036319	0.159997	CS pos: 23-24. ARA-AP. Pr: 0.6960    26
NZ_CP027599.1_79658	TAT(Tat/SPI)	0.254657	0.433549	0.215582	0.096212	CS pos: 31-32. VSS-TR. Pr: 0.1851    42
NZ_CP027599.1_79683	SP(Sec/SPI)	0.325978	0.033151	0.322270	0.318600	CS pos: ?. Probable protein fragment    22
NZ_CP027599.1_79685	LIPO(Sec/SPII)	0.044018	0.019119	0.652090	0.284773	CS pos: 18-19. ALA-CL. Pr: 0.6460    44
NZ_CP027599.1_79689	LIPO(Sec/SPII)	0.299045	0.096684	0.348978	0.255293	CS pos: 23-24. VAY-CQ. Pr: 0.0613    39
NZ_CP027599.1_79697	SP(Sec/SPI)	0.518808	0.145051	0.126535	0.209607	CS pos: 19-20. AVA-SQ. Pr: 0.4753    42
NZ_CP027599.1_79769	SP(Sec/SPI)	0.342233	0.074712	0.322989	0.260067	CS pos: 26-27. AAA-GT. Pr: 0.0931    41
NZ_CP027599.1_79806	SP(Sec/SPI)	0.654307	0.012996	0.105419	0.227278	CS pos: 20-21. SVA-DE. Pr: 0.5752    23
NZ_CP027599.1_79811	SP(Sec/SPI)	0.450192	0.014893	0.088314	0.446601	CS pos: 21-22. HKA-AP. Pr: 0.1306    38
NZ_CP027599.1_79812	LIPO(Sec/SPII)	0.226789	0.023034	0.401337	0.348840	CS pos: 13-14. VCA-CV. Pr: 0.0743    19
NZ_CP027599.1_79831	LIPO(Sec/SPII)	0.126873	0.003865	0.740825	0.128437	CS pos: 13-14. ATS-CS. Pr: 0.6624    22
NZ_CP027599.1_79841	SP(Sec/SPI)	0.473280	0.077326	0.110656	0.338739	CS pos: 22-23. IWS-AA. Pr: 0.3670    26
NZ_CP027599.1_79845	LIPO(Sec/SPII)	0.130483	0.012391	0.620002	0.237124	CS pos: 28-29. VFS-CS. Pr: 0.5576    34
NZ_CP027599.1_79856	SP(Sec/SPI)	0.641106	0.011257	0.179856	0.167781	CS pos: 22-23. SRC-LN. Pr: 0.5960    36
NZ_CP027599.1_79869	SP(Sec/SPI)	0.543535	0.033200	0.012198	0.411067	CS pos: 25-26. IHA-FT. Pr: 0.5246    48
NZ_CP027599.1_79914	LIPO(Sec/SPII)	0.129567	0.010867	0.729640	0.129927	CS pos: 16-17. AGS-CS. Pr: 0.6424    19
NZ_CP027599.1_79928	SP(Sec/SPI)	0.703792	0.015065	0.174623	0.106520	CS pos: 23-24. SVA-TI. Pr: 0.2792    30
NZ_CP027599.1_79933	LIPO(Sec/SPII)	0.145468	0.336626	0.343236	0.174670	CS pos: 15-16. SAS-CA. Pr: 0.1638    20
NZ_CP027599.1_79939	LIPO(Sec/SPII)	0.002712	0.000585	0.910849	0.085854	CS pos: 20-21. MSG-CQ. Pr: 0.9150    49
NZ_CP027599.1_79964	LIPO(Sec/SPII)	0.095520	0.054372	0.724031	0.126077	CS pos: 20-21. ARS-CS. Pr: 0.6780    43
NZ_CP027599.1_79973	LIPO(Sec/SPII)	0.318501	0.041158	0.326458	0.313882	CS pos: 29-30. TAI-CS. Pr: 0.1911    36
NZ_CP027599.1_79977	LIPO(Sec/SPII)	0.221238	0.041261	0.453180	0.284321	CS pos: 14-15. LST-CC. Pr: 0.0621    16
NZ_CP027599.1_79986	LIPO(Sec/SPII)	0.264885	0.009980	0.434194	0.290942	CS pos: 13-14. SCF-CA. Pr: 0.0566    18
NZ_CP027599.1_80025	LIPO(Sec/SPII)	0.284029	0.037965	0.586846	0.091159	CS pos: 17-18. SAV-CF. Pr: 0.4953    37
NZ_CP027599.1_80041	LIPO(Sec/SPII)	0.056233	0.050470	0.498261	0.395036	CS pos: 17-18. VTA-CW. Pr: 0.4973    42
NZ_CP027599.1_80079	SP(Sec/SPI)	0.467277	0.099815	0.124831	0.308077	CS pos: 19-20. ASA-AI. Pr: 0.2907    21
NZ_CP027599.1_80082	TAT(Tat/SPI)	0.094979	0.488177	0.014925	0.401920	CS pos: 41-42. ATA-AI. Pr: 0.2737    43
NZ_CP027599.1_80091	LIPO(Sec/SPII)	0.215198	0.023600	0.499856	0.261345	CS pos: 17-18. SRA-CE. Pr: 0.3945    25
NZ_CP027599.1_80123	LIPO(Sec/SPII)	0.259747	0.009846	0.409054	0.321354	CS pos: ?. Probable protein fragment    20
NZ_CP027599.1_80128	TAT(Tat/SPI)	0.044034	0.397049	0.273023	0.285894	CS pos: 32-33. AVL-RW. Pr: 0.0760    44
NZ_CP027599.1_80205	TAT(Tat/SPI)	0.328998	0.350477	0.028681	0.291844	CS pos: 25-26. AAA-AE. Pr: 0.3553    32
NZ_CP027599.1_80207	SP(Sec/SPI)	0.467101	0.048053	0.218294	0.266553	CS pos: 15-16. ASA-SG. Pr: 0.1604    17
NZ_CP027599.1_80266	LIPO(Sec/SPII)	0.145152	0.018945	0.530362	0.305542	CS pos: 16-17. TIA-CA. Pr: 0.2133    37
NZ_CP027599.1_80267	SP(Sec/SPI)	0.413317	0.127213	0.063234	0.396235	CS pos: 18-19. ASS-VT. Pr: 0.1282    35
NZ_CP027599.1_80270	LIPO(Sec/SPII)	0.196379	0.013817	0.448608	0.341196	CS pos: 17-18. FCQ-CC. Pr: 0.2094    20
NZ_CP027599.1_80282	TAT(Tat/SPI)	0.265666	0.322181	0.094126	0.318027	CS pos: 19-20. AHT-LS. Pr: 0.1467    40
NZ_CP027599.1_80297	LIPO(Sec/SPII)	0.032705	0.000164	0.966155	0.000975	CS pos: 17-18. LCS-CT. Pr: 0.9634    34
NZ_CP027599.1_80370	LIPO(Sec/SPII)	0.228537	0.012496	0.481229	0.277739	CS pos: 16-17. TIC-CQ. Pr: 0.2685    20
NZ_CP027599.1_80372	SP(Sec/SPI)	0.517181	0.033137	0.109202	0.340480	CS pos: 20-21. ASG-LW. Pr: 0.2037    35
NZ_CP027599.1_80375	LIPO(Sec/SPII)	0.094934	0.015035	0.679816	0.210215	CS pos: 20-21. VSG-CD. Pr: 0.6533    22
NZ_CP027599.1_80383	LIPO(Sec/SPII)	0.203300	0.086485	0.437734	0.272481	CS pos: 15-16. ALS-CP. Pr: 0.2121    25
NZ_CP027599.1_80404	LIPO(Sec/SPII)	0.053621	0.004815	0.546768	0.394796	CS pos: 15-16. VQG-CR. Pr: 0.5187    31
NZ_CP027599.1_80421	SP(Sec/SPI)	0.446215	0.198558	0.070530	0.284696	CS pos: 16-17. ASG-AA. Pr: 0.0636    32
NZ_CP027599.1_80423	SP(Sec/SPI)	0.454726	0.140396	0.055875	0.349003	CS pos: 12-13. GSA-AN. Pr: 0.1518    34
NZ_CP027599.1_80433	LIPO(Sec/SPII)	0.114144	0.011831	0.709478	0.164547	CS pos: 33-34. GVA-CS. Pr: 0.6845    43
NZ_CP027599.1_80443	LIPO(Sec/SPII)	0.354822	0.067313	0.441999	0.135866	CS pos: 13-14. TGS-CL. Pr: 0.4251    45
NZ_CP027599.1_80463	LIPO(Sec/SPII)	0.062505	0.000710	0.808450	0.128335	CS pos: 21-22. GAG-CS. Pr: 0.3807    30
NZ_CP027599.1_80465	SP(Sec/SPI)	0.556854	0.041330	0.092521	0.309295	CS pos: 16-17. GEA-SP. Pr: 0.2700    43
NZ_CP027599.1_80469	LIPO(Sec/SPII)	0.293944	0.010313	0.514462	0.181280	CS pos: ?. Probable protein fragment    17
NZ_CP027599.1_80484	LIPO(Sec/SPII)	0.065486	0.005763	0.704486	0.224264	CS pos: 18-19. HCG-CL. Pr: 0.6878    44
NZ_CP027599.1_80487	LIPO(Sec/SPII)	0.275982	0.015630	0.433826	0.274562	CS pos: ?. Probable protein fragment    15
NZ_CP027599.1_80499	LIPO(Sec/SPII)	0.332385	0.027017	0.415524	0.225074	CS pos: ?. Probable protein fragment    15
NZ_CP027599.1_80500	LIPO(Sec/SPII)	0.116755	0.006045	0.698013	0.179186	CS pos: 17-18. FSG-CA. Pr: 0.5638    21
NZ_CP027599.1_80502	LIPO(Sec/SPII)	0.148982	0.022219	0.460750	0.368048	CS pos: 28-29. RAG-CA. Pr: 0.3927    49
NZ_CP027599.1_80543	SP(Sec/SPI)	0.555113	0.004517	0.112236	0.328134	CS pos: 18-19. SEG-FS. Pr: 0.3042    35
NZ_CP027599.1_80546	LIPO(Sec/SPII)	0.015102	0.000740	0.842569	0.141589	CS pos: 20-21. FAL-CA. Pr: 0.8098    50
NZ_CP027599.1_80559	LIPO(Sec/SPII)	0.112210	0.025165	0.497565	0.365059	CS pos: 18-19. SQT-CC. Pr: 0.3613    31
NZ_CP027599.1_80591	LIPO(Sec/SPII)	0.236173	0.020783	0.496760	0.246284	CS pos: 18-19. DVA-CL. Pr: 0.4762    26
NZ_CP027599.1_80595	LIPO(Sec/SPII)	0.120530	0.002431	0.730696	0.146343	CS pos: 20-21. LLY-CS. Pr: 0.6927    35
NZ_CP027599.1_80672	LIPO(Sec/SPII)	0.079555	0.005797	0.857966	0.056683	CS pos: 13-14. LTS-CA. Pr: 0.8188    17
NZ_CP027599.1_80711	LIPO(Sec/SPII)	0.338629	0.037361	0.393342	0.230668	CS pos: 17-18. LAA-GP. Pr: 0.0199    21
NZ_CP027599.1_80713	LIPO(Sec/SPII)	0.258154	0.008513	0.583006	0.150328	CS pos: 14-15. LSK-CG. Pr: 0.5010    20
NZ_CP027599.1_80724	LIPO(Sec/SPII)	0.180228	0.001529	0.758735	0.059508	CS pos: 16-17. LPG-CP. Pr: 0.6003    20
NZ_CP027599.1_80744	SP(Sec/SPI)	0.441102	0.035043	0.205368	0.318487	CS pos: 18-19. TSS-QK. Pr: 0.1091    31
NZ_CP027599.1_80775	LIPO(Sec/SPII)	0.175850	0.027502	0.522659	0.273989	CS pos: 23-24. TLC-CS. Pr: 0.2810    45
NZ_CP027599.1_80778	LIPO(Sec/SPII)	0.156744	0.011008	0.729514	0.102734	CS pos: 14-15. SVA-CA. Pr: 0.7018    21
NZ_CP027599.1_80796	SP(Sec/SPI)	0.499793	0.162997	0.063419	0.273791	CS pos: 27-28. AVA-FR. Pr: 0.2890    40
NZ_CP027599.1_80803	TAT(Tat/SPI)	0.084214	0.669849	0.048932	0.197005	CS pos: 33-34. RSA-AG. Pr: 0.1185    35
NZ_CP027599.1_80804	LIPO(Sec/SPII)	0.108676	0.005942	0.845577	0.039805	CS pos: 22-23. LTG-CI. Pr: 0.8324    46
NZ_CP027599.1_80821	LIPO(Sec/SPII)	0.222014	0.018935	0.386255	0.372795	CS pos: ?. Probable protein fragment    19
NZ_CP027599.1_80846	LIPO(Sec/SPII)	0.261569	0.179847	0.299235	0.259350	CS pos: 22-23. LPT-CW. Pr: 0.1760    43
NZ_CP027599.1_80850	LIPO(Sec/SPII)	0.357985	0.013409	0.413344	0.215262	CS pos: 11-12. TAG-KT. Pr: 0.0807    15
NZ_CP027599.1_80873	LIPO(Sec/SPII)	0.307100	0.010150	0.398762	0.283988	CS pos: ?. Probable protein fragment    15
NZ_CP027599.1_80894	SP(Sec/SPI)	0.640646	0.028558	0.123483	0.207313	CS pos: 24-25. TLS-SL. Pr: 0.2078    39
NZ_CP027599.1_80901	SP(Sec/SPI)	0.461937	0.048127	0.161930	0.328007	CS pos: 14-15. ATA-AS. Pr: 0.3181    17
NZ_CP027599.1_80907	SP(Sec/SPI)	0.522755	0.139427	0.155132	0.182686	CS pos: 27-28. AFA-TG. Pr: 0.2280    37
NZ_CP027599.1_80918	LIPO(Sec/SPII)	0.096466	0.003163	0.551268	0.349103	CS pos: 14-15. SFC-CV. Pr: 0.3119    21
NZ_CP027599.1_80920	SP(Sec/SPI)	0.597290	0.008751	0.114549	0.279410	CS pos: 22-23. IRT-HT. Pr: 0.4722    40
NZ_CP027599.1_80935	LIPO(Sec/SPII)	0.172049	0.004036	0.784932	0.038984	CS pos: 15-16. LLS-CQ. Pr: 0.7312    23
NZ_CP027599.1_80944	LIPO(Sec/SPII)	0.196968	0.013030	0.435163	0.354839	CS pos: 17-18. LTP-CA. Pr: 0.3470    26
NZ_CP027599.1_80946	LIPO(Sec/SPII)	0.149380	0.354570	0.383225	0.112826	CS pos: 18-19. LTG-CR. Pr: 0.1712    33
NZ_CP027599.1_80951	LIPO(Sec/SPII)	0.087194	0.059332	0.627710	0.225764	CS pos: 33-34. VAG-CS. Pr: 0.6208    47
NZ_CP027599.1_80972	LIPO(Sec/SPII)	0.075231	0.016321	0.700835	0.207613	CS pos: 15-16. IMA-CR. Pr: 0.6674    25
NZ_CP027599.1_80974	LIPO(Sec/SPII)	0.228032	0.035773	0.473566	0.262629	CS pos: 27-28. SSS-CF. Pr: 0.4499    36
NZ_CP027599.1_80985	LIPO(Sec/SPII)	0.253743	0.015484	0.444087	0.286686	CS pos: 14-15. LGA-DG. Pr: 0.2982    25
NZ_CP027599.1_81051	LIPO(Sec/SPII)	0.164351	0.007729	0.751843	0.076076	CS pos: 19-20. TTS-CA. Pr: 0.6992    22
NZ_CP027599.1_81052	SP(Sec/SPI)	0.465458	0.287500	0.116338	0.130704	CS pos: 28-29. VSA-GT. Pr: 0.4867    38
NZ_CP027599.1_81076	LIPO(Sec/SPII)	0.087995	0.151388	0.432136	0.328481	CS pos: 20-21. LAG-GS. Pr: 0.2148    39
NZ_CP027599.1_81078	TAT(Tat/SPI)	0.106283	0.527401	0.063345	0.302972	CS pos: 27-28. SPA-PI. Pr: 0.1153    45
NZ_CP027599.1_81080	LIPO(Sec/SPII)	0.042367	0.002665	0.656453	0.298514	CS pos: 21-22. LFS-CL. Pr: 0.6040    24
NZ_CP027599.1_81081	LIPO(Sec/SPII)	0.182761	0.022349	0.451856	0.343035	CS pos: 18-19. VLV-CG. Pr: 0.2800    24
NZ_CP027599.1_81115	SP(Sec/SPI)	0.501694	0.019577	0.358351	0.120378	CS pos: 19-20. TLA-SF. Pr: 0.1337    40
NZ_CP027599.1_81119	LIPO(Sec/SPII)	0.277885	0.036166	0.380197	0.305753	CS pos: 19-20. SAG-CG. Pr: 0.3677    31
NZ_CP027599.1_81124	LIPO(Sec/SPII)	0.202985	0.072063	0.369955	0.354997	CS pos: 13-14. SSV-CE. Pr: 0.3030    34
NZ_CP027599.1_81134	SP(Sec/SPI)	0.604020	0.080168	0.090947	0.224865	CS pos: 22-23. KRA-RP. Pr: 0.2277    30
NZ_CP027599.1_81138	SP(Sec/SPI)	0.386837	0.057124	0.195027	0.361012	CS pos: 17-18. TSA-ST. Pr: 0.2204    22
NZ_CP027599.1_81144	SP(Sec/SPI)	0.379886	0.286942	0.029014	0.304157	CS pos: 41-42. AVA-AG. Pr: 0.1483    49
NZ_CP027599.1_81184	LIPO(Sec/SPII)	0.014213	0.006458	0.972156	0.007172	CS pos: 19-20. SAG-CR. Pr: 0.9600    39
NZ_CP027599.1_81203	LIPO(Sec/SPII)	0.133028	0.086764	0.403479	0.376729	CS pos: 26-27. FTS-CL. Pr: 0.3804    38
NZ_CP027599.1_81212	LIPO(Sec/SPII)	0.262762	0.024115	0.405836	0.307286	CS pos: ?. Probable protein fragment    17
NZ_CP027599.1_81265	SP(Sec/SPI)	0.374721	0.016040	0.315597	0.293642	CS pos: 18-19. VNC-NA. Pr: 0.2712    31
NZ_CP027599.1_81299	SP(Sec/SPI)	0.879279	0.044235	0.028732	0.047754	CS pos: 24-25. IGA-KN. Pr: 0.6469    45
NZ_CP027599.1_81322	LIPO(Sec/SPII)	0.303538	0.023629	0.385787	0.287045	CS pos: 12-13. LIC-CS. Pr: 0.0578    18
NZ_CP027599.1_81451	SP(Sec/SPI)	0.589252	0.249186	0.065764	0.095798	CS pos: 32-33. SFA-NG. Pr: 0.5706    43
NZ_CP027599.1_81454	TAT(Tat/SPI)	0.147461	0.462795	0.049445	0.340299	CS pos: 23-24. VSA-IP. Pr: 0.2005    36
NZ_CP027599.1_81482	LIPO(Sec/SPII)	0.117791	0.002592	0.491531	0.388086	CS pos: 26-27. LSH-CS. Pr: 0.3187    29
NZ_CP027599.1_81494	LIPO(Sec/SPII)	0.230958	0.013509	0.444509	0.311024	CS pos: 18-19. LAR-CS. Pr: 0.2364    21
NZ_CP027599.1_81523	SP(Sec/SPI)	0.320116	0.222102	0.243687	0.214095	CS pos: 30-31. SSA-RS. Pr: 0.1785    35
NZ_CP027599.1_81542	LIPO(Sec/SPII)	0.133020	0.001475	0.781282	0.084223	CS pos: 22-23. YCA-CC. Pr: 0.3660    30
NZ_CP027599.1_81548	SP(Sec/SPI)	0.561702	0.044452	0.118059	0.275787	CS pos: 25-26. TKA-LS. Pr: 0.1943    33
NZ_CP027599.1_81588	LIPO(Sec/SPII)	0.274901	0.012773	0.482674	0.229653	CS pos: 11-12. SIP-CG. Pr: 0.0849    15
NZ_CP027599.1_81609	SP(Sec/SPI)	0.341349	0.058071	0.319531	0.281048	CS pos: ?. Probable protein fragment    20
NZ_CP027599.1_81632	LIPO(Sec/SPII)	0.061097	0.023137	0.831480	0.084287	CS pos: 19-20. AMS-CA. Pr: 0.8106    37
NZ_CP027599.1_81636	LIPO(Sec/SPII)	0.037550	0.003265	0.888581	0.070603	CS pos: 28-29. WSG-CK. Pr: 0.8775    37
NZ_CP027599.1_81637	SP(Sec/SPI)	0.346408	0.070961	0.303021	0.279610	CS pos: 21-22. ANA-KR. Pr: 0.2091    25
NZ_CP027599.1_81728	SP(Sec/SPI)	0.524389	0.067712	0.075652	0.332247	CS pos: ?. Probable protein fragment    27
NZ_CP027599.1_81759	LIPO(Sec/SPII)	0.160581	0.011555	0.762813	0.065051	CS pos: 12-13. SAS-CS. Pr: 0.4452    23
NZ_CP027599.1_81767	LIPO(Sec/SPII)	0.162010	0.020441	0.790937	0.026612	CS pos: 15-16. IPS-CS. Pr: 0.7705    25
NZ_CP027599.1_81803	LIPO(Sec/SPII)	0.217162	0.045647	0.369509	0.367682	CS pos: 17-18. WAM-CR. Pr: 0.2139    19
NZ_CP027599.1_81808	LIPO(Sec/SPII)	0.236967	0.016190	0.504585	0.242257	CS pos: 14-15. QLP-CW. Pr: 0.1210    16
NZ_CP027599.1_81819	LIPO(Sec/SPII)	0.105346	0.009438	0.469777	0.415439	CS pos: 13-14. LPA-CQ. Pr: 0.4208    23
NZ_CP027599.1_81836	LIPO(Sec/SPII)	0.060881	0.368084	0.476276	0.094759	CS pos: 22-23. LSA-CS. Pr: 0.4056    27
NZ_CP027599.1_81847	LIPO(Sec/SPII)	0.165797	0.060852	0.433890	0.339461	CS pos: 15-16. ATS-CA. Pr: 0.3612    23
NZ_CP027599.1_81873	TAT(Tat/SPI)	0.163353	0.483175	0.069998	0.283475	CS pos: 26-27. INA-HT. Pr: 0.0544    28
NZ_CP027599.1_81904	LIPO(Sec/SPII)	0.242647	0.019314	0.408701	0.329337	CS pos: 23-24. FSG-CS. Pr: 0.3631    25
NZ_CP027599.1_81906	SP(Sec/SPI)	0.494006	0.057902	0.233880	0.214212	CS pos: 25-26. ATS-DT. Pr: 0.1733    30
NZ_CP027599.1_81924	LIPO(Sec/SPII)	0.191467	0.025401	0.437519	0.345614	CS pos: 19-20. RAG-CF. Pr: 0.3624    24
NZ_CP027599.1_81994	SP(Sec/SPI)	0.441331	0.129744	0.133163	0.295762	CS pos: 17-18. TSA-GS. Pr: 0.1652    36
NZ_CP027599.1_81998	SP(Sec/SPI)	0.581714	0.167650	0.157346	0.093290	CS pos: 17-18. ASA-SS. Pr: 0.4959    41
NZ_CP027599.1_81999	SP(Sec/SPI)	0.421679	0.332881	0.054841	0.190600	CS pos: 19-20. VGA-RP. Pr: 0.4618    37
NZ_CP027599.1_82040	SP(Sec/SPI)	0.440454	0.022931	0.314563	0.222051	CS pos: 22-23. GNA-RQ. Pr: 0.1695    30
NZ_CP027599.1_82050	SP(Sec/SPI)	0.552528	0.030662	0.191030	0.225780	CS pos: 15-16. ANA-FS. Pr: 0.1932    25
NZ_CP027599.1_82058	LIPO(Sec/SPII)	0.101225	0.004855	0.640924	0.252996	CS pos: 18-19. GEA-CV. Pr: 0.6663    35
NZ_CP027599.1_82075	LIPO(Sec/SPII)	0.232823	0.027333	0.411694	0.328149	CS pos: ?. Probable protein fragment    15
NZ_CP027599.1_82083	LIPO(Sec/SPII)	0.204602	0.020255	0.474210	0.300932	CS pos: 16-17. SPG-CC. Pr: 0.2344    20
NZ_CP027599.1_82089	LIPO(Sec/SPII)	0.209708	0.036861	0.434988	0.318442	CS pos: 15-16. TSS-CC. Pr: 0.2995    35
NZ_CP027599.1_82125	LIPO(Sec/SPII)	0.214959	0.049207	0.496641	0.239193	CS pos: ?. Probable protein fragment    15
NZ_CP027599.1_82129	SP(Sec/SPI)	0.503792	0.033917	0.135072	0.327220	CS pos: 26-27. IWG-KT. Pr: 0.2910    31
NZ_CP027599.1_82191	LIPO(Sec/SPII)	0.144786	0.013590	0.795957	0.045667	CS pos: 15-16. LAA-CF. Pr: 0.7938    47
NZ_CP027599.1_82212	SP(Sec/SPI)	0.685863	0.005284	0.044275	0.264578	CS pos: 20-21. TQA-GV. Pr: 0.6591    40
NZ_CP027599.1_82217	TAT(Tat/SPI)	0.045337	0.784602	0.020603	0.149459	CS pos: 28-29. AHA-TG. Pr: 0.6842    50
NZ_CP027599.1_82236	LIPO(Sec/SPII)	0.159846	0.012123	0.486816	0.341214	CS pos: 24-25. FAS-CF. Pr: 0.4514    29
NZ_CP027599.1_82238	SP(Sec/SPI)	0.556677	0.227368	0.192679	0.023275	CS pos: 25-26. ALA-SS. Pr: 0.1596    48
NZ_CP027599.1_82252	LIPO(Sec/SPII)	0.184299	0.003775	0.517590	0.294336	CS pos: 15-16. ATG-KQ. Pr: 0.4543    40
NZ_CP027599.1_82260	SP(Sec/SPI)	0.446142	0.027350	0.259254	0.267255	CS pos: 17-18. MFS-SR. Pr: 0.1059    20
NZ_CP027599.1_82267	SP(Sec/SPI)	0.403530	0.084342	0.155465	0.356663	CS pos: 36-37. STA-AV. Pr: 0.0547    43
NZ_CP027599.1_82283	SP(Sec/SPI)	0.410310	0.009617	0.260519	0.319554	CS pos: 20-21. VNC-RS. Pr: 0.1905    48
NZ_CP027599.1_82316	SP(Sec/SPI)	0.511563	0.032775	0.025698	0.429964	CS pos: 20-21. ATA-IY. Pr: 0.2828    43
NZ_CP027599.1_82332	SP(Sec/SPI)	0.441204	0.030267	0.148364	0.380165	CS pos: 24-25. ILS-AN. Pr: 0.2065    40
NZ_CP027599.1_82339	SP(Sec/SPI)	0.632896	0.057288	0.140769	0.169047	CS pos: 21-22. STA-AY. Pr: 0.3324    23
NZ_CP027599.1_82343	TAT(Tat/SPI)	0.126885	0.688748	0.044478	0.139888	CS pos: ?. Probable protein fragment    23
NZ_CP027599.1_82367	TAT(Tat/SPI)	0.208565	0.603447	0.005464	0.182524	CS pos: 32-33. AYA-SA. Pr: 0.7244    44
NZ_CP027599.1_82382	SP(Sec/SPI)	0.540195	0.124252	0.006705	0.328848	CS pos: 24-25. ANA-FG. Pr: 0.3476    35
NZ_CP027599.1_82398	LIPO(Sec/SPII)	0.174208	0.024395	0.510455	0.290943	CS pos: 18-19. LAS-CL. Pr: 0.4732    22
NZ_CP027599.1_82409	LIPO(Sec/SPII)	0.301838	0.026271	0.368692	0.303199	CS pos: ?. Probable protein fragment    16
NZ_CP027599.1_82410	LIPO(Sec/SPII)	0.126881	0.011045	0.610678	0.251396	CS pos: 15-16. ITG-SH. Pr: 0.5721    28
NZ_CP027599.1_82414	LIPO(Sec/SPII)	0.240266	0.087255	0.390245	0.282235	CS pos: 16-17. VSV-CM. Pr: 0.2053    38
NZ_CP027599.1_82425	SP(Sec/SPI)	0.587254	0.046474	0.057377	0.308895	CS pos: 16-17. AQA-HT. Pr: 0.4949    39
NZ_CP027599.1_82465	LIPO(Sec/SPII)	0.121126	0.007774	0.590229	0.280871	CS pos: 31-32. YFA-CN. Pr: 0.6344    38
NZ_CP027599.1_82476	SP(Sec/SPI)	0.382102	0.190364	0.101121	0.326412	CS pos: 22-23. LNG-AP. Pr: 0.1801    29
NZ_CP027599.1_82480	SP(Sec/SPI)	0.811245	0.016452	0.049861	0.122442	CS pos: 20-21. VYA-LS. Pr: 0.6925    25
NZ_CP027599.1_82487	SP(Sec/SPI)	0.416637	0.281583	0.157872	0.143907	CS pos: 22-23. CAA-SP. Pr: 0.2689    32
NZ_CP027599.1_82488	SP(Sec/SPI)	0.451992	0.057937	0.209061	0.281011	CS pos: 28-29. VMP-IS. Pr: 0.0829    34
NZ_CP027599.1_82500	SP(Sec/SPI)	0.407800	0.002823	0.216816	0.372561	CS pos: 21-22. VTG-YR. Pr: 0.3401    46
NZ_CP027599.1_82526	TAT(Tat/SPI)	0.140092	0.451633	0.159966	0.248308	CS pos: 30-31. SPA-RP. Pr: 0.0746    44
NZ_CP027599.1_82560	SP(Sec/SPI)	0.410354	0.022532	0.271947	0.295168	CS pos: 12-13. TWA-AN. Pr: 0.1251    16
NZ_CP027599.1_82565	SP(Sec/SPI)	0.546748	0.197072	0.151702	0.104478	CS pos: 24-25. ISA-RP. Pr: 0.3719    31
NZ_CP027599.1_82580	SP(Sec/SPI)	0.398699	0.125749	0.166560	0.308992	CS pos: 22-23. INA-LS. Pr: 0.1109    36
NZ_CP027599.1_82583	SP(Sec/SPI)	0.412320	0.101901	0.112802	0.372976	CS pos: 23-24. SQA-TP. Pr: 0.2254    26
NZ_CP027599.1_82585	SP(Sec/SPI)	0.355968	0.064309	0.233905	0.345818	CS pos: 26-27. VSG-RT. Pr: 0.2502    48
NZ_CP027599.1_82601	LIPO(Sec/SPII)	0.109907	0.060485	0.471602	0.358006	CS pos: 17-18. QSG-CR. Pr: 0.4508    45
NZ_CP027599.1_82645	SP(Sec/SPI)	0.671102	0.019930	0.155075	0.153893	CS pos: 15-16. ASA-WQ. Pr: 0.4034    29
NZ_CP027599.1_82658	SP(Sec/SPI)	0.406891	0.041280	0.147095	0.404734	CS pos: ?. Probable protein fragment    19
NZ_CP027599.1_82663	LIPO(Sec/SPII)	0.157193	0.073827	0.423659	0.345322	CS pos: 18-19. SAA-CN. Pr: 0.3744    37
NZ_CP027599.1_82716	LIPO(Sec/SPII)	0.058087	0.005482	0.555814	0.380618	CS pos: 15-16. SLA-CW. Pr: 0.5385    38
NZ_CP027599.1_82722	LIPO(Sec/SPII)	0.110594	0.024065	0.506324	0.359016	CS pos: 27-28. LSS-CD. Pr: 0.4905    46
NZ_CP027599.1_82734	SP(Sec/SPI)	0.667836	0.018167	0.009528	0.304469	CS pos: 26-27. AQA-QA. Pr: 0.3938    40
NZ_CP027599.1_82755	SP(Sec/SPI)	0.482868	0.053283	0.109138	0.354711	CS pos: 25-26. IFA-AV. Pr: 0.4475    36
NZ_CP027599.1_82766	LIPO(Sec/SPII)	0.185326	0.230815	0.308929	0.274930	CS pos: 16-17. LLW-CG. Pr: 0.1903    27
NZ_CP027599.1_82771	SP(Sec/SPI)	0.420623	0.080390	0.111733	0.387254	CS pos: 15-16. AFS-AS. Pr: 0.2491    26
NZ_CP027599.1_82812	LIPO(Sec/SPII)	0.122376	0.076722	0.521719	0.279182	CS pos: 29-30. GSS-CS. Pr: 0.4963    33
NZ_CP027599.1_82820	LIPO(Sec/SPII)	0.263273	0.090888	0.341720	0.304118	CS pos: 25-26. SAA-CP. Pr: 0.3360    30
NZ_CP027599.1_82862	LIPO(Sec/SPII)	0.307483	0.216946	0.350973	0.124598	CS pos: 15-16. RAS-CA. Pr: 0.2696    30
NZ_CP027599.1_82868	LIPO(Sec/SPII)	0.034535	0.004608	0.840636	0.120222	CS pos: 16-17. LHS-CG. Pr: 0.8293    42
NZ_CP027599.1_82878	SP(Sec/SPI)	0.412888	0.186940	0.101600	0.298571	CS pos: 21-22. SLA-TP. Pr: 0.1787    41
NZ_CP027599.1_82902	SP(Sec/SPI)	0.415953	0.129349	0.078119	0.376579	CS pos: 19-20. TWS-LR. Pr: 0.2131    50
NZ_CP027599.1_82911	LIPO(Sec/SPII)	0.096689	0.015892	0.729034	0.158385	CS pos: 21-22. FNG-CC. Pr: 0.6573    39
NZ_CP027599.1_82936	SP(Sec/SPI)	0.557103	0.029756	0.068235	0.344905	CS pos: 21-22. SAA-FL. Pr: 0.1793    49
NZ_CP027599.1_82947	LIPO(Sec/SPII)	0.127347	0.103082	0.564512	0.205058	CS pos: 17-18. LMA-CC. Pr: 0.3847    21
NZ_CP027599.1_82949	LIPO(Sec/SPII)	0.325045	0.034828	0.485210	0.154917	CS pos: 17-18. ASQ-CV. Pr: 0.3964    33
NZ_CP027599.1_83071	LIPO(Sec/SPII)	0.036384	0.002249	0.880014	0.081354	CS pos: 17-18. LSR-CN. Pr: 0.8718    26
NZ_CP027599.1_83103	LIPO(Sec/SPII)	0.227843	0.011167	0.421559	0.339432	CS pos: 13-14. PMV-CV. Pr: 0.0940    15
NZ_CP027599.1_83127	SP(Sec/SPI)	0.443929	0.079837	0.107595	0.368639	CS pos: 20-21. VPS-NP. Pr: 0.0823    50
NZ_CP027599.1_83134	LIPO(Sec/SPII)	0.274451	0.034326	0.510011	0.181211	CS pos: 19-20. AFC-CL. Pr: 0.4142    31
NZ_CP027599.1_83141	SP(Sec/SPI)	0.411584	0.112743	0.091533	0.384140	CS pos: 17-18. VAA-SL. Pr: 0.3198    23
NZ_CP027599.1_83165	LIPO(Sec/SPII)	0.148615	0.069133	0.460619	0.321632	CS pos: 14-15. LLT-CP. Pr: 0.3556    41
NZ_CP027599.1_83188	LIPO(Sec/SPII)	0.249735	0.009887	0.465961	0.274416	CS pos: 12-13. FCS-CS. Pr: 0.2105    15
NZ_CP027599.1_83229	LIPO(Sec/SPII)	0.170100	0.035147	0.547522	0.247232	CS pos: 16-17. PSA-CV. Pr: 0.3426    19
NZ_CP027599.1_83255	LIPO(Sec/SPII)	0.243848	0.047218	0.365911	0.343022	CS pos: 14-15. VKR-CA. Pr: 0.0930    18
NZ_CP027599.1_83264	LIPO(Sec/SPII)	0.137545	0.008008	0.615117	0.239331	CS pos: 20-21. PIA-CT. Pr: 0.3911    29
NZ_CP027599.1_83271	LIPO(Sec/SPII)	0.098276	0.013562	0.788798	0.099364	CS pos: 20-21. WNA-CK. Pr: 0.7832    32
NZ_CP027599.1_83308	SP(Sec/SPI)	0.367972	0.163641	0.106180	0.362207	CS pos: 29-30. TYG-AG. Pr: 0.2441    43
NZ_CP027599.1_83385	LIPO(Sec/SPII)	0.189275	0.035620	0.656431	0.118674	CS pos: 27-28. QTS-CS. Pr: 0.6006    37
NZ_CP027599.1_83412	SP(Sec/SPI)	0.688584	0.107986	0.058377	0.145053	CS pos: 24-25. AWG-IT. Pr: 0.6929    31
NZ_CP027599.1_83445	LIPO(Sec/SPII)	0.326990	0.020628	0.401120	0.251262	CS pos: 17-18. FLK-CS. Pr: 0.2957    22
NZ_CP027599.1_83449	TAT(Tat/SPI)	0.088029	0.568750	0.039240	0.303981	CS pos: 23-24. AAA-RY. Pr: 0.4001    36
NZ_CP027599.1_83465	LIPO(Sec/SPII)	0.279574	0.021833	0.399610	0.298983	CS pos: 14-15. AAI-CL. Pr: 0.2541    19
NZ_CP027599.1_83494	LIPO(Sec/SPII)	0.372659	0.011090	0.376716	0.239534	CS pos: 16-17. ITA-SS. Pr: 0.1652    27
NZ_CP027599.1_83514	LIPO(Sec/SPII)	0.285846	0.039088	0.376021	0.299045	CS pos: ?. Probable protein fragment    15
NZ_CP027599.1_83547	LIPO(Sec/SPII)	0.250112	0.012889	0.475915	0.261084	CS pos: 23-24. IAS-QS. Pr: 0.0780    27
NZ_CP027599.1_83553	LIPO(Sec/SPII)	0.223051	0.008801	0.437959	0.330188	CS pos: 15-16. TVK-CL. Pr: 0.3799    21
NZ_CP027599.1_83611	LIPO(Sec/SPII)	0.266792	0.063187	0.394606	0.275415	CS pos: 12-13. SAG-CN. Pr: 0.0811    17
NZ_CP027599.1_83619	LIPO(Sec/SPII)	0.079798	0.035234	0.459750	0.425218	CS pos: 19-20. VSR-CT. Pr: 0.4432    46
NZ_CP027599.1_83629	LIPO(Sec/SPII)	0.166977	0.024208	0.534214	0.274601	CS pos: ?. Probable protein fragment    20
NZ_CP027599.1_83633	LIPO(Sec/SPII)	0.228097	0.023724	0.396629	0.351550	CS pos: ?. Probable protein fragment    18
NZ_CP027599.1_83649	SP(Sec/SPI)	0.551543	0.006330	0.263871	0.178256	CS pos: 19-20. ASS-TP. Pr: 0.3569    29
NZ_CP027599.1_83669	SP(Sec/SPI)	0.652669	0.005801	0.127647	0.213882	CS pos: 27-28. SWG-EE. Pr: 0.5661    44
NZ_CP027599.1_83696	LIPO(Sec/SPII)	0.141145	0.015404	0.699978	0.143473	CS pos: 14-15. LPG-CA. Pr: 0.6546    40
NZ_CP027599.1_83728	SP(Sec/SPI)	0.398933	0.013034	0.352467	0.235565	CS pos: 17-18. VGG-QL. Pr: 0.2667    20
NZ_CP027599.1_83729	SP(Sec/SPI)	0.532982	0.003072	0.117704	0.346242	CS pos: 23-24. IMA-KE. Pr: 0.4742    40
NZ_CP027599.1_83748	LIPO(Sec/SPII)	0.233580	0.013443	0.389266	0.363711	CS pos: ?. Probable protein fragment    17
NZ_CP027599.1_83806	LIPO(Sec/SPII)	0.072614	0.008309	0.747300	0.171777	CS pos: 31-32. FSS-CQ. Pr: 0.6926    35
NZ_CP027599.1_83814	SP(Sec/SPI)	0.374864	0.093098	0.172214	0.359824	CS pos: 25-26. SSS-LP. Pr: 0.1949    28
NZ_CP027599.1_83818	LIPO(Sec/SPII)	0.291704	0.015671	0.383948	0.308677	CS pos: 11-12. VSV-CS. Pr: 0.1134    15
NZ_CP027599.1_83821	SP(Sec/SPI)	0.362797	0.014471	0.331835	0.290897	CS pos: 15-16. TMA-SF. Pr: 0.1340    22
NZ_CP027599.1_83828	LIPO(Sec/SPII)	0.333557	0.011290	0.334590	0.320563	CS pos: 14-15. LSF-CR. Pr: 0.2087    30
NZ_CP027599.1_83844	SP(Sec/SPI)	0.430036	0.155716	0.147869	0.266379	CS pos: 26-27. VTA-TD. Pr: 0.2458    41
NZ_CP027599.1_83892	SP(Sec/SPI)	0.450983	0.352997	0.083901	0.112119	CS pos: 22-23. MVA-HS. Pr: 0.3572    30
NZ_CP027599.1_83932	SP(Sec/SPI)	0.743708	0.024678	0.118987	0.112627	CS pos: 23-24. SVS-KS. Pr: 0.3174    47
NZ_CP027599.1_83982	LIPO(Sec/SPII)	0.114638	0.028808	0.601824	0.254730	CS pos: 23-24. IGT-CS. Pr: 0.5492    27
NZ_CP027599.1_84057	SP(Sec/SPI)	0.451882	0.017241	0.166322	0.364554	CS pos: 14-15. VQT-AE. Pr: 0.2033    19
NZ_CP027599.1_84058	LIPO(Sec/SPII)	0.295247	0.024333	0.501531	0.178889	CS pos: 24-25. VAS-CT. Pr: 0.4126    27
NZ_CP027599.1_84066	SP(Sec/SPI)	0.577481	0.041589	0.139415	0.241514	CS pos: 19-20. STA-HP. Pr: 0.3765    29
NZ_CP027599.1_84076	TAT(Tat/SPI)	0.281902	0.348993	0.080436	0.288670	CS pos: 25-26. AFA-AR. Pr: 0.3268    27
NZ_CP027599.1_84118	SP(Sec/SPI)	0.480955	0.043502	0.080768	0.394775	CS pos: 18-19. GFS-GV. Pr: 0.1598    38
NZ_CP027599.1_84122	SP(Sec/SPI)	0.487051	0.024297	0.189467	0.299186	CS pos: 14-15. GSA-QP. Pr: 0.1411    24
NZ_CP027599.1_84127	LIPO(Sec/SPII)	0.208627	0.031511	0.501834	0.258027	CS pos: 15-16. SFA-CW. Pr: 0.3867    21
NZ_CP027599.1_84147	LIPO(Sec/SPII)	0.247571	0.016714	0.390602	0.345113	CS pos: ?. Probable protein fragment    17
NZ_CP027599.1_84149	SP(Sec/SPI)	0.485127	0.045289	0.083861	0.385722	CS pos: 18-19. ANG-QH. Pr: 0.1841    36
NZ_CP027599.1_84156	LIPO(Sec/SPII)	0.195759	0.153839	0.325992	0.324410	CS pos: 33-34. AVG-CS. Pr: 0.3186    39
NZ_CP027599.1_84194	LIPO(Sec/SPII)	0.082456	0.007781	0.794840	0.114923	CS pos: 14-15. IAS-CE. Pr: 0.7647    18
NZ_CP027599.1_84213	LIPO(Sec/SPII)	0.178718	0.001107	0.687603	0.132571	CS pos: 20-21. QTG-CY. Pr: 0.6140    45
NZ_CP027599.1_84220	SP(Sec/SPI)	0.351496	0.045941	0.303449	0.299114	CS pos: ?. Probable protein fragment    22
NZ_CP027599.1_84248	SP(Sec/SPI)	0.480119	0.051516	0.117343	0.351022	CS pos: ?. Probable protein fragment    22
NZ_CP027599.1_84263	LIPO(Sec/SPII)	0.355403	0.002933	0.406720	0.234943	CS pos: 13-14. CLF-CR. Pr: 0.0740    18
NZ_CP027599.1_84273	SP(Sec/SPI)	0.396184	0.001794	0.327487	0.274536	CS pos: 15-16. TQG-DV. Pr: 0.5023    40
NZ_CP027599.1_84303	LIPO(Sec/SPII)	0.066787	0.003841	0.856701	0.072671	CS pos: 18-19. IGS-CC. Pr: 0.7042    33
NZ_CP027599.1_84310	SP(Sec/SPI)	0.482631	0.071953	0.113646	0.331770	CS pos: 13-14. ALA-DV. Pr: 0.4239    15
NZ_CP027599.1_84329	LIPO(Sec/SPII)	0.201817	0.241668	0.421493	0.135022	CS pos: 15-16. SGA-CC. Pr: 0.2778    41
NZ_CP027599.1_84330	LIPO(Sec/SPII)	0.304246	0.019172	0.377089	0.299493	CS pos: 12-13. LAL-CF. Pr: 0.0378    18
NZ_CP027599.1_84345	SP(Sec/SPI)	0.611155	0.059036	0.124172	0.205637	CS pos: 17-18. AAG-YP. Pr: 0.3339    33
NZ_CP027599.1_84356	SP(Sec/SPI)	0.527574	0.091286	0.207304	0.173835	CS pos: 20-21. SLS-SS. Pr: 0.1775    26
NZ_CP027599.1_84369	LIPO(Sec/SPII)	0.036994	0.003962	0.925635	0.033409	CS pos: 17-18. SSS-CL. Pr: 0.9228    41
NZ_CP027599.1_84374	LIPO(Sec/SPII)	0.286434	0.107591	0.366587	0.239388	CS pos: 26-27. VSA-CS. Pr: 0.2271    32
NZ_CP027599.1_84375	TAT(Tat/SPI)	0.156386	0.582348	0.239263	0.022002	CS pos: 29-30. ASA-IT. Pr: 0.6186    46
NZ_CP027599.1_84391	TAT(Tat/SPI)	0.196408	0.393048	0.040389	0.370155	CS pos: 31-32. AQA-QS. Pr: 0.4031    49
NZ_CP027599.1_84399	LIPO(Sec/SPII)	0.243752	0.013101	0.539021	0.204126	CS pos: 18-19. ART-CS. Pr: 0.4703    28
NZ_CP027599.1_84401	SP(Sec/SPI)	0.583889	0.018697	0.197235	0.200179	CS pos: 15-16. AQS-KN. Pr: 0.2708    28
NZ_CP027599.1_84402	SP(Sec/SPI)	0.426347	0.009888	0.360337	0.203429	CS pos: ?. Probable protein fragment    27
NZ_CP027599.1_84496	LIPO(Sec/SPII)	0.211341	0.008085	0.627059	0.153515	CS pos: 14-15. SLC-CS. Pr: 0.3768    22
NZ_CP027599.1_84525	SP(Sec/SPI)	0.367644	0.023530	0.247809	0.361017	CS pos: 22-23. LLT-KP. Pr: 0.0267    26
NZ_CP027599.1_84527	TAT(Tat/SPI)	0.230814	0.626424	0.024101	0.118660	CS pos: 34-35. ISA-SG. Pr: 0.3686    44
NZ_CP027599.1_84535	LIPO(Sec/SPII)	0.109332	0.009823	0.745847	0.134998	CS pos: 15-16. AFG-CS. Pr: 0.6062    17
NZ_CP027599.1_84542	LIPO(Sec/SPII)	0.156354	0.010591	0.728416	0.104639	CS pos: 23-24. TTM-CS. Pr: 0.6215    44
NZ_CP027599.1_84550	SP(Sec/SPI)	0.475758	0.063804	0.155004	0.305433	CS pos: 17-18. ISA-SP. Pr: 0.3246    20
NZ_CP027599.1_84555	LIPO(Sec/SPII)	0.196278	0.074920	0.415946	0.312856	CS pos: 24-25. FSA-CS. Pr: 0.4013    28
NZ_CP027599.1_84576	TAT(Tat/SPI)	0.212506	0.368871	0.105800	0.312823	CS pos: 17-18. ARA-SS. Pr: 0.2149    45
NZ_CP027599.1_84579	SP(Sec/SPI)	0.358366	0.040902	0.247210	0.353523	CS pos: ?. Probable protein fragment    22
NZ_CP027599.1_84594	LIPO(Sec/SPII)	0.218399	0.050152	0.412732	0.318716	CS pos: 29-30. RAA-CS. Pr: 0.3800    39
NZ_CP027599.1_84624	LIPO(Sec/SPII)	0.163587	0.015895	0.536868	0.283650	CS pos: 15-16. EFS-CM. Pr: 0.4300    21
NZ_CP027599.1_84682	LIPO(Sec/SPII)	0.117233	0.024759	0.536543	0.321465	CS pos: 19-20. ISS-CW. Pr: 0.4881    24
NZ_CP027599.1_84685	SP(Sec/SPI)	0.462477	0.056394	0.073710	0.407419	CS pos: 15-16. AGA-NG. Pr: 0.1917    24
NZ_CP027599.1_84715	LIPO(Sec/SPII)	0.137834	0.026668	0.632926	0.202572	CS pos: 19-20. GST-CG. Pr: 0.5811    25
NZ_CP027599.1_84719	LIPO(Sec/SPII)	0.084217	0.003533	0.495017	0.417232	CS pos: 12-13. IST-CW. Pr: 0.4674    28
NZ_CP027599.1_84726	LIPO(Sec/SPII)	0.108696	0.012568	0.571398	0.307338	CS pos: 21-22. LPG-CH. Pr: 0.5408    33
NZ_CP027599.1_84734	TAT(Tat/SPI)	0.114147	0.396753	0.122990	0.366110	CS pos: 21-22. CRA-VK. Pr: 0.1788    27
NZ_CP027599.1_84747	LIPO(Sec/SPII)	0.250849	0.022283	0.386799	0.340069	CS pos: ?. Probable protein fragment    17
NZ_CP027599.1_84758	LIPO(Sec/SPII)	0.126878	0.071495	0.411539	0.390088	CS pos: 21-22. GSS-CP. Pr: 0.3723    29
NZ_CP027599.1_84769	LIPO(Sec/SPII)	0.284064	0.004024	0.574009	0.137903	CS pos: 20-21. LCC-CW. Pr: 0.1281    25
NZ_CP027599.1_84774	SP(Sec/SPI)	0.459644	0.067063	0.126563	0.346730	CS pos: 16-17. SYS-SS. Pr: 0.1800    33
NZ_CP027599.1_84785	LIPO(Sec/SPII)	0.244473	0.007979	0.398220	0.349328	CS pos: 17-18. ANL-CG. Pr: 0.2157    21
NZ_CP027599.1_84790	LIPO(Sec/SPII)	0.251112	0.037640	0.366625	0.344623	CS pos: ?. Probable protein fragment    17
NZ_CP027599.1_84805	LIPO(Sec/SPII)	0.259757	0.027533	0.492711	0.219999	CS pos: 17-18. SIN-CS. Pr: 0.2794    25
NZ_CP027599.1_84874	SP(Sec/SPI)	0.545756	0.036081	0.085202	0.332960	CS pos: 20-21. AAA-SN. Pr: 0.2557    38
NZ_CP027599.1_84878	SP(Sec/SPI)	0.412483	0.061267	0.166921	0.359329	CS pos: 20-21. CWA-ET. Pr: 0.3867    22
NZ_CP027599.1_84886	LIPO(Sec/SPII)	0.050383	0.004666	0.480538	0.464413	CS pos: 19-20. TIG-CF. Pr: 0.4764    28
NZ_CP027599.1_84890	TAT(Tat/SPI)	0.066127	0.467527	0.100323	0.366022	CS pos: 26-27. GKC-DG. Pr: 0.1733    40
NZ_CP027599.1_84913	LIPO(Sec/SPII)	0.088145	0.026334	0.521575	0.363946	CS pos: 27-28. LSG-CH. Pr: 0.5138    37
NZ_CP027599.1_85084	LIPO(Sec/SPII)	0.242185	0.041418	0.478399	0.237997	CS pos: 14-15. YSK-CR. Pr: 0.3744    37
NZ_CP027599.1_85088	SP(Sec/SPI)	0.354881	0.024291	0.267243	0.353586	CS pos: 18-19. GRA-GI. Pr: 0.2135    38
NZ_CP027599.1_85092	LIPO(Sec/SPII)	0.069445	0.008334	0.833159	0.089062	CS pos: 18-19. VKG-CA. Pr: 0.7884    24
NZ_CP027599.1_85140	LIPO(Sec/SPII)	0.319080	0.008349	0.348739	0.323831	CS pos: ?. Probable protein fragment    16
NZ_CP027599.1_85157	SP(Sec/SPI)	0.440808	0.114789	0.126162	0.318242	CS pos: 18-19. PWS-AS. Pr: 0.0795    30
NZ_CP027599.1_85163	LIPO(Sec/SPII)	0.135012	0.023389	0.696731	0.144867	CS pos: 23-24. VSS-CS. Pr: 0.6740    34
NZ_CP027599.1_85206	SP(Sec/SPI)	0.535583	0.146677	0.060511	0.257228	CS pos: 25-26. ARA-TF. Pr: 0.5885    31
NZ_CP027599.1_85223	LIPO(Sec/SPII)	0.151257	0.005891	0.523237	0.319615	CS pos: 13-14. VTI-CS. Pr: 0.1779    22
NZ_CP027599.1_85241	LIPO(Sec/SPII)	0.161930	0.007956	0.665192	0.164921	CS pos: 15-16. IST-CI. Pr: 0.6198    23
NZ_CP027599.1_85258	LIPO(Sec/SPII)	0.106631	0.027128	0.541345	0.324895	CS pos: 34-35. VMG-CM. Pr: 0.5277    39
NZ_CP027599.1_85262	SP(Sec/SPI)	0.578769	0.063765	0.094320	0.263145	CS pos: 25-26. GAA-HV. Pr: 0.2455    33
NZ_CP027599.1_85282	SP(Sec/SPI)	0.441919	0.300499	0.091607	0.165975	CS pos: 28-29. SSA-TG. Pr: 0.4477    34
NZ_CP027599.1_85299	LIPO(Sec/SPII)	0.039436	0.001716	0.898469	0.060379	CS pos: 25-26. MIS-CN. Pr: 0.5544    41
NZ_CP027599.1_85321	LIPO(Sec/SPII)	0.153775	0.018462	0.599982	0.227781	CS pos: 20-21. TFS-CL. Pr: 0.5245    23
NZ_CP027599.1_85327	LIPO(Sec/SPII)	0.125900	0.086887	0.527287	0.259926	CS pos: 16-17. VCA-CP. Pr: 0.4960    32
NZ_CP027599.1_85343	LIPO(Sec/SPII)	0.031852	0.002406	0.923355	0.042386	CS pos: 19-20. VLS-CD. Pr: 0.9202    36
NZ_CP027599.1_85370	SP(Sec/SPI)	0.678334	0.000872	0.193654	0.127139	CS pos: 19-20. MHC-EF. Pr: 0.5266    26
NZ_CP027599.1_85377	LIPO(Sec/SPII)	0.043556	0.001908	0.941332	0.013204	CS pos: 20-21. LMA-CW. Pr: 0.6788    34
NZ_CP027599.1_85391	SP(Sec/SPI)	0.441833	0.030211	0.203248	0.324708	CS pos: 26-27. VQP-AI. Pr: 0.1907    28
NZ_CP027599.1_85410	LIPO(Sec/SPII)	0.036650	0.005340	0.827836	0.130174	CS pos: 14-15. TSG-CL. Pr: 0.8230    27
NZ_CP027599.1_85423	LIPO(Sec/SPII)	0.359894	0.016155	0.429233	0.194718	CS pos: 14-15. INA-PV. Pr: 0.0654    17
NZ_CP027599.1_85463	SP(Sec/SPI)	0.456000	0.319204	0.048016	0.176781	CS pos: 35-36. VAA-SS. Pr: 0.2963    49
NZ_CP027599.1_85483	SP(Sec/SPI)	0.411852	0.049417	0.149962	0.388769	CS pos: 16-17. ANG-DR. Pr: 0.1302    35
NZ_CP027599.1_85492	LIPO(Sec/SPII)	0.022672	0.002846	0.944725	0.029756	CS pos: 23-24. LSG-CC. Pr: 0.8627    40
NZ_CP027599.1_85494	LIPO(Sec/SPII)	0.049188	0.003271	0.831194	0.116346	CS pos: 26-27. VVA-CF. Pr: 0.8283    49
NZ_CP027599.1_85513	LIPO(Sec/SPII)	0.313530	0.015600	0.524653	0.146217	CS pos: 18-19. FHC-CF. Pr: 0.2815    29
NZ_CP027599.1_85517	SP(Sec/SPI)	0.388762	0.118171	0.227692	0.265375	CS pos: 22-23. VRS-SP. Pr: 0.3646    31
NZ_CP027599.1_85539	SP(Sec/SPI)	0.533238	0.050339	0.063864	0.352558	CS pos: 21-22. SMA-VS. Pr: 0.3230    31
NZ_CP027599.1_85545	LIPO(Sec/SPII)	0.146828	0.019757	0.518811	0.314604	CS pos: 18-19. VPA-CF. Pr: 0.5092    27
NZ_CP027599.1_85553	TAT(Tat/SPI)	0.279463	0.374790	0.146513	0.199234	CS pos: ?. Probable protein fragment    26
NZ_CP027599.1_85578	TAT(Tat/SPI)	0.434752	0.484700	0.036834	0.043715	CS pos: 24-25. ASA-NN. Pr: 0.8446    39
NZ_CP027599.1_85586	LIPO(Sec/SPII)	0.297773	0.045734	0.368751	0.287741	CS pos: ?. Probable protein fragment    15
NZ_CP027599.1_85619	SP(Sec/SPI)	0.575343	0.033662	0.171417	0.219577	CS pos: 23-24. FLA-DD. Pr: 0.4843    28
NZ_CP027599.1_85630	SP(Sec/SPI)	0.469252	0.019893	0.216056	0.294800	CS pos: ?. Probable protein fragment    20
NZ_CP027599.1_85662	SP(Sec/SPI)	0.654850	0.039020	0.028523	0.277608	CS pos: 20-21. SIA-KS. Pr: 0.3302    47
NZ_CP027599.1_85680	LIPO(Sec/SPII)	0.252848	0.130424	0.340453	0.276275	CS pos: 14-15. VLN-CA. Pr: 0.2645    43
NZ_CP027599.1_85685	SP(Sec/SPI)	0.917757	0.041241	0.007188	0.033813	CS pos: 27-28. SEA-YP. Pr: 0.9124    36
NZ_CP027599.1_85687	LIPO(Sec/SPII)	0.047252	0.000840	0.940639	0.011269	CS pos: 13-14. VAA-CS. Pr: 0.9351    37
NZ_CP027599.1_85689	LIPO(Sec/SPII)	0.223582	0.032428	0.489443	0.254547	CS pos: 18-19. VCC-CV. Pr: 0.1898    22
NZ_CP027599.1_85697	LIPO(Sec/SPII)	0.082189	0.011685	0.666280	0.239846	CS pos: 15-16. LST-CS. Pr: 0.6397    22
NZ_CP027599.1_85708	SP(Sec/SPI)	0.557318	0.064064	0.033673	0.344944	CS pos: 22-23. VYS-LP. Pr: 0.4811    48
NZ_CP027599.1_85728	SP(Sec/SPI)	0.531160	0.034880	0.077724	0.356235	CS pos: 16-17. NEA-TS. Pr: 0.0978    32
NZ_CP027599.1_85742	LIPO(Sec/SPII)	0.290966	0.026556	0.411348	0.271130	CS pos: 14-15. IIL-CT. Pr: 0.0989    19
NZ_CP027599.1_85758	SP(Sec/SPI)	0.325326	0.055528	0.307758	0.311389	CS pos: ?. Probable protein fragment    18
NZ_CP027599.1_85773	LIPO(Sec/SPII)	0.309515	0.018395	0.558117	0.113973	CS pos: 16-17. YST-CS. Pr: 0.4834    30
NZ_CP027599.1_85782	LIPO(Sec/SPII)	0.312197	0.010027	0.390288	0.287489	CS pos: 18-19. TVQ-CW. Pr: 0.3088    21
NZ_CP027599.1_85794	LIPO(Sec/SPII)	0.042871	0.019858	0.505521	0.431750	CS pos: 21-22. LSG-CG. Pr: 0.5022    41
NZ_CP027599.1_85812	LIPO(Sec/SPII)	0.261584	0.024565	0.428496	0.285356	CS pos: ?. Probable protein fragment    15
NZ_CP027599.1_85858	LIPO(Sec/SPII)	0.209031	0.032985	0.396436	0.361547	CS pos: 16-17. RTG-CN. Pr: 0.2427    22
NZ_CP027599.1_85860	LIPO(Sec/SPII)	0.231221	0.023023	0.435626	0.310130	CS pos: 18-19. LFS-CV. Pr: 0.2732    21
NZ_CP027599.1_85917	LIPO(Sec/SPII)	0.138222	0.327675	0.332439	0.201663	CS pos: 22-23. WLS-CR. Pr: 0.2849    25
NZ_CP027599.1_85974	LIPO(Sec/SPII)	0.248666	0.043510	0.581871	0.125952	CS pos: 21-22. ALG-CA. Pr: 0.5575    34
NZ_CP027599.1_85978	SP(Sec/SPI)	0.350626	0.022428	0.320099	0.306848	CS pos: 18-19. CYA-VH. Pr: 0.1893    20
NZ_CP027599.1_86000	LIPO(Sec/SPII)	0.281105	0.018257	0.429733	0.270905	CS pos: ?. Probable protein fragment    16
NZ_CP027599.1_86009	SP(Sec/SPI)	0.409966	0.054309	0.183910	0.351815	CS pos: 32-33. VNS-AP. Pr: 0.1430    46
NZ_CP027599.1_86026	LIPO(Sec/SPII)	0.021807	0.000587	0.852189	0.125417	CS pos: 12-13. LVS-CQ. Pr: 0.8558    45
NZ_CP027599.1_86028	LIPO(Sec/SPII)	0.317169	0.013109	0.456122	0.213601	CS pos: ?. Probable protein fragment    15
NZ_CP027599.1_86031	LIPO(Sec/SPII)	0.068085	0.011320	0.653959	0.266637	CS pos: 18-19. GLA-CC. Pr: 0.4722    38
NZ_CP027599.1_86037	SP(Sec/SPI)	0.869569	0.059556	0.014194	0.056681	CS pos: 27-28. AFA-QG. Pr: 0.6951    46
NZ_CP027599.1_86062	LIPO(Sec/SPII)	0.163577	0.026106	0.450708	0.359609	CS pos: 29-30. LLT-CG. Pr: 0.2094    34
NZ_CP027599.1_86066	LIPO(Sec/SPII)	0.216574	0.051982	0.408096	0.323348	CS pos: ?. Probable protein fragment    19
NZ_CP027599.1_86067	LIPO(Sec/SPII)	0.083975	0.007806	0.627418	0.280801	CS pos: 28-29. LLN-CT. Pr: 0.2766    42
NZ_CP027599.1_86082	LIPO(Sec/SPII)	0.254295	0.131253	0.316925	0.297527	CS pos: ?. Probable protein fragment    19
NZ_CP027599.1_86166	TAT(Tat/SPI)	0.168621	0.374508	0.149713	0.307158	CS pos: 30-31. SGA-RV. Pr: 0.1235    37
NZ_CP027599.1_86170	SP(Sec/SPI)	0.380304	0.091367	0.217217	0.311112	CS pos: 28-29. TLA-TS. Pr: 0.1493    31
NZ_CP027599.1_86187	SP(Sec/SPI)	0.388172	0.115836	0.134929	0.361063	CS pos: 24-25. ARA-GG. Pr: 0.1936    32
NZ_CP027599.1_86192	SP(Sec/SPI)	0.416483	0.027496	0.240759	0.315263	CS pos: 23-24. TSS-RQ. Pr: 0.1144    32
NZ_CP027599.1_86193	LIPO(Sec/SPII)	0.263859	0.018829	0.399682	0.317630	CS pos: ?. Probable protein fragment    15
NZ_CP027599.1_86199	SP(Sec/SPI)	0.624613	0.019543	0.117278	0.238566	CS pos: 22-23. SNS-ME. Pr: 0.3506    35
NZ_CP027599.1_86269	SP(Sec/SPI)	0.793530	0.017967	0.067477	0.121026	CS pos: 17-18. ASA-DV. Pr: 0.7695    27
NZ_CP027599.1_86293	SP(Sec/SPI)	0.496350	0.010085	0.301379	0.192186	CS pos: 23-24. VIS-VR. Pr: 0.1953    44
NZ_CP027599.1_86300	SP(Sec/SPI)	0.885674	0.010225	0.068975	0.035126	CS pos: 16-17. ISA-SP. Pr: 0.7269    29
NZ_CP027599.1_86312	LIPO(Sec/SPII)	0.065621	0.191052	0.374153	0.369174	CS pos: 25-26. ALC-CG. Pr: 0.2978    43
NZ_CP027599.1_86316	SP(Sec/SPI)	0.466992	0.006837	0.419031	0.107140	CS pos: 17-18. SIA-QK. Pr: 0.2456    23
NZ_CP027599.1_86485	LIPO(Sec/SPII)	0.218628	0.015501	0.391054	0.374817	CS pos: ?. Probable protein fragment    15
NZ_CP027599.1_86486	SP(Sec/SPI)	0.392912	0.058597	0.290412	0.258078	CS pos: 16-17. ANA-AL. Pr: 0.0680    19
NZ_CP027599.1_86503	LIPO(Sec/SPII)	0.195146	0.014403	0.426805	0.363646	CS pos: 15-16. VFK-CK. Pr: 0.1813    17
NZ_CP027599.1_86526	SP(Sec/SPI)	0.528336	0.090714	0.067792	0.313158	CS pos: 20-21. AIA-MP. Pr: 0.2329    30
NZ_CP027599.1_86558	SP(Sec/SPI)	0.531033	0.022970	0.248815	0.197182	CS pos: 19-20. SLA-SV. Pr: 0.3850    25
NZ_CP027599.1_86561	LIPO(Sec/SPII)	0.220494	0.015081	0.395015	0.369409	CS pos: 21-22. LIP-CW. Pr: 0.2121    44
NZ_CP027599.1_86596	LIPO(Sec/SPII)	0.140041	0.046097	0.530021	0.283841	CS pos: 23-24. GTA-CK. Pr: 0.4852    34
NZ_CP027599.1_86612	LIPO(Sec/SPII)	0.293232	0.018016	0.400293	0.288459	CS pos: ?. Probable protein fragment    19
NZ_CP027599.1_86623	LIPO(Sec/SPII)	0.096329	0.006003	0.799388	0.098279	CS pos: 17-18. YSG-CR. Pr: 0.7844    28
NZ_CP027599.1_86654	LIPO(Sec/SPII)	0.202119	0.044476	0.623854	0.129551	CS pos: 19-20. LSG-CI. Pr: 0.5744    38
NZ_CP027599.1_86690	LIPO(Sec/SPII)	0.252339	0.042327	0.385351	0.319983	CS pos: 14-15. ALA-CL. Pr: 0.2526    21
NZ_CP027599.1_86706	LIPO(Sec/SPII)	0.218225	0.083811	0.373168	0.324796	CS pos: 14-15. CGG-CL. Pr: 0.1363    16
NZ_CP027599.1_86718	SP(Sec/SPI)	0.433088	0.174063	0.086856	0.305993	CS pos: 41-42. ALA-AS. Pr: 0.2639    47
NZ_CP027599.1_86722	LIPO(Sec/SPII)	0.254987	0.018814	0.452164	0.274036	CS pos: 18-19. NCT-CL. Pr: 0.2005    21
NZ_CP027599.1_86734	SP(Sec/SPI)	0.883829	0.005017	0.078081	0.033072	CS pos: 22-23. VSA-HQ. Pr: 0.7566    50
NZ_CP027599.1_86745	SP(Sec/SPI)	0.567242	0.029361	0.155900	0.247497	CS pos: 27-28. AAG-KS. Pr: 0.3158    32
NZ_CP027599.1_86764	SP(Sec/SPI)	0.496957	0.010209	0.037726	0.455108	CS pos: 21-22. YRA-DT. Pr: 0.4195    38
NZ_CP027599.1_86788	LIPO(Sec/SPII)	0.317969	0.018332	0.402191	0.261508	CS pos: ?. Probable protein fragment    15
NZ_CP027599.1_86817	LIPO(Sec/SPII)	0.120024	0.201506	0.567262	0.111207	CS pos: 26-27. LPQ-CG. Pr: 0.4770    44
NZ_CP027599.1_86819	LIPO(Sec/SPII)	0.289421	0.014708	0.378816	0.317054	CS pos: 14-15. WSA-CA. Pr: 0.0756    20
NZ_CP027599.1_86844	LIPO(Sec/SPII)	0.110821	0.019887	0.496230	0.373062	CS pos: 15-16. TGG-CD. Pr: 0.4705    17
NZ_CP027599.1_86847	SP(Sec/SPI)	0.566387	0.142938	0.036815	0.253860	CS pos: 24-25. VQA-WT. Pr: 0.2981    32
NZ_CP027599.1_86887	SP(Sec/SPI)	0.350672	0.064667	0.288589	0.296072	CS pos: 24-25. RQA-SS. Pr: 0.1595    27
NZ_CP027599.1_86900	LIPO(Sec/SPII)	0.051925	0.002742	0.916159	0.029174	CS pos: 19-20. SSS-CH. Pr: 0.8780    26
NZ_CP027599.1_86927	TAT(Tat/SPI)	0.230496	0.658776	0.041965	0.068762	CS pos: 27-28. AAA-NI. Pr: 0.6017    35
NZ_CP027599.1_86953	LIPO(Sec/SPII)	0.311509	0.045394	0.437407	0.205690	CS pos: 16-17. STG-LQ. Pr: 0.0308    19
NZ_CP027599.1_86956	TAT(Tat/SPI)	0.050407	0.561155	0.031912	0.356526	CS pos: 28-29. CSG-VK. Pr: 0.1198    41
NZ_CP027599.1_86958	LIPO(Sec/SPII)	0.182628	0.005165	0.450190	0.362017	CS pos: 12-13. CIK-CQ. Pr: 0.3872    30
NZ_CP027599.1_86978	LIPO(Sec/SPII)	0.186960	0.136549	0.346820	0.329670	CS pos: 19-20. GVC-CA. Pr: 0.2573    30
NZ_CP027599.1_86986	LIPO(Sec/SPII)	0.108939	0.003203	0.462281	0.425577	CS pos: 20-21. VQH-CS. Pr: 0.4083    27
NZ_CP027599.1_86990	SP(Sec/SPI)	0.441896	0.103473	0.124401	0.330230	CS pos: 37-38. SLA-MP. Pr: 0.1485    42
NZ_CP027599.1_87002	TAT(Tat/SPI)	0.163825	0.361066	0.124825	0.350284	CS pos: ?. Probable protein fragment    21
NZ_CP027599.1_87010	LIPO(Sec/SPII)	0.017425	0.000684	0.944956	0.036934	CS pos: 15-16. ALS-CG. Pr: 0.9333    32
NZ_CP027599.1_87024	TAT(Tat/SPI)	0.166259	0.367085	0.234801	0.231855	CS pos: ?. Probable protein fragment    16
NZ_CP027599.1_87052	LIPO(Sec/SPII)	0.035582	0.002333	0.824364	0.137721	CS pos: 21-22. IQG-CF. Pr: 0.7989    24
NZ_CP027599.1_87083	LIPO(Sec/SPII)	0.130854	0.046844	0.692599	0.129704	CS pos: 13-14. IAA-CS. Pr: 0.6631    20
NZ_CP027599.1_87089	TAT(Tat/SPI)	0.235713	0.631083	0.056097	0.077107	CS pos: 26-27. ISA-IS. Pr: 0.3616    39
NZ_CP027599.1_87095	SP(Sec/SPI)	0.539706	0.034265	0.052727	0.373301	CS pos: 12-13. ATA-AN. Pr: 0.4051    32
NZ_CP027599.1_87105	LIPO(Sec/SPII)	0.408463	0.037924	0.442841	0.110771	CS pos: 14-15. YIT-CV. Pr: 0.3821    29
NZ_CP027599.1_87132	LIPO(Sec/SPII)	0.145869	0.009428	0.748863	0.095839	CS pos: 21-22. VLA-CW. Pr: 0.6988    24
NZ_CP027599.1_87156	SP(Sec/SPI)	0.391417	0.077253	0.142531	0.388800	CS pos: 23-24. KLA-AR. Pr: 0.0793    35
NZ_CP027599.1_87165	SP(Sec/SPI)	0.474658	0.064184	0.134785	0.326374	CS pos: 27-28. SLS-VK. Pr: 0.2204    31
NZ_CP027599.1_87166	LIPO(Sec/SPII)	0.289183	0.028278	0.479574	0.202964	CS pos: 14-15. CAA-TN. Pr: 0.0295    16
NZ_CP027599.1_87216	LIPO(Sec/SPII)	0.094430	0.035337	0.833279	0.036954	CS pos: 18-19. TSS-CC. Pr: 0.6905    49
NZ_CP027599.1_87246	LIPO(Sec/SPII)	0.113713	0.025009	0.785349	0.075930	CS pos: 23-24. NTA-CS. Pr: 0.7781    29
NZ_CP027599.1_87265	LIPO(Sec/SPII)	0.178593	0.050945	0.611583	0.158879	CS pos: 25-26. VNG-CA. Pr: 0.5988    31
NZ_CP027599.1_87292	SP(Sec/SPI)	0.455858	0.020859	0.321013	0.202271	CS pos: ?. Probable protein fragment    17
NZ_CP027599.1_87298	LIPO(Sec/SPII)	0.045626	0.028892	0.701048	0.224433	CS pos: 22-23. LSG-CE. Pr: 0.7016    34
NZ_CP027599.1_87314	SP(Sec/SPI)	0.579149	0.006449	0.075580	0.338821	CS pos: 21-22. VNG-VW. Pr: 0.2776    36
NZ_CP027599.1_87319	LIPO(Sec/SPII)	0.134485	0.018399	0.599061	0.248055	CS pos: 14-15. SSS-CR. Pr: 0.5267    20
NZ_CP027599.1_87340	LIPO(Sec/SPII)	0.185627	0.023385	0.578573	0.212415	CS pos: 11-12. TAG-CT. Pr: 0.5439    21
NZ_CP027599.1_87386	LIPO(Sec/SPII)	0.069991	0.005124	0.882462	0.042423	CS pos: 26-27. TTA-CS. Pr: 0.8775    31
NZ_CP027599.1_87423	LIPO(Sec/SPII)	0.072244	0.017631	0.628070	0.282054	CS pos: 19-20. CCA-CV. Pr: 0.3796    33
NZ_CP027599.1_87439	TAT(Tat/SPI)	0.065631	0.543941	0.018012	0.372416	CS pos: 36-37. SNA-VP. Pr: 0.4274    49
NZ_CP027599.1_87450	SP(Sec/SPI)	0.549484	0.049862	0.075377	0.325276	CS pos: 19-20. VHG-KP. Pr: 0.3899    33
NZ_CP027599.1_87487	LIPO(Sec/SPII)	0.219060	0.015792	0.480469	0.284679	CS pos: 20-21. WVQ-CV. Pr: 0.3533    22
NZ_CP027599.1_87523	SP(Sec/SPI)	0.743225	0.132823	0.040008	0.083944	CS pos: 17-18. ASA-FR. Pr: 0.5561    31
NZ_CP027599.1_87555	LIPO(Sec/SPII)	0.186745	0.014181	0.405793	0.393281	CS pos: 15-16. FPR-CK. Pr: 0.1457    17
NZ_CP027599.1_87560	LIPO(Sec/SPII)	0.222062	0.018376	0.380157	0.379405	CS pos: 18-19. FLS-RN. Pr: 0.2203    36
NZ_CP027599.1_87580	LIPO(Sec/SPII)	0.284747	0.014519	0.379974	0.320760	CS pos: 27-28. FFS-CF. Pr: 0.3081    30
NZ_CP027599.1_87592	SP(Sec/SPI)	0.480768	0.138958	0.134982	0.245292	CS pos: 19-20. VSG-LP. Pr: 0.4273    24
NZ_CP027599.1_87595	LIPO(Sec/SPII)	0.130447	0.055579	0.557557	0.256417	CS pos: 19-20. AFS-CS. Pr: 0.5273    35
NZ_CP027599.1_87608	LIPO(Sec/SPII)	0.195048	0.034477	0.423258	0.347217	CS pos: 25-26. IGS-CS. Pr: 0.4029    33
NZ_CP027599.1_87679	TAT(Tat/SPI)	0.076805	0.622318	0.063626	0.237251	CS pos: 37-38. VPA-AV. Pr: 0.3406    46
NZ_CP027599.1_87687	TAT(Tat/SPI)	0.238142	0.399734	0.042507	0.319617	CS pos: 28-29. ARA-AA. Pr: 0.3185    32
NZ_CP027599.1_87688	LIPO(Sec/SPII)	0.056704	0.007504	0.717897	0.217894	CS pos: 17-18. CAA-CD. Pr: 0.7062    31
NZ_CP027599.1_87698	LIPO(Sec/SPII)	0.155501	0.008082	0.494464	0.341953	CS pos: 17-18. CVG-CW. Pr: 0.2084    29
NZ_CP027599.1_87724	SP(Sec/SPI)	0.352454	0.093630	0.247502	0.306414	CS pos: 28-29. ARP-AT. Pr: 0.1103    32
NZ_CP027599.1_87738	LIPO(Sec/SPII)	0.345552	0.054446	0.345953	0.254050	CS pos: ?. Probable protein fragment    30
NZ_CP027599.1_87754	LIPO(Sec/SPII)	0.317529	0.021884	0.349761	0.310826	CS pos: 17-18. ALA-VT. Pr: 0.0172    19
NZ_CP027599.1_87768	TAT(Tat/SPI)	0.068093	0.494294	0.043189	0.394425	CS pos: 25-26. AGA-AG. Pr: 0.1832    45
NZ_CP027599.1_87777	SP(Sec/SPI)	0.484815	0.028984	0.113066	0.373134	CS pos: 23-24. TYP-AQ. Pr: 0.1185    35
NZ_CP027599.1_87785	LIPO(Sec/SPII)	0.309650	0.028486	0.359344	0.302520	CS pos: ?. Probable protein fragment    16
NZ_CP027599.1_87793	LIPO(Sec/SPII)	0.220399	0.144066	0.324981	0.310554	CS pos: 14-15. ATA-CT. Pr: 0.3072    42
NZ_CP027599.1_87795	TAT(Tat/SPI)	0.410678	0.439202	0.041669	0.108451	CS pos: 24-25. ARA-RP. Pr: 0.2341    36
NZ_CP027599.1_87801	LIPO(Sec/SPII)	0.199019	0.064878	0.382294	0.353809	CS pos: 13-14. LSA-CR. Pr: 0.2657    47
NZ_CP027599.1_87837	SP(Sec/SPI)	0.658005	0.046657	0.010037	0.285301	CS pos: 28-29. IFA-AP. Pr: 0.5449    41
NZ_CP027599.1_87849	LIPO(Sec/SPII)	0.275034	0.006368	0.393947	0.324651	CS pos: ?. Probable protein fragment    22
NZ_CP027599.1_87854	SP(Sec/SPI)	0.413757	0.193244	0.070921	0.322078	CS pos: 23-24. QRA-GD. Pr: 0.1214    49
NZ_CP027599.1_87865	SP(Sec/SPI)	0.394341	0.050334	0.225514	0.329810	CS pos: 23-24. LSA-WR. Pr: 0.1477    50
NZ_CP027599.1_87867	LIPO(Sec/SPII)	0.402347	0.013863	0.540297	0.043493	CS pos: 16-17. TSG-QT. Pr: 0.3283    31
NZ_CP027599.1_87875	LIPO(Sec/SPII)	0.153581	0.009916	0.739726	0.096777	CS pos: 17-18. IAS-CC. Pr: 0.5562    31
NZ_CP027599.1_87886	TAT(Tat/SPI)	0.194340	0.361142	0.130795	0.313723	CS pos: ?. Probable protein fragment    16
NZ_CP027599.1_87909	LIPO(Sec/SPII)	0.311766	0.019169	0.415949	0.253117	CS pos: 12-13. VFA-LL. Pr: 0.0111    15
NZ_CP027599.1_87919	SP(Sec/SPI)	0.463659	0.156417	0.019079	0.360845	CS pos: 27-28. ARG-LT. Pr: 0.4677    47
NZ_CP027599.1_87940	SP(Sec/SPI)	0.669251	0.023471	0.165904	0.141374	CS pos: 16-17. SMA-AK. Pr: 0.3857    28
NZ_CP027599.1_87944	LIPO(Sec/SPII)	0.032132	0.003862	0.482330	0.481675	CS pos: 16-17. TLS-CV. Pr: 0.4777    41
NZ_CP027599.1_87957	LIPO(Sec/SPII)	0.120069	0.014407	0.606475	0.259049	CS pos: 15-16. PGG-CS. Pr: 0.5188    30
NZ_CP027599.1_87964	TAT(Tat/SPI)	0.024346	0.955071	0.012050	0.008533	CS pos: 30-31. SHA-NS. Pr: 0.8021    34
NZ_CP027599.1_87979	SP(Sec/SPI)	0.724377	0.105810	0.016280	0.153532	CS pos: 18-19. AHA-AS. Pr: 0.6603    35
NZ_CP027599.1_87980	SP(Sec/SPI)	0.688975	0.059232	0.224274	0.027519	CS pos: 25-26. AFS-ST. Pr: 0.5042    39
NZ_CP027599.1_87982	SP(Sec/SPI)	0.298459	0.222803	0.295455	0.183283	CS pos: 22-23. SIA-FS. Pr: 0.1057    31
NZ_CP027599.1_87993	LIPO(Sec/SPII)	0.077584	0.004425	0.906638	0.011353	CS pos: 15-16. SGA-CI. Pr: 0.5841    24
NZ_CP027599.1_87994	SP(Sec/SPI)	0.683573	0.071274	0.106179	0.138973	CS pos: 18-19. ALA-AP. Pr: 0.6100    34
NZ_CP027599.1_88021	LIPO(Sec/SPII)	0.061586	0.130779	0.785482	0.022154	CS pos: 20-21. MAG-CV. Pr: 0.7866    33
NZ_CP027599.1_88025	TAT(Tat/SPI)	0.284024	0.498556	0.081151	0.136269	CS pos: 19-20. AGA-DN. Pr: 0.4759    28
NZ_CP027599.1_88061	LIPO(Sec/SPII)	0.283447	0.058271	0.370972	0.287310	CS pos: ?. Probable protein fragment    16
NZ_CP027599.1_88086	TAT(Tat/SPI)	0.083984	0.583551	0.033408	0.299058	CS pos: 20-21. CRA-GG. Pr: 0.3368    40
NZ_CP027599.1_88090	TAT(Tat/SPI)	0.085459	0.531126	0.049235	0.334180	CS pos: 32-33. AAA-VV. Pr: 0.2896    40
NZ_CP027599.1_88092	LIPO(Sec/SPII)	0.171700	0.041782	0.766875	0.019643	CS pos: 17-18. CGA-CH. Pr: 0.4163    46
NZ_CP027599.1_88122	LIPO(Sec/SPII)	0.319788	0.216713	0.357478	0.106020	CS pos: 20-21. VSG-TG. Pr: 0.2408    27
NZ_CP027599.1_88144	LIPO(Sec/SPII)	0.013736	0.001380	0.978989	0.005895	CS pos: 17-18. INA-CS. Pr: 0.9818    48
NZ_CP027599.1_88148	LIPO(Sec/SPII)	0.025829	0.086217	0.791480	0.096474	CS pos: 27-28. SSS-CR. Pr: 0.7793    47
NZ_CP027599.1_88159	SP(Sec/SPI)	0.530139	0.122321	0.088868	0.258672	CS pos: 19-20. GVA-ST. Pr: 0.1691    29
NZ_CP027599.1_88164	LIPO(Sec/SPII)	0.087482	0.049460	0.738194	0.124864	CS pos: 15-16. YAG-CG. Pr: 0.7047    46
NZ_CP027599.1_88177	SP(Sec/SPI)	0.850108	0.091545	0.026100	0.032247	CS pos: 29-30. AGS-LE. Pr: 0.7501    36
NZ_CP027599.1_88241	SP(Sec/SPI)	0.654590	0.052958	0.065173	0.227279	CS pos: 31-32. ANA-YR. Pr: 0.4985    42
NZ_CP027599.1_88251	LIPO(Sec/SPII)	0.119940	0.037057	0.725139	0.117864	CS pos: 19-20. TSA-CA. Pr: 0.7059    27
NZ_CP027599.1_88261	TAT(Tat/SPI)	0.252127	0.423127	0.034943	0.289803	CS pos: 26-27. SSA-NV. Pr: 0.4631    42
NZ_CP027599.1_88275	LIPO(Sec/SPII)	0.200650	0.013316	0.461934	0.324100	CS pos: ?. Probable protein fragment    22
NZ_CP027599.1_88286	LIPO(Sec/SPII)	0.277780	0.012299	0.423813	0.286108	CS pos: 13-14. IAL-CR. Pr: 0.1359    15
NZ_CP027599.1_88287	LIPO(Sec/SPII)	0.273389	0.004732	0.585964	0.135915	CS pos: 15-16. AYC-CT. Pr: 0.2973    19
NZ_CP027599.1_88302	LIPO(Sec/SPII)	0.285131	0.012928	0.353939	0.348002	CS pos: 13-14. FGG-HD. Pr: 0.0610    17
NZ_CP027599.1_88310	SP(Sec/SPI)	0.476277	0.074088	0.055834	0.393801	CS pos: 31-32. SRA-AL. Pr: 0.2735    40
NZ_CP027599.1_88466	LIPO(Sec/SPII)	0.219286	0.040786	0.376426	0.363502	CS pos: 16-17. SVV-CR. Pr: 0.1170    18
NZ_CP027599.1_88548	SP(Sec/SPI)	0.420900	0.177946	0.083996	0.317158	CS pos: 17-18. VKA-AV. Pr: 0.2903    25
NZ_CP027599.1_88556	LIPO(Sec/SPII)	0.112645	0.005305	0.465189	0.416861	CS pos: 22-23. ATL-CC. Pr: 0.2095    30
NZ_CP027599.1_88589	SP(Sec/SPI)	0.735892	0.023000	0.016450	0.224657	CS pos: 22-23. LNA-DV. Pr: 0.5674    37
NZ_CP027599.1_88598	LIPO(Sec/SPII)	0.101804	0.005881	0.479176	0.413139	CS pos: 20-21. VTP-CC. Pr: 0.2930    33
NZ_CP027599.1_88614	LIPO(Sec/SPII)	0.238439	0.009804	0.388916	0.362841	CS pos: ?. Probable protein fragment    19
NZ_CP027599.1_88688	SP(Sec/SPI)	0.379483	0.008568	0.240253	0.371697	CS pos: 22-23. AYC-TL. Pr: 0.1847    33
NZ_CP027599.1_88706	LIPO(Sec/SPII)	0.125480	0.086545	0.597823	0.190151	CS pos: 26-27. FSA-CA. Pr: 0.5366    29
NZ_CP027599.1_88707	LIPO(Sec/SPII)	0.366103	0.008811	0.425472	0.199614	CS pos: 22-23. ALK-CV. Pr: 0.3783    35
NZ_CP027599.1_88734	LIPO(Sec/SPII)	0.197687	0.110044	0.388361	0.303909	CS pos: 19-20. WCS-CC. Pr: 0.1732    26
NZ_CP027599.1_88767	LIPO(Sec/SPII)	0.147505	0.037958	0.629658	0.184879	CS pos: 20-21. ASG-CT. Pr: 0.6156    36
NZ_CP027599.1_88769	LIPO(Sec/SPII)	0.248848	0.025113	0.448838	0.277202	CS pos: ?. Probable protein fragment    15
NZ_CP027599.1_88777	LIPO(Sec/SPII)	0.152544	0.095645	0.491317	0.260494	CS pos: 18-19. PAG-CR. Pr: 0.4657    38
NZ_CP027599.1_88779	LIPO(Sec/SPII)	0.274804	0.010075	0.384370	0.330751	CS pos: 15-16. CAH-CS. Pr: 0.0610    22
NZ_CP027599.1_88793	LIPO(Sec/SPII)	0.070638	0.204283	0.594441	0.130638	CS pos: 14-15. ISS-CV. Pr: 0.5987    45
NZ_CP027599.1_88810	TAT(Tat/SPI)	0.153115	0.452157	0.102982	0.291746	CS pos: 21-22. SAA-VR. Pr: 0.0977    26
NZ_CP027599.1_88828	TAT(Tat/SPI)	0.236872	0.524802	0.052112	0.186214	CS pos: 30-31. ASS-AS. Pr: 0.2002    39
NZ_CP027599.1_88854	LIPO(Sec/SPII)	0.171690	0.243030	0.303205	0.282075	CS pos: ?. Probable protein fragment    15
NZ_CP027599.1_88880	LIPO(Sec/SPII)	0.290567	0.014897	0.415544	0.278993	CS pos: ?. Probable protein fragment    15
NZ_CP027599.1_88884	SP(Sec/SPI)	0.461438	0.019469	0.271711	0.247382	CS pos: 20-21. GRC-AV. Pr: 0.1836    26
NZ_CP027599.1_88895	SP(Sec/SPI)	0.774488	0.002909	0.183995	0.038608	CS pos: 20-21. GFA-AN. Pr: 0.6512    27
NZ_CP027599.1_88896	SP(Sec/SPI)	0.567988	0.015317	0.359655	0.057041	CS pos: 19-20. GAA-FC. Pr: 0.3343    28
NZ_CP027599.1_88904	TAT(Tat/SPI)	0.227833	0.433764	0.064188	0.274216	CS pos: 26-27. GRA-AW. Pr: 0.2403    36
NZ_CP027599.1_88936	SP(Sec/SPI)	0.436895	0.182732	0.161825	0.218548	CS pos: 25-26. VPA-WN. Pr: 0.1990    46
NZ_CP027599.1_88951	SP(Sec/SPI)	0.751064	0.077806	0.046811	0.124318	CS pos: 21-22. SLA-EG. Pr: 0.5194    30
NZ_CP027599.1_88952	SP(Sec/SPI)	0.487030	0.048601	0.050376	0.413993	CS pos: 17-18. LKA-MM. Pr: 0.3116    33
NZ_CP027599.1_88957	LIPO(Sec/SPII)	0.169258	0.116093	0.416249	0.298399	CS pos: 18-19. AGG-CS. Pr: 0.3530    28
NZ_CP027599.1_88973	LIPO(Sec/SPII)	0.074291	0.019618	0.581593	0.324498	CS pos: 24-25. IAA-CG. Pr: 0.5832    49
NZ_CP027599.1_89105	LIPO(Sec/SPII)	0.063924	0.063329	0.823583	0.049164	CS pos: 25-26. IFS-CC. Pr: 0.5744    41
NZ_CP027599.1_89147	LIPO(Sec/SPII)	0.121124	0.023690	0.580700	0.274486	CS pos: 19-20. GAS-CG. Pr: 0.5655    40
NZ_CP027599.1_89193	SP(Sec/SPI)	0.366941	0.026797	0.317018	0.289243	CS pos: 25-26. AES-SV. Pr: 0.1554    28
NZ_CP027599.1_89209	LIPO(Sec/SPII)	0.001433	0.000147	0.995050	0.003370	CS pos: 18-19. LSA-CK. Pr: 0.9957    35
NZ_CP027599.1_89225	LIPO(Sec/SPII)	0.198472	0.041921	0.518964	0.240643	CS pos: 24-25. IAQ-CP. Pr: 0.3152    30
NZ_CP027599.1_89239	SP(Sec/SPI)	0.686916	0.033748	0.103089	0.176247	CS pos: 15-16. GHA-IS. Pr: 0.2515    30
NZ_CP027599.1_89259	SP(Sec/SPI)	0.599335	0.142404	0.031426	0.226835	CS pos: 22-23. AAA-KP. Pr: 0.3585    39
NZ_CP027599.1_89342	LIPO(Sec/SPII)	0.270218	0.148049	0.469094	0.112638	CS pos: 20-21. ITT-CV. Pr: 0.4404    31
NZ_CP027599.1_89381	LIPO(Sec/SPII)	0.280587	0.017858	0.383043	0.318512	CS pos: 13-14. VTP-VM. Pr: 0.0178    15
NZ_CP027599.1_89408	LIPO(Sec/SPII)	0.257794	0.015774	0.552455	0.173977	CS pos: 13-14. VIS-CS. Pr: 0.2348    15
NZ_CP027599.1_89419	LIPO(Sec/SPII)	0.297204	0.104690	0.394168	0.203939	CS pos: 27-28. ANA-CS. Pr: 0.5386    40
NZ_CP027599.1_89422	LIPO(Sec/SPII)	0.169869	0.031417	0.520712	0.278001	CS pos: 17-18. GRG-CR. Pr: 0.4335    23
NZ_CP027599.1_89444	LIPO(Sec/SPII)	0.082843	0.007375	0.639639	0.270144	CS pos: 18-19. TPA-CR. Pr: 0.6243    29
NZ_CP027599.1_89446	LIPO(Sec/SPII)	0.212247	0.003504	0.713072	0.071177	CS pos: 19-20. TAT-CY. Pr: 0.6126    26
NZ_CP027599.1_89457	SP(Sec/SPI)	0.493104	0.100476	0.162084	0.244335	CS pos: 30-31. VSA-SR. Pr: 0.3046    38
NZ_CP027599.1_89463	LIPO(Sec/SPII)	0.101822	0.143063	0.713817	0.041298	CS pos: 20-21. VYS-CG. Pr: 0.6251    34
NZ_CP027599.1_89477	LIPO(Sec/SPII)	0.347684	0.032217	0.359180	0.260919	CS pos: 14-15. SAG-VE. Pr: 0.0826    16
NZ_CP027599.1_89507	LIPO(Sec/SPII)	0.239859	0.029804	0.408564	0.321773	CS pos: ?. Probable protein fragment    16
NZ_CP027599.1_89553	SP(Sec/SPI)	0.546853	0.057349	0.164685	0.231113	CS pos: 17-18. VAG-NN. Pr: 0.2427    42
NZ_CP027599.1_89570	LIPO(Sec/SPII)	0.180873	0.034679	0.492756	0.291692	CS pos: 13-14. SSS-CM. Pr: 0.3664    16
NZ_CP027599.1_89580	LIPO(Sec/SPII)	0.177960	0.013706	0.461137	0.347197	CS pos: 22-23. ILA-CC. Pr: 0.2986    27
NZ_CP027599.1_89589	SP(Sec/SPI)	0.667814	0.053866	0.028706	0.249614	CS pos: 20-21. AFG-KI. Pr: 0.5133    40
NZ_CP027599.1_89652	LIPO(Sec/SPII)	0.057549	0.026568	0.899226	0.016657	CS pos: 22-23. SFS-CS. Pr: 0.8129    36
NZ_CP027599.1_89673	SP(Sec/SPI)	0.608357	0.191916	0.131649	0.068078	CS pos: 21-22. ALS-TP. Pr: 0.4343    29
NZ_CP027599.1_89676	LIPO(Sec/SPII)	0.231185	0.024584	0.402130	0.342101	CS pos: 15-16. SCV-CF. Pr: 0.0305    17
NZ_CP027599.1_89687	SP(Sec/SPI)	0.462235	0.087346	0.009788	0.440631	CS pos: 19-20. ARA-EA. Pr: 0.2330    48
NZ_CP027599.1_89708	SP(Sec/SPI)	0.783147	0.067957	0.093112	0.055784	CS pos: 19-20. VLA-GQ. Pr: 0.4466    50
NZ_CP027599.1_89714	LIPO(Sec/SPII)	0.111760	0.031990	0.662511	0.193739	CS pos: 30-31. VTC-CV. Pr: 0.4199    46
NZ_CP027599.1_89753	SP(Sec/SPI)	0.530375	0.409474	0.011171	0.048980	CS pos: 23-24. ARA-SA. Pr: 0.6573    45
NZ_CP027599.1_89755	LIPO(Sec/SPII)	0.252166	0.043214	0.375643	0.328977	CS pos: 14-15. ATA-CA. Pr: 0.1449    19
NZ_CP027599.1_89756	LIPO(Sec/SPII)	0.128815	0.007768	0.488939	0.374478	CS pos: 22-23. STG-CC. Pr: 0.3467    28
NZ_CP027599.1_89766	SP(Sec/SPI)	0.730859	0.069924	0.099235	0.099982	CS pos: 25-26. SSA-LD. Pr: 0.4851    46
NZ_CP027599.1_89775	LIPO(Sec/SPII)	0.383352	0.009410	0.423574	0.183664	CS pos: 19-20. RAV-CL. Pr: 0.1953    31
NZ_CP027599.1_89797	TAT(Tat/SPI)	0.064135	0.531955	0.030405	0.373505	CS pos: 28-29. RRA-VL. Pr: 0.1842    37
NZ_CP027599.1_89805	TAT(Tat/SPI)	0.107508	0.421994	0.105254	0.365244	CS pos: 21-22. VAG-SP. Pr: 0.1171    50
NZ_CP027599.1_89823	LIPO(Sec/SPII)	0.221197	0.008291	0.608830	0.161682	CS pos: 19-20. LPA-CC. Pr: 0.3624    25
NZ_CP027599.1_89830	LIPO(Sec/SPII)	0.107139	0.033573	0.528404	0.330883	CS pos: 21-22. FVC-CR. Pr: 0.2805    31
NZ_CP027599.1_89842	LIPO(Sec/SPII)	0.077848	0.106381	0.656034	0.159738	CS pos: 17-18. YSA-CN. Pr: 0.6242    24
NZ_CP027599.1_89849	LIPO(Sec/SPII)	0.221062	0.011683	0.450958	0.316297	CS pos: ?. Probable protein fragment    18
NZ_CP027599.1_89851	LIPO(Sec/SPII)	0.235218	0.007168	0.594574	0.163041	CS pos: 14-15. WTA-CL. Pr: 0.3764    16
NZ_CP027599.1_89855	LIPO(Sec/SPII)	0.265552	0.021240	0.416282	0.296927	CS pos: 14-15. VCG-WH. Pr: 0.0183    16
NZ_CP027599.1_89856	SP(Sec/SPI)	0.336720	0.087303	0.250542	0.325435	CS pos: 19-20. VTG-AT. Pr: 0.2151    30
NZ_CP027599.1_89886	LIPO(Sec/SPII)	0.163335	0.015975	0.504141	0.316550	CS pos: 13-14. LYQ-CY. Pr: 0.2690    15
NZ_CP027599.1_89892	SP(Sec/SPI)	0.500935	0.049438	0.304748	0.144880	CS pos: ?. Probable protein fragment    22
NZ_CP027599.1_89900	SP(Sec/SPI)	0.534053	0.386559	0.027897	0.051492	CS pos: 26-27. AKA-SV. Pr: 0.7969    42
NZ_CP027599.1_89928	SP(Sec/SPI)	0.808946	0.054669	0.092400	0.043985	CS pos: 23-24. AAS-VP. Pr: 0.5000    34
NZ_CP027599.1_89931	SP(Sec/SPI)	0.615841	0.022796	0.168582	0.192781	CS pos: 27-28. AGS-AG. Pr: 0.1485    34
NZ_CP027599.1_89941	LIPO(Sec/SPII)	0.045530	0.025660	0.660431	0.268379	CS pos: 24-25. WQS-CQ. Pr: 0.6516    50
NZ_CP027599.1_89953	SP(Sec/SPI)	0.451832	0.040186	0.293971	0.214012	CS pos: 18-19. TAA-SG. Pr: 0.1497    22
NZ_CP027599.1_89992	SP(Sec/SPI)	0.454033	0.004306	0.172668	0.368993	CS pos: 17-18. ATT-QR. Pr: 0.1439    30
NZ_CP027599.1_89998	LIPO(Sec/SPII)	0.062764	0.004800	0.865492	0.066945	CS pos: 17-18. SAA-CS. Pr: 0.8417    23
NZ_CP027599.1_90000	LIPO(Sec/SPII)	0.116978	0.042636	0.541211	0.299175	CS pos: 21-22. AVA-CV. Pr: 0.5397    26
NZ_CP027599.1_90006	LIPO(Sec/SPII)	0.051332	0.002296	0.543487	0.402885	CS pos: 22-23. SLS-CF. Pr: 0.5408    37
NZ_CP027599.1_90029	LIPO(Sec/SPII)	0.056536	0.011729	0.808221	0.123514	CS pos: 29-30. TSG-CV. Pr: 0.7763    32
NZ_CP027599.1_90033	LIPO(Sec/SPII)	0.053505	0.049617	0.506589	0.390289	CS pos: 17-18. SLS-CC. Pr: 0.4102    49
NZ_CP027599.1_90034	LIPO(Sec/SPII)	0.200405	0.030462	0.468027	0.301107	CS pos: 16-17. CIC-CC. Pr: 0.2069    24
NZ_CP027599.1_90037	LIPO(Sec/SPII)	0.175039	0.114551	0.449309	0.261101	CS pos: 18-19. NIA-CI. Pr: 0.3402    23
NZ_CP027599.1_90042	TAT(Tat/SPI)	0.081204	0.603395	0.274265	0.041135	CS pos: 29-30. AGS-EF. Pr: 0.1339    37
NZ_CP027599.1_90052	LIPO(Sec/SPII)	0.088481	0.016570	0.747782	0.147167	CS pos: 22-23. LSK-CS. Pr: 0.7221    26
NZ_CP027599.1_90078	SP(Sec/SPI)	0.418087	0.089866	0.112069	0.379977	CS pos: 30-31. ANQ-QA. Pr: 0.0787    46
NZ_CP027599.1_90094	LIPO(Sec/SPII)	0.222137	0.019461	0.416054	0.342348	CS pos: ?. Probable protein fragment    15
NZ_CP027599.1_90140	LIPO(Sec/SPII)	0.136721	0.014742	0.466212	0.382326	CS pos: 15-16. LSG-CR. Pr: 0.3963    27
NZ_CP027599.1_90167	LIPO(Sec/SPII)	0.257653	0.019912	0.400639	0.321795	CS pos: ?. Probable protein fragment    19
NZ_CP027599.1_90175	LIPO(Sec/SPII)	0.162578	0.005462	0.498853	0.333106	CS pos: 23-24. SSV-CD. Pr: 0.3957    28
NZ_CP027599.1_90184	LIPO(Sec/SPII)	0.344652	0.006801	0.437852	0.210696	CS pos: ?. Probable protein fragment    15
NZ_CP027599.1_90242	LIPO(Sec/SPII)	0.050116	0.005722	0.935728	0.008434	CS pos: 17-18. IFG-CA. Pr: 0.9274    31
NZ_CP027599.1_90276	SP(Sec/SPI)	0.395846	0.202321	0.139229	0.262605	CS pos: 18-19. AAA-RK. Pr: 0.2841    24
NZ_CP027599.1_90282	LIPO(Sec/SPII)	0.178864	0.017048	0.421927	0.382161	CS pos: 20-21. LTP-CR. Pr: 0.2874    26
NZ_CP027599.1_90297	LIPO(Sec/SPII)	0.151811	0.024516	0.674006	0.149667	CS pos: 12-13. ASA-CW. Pr: 0.6898    28
NZ_CP027599.1_90298	SP(Sec/SPI)	0.497488	0.047313	0.059296	0.395903	CS pos: 18-19. ASA-VP. Pr: 0.4357    28
NZ_CP027599.1_90304	LIPO(Sec/SPII)	0.224658	0.018986	0.414357	0.341999	CS pos: 20-21. PST-CF. Pr: 0.1082    22
NZ_CP027599.1_90316	SP(Sec/SPI)	0.628748	0.017102	0.085102	0.269048	CS pos: 24-25. VGA-GH. Pr: 0.3360    32
NZ_CP027599.1_90317	TAT(Tat/SPI)	0.321836	0.351195	0.053166	0.273803	CS pos: 18-19. AGA-AG. Pr: 0.2891    45
NZ_CP027599.1_90345	SP(Sec/SPI)	0.443938	0.009740	0.324854	0.221467	CS pos: 28-29. ATA-AT. Pr: 0.1775    46
NZ_CP027599.1_90365	LIPO(Sec/SPII)	0.248489	0.031842	0.632994	0.086675	CS pos: 17-18. LPA-CA. Pr: 0.5342    29
NZ_CP027599.1_90367	LIPO(Sec/SPII)	0.051968	0.047263	0.611619	0.289149	CS pos: 22-23. NTG-CQ. Pr: 0.6060    41
NZ_CP027599.1_90374	SP(Sec/SPI)	0.491936	0.098363	0.048681	0.361020	CS pos: 10-11. ASA-AQ. Pr: 0.4004    20
NZ_CP027599.1_90408	LIPO(Sec/SPII)	0.081018	0.016542	0.516602	0.385837	CS pos: 18-19. QSS-CC. Pr: 0.3886    44
NZ_CP027599.1_90425	LIPO(Sec/SPII)	0.202498	0.037009	0.446244	0.314249	CS pos: 12-13. SSA-CA. Pr: 0.4092    22
NZ_CP027599.1_90430	LIPO(Sec/SPII)	0.197132	0.050304	0.432681	0.319883	CS pos: 17-18. NAA-CR. Pr: 0.3982    25
NZ_CP027599.1_90432	SP(Sec/SPI)	0.385420	0.077808	0.329583	0.207189	CS pos: 32-33. VRA-SL. Pr: 0.1809    40
NZ_CP027599.1_90433	SP(Sec/SPI)	0.554789	0.066145	0.187822	0.191244	CS pos: 22-23. VFA-AV. Pr: 0.5606    44
NZ_CP027599.1_90441	SP(Sec/SPI)	0.526411	0.071487	0.285755	0.116347	CS pos: 15-16. ALA-AY. Pr: 0.1990    45
NZ_CP027599.1_90475	LIPO(Sec/SPII)	0.024545	0.002128	0.742928	0.230399	CS pos: 17-18. LIG-CI. Pr: 0.7177    21
NZ_CP027599.1_90480	LIPO(Sec/SPII)	0.193231	0.143384	0.367290	0.296095	CS pos: ?. Probable protein fragment    15
NZ_CP027599.1_90482	LIPO(Sec/SPII)	0.240398	0.046516	0.624073	0.089013	CS pos: 23-24. AIT-CF. Pr: 0.5805    32
NZ_CP027599.1_90490	SP(Sec/SPI)	0.490336	0.016345	0.216069	0.277250	CS pos: 18-19. FRA-GI. Pr: 0.1678    20
NZ_CP027599.1_90493	SP(Sec/SPI)	0.678121	0.266773	0.044100	0.011006	CS pos: 25-26. AGA-IT. Pr: 0.8329    45
NZ_CP027599.1_90498	LIPO(Sec/SPII)	0.343251	0.039040	0.402329	0.215380	CS pos: 16-17. LIS-NL. Pr: 0.0641    18
NZ_CP027599.1_90502	SP(Sec/SPI)	0.517225	0.035515	0.031909	0.415351	CS pos: 23-24. VNA-IT. Pr: 0.4349    37
NZ_CP027599.1_90526	LIPO(Sec/SPII)	0.174658	0.039131	0.407795	0.378416	CS pos: 14-15. GVT-CN. Pr: 0.3574    50
NZ_CP027599.1_90532	SP(Sec/SPI)	0.382934	0.369301	0.029582	0.218183	CS pos: 29-30. AHA-SN. Pr: 0.5701    47
NZ_CP027599.1_90543	TAT(Tat/SPI)	0.214683	0.394814	0.037915	0.352588	CS pos: 28-29. AAA-PI. Pr: 0.0704    44
NZ_CP027599.1_90552	LIPO(Sec/SPII)	0.004914	0.002125	0.990324	0.002637	CS pos: 15-16. LTA-CG. Pr: 0.9917    38
NZ_CP027599.1_90554	SP(Sec/SPI)	0.533226	0.102047	0.016227	0.348500	CS pos: 20-21. VRA-EP. Pr: 0.4369    46
NZ_CP027599.1_90579	LIPO(Sec/SPII)	0.052872	0.016651	0.756966	0.173510	CS pos: 20-21. SSA-CM. Pr: 0.7737    46
NZ_CP027599.1_90587	LIPO(Sec/SPII)	0.303875	0.022218	0.355334	0.318573	CS pos: 13-14. LQT-FE. Pr: 0.0516    15
NZ_CP027599.1_90595	TAT(Tat/SPI)	0.149549	0.446928	0.089725	0.313798	CS pos: 23-24. SFA-SV. Pr: 0.1107    27
NZ_CP027599.1_90602	SP(Sec/SPI)	0.529743	0.066761	0.313147	0.090349	CS pos: 23-24. SLS-AS. Pr: 0.2413    43
NZ_CP027599.1_90632	LIPO(Sec/SPII)	0.215434	0.060870	0.379566	0.344129	CS pos: ?. Probable protein fragment    19
NZ_CP027599.1_90635	LIPO(Sec/SPII)	0.240453	0.047970	0.370381	0.341196	CS pos: ?. Probable protein fragment    15
NZ_CP027599.1_90660	LIPO(Sec/SPII)	0.082059	0.003980	0.496922	0.417038	CS pos: 14-15. ANS-CS. Pr: 0.4825    48
NZ_CP027599.1_90666	LIPO(Sec/SPII)	0.313340	0.019239	0.366036	0.301384	CS pos: ?. Probable protein fragment    15
NZ_CP027599.1_90671	LIPO(Sec/SPII)	0.224988	0.022378	0.379736	0.372898	CS pos: ?. Probable protein fragment    17
NZ_CP027599.1_90680	LIPO(Sec/SPII)	0.073911	0.054340	0.472283	0.399466	CS pos: 15-16. GFS-CA. Pr: 0.4121    23
NZ_CP027599.1_90684	LIPO(Sec/SPII)	0.319651	0.053681	0.327656	0.299013	CS pos: 17-18. TAR-CG. Pr: 0.2159    29
NZ_CP027599.1_90688	LIPO(Sec/SPII)	0.201605	0.016186	0.736550	0.045659	CS pos: 25-26. LAS-CS. Pr: 0.6745    43
NZ_CP027599.1_90698	LIPO(Sec/SPII)	0.321287	0.027386	0.357945	0.293381	CS pos: ?. Probable protein fragment    19
NZ_CP027599.1_90699	LIPO(Sec/SPII)	0.222476	0.110555	0.367191	0.299778	CS pos: 16-17. FSG-SG. Pr: 0.0948    21
NZ_CP027599.1_90703	LIPO(Sec/SPII)	0.196514	0.030908	0.407846	0.364732	CS pos: ?. Probable protein fragment    16
NZ_CP027599.1_90704	LIPO(Sec/SPII)	0.262464	0.037643	0.367801	0.332092	CS pos: 21-22. LLS-RS. Pr: 0.2214    45
NZ_CP027599.1_90725	LIPO(Sec/SPII)	0.115018	0.018845	0.460880	0.405257	CS pos: ?. Probable protein fragment    19
NZ_CP027599.1_90735	SP(Sec/SPI)	0.391165	0.091118	0.327720	0.189997	CS pos: 25-26. SSA-VP. Pr: 0.2567    48
NZ_CP027599.1_90742	LIPO(Sec/SPII)	0.233731	0.245140	0.266894	0.254235	CS pos: 15-16. VAG-RA. Pr: 0.0863    19
NZ_CP027599.1_90775	SP(Sec/SPI)	0.821740	0.069508	0.023587	0.085165	CS pos: 18-19. AHA-AY. Pr: 0.8346    38
NZ_CP027599.1_90821	LIPO(Sec/SPII)	0.102501	0.047973	0.624589	0.224938	CS pos: 17-18. RAS-CC. Pr: 0.4880    34
NZ_CP027599.1_90833	LIPO(Sec/SPII)	0.094215	0.009680	0.572044	0.324061	CS pos: 11-12. SVS-CS. Pr: 0.5644    27
NZ_CP027599.1_90851	LIPO(Sec/SPII)	0.188338	0.006020	0.564180	0.241462	CS pos: 23-24. VSG-CI. Pr: 0.5294    28
NZ_CP027599.1_90863	LIPO(Sec/SPII)	0.269887	0.055587	0.357138	0.317388	CS pos: ?. Probable protein fragment    15
NZ_CP027599.1_90865	LIPO(Sec/SPII)	0.041688	0.008720	0.484594	0.464998	CS pos: 24-25. FSG-CK. Pr: 0.4707    39
NZ_CP027599.1_90879	SP(Sec/SPI)	0.424213	0.085831	0.081968	0.407988	CS pos: 40-41. VQA-QN. Pr: 0.4119    45
NZ_CP027599.1_90923	LIPO(Sec/SPII)	0.270114	0.026948	0.366637	0.336301	CS pos: ?. Probable protein fragment    15
NZ_CP027599.1_90927	SP(Sec/SPI)	0.434831	0.064517	0.085148	0.415503	CS pos: 27-28. SWA-EM. Pr: 0.2791    31
NZ_CP027599.1_90931	SP(Sec/SPI)	0.547128	0.065140	0.226365	0.161368	CS pos: ?. Probable protein fragment    23
NZ_CP027599.1_90940	LIPO(Sec/SPII)	0.207299	0.068806	0.443852	0.280043	CS pos: 31-32. SSS-CS. Pr: 0.3764    40
NZ_CP027599.1_90983	SP(Sec/SPI)	0.773206	0.096485	0.030292	0.100017	CS pos: 25-26. VEA-VP. Pr: 0.7878    29
NZ_CP027599.1_90985	LIPO(Sec/SPII)	0.102832	0.294574	0.425536	0.177058	CS pos: 27-28. LII-CS. Pr: 0.3631    42
NZ_CP027599.1_90989	LIPO(Sec/SPII)	0.236811	0.056200	0.375101	0.331888	CS pos: 16-17. TSQ-CS. Pr: 0.3043    20
NZ_CP027599.1_91003	SP(Sec/SPI)	0.525453	0.152776	0.024979	0.296793	CS pos: 20-21. STA-TT. Pr: 0.4051    41
NZ_CP027599.1_91011	LIPO(Sec/SPII)	0.225510	0.038495	0.414770	0.321224	CS pos: 29-30. PLS-CG. Pr: 0.3521    36
NZ_CP027599.1_91030	LIPO(Sec/SPII)	0.166561	0.026561	0.496555	0.310322	CS pos: 13-14. FRS-CS. Pr: 0.2205    15
NZ_CP027599.1_91038	LIPO(Sec/SPII)	0.213161	0.039794	0.389773	0.357273	CS pos: 13-14. ALT-CS. Pr: 0.2896    20
NZ_CP027599.1_91062	TAT(Tat/SPI)	0.048985	0.800269	0.066035	0.084711	CS pos: 27-28. VSC-SD. Pr: 0.6301    41
NZ_CP027599.1_91066	SP(Sec/SPI)	0.515140	0.087724	0.035005	0.362130	CS pos: 20-21. AKA-NT. Pr: 0.4883    35
NZ_CP027599.1_91071	TAT(Tat/SPI)	0.250745	0.419218	0.037729	0.292308	CS pos: 30-31. ISA-SP. Pr: 0.2948    40
NZ_CP027599.1_91103	LIPO(Sec/SPII)	0.133766	0.046281	0.441008	0.378945	CS pos: 25-26. MVA-CW. Pr: 0.3977    38
NZ_CP027599.1_91106	SP(Sec/SPI)	0.445792	0.086489	0.085279	0.382440	CS pos: 16-17. SYG-QS. Pr: 0.1634    48
NZ_CP027599.1_91107	LIPO(Sec/SPII)	0.323503	0.029718	0.389638	0.257141	CS pos: 16-17. ASL-CG. Pr: 0.0719    20
NZ_CP027599.1_91109	LIPO(Sec/SPII)	0.272022	0.024122	0.369755	0.334101	CS pos: ?. Probable protein fragment    15
NZ_CP027599.1_91147	SP(Sec/SPI)	0.332582	0.198903	0.305765	0.162751	CS pos: 25-26. ANC-FS. Pr: 0.1763    31
NZ_CP027599.1_91164	LIPO(Sec/SPII)	0.175550	0.012197	0.443840	0.368412	CS pos: 14-15. LLR-CT. Pr: 0.2499    17
NZ_CP027599.1_91192	SP(Sec/SPI)	0.520577	0.045048	0.085519	0.348857	CS pos: 23-24. VIG-SS. Pr: 0.2529    41
NZ_CP027599.1_91205	LIPO(Sec/SPII)	0.073992	0.020560	0.674217	0.231231	CS pos: 22-23. VAS-CR. Pr: 0.5770    28
NZ_CP027599.1_91210	LIPO(Sec/SPII)	0.279073	0.035736	0.360056	0.325135	CS pos: ?. Probable protein fragment    19
NZ_CP027599.1_91293	LIPO(Sec/SPII)	0.127531	0.001983	0.771576	0.098909	CS pos: 18-19. LAG-TH. Pr: 0.6926    48
NZ_CP027599.1_91343	LIPO(Sec/SPII)	0.157553	0.000209	0.802865	0.039373	CS pos: 19-20. GKA-CY. Pr: 0.8347    39
NZ_CP027599.1_91364	LIPO(Sec/SPII)	0.212663	0.021127	0.415000	0.351211	CS pos: ?. Probable protein fragment    19
NZ_CP027599.1_91369	LIPO(Sec/SPII)	0.190333	0.009128	0.451970	0.348570	CS pos: 17-18. GVN-CR. Pr: 0.3708    33
NZ_CP027599.1_91385	LIPO(Sec/SPII)	0.014823	0.002331	0.727232	0.255615	CS pos: 18-19. YFS-CS. Pr: 0.7241    41
NZ_CP027599.1_91427	LIPO(Sec/SPII)	0.047489	0.001688	0.501357	0.449466	CS pos: 24-25. LLT-CL. Pr: 0.4462    33
NZ_CP027599.1_91466	LIPO(Sec/SPII)	0.051256	0.002711	0.891147	0.054886	CS pos: 17-18. LYG-CN. Pr: 0.9078    36
NZ_CP027599.1_91493	LIPO(Sec/SPII)	0.188856	0.005741	0.658939	0.146464	CS pos: 18-19. FPA-CI. Pr: 0.4884    24
NZ_CP027599.1_91506	LIPO(Sec/SPII)	0.056481	0.003512	0.781484	0.158523	CS pos: 19-20. IRA-CG. Pr: 0.7148    39
NZ_CP027599.1_91525	LIPO(Sec/SPII)	0.264547	0.005650	0.443844	0.285959	CS pos: ?. Probable protein fragment    19
NZ_CP027599.1_91533	LIPO(Sec/SPII)	0.268110	0.015890	0.393900	0.322101	CS pos: ?. Probable protein fragment    18
NZ_CP027599.1_91544	LIPO(Sec/SPII)	0.234806	0.015357	0.454739	0.295098	CS pos: 13-14. IIH-CF. Pr: 0.1687    15
NZ_CP027599.1_91596	LIPO(Sec/SPII)	0.050047	0.004434	0.483274	0.462244	CS pos: 16-17. FIG-KT. Pr: 0.4377    29
NZ_CP027599.1_91609	LIPO(Sec/SPII)	0.329259	0.018009	0.386855	0.265877	CS pos: ?. Probable protein fragment    15
NZ_CP027599.1_91624	LIPO(Sec/SPII)	0.291377	0.033929	0.375218	0.299477	CS pos: ?. Probable protein fragment    15
NZ_CP027599.1_91631	LIPO(Sec/SPII)	0.069830	0.030802	0.805162	0.094207	CS pos: 17-18. PIS-CS. Pr: 0.7877    28
NZ_CP027599.1_91633	LIPO(Sec/SPII)	0.073195	0.004984	0.521125	0.400697	CS pos: 19-20. FTQ-CS. Pr: 0.5061    41
NZ_CP027599.1_91653	LIPO(Sec/SPII)	0.201944	0.013338	0.587700	0.197017	CS pos: 18-19. NMG-CC. Pr: 0.4099    21
NZ_CP027599.1_91657	LIPO(Sec/SPII)	0.155156	0.010571	0.528236	0.306037	CS pos: ?. Probable protein fragment    20
NZ_CP027599.1_91659	SP(Sec/SPI)	0.362185	0.027168	0.308676	0.301971	CS pos: ?. Probable protein fragment    20
NZ_CP027599.1_91677	SP(Sec/SPI)	0.595882	0.040802	0.128718	0.234598	CS pos: 22-23. AFG-ES. Pr: 0.3502    26
NZ_CP027599.1_91735	LIPO(Sec/SPII)	0.230652	0.042971	0.392270	0.334108	CS pos: ?. Probable protein fragment    16
NZ_CP027599.1_91757	LIPO(Sec/SPII)	0.236420	0.032833	0.421715	0.309032	CS pos: ?. Probable protein fragment    15
NZ_CP027599.1_91764	LIPO(Sec/SPII)	0.025662	0.000790	0.966844	0.006705	CS pos: 19-20. PSG-CS. Pr: 0.9647    25
NZ_CP027599.1_91789	SP(Sec/SPI)	0.633403	0.010882	0.069987	0.285728	CS pos: 23-24. VWS-IV. Pr: 0.3604    45
NZ_CP027599.1_91798	LIPO(Sec/SPII)	0.349771	0.011018	0.439115	0.200096	CS pos: 15-16. VVN-CA. Pr: 0.2336    28
NZ_CP027599.1_91856	LIPO(Sec/SPII)	0.108320	0.004367	0.781261	0.106052	CS pos: 10-11. LSA-CS. Pr: 0.7382    20
NZ_CP027599.1_91866	LIPO(Sec/SPII)	0.139840	0.010829	0.498280	0.351051	CS pos: 18-19. LMK-CT. Pr: 0.4493    23
NZ_CP027599.1_91883	LIPO(Sec/SPII)	0.029996	0.003245	0.681347	0.285412	CS pos: 17-18. SSS-CG. Pr: 0.6839    41
NZ_CP027599.1_91889	LIPO(Sec/SPII)	0.273752	0.028574	0.384453	0.313221	CS pos: 13-14. TLS-IL. Pr: 0.0257    15
NZ_CP027599.1_91923	LIPO(Sec/SPII)	0.230894	0.015335	0.443589	0.310182	CS pos: 14-15. LPL-CD. Pr: 0.3982    32
NZ_CP027599.1_91944	LIPO(Sec/SPII)	0.145159	0.003821	0.764607	0.086413	CS pos: ?. Probable protein fragment    18
NZ_CP027599.1_91976	LIPO(Sec/SPII)	0.251943	0.013071	0.420765	0.314222	CS pos: 17-18. LRS-CQ. Pr: 0.2924    27
NZ_CP027599.1_91991	LIPO(Sec/SPII)	0.139572	0.004776	0.690831	0.164822	CS pos: 16-17. PQA-CS. Pr: 0.5268    18
NZ_CP027599.1_92006	LIPO(Sec/SPII)	0.013307	0.001940	0.692216	0.292537	CS pos: 27-28. IFS-CL. Pr: 0.6879    38
NZ_CP027599.1_92018	LIPO(Sec/SPII)	0.029811	0.001910	0.544503	0.423777	CS pos: 27-28. KYG-CS. Pr: 0.5425    49
NZ_CP027599.1_92037	LIPO(Sec/SPII)	0.125471	0.010175	0.627529	0.236825	CS pos: 15-16. YLT-CT. Pr: 0.4998    20
NZ_CP027599.1_92047	LIPO(Sec/SPII)	0.253849	0.020366	0.457112	0.268674	CS pos: ?. Probable protein fragment    15
NZ_CP027599.1_92059	SP(Sec/SPI)	0.472161	0.030153	0.426960	0.070726	CS pos: 20-21. AIA-CP. Pr: 0.8294    24
NZ_CP027599.1_92077	LIPO(Sec/SPII)	0.273604	0.018402	0.363609	0.344385	CS pos: ?. Probable protein fragment    17
NZ_CP027599.1_92101	SP(Sec/SPI)	0.550003	0.100616	0.096555	0.252826	CS pos: 27-28. ASA-LD. Pr: 0.2882    35
NZ_CP027599.1_92114	LIPO(Sec/SPII)	0.162700	0.043197	0.487492	0.306610	CS pos: ?. Probable protein fragment    21
NZ_CP027599.1_92139	LIPO(Sec/SPII)	0.220604	0.030932	0.488514	0.259949	CS pos: 28-29. RGS-CA. Pr: 0.4516    42
NZ_CP027599.1_92198	LIPO(Sec/SPII)	0.199914	0.027743	0.480710	0.291633	CS pos: 13-14. SYS-CS. Pr: 0.3564    20
NZ_CP027599.1_92200	SP(Sec/SPI)	0.597665	0.026285	0.056492	0.319558	CS pos: 21-22. GSA-GD. Pr: 0.4021    38
NZ_CP027599.1_92227	LIPO(Sec/SPII)	0.065378	0.013039	0.590643	0.330939	CS pos: 15-16. LSA-CS. Pr: 0.5880    27
NZ_CP027599.1_92228	LIPO(Sec/SPII)	0.105213	0.014970	0.694228	0.185589	CS pos: ?. Probable protein fragment    20
NZ_CP027599.1_92288	LIPO(Sec/SPII)	0.229544	0.022150	0.408867	0.339440	CS pos: ?. Probable protein fragment    22
NZ_CP027599.1_92301	SP(Sec/SPI)	0.504868	0.103277	0.188079	0.203776	CS pos: 18-19. ATA-TT. Pr: 0.3082    31
NZ_CP027599.1_92347	LIPO(Sec/SPII)	0.045112	0.017601	0.673410	0.263876	CS pos: 25-26. CCS-CR. Pr: 0.2623    49
NZ_CP027599.1_92348	LIPO(Sec/SPII)	0.291931	0.001825	0.662549	0.043696	CS pos: 12-13. LAG-CG. Pr: 0.6535    43
NZ_CP027599.1_92357	LIPO(Sec/SPII)	0.300397	0.107895	0.522492	0.069217	CS pos: 12-13. ASS-CV. Pr: 0.3644    20
NZ_CP027599.1_92364	LIPO(Sec/SPII)	0.276431	0.020319	0.450959	0.252291	CS pos: ?. Probable protein fragment    16
NZ_CP027599.1_92368	LIPO(Sec/SPII)	0.069287	0.006901	0.730491	0.193321	CS pos: 21-22. LNG-CW. Pr: 0.7173    29
NZ_CP027599.1_92371	LIPO(Sec/SPII)	0.206103	0.033386	0.397405	0.363107	CS pos: ?. Probable protein fragment    17
NZ_CP027599.1_92378	LIPO(Sec/SPII)	0.224982	0.067500	0.359876	0.347642	CS pos: ?. Probable protein fragment    16
NZ_CP027599.1_92407	LIPO(Sec/SPII)	0.093232	0.035349	0.669582	0.201837	CS pos: 17-18. SVG-CE. Pr: 0.6261    20
NZ_CP027599.1_92440	TAT(Tat/SPI)	0.388209	0.389410	0.036172	0.186210	CS pos: 21-22. AFA-SS. Pr: 0.5915    37
NZ_CP027599.1_92473	LIPO(Sec/SPII)	0.163979	0.007060	0.621366	0.207595	CS pos: 17-18. AQC-CA. Pr: 0.4110    30
NZ_CP027599.1_92474	LIPO(Sec/SPII)	0.034549	0.012022	0.563095	0.390333	CS pos: 23-24. YAA-CS. Pr: 0.5574    41
NZ_CP027599.1_92485	SP(Sec/SPI)	0.432965	0.027836	0.172519	0.366680	CS pos: 15-16. AYA-GG. Pr: 0.1736    36
NZ_CP027599.1_92493	LIPO(Sec/SPII)	0.033852	0.002555	0.876686	0.086907	CS pos: 21-22. SSS-CW. Pr: 0.8642    37
NZ_CP027599.1_92522	TAT(Tat/SPI)	0.110111	0.481437	0.080360	0.328092	CS pos: ?. Probable protein fragment    32
NZ_CP027599.1_92523	LIPO(Sec/SPII)	0.197206	0.030556	0.662333	0.109904	CS pos: 14-15. SSS-CP. Pr: 0.6117    41
NZ_CP027599.1_92527	TAT(Tat/SPI)	0.126912	0.443901	0.038325	0.390862	CS pos: 36-37. ARS-AS. Pr: 0.1312    39
NZ_CP027599.1_92530	SP(Sec/SPI)	0.416020	0.017079	0.377831	0.189070	CS pos: 19-20. ASS-ER. Pr: 0.1240    26
NZ_CP027599.1_92548	LIPO(Sec/SPII)	0.204348	0.023915	0.395886	0.375851	CS pos: 14-15. PLS-CR. Pr: 0.1061    20
NZ_CP027599.1_92572	LIPO(Sec/SPII)	0.103217	0.321746	0.373739	0.201297	CS pos: 22-23. VVS-CL. Pr: 0.2806    43
NZ_CP027599.1_92573	LIPO(Sec/SPII)	0.195101	0.027829	0.536789	0.240281	CS pos: 15-16. LSR-CQ. Pr: 0.5225    44
NZ_CP027599.1_92590	LIPO(Sec/SPII)	0.023955	0.001417	0.867471	0.107157	CS pos: 19-20. TNS-CK. Pr: 0.8668    47
NZ_CP027599.1_92606	LIPO(Sec/SPII)	0.188666	0.012958	0.570054	0.228322	CS pos: 16-17. SHA-CS. Pr: 0.5539    33
NZ_CP027599.1_92620	SP(Sec/SPI)	0.414718	0.034994	0.138499	0.411789	CS pos: 18-19. GGG-YS. Pr: 0.0657    40
NZ_CP027599.1_92642	LIPO(Sec/SPII)	0.340610	0.065721	0.392104	0.201565	CS pos: 13-14. ARG-CE. Pr: 0.3643    17
NZ_CP027599.1_92668	LIPO(Sec/SPII)	0.204566	0.105016	0.380770	0.309649	CS pos: ?. Probable protein fragment    22
NZ_CP027599.1_92671	LIPO(Sec/SPII)	0.134326	0.056761	0.632489	0.176425	CS pos: 21-22. RSG-CG. Pr: 0.5886    29
NZ_CP027599.1_92689	SP(Sec/SPI)	0.506887	0.031690	0.314820	0.146604	CS pos: 21-22. APA-LF. Pr: 0.1403    23
NZ_CP027599.1_92735	LIPO(Sec/SPII)	0.226612	0.028357	0.375161	0.369870	CS pos: ?. Probable protein fragment    16
NZ_CP027599.1_92746	LIPO(Sec/SPII)	0.235559	0.006014	0.538256	0.220171	CS pos: 14-15. SVC-CC. Pr: 0.2022    21
NZ_CP027599.1_92778	TAT(Tat/SPI)	0.161577	0.363012	0.124749	0.350662	CS pos: 26-27. CAA-GT. Pr: 0.1038    40
NZ_CP027599.1_92779	LIPO(Sec/SPII)	0.329815	0.006512	0.350990	0.312683	CS pos: 13-14. TAF-CG. Pr: 0.2199    29
NZ_CP027599.1_92786	TAT(Tat/SPI)	0.146114	0.450449	0.050261	0.353176	CS pos: 31-32. ANA-AG. Pr: 0.0481    37
NZ_CP027599.1_92800	LIPO(Sec/SPII)	0.266613	0.014545	0.417657	0.301185	CS pos: ?. Probable protein fragment    18
NZ_CP027599.1_92858	LIPO(Sec/SPII)	0.148446	0.020361	0.539430	0.291764	CS pos: 11-12. AGG-CP. Pr: 0.4749    20
NZ_CP027599.1_92867	TAT(Tat/SPI)	0.056614	0.656513	0.035692	0.251180	CS pos: 28-29. KRA-EW. Pr: 0.4100    37
NZ_CP027599.1_92877	LIPO(Sec/SPII)	0.086323	0.007747	0.601737	0.304193	CS pos: 22-23. LAG-CW. Pr: 0.5657    32
NZ_CP027599.1_92878	LIPO(Sec/SPII)	0.183408	0.012689	0.437527	0.366376	CS pos: 16-17. VVG-AG. Pr: 0.1996    34
NZ_CP027599.1_92884	SP(Sec/SPI)	0.419345	0.023712	0.330074	0.226869	CS pos: 24-25. KRA-YT. Pr: 0.2363    35
NZ_CP027599.1_92886	LIPO(Sec/SPII)	0.027823	0.000818	0.935916	0.035443	CS pos: 17-18. SSS-CA. Pr: 0.9299    42
NZ_CP027599.1_92891	SP(Sec/SPI)	0.685093	0.097841	0.010685	0.206381	CS pos: 28-29. VRA-SY. Pr: 0.6972    38
NZ_CP027599.1_92910	LIPO(Sec/SPII)	0.088904	0.004081	0.548977	0.358038	CS pos: 17-18. LSG-KK. Pr: 0.4909    25
NZ_CP027599.1_92927	LIPO(Sec/SPII)	0.097062	0.011313	0.739128	0.152497	CS pos: 13-14. TLS-CS. Pr: 0.5943    15
NZ_CP027599.1_92953	SP(Sec/SPI)	0.538068	0.035878	0.079536	0.346518	CS pos: 16-17. INA-NV. Pr: 0.2808    22
NZ_CP027599.1_92969	LIPO(Sec/SPII)	0.176959	0.012652	0.562580	0.247808	CS pos: ?. Probable protein fragment    17
NZ_CP027599.1_92979	LIPO(Sec/SPII)	0.300105	0.003437	0.512784	0.183675	CS pos: 12-13. AAH-CA. Pr: 0.4652    32
NZ_CP027599.1_92982	SP(Sec/SPI)	0.613328	0.022447	0.140533	0.223692	CS pos: 19-20. TLA-RN. Pr: 0.5494    24
NZ_CP027599.1_92988	LIPO(Sec/SPII)	0.278690	0.030937	0.381545	0.308828	CS pos: 17-18. STG-SH. Pr: 0.0801    19
NZ_CP027599.1_92992	LIPO(Sec/SPII)	0.175393	0.013953	0.465045	0.345609	CS pos: 19-20. AKA-CV. Pr: 0.3948    25
NZ_CP027599.1_93001	LIPO(Sec/SPII)	0.291662	0.045145	0.431282	0.231911	CS pos: ?. Probable protein fragment    20
NZ_CP027599.1_93011	SP(Sec/SPI)	0.404147	0.076885	0.128201	0.390767	CS pos: 14-15. ANA-GW. Pr: 0.2908    17
NZ_CP027599.1_93018	LIPO(Sec/SPII)	0.224755	0.022808	0.410603	0.341834	CS pos: ?. Probable protein fragment    24
NZ_CP027599.1_93019	SP(Sec/SPI)	0.651852	0.041227	0.088478	0.218443	CS pos: 21-22. TRA-AE. Pr: 0.6222    29
NZ_CP027599.1_93041	LIPO(Sec/SPII)	0.306185	0.085343	0.383722	0.224750	CS pos: 19-20. ASS-AV. Pr: 0.1069    37
NZ_CP027599.1_93054	LIPO(Sec/SPII)	0.140426	0.010057	0.443476	0.406042	CS pos: 21-22. STS-CN. Pr: 0.2612    35
NZ_CP027599.1_93104	LIPO(Sec/SPII)	0.131719	0.010941	0.665032	0.192308	CS pos: 17-18. VCG-CS. Pr: 0.5640    34
NZ_CP027599.1_93107	SP(Sec/SPI)	0.488412	0.017774	0.033243	0.460571	CS pos: 24-25. LHA-SP. Pr: 0.2567    47
NZ_CP027599.1_93120	TAT(Tat/SPI)	0.053036	0.748699	0.012620	0.185645	CS pos: 20-21. LRS-AP. Pr: 0.5082    50
NZ_CP027599.1_93136	LIPO(Sec/SPII)	0.251492	0.026035	0.423788	0.298685	CS pos: ?. Probable protein fragment    21
NZ_CP027599.1_93138	LIPO(Sec/SPII)	0.186335	0.037147	0.390719	0.385799	CS pos: 18-19. GRC-CT. Pr: 0.1756    24
NZ_CP027599.1_93139	LIPO(Sec/SPII)	0.192462	0.101656	0.625309	0.080574	CS pos: 17-18. AVC-CL. Pr: 0.5487    43
NZ_CP027599.1_93145	LIPO(Sec/SPII)	0.289014	0.022582	0.394072	0.294332	CS pos: ?. Probable protein fragment    15
NZ_CP027599.1_93168	LIPO(Sec/SPII)	0.015638	0.001575	0.936565	0.046222	CS pos: 13-14. VAG-CT. Pr: 0.9374    34
NZ_CP027599.1_93178	LIPO(Sec/SPII)	0.229559	0.024583	0.538086	0.207772	CS pos: 14-15. SGS-CS. Pr: 0.3496    17
NZ_CP027599.1_93200	LIPO(Sec/SPII)	0.229779	0.056810	0.359568	0.353844	CS pos: ?. Probable protein fragment    18
NZ_CP027599.1_93202	SP(Sec/SPI)	0.575299	0.034231	0.310892	0.079578	CS pos: 20-21. VQA-LS. Pr: 0.3630    26
NZ_CP027599.1_93208	LIPO(Sec/SPII)	0.271957	0.026367	0.370913	0.330762	CS pos: 16-17. TLR-CC. Pr: 0.1559    21
NZ_CP027599.1_93216	LIPO(Sec/SPII)	0.346959	0.008704	0.518727	0.125611	CS pos: 14-15. LAT-CG. Pr: 0.3548    21
NZ_CP027599.1_93232	LIPO(Sec/SPII)	0.098644	0.008353	0.868845	0.024158	CS pos: 18-19. GSS-CT. Pr: 0.8103    23
NZ_CP027599.1_93236	LIPO(Sec/SPII)	0.024722	0.001066	0.965582	0.008631	CS pos: 20-21. LLS-CK. Pr: 0.9611    27
NZ_CP027599.1_93238	SP(Sec/SPI)	0.561495	0.146235	0.057411	0.234859	CS pos: 26-27. ISA-KS. Pr: 0.4311    34
NZ_CP027599.1_93254	SP(Sec/SPI)	0.364930	0.067056	0.253348	0.314667	CS pos: ?. Probable protein fragment    24
NZ_CP027599.1_93266	SP(Sec/SPI)	0.416862	0.081875	0.091389	0.409875	CS pos: 21-22. SFA-EV. Pr: 0.2667    44
NZ_CP027599.1_93307	LIPO(Sec/SPII)	0.286102	0.059181	0.460592	0.194124	CS pos: ?. Probable protein fragment    17
NZ_CP027599.1_93330	LIPO(Sec/SPII)	0.201800	0.026666	0.505363	0.266171	CS pos: 18-19. LAA-CH. Pr: 0.4637    20
NZ_CP027599.1_93381	SP(Sec/SPI)	0.636795	0.046212	0.054569	0.262423	CS pos: 18-19. TRA-GE. Pr: 0.5555    45
NZ_CP027599.1_93385	SP(Sec/SPI)	0.571895	0.014471	0.070226	0.343408	CS pos: 15-16. SNA-NI. Pr: 0.4145    44
NZ_CP027599.1_93403	SP(Sec/SPI)	0.401406	0.165791	0.091580	0.341223	CS pos: 20-21. SGA-DD. Pr: 0.0772    37
NZ_CP027599.1_93422	LIPO(Sec/SPII)	0.239567	0.053841	0.393899	0.312693	CS pos: ?. Probable protein fragment    18
NZ_CP027599.1_93444	LIPO(Sec/SPII)	0.153530	0.008963	0.574569	0.262937	CS pos: 17-18. WLA-CW. Pr: 0.5507    28
NZ_CP027599.1_93464	LIPO(Sec/SPII)	0.074938	0.032387	0.483868	0.408807	CS pos: 13-14. AFI-CS. Pr: 0.4515    39
NZ_CP027599.1_93472	LIPO(Sec/SPII)	0.138215	0.020240	0.429436	0.412109	CS pos: 25-26. LPA-CQ. Pr: 0.3755    29
NZ_CP027599.1_93495	LIPO(Sec/SPII)	0.094124	0.006298	0.565873	0.333705	CS pos: 20-21. VWS-CV. Pr: 0.5085    27
NZ_CP027599.1_93515	SP(Sec/SPI)	0.335515	0.023696	0.332808	0.307980	CS pos: ?. Probable protein fragment    19
NZ_CP027599.1_93517	LIPO(Sec/SPII)	0.109026	0.022508	0.540185	0.328281	CS pos: 20-21. YRA-CH. Pr: 0.5116    28
NZ_CP027599.1_93531	LIPO(Sec/SPII)	0.212074	0.011433	0.432772	0.343721	CS pos: 18-19. CVV-CR. Pr: 0.2031    20
NZ_CP027599.1_93584	LIPO(Sec/SPII)	0.163387	0.121782	0.405785	0.309046	CS pos: 17-18. ARS-CS. Pr: 0.2498    21
NZ_CP027599.1_93590	LIPO(Sec/SPII)	0.237106	0.030379	0.457325	0.275190	CS pos: 16-17. SAS-CL. Pr: 0.2309    20
NZ_CP027599.1_93617	LIPO(Sec/SPII)	0.287170	0.013616	0.507033	0.192182	CS pos: 18-19. FAA-GT. Pr: 0.3424    34
NZ_CP027599.1_93624	LIPO(Sec/SPII)	0.193734	0.028722	0.392486	0.385058	CS pos: ?. Probable protein fragment    18
NZ_CP027599.1_93627	SP(Sec/SPI)	0.336217	0.036961	0.321549	0.305272	CS pos: 18-19. ASA-NT. Pr: 0.1833    22
NZ_CP027599.1_93632	LIPO(Sec/SPII)	0.123447	0.287645	0.380581	0.208327	CS pos: 20-21. TLA-CH. Pr: 0.3460    31
NZ_CP027599.1_93635	SP(Sec/SPI)	0.386691	0.126663	0.134688	0.351958	CS pos: 20-21. ANS-AG. Pr: 0.2111    26
NZ_CP027599.1_93640	LIPO(Sec/SPII)	0.118050	0.040770	0.726478	0.114701	CS pos: 22-23. LST-CA. Pr: 0.3827    32
NZ_CP027599.1_93645	LIPO(Sec/SPII)	0.146710	0.051186	0.450898	0.351206	CS pos: 21-22. VFT-CA. Pr: 0.2973    32
NZ_CP027599.1_93654	TAT(Tat/SPI)	0.233779	0.704561	0.012018	0.049642	CS pos: 28-29. ARA-ER. Pr: 0.8803    36
NZ_CP027599.1_93680	LIPO(Sec/SPII)	0.220633	0.013152	0.486009	0.280206	CS pos: 20-21. ANA-CC. Pr: 0.4860    26
NZ_CP027599.1_93714	SP(Sec/SPI)	0.543016	0.099503	0.153169	0.204313	CS pos: 20-21. ATS-TQ. Pr: 0.1967    37
NZ_CP027599.1_93731	SP(Sec/SPI)	0.439359	0.101865	0.047709	0.411067	CS pos: 21-22. AFS-TG. Pr: 0.3319    39
NZ_CP027599.1_93734	SP(Sec/SPI)	0.558106	0.045100	0.147452	0.249342	CS pos: 19-20. LSP-AP. Pr: 0.1569    22
NZ_CP027599.1_93743	LIPO(Sec/SPII)	0.226876	0.018014	0.514833	0.240278	CS pos: 16-17. SSN-CF. Pr: 0.4319    22
NZ_CP027599.1_93745	SP(Sec/SPI)	0.438474	0.051993	0.172871	0.336662	CS pos: 16-17. AAA-RV. Pr: 0.1666    30
NZ_CP027599.1_93787	LIPO(Sec/SPII)	0.282259	0.018524	0.373290	0.325927	CS pos: ?. Probable protein fragment    17
NZ_CP027599.1_93818	TAT(Tat/SPI)	0.288654	0.536842	0.024873	0.149632	CS pos: 24-25. AKT-AT. Pr: 0.5898    41
NZ_CP027599.1_93857	LIPO(Sec/SPII)	0.193719	0.068275	0.396364	0.341642	CS pos: 19-20. STA-CY. Pr: 0.4188    34
NZ_CP027599.1_93864	SP(Sec/SPI)	0.371144	0.220052	0.080692	0.328112	CS pos: 17-18. TSA-RT. Pr: 0.1972    36
NZ_CP027599.1_93869	LIPO(Sec/SPII)	0.005725	0.005428	0.978821	0.010026	CS pos: 20-21. MSA-CS. Pr: 0.9824    44
NZ_CP027599.1_93879	LIPO(Sec/SPII)	0.250581	0.044568	0.391597	0.313254	CS pos: 17-18. CPA-CA. Pr: 0.2382    26
NZ_CP027599.1_93883	SP(Sec/SPI)	0.481803	0.036500	0.102244	0.379453	CS pos: 33-34. ALT-AA. Pr: 0.2245    50
NZ_CP027599.1_93888	LIPO(Sec/SPII)	0.184006	0.021707	0.471028	0.323259	CS pos: 24-25. VQC-CV. Pr: 0.2140    26
NZ_CP027599.1_93900	LIPO(Sec/SPII)	0.113201	0.021211	0.545423	0.320165	CS pos: 20-21. IGS-CS. Pr: 0.5228    30
NZ_CP027599.1_93934	LIPO(Sec/SPII)	0.204548	0.050393	0.454632	0.290427	CS pos: 19-20. SAA-CA. Pr: 0.4445    37
NZ_CP027599.1_93937	LIPO(Sec/SPII)	0.205672	0.011555	0.479122	0.303651	CS pos: 23-24. VLG-CW. Pr: 0.4242    32
NZ_CP027599.1_93943	SP(Sec/SPI)	0.657027	0.024902	0.114912	0.203158	CS pos: 24-25. VSA-SV. Pr: 0.3594    38
NZ_CP027599.1_93957	SP(Sec/SPI)	0.355875	0.263779	0.072710	0.307635	CS pos: 9-10. ATA-AP. Pr: 0.2212    33
NZ_CP027599.1_93973	LIPO(Sec/SPII)	0.312167	0.035207	0.413081	0.239546	CS pos: 21-22. ITS-CP. Pr: 0.3678    42
NZ_CP027599.1_93978	LIPO(Sec/SPII)	0.010529	0.001655	0.976209	0.011607	CS pos: 17-18. MVA-CD. Pr: 0.9652    38
NZ_CP027599.1_94017	LIPO(Sec/SPII)	0.033207	0.012053	0.626071	0.328668	CS pos: 25-26. HLG-CP. Pr: 0.6183    36
NZ_CP027599.1_94041	SP(Sec/SPI)	0.451933	0.030052	0.198629	0.319386	CS pos: 17-18. VRS-IS. Pr: 0.1296    23
NZ_CP027599.1_94120	SP(Sec/SPI)	0.373296	0.099877	0.179260	0.347566	CS pos: 19-20. VGA-AG. Pr: 0.0980    29
NZ_CP027599.1_94123	LIPO(Sec/SPII)	0.035327	0.004740	0.611414	0.348519	CS pos: 16-17. TGG-CI. Pr: 0.5810    42
NZ_CP027599.1_94156	SP(Sec/SPI)	0.459315	0.097671	0.131844	0.311170	CS pos: 24-25. VHC-QT. Pr: 0.3133    34
NZ_CP027599.1_94161	LIPO(Sec/SPII)	0.113635	0.013526	0.803066	0.069773	CS pos: 22-23. SAG-CA. Pr: 0.8050    34
NZ_CP027599.1_94165	LIPO(Sec/SPII)	0.073383	0.010108	0.526525	0.389984	CS pos: 19-20. SAA-CG. Pr: 0.5252    45
NZ_CP027599.1_94235	TAT(Tat/SPI)	0.176097	0.348832	0.156273	0.318798	CS pos: 17-18. SSA-LS. Pr: 0.0561    22
NZ_CP027599.1_94248	LIPO(Sec/SPII)	0.179124	0.027162	0.487899	0.305814	CS pos: 16-17. LPG-CA. Pr: 0.3822    18
NZ_CP027599.1_94252	LIPO(Sec/SPII)	0.237000	0.016507	0.459389	0.287103	CS pos: ?. Probable protein fragment    17
NZ_CP027599.1_94256	LIPO(Sec/SPII)	0.391679	0.039840	0.469691	0.098790	CS pos: 18-19. RAA-CN. Pr: 0.4700    29
NZ_CP027599.1_94264	SP(Sec/SPI)	0.506950	0.263999	0.068877	0.160174	CS pos: 20-21. ARA-AV. Pr: 0.4544    34
NZ_CP027599.1_94282	LIPO(Sec/SPII)	0.239448	0.039735	0.558143	0.162674	CS pos: 14-15. PAS-CS. Pr: 0.5306    31
NZ_CP027599.1_94284	TAT(Tat/SPI)	0.236330	0.423966	0.039219	0.300485	CS pos: 26-27. SRA-RC. Pr: 0.1536    33
NZ_CP027599.1_94286	LIPO(Sec/SPII)	0.144220	0.013604	0.718027	0.124149	CS pos: 12-13. LQA-CC. Pr: 0.5595    15
NZ_CP027599.1_94292	LIPO(Sec/SPII)	0.186388	0.017660	0.435360	0.360593	CS pos: ?. Probable protein fragment    19
NZ_CP027599.1_94311	SP(Sec/SPI)	0.822896	0.067861	0.050862	0.058382	CS pos: 16-17. AFA-AA. Pr: 0.4804    37
NZ_CP027599.1_94347	SP(Sec/SPI)	0.378183	0.004539	0.286901	0.330377	CS pos: 16-17. AEP-WL. Pr: 0.1134    45
NZ_CP027599.1_94402	SP(Sec/SPI)	0.356386	0.025804	0.290212	0.327598	CS pos: 24-25. GNA-SR. Pr: 0.1299    26
NZ_CP027599.1_94413	SP(Sec/SPI)	0.330703	0.043878	0.326427	0.298992	CS pos: 14-15. LYS-AD. Pr: 0.0968    16
NZ_CP027599.1_94499	SP(Sec/SPI)	0.453867	0.070688	0.052237	0.423208	CS pos: 24-25. LRA-YE. Pr: 0.3920    35
NZ_CP027599.1_94538	LIPO(Sec/SPII)	0.061562	0.034005	0.796600	0.107833	CS pos: 22-23. PAG-CQ. Pr: 0.7769    27
NZ_CP027599.1_94612	LIPO(Sec/SPII)	0.141563	0.005105	0.585490	0.267841	CS pos: 15-16. FET-CP. Pr: 0.5707    34
NZ_CP027599.1_94653	SP(Sec/SPI)	0.828227	0.049279	0.043188	0.079306	CS pos: 19-20. TSA-QT. Pr: 0.6845    32
NZ_CP027599.1_94656	SP(Sec/SPI)	0.795054	0.130053	0.029431	0.045463	CS pos: 18-19. ARA-GT. Pr: 0.7992    41
NZ_CP027599.1_94657	LIPO(Sec/SPII)	0.150706	0.012927	0.569706	0.266661	CS pos: 18-19. DTS-CT. Pr: 0.4485    29
NZ_CP027599.1_94659	LIPO(Sec/SPII)	0.092069	0.016445	0.550108	0.341378	CS pos: 16-17. GSA-CR. Pr: 0.4396    19
NZ_CP027599.1_94668	LIPO(Sec/SPII)	0.170809	0.020697	0.408748	0.399745	CS pos: ?. Probable protein fragment    21
NZ_CP027599.1_94703	TAT(Tat/SPI)	0.402409	0.412615	0.011725	0.173252	CS pos: 34-35. AAA-AM. Pr: 0.4375    44
NZ_CP027599.1_94705	SP(Sec/SPI)	0.703362	0.031958	0.114817	0.149862	CS pos: 24-25. VPA-RS. Pr: 0.2054    36
NZ_CP027599.1_94792	SP(Sec/SPI)	0.349563	0.119806	0.334551	0.196080	CS pos: 26-27. SEA-CS. Pr: 0.5459    42
NZ_CP027599.1_94825	LIPO(Sec/SPII)	0.062695	0.002792	0.642454	0.292059	CS pos: 28-29. FAA-CS. Pr: 0.6320    33
NZ_CP027599.1_94876	LIPO(Sec/SPII)	0.248392	0.004628	0.613156	0.133824	CS pos: 15-16. LVP-CR. Pr: 0.3058    21
NZ_CP027599.1_94933	SP(Sec/SPI)	0.705179	0.018733	0.105639	0.170449	CS pos: 25-26. AMQ-GV. Pr: 0.2565    47
NZ_CP027599.1_94971	LIPO(Sec/SPII)	0.215467	0.013963	0.505077	0.265493	CS pos: 26-27. TLA-CR. Pr: 0.5935    36
NZ_CP027599.1_94985	LIPO(Sec/SPII)	0.226584	0.009611	0.468877	0.294928	CS pos: 17-18. ITN-CH. Pr: 0.4315    27
NZ_CP027599.1_95003	SP(Sec/SPI)	0.791186	0.002086	0.083492	0.123236	CS pos: 18-19. TFA-AH. Pr: 0.5900    38
NZ_CP027599.1_95018	SP(Sec/SPI)	0.482650	0.021147	0.425984	0.070219	CS pos: 20-21. LSG-DM. Pr: 0.1992    36
NZ_CP027599.1_95020	LIPO(Sec/SPII)	0.115532	0.014471	0.743707	0.126290	CS pos: 19-20. AIA-CK. Pr: 0.7473    39
NZ_CP027599.1_95100	LIPO(Sec/SPII)	0.326335	0.028384	0.347850	0.297431	CS pos: 18-19. WLR-CN. Pr: 0.1549    20
NZ_CP027599.1_95121	SP(Sec/SPI)	0.906679	0.038373	0.018003	0.036945	CS pos: 22-23. ARA-NP. Pr: 0.8699    35
NZ_CP027599.1_95235	LIPO(Sec/SPII)	0.273933	0.023910	0.392103	0.310054	CS pos: 13-14. LCG-FV. Pr: 0.0275    15
NZ_CP027599.1_95378	LIPO(Sec/SPII)	0.072167	0.003379	0.538795	0.385659	CS pos: 13-14. IAG-CY. Pr: 0.5040    34
NZ_CP027599.1_95423	SP(Sec/SPI)	0.786500	0.107711	0.010904	0.094885	CS pos: 17-18. ASA-AP. Pr: 0.8338    45
NZ_CP027599.1_95426	SP(Sec/SPI)	0.489807	0.003976	0.340048	0.166169	CS pos: 20-21. SSG-SW. Pr: 0.1656    27
NZ_CP027599.1_95427	LIPO(Sec/SPII)	0.041906	0.069708	0.812149	0.076237	CS pos: 22-23. FHA-CS. Pr: 0.8103    43
NZ_CP027599.1_95430	LIPO(Sec/SPII)	0.216393	0.018322	0.445343	0.319942	CS pos: 19-20. ASR-CG. Pr: 0.2938    35
NZ_CP027599.1_95456	LIPO(Sec/SPII)	0.018862	0.015185	0.786557	0.179396	CS pos: 20-21. FFT-CS. Pr: 0.7779    35
NZ_CP027599.1_95486	LIPO(Sec/SPII)	0.323954	0.006986	0.408556	0.260504	CS pos: ?. Probable protein fragment    19
NZ_CP027599.1_95498	SP(Sec/SPI)	0.470376	0.353400	0.067047	0.109176	CS pos: 22-23. AAG-FP. Pr: 0.5189    30
NZ_CP027599.1_95504	LIPO(Sec/SPII)	0.196849	0.015070	0.737936	0.050144	CS pos: 16-17. SSA-CT. Pr: 0.7070    29
NZ_CP027599.1_95513	LIPO(Sec/SPII)	0.235588	0.017073	0.383307	0.364031	CS pos: 12-13. VFI-CS. Pr: 0.0569    15
NZ_CP027599.1_95537	LIPO(Sec/SPII)	0.105128	0.109223	0.513239	0.272410	CS pos: 16-17. ATA-CR. Pr: 0.4930    37
NZ_CP027599.1_95560	LIPO(Sec/SPII)	0.255851	0.018136	0.382593	0.343420	CS pos: ?. Probable protein fragment    16
NZ_CP027599.1_95579	LIPO(Sec/SPII)	0.189075	0.200794	0.590666	0.019464	CS pos: 25-26. AAA-CR. Pr: 0.5834    43
NZ_CP027599.1_95615	SP(Sec/SPI)	0.464961	0.313861	0.113517	0.107660	CS pos: 23-24. ARA-SR. Pr: 0.2385    40
NZ_CP027599.1_95616	LIPO(Sec/SPII)	0.190239	0.027319	0.634419	0.148023	CS pos: 29-30. IAA-CT. Pr: 0.2524    34
NZ_CP027599.1_95622	LIPO(Sec/SPII)	0.122499	0.041041	0.679659	0.156800	CS pos: 10-11. FGA-CS. Pr: 0.6570    29
NZ_CP027599.1_95641	SP(Sec/SPI)	0.519455	0.237345	0.057457	0.185742	CS pos: 29-30. ASS-AI. Pr: 0.2321    40
NZ_CP027599.1_95644	LIPO(Sec/SPII)	0.215439	0.026622	0.380604	0.377335	CS pos: ?. Probable protein fragment    16
NZ_CP027599.1_95660	SP(Sec/SPI)	0.356807	0.053667	0.242170	0.347357	CS pos: ?. Probable protein fragment    22
NZ_CP027599.1_95666	LIPO(Sec/SPII)	0.042362	0.006209	0.846449	0.104980	CS pos: 18-19. QVG-CD. Pr: 0.8396    27
NZ_CP027599.1_95717	LIPO(Sec/SPII)	0.273632	0.159106	0.416194	0.151067	CS pos: 18-19. APS-CA. Pr: 0.3136    28
NZ_CP027599.1_95735	TAT(Tat/SPI)	0.205278	0.488357	0.026227	0.280139	CS pos: 18-19. AKA-AL. Pr: 0.4425    39
NZ_CP027599.1_95740	LIPO(Sec/SPII)	0.256972	0.029457	0.483554	0.230016	CS pos: ?. Probable protein fragment    15
NZ_CP027599.1_95749	LIPO(Sec/SPII)	0.227923	0.013103	0.427997	0.330977	CS pos: 23-24. NSF-CG. Pr: 0.3273    40
NZ_CP027599.1_95751	LIPO(Sec/SPII)	0.017909	0.000766	0.974169	0.007155	CS pos: 18-19. IMA-CS. Pr: 0.5788    32
NZ_CP027599.1_95817	LIPO(Sec/SPII)	0.210408	0.125951	0.341207	0.322434	CS pos: ?. Probable protein fragment    19
NZ_CP027599.1_95829	LIPO(Sec/SPII)	0.028736	0.007275	0.893014	0.070974	CS pos: 16-17. KVS-CS. Pr: 0.8666    30
NZ_CP027599.1_95839	LIPO(Sec/SPII)	0.303068	0.032095	0.339622	0.325215	CS pos: ?. Probable protein fragment    15
NZ_CP027599.1_95841	LIPO(Sec/SPII)	0.242518	0.017239	0.473014	0.267229	CS pos: ?. Probable protein fragment    22
NZ_CP027599.1_95880	SP(Sec/SPI)	0.496340	0.064112	0.152839	0.286709	CS pos: 22-23. SSA-LH. Pr: 0.2104    44
NZ_CP027599.1_95904	LIPO(Sec/SPII)	0.272008	0.019330	0.380872	0.327790	CS pos: 14-15. VTT-CI. Pr: 0.1920    21
NZ_CP027599.1_95905	TAT(Tat/SPI)	0.109637	0.385142	0.149202	0.356019	CS pos: ?. Probable protein fragment    16
NZ_CP027599.1_95930	SP(Sec/SPI)	0.468239	0.008447	0.375042	0.148273	CS pos: 17-18. FQS-AR. Pr: 0.2484    23
NZ_CP027599.1_96002	SP(Sec/SPI)	0.323421	0.169451	0.285858	0.221270	CS pos: 26-27. VRL-PS. Pr: 0.1123    44
NZ_CP027599.1_96015	LIPO(Sec/SPII)	0.279677	0.030241	0.480715	0.209368	CS pos: 15-16. VGS-CA. Pr: 0.3582    22
NZ_CP027599.1_96021	LIPO(Sec/SPII)	0.198671	0.136718	0.593903	0.070709	CS pos: 20-21. SSA-CT. Pr: 0.5771    37
NZ_CP027599.1_96029	LIPO(Sec/SPII)	0.296968	0.015603	0.345921	0.341507	CS pos: 17-18. TVQ-CV. Pr: 0.2984    23
NZ_CP027599.1_96049	LIPO(Sec/SPII)	0.291952	0.046266	0.428863	0.232919	CS pos: ?. Probable protein fragment    16
NZ_CP027599.1_96068	LIPO(Sec/SPII)	0.046940	0.009910	0.612608	0.330541	CS pos: 32-33. PAA-CN. Pr: 0.6058    47
NZ_CP027599.1_96082	SP(Sec/SPI)	0.316563	0.082035	0.289716	0.311686	CS pos: 16-17. INT-AS. Pr: 0.0583    24
NZ_CP027599.1_96100	LIPO(Sec/SPII)	0.290786	0.031525	0.362643	0.315046	CS pos: 12-13. AIC-CW. Pr: 0.0442    15
NZ_CP027599.1_96107	SP(Sec/SPI)	0.364899	0.062449	0.268724	0.303927	CS pos: 26-27. FFA-TS. Pr: 0.1666    39
NZ_CP027599.1_96112	LIPO(Sec/SPII)	0.043931	0.001688	0.917281	0.037100	CS pos: 20-21. TYG-CN. Pr: 0.8984    29
NZ_CP027599.1_96116	LIPO(Sec/SPII)	0.253901	0.016022	0.411331	0.318747	CS pos: 25-26. VTI-CW. Pr: 0.2947    35
NZ_CP027599.1_96120	SP(Sec/SPI)	0.757711	0.054432	0.006714	0.181144	CS pos: 23-24. THS-FE. Pr: 0.7670    41
NZ_CP027599.1_96135	SP(Sec/SPI)	0.335030	0.034065	0.303783	0.327122	CS pos: 12-13. APA-AT. Pr: 0.0789    15
NZ_CP027599.1_96138	SP(Sec/SPI)	0.479756	0.025375	0.271188	0.223682	CS pos: 21-22. KGR-LP. Pr: 0.0375    26
NZ_CP027599.1_96146	LIPO(Sec/SPII)	0.181851	0.009958	0.616896	0.191295	CS pos: 29-30. ALA-CA. Pr: 0.5855    38
NZ_CP027599.1_96168	SP(Sec/SPI)	0.597108	0.070559	0.149883	0.182449	CS pos: 20-21. LLG-AT. Pr: 0.2166    42
NZ_CP027599.1_96169	TAT(Tat/SPI)	0.248283	0.338502	0.110051	0.303164	CS pos: 28-29. AGA-DV. Pr: 0.3210    34
NZ_CP027599.1_96180	LIPO(Sec/SPII)	0.321429	0.017533	0.458894	0.202144	CS pos: 12-13. AQF-CR. Pr: 0.0927    15
NZ_CP027599.1_96182	LIPO(Sec/SPII)	0.210550	0.003185	0.767789	0.018476	CS pos: 19-20. PLT-CS. Pr: 0.5261    30
NZ_CP027599.1_96193	LIPO(Sec/SPII)	0.257938	0.019136	0.377704	0.345223	CS pos: ?. Probable protein fragment    16
NZ_CP027599.1_96227	LIPO(Sec/SPII)	0.133686	0.001653	0.744020	0.120641	CS pos: 27-28. LNT-CA. Pr: 0.4510    33
NZ_CP027599.1_96234	LIPO(Sec/SPII)	0.140572	0.012260	0.781289	0.065879	CS pos: 16-17. CLS-CL. Pr: 0.6693    34
NZ_CP027599.1_96238	LIPO(Sec/SPII)	0.174240	0.011426	0.692681	0.121653	CS pos: 22-23. ALA-CR. Pr: 0.3243    40
NZ_CP027599.1_96258	SP(Sec/SPI)	0.426695	0.055503	0.181542	0.336259	CS pos: 16-17. SRA-VN. Pr: 0.2349    21
NZ_CP027599.1_96261	SP(Sec/SPI)	0.436973	0.096259	0.060444	0.406324	CS pos: 22-23. AKS-TK. Pr: 0.1939    33
NZ_CP027599.1_96272	SP(Sec/SPI)	0.654272	0.007853	0.104969	0.232906	CS pos: 21-22. TSS-QT. Pr: 0.4746    33
NZ_CP027599.1_96274	LIPO(Sec/SPII)	0.101708	0.026771	0.570896	0.300625	CS pos: 18-19. LSG-CS. Pr: 0.5306    20
NZ_CP027599.1_96285	SP(Sec/SPI)	0.410551	0.115741	0.173148	0.300560	CS pos: 23-24. VPA-AG. Pr: 0.1342    28
NZ_CP027599.1_96290	LIPO(Sec/SPII)	0.204342	0.008542	0.491214	0.295902	CS pos: ?. Probable protein fragment    22
NZ_CP027599.1_96296	LIPO(Sec/SPII)	0.234750	0.019171	0.392791	0.353288	CS pos: 17-18. LAR-CN. Pr: 0.3440    35
NZ_CP027599.1_96311	LIPO(Sec/SPII)	0.049682	0.112128	0.519737	0.318452	CS pos: 18-19. PDG-CS. Pr: 0.4898    27
NZ_CP027599.1_96320	LIPO(Sec/SPII)	0.343599	0.011570	0.504154	0.140677	CS pos: 17-18. SKS-CC. Pr: 0.2836    22
NZ_CP027599.1_96336	LIPO(Sec/SPII)	0.148037	0.044338	0.483162	0.324463	CS pos: 23-24. ILA-CV. Pr: 0.4154    26
NZ_CP027599.1_96342	LIPO(Sec/SPII)	0.102599	0.047326	0.552827	0.297248	CS pos: 21-22. INS-CT. Pr: 0.5427    29
NZ_CP027599.1_96444	LIPO(Sec/SPII)	0.345053	0.002556	0.523639	0.128752	CS pos: 21-22. LTA-MG. Pr: 0.2415    46
NZ_CP027599.1_96466	LIPO(Sec/SPII)	0.249236	0.013957	0.407880	0.328927	CS pos: 15-16. IRC-CS. Pr: 0.2065    26
NZ_CP027599.1_96481	LIPO(Sec/SPII)	0.035392	0.280797	0.563408	0.120404	CS pos: 20-21. PIS-CR. Pr: 0.5581    48
NZ_CP027599.1_96499	LIPO(Sec/SPII)	0.271534	0.042018	0.436313	0.250136	CS pos: 17-18. SVS-CA. Pr: 0.1617    20
NZ_CP027599.1_96521	SP(Sec/SPI)	0.386727	0.015031	0.276879	0.321364	CS pos: 27-28. FRA-SW. Pr: 0.1924    42
NZ_CP027599.1_96608	LIPO(Sec/SPII)	0.282762	0.060563	0.395781	0.260893	CS pos: 15-16. STA-SD. Pr: 0.0813    17
NZ_CP027599.1_96611	LIPO(Sec/SPII)	0.059008	0.057981	0.764169	0.118842	CS pos: 19-20. FTS-CP. Pr: 0.7518    39
NZ_CP027599.1_96647	LIPO(Sec/SPII)	0.217977	0.089346	0.395737	0.296940	CS pos: ?. Probable protein fragment    19
NZ_CP027599.1_96652	SP(Sec/SPI)	0.397358	0.107695	0.122526	0.372421	CS pos: 25-26. AVA-HR. Pr: 0.2251    39
NZ_CP027599.1_96677	SP(Sec/SPI)	0.534607	0.012755	0.164788	0.287850	CS pos: 19-20. VSA-ED. Pr: 0.5012    43
NZ_CP027599.1_96678	LIPO(Sec/SPII)	0.196274	0.030084	0.416730	0.356913	CS pos: 16-17. SSH-CS. Pr: 0.3598    32
NZ_CP027599.1_96695	SP(Sec/SPI)	0.611257	0.016729	0.017889	0.354126	CS pos: 23-24. AWS-VA. Pr: 0.5162    31
NZ_CP027599.1_96779	LIPO(Sec/SPII)	0.207341	0.014338	0.395899	0.382423	CS pos: 12-13. FAF-CD. Pr: 0.2166    16
NZ_CP027599.1_96797	SP(Sec/SPI)	0.662597	0.076032	0.044052	0.217318	CS pos: 23-24. SIA-AY. Pr: 0.4696    47
NZ_CP027599.1_96806	TAT(Tat/SPI)	0.317837	0.429220	0.041585	0.211358	CS pos: 22-23. AQA-QL. Pr: 0.6092    31
NZ_CP027599.1_96809	LIPO(Sec/SPII)	0.069101	0.006787	0.812875	0.111237	CS pos: 20-21. CCA-CV. Pr: 0.5914    29
NZ_CP027599.1_96823	LIPO(Sec/SPII)	0.247342	0.219976	0.285969	0.246712	CS pos: 20-21. ATV-CR. Pr: 0.1634    24
NZ_CP027599.1_96845	LIPO(Sec/SPII)	0.232386	0.027284	0.431555	0.308775	CS pos: 16-17. RAS-CW. Pr: 0.3761    20
NZ_CP027599.1_96856	LIPO(Sec/SPII)	0.310117	0.012639	0.389994	0.287249	CS pos: ?. Probable protein fragment    15
NZ_CP027599.1_96857	LIPO(Sec/SPII)	0.308033	0.039337	0.347201	0.305429	CS pos: 12-13. STA-CG. Pr: 0.1201    20
NZ_CP027599.1_96881	LIPO(Sec/SPII)	0.184510	0.026008	0.408932	0.380550	CS pos: ?. Probable protein fragment    16
NZ_CP027599.1_96886	LIPO(Sec/SPII)	0.113107	0.031365	0.654151	0.201377	CS pos: 18-19. GSG-CE. Pr: 0.6080    27
NZ_CP027599.1_96887	SP(Sec/SPI)	0.416967	0.016501	0.403337	0.163194	CS pos: 22-23. THA-FH. Pr: 0.3588    24
NZ_CP027599.1_96899	LIPO(Sec/SPII)	0.100136	0.009723	0.732848	0.157292	CS pos: 35-36. LTS-CL. Pr: 0.6460    45
NZ_CP027599.1_96906	LIPO(Sec/SPII)	0.140239	0.003597	0.597920	0.258243	CS pos: 16-17. FLN-CL. Pr: 0.4281    18
NZ_CP027599.1_96925	LIPO(Sec/SPII)	0.051730	0.002751	0.811083	0.134436	CS pos: 28-29. ATS-CA. Pr: 0.4245    38
NZ_CP027599.1_96948	LIPO(Sec/SPII)	0.275789	0.066533	0.341084	0.316594	CS pos: 18-19. VRA-CL. Pr: 0.2677    26
NZ_CP027599.1_97006	LIPO(Sec/SPII)	0.258248	0.034241	0.357816	0.349695	CS pos: 17-18. AFC-CR. Pr: 0.0812    20
NZ_CP027599.1_97035	SP(Sec/SPI)	0.593972	0.026682	0.214599	0.164746	CS pos: 20-21. SQA-SR. Pr: 0.4631    27
NZ_CP027599.1_97047	SP(Sec/SPI)	0.478880	0.211866	0.067835	0.241419	CS pos: 35-36. ASA-AV. Pr: 0.2142    44
NZ_CP027599.1_97054	LIPO(Sec/SPII)	0.058209	0.006943	0.877128	0.057720	CS pos: 16-17. LHS-CS. Pr: 0.8541    25
NZ_CP027599.1_97058	LIPO(Sec/SPII)	0.164152	0.010527	0.640960	0.184362	CS pos: 13-14. HTA-CF. Pr: 0.5277    20
NZ_CP027599.1_97095	LIPO(Sec/SPII)	0.142623	0.004353	0.666654	0.186370	CS pos: 17-18. MLC-CE. Pr: 0.4036    19
NZ_CP027599.1_97110	LIPO(Sec/SPII)	0.310463	0.022891	0.374652	0.291995	CS pos: 13-14. GCC-CF. Pr: 0.0115    16
NZ_CP027599.1_97115	LIPO(Sec/SPII)	0.225753	0.035230	0.480078	0.258939	CS pos: 15-16. LLV-CR. Pr: 0.2178    18
NZ_CP027599.1_97137	SP(Sec/SPI)	0.344602	0.034322	0.322265	0.298811	CS pos: ?. Probable protein fragment    15
NZ_CP027599.1_97140	LIPO(Sec/SPII)	0.295497	0.030447	0.375548	0.298508	CS pos: ?. Probable protein fragment    17
NZ_CP027599.1_97172	TAT(Tat/SPI)	0.162316	0.362701	0.145195	0.329788	CS pos: ?. Probable protein fragment    18
NZ_CP027599.1_97182	LIPO(Sec/SPII)	0.110572	0.007660	0.560202	0.321566	CS pos: 14-15. YLG-CA. Pr: 0.4391    21
NZ_CP027599.1_97188	LIPO(Sec/SPII)	0.403315	0.005870	0.461202	0.129613	CS pos: 15-16. SFC-CS. Pr: 0.2051    28
NZ_CP027599.1_97206	SP(Sec/SPI)	0.477376	0.013581	0.395351	0.113692	CS pos: 17-18. CNA-AS. Pr: 0.3424    30
NZ_CP027599.1_97296	LIPO(Sec/SPII)	0.155935	0.032814	0.472976	0.338275	CS pos: ?. Probable protein fragment    24
NZ_CP027599.1_97305	SP(Sec/SPI)	0.483331	0.248615	0.060093	0.207961	CS pos: 21-22. ISA-AN. Pr: 0.3807    39
NZ_CP027599.1_97313	LIPO(Sec/SPII)	0.290971	0.017660	0.636575	0.054793	CS pos: 20-21. AAI-CS. Pr: 0.4844    43
NZ_CP027599.1_97316	LIPO(Sec/SPII)	0.212971	0.028554	0.503994	0.254481	CS pos: 12-13. FSA-CW. Pr: 0.3434    17
NZ_CP027599.1_97325	LIPO(Sec/SPII)	0.114474	0.037237	0.736779	0.111510	CS pos: 19-20. YTA-CC. Pr: 0.5638    32
NZ_CP027599.1_97338	LIPO(Sec/SPII)	0.280855	0.021222	0.400419	0.297503	CS pos: 14-15. LTK-CT. Pr: 0.2552    19
NZ_CP027599.1_97344	TAT(Tat/SPI)	0.186826	0.390318	0.196970	0.225887	CS pos: ?. Probable protein fragment    15
NZ_CP027599.1_97356	SP(Sec/SPI)	0.373201	0.075822	0.231106	0.319871	CS pos: ?. Probable protein fragment    27
NZ_CP027599.1_97357	LIPO(Sec/SPII)	0.150411	0.017600	0.522006	0.309984	CS pos: 18-19. VSP-CT. Pr: 0.4328    24
NZ_CP027599.1_97394	LIPO(Sec/SPII)	0.020718	0.002832	0.920711	0.055739	CS pos: 23-24. ISA-CS. Pr: 0.9228    38
NZ_CP027599.1_97442	LIPO(Sec/SPII)	0.195889	0.022901	0.398802	0.382408	CS pos: 9-10. FSA-CE. Pr: 0.2194    16
NZ_CP027599.1_97461	SP(Sec/SPI)	0.482039	0.059802	0.074686	0.383473	CS pos: 22-23. THT-GE. Pr: 0.3825    31
NZ_CP027599.1_97474	SP(Sec/SPI)	0.382341	0.291124	0.045254	0.281281	CS pos: 23-24. SRA-GS. Pr: 0.4798    33
NZ_CP027599.1_97489	LIPO(Sec/SPII)	0.119398	0.144938	0.687509	0.048155	CS pos: 16-17. GSS-CF. Pr: 0.3929    47
NZ_CP027599.1_97507	SP(Sec/SPI)	0.624610	0.111413	0.163168	0.100808	CS pos: ?. Probable protein fragment    25
NZ_CP027599.1_97511	LIPO(Sec/SPII)	0.221756	0.025749	0.381235	0.371260	CS pos: ?. Probable protein fragment    16
NZ_CP027599.1_97550	LIPO(Sec/SPII)	0.178123	0.013919	0.618376	0.189582	CS pos: 19-20. LVN-CS. Pr: 0.6014    42
NZ_CP027599.1_97552	SP(Sec/SPI)	0.493619	0.091541	0.229621	0.185219	CS pos: 24-25. VRA-AT. Pr: 0.3864    30
NZ_CP027599.1_97555	LIPO(Sec/SPII)	0.111811	0.009046	0.821290	0.057853	CS pos: 19-20. CQA-CG. Pr: 0.7332    25
NZ_CP027599.1_97569	LIPO(Sec/SPII)	0.191051	0.015175	0.474060	0.319714	CS pos: 13-14. ITR-CS. Pr: 0.2125    16
NZ_CP027599.1_97575	TAT(Tat/SPI)	0.103705	0.468704	0.051419	0.376173	CS pos: 28-29. SSA-IS. Pr: 0.2048    43
NZ_CP027599.1_97603	LIPO(Sec/SPII)	0.089981	0.055808	0.560683	0.293528	CS pos: 20-21. TYG-CY. Pr: 0.5204    27
NZ_CP027599.1_97608	LIPO(Sec/SPII)	0.102152	0.003871	0.760556	0.133422	CS pos: 17-18. VLG-CY. Pr: 0.7640    23
NZ_CP027599.1_97612	LIPO(Sec/SPII)	0.143270	0.001548	0.601579	0.253603	CS pos: 29-30. LGN-CG. Pr: 0.3736    43
NZ_CP027599.1_97631	LIPO(Sec/SPII)	0.260231	0.025187	0.363260	0.351321	CS pos: ?. Probable protein fragment    15
NZ_CP027599.1_97646	SP(Sec/SPI)	0.687423	0.135156	0.072849	0.104572	CS pos: 25-26. ALA-ED. Pr: 0.7162    43
NZ_CP027599.1_97648	SP(Sec/SPI)	0.671892	0.160445	0.034885	0.132778	CS pos: 24-25. LTA-AV. Pr: 0.1814    37
NZ_CP027599.1_97650	SP(Sec/SPI)	0.464318	0.100685	0.242524	0.192473	CS pos: 18-19. ASA-SR. Pr: 0.3577    21
NZ_CP027599.1_97655	SP(Sec/SPI)	0.580304	0.134116	0.245858	0.039721	CS pos: 24-25. ARS-AM. Pr: 0.2383    41
NZ_CP027599.1_97731	TAT(Tat/SPI)	0.137617	0.438402	0.172305	0.251676	CS pos: 17-18. AFC-QL. Pr: 0.0492    21
NZ_CP027599.1_97733	LIPO(Sec/SPII)	0.243425	0.122465	0.525102	0.109008	CS pos: 11-12. PGA-CS. Pr: 0.3813    36
NZ_CP027599.1_97734	SP(Sec/SPI)	0.537008	0.016819	0.252151	0.194022	CS pos: 16-17. AVA-KP. Pr: 0.3447    25
NZ_CP027599.1_97741	SP(Sec/SPI)	0.525941	0.057196	0.082707	0.334157	CS pos: 19-20. ASS-AT. Pr: 0.2655    34
NZ_CP027599.1_97771	SP(Sec/SPI)	0.452889	0.014285	0.272169	0.260657	CS pos: ?. Probable protein fragment    18
NZ_CP027599.1_97794	LIPO(Sec/SPII)	0.009423	0.000726	0.981870	0.007981	CS pos: 19-20. LRG-CQ. Pr: 0.9817    30
NZ_CP027599.1_97821	SP(Sec/SPI)	0.362728	0.042383	0.262975	0.331914	CS pos: 16-17. CEC-AG. Pr: 0.1518    30
NZ_CP027599.1_97825	LIPO(Sec/SPII)	0.252595	0.036418	0.359603	0.351384	CS pos: 14-15. GKS-CW. Pr: 0.0829    17
NZ_CP027599.1_97849	LIPO(Sec/SPII)	0.075544	0.011558	0.797426	0.115472	CS pos: 19-20. ILA-CQ. Pr: 0.7474    22
NZ_CP027599.1_97904	SP(Sec/SPI)	0.411634	0.057458	0.248729	0.282180	CS pos: 17-18. AWS-VP. Pr: 0.1397    24
NZ_CP027599.1_97907	LIPO(Sec/SPII)	0.274570	0.007218	0.461401	0.256811	CS pos: ?. Probable protein fragment    17
NZ_CP027599.1_97929	SP(Sec/SPI)	0.652655	0.011005	0.148368	0.187971	CS pos: 15-16. SRA-AK. Pr: 0.5010    25
NZ_CP027599.1_97951	LIPO(Sec/SPII)	0.284422	0.003288	0.448037	0.264253	CS pos: 23-24. IVC-CM. Pr: 0.1777    25
NZ_CP027599.1_97962	LIPO(Sec/SPII)	0.129438	0.123891	0.422522	0.324149	CS pos: 16-17. LSA-CF. Pr: 0.3722    27
NZ_CP027599.1_97966	SP(Sec/SPI)	0.663547	0.028873	0.101669	0.205911	CS pos: 21-22. ASA-LK. Pr: 0.5000    29
NZ_CP027599.1_98004	SP(Sec/SPI)	0.456824	0.068439	0.191202	0.283536	CS pos: 19-20. QRA-AD. Pr: 0.2685    27
NZ_CP027599.1_98008	LIPO(Sec/SPII)	0.030538	0.001529	0.946634	0.021299	CS pos: 14-15. CAG-CA. Pr: 0.9332    36
NZ_CP027599.1_98011	SP(Sec/SPI)	0.785396	0.046736	0.049643	0.118225	CS pos: 26-27. SYS-AV. Pr: 0.5635    46
NZ_CP027599.1_98020	LIPO(Sec/SPII)	0.249647	0.015383	0.488369	0.246600	CS pos: ?. Probable protein fragment    18
NZ_CP027599.1_98032	SP(Sec/SPI)	0.497813	0.071393	0.100010	0.330784	CS pos: 24-25. GRC-AD. Pr: 0.2294    39
NZ_CP027599.1_98042	LIPO(Sec/SPII)	0.099702	0.023851	0.578398	0.298049	CS pos: 20-21. MVA-CN. Pr: 0.5548    24
NZ_CP027599.1_98082	SP(Sec/SPI)	0.525017	0.140066	0.145380	0.189537	CS pos: 37-38. TQA-AN. Pr: 0.4921    50
NZ_CP027599.1_98083	TAT(Tat/SPI)	0.188237	0.601487	0.046171	0.164105	CS pos: 26-27. ATA-RR. Pr: 0.3327    33
NZ_CP027599.1_98092	SP(Sec/SPI)	0.567347	0.086398	0.014074	0.332182	CS pos: 32-33. VKA-TI. Pr: 0.3458    45
NZ_CP027599.1_98103	LIPO(Sec/SPII)	0.087118	0.037425	0.499033	0.376424	CS pos: 15-16. NTS-CS. Pr: 0.4814    35
NZ_CP027599.1_98142	SP(Sec/SPI)	0.369884	0.008924	0.274016	0.347176	CS pos: 19-20. LLC-AT. Pr: 0.1340    47
NZ_CP027599.1_98143	LIPO(Sec/SPII)	0.242710	0.025497	0.427299	0.304494	CS pos: 19-20. VAK-CN. Pr: 0.3045    35
NZ_CP027599.1_98145	LIPO(Sec/SPII)	0.324335	0.023974	0.451726	0.199965	CS pos: ?. Probable protein fragment    15
NZ_CP027599.1_98171	TAT(Tat/SPI)	0.089436	0.813079	0.051922	0.045562	CS pos: 29-30. AWA-TA. Pr: 0.7451    50
NZ_CP027599.1_98177	LIPO(Sec/SPII)	0.286243	0.006611	0.612578	0.094568	CS pos: 15-16. STA-CG. Pr: 0.5136    23
NZ_CP027599.1_98187	LIPO(Sec/SPII)	0.126070	0.007919	0.522768	0.343243	CS pos: 15-16. SCG-CG. Pr: 0.3299    24
NZ_CP027599.1_98198	SP(Sec/SPI)	0.440724	0.143864	0.150541	0.264871	CS pos: 38-39. TSA-IN. Pr: 0.2795    49
NZ_CP027599.1_98203	SP(Sec/SPI)	0.960571	0.007058	0.028602	0.003769	CS pos: 18-19. ASA-AV. Pr: 0.8936    50
NZ_CP027599.1_98204	SP(Sec/SPI)	0.507241	0.059050	0.129553	0.304156	CS pos: 12-13. AMA-TK. Pr: 0.3048    19
NZ_CP027599.1_98256	SP(Sec/SPI)	0.362035	0.092371	0.282000	0.263593	CS pos: 25-26. ATS-KR. Pr: 0.0992    30
NZ_CP027599.1_98258	LIPO(Sec/SPII)	0.153615	0.007583	0.686109	0.152693	CS pos: 26-27. WSV-CT. Pr: 0.6283    41
NZ_CP027599.1_98265	TAT(Tat/SPI)	0.166000	0.584343	0.085797	0.163860	CS pos: 23-24. AGG-YR. Pr: 0.0329    25
NZ_CP027599.1_98275	TAT(Tat/SPI)	0.061104	0.495594	0.069750	0.373551	CS pos: 28-29. TES-QR. Pr: 0.0504    32
NZ_CP027599.1_98287	SP(Sec/SPI)	0.437947	0.069004	0.149065	0.343984	CS pos: 16-17. ASA-AW. Pr: 0.2294    26
NZ_CP027599.1_98317	SP(Sec/SPI)	0.441063	0.019411	0.176711	0.362815	CS pos: ?. Probable protein fragment    33
NZ_CP027599.1_98322	LIPO(Sec/SPII)	0.206185	0.018982	0.655773	0.119060	CS pos: 15-16. LSP-CS. Pr: 0.5821    26
NZ_CP027599.1_98332	LIPO(Sec/SPII)	0.236746	0.039571	0.371383	0.352299	CS pos: 11-12. GAA-CV. Pr: 0.1082    15
NZ_CP027599.1_98334	LIPO(Sec/SPII)	0.340782	0.026977	0.342142	0.290099	CS pos: ?. Probable protein fragment    21
NZ_CP027599.1_98336	LIPO(Sec/SPII)	0.220461	0.009474	0.478596	0.291469	CS pos: 33-34. PLC-CQ. Pr: 0.3404    40
NZ_CP027599.1_98365	LIPO(Sec/SPII)	0.097139	0.093466	0.553025	0.256369	CS pos: 21-22. LGG-CR. Pr: 0.5289    32
NZ_CP027599.1_98367	SP(Sec/SPI)	0.510845	0.118666	0.069818	0.300672	CS pos: 18-19. ARA-GD. Pr: 0.5211    25
NZ_CP027599.1_98408	LIPO(Sec/SPII)	0.128129	0.016618	0.483079	0.372174	CS pos: 26-27. AIS-CS. Pr: 0.4346    31
NZ_CP027599.1_98421	LIPO(Sec/SPII)	0.279533	0.161410	0.301810	0.257248	CS pos: 15-16. GPG-CS. Pr: 0.2215    41
NZ_CP027599.1_98430	LIPO(Sec/SPII)	0.121739	0.042550	0.471933	0.363778	CS pos: 12-13. ASS-CC. Pr: 0.3830    36
NZ_CP027599.1_98445	LIPO(Sec/SPII)	0.246831	0.072818	0.341602	0.338749	CS pos: ?. Probable protein fragment    16
NZ_CP027599.1_98457	SP(Sec/SPI)	0.369221	0.280996	0.157626	0.192158	CS pos: 23-24. SLC-GG. Pr: 0.4092    32
NZ_CP027599.1_98469	SP(Sec/SPI)	0.608992	0.061650	0.142666	0.186691	CS pos: 29-30. ARS-IS. Pr: 0.5389    40
NZ_CP027599.1_98475	LIPO(Sec/SPII)	0.239546	0.037334	0.411495	0.311624	CS pos: 13-14. PVL-CQ. Pr: 0.0535    17
NZ_CP027599.1_98481	LIPO(Sec/SPII)	0.089284	0.054110	0.432834	0.423772	CS pos: 14-15. SVS-CQ. Pr: 0.4256    34
NZ_CP027599.1_98494	LIPO(Sec/SPII)	0.139899	0.050047	0.477268	0.332786	CS pos: 10-11. SVG-CA. Pr: 0.4161    21
NZ_CP027599.1_98508	LIPO(Sec/SPII)	0.041699	0.003159	0.856822	0.098321	CS pos: 20-21. SFG-CF. Pr: 0.8679    49
NZ_CP027599.1_98518	LIPO(Sec/SPII)	0.272166	0.007738	0.437527	0.282569	CS pos: 16-17. AKT-CP. Pr: 0.1890    24
NZ_CP027599.1_98555	LIPO(Sec/SPII)	0.171027	0.040453	0.445267	0.343253	CS pos: 15-16. VSG-CR. Pr: 0.3603    25
NZ_CP027599.1_98556	LIPO(Sec/SPII)	0.418053	0.003178	0.497188	0.081581	CS pos: 12-13. SAI-CS. Pr: 0.3481    19
NZ_CP027599.1_98576	LIPO(Sec/SPII)	0.133548	0.005539	0.603209	0.257705	CS pos: 16-17. IFS-CT. Pr: 0.4597    25
NZ_CP027599.1_98596	SP(Sec/SPI)	0.403316	0.180431	0.139885	0.276368	CS pos: 22-23. IPA-AS. Pr: 0.2056    35
NZ_CP027599.1_98641	LIPO(Sec/SPII)	0.080903	0.008652	0.570139	0.340306	CS pos: 20-21. VPS-CC. Pr: 0.4423    36
NZ_CP027599.1_98659	SP(Sec/SPI)	0.526149	0.007256	0.161371	0.305224	CS pos: 16-17. TVA-SP. Pr: 0.2452    26
NZ_CP027599.1_98675	SP(Sec/SPI)	0.491328	0.100263	0.133213	0.275196	CS pos: 18-19. SLA-NI. Pr: 0.2438    38
NZ_CP027599.1_98696	LIPO(Sec/SPII)	0.295994	0.013202	0.361067	0.329737	CS pos: ?. Probable protein fragment    15
NZ_CP027599.1_98710	LIPO(Sec/SPII)	0.247282	0.092331	0.625899	0.034488	CS pos: 19-20. IFP-CC. Pr: 0.3107    43
NZ_CP027599.1_98789	SP(Sec/SPI)	0.467971	0.025139	0.095057	0.411833	CS pos: 17-18. LHA-TS. Pr: 0.3825    36
NZ_CP027599.1_98849	LIPO(Sec/SPII)	0.133939	0.005879	0.826962	0.033220	CS pos: 28-29. LAA-CS. Pr: 0.8258    42
NZ_CP027599.1_98869	LIPO(Sec/SPII)	0.192626	0.182304	0.368682	0.256388	CS pos: 18-19. PGA-CG. Pr: 0.1865    22
NZ_CP027599.1_98871	LIPO(Sec/SPII)	0.244260	0.047472	0.369916	0.338352	CS pos: 15-16. VSA-CI. Pr: 0.3297    17
NZ_CP027599.1_98890	SP(Sec/SPI)	0.464868	0.064086	0.032111	0.438935	CS pos: 31-32. AKA-KG. Pr: 0.0838    46
NZ_CP027599.1_98902	LIPO(Sec/SPII)	0.220981	0.031699	0.423925	0.323395	CS pos: 13-14. FLS-CI. Pr: 0.1764    15
NZ_CP027599.1_98917	LIPO(Sec/SPII)	0.343205	0.163616	0.418454	0.074725	CS pos: 13-14. TAT-CS. Pr: 0.3975    33
NZ_CP027599.1_98953	LIPO(Sec/SPII)	0.051988	0.009205	0.826710	0.112098	CS pos: 19-20. NLS-CR. Pr: 0.8150    33
NZ_CP027599.1_98977	LIPO(Sec/SPII)	0.107111	0.011720	0.812671	0.068498	CS pos: 18-19. TTS-CK. Pr: 0.6791    29
NZ_CP027599.1_98979	SP(Sec/SPI)	0.350278	0.042838	0.288350	0.318534	CS pos: ?. Probable protein fragment    18
NZ_CP027599.1_98982	LIPO(Sec/SPII)	0.128850	0.024572	0.584003	0.262575	CS pos: 10-11. LSG-CS. Pr: 0.5343    28
NZ_CP027599.1_98991	LIPO(Sec/SPII)	0.309223	0.012062	0.436752	0.241964	CS pos: 12-13. LAG-CY. Pr: 0.2516    22
NZ_CP027599.1_98995	LIPO(Sec/SPII)	0.209545	0.012918	0.621313	0.156223	CS pos: 20-21. GWC-CF. Pr: 0.3986    43
NZ_CP027599.1_99022	TAT(Tat/SPI)	0.056982	0.555094	0.008922	0.379002	CS pos: 28-29. IRA-GS. Pr: 0.3445    38
NZ_CP027599.1_99033	LIPO(Sec/SPII)	0.118630	0.002198	0.868136	0.011036	CS pos: 16-17. ING-CW. Pr: 0.8611    36
NZ_CP027599.1_99057	LIPO(Sec/SPII)	0.155561	0.099992	0.512040	0.232407	CS pos: 13-14. LSG-CG. Pr: 0.3692    20
NZ_CP027599.1_99061	LIPO(Sec/SPII)	0.077629	0.013719	0.731479	0.177172	CS pos: 21-22. VGS-CG. Pr: 0.7245    32
NZ_CP027599.1_99128	SP(Sec/SPI)	0.413127	0.046823	0.231509	0.308541	CS pos: 18-19. ATA-GN. Pr: 0.2029    28
NZ_CP027599.1_99156	LIPO(Sec/SPII)	0.064118	0.048884	0.730631	0.156367	CS pos: 13-14. AVA-CN. Pr: 0.7359    40
NZ_CP027599.1_99182	LIPO(Sec/SPII)	0.278965	0.022394	0.352599	0.346042	CS pos: 16-17. RVA-CG. Pr: 0.1927    39
NZ_CP027599.1_99186	TAT(Tat/SPI)	0.197537	0.524843	0.048447	0.229174	CS pos: 25-26. ASA-WS. Pr: 0.4090    28
NZ_CP027599.1_99190	LIPO(Sec/SPII)	0.349961	0.034897	0.411667	0.203475	CS pos: ?. Probable protein fragment    19
NZ_CP027599.1_99199	LIPO(Sec/SPII)	0.086724	0.040323	0.570938	0.302015	CS pos: 17-18. HSG-CC. Pr: 0.4877    33
NZ_CP027599.1_99265	SP(Sec/SPI)	0.452623	0.212793	0.113243	0.221340	CS pos: 25-26. CGA-AL. Pr: 0.2174    34
NZ_CP027599.1_99285	SP(Sec/SPI)	0.610507	0.053998	0.078361	0.257134	CS pos: 13-14. ASA-QQ. Pr: 0.5600    36
NZ_CP027599.1_99308	LIPO(Sec/SPII)	0.202566	0.019803	0.392176	0.385455	CS pos: ?. Probable protein fragment    17
NZ_CP027599.1_99333	SP(Sec/SPI)	0.558392	0.054137	0.052629	0.334842	CS pos: 23-24. ADA-FS. Pr: 0.2767    38
NZ_CP027599.1_99375	SP(Sec/SPI)	0.519982	0.145089	0.061670	0.273259	CS pos: 22-23. AYS-RC. Pr: 0.2888    37
NZ_CP027599.1_99398	LIPO(Sec/SPII)	0.106918	0.139571	0.548282	0.205229	CS pos: 19-20. WAA-CS. Pr: 0.4717    23
NZ_CP027599.1_99431	SP(Sec/SPI)	0.489212	0.129526	0.056752	0.324509	CS pos: 20-21. AKA-SP. Pr: 0.2153    32
NZ_CP027599.1_99456	LIPO(Sec/SPII)	0.167117	0.063551	0.482736	0.286596	CS pos: 15-16. GCG-CG. Pr: 0.2282    17
NZ_CP027599.1_99498	SP(Sec/SPI)	0.880876	0.001714	0.097649	0.019762	CS pos: 17-18. VMA-ES. Pr: 0.8164    45
NZ_CP027599.1_99504	LIPO(Sec/SPII)	0.147749	0.047226	0.456644	0.348380	CS pos: 19-20. CSA-CW. Pr: 0.4248    43
NZ_CP027599.1_99553	SP(Sec/SPI)	0.411802	0.001615	0.292422	0.294161	CS pos: 19-20. IKP-KQ. Pr: 0.1072    27
NZ_CP027599.1_99569	LIPO(Sec/SPII)	0.155896	0.058947	0.639876	0.145282	CS pos: 17-18. AAF-CG. Pr: 0.5143    29
NZ_CP027599.1_99580	LIPO(Sec/SPII)	0.196678	0.012291	0.452718	0.338312	CS pos: 15-16. QLK-CQ. Pr: 0.2906    18
NZ_CP027599.1_99639	LIPO(Sec/SPII)	0.231284	0.022809	0.388021	0.357886	CS pos: ?. Probable protein fragment    18
NZ_CP027599.1_99669	SP(Sec/SPI)	0.408819	0.029081	0.285828	0.276272	CS pos: 21-22. ISA-AG. Pr: 0.0516    27
NZ_CP027599.1_99694	SP(Sec/SPI)	0.554677	0.008423	0.302168	0.134732	CS pos: 19-20. LNA-SF. Pr: 0.3848    24
NZ_CP027599.1_99696	LIPO(Sec/SPII)	0.155655	0.039705	0.684022	0.120617	CS pos: 24-25. SAT-CC. Pr: 0.3564    43
NZ_CP027599.1_99699	LIPO(Sec/SPII)	0.118905	0.009903	0.515442	0.355750	CS pos: 17-18. NVT-CE. Pr: 0.4116    19
NZ_CP027599.1_99712	LIPO(Sec/SPII)	0.146057	0.041155	0.685556	0.127232	CS pos: 17-18. MAA-CV. Pr: 0.5462    38
NZ_CP027599.1_99713	SP(Sec/SPI)	0.471669	0.062126	0.108005	0.358200	CS pos: 18-19. AVS-ES. Pr: 0.2711    26
NZ_CP027599.1_99902	LIPO(Sec/SPII)	0.295503	0.013648	0.395508	0.295340	CS pos: 21-22. LNG-CR. Pr: 0.3006    24
NZ_CP027599.1_99925	LIPO(Sec/SPII)	0.268375	0.026205	0.376302	0.329118	CS pos: ?. Probable protein fragment    18
NZ_CP027599.1_99926	LIPO(Sec/SPII)	0.281601	0.015336	0.649480	0.053582	CS pos: 19-20. NLA-CC. Pr: 0.3244    46
NZ_CP027599.1_99930	SP(Sec/SPI)	0.599763	0.016863	0.264786	0.118588	CS pos: 17-18. CTA-AI. Pr: 0.3130    28
NZ_CP027599.1_99935	SP(Sec/SPI)	0.574380	0.026950	0.177587	0.221083	CS pos: 16-17. ALA-PD. Pr: 0.3584    20
NZ_CP027599.1_99942	SP(Sec/SPI)	0.408207	0.186259	0.071426	0.334108	CS pos: 29-30. MKA-HK. Pr: 0.2754    46
NZ_CP027599.1_99958	SP(Sec/SPI)	0.686168	0.084829	0.173723	0.055281	CS pos: 23-24. GSA-SP. Pr: 0.4150    41
NZ_CP027599.1_100008	LIPO(Sec/SPII)	0.036748	0.027564	0.883011	0.052677	CS pos: 18-19. AGG-CG. Pr: 0.8506    22
NZ_CP027599.1_100044	SP(Sec/SPI)	0.806567	0.011098	0.067135	0.115200	CS pos: 17-18. AFA-SN. Pr: 0.6384    32
NZ_CP027599.1_100056	LIPO(Sec/SPII)	0.123847	0.096253	0.626106	0.153794	CS pos: 20-21. VYA-CS. Pr: 0.5928    23
NZ_CP027599.1_100059	LIPO(Sec/SPII)	0.157181	0.029863	0.740704	0.072252	CS pos: 21-22. QIS-CN. Pr: 0.7079    28
NZ_CP027599.1_100077	LIPO(Sec/SPII)	0.311658	0.038939	0.432791	0.216612	CS pos: 20-21. FSG-AN. Pr: 0.1650    31
NZ_CP027599.1_100101	SP(Sec/SPI)	0.334080	0.113722	0.320980	0.231218	CS pos: 20-21. AGA-SS. Pr: 0.1504    25
NZ_CP027599.1_100104	SP(Sec/SPI)	0.431809	0.143099	0.115559	0.309533	CS pos: 19-20. SSA-IP. Pr: 0.2125    22
NZ_CP027599.1_100125	SP(Sec/SPI)	0.549789	0.145407	0.130873	0.173931	CS pos: 20-21. APA-GQ. Pr: 0.3291    23
NZ_CP027599.1_100127	SP(Sec/SPI)	0.513738	0.051588	0.243566	0.191108	CS pos: ?. Probable protein fragment    19
NZ_CP027599.1_100147	LIPO(Sec/SPII)	0.034222	0.029915	0.850534	0.085329	CS pos: 14-15. TVA-CS. Pr: 0.8525    47
NZ_CP027599.1_100158	LIPO(Sec/SPII)	0.199827	0.007701	0.708715	0.083758	CS pos: 21-22. VFA-CH. Pr: 0.8433    46
NZ_CP027599.1_100161	LIPO(Sec/SPII)	0.258066	0.058252	0.369046	0.314635	CS pos: ?. Probable protein fragment    15
NZ_CP027599.1_100164	SP(Sec/SPI)	0.464592	0.035998	0.124739	0.374671	CS pos: 18-19. AWS-SE. Pr: 0.3675    21
NZ_CP027599.1_100201	LIPO(Sec/SPII)	0.238780	0.011193	0.414169	0.335858	CS pos: 14-15. FIC-CL. Pr: 0.0863    19
NZ_CP027599.1_100211	SP(Sec/SPI)	0.478407	0.023386	0.202380	0.295827	CS pos: ?. Probable protein fragment    19
NZ_CP027599.1_100215	LIPO(Sec/SPII)	0.257364	0.018067	0.420032	0.304537	CS pos: 18-19. LTY-CI. Pr: 0.0606    20
NZ_CP027599.1_100223	LIPO(Sec/SPII)	0.135538	0.057632	0.448751	0.358080	CS pos: ?. Probable protein fragment    18
NZ_CP027599.1_100267	LIPO(Sec/SPII)	0.126015	0.004616	0.462185	0.407183	CS pos: 12-13. TSG-CC. Pr: 0.3703    33
NZ_CP027599.1_100280	SP(Sec/SPI)	0.531899	0.243746	0.099314	0.125041	CS pos: 30-31. SPA-LP. Pr: 0.2334    38
NZ_CP027599.1_100293	SP(Sec/SPI)	0.391683	0.018430	0.303374	0.286514	CS pos: 21-22. SIA-SI. Pr: 0.3000    32
NZ_CP027599.1_100308	LIPO(Sec/SPII)	0.035805	0.003917	0.694018	0.266260	CS pos: 29-30. LTT-CD. Pr: 0.6900    47
NZ_CP027599.1_100313	LIPO(Sec/SPII)	0.252663	0.028213	0.417809	0.301315	CS pos: 22-23. ATL-CT. Pr: 0.3594    28
NZ_CP027599.1_100340	SP(Sec/SPI)	0.424010	0.332761	0.061390	0.181839	CS pos: 20-21. ASA-AP. Pr: 0.5769    25
NZ_CP027599.1_100377	SP(Sec/SPI)	0.437283	0.048930	0.320117	0.193670	CS pos: 21-22. CHA-AS. Pr: 0.4179    39
NZ_CP027599.1_100383	LIPO(Sec/SPII)	0.373762	0.021516	0.399820	0.204901	CS pos: 20-21. MSA-TT. Pr: 0.3775    42
NZ_CP027599.1_100386	LIPO(Sec/SPII)	0.123303	0.008790	0.588185	0.279722	CS pos: 18-19. SLQ-CD. Pr: 0.5428    22
NZ_CP027599.1_100390	LIPO(Sec/SPII)	0.028569	0.095431	0.459615	0.416385	CS pos: 20-21. VSS-CL. Pr: 0.4581    43
NZ_CP027599.1_100393	LIPO(Sec/SPII)	0.107033	0.011822	0.800118	0.081027	CS pos: 20-21. ATG-CN. Pr: 0.7497    22
NZ_CP027599.1_100398	SP(Sec/SPI)	0.603657	0.040931	0.081756	0.273656	CS pos: 22-23. PYA-GS. Pr: 0.2882    33
NZ_CP027599.1_100412	SP(Sec/SPI)	0.570494	0.082666	0.071312	0.275528	CS pos: 16-17. AAA-RD. Pr: 0.4397    26
NZ_CP027599.1_100417	TAT(Tat/SPI)	0.125811	0.444757	0.050726	0.378705	CS pos: 30-31. SPS-SF. Pr: 0.0754    50
NZ_CP027599.1_100438	SP(Sec/SPI)	0.485021	0.064949	0.139931	0.310099	CS pos: 24-25. AAA-TA. Pr: 0.1783    27
NZ_CP027599.1_100439	SP(Sec/SPI)	0.664501	0.227273	0.049508	0.058718	CS pos: 19-20. ANA-TG. Pr: 0.5428    32
NZ_CP027599.1_100441	SP(Sec/SPI)	0.704617	0.064748	0.123637	0.106998	CS pos: 23-24. VLA-AS. Pr: 0.5867    35
NZ_CP027599.1_100500	LIPO(Sec/SPII)	0.278189	0.026401	0.369967	0.325442	CS pos: 25-26. MTA-CW. Pr: 0.1474    31
NZ_CP027599.1_100514	LIPO(Sec/SPII)	0.148818	0.068491	0.496038	0.286652	CS pos: 16-17. APA-CG. Pr: 0.4610    27
NZ_CP027599.1_100523	SP(Sec/SPI)	0.371249	0.039975	0.230324	0.358453	CS pos: ?. Probable protein fragment    20
NZ_CP027599.1_100545	SP(Sec/SPI)	0.656503	0.032705	0.175262	0.135530	CS pos: 26-27. AHW-AS. Pr: 0.2314    38
NZ_CP027599.1_100552	TAT(Tat/SPI)	0.258855	0.382195	0.091124	0.267825	CS pos: 31-32. SPA-LP. Pr: 0.0999    39
NZ_CP027599.1_100576	TAT(Tat/SPI)	0.154177	0.478206	0.109346	0.258271	CS pos: 23-24. ASS-SR. Pr: 0.1376    41
NZ_CP027599.1_100614	LIPO(Sec/SPII)	0.313939	0.045665	0.346448	0.293948	CS pos: 27-28. LSG-DC. Pr: 0.1972    31
NZ_CP027599.1_100623	LIPO(Sec/SPII)	0.230348	0.046327	0.407753	0.315572	CS pos: 24-25. ALT-CS. Pr: 0.3319    37
NZ_CP027599.1_100718	SP(Sec/SPI)	0.490136	0.056791	0.090933	0.362139	CS pos: 21-22. ISA-NW. Pr: 0.2070    26
NZ_CP027599.1_100727	TAT(Tat/SPI)	0.153398	0.457721	0.034626	0.354256	CS pos: 42-43. ASA-AS. Pr: 0.1578    50
NZ_CP027599.1_100757	SP(Sec/SPI)	0.495654	0.007075	0.236257	0.261014	CS pos: 23-24. LNS-DT. Pr: 0.1709    28
NZ_CP027599.1_100768	SP(Sec/SPI)	0.626671	0.005895	0.230272	0.137162	CS pos: 19-20. SIA-TR. Pr: 0.4704    44
NZ_CP027599.1_100813	SP(Sec/SPI)	0.325536	0.315340	0.104024	0.255100	CS pos: 18-19. TSA-KI. Pr: 0.2686    37
NZ_CP027599.1_100818	SP(Sec/SPI)	0.477646	0.082761	0.198875	0.240718	CS pos: 22-23. VIS-RS. Pr: 0.3390    34
NZ_CP027599.1_100822	TAT(Tat/SPI)	0.144926	0.524286	0.070280	0.260507	CS pos: 28-29. GRT-GT. Pr: 0.1316    35
NZ_CP027599.1_100827	SP(Sec/SPI)	0.569322	0.204562	0.016883	0.209233	CS pos: 16-17. ASA-VD. Pr: 0.6721    42
NZ_CP027599.1_100856	LIPO(Sec/SPII)	0.098005	0.011185	0.615581	0.275229	CS pos: 22-23. LSK-CC. Pr: 0.4975    30
NZ_CP027599.1_100931	TAT(Tat/SPI)	0.011378	0.955077	0.005504	0.028041	CS pos: 26-27. GMA-LR. Pr: 0.5034    44
NZ_CP027599.1_100943	LIPO(Sec/SPII)	0.156059	0.012515	0.696630	0.134796	CS pos: 19-20. SAS-CS. Pr: 0.6405    22
NZ_CP027599.1_100999	SP(Sec/SPI)	0.543873	0.209192	0.080429	0.166506	CS pos: 32-33. ANS-AS. Pr: 0.4502    37
NZ_CP027599.1_101001	LIPO(Sec/SPII)	0.064125	0.002975	0.884216	0.048684	CS pos: 14-15. SAA-CT. Pr: 0.8851    40
NZ_CP027599.1_101016	SP(Sec/SPI)	0.498869	0.024068	0.154612	0.322451	CS pos: 21-22. FQA-SE. Pr: 0.2204    26
NZ_CP027599.1_101145	SP(Sec/SPI)	0.455232	0.064029	0.147371	0.333368	CS pos: 15-16. AQA-RS. Pr: 0.3207    19
NZ_CP027599.1_101148	LIPO(Sec/SPII)	0.138116	0.002416	0.818262	0.041206	CS pos: 16-17. FIS-CW. Pr: 0.6845    24
NZ_CP027599.1_101181	LIPO(Sec/SPII)	0.071230	0.073335	0.534803	0.320632	CS pos: 21-22. ITG-QR. Pr: 0.4941    47
NZ_CP027599.1_101198	SP(Sec/SPI)	0.669447	0.127672	0.059633	0.143248	CS pos: 18-19. SRA-QV. Pr: 0.6153    39
NZ_CP027599.1_101212	LIPO(Sec/SPII)	0.254296	0.016202	0.479061	0.250441	CS pos: ?. Probable protein fragment    16
NZ_CP027599.1_101237	LIPO(Sec/SPII)	0.139742	0.001794	0.724366	0.134098	CS pos: 17-18. LGG-LD. Pr: 0.6738    30
NZ_CP027599.1_101238	LIPO(Sec/SPII)	0.075372	0.001579	0.830028	0.093020	CS pos: 27-28. LSL-CS. Pr: 0.7658    35
NZ_CP027599.1_101243	SP(Sec/SPI)	0.514837	0.035499	0.043213	0.406451	CS pos: 16-17. SNA-EL. Pr: 0.2489    41
NZ_CP027599.1_101265	LIPO(Sec/SPII)	0.219113	0.027911	0.391042	0.361933	CS pos: ?. Probable protein fragment    18
NZ_CP027599.1_101285	LIPO(Sec/SPII)	0.297605	0.008757	0.352815	0.340823	CS pos: ?. Probable protein fragment    20
NZ_CP027599.1_101362	SP(Sec/SPI)	0.416560	0.374534	0.062088	0.146818	CS pos: 19-20. AAA-AS. Pr: 0.3812    30
NZ_CP027599.1_101401	LIPO(Sec/SPII)	0.250349	0.036111	0.389759	0.323781	CS pos: 12-13. KAA-CM. Pr: 0.1288    15
NZ_CP027599.1_101455	LIPO(Sec/SPII)	0.304110	0.007146	0.399075	0.289669	CS pos: 21-22. AGQ-CN. Pr: 0.2075    23
NZ_CP027599.1_101457	SP(Sec/SPI)	0.503007	0.121557	0.086877	0.288559	CS pos: ?. Probable protein fragment    22
NZ_CP027599.1_101550	LIPO(Sec/SPII)	0.103810	0.007783	0.834147	0.054260	CS pos: 14-15. FSG-CV. Pr: 0.8106    23
NZ_CP027599.1_101552	SP(Sec/SPI)	0.509669	0.008937	0.281154	0.200240	CS pos: 21-22. ALA-SG. Pr: 0.3213    23
NZ_CP027599.1_101569	SP(Sec/SPI)	0.422960	0.081919	0.083678	0.411443	CS pos: 28-29. STA-AP. Pr: 0.2197    31
NZ_CP027599.1_101571	LIPO(Sec/SPII)	0.148094	0.051791	0.415912	0.384203	CS pos: 16-17. FFG-CC. Pr: 0.3084    18
NZ_CP027599.1_101588	LIPO(Sec/SPII)	0.275115	0.012317	0.446787	0.265780	CS pos: 12-13. WSG-TL. Pr: 0.0258    15
NZ_CP027599.1_101624	LIPO(Sec/SPII)	0.253550	0.040916	0.357121	0.348414	CS pos: ?. Probable protein fragment    15
NZ_CP027599.1_101628	LIPO(Sec/SPII)	0.026332	0.001596	0.898921	0.073151	CS pos: 17-18. LLG-CY. Pr: 0.8886    25
NZ_CP027599.1_101689	LIPO(Sec/SPII)	0.268339	0.020570	0.424134	0.286956	CS pos: 16-17. VFP-CR. Pr: 0.2264    20
NZ_CP027599.1_101703	LIPO(Sec/SPII)	0.258652	0.026574	0.460485	0.254289	CS pos: 14-15. FQG-AW. Pr: 0.0425    16
NZ_CP027599.1_101723	SP(Sec/SPI)	0.374207	0.025784	0.257492	0.342516	CS pos: 16-17. LAG-NS. Pr: 0.1591    20
NZ_CP027599.1_101739	SP(Sec/SPI)	0.534452	0.169079	0.038068	0.258401	CS pos: 22-23. ARA-KA. Pr: 0.3243    50
NZ_CP027599.1_101748	LIPO(Sec/SPII)	0.141696	0.027167	0.528020	0.303117	CS pos: 15-16. LSS-CS. Pr: 0.4596    21
NZ_CP027599.1_101752	LIPO(Sec/SPII)	0.263752	0.013528	0.442122	0.280598	CS pos: ?. Probable protein fragment    19
NZ_CP027599.1_101807	LIPO(Sec/SPII)	0.050045	0.013660	0.799827	0.136468	CS pos: 16-17. LFG-CN. Pr: 0.7858    24
NZ_CP027599.1_101810	TAT(Tat/SPI)	0.276833	0.358201	0.045810	0.319156	CS pos: 20-21. ANA-GN. Pr: 0.3644    48
NZ_CP027599.1_101846	LIPO(Sec/SPII)	0.306046	0.013411	0.380282	0.300260	CS pos: 14-15. MLA-FR. Pr: 0.0428    16
NZ_CP027599.1_101859	LIPO(Sec/SPII)	0.025690	0.001100	0.863076	0.110133	CS pos: 26-27. VTA-CV. Pr: 0.8373    36
NZ_CP027599.1_101872	LIPO(Sec/SPII)	0.150151	0.038980	0.650756	0.160113	CS pos: 16-17. ALS-CR. Pr: 0.5333    19
NZ_CP027599.1_101880	SP(Sec/SPI)	0.595569	0.017240	0.065416	0.321775	CS pos: 19-20. SNA-RI. Pr: 0.4735    31
NZ_CP027599.1_101893	LIPO(Sec/SPII)	0.032419	0.001206	0.789788	0.176587	CS pos: 12-13. FLG-CN. Pr: 0.7719    21
NZ_CP027599.1_101965	LIPO(Sec/SPII)	0.163232	0.058609	0.408252	0.369907	CS pos: 34-35. ASS-CW. Pr: 0.3455    38
NZ_CP027599.1_101989	LIPO(Sec/SPII)	0.124743	0.001150	0.797338	0.076769	CS pos: 12-13. LFG-CI. Pr: 0.7227    20
NZ_CP027599.1_101996	SP(Sec/SPI)	0.483032	0.026622	0.217198	0.273148	CS pos: ?. Probable protein fragment    20
NZ_CP027599.1_102033	LIPO(Sec/SPII)	0.261639	0.025264	0.390441	0.322656	CS pos: ?. Probable protein fragment    17
NZ_CP027599.1_102053	LIPO(Sec/SPII)	0.351019	0.012666	0.552852	0.083462	CS pos: 13-14. LSA-ST. Pr: 0.1461    16
NZ_CP027599.1_102066	SP(Sec/SPI)	0.369968	0.071952	0.346053	0.212027	CS pos: 14-15. TKA-NG. Pr: 0.1237    16
NZ_CP027599.1_102102	LIPO(Sec/SPII)	0.299207	0.010802	0.345842	0.344148	CS pos: 24-25. CSY-CW. Pr: 0.1253    33
NZ_CP027599.1_102115	LIPO(Sec/SPII)	0.254749	0.003504	0.563135	0.178612	CS pos: 14-15. ATC-CM. Pr: 0.2915    23
NZ_CP027599.1_102124	SP(Sec/SPI)	0.443374	0.292513	0.054319	0.209794	CS pos: 35-36. APA-AR. Pr: 0.3040    38
NZ_CP027599.1_102130	LIPO(Sec/SPII)	0.235368	0.119231	0.344840	0.300561	CS pos: 23-24. AAR-CA. Pr: 0.2242    31
NZ_CP027599.1_102145	SP(Sec/SPI)	0.303324	0.146983	0.255590	0.294104	CS pos: ?. Probable protein fragment    22
NZ_CP027599.1_102156	LIPO(Sec/SPII)	0.337196	0.019413	0.351423	0.291968	CS pos: 12-13. ATA-LS. Pr: 0.1838    28
NZ_CP027599.1_102157	LIPO(Sec/SPII)	0.224073	0.007459	0.454543	0.313924	CS pos: ?. Probable protein fragment    18
NZ_CP027599.1_102203	SP(Sec/SPI)	0.433659	0.013923	0.345373	0.207045	CS pos: 15-16. IWA-NT. Pr: 0.1031    18
NZ_CP027599.1_102231	LIPO(Sec/SPII)	0.271591	0.034598	0.351506	0.342304	CS pos: ?. Probable protein fragment    16
NZ_CP027599.1_102240	LIPO(Sec/SPII)	0.348498	0.023699	0.374324	0.253479	CS pos: ?. Probable protein fragment    15
NZ_CP027599.1_102245	LIPO(Sec/SPII)	0.283468	0.016399	0.389851	0.310282	CS pos: 15-16. LSS-SL. Pr: 0.1103    20
NZ_CP027599.1_102251	SP(Sec/SPI)	0.482354	0.008648	0.368703	0.140295	CS pos: 17-18. AGA-AR. Pr: 0.1941    19
NZ_CP027599.1_102262	LIPO(Sec/SPII)	0.127889	0.004311	0.613190	0.254610	CS pos: 14-15. VES-CA. Pr: 0.5897    44
NZ_CP027599.1_102274	SP(Sec/SPI)	0.568270	0.182491	0.075917	0.173322	CS pos: 23-24. AKS-VK. Pr: 0.4197    34
NZ_CP027599.1_102306	SP(Sec/SPI)	0.599082	0.012496	0.175209	0.213213	CS pos: 27-28. SLT-EN. Pr: 0.2291    31
NZ_CP027599.1_102316	LIPO(Sec/SPII)	0.020657	0.002399	0.950780	0.026164	CS pos: 15-16. GGA-CC. Pr: 0.7501    30
NZ_CP027599.1_102334	LIPO(Sec/SPII)	0.224734	0.013829	0.422984	0.338454	CS pos: 18-19. LLW-CQ. Pr: 0.0725    20
NZ_CP027599.1_102343	SP(Sec/SPI)	0.416970	0.193206	0.019723	0.370100	CS pos: 20-21. TAA-LE. Pr: 0.2447    38
NZ_CP027599.1_102356	LIPO(Sec/SPII)	0.165831	0.017447	0.518316	0.298406	CS pos: 18-19. HNC-CN. Pr: 0.3411    23
NZ_CP027599.1_102398	LIPO(Sec/SPII)	0.138360	0.002526	0.753815	0.105300	CS pos: 17-18. AIG-CW. Pr: 0.6656    23
NZ_CP027599.1_102450	LIPO(Sec/SPII)	0.388453	0.009079	0.437043	0.165426	CS pos: 17-18. KGK-CG. Pr: 0.3501    26
NZ_CP027599.1_102469	SP(Sec/SPI)	0.539939	0.026018	0.108352	0.325691	CS pos: 17-18. AIS-SL. Pr: 0.2045    44
NZ_CP027599.1_102474	SP(Sec/SPI)	0.554270	0.020163	0.322244	0.103324	CS pos: 20-21. CSA-KL. Pr: 0.5050    41
NZ_CP027599.1_102490	LIPO(Sec/SPII)	0.046816	0.006685	0.859292	0.087208	CS pos: 16-17. LSG-CR. Pr: 0.8024    30
NZ_CP027599.1_102522	TAT(Tat/SPI)	0.114394	0.461067	0.039379	0.385161	CS pos: 23-24. APA-GR. Pr: 0.1992    43
NZ_CP027599.1_102542	LIPO(Sec/SPII)	0.181645	0.028047	0.514464	0.275843	CS pos: 17-18. RIS-CT. Pr: 0.2393    26
NZ_CP027599.1_102546	LIPO(Sec/SPII)	0.116799	0.028499	0.438163	0.416539	CS pos: 18-19. LAT-CV. Pr: 0.2927    31
NZ_CP027599.1_102548	LIPO(Sec/SPII)	0.081705	0.014469	0.531744	0.372082	CS pos: 28-29. VGL-CS. Pr: 0.4596    44
NZ_CP027599.1_102593	SP(Sec/SPI)	0.445245	0.032131	0.385315	0.137309	CS pos: 23-24. PSA-SK. Pr: 0.1521    28
NZ_CP027599.1_102610	LIPO(Sec/SPII)	0.292814	0.042851	0.397536	0.266799	CS pos: 16-17. GGV-CR. Pr: 0.2595    25
NZ_CP027599.1_102631	LIPO(Sec/SPII)	0.379350	0.028103	0.415552	0.176995	CS pos: 26-27. VLN-CI. Pr: 0.3692    49
NZ_CP027599.1_102671	LIPO(Sec/SPII)	0.109160	0.010170	0.684447	0.196222	CS pos: 16-17. TAG-CG. Pr: 0.6910    28
NZ_CP027599.1_102693	LIPO(Sec/SPII)	0.170366	0.069331	0.405636	0.354667	CS pos: 18-19. PTA-CG. Pr: 0.2661    25
NZ_CP027599.1_102697	LIPO(Sec/SPII)	0.247335	0.014595	0.397744	0.340327	CS pos: 20-21. VRS-CS. Pr: 0.3622    23
NZ_CP027599.1_102705	LIPO(Sec/SPII)	0.305490	0.034646	0.348254	0.311610	CS pos: 14-15. IML-CS. Pr: 0.1031    18
NZ_CP027599.1_102739	TAT(Tat/SPI)	0.328659	0.517236	0.038953	0.115152	CS pos: 24-25. AYA-KL. Pr: 0.7587    29
NZ_CP027599.1_102772	SP(Sec/SPI)	0.427954	0.100370	0.248947	0.222730	CS pos: 23-24. SLT-DS. Pr: 0.1040    27
NZ_CP027599.1_102799	LIPO(Sec/SPII)	0.209032	0.012381	0.399823	0.378763	CS pos: ?. Probable protein fragment    15
NZ_CP027599.1_102804	LIPO(Sec/SPII)	0.173402	0.033871	0.413859	0.378868	CS pos: 26-27. VSG-CS. Pr: 0.3761    34
NZ_CP027599.1_102834	SP(Sec/SPI)	0.452407	0.066467	0.095315	0.385811	CS pos: 15-16. ATA-AD. Pr: 0.2659    26
NZ_CP027599.1_102838	SP(Sec/SPI)	0.409430	0.197882	0.022868	0.369820	CS pos: 29-30. ASA-AN. Pr: 0.4506    40
NZ_CP027599.1_102850	LIPO(Sec/SPII)	0.078670	0.005074	0.768899	0.147357	CS pos: 14-15. AFG-CA. Pr: 0.6906    19
NZ_CP027599.1_102852	LIPO(Sec/SPII)	0.264308	0.012801	0.497309	0.225582	CS pos: 14-15. SGL-CF. Pr: 0.0814    16
NZ_CP027599.1_102909	LIPO(Sec/SPII)	0.239033	0.023577	0.381045	0.356345	CS pos: 9-10. TTA-CV. Pr: 0.1513    15
NZ_CP027599.1_102917	LIPO(Sec/SPII)	0.218225	0.042774	0.426632	0.312369	CS pos: ?. Probable protein fragment    18
NZ_CP027599.1_102940	LIPO(Sec/SPII)	0.355143	0.034958	0.380802	0.229097	CS pos: 19-20. VAP-LP. Pr: 0.0459    21
NZ_CP027599.1_102948	LIPO(Sec/SPII)	0.146673	0.013878	0.762568	0.076882	CS pos: 13-14. TNA-CI. Pr: 0.6336    25
NZ_CP027599.1_102962	LIPO(Sec/SPII)	0.302512	0.022257	0.438509	0.236722	CS pos: ?. Probable protein fragment    16
NZ_CP027599.1_102963	LIPO(Sec/SPII)	0.252168	0.007221	0.458227	0.282384	CS pos: 12-13. VNC-CR. Pr: 0.3550    39
NZ_CP027599.1_102993	LIPO(Sec/SPII)	0.267974	0.024894	0.365079	0.342053	CS pos: ?. Probable protein fragment    19
NZ_CP027599.1_102998	SP(Sec/SPI)	0.628385	0.074944	0.148081	0.148590	CS pos: 22-23. TFA-PS. Pr: 0.2132    31
NZ_CP027599.1_103001	SP(Sec/SPI)	0.310075	0.229243	0.246211	0.214471	CS pos: 24-25. AHS-IS. Pr: 0.4292    37
NZ_CP027599.1_103021	LIPO(Sec/SPII)	0.252992	0.017844	0.383125	0.346039	CS pos: ?. Probable protein fragment    16
NZ_CP027599.1_103023	LIPO(Sec/SPII)	0.190133	0.022741	0.448682	0.338444	CS pos: 17-18. VYP-CD. Pr: 0.4520    49
NZ_CP027599.1_103027	LIPO(Sec/SPII)	0.293530	0.030782	0.357572	0.318115	CS pos: ?. Probable protein fragment    17
NZ_CP027599.1_103034	LIPO(Sec/SPII)	0.224545	0.007610	0.649075	0.118770	CS pos: 19-20. ICQ-CA. Pr: 0.4099    22
NZ_CP027599.1_103059	SP(Sec/SPI)	0.485532	0.068315	0.062886	0.383267	CS pos: 21-22. AIA-SI. Pr: 0.2235    27
NZ_CP027599.1_103076	LIPO(Sec/SPII)	0.020090	0.005817	0.917114	0.056979	CS pos: 29-30. ISG-CN. Pr: 0.9170    35
NZ_CP027599.1_103090	LIPO(Sec/SPII)	0.203000	0.005898	0.639066	0.152036	CS pos: 13-14. IIA-CW. Pr: 0.4406    17
NZ_CP027599.1_103098	LIPO(Sec/SPII)	0.161655	0.012756	0.414335	0.411254	CS pos: 18-19. FLS-CC. Pr: 0.2472    23
NZ_CP027599.1_103146	LIPO(Sec/SPII)	0.139404	0.015501	0.617453	0.227642	CS pos: 21-22. SAA-CW. Pr: 0.5835    25
NZ_CP027599.1_103181	SP(Sec/SPI)	0.649742	0.020004	0.317336	0.012918	CS pos: 23-24. ISA-AR. Pr: 0.4068    28
NZ_CP027599.1_103183	SP(Sec/SPI)	0.451815	0.166076	0.271290	0.110819	CS pos: 16-17. AWA-FC. Pr: 0.2963    42
NZ_CP027599.1_103184	SP(Sec/SPI)	0.332209	0.090786	0.293616	0.283389	CS pos: 20-21. SLC-GN. Pr: 0.2079    30
NZ_CP027599.1_103186	LIPO(Sec/SPII)	0.230911	0.013052	0.443319	0.312718	CS pos: ?. Probable protein fragment    20
NZ_CP027599.1_103194	LIPO(Sec/SPII)	0.169371	0.022231	0.515819	0.292578	CS pos: 16-17. VTA-CH. Pr: 0.3966    19
NZ_CP027599.1_103202	LIPO(Sec/SPII)	0.088629	0.021008	0.603449	0.286914	CS pos: 27-28. SAS-CC. Pr: 0.2923    33
NZ_CP027599.1_103204	LIPO(Sec/SPII)	0.146623	0.012025	0.433228	0.408124	CS pos: 25-26. TIN-CA. Pr: 0.3081    43
NZ_CP027599.1_103242	SP(Sec/SPI)	0.420221	0.103145	0.163357	0.313277	CS pos: 21-22. SSA-SR. Pr: 0.1432    23
NZ_CP027599.1_103252	LIPO(Sec/SPII)	0.090880	0.008819	0.583665	0.316636	CS pos: 17-18. HGG-CG. Pr: 0.5152    23
NZ_CP027599.1_103258	LIPO(Sec/SPII)	0.251111	0.007105	0.389008	0.352777	CS pos: 23-24. FAS-CL. Pr: 0.2396    31
NZ_CP027599.1_103298	SP(Sec/SPI)	0.633757	0.064921	0.183564	0.117758	CS pos: 22-23. LHS-AI. Pr: 0.5431    42
NZ_CP027599.1_103327	SP(Sec/SPI)	0.409616	0.020695	0.190036	0.379653	CS pos: 15-16. AEA-GL. Pr: 0.1826    24
NZ_CP027599.1_103328	SP(Sec/SPI)	0.406594	0.037372	0.150958	0.405075	CS pos: 23-24. RLA-AG. Pr: 0.0469    38
NZ_CP027599.1_103333	LIPO(Sec/SPII)	0.162133	0.023959	0.473333	0.340575	CS pos: ?. Probable protein fragment    30
NZ_CP027599.1_103372	LIPO(Sec/SPII)	0.141775	0.069476	0.620757	0.167991	CS pos: 21-22. TCG-CA. Pr: 0.5262    28
NZ_CP027599.1_103398	LIPO(Sec/SPII)	0.254345	0.035670	0.376973	0.333013	CS pos: 14-15. SIS-CV. Pr: 0.0361    18
NZ_CP027599.1_103400	LIPO(Sec/SPII)	0.023275	0.016755	0.483189	0.476780	CS pos: 21-22. LLN-CQ. Pr: 0.4500    45
NZ_CP027599.1_103407	SP(Sec/SPI)	0.365264	0.358668	0.097894	0.178175	CS pos: 20-21. AST-TR. Pr: 0.1667    36
NZ_CP027599.1_103414	LIPO(Sec/SPII)	0.327521	0.018871	0.405639	0.247970	CS pos: ?. Probable protein fragment    23
NZ_CP027599.1_103432	SP(Sec/SPI)	0.719919	0.013915	0.120335	0.145831	CS pos: 13-14. VYA-AS. Pr: 0.5495    30
NZ_CP027599.1_103460	LIPO(Sec/SPII)	0.227779	0.038690	0.450945	0.282586	CS pos: ?. Probable protein fragment    22
NZ_CP027599.1_103474	LIPO(Sec/SPII)	0.294789	0.018031	0.396489	0.290692	CS pos: ?. Probable protein fragment    16
NZ_CP027599.1_103486	LIPO(Sec/SPII)	0.079425	0.016693	0.452048	0.451834	CS pos: 17-18. FSG-CM. Pr: 0.4420    33
NZ_CP027599.1_103491	LIPO(Sec/SPII)	0.043871	0.000886	0.898428	0.056816	CS pos: 15-16. PMS-CR. Pr: 0.8791    31
NZ_CP027599.1_103509	SP(Sec/SPI)	0.728441	0.003596	0.219017	0.048946	CS pos: 25-26. SLA-AI. Pr: 0.6505    34
NZ_CP027599.1_103518	LIPO(Sec/SPII)	0.067230	0.009339	0.548831	0.374601	CS pos: 17-18. RAG-CG. Pr: 0.5145    44
NZ_CP027599.1_103535	LIPO(Sec/SPII)	0.134544	0.010647	0.576682	0.278128	CS pos: 18-19. QVA-CA. Pr: 0.5543    32
NZ_CP027599.1_103538	TAT(Tat/SPI)	0.159617	0.462125	0.062914	0.315345	CS pos: 26-27. SSA-RI. Pr: 0.2937    30
NZ_CP027599.1_103575	LIPO(Sec/SPII)	0.058709	0.002126	0.923087	0.016078	CS pos: 21-22. ASS-CC. Pr: 0.8400    32
NZ_CP027599.1_103611	LIPO(Sec/SPII)	0.151300	0.037099	0.528671	0.282929	CS pos: 18-19. IIS-CG. Pr: 0.4396    20
NZ_CP027599.1_103617	LIPO(Sec/SPII)	0.115387	0.054384	0.490872	0.339357	CS pos: ?. Probable protein fragment    20
NZ_CP027599.1_103628	LIPO(Sec/SPII)	0.218592	0.026320	0.396249	0.358840	CS pos: ?. Probable protein fragment    18
NZ_CP027599.1_103649	LIPO(Sec/SPII)	0.180234	0.274385	0.295362	0.250019	CS pos: ?. Probable protein fragment    15
NZ_CP027599.1_103702	SP(Sec/SPI)	0.390290	0.117992	0.117188	0.374531	CS pos: 13-14. AYA-SP. Pr: 0.3556    17
NZ_CP027599.1_103756	LIPO(Sec/SPII)	0.145287	0.051726	0.660507	0.142480	CS pos: 19-20. FSS-CA. Pr: 0.6311    29
NZ_CP027599.1_103758	LIPO(Sec/SPII)	0.088070	0.020024	0.758473	0.133433	CS pos: 17-18. SSG-CT. Pr: 0.7143    19
NZ_CP027599.1_103790	LIPO(Sec/SPII)	0.052997	0.045946	0.842979	0.058078	CS pos: 22-23. IQA-CK. Pr: 0.8480    48
NZ_CP027599.1_103799	LIPO(Sec/SPII)	0.150356	0.023016	0.570177	0.256450	CS pos: 11-12. STS-CS. Pr: 0.5191    26
NZ_CP027599.1_103848	SP(Sec/SPI)	0.406770	0.257727	0.079052	0.256450	CS pos: 24-25. VWA-RR. Pr: 0.4910    33
NZ_CP027599.1_103854	LIPO(Sec/SPII)	0.164592	0.196541	0.323225	0.315641	CS pos: ?. Probable protein fragment    17
NZ_CP027599.1_103859	SP(Sec/SPI)	0.432043	0.023400	0.240425	0.304132	CS pos: 20-21. AKA-SM. Pr: 0.2516    26
NZ_CP027599.1_103875	LIPO(Sec/SPII)	0.168252	0.009832	0.441286	0.380629	CS pos: 20-21. GVE-CG. Pr: 0.3853    28
NZ_CP027599.1_103877	LIPO(Sec/SPII)	0.296121	0.009145	0.418025	0.276709	CS pos: 17-18. FSA-LN. Pr: 0.3431    49
NZ_CP027599.1_103885	SP(Sec/SPI)	0.365183	0.080982	0.261083	0.292752	CS pos: 16-17. TYA-AE. Pr: 0.2135    20
NZ_CP027599.1_103904	SP(Sec/SPI)	0.345971	0.153488	0.208067	0.292474	CS pos: 18-19. VYS-GG. Pr: 0.0487    35
NZ_CP027599.1_103915	LIPO(Sec/SPII)	0.270954	0.016046	0.468304	0.244696	CS pos: 12-13. IKG-CC. Pr: 0.1658    21
NZ_CP027599.1_103922	SP(Sec/SPI)	0.427440	0.021779	0.177464	0.373317	CS pos: 24-25. LWA-DN. Pr: 0.3877    33
NZ_CP027599.1_103925	LIPO(Sec/SPII)	0.141540	0.021433	0.568066	0.268961	CS pos: 21-22. SLS-CR. Pr: 0.5064    25
NZ_CP027599.1_103926	LIPO(Sec/SPII)	0.178474	0.074903	0.728964	0.017659	CS pos: 20-21. VIA-CS. Pr: 0.7280    38
NZ_CP027599.1_103967	LIPO(Sec/SPII)	0.232897	0.014668	0.396330	0.356104	CS pos: 19-20. GSG-CA. Pr: 0.2741    27
NZ_CP027599.1_103980	TAT(Tat/SPI)	0.130464	0.740315	0.040605	0.088616	CS pos: 26-27. TLC-AR. Pr: 0.1946    46
NZ_CP027599.1_104012	TAT(Tat/SPI)	0.303439	0.385781	0.048055	0.262725	CS pos: 29-30. ATA-YE. Pr: 0.4348    44
NZ_CP027599.1_104014	LIPO(Sec/SPII)	0.212505	0.066920	0.373638	0.346937	CS pos: 30-31. AEG-CH. Pr: 0.3143    34
NZ_CP027599.1_104023	LIPO(Sec/SPII)	0.091933	0.015789	0.670410	0.221868	CS pos: 25-26. LHA-CR. Pr: 0.6477    33
NZ_CP027599.1_104040	LIPO(Sec/SPII)	0.240100	0.047540	0.528743	0.183618	CS pos: 27-28. IAS-CL. Pr: 0.5147    35
NZ_CP027599.1_104075	LIPO(Sec/SPII)	0.215077	0.020079	0.615699	0.149145	CS pos: 16-17. VSA-CL. Pr: 0.3936    19
NZ_CP027599.1_104077	SP(Sec/SPI)	0.739247	0.047060	0.119559	0.094134	CS pos: 22-23. AVA-KA. Pr: 0.6279    29
NZ_CP027599.1_104090	LIPO(Sec/SPII)	0.079128	0.008033	0.734912	0.177928	CS pos: 14-15. HTA-CN. Pr: 0.6631    20
NZ_CP027599.1_104091	LIPO(Sec/SPII)	0.339977	0.021579	0.376204	0.262241	CS pos: 28-29. PSS-CS. Pr: 0.2427    36
NZ_CP027599.1_104104	TAT(Tat/SPI)	0.045632	0.790599	0.014118	0.149651	CS pos: 32-33. VLA-RL. Pr: 0.6339    39
NZ_CP027599.1_104105	LIPO(Sec/SPII)	0.172978	0.019856	0.480568	0.326598	CS pos: 14-15. SNA-CC. Pr: 0.2614    37
NZ_CP027599.1_104135	LIPO(Sec/SPII)	0.198973	0.034752	0.423944	0.342332	CS pos: 14-15. AMG-CN. Pr: 0.3392    16
NZ_CP027599.1_104144	LIPO(Sec/SPII)	0.095563	0.058714	0.490584	0.355139	CS pos: 24-25. CAA-CR. Pr: 0.3192    38
NZ_CP027599.1_104163	SP(Sec/SPI)	0.626659	0.011889	0.149077	0.212375	CS pos: 18-19. IMA-AS. Pr: 0.4824    25
NZ_CP027599.1_104167	LIPO(Sec/SPII)	0.065481	0.101473	0.782071	0.050975	CS pos: 22-23. SSS-CS. Pr: 0.7529    42
NZ_CP027599.1_104245	SP(Sec/SPI)	0.403195	0.134010	0.105072	0.357722	CS pos: 19-20. RYA-SR. Pr: 0.2458    36
NZ_CP027599.1_104261	LIPO(Sec/SPII)	0.149828	0.005347	0.838357	0.006469	CS pos: 20-21. AFA-CC. Pr: 0.7149    27
NZ_CP027599.1_104263	SP(Sec/SPI)	0.593622	0.021568	0.120399	0.264411	CS pos: 16-17. AFA-RS. Pr: 0.2829    26
NZ_CP027599.1_104266	LIPO(Sec/SPII)	0.111842	0.202939	0.536982	0.148237	CS pos: 26-27. GLS-CL. Pr: 0.4820    37
NZ_CP027599.1_104269	LIPO(Sec/SPII)	0.076731	0.004987	0.595296	0.322986	CS pos: 25-26. LSS-CY. Pr: 0.5883    35
NZ_CP027599.1_104291	LIPO(Sec/SPII)	0.200188	0.011617	0.568753	0.219442	CS pos: 12-13. SCS-CC. Pr: 0.2898    17
NZ_CP027599.1_104303	LIPO(Sec/SPII)	0.223353	0.012954	0.471851	0.291842	CS pos: 18-19. VCR-CC. Pr: 0.2693    20
NZ_CP027599.1_104304	LIPO(Sec/SPII)	0.381885	0.012232	0.410609	0.195273	CS pos: 19-20. IAS-ST. Pr: 0.1847    29
NZ_CP027599.1_104353	SP(Sec/SPI)	0.465574	0.018860	0.119538	0.396028	CS pos: 17-18. ILA-FS. Pr: 0.1550    33
NZ_CP027599.1_104362	SP(Sec/SPI)	0.530735	0.014967	0.147051	0.307247	CS pos: 15-16. VAS-EK. Pr: 0.3858    27
NZ_CP027599.1_104373	SP(Sec/SPI)	0.390551	0.043042	0.214800	0.351608	CS pos: 21-22. VAS-YC. Pr: 0.0909    39
NZ_CP027599.1_104377	SP(Sec/SPI)	0.632365	0.015528	0.259063	0.093044	CS pos: 21-22. CHA-SP. Pr: 0.5673    31
NZ_CP027599.1_104391	LIPO(Sec/SPII)	0.148193	0.022918	0.464510	0.364379	CS pos: 23-24. PSS-CF. Pr: 0.3585    25
NZ_CP027599.1_104415	LIPO(Sec/SPII)	0.081297	0.009576	0.789280	0.119847	CS pos: 17-18. MVS-CW. Pr: 0.7320    31
NZ_CP027599.1_104435	TAT(Tat/SPI)	0.205188	0.437435	0.070855	0.286521	CS pos: ?. Probable protein fragment    32
NZ_CP027599.1_104445	LIPO(Sec/SPII)	0.076986	0.268725	0.332469	0.321820	CS pos: 20-21. CKS-CC. Pr: 0.2256    41
NZ_CP027599.1_104479	SP(Sec/SPI)	0.607199	0.055144	0.059052	0.278605	CS pos: 15-16. ARA-DA. Pr: 0.3501    23
NZ_CP027599.1_104544	TAT(Tat/SPI)	0.236591	0.457115	0.100070	0.206225	CS pos: 22-23. ASS-IS. Pr: 0.1805    32
NZ_CP027599.1_104548	LIPO(Sec/SPII)	0.268585	0.046268	0.386422	0.298725	CS pos: 20-21. AGS-CS. Pr: 0.3254    22
NZ_CP027599.1_104572	SP(Sec/SPI)	0.585260	0.121441	0.090415	0.202885	CS pos: 19-20. SRA-HP. Pr: 0.3892    31
NZ_CP027599.1_104575	LIPO(Sec/SPII)	0.217260	0.034364	0.445731	0.302646	CS pos: 13-14. PTC-CS. Pr: 0.2479    19
NZ_CP027599.1_104592	LIPO(Sec/SPII)	0.417373	0.005366	0.542952	0.034310	CS pos: 18-19. PVT-CA. Pr: 0.4370    44
NZ_CP027599.1_104601	LIPO(Sec/SPII)	0.287567	0.054991	0.329783	0.327658	CS pos: 13-14. SGE-CT. Pr: 0.0495    15
NZ_CP027599.1_104616	SP(Sec/SPI)	0.627452	0.054276	0.061231	0.257040	CS pos: 22-23. ALG-QW. Pr: 0.5278    38
NZ_CP027599.1_104618	LIPO(Sec/SPII)	0.248362	0.035629	0.374672	0.341338	CS pos: 13-14. LMP-CS. Pr: 0.2176    36
NZ_CP027599.1_104624	SP(Sec/SPI)	0.421206	0.094796	0.100577	0.383421	CS pos: 29-30. TWA-AN. Pr: 0.1990    36
NZ_CP027599.1_104643	LIPO(Sec/SPII)	0.267185	0.139390	0.462380	0.131045	CS pos: 18-19. TST-CV. Pr: 0.4490    39
NZ_CP027599.1_104650	SP(Sec/SPI)	0.633602	0.008701	0.044287	0.313410	CS pos: 15-16. IPA-ID. Pr: 0.2345    50
NZ_CP027599.1_104688	SP(Sec/SPI)	0.404409	0.207362	0.086358	0.301871	CS pos: 20-21. ASS-LR. Pr: 0.0616    49
NZ_CP027599.1_104712	LIPO(Sec/SPII)	0.171332	0.050536	0.570399	0.207733	CS pos: 19-20. LTS-CK. Pr: 0.5312    32
NZ_CP027599.1_104730	LIPO(Sec/SPII)	0.282172	0.008385	0.373320	0.336122	CS pos: 13-14. LCC-CS. Pr: 0.0398    17
NZ_CP027599.1_104731	SP(Sec/SPI)	0.379735	0.013544	0.320859	0.285861	CS pos: 17-18. SRG-QH. Pr: 0.1232    19
NZ_CP027599.1_104733	LIPO(Sec/SPII)	0.236038	0.005057	0.510498	0.248407	CS pos: 27-28. TAG-SS. Pr: 0.2538    39
NZ_CP027599.1_104751	SP(Sec/SPI)	0.337874	0.001462	0.327288	0.333376	CS pos: 22-23. TQG-YE. Pr: 0.3252    25
NZ_CP027599.1_104822	SP(Sec/SPI)	0.718330	0.024016	0.111848	0.145807	CS pos: 18-19. SWA-AS. Pr: 0.5515    22
NZ_CP027599.1_104833	SP(Sec/SPI)	0.694113	0.094951	0.062363	0.148572	CS pos: 14-15. ASA-AS. Pr: 0.5400    21
NZ_CP027599.1_104835	TAT(Tat/SPI)	0.095308	0.325630	0.273211	0.305851	CS pos: 30-31. IGA-RT. Pr: 0.1501    44
NZ_CP027599.1_104841	SP(Sec/SPI)	0.477482	0.072093	0.072246	0.378178	CS pos: 22-23. SMA-KE. Pr: 0.3978    32
NZ_CP027599.1_104873	LIPO(Sec/SPII)	0.281859	0.010843	0.376629	0.330669	CS pos: 13-14. LVG-RS. Pr: 0.0958    15
NZ_CP027599.1_104903	SP(Sec/SPI)	0.372079	0.073912	0.185927	0.368083	CS pos: 31-32. ANA-LC. Pr: 0.2164    43
NZ_CP027599.1_104943	LIPO(Sec/SPII)	0.344599	0.020034	0.358034	0.277333	CS pos: 15-16. LVL-CW. Pr: 0.2185    28
NZ_CP027599.1_104957	LIPO(Sec/SPII)	0.312655	0.015142	0.400018	0.272184	CS pos: 16-17. SAE-CL. Pr: 0.2275    20
NZ_CP027599.1_104982	LIPO(Sec/SPII)	0.211824	0.044911	0.430933	0.312332	CS pos: 12-13. VMA-CW. Pr: 0.2198    17
NZ_CP027599.1_104984	LIPO(Sec/SPII)	0.024701	0.002441	0.608738	0.364119	CS pos: 18-19. LFA-CW. Pr: 0.6062    37
NZ_CP027599.1_104986	SP(Sec/SPI)	0.546070	0.019926	0.162253	0.271750	CS pos: 20-21. CLA-SK. Pr: 0.4454    22
NZ_CP027599.1_104988	LIPO(Sec/SPII)	0.111577	0.145159	0.425880	0.317384	CS pos: 28-29. ITA-CV. Pr: 0.4210    43
NZ_CP027599.1_104995	LIPO(Sec/SPII)	0.157232	0.029859	0.480939	0.331970	CS pos: 15-16. NSS-CA. Pr: 0.3794    18
NZ_CP027599.1_105017	SP(Sec/SPI)	0.466865	0.020666	0.156941	0.355528	CS pos: 20-21. VIK-EP. Pr: 0.0608    25
NZ_CP027599.1_105023	LIPO(Sec/SPII)	0.274044	0.019463	0.406485	0.300008	CS pos: ?. Probable protein fragment    16
NZ_CP027599.1_105085	LIPO(Sec/SPII)	0.178145	0.008808	0.471612	0.341435	CS pos: 15-16. VCR-CW. Pr: 0.3614    21
NZ_CP027599.1_105089	LIPO(Sec/SPII)	0.155737	0.014858	0.691569	0.137836	CS pos: 14-15. VNA-CA. Pr: 0.6358    25
NZ_CP027599.1_105102	LIPO(Sec/SPII)	0.047022	0.002037	0.938136	0.012805	CS pos: 19-20. STA-CS. Pr: 0.8384    46
NZ_CP027599.1_105118	LIPO(Sec/SPII)	0.039224	0.015085	0.664581	0.281110	CS pos: 18-19. TTG-CG. Pr: 0.6595    43
NZ_CP027599.1_105136	SP(Sec/SPI)	0.768594	0.105527	0.057155	0.068724	CS pos: 13-14. AFA-AP. Pr: 0.2484    34
NZ_CP027599.1_105137	SP(Sec/SPI)	0.701647	0.151306	0.051214	0.095832	CS pos: 23-24. VLA-AI. Pr: 0.7029    40
NZ_CP027599.1_105158	SP(Sec/SPI)	0.342695	0.059577	0.301540	0.296188	CS pos: 17-18. VLM-TI. Pr: 0.0644    21
NZ_CP027599.1_105178	LIPO(Sec/SPII)	0.035479	0.009500	0.739070	0.215950	CS pos: 23-24. YWA-CW. Pr: 0.7342    49
NZ_CP027599.1_105201	SP(Sec/SPI)	0.849598	0.024911	0.095267	0.030223	CS pos: 21-22. SSA-SL. Pr: 0.6565    29
NZ_CP027599.1_105214	LIPO(Sec/SPII)	0.137628	0.009735	0.469785	0.382852	CS pos: 14-15. CAG-CR. Pr: 0.3756    22
NZ_CP027599.1_105240	LIPO(Sec/SPII)	0.190069	0.015379	0.470041	0.324511	CS pos: 14-15. LQR-CA. Pr: 0.2405    16
NZ_CP027599.1_105244	LIPO(Sec/SPII)	0.224907	0.013611	0.398851	0.362632	CS pos: ?. Probable protein fragment    16
NZ_CP027599.1_105276	LIPO(Sec/SPII)	0.199621	0.008127	0.538645	0.253606	CS pos: 22-23. GLK-CR. Pr: 0.2804    28
NZ_CP027599.1_105282	SP(Sec/SPI)	0.414989	0.014529	0.372105	0.198377	CS pos: 15-16. ISP-VP. Pr: 0.0262    17
NZ_CP027599.1_105294	LIPO(Sec/SPII)	0.135228	0.005749	0.517152	0.341871	CS pos: 23-24. LSL-CS. Pr: 0.4301    28
NZ_CP027599.1_105312	LIPO(Sec/SPII)	0.198889	0.004831	0.448725	0.347555	CS pos: ?. Probable protein fragment    19
NZ_CP027599.1_105313	SP(Sec/SPI)	0.394495	0.028857	0.245149	0.331498	CS pos: 19-20. AFC-LQ. Pr: 0.1438    31
NZ_CP027599.1_105315	LIPO(Sec/SPII)	0.168722	0.021704	0.741887	0.067687	CS pos: 17-18. LFA-CR. Pr: 0.7145    34
NZ_CP027599.1_105317	LIPO(Sec/SPII)	0.254073	0.030022	0.395799	0.320106	CS pos: 16-17. WTV-CS. Pr: 0.2647    20
NZ_CP027599.1_105322	LIPO(Sec/SPII)	0.261373	0.021284	0.426727	0.290616	CS pos: 10-11. LNA-CH. Pr: 0.0889    15
NZ_CP027599.1_105323	TAT(Tat/SPI)	0.181530	0.545149	0.039857	0.233464	CS pos: 35-36. ASA-LF. Pr: 0.5379    42
NZ_CP027599.1_105326	LIPO(Sec/SPII)	0.188295	0.006203	0.532517	0.272986	CS pos: 13-14. LFG-CS. Pr: 0.1863    20
NZ_CP027599.1_105391	LIPO(Sec/SPII)	0.101251	0.017962	0.582831	0.297956	CS pos: 26-27. SAA-CS. Pr: 0.5399    29
NZ_CP027599.1_105405	LIPO(Sec/SPII)	0.085730	0.000753	0.792354	0.121163	CS pos: 16-17. HGG-CY. Pr: 0.7872    47
NZ_CP027599.1_105412	SP(Sec/SPI)	0.545156	0.149379	0.250993	0.054472	CS pos: 21-22. VHA-RS. Pr: 0.3669    43
NZ_CP027599.1_105416	LIPO(Sec/SPII)	0.317323	0.010194	0.378667	0.293816	CS pos: 18-19. SWL-VH. Pr: 0.0316    20
NZ_CP027599.1_105457	LIPO(Sec/SPII)	0.172604	0.003647	0.719211	0.104538	CS pos: 17-18. CNC-CV. Pr: 0.3104    24
NZ_CP027599.1_105466	LIPO(Sec/SPII)	0.333527	0.035723	0.389627	0.241123	CS pos: ?. Probable protein fragment    18
NZ_CP027599.1_105480	LIPO(Sec/SPII)	0.218187	0.006323	0.444084	0.331406	CS pos: 13-14. LWV-CS. Pr: 0.1146    15
NZ_CP027599.1_105554	LIPO(Sec/SPII)	0.071254	0.014288	0.715959	0.198498	CS pos: 19-20. FYS-CS. Pr: 0.7015    31
NZ_CP027599.1_105598	SP(Sec/SPI)	0.506156	0.110939	0.142201	0.240705	CS pos: 27-28. ISG-AV. Pr: 0.2577    37
NZ_CP027599.1_105845	SP(Sec/SPI)	0.495101	0.027478	0.121077	0.356343	CS pos: 12-13. AEA-AD. Pr: 0.1795    26
NZ_CP027599.1_105917	SP(Sec/SPI)	0.666734	0.008906	0.011856	0.312504	CS pos: 21-22. VDA-AF. Pr: 0.5680    40
NZ_CP027599.1_105924	LIPO(Sec/SPII)	0.226473	0.013677	0.397561	0.362289	CS pos: ?. Probable protein fragment    16
NZ_CP027599.1_105960	SP(Sec/SPI)	0.735542	0.005301	0.054969	0.204188	CS pos: 29-30. VNA-SL. Pr: 0.7024    37
NZ_CP027599.1_106000	SP(Sec/SPI)	0.373966	0.024020	0.271511	0.330503	CS pos: 24-25. RLA-GT. Pr: 0.1222    35
NZ_CP027599.1_106010	LIPO(Sec/SPII)	0.200332	0.026545	0.570831	0.202292	CS pos: 15-16. ALA-CR. Pr: 0.5685    17
NZ_CP027599.1_106012	LIPO(Sec/SPII)	0.227494	0.026691	0.587407	0.158408	CS pos: 15-16. LPS-CT. Pr: 0.4331    32
NZ_CP027599.1_106032	LIPO(Sec/SPII)	0.061298	0.013536	0.691675	0.233492	CS pos: 16-17. LCA-CS. Pr: 0.6632    33
NZ_CP027599.1_106033	SP(Sec/SPI)	0.560724	0.064355	0.164941	0.209980	CS pos: 16-17. SSA-AR. Pr: 0.1889    27
NZ_CP027599.1_106046	TAT(Tat/SPI)	0.132897	0.403732	0.150838	0.312534	CS pos: ?. Probable protein fragment    20
NZ_CP027599.1_106055	SP(Sec/SPI)	0.574551	0.029128	0.129502	0.266820	CS pos: 20-21. VSA-WD. Pr: 0.4719    26
NZ_CP027599.1_106089	SP(Sec/SPI)	0.581628	0.037193	0.018679	0.362500	CS pos: 20-21. FHA-GT. Pr: 0.4580    36
NZ_CP027599.1_106091	SP(Sec/SPI)	0.763703	0.010290	0.065343	0.160664	CS pos: 18-19. VAA-IN. Pr: 0.5520    48
NZ_CP027599.1_106098	LIPO(Sec/SPII)	0.160129	0.005457	0.605312	0.229102	CS pos: 15-16. VAV-CV. Pr: 0.3790    32
NZ_CP027599.1_106150	SP(Sec/SPI)	0.445003	0.042631	0.189238	0.323128	CS pos: 16-17. SYS-RP. Pr: 0.1811    21
NZ_CP027599.1_106180	LIPO(Sec/SPII)	0.215207	0.033474	0.403627	0.347692	CS pos: 13-14. SVS-CS. Pr: 0.2114    19
NZ_CP027599.1_106195	LIPO(Sec/SPII)	0.263465	0.035170	0.414015	0.287350	CS pos: 15-16. CSP-CR. Pr: 0.2073    32
NZ_CP027599.1_106197	SP(Sec/SPI)	0.584166	0.009091	0.100562	0.306182	CS pos: 19-20. IQA-GQ. Pr: 0.5757    46
NZ_CP027599.1_106199	LIPO(Sec/SPII)	0.209462	0.079372	0.399342	0.311824	CS pos: 16-17. QAG-SV. Pr: 0.2666    48
NZ_CP027599.1_106201	SP(Sec/SPI)	0.592008	0.045270	0.126191	0.236531	CS pos: 31-32. VSA-AG. Pr: 0.4478    44
NZ_CP027599.1_106219	LIPO(Sec/SPII)	0.089431	0.019835	0.868805	0.021928	CS pos: 20-21. PAG-CR. Pr: 0.8079    33
NZ_CP027599.1_106236	LIPO(Sec/SPII)	0.224170	0.020427	0.412487	0.342917	CS pos: ?. Probable protein fragment    17
NZ_CP027599.1_106248	LIPO(Sec/SPII)	0.210561	0.018738	0.629224	0.141476	CS pos: 22-23. TVT-CT. Pr: 0.5258    25
NZ_CP027599.1_106274	TAT(Tat/SPI)	0.227316	0.429342	0.038636	0.304706	CS pos: 36-37. CEA-IS. Pr: 0.4081    45
NZ_CP027599.1_106283	LIPO(Sec/SPII)	0.071022	0.027403	0.478046	0.423530	CS pos: 19-20. SFS-CH. Pr: 0.4617    33
NZ_CP027599.1_106284	TAT(Tat/SPI)	0.282746	0.459936	0.025587	0.231731	CS pos: 27-28. ARA-AA. Pr: 0.5228    38
NZ_CP027599.1_106290	SP(Sec/SPI)	0.381026	0.139705	0.202206	0.277063	CS pos: ?. Probable protein fragment    23
NZ_CP027599.1_106313	TAT(Tat/SPI)	0.047458	0.461370	0.032812	0.458360	CS pos: 23-24. RLA-LP. Pr: 0.1569    48
NZ_CP027599.1_106323	LIPO(Sec/SPII)	0.145354	0.008121	0.427847	0.418679	CS pos: 13-14. WSG-CA. Pr: 0.3917    29
NZ_CP027599.1_106335	LIPO(Sec/SPII)	0.239182	0.061907	0.351881	0.347030	CS pos: 20-21. AAS-CW. Pr: 0.2750    29
NZ_CP027599.1_106336	LIPO(Sec/SPII)	0.032072	0.000806	0.905994	0.061128	CS pos: 29-30. LLS-CT. Pr: 0.8769    34
NZ_CP027599.1_106362	TAT(Tat/SPI)	0.279826	0.506306	0.037072	0.176796	CS pos: 30-31. ALA-LS. Pr: 0.7337    43
NZ_CP027599.1_106374	SP(Sec/SPI)	0.454550	0.044244	0.157169	0.344036	CS pos: 23-24. TSG-AT. Pr: 0.1022    35
NZ_CP027599.1_106379	LIPO(Sec/SPII)	0.080194	0.004248	0.821478	0.094080	CS pos: 15-16. TAA-CC. Pr: 0.6902    29
NZ_CP027599.1_106391	LIPO(Sec/SPII)	0.217506	0.014854	0.499785	0.267855	CS pos: ?. Probable protein fragment    20
NZ_CP027599.1_106453	LIPO(Sec/SPII)	0.289067	0.034671	0.350220	0.326042	CS pos: ?. Probable protein fragment    16
NZ_CP027599.1_106466	LIPO(Sec/SPII)	0.256334	0.008338	0.559792	0.175536	CS pos: 15-16. ICQ-CT. Pr: 0.4757    24
NZ_CP027599.1_106483	SP(Sec/SPI)	0.436320	0.061215	0.316999	0.185467	CS pos: 17-18. ALS-ST. Pr: 0.1398    23
NZ_CP027599.1_106493	SP(Sec/SPI)	0.392986	0.143126	0.108530	0.355357	CS pos: 21-22. SVA-DS. Pr: 0.2497    32
NZ_CP027599.1_106519	SP(Sec/SPI)	0.388188	0.029152	0.350861	0.231800	CS pos: 21-22. VLV-GC. Pr: 0.1059    39
NZ_CP027599.1_106540	SP(Sec/SPI)	0.337460	0.250637	0.141029	0.270873	CS pos: 21-22. AAG-TG. Pr: 0.1244    46
NZ_CP027599.1_106545	LIPO(Sec/SPII)	0.120109	0.077733	0.426816	0.375342	CS pos: 18-19. ILC-CQ. Pr: 0.3743    40
NZ_CP027599.1_106564	LIPO(Sec/SPII)	0.087310	0.002304	0.809299	0.101086	CS pos: 15-16. VNG-CI. Pr: 0.8738    40
NZ_CP027599.1_106586	LIPO(Sec/SPII)	0.291803	0.017834	0.474700	0.215663	CS pos: ?. Probable protein fragment    16
NZ_CP027599.1_106599	LIPO(Sec/SPII)	0.343164	0.032100	0.347299	0.277438	CS pos: 13-14. SFG-AP. Pr: 0.0508    15
NZ_CP027599.1_106607	LIPO(Sec/SPII)	0.196029	0.078493	0.411657	0.313821	CS pos: 18-19. VAF-CA. Pr: 0.3414    32
NZ_CP027599.1_106637	TAT(Tat/SPI)	0.253741	0.688061	0.018731	0.039467	CS pos: 20-21. ASA-TP. Pr: 0.5513    35
NZ_CP027599.1_106647	LIPO(Sec/SPII)	0.226688	0.118641	0.527984	0.126686	CS pos: 21-22. LWV-CS. Pr: 0.1784    32
NZ_CP027599.1_106666	SP(Sec/SPI)	0.466914	0.030942	0.110389	0.391756	CS pos: 20-21. NFA-SV. Pr: 0.3422    47
NZ_CP027599.1_106677	LIPO(Sec/SPII)	0.126754	0.005762	0.729987	0.137497	CS pos: 18-19. CHG-CQ. Pr: 0.6435    20
NZ_CP027599.1_106692	LIPO(Sec/SPII)	0.089609	0.017186	0.820818	0.072388	CS pos: 19-20. VAS-CW. Pr: 0.7816    40
NZ_CP027599.1_106711	LIPO(Sec/SPII)	0.236823	0.097627	0.415497	0.250053	CS pos: 11-12. TTA-CV. Pr: 0.3556    38
NZ_CP027599.1_106741	LIPO(Sec/SPII)	0.032682	0.006774	0.938888	0.021656	CS pos: 17-18. TLS-CW. Pr: 0.9340    35
NZ_CP027599.1_106756	LIPO(Sec/SPII)	0.229039	0.011002	0.512605	0.247355	CS pos: ?. Probable protein fragment    15
NZ_CP027599.1_106765	TAT(Tat/SPI)	0.164193	0.484458	0.074173	0.277175	CS pos: 26-27. VAA-GP. Pr: 0.0550    29
NZ_CP027599.1_106785	SP(Sec/SPI)	0.386745	0.020120	0.291734	0.301401	CS pos: ?. Probable protein fragment    17
NZ_CP027599.1_106834	LIPO(Sec/SPII)	0.200869	0.012392	0.526585	0.260154	CS pos: 21-22. CLG-CN. Pr: 0.3974    24
NZ_CP027599.1_106839	LIPO(Sec/SPII)	0.283460	0.043032	0.412105	0.261403	CS pos: 17-18. AYS-CQ. Pr: 0.5229    31
NZ_CP027599.1_106863	LIPO(Sec/SPII)	0.112134	0.009372	0.637385	0.241109	CS pos: ?. Probable protein fragment    19
NZ_CP027599.1_106889	LIPO(Sec/SPII)	0.209103	0.045003	0.384358	0.361536	CS pos: 20-21. FGG-KN. Pr: 0.1628    40
NZ_CP027599.1_106890	SP(Sec/SPI)	0.634205	0.072728	0.113972	0.179096	CS pos: 20-21. APA-AR. Pr: 0.3910    37
NZ_CP027599.1_106900	LIPO(Sec/SPII)	0.124712	0.022734	0.428915	0.423639	CS pos: 25-26. SQS-CL. Pr: 0.3882    32
NZ_CP027599.1_106934	LIPO(Sec/SPII)	0.230706	0.005768	0.416546	0.346980	CS pos: 16-17. NGF-CD. Pr: 0.2037    18
NZ_CP027599.1_106969	SP(Sec/SPI)	0.422198	0.293634	0.021627	0.262541	CS pos: 28-29. AKA-AS. Pr: 0.5135    39
NZ_CP027599.1_106976	SP(Sec/SPI)	0.483999	0.021695	0.174799	0.319507	CS pos: 21-22. AFG-ER. Pr: 0.3074    38
NZ_CP027599.1_107071	LIPO(Sec/SPII)	0.237063	0.052159	0.386533	0.324244	CS pos: 13-14. VSS-LR. Pr: 0.0369    15
NZ_CP027599.1_107076	LIPO(Sec/SPII)	0.292954	0.009072	0.427258	0.270717	CS pos: 19-20. CLS-CC. Pr: 0.1694    21
NZ_CP027599.1_107125	LIPO(Sec/SPII)	0.225102	0.014262	0.401432	0.359204	CS pos: 20-21. VTL-CA. Pr: 0.1702    23
NZ_CP027599.1_107146	LIPO(Sec/SPII)	0.231772	0.003093	0.708149	0.056987	CS pos: 16-17. LPG-CA. Pr: 0.6982    49
NZ_CP027599.1_107201	SP(Sec/SPI)	0.404032	0.012225	0.193097	0.390645	CS pos: 16-17. TSA-AI. Pr: 0.1445    22
NZ_CP027599.1_107208	LIPO(Sec/SPII)	0.255297	0.121907	0.391785	0.231012	CS pos: 25-26. IVS-LS. Pr: 0.1245    49
NZ_CP027599.1_107231	SP(Sec/SPI)	0.522358	0.004715	0.469403	0.003524	CS pos: 22-23. AHG-AV. Pr: 0.5100    39
NZ_CP027599.1_107237	TAT(Tat/SPI)	0.226659	0.326236	0.148680	0.298425	CS pos: 21-22. ARS-FC. Pr: 0.2354    28
NZ_CP027599.1_107248	SP(Sec/SPI)	0.427326	0.234577	0.048453	0.289644	CS pos: 19-20. AMA-TQ. Pr: 0.3065    34
NZ_CP027599.1_107268	LIPO(Sec/SPII)	0.162615	0.031298	0.512895	0.293193	CS pos: 26-27. TAG-CG. Pr: 0.5050    34
NZ_CP027599.1_107294	TAT(Tat/SPI)	0.107942	0.449718	0.018493	0.423847	CS pos: 42-43. ANA-EP. Pr: 0.2951    49
NZ_CP027599.1_107348	LIPO(Sec/SPII)	0.304732	0.039467	0.476535	0.179266	CS pos: 19-20. FAQ-CK. Pr: 0.4377    33
NZ_CP027599.1_107359	LIPO(Sec/SPII)	0.171855	0.034929	0.521893	0.271323	CS pos: 11-12. FTA-CS. Pr: 0.4950    32
NZ_CP027599.1_107364	SP(Sec/SPI)	0.371420	0.128770	0.166937	0.332873	CS pos: 19-20. STA-GR. Pr: 0.1780    26
NZ_CP027599.1_107375	LIPO(Sec/SPII)	0.329177	0.018516	0.476436	0.175871	CS pos: 13-14. IVL-CT. Pr: 0.3712    21
NZ_CP027599.1_107385	LIPO(Sec/SPII)	0.241780	0.039918	0.518622	0.199680	CS pos: 14-15. LGK-CS. Pr: 0.4393    24
NZ_CP027599.1_107386	SP(Sec/SPI)	0.733353	0.098990	0.099955	0.067702	CS pos: 20-21. LKA-AS. Pr: 0.2923    42
NZ_CP027599.1_107415	SP(Sec/SPI)	0.432809	0.102943	0.070609	0.393639	CS pos: ?. Probable protein fragment    25
NZ_CP027599.1_107418	LIPO(Sec/SPII)	0.180724	0.005644	0.726409	0.087224	CS pos: 16-17. NAA-CL. Pr: 0.6983    25
NZ_CP027599.1_107430	LIPO(Sec/SPII)	0.096738	0.015763	0.525381	0.362118	CS pos: 19-20. MTC-CA. Pr: 0.2608    25
NZ_CP027599.1_107451	SP(Sec/SPI)	0.678551	0.004051	0.301426	0.015972	CS pos: 17-18. ISA-GE. Pr: 0.5357    33
NZ_CP027599.1_107462	SP(Sec/SPI)	0.393983	0.008751	0.206762	0.390503	CS pos: 19-20. LGV-AN. Pr: 0.1085    35
NZ_CP027599.1_107465	SP(Sec/SPI)	0.370935	0.021101	0.364201	0.243763	CS pos: 14-15. AHG-NT. Pr: 0.0888    16
NZ_CP027599.1_107469	LIPO(Sec/SPII)	0.032799	0.002604	0.917326	0.047272	CS pos: 23-24. TAG-CT. Pr: 0.9071    31
NZ_CP027599.1_107535	LIPO(Sec/SPII)	0.170434	0.004296	0.512518	0.312751	CS pos: 21-22. LVV-CF. Pr: 0.2280    42
NZ_CP027599.1_107554	SP(Sec/SPI)	0.389643	0.101525	0.125805	0.383027	CS pos: 16-17. TSA-SP. Pr: 0.1189    31
NZ_CP027599.1_107618	SP(Sec/SPI)	0.917067	0.026139	0.033430	0.023364	CS pos: 17-18. AHA-FA. Pr: 0.7052    28
NZ_CP027599.1_107652	SP(Sec/SPI)	0.367043	0.122508	0.171237	0.339212	CS pos: 16-17. SSA-SS. Pr: 0.1084    21
NZ_CP027599.1_107654	LIPO(Sec/SPII)	0.279323	0.016083	0.523770	0.180824	CS pos: 21-22. GLP-CS. Pr: 0.3064    23
NZ_CP027599.1_107655	SP(Sec/SPI)	0.515913	0.006160	0.035274	0.442654	CS pos: 31-32. LTA-DN. Pr: 0.4459    37
NZ_CP027599.1_107658	SP(Sec/SPI)	0.436986	0.023713	0.245098	0.294203	CS pos: 18-19. VTS-DS. Pr: 0.2594    21
NZ_CP027599.1_107668	LIPO(Sec/SPII)	0.197410	0.082585	0.386733	0.333273	CS pos: 15-16. GLA-CA. Pr: 0.1702    18
NZ_CP027599.1_107677	TAT(Tat/SPI)	0.326667	0.528141	0.079348	0.065843	CS pos: 31-32. GRA-EK. Pr: 0.4204    36
NZ_CP027599.1_107700	SP(Sec/SPI)	0.551420	0.017151	0.123668	0.307762	CS pos: 17-18. SLP-QT. Pr: 0.1115    31
NZ_CP027599.1_107705	LIPO(Sec/SPII)	0.144504	0.172392	0.358113	0.324991	CS pos: 17-18. RTA-CV. Pr: 0.1700    23
NZ_CP027599.1_107740	LIPO(Sec/SPII)	0.297236	0.041005	0.410213	0.251546	CS pos: 13-14. FTA-SK. Pr: 0.2564    20
NZ_CP027599.1_107749	LIPO(Sec/SPII)	0.097595	0.002476	0.841974	0.057955	CS pos: 14-15. VFA-CL. Pr: 0.8249    33
NZ_CP027599.1_107778	LIPO(Sec/SPII)	0.152736	0.030158	0.431412	0.385694	CS pos: 18-19. YAA-CN. Pr: 0.4255    49
NZ_CP027599.1_107784	LIPO(Sec/SPII)	0.342843	0.010571	0.349398	0.297187	CS pos: 15-16. LCS-AI. Pr: 0.0712    17
NZ_CP027599.1_107809	LIPO(Sec/SPII)	0.125973	0.026146	0.541613	0.306268	CS pos: 17-18. SSA-CR. Pr: 0.5021    33
NZ_CP027599.1_107822	TAT(Tat/SPI)	0.137002	0.413115	0.072209	0.377674	CS pos: 31-32. VTA-PR. Pr: 0.0995    43
NZ_CP027599.1_107827	LIPO(Sec/SPII)	0.240001	0.027535	0.478930	0.253534	CS pos: 27-28. TSW-CS. Pr: 0.1660    37
NZ_CP027599.1_107867	LIPO(Sec/SPII)	0.158628	0.003002	0.596346	0.242024	CS pos: 18-19. CSA-CR. Pr: 0.3461    30
NZ_CP027599.1_107886	LIPO(Sec/SPII)	0.244609	0.033083	0.368622	0.353686	CS pos: ?. Probable protein fragment    15
NZ_CP027599.1_107900	LIPO(Sec/SPII)	0.042168	0.019360	0.878681	0.059790	CS pos: 20-21. SCA-CS. Pr: 0.7902    31
NZ_CP027599.1_107918	LIPO(Sec/SPII)	0.386828	0.025455	0.498756	0.088961	CS pos: 21-22. LPS-CF. Pr: 0.3515    23
NZ_CP027599.1_107941	SP(Sec/SPI)	0.428073	0.265706	0.060222	0.245999	CS pos: 19-20. ASA-VS. Pr: 0.2451    30
NZ_CP027599.1_107946	LIPO(Sec/SPII)	0.208276	0.005754	0.546323	0.239647	CS pos: 14-15. LAT-CI. Pr: 0.4739    25
NZ_CP027599.1_107947	SP(Sec/SPI)	0.906984	0.048491	0.028531	0.015995	CS pos: 23-24. ARA-HP. Pr: 0.8804    31
NZ_CP027599.1_107948	LIPO(Sec/SPII)	0.054941	0.088383	0.649583	0.207093	CS pos: 22-23. ITA-CC. Pr: 0.5712    46
NZ_CP027599.1_107963	SP(Sec/SPI)	0.585132	0.022640	0.125026	0.267202	CS pos: 19-20. VLA-SI. Pr: 0.4683    25
NZ_CP027599.1_108009	LIPO(Sec/SPII)	0.297514	0.018233	0.386051	0.298202	CS pos: ?. Probable protein fragment    15
NZ_CP027599.1_108010	LIPO(Sec/SPII)	0.299203	0.008525	0.459576	0.232696	CS pos: 13-14. LWI-CE. Pr: 0.0970    16
NZ_CP027599.1_108019	SP(Sec/SPI)	0.395361	0.024222	0.333081	0.247336	CS pos: 17-18. IHG-AP. Pr: 0.1350    20
NZ_CP027599.1_108025	LIPO(Sec/SPII)	0.133895	0.014960	0.650461	0.200684	CS pos: 16-17. IHA-CT. Pr: 0.6279    33
NZ_CP027599.1_108058	LIPO(Sec/SPII)	0.242218	0.044030	0.402469	0.311283	CS pos: ?. Probable protein fragment    18
NZ_CP027599.1_108067	SP(Sec/SPI)	0.485395	0.191342	0.196409	0.126854	CS pos: 23-24. ARA-FD. Pr: 0.6537    36
NZ_CP027599.1_108106	TAT(Tat/SPI)	0.322070	0.404532	0.164656	0.108742	CS pos: 26-27. VIA-TK. Pr: 0.3741    32
NZ_CP027599.1_108139	SP(Sec/SPI)	0.421225	0.101500	0.081942	0.395333	CS pos: 18-19. ARS-HD. Pr: 0.3353    31
NZ_CP027599.1_108259	LIPO(Sec/SPII)	0.277104	0.009853	0.402895	0.310147	CS pos: ?. Probable protein fragment    22
NZ_CP027599.1_108309	LIPO(Sec/SPII)	0.238162	0.037273	0.406793	0.317772	CS pos: ?. Probable protein fragment    15
NZ_CP027599.1_108330	LIPO(Sec/SPII)	0.371512	0.009745	0.471934	0.146808	CS pos: ?. Probable protein fragment    16
NZ_CP027599.1_108336	LIPO(Sec/SPII)	0.116770	0.231815	0.363482	0.287933	CS pos: 29-30. WIS-CR. Pr: 0.2953    41
NZ_CP027599.1_108338	LIPO(Sec/SPII)	0.074974	0.067963	0.461612	0.395451	CS pos: 22-23. AAP-CS. Pr: 0.2062    50
NZ_CP027599.1_108355	TAT(Tat/SPI)	0.295888	0.457222	0.034014	0.212876	CS pos: 37-38. AMT-AT. Pr: 0.3676    49
NZ_CP027599.1_108377	LIPO(Sec/SPII)	0.408038	0.021808	0.421183	0.148971	CS pos: 18-19. PSN-CT. Pr: 0.3101    22
NZ_CP027599.1_108392	LIPO(Sec/SPII)	0.076530	0.004812	0.828537	0.090120	CS pos: 18-19. TCN-CS. Pr: 0.6351    41
NZ_CP027599.1_108413	LIPO(Sec/SPII)	0.077447	0.005609	0.515556	0.401389	CS pos: 21-22. FSS-CA. Pr: 0.4235    29
NZ_CP027599.1_108414	LIPO(Sec/SPII)	0.228965	0.035343	0.380236	0.355456	CS pos: 12-13. AST-CL. Pr: 0.1482    15
NZ_CP027599.1_108454	LIPO(Sec/SPII)	0.219678	0.021827	0.431760	0.326735	CS pos: 17-18. IVE-CF. Pr: 0.1073    19
NZ_CP027599.1_108457	LIPO(Sec/SPII)	0.161593	0.017723	0.558677	0.262007	CS pos: 15-16. VYS-CN. Pr: 0.4483    17
NZ_CP027599.1_108465	SP(Sec/SPI)	0.930377	0.023750	0.008025	0.037847	CS pos: 24-25. VRA-IA. Pr: 0.7218    45
NZ_CP027599.1_108470	LIPO(Sec/SPII)	0.084031	0.034708	0.455355	0.425906	CS pos: 15-16. AIG-CE. Pr: 0.4352    34
NZ_CP027599.1_108471	LIPO(Sec/SPII)	0.168029	0.043806	0.438620	0.349545	CS pos: 15-16. SAG-CN. Pr: 0.3997    22
NZ_CP027599.1_108497	LIPO(Sec/SPII)	0.177575	0.007869	0.459869	0.354686	CS pos: 25-26. LLS-CF. Pr: 0.4357    48
NZ_CP027599.1_108521	SP(Sec/SPI)	0.676844	0.024644	0.095167	0.203345	CS pos: 18-19. ALS-AW. Pr: 0.5197    24
NZ_CP027599.1_108523	TAT(Tat/SPI)	0.161402	0.444249	0.144276	0.250073	CS pos: 23-24. IAA-ST. Pr: 0.2123    46
NZ_CP027599.1_108527	LIPO(Sec/SPII)	0.359175	0.027402	0.376187	0.237235	CS pos: 16-17. VKV-CA. Pr: 0.0651    22
NZ_CP027599.1_108542	SP(Sec/SPI)	0.384477	0.031898	0.247029	0.336597	CS pos: ?. Probable protein fragment    16
NZ_CP027599.1_108556	SP(Sec/SPI)	0.434157	0.095904	0.178339	0.291600	CS pos: 16-17. SRA-AT. Pr: 0.3782    30
NZ_CP027599.1_108560	SP(Sec/SPI)	0.513494	0.132676	0.205458	0.148372	CS pos: 20-21. TWC-AT. Pr: 0.2192    38
NZ_CP027599.1_108585	SP(Sec/SPI)	0.391784	0.034942	0.247000	0.326274	CS pos: 19-20. GSG-CS. Pr: 0.1329    30
NZ_CP027599.1_108600	LIPO(Sec/SPII)	0.119905	0.002814	0.781155	0.096126	CS pos: 22-23. SFT-CT. Pr: 0.7412    29
NZ_CP027599.1_108601	LIPO(Sec/SPII)	0.231933	0.025682	0.372043	0.370342	CS pos: 13-14. WIG-CR. Pr: 0.0638    18
NZ_CP027599.1_108617	LIPO(Sec/SPII)	0.289118	0.024404	0.374998	0.311480	CS pos: ?. Probable protein fragment    15
NZ_CP027599.1_108639	LIPO(Sec/SPII)	0.197201	0.158293	0.578637	0.065869	CS pos: 19-20. AFA-CD. Pr: 0.5827    34
NZ_CP027599.1_108641	LIPO(Sec/SPII)	0.232791	0.019103	0.473727	0.274379	CS pos: 16-17. ICS-CC. Pr: 0.1373    18
NZ_CP027599.1_108668	LIPO(Sec/SPII)	0.166170	0.011272	0.413235	0.409323	CS pos: 40-41. AAG-CS. Pr: 0.2591    44
NZ_CP027599.1_108683	LIPO(Sec/SPII)	0.036013	0.002853	0.928127	0.033007	CS pos: 19-20. GGG-CN. Pr: 0.9223    34
NZ_CP027599.1_108723	SP(Sec/SPI)	0.654282	0.007404	0.223741	0.114573	CS pos: 20-21. VLA-SD. Pr: 0.6443    26
NZ_CP027599.1_108737	LIPO(Sec/SPII)	0.071550	0.010945	0.492934	0.424572	CS pos: 17-18. RSG-CG. Pr: 0.4716    30
NZ_CP027599.1_108753	LIPO(Sec/SPII)	0.296100	0.008658	0.402626	0.292616	CS pos: ?. Probable protein fragment    17
NZ_CP027599.1_108756	LIPO(Sec/SPII)	0.337621	0.033843	0.372704	0.255832	CS pos: 14-15. GWA-CS. Pr: 0.3464    29
NZ_CP027599.1_108760	LIPO(Sec/SPII)	0.175641	0.017538	0.661781	0.145040	CS pos: 27-28. SSS-CL. Pr: 0.5955    38
NZ_CP027599.1_108770	LIPO(Sec/SPII)	0.106707	0.005872	0.520911	0.366510	CS pos: 24-25. LLA-CS. Pr: 0.5142    48
NZ_CP027599.1_108791	LIPO(Sec/SPII)	0.154607	0.028392	0.437054	0.379947	CS pos: 33-34. GGS-CT. Pr: 0.3907    42
NZ_CP027599.1_108880	SP(Sec/SPI)	0.384340	0.122170	0.212159	0.281331	CS pos: 22-23. VRA-YC. Pr: 0.2771    50
NZ_CP027599.1_108914	SP(Sec/SPI)	0.812696	0.054135	0.048377	0.084792	CS pos: 27-28. AFA-GE. Pr: 0.7971    34
NZ_CP027599.1_108943	SP(Sec/SPI)	0.411002	0.074997	0.123261	0.390741	CS pos: 18-19. AFA-AI. Pr: 0.1473    26
NZ_CP027599.1_109037	SP(Sec/SPI)	0.373879	0.091167	0.210596	0.324358	CS pos: 20-21. GSA-IN. Pr: 0.1569    32
NZ_CP027599.1_109068	TAT(Tat/SPI)	0.304780	0.381641	0.041602	0.271977	CS pos: 26-27. AGA-AR. Pr: 0.5138    38
NZ_CP027599.1_109079	SP(Sec/SPI)	0.448391	0.146773	0.254268	0.150568	CS pos: 32-33. AWQ-SA. Pr: 0.2410    46
NZ_CP027599.1_109092	SP(Sec/SPI)	0.377976	0.107956	0.171995	0.342073	CS pos: 21-22. GSA-SS. Pr: 0.0379    27
NZ_CP027599.1_109096	LIPO(Sec/SPII)	0.203803	0.040847	0.445414	0.309936	CS pos: ?. Probable protein fragment    17
NZ_CP027599.1_109100	SP(Sec/SPI)	0.503690	0.053912	0.086779	0.355619	CS pos: 16-17. AGA-AD. Pr: 0.1490    33
NZ_CP027599.1_109119	LIPO(Sec/SPII)	0.215524	0.127413	0.377660	0.279402	CS pos: 14-15. LTY-LL. Pr: 0.0165    16
NZ_CP027599.1_109123	LIPO(Sec/SPII)	0.216864	0.031901	0.433563	0.317671	CS pos: ?. Probable protein fragment    18
NZ_CP027599.1_109173	LIPO(Sec/SPII)	0.254300	0.039535	0.420952	0.285214	CS pos: ?. Probable protein fragment    17
NZ_CP027599.1_109229	LIPO(Sec/SPII)	0.020241	0.001594	0.892624	0.085541	CS pos: 24-25. IES-CR. Pr: 0.8919    43
NZ_CP027599.1_109242	LIPO(Sec/SPII)	0.275792	0.011404	0.439443	0.273361	CS pos: ?. Probable protein fragment    16
NZ_CP027599.1_109266	SP(Sec/SPI)	0.413562	0.035115	0.192227	0.359096	CS pos: 15-16. TGA-NP. Pr: 0.1361    22
NZ_CP027599.1_109284	SP(Sec/SPI)	0.393396	0.137082	0.082878	0.386644	CS pos: 14-15. GNA-AG. Pr: 0.1382    24
NZ_CP027599.1_109286	SP(Sec/SPI)	0.509640	0.027844	0.178834	0.283681	CS pos: 25-26. AMP-EQ. Pr: 0.2700    36
NZ_CP027599.1_109328	LIPO(Sec/SPII)	0.031347	0.001972	0.490321	0.476361	CS pos: 14-15. LNS-CQ. Pr: 0.3032    47
NZ_CP027599.1_109353	SP(Sec/SPI)	0.732892	0.022348	0.040411	0.204349	CS pos: 15-16. SYA-TT. Pr: 0.3272    32
NZ_CP027599.1_109454	SP(Sec/SPI)	0.395562	0.015169	0.232633	0.356636	CS pos: ?. Probable protein fragment    23
NZ_CP027599.1_109457	LIPO(Sec/SPII)	0.073671	0.017207	0.655138	0.253984	CS pos: 17-18. MQG-CS. Pr: 0.6095    20
NZ_CP027599.1_109481	LIPO(Sec/SPII)	0.301781	0.014401	0.446016	0.237803	CS pos: 14-15. SCT-CT. Pr: 0.1509    23
NZ_CP027599.1_109482	LIPO(Sec/SPII)	0.291521	0.006756	0.454333	0.247390	CS pos: 20-21. ALN-CF. Pr: 0.2539    26
NZ_CP027599.1_109811	LIPO(Sec/SPII)	0.263275	0.014209	0.459442	0.263075	CS pos: 14-15. LAG-TG. Pr: 0.0248    16
NZ_CP027599.1_109845	SP(Sec/SPI)	0.603211	0.035400	0.113553	0.247836	CS pos: 18-19. AAA-IS. Pr: 0.4231    28
NZ_CP027599.1_109888	SP(Sec/SPI)	0.505766	0.003757	0.115639	0.374838	CS pos: 21-22. VAV-MT. Pr: 0.1600    29
NZ_CP027599.1_109895	LIPO(Sec/SPII)	0.165561	0.028979	0.433836	0.371624	CS pos: 14-15. FGA-CG. Pr: 0.3591    17
NZ_CP027599.1_109957	LIPO(Sec/SPII)	0.227023	0.040621	0.368760	0.363596	CS pos: ?. Probable protein fragment    18
NZ_CP027599.1_109962	LIPO(Sec/SPII)	0.080393	0.011078	0.552244	0.356285	CS pos: 18-19. AAG-CG. Pr: 0.5180    25
NZ_CP027599.1_109969	LIPO(Sec/SPII)	0.210458	0.145347	0.335121	0.309074	CS pos: 20-21. AAG-CK. Pr: 0.2946    23
NZ_CP027599.1_109974	TAT(Tat/SPI)	0.169238	0.523586	0.032235	0.274941	CS pos: ?. Probable protein fragment    44
NZ_CP027599.1_109980	SP(Sec/SPI)	0.801144	0.039895	0.122428	0.036533	CS pos: 27-28. AIS-SD. Pr: 0.3503    39
NZ_CP027599.1_110024	LIPO(Sec/SPII)	0.060229	0.041445	0.760895	0.137431	CS pos: 24-25. CVS-CL. Pr: 0.6654    44
NZ_CP027599.1_110091	LIPO(Sec/SPII)	0.244198	0.003184	0.697428	0.055190	CS pos: 26-27. LPG-CS. Pr: 0.6372    30
NZ_CP027599.1_110097	SP(Sec/SPI)	0.489943	0.002506	0.075796	0.431755	CS pos: 21-22. IFS-KD. Pr: 0.3926    24
NZ_CP027599.1_110114	SP(Sec/SPI)	0.586195	0.096005	0.112571	0.205229	CS pos: 19-20. SSA-IN. Pr: 0.2727    50
NZ_CP027599.1_110147	LIPO(Sec/SPII)	0.243262	0.028495	0.376199	0.352045	CS pos: 14-15. AAV-CR. Pr: 0.2290    22
NZ_CP027599.1_110148	LIPO(Sec/SPII)	0.079777	0.174079	0.623352	0.122792	CS pos: 19-20. SAA-CS. Pr: 0.4251    50
NZ_CP027599.1_110168	SP(Sec/SPI)	0.742350	0.040519	0.101528	0.115602	CS pos: 17-18. VAA-TN. Pr: 0.6441    35
NZ_CP027599.1_110171	LIPO(Sec/SPII)	0.069443	0.054834	0.528950	0.346773	CS pos: 17-18. INA-CC. Pr: 0.2890    37
NZ_CP027599.1_110180	LIPO(Sec/SPII)	0.299254	0.022811	0.525444	0.152491	CS pos: ?. Probable protein fragment    26
NZ_CP027599.1_110183	SP(Sec/SPI)	0.496651	0.052659	0.106488	0.344201	CS pos: 13-14. VAA-NG. Pr: 0.1974    19
NZ_CP027599.1_110186	TAT(Tat/SPI)	0.255448	0.376378	0.140138	0.228036	CS pos: 27-28. SIS-DE. Pr: 0.2361    34
NZ_CP027599.1_110224	SP(Sec/SPI)	0.359472	0.148986	0.152812	0.338730	CS pos: 20-21. AVG-ET. Pr: 0.2588    27
NZ_CP027599.1_110234	SP(Sec/SPI)	0.524748	0.070317	0.086020	0.318915	CS pos: 16-17. SNA-VQ. Pr: 0.3844    39
NZ_CP027599.1_110236	LIPO(Sec/SPII)	0.239896	0.049932	0.373836	0.336335	CS pos: 32-33. TCS-CT. Pr: 0.2621    35
NZ_CP027599.1_110254	LIPO(Sec/SPII)	0.195266	0.023056	0.560800	0.220878	CS pos: ?. Probable protein fragment    28
NZ_CP027599.1_110263	LIPO(Sec/SPII)	0.334850	0.015034	0.449518	0.200598	CS pos: 15-16. CPA-SG. Pr: 0.0528    17
NZ_CP027599.1_110270	LIPO(Sec/SPII)	0.394801	0.023794	0.513049	0.068356	CS pos: 24-25. IAS-CA. Pr: 0.4713    28
NZ_CP027599.1_110275	LIPO(Sec/SPII)	0.120281	0.002538	0.740455	0.136726	CS pos: 18-19. FLC-CT. Pr: 0.6588    37
NZ_CP027599.1_110276	SP(Sec/SPI)	0.555002	0.007811	0.306637	0.130550	CS pos: 15-16. LHA-GR. Pr: 0.2874    35
NZ_CP027599.1_110292	LIPO(Sec/SPII)	0.009455	0.052262	0.930956	0.007327	CS pos: 22-23. TSG-CS. Pr: 0.9332    37
NZ_CP027599.1_110305	TAT(Tat/SPI)	0.109005	0.628332	0.035659	0.227004	CS pos: ?. Probable protein fragment    35
NZ_CP027599.1_110312	SP(Sec/SPI)	0.675565	0.128032	0.082205	0.114199	CS pos: 21-22. AMA-MP. Pr: 0.6581    26
NZ_CP027599.1_110349	SP(Sec/SPI)	0.528945	0.077918	0.142937	0.250201	CS pos: ?. Probable protein fragment    29
NZ_CP027599.1_110381	LIPO(Sec/SPII)	0.074609	0.004958	0.584723	0.335710	CS pos: 13-14. LIT-CD. Pr: 0.5739    28
NZ_CP027599.1_110389	SP(Sec/SPI)	0.431697	0.042351	0.125924	0.400029	CS pos: 26-27. AAG-QD. Pr: 0.2668    46
NZ_CP027599.1_110396	LIPO(Sec/SPII)	0.255582	0.014550	0.474813	0.255055	CS pos: 19-20. ASS-LW. Pr: 0.0627    21
NZ_CP027599.1_110401	SP(Sec/SPI)	0.461845	0.026036	0.066319	0.445800	CS pos: 23-24. GLA-SQ. Pr: 0.2921    28
NZ_CP027599.1_110411	LIPO(Sec/SPII)	0.285612	0.017909	0.440945	0.255534	CS pos: 15-16. LFL-CS. Pr: 0.1018    18
NZ_CP027599.1_110426	SP(Sec/SPI)	0.523664	0.040282	0.120188	0.315866	CS pos: 19-20. AAA-AS. Pr: 0.1941    42
NZ_CP027599.1_110434	LIPO(Sec/SPII)	0.264530	0.024195	0.427145	0.284130	CS pos: ?. Probable protein fragment    18
NZ_CP027599.1_110468	SP(Sec/SPI)	0.491565	0.041225	0.142002	0.325209	CS pos: 23-24. SIA-DG. Pr: 0.3387    28
NZ_CP027599.1_110501	LIPO(Sec/SPII)	0.064922	0.030904	0.730401	0.173774	CS pos: 25-26. TAA-CG. Pr: 0.7285    41
NZ_CP027599.1_110510	LIPO(Sec/SPII)	0.089424	0.010655	0.508032	0.391889	CS pos: 26-27. ATG-CS. Pr: 0.4869    31
NZ_CP027599.1_110530	SP(Sec/SPI)	0.458656	0.170135	0.157223	0.213986	CS pos: 23-24. ASA-SK. Pr: 0.3538    28
NZ_CP027599.1_110533	SP(Sec/SPI)	0.667948	0.080597	0.176482	0.074972	CS pos: 17-18. GLA-KS. Pr: 0.2808    38
NZ_CP027599.1_110552	SP(Sec/SPI)	0.609394	0.028957	0.178937	0.182711	CS pos: 24-25. ILA-SG. Pr: 0.3849    37
NZ_CP027599.1_110558	TAT(Tat/SPI)	0.269961	0.422549	0.022769	0.284721	CS pos: 25-26. AAA-RW. Pr: 0.1614    40
NZ_CP027599.1_110564	LIPO(Sec/SPII)	0.245605	0.028635	0.379737	0.346024	CS pos: ?. Probable protein fragment    16
NZ_CP027599.1_110570	SP(Sec/SPI)	0.923365	0.063147	0.003025	0.010463	CS pos: 21-22. AAA-AD. Pr: 0.7791    50
NZ_CP027599.1_110579	LIPO(Sec/SPII)	0.203109	0.027593	0.480377	0.288921	CS pos: 14-15. PAA-CI. Pr: 0.2343    17
NZ_CP027599.1_110583	LIPO(Sec/SPII)	0.183415	0.006211	0.512765	0.297609	CS pos: 20-21. IIC-CG. Pr: 0.3952    29
NZ_CP027599.1_110638	SP(Sec/SPI)	0.425567	0.016185	0.269893	0.288355	CS pos: 14-15. PIA-KE. Pr: 0.1626    16
NZ_CP027599.1_110640	LIPO(Sec/SPII)	0.275900	0.020915	0.374353	0.328831	CS pos: ?. Probable protein fragment    20
NZ_CP027599.1_110655	LIPO(Sec/SPII)	0.251561	0.070565	0.385081	0.292793	CS pos: 13-14. AAS-CC. Pr: 0.2315    15
NZ_CP027599.1_110662	TAT(Tat/SPI)	0.123280	0.665956	0.030809	0.179954	CS pos: 31-32. SYA-AS. Pr: 0.5865    43
NZ_CP027599.1_110675	SP(Sec/SPI)	0.659840	0.210995	0.020013	0.109152	CS pos: 24-25. TLA-AL. Pr: 0.6396    48
NZ_CP027599.1_110679	LIPO(Sec/SPII)	0.005138	0.000829	0.991519	0.002514	CS pos: 16-17. ISG-CI. Pr: 0.9911    33
NZ_CP027599.1_110682	SP(Sec/SPI)	0.402545	0.344062	0.214820	0.038574	CS pos: 24-25. VNA-CV. Pr: 0.8255    43
NZ_CP027599.1_110684	TAT(Tat/SPI)	0.109678	0.676731	0.022950	0.190641	CS pos: 28-29. SRA-SY. Pr: 0.4943    42
NZ_CP027599.1_110705	LIPO(Sec/SPII)	0.099297	0.038667	0.547901	0.314136	CS pos: 10-11. SIA-CN. Pr: 0.5460    41
NZ_CP027599.1_110754	LIPO(Sec/SPII)	0.297091	0.032000	0.365473	0.305436	CS pos: ?. Probable protein fragment    17
NZ_CP027599.1_110764	LIPO(Sec/SPII)	0.197350	0.019673	0.502164	0.280813	CS pos: ?. Probable protein fragment    18
NZ_CP027599.1_110788	LIPO(Sec/SPII)	0.276041	0.003975	0.479475	0.240509	CS pos: 17-18. CIC-CP. Pr: 0.1731    24
NZ_CP027599.1_110790	SP(Sec/SPI)	0.763213	0.165272	0.033000	0.038516	CS pos: 23-24. VLA-LY. Pr: 0.8176    45
NZ_CP027599.1_110835	SP(Sec/SPI)	0.487931	0.018132	0.263148	0.230789	CS pos: 25-26. CRG-KT. Pr: 0.1297    34
NZ_CP027599.1_110837	SP(Sec/SPI)	0.429804	0.015853	0.233372	0.320971	CS pos: 20-21. VMT-RN. Pr: 0.1349    25
NZ_CP027599.1_110864	SP(Sec/SPI)	0.681609	0.002313	0.148526	0.167552	CS pos: 22-23. TLT-TP. Pr: 0.2173    33
NZ_CP027599.1_110981	LIPO(Sec/SPII)	0.130171	0.012537	0.579496	0.277797	CS pos: 16-17. VGN-CN. Pr: 0.5438    25
NZ_CP027599.1_111012	SP(Sec/SPI)	0.408185	0.008997	0.183240	0.399577	CS pos: 18-19. VHR-KD. Pr: 0.1823    24
NZ_CP027599.1_111020	SP(Sec/SPI)	0.840926	0.026918	0.037103	0.095054	CS pos: 23-24. AFA-TI. Pr: 0.5107    42
NZ_CP027599.1_111028	SP(Sec/SPI)	0.354804	0.212741	0.098234	0.334221	CS pos: 24-25. VSA-IP. Pr: 0.2044    36
NZ_CP027599.1_111048	SP(Sec/SPI)	0.637319	0.043047	0.187282	0.132351	CS pos: 23-24. VRA-PI. Pr: 0.3664    38
NZ_CP027599.1_111060	TAT(Tat/SPI)	0.131255	0.561938	0.094221	0.212587	CS pos: 15-16. ATS-SG. Pr: 0.0322    20
NZ_CP027599.1_111080	LIPO(Sec/SPII)	0.189358	0.022678	0.507171	0.280793	CS pos: 16-17. AFC-CR. Pr: 0.3551    31
NZ_CP027599.1_111093	LIPO(Sec/SPII)	0.119841	0.075258	0.408771	0.396131	CS pos: 15-16. SAA-CA. Pr: 0.3413    22
NZ_CP027599.1_111094	LIPO(Sec/SPII)	0.162754	0.014974	0.570316	0.251955	CS pos: 16-17. WLA-CG. Pr: 0.4682    18
NZ_CP027599.1_111111	LIPO(Sec/SPII)	0.316057	0.014478	0.371290	0.298175	CS pos: 14-15. VNG-SM. Pr: 0.0674    19
NZ_CP027599.1_111128	LIPO(Sec/SPII)	0.307795	0.017291	0.363075	0.311839	CS pos: ?. Probable protein fragment    20
NZ_CP027599.1_111142	LIPO(Sec/SPII)	0.209964	0.059825	0.365319	0.364893	CS pos: 19-20. VRS-CS. Pr: 0.1821    22
NZ_CP027599.1_111163	LIPO(Sec/SPII)	0.038223	0.187759	0.486598	0.287420	CS pos: 21-22. TGG-CD. Pr: 0.4907    42
NZ_CP027599.1_111182	SP(Sec/SPI)	0.607516	0.025726	0.181350	0.185408	CS pos: 17-18. IAA-YK. Pr: 0.3796    22
NZ_CP027599.1_111186	LIPO(Sec/SPII)	0.109016	0.040554	0.499350	0.351080	CS pos: 14-15. SSS-CN. Pr: 0.4574    23
NZ_CP027599.1_111203	LIPO(Sec/SPII)	0.043571	0.006163	0.794954	0.155313	CS pos: 21-22. DAA-CT. Pr: 0.7916    43
NZ_CP027599.1_111224	SP(Sec/SPI)	0.675795	0.055958	0.034787	0.233459	CS pos: 17-18. ISA-HN. Pr: 0.3719    41
NZ_CP027599.1_111225	LIPO(Sec/SPII)	0.296759	0.031250	0.360741	0.311250	CS pos: 14-15. VNS-VI. Pr: 0.0510    16
NZ_CP027599.1_111236	LIPO(Sec/SPII)	0.223035	0.024644	0.551346	0.200975	CS pos: 15-16. SFC-CS. Pr: 0.3168    21
NZ_CP027599.1_111238	SP(Sec/SPI)	0.428427	0.202013	0.083329	0.286231	CS pos: 24-25. TTA-VS. Pr: 0.1990    43
NZ_CP027599.1_111242	LIPO(Sec/SPII)	0.190548	0.085814	0.413031	0.310608	CS pos: 19-20. GSG-CQ. Pr: 0.3921    24
NZ_CP027599.1_111267	SP(Sec/SPI)	0.842315	0.020524	0.037250	0.099911	CS pos: 17-18. SLA-DV. Pr: 0.7676    37
NZ_CP027599.1_111302	SP(Sec/SPI)	0.677665	0.003551	0.225835	0.092949	CS pos: 21-22. CHS-AK. Pr: 0.3717    32
NZ_CP027599.1_111328	LIPO(Sec/SPII)	0.123259	0.033396	0.557338	0.286008	CS pos: 27-28. FAS-CS. Pr: 0.5232    35
NZ_CP027599.1_111339	LIPO(Sec/SPII)	0.308807	0.034715	0.423099	0.233379	CS pos: 17-18. RCG-CF. Pr: 0.1671    21
NZ_CP027599.1_111351	SP(Sec/SPI)	0.339086	0.111727	0.272850	0.276336	CS pos: 15-16. LRG-NR. Pr: 0.1534    21
NZ_CP027599.1_111355	SP(Sec/SPI)	0.478455	0.038869	0.081996	0.400679	CS pos: 17-18. ALA-IE. Pr: 0.4444    35
NZ_CP027599.1_111368	LIPO(Sec/SPII)	0.140084	0.050644	0.506831	0.302442	CS pos: 18-19. TTG-CG. Pr: 0.4375    21
NZ_CP027599.1_111410	TAT(Tat/SPI)	0.153614	0.453903	0.030870	0.361614	CS pos: 24-25. ALA-ST. Pr: 0.2835    43
NZ_CP027599.1_111465	SP(Sec/SPI)	0.477409	0.023669	0.029048	0.469874	CS pos: 19-20. VQA-KD. Pr: 0.4643    24
NZ_CP027599.1_111472	LIPO(Sec/SPII)	0.205120	0.013463	0.492588	0.288829	CS pos: 15-16. STV-CR. Pr: 0.2614    17
NZ_CP027599.1_111484	LIPO(Sec/SPII)	0.212362	0.013770	0.409805	0.364063	CS pos: ?. Probable protein fragment    19
NZ_CP027599.1_111485	SP(Sec/SPI)	0.650056	0.070061	0.054816	0.225066	CS pos: 24-25. AIA-AH. Pr: 0.5282    32
NZ_CP027599.1_111496	LIPO(Sec/SPII)	0.361683	0.075942	0.422272	0.140103	CS pos: 20-21. RAI-CA. Pr: 0.2669    25
NZ_CP027599.1_111568	LIPO(Sec/SPII)	0.179723	0.021552	0.415186	0.383539	CS pos: 15-16. GFG-CA. Pr: 0.3488    25
NZ_CP027599.1_111591	SP(Sec/SPI)	0.604205	0.014347	0.186275	0.195172	CS pos: 22-23. IWN-AI. Pr: 0.2390    28
NZ_CP027599.1_111606	LIPO(Sec/SPII)	0.173084	0.009844	0.461984	0.355088	CS pos: ?. Probable protein fragment    26
NZ_CP027599.1_111639	LIPO(Sec/SPII)	0.193542	0.018915	0.397775	0.389767	CS pos: 18-19. AFG-CG. Pr: 0.2523    21
NZ_CP027599.1_111656	SP(Sec/SPI)	0.513128	0.227149	0.053384	0.206339	CS pos: 15-16. ANA-QK. Pr: 0.3898    26
NZ_CP027599.1_111660	LIPO(Sec/SPII)	0.155637	0.015750	0.618375	0.210238	CS pos: 19-20. AVS-CW. Pr: 0.5484    27
NZ_CP027599.1_111688	LIPO(Sec/SPII)	0.296414	0.013857	0.446330	0.243399	CS pos: 13-14. LYF-CY. Pr: 0.0474    15
NZ_CP027599.1_111713	LIPO(Sec/SPII)	0.325098	0.001780	0.388767	0.284355	CS pos: 14-15. AIG-SI. Pr: 0.1469    40
NZ_CP027599.1_111740	LIPO(Sec/SPII)	0.204142	0.037887	0.564311	0.193661	CS pos: 12-13. LAA-CT. Pr: 0.5501    43
NZ_CP027599.1_111741	LIPO(Sec/SPII)	0.255814	0.036923	0.386370	0.320892	CS pos: 15-16. LCT-CS. Pr: 0.2302    17
NZ_CP027599.1_111767	LIPO(Sec/SPII)	0.295087	0.012039	0.438868	0.254006	CS pos: ?. Probable protein fragment    15
NZ_CP027599.1_111800	SP(Sec/SPI)	0.463336	0.036804	0.198985	0.300875	CS pos: 18-19. AVA-TS. Pr: 0.2747    22
NZ_CP027599.1_111808	LIPO(Sec/SPII)	0.308106	0.017133	0.375380	0.299381	CS pos: ?. Probable protein fragment    16
NZ_CP027599.1_111821	LIPO(Sec/SPII)	0.032285	0.002195	0.516452	0.449067	CS pos: 20-21. IAS-CY. Pr: 0.5119    39
NZ_CP027599.1_111825	LIPO(Sec/SPII)	0.212295	0.072573	0.426202	0.288930	CS pos: 20-21. ASP-CL. Pr: 0.3618    38
NZ_CP027599.1_111867	LIPO(Sec/SPII)	0.119493	0.029360	0.532762	0.318384	CS pos: 16-17. SLT-CH. Pr: 0.5003    30
NZ_CP027599.1_111900	LIPO(Sec/SPII)	0.162242	0.013250	0.420783	0.403725	CS pos: 16-17. KNS-CD. Pr: 0.3418    23
NZ_CP027599.1_111902	SP(Sec/SPI)	0.407849	0.004971	0.302038	0.285142	CS pos: 24-25. TLC-AN. Pr: 0.2464    45
NZ_CP027599.1_111904	LIPO(Sec/SPII)	0.362266	0.010277	0.444177	0.183279	CS pos: ?. Probable protein fragment    15
NZ_CP027599.1_111922	SP(Sec/SPI)	0.342655	0.252057	0.064588	0.340701	CS pos: 34-35. SFA-NC. Pr: 0.1339    44
NZ_CP027599.1_111937	LIPO(Sec/SPII)	0.047252	0.009928	0.725128	0.217692	CS pos: 25-26. IQS-CL. Pr: 0.7129    31
NZ_CP027599.1_111940	LIPO(Sec/SPII)	0.030089	0.002156	0.621285	0.346471	CS pos: 16-17. SLS-CV. Pr: 0.6304    43
NZ_CP027599.1_111944	SP(Sec/SPI)	0.376086	0.291128	0.062979	0.269806	CS pos: 26-27. LYS-SP. Pr: 0.4318    39
NZ_CP027599.1_111988	SP(Sec/SPI)	0.377918	0.118524	0.134088	0.369471	CS pos: 19-20. VVA-SV. Pr: 0.1481    34
NZ_CP027599.1_111990	SP(Sec/SPI)	0.445487	0.137965	0.046239	0.370310	CS pos: 22-23. AVA-NF. Pr: 0.2552    30
NZ_CP027599.1_112011	SP(Sec/SPI)	0.717930	0.172022	0.049775	0.060273	CS pos: 17-18. ASA-PY. Pr: 0.2162    46
NZ_CP027599.1_112051	LIPO(Sec/SPII)	0.087830	0.008522	0.494449	0.409200	CS pos: 22-23. IAM-CV. Pr: 0.4078    26
NZ_CP027599.1_112108	LIPO(Sec/SPII)	0.171647	0.013118	0.674303	0.140932	CS pos: 14-15. GFG-CN. Pr: 0.6497    29
NZ_CP027599.1_112117	SP(Sec/SPI)	0.374651	0.010621	0.359691	0.255037	CS pos: ?. Probable protein fragment    21
NZ_CP027599.1_112135	LIPO(Sec/SPII)	0.297905	0.058284	0.332845	0.310966	CS pos: ?. Probable protein fragment    15
NZ_CP027599.1_112141	LIPO(Sec/SPII)	0.166453	0.132611	0.509596	0.191339	CS pos: 26-27. VSL-CT. Pr: 0.4172    43
NZ_CP027599.1_112149	TAT(Tat/SPI)	0.116095	0.401030	0.192646	0.290229	CS pos: ?. Probable protein fragment    16
NZ_CP027599.1_112158	SP(Sec/SPI)	0.575172	0.080938	0.108086	0.235805	CS pos: 17-18. SFA-TG. Pr: 0.4883    35
NZ_CP027599.1_112197	SP(Sec/SPI)	0.369163	0.003770	0.289636	0.337431	CS pos: 18-19. LLS-LE. Pr: 0.1868    28
NZ_CP027599.1_112202	LIPO(Sec/SPII)	0.300728	0.012861	0.347018	0.339393	CS pos: 20-21. SPG-CM. Pr: 0.1025    24
NZ_CP027599.1_112208	TAT(Tat/SPI)	0.140210	0.390646	0.134640	0.334504	CS pos: ?. Probable protein fragment    17
NZ_CP027599.1_112210	LIPO(Sec/SPII)	0.147780	0.003879	0.715359	0.132982	CS pos: 30-31. AGG-CR. Pr: 0.6138    42
NZ_CP027599.1_112218	SP(Sec/SPI)	0.500007	0.021441	0.278168	0.200383	CS pos: 13-14. AAA-FD. Pr: 0.1625    15
NZ_CP027599.1_112223	LIPO(Sec/SPII)	0.004985	0.000915	0.982860	0.011240	CS pos: 22-23. ATA-CW. Pr: 0.9839    47
NZ_CP027599.1_112232	LIPO(Sec/SPII)	0.265301	0.038980	0.350999	0.344720	CS pos: ?. Probable protein fragment    16
NZ_CP027599.1_112270	LIPO(Sec/SPII)	0.082490	0.018930	0.603256	0.295324	CS pos: 19-20. LYS-CH. Pr: 0.5850    29
NZ_CP027599.1_112274	LIPO(Sec/SPII)	0.140837	0.061885	0.560941	0.236337	CS pos: 16-17. AGG-CH. Pr: 0.5369    26
NZ_CP027599.1_112297	SP(Sec/SPI)	0.778525	0.060870	0.060741	0.099864	CS pos: 21-22. CSA-SE. Pr: 0.6418    38
NZ_CP027599.1_112308	LIPO(Sec/SPII)	0.151842	0.035878	0.704368	0.107912	CS pos: 20-21. ATT-CC. Pr: 0.3742    43
NZ_CP027599.1_112310	LIPO(Sec/SPII)	0.247142	0.033977	0.379855	0.339027	CS pos: ?. Probable protein fragment    17
NZ_CP027599.1_112324	SP(Sec/SPI)	0.454051	0.055445	0.088446	0.402057	CS pos: 20-21. TLA-WK. Pr: 0.2784    45
NZ_CP027599.1_112325	SP(Sec/SPI)	0.447008	0.090605	0.062274	0.400113	CS pos: 23-24. ARS-VT. Pr: 0.2454    27
NZ_CP027599.1_112364	LIPO(Sec/SPII)	0.350586	0.024557	0.370491	0.254367	CS pos: 17-18. SAI-CG. Pr: 0.2193    21
NZ_CP027599.1_112393	SP(Sec/SPI)	0.551822	0.036590	0.084622	0.326966	CS pos: 24-25. APA-AV. Pr: 0.3542    27
NZ_CP027599.1_112403	LIPO(Sec/SPII)	0.169188	0.007912	0.611738	0.211162	CS pos: ?. Probable protein fragment    24
NZ_CP027599.1_112406	LIPO(Sec/SPII)	0.065806	0.009679	0.497997	0.426518	CS pos: 21-22. IPS-CK. Pr: 0.3451    37
NZ_CP027599.1_112430	LIPO(Sec/SPII)	0.350957	0.040472	0.461522	0.147049	CS pos: 10-11. SLG-CS. Pr: 0.1271    16
NZ_CP027599.1_112498	TAT(Tat/SPI)	0.102412	0.570208	0.027786	0.299594	CS pos: 37-38. ASA-AR. Pr: 0.2046    49
NZ_CP027599.1_112563	TAT(Tat/SPI)	0.191979	0.364437	0.108424	0.335160	CS pos: ?. Probable protein fragment    24
NZ_CP027599.1_112578	LIPO(Sec/SPII)	0.084164	0.060745	0.804076	0.051015	CS pos: 21-22. FSG-CG. Pr: 0.7601    49
NZ_CP027599.1_112595	LIPO(Sec/SPII)	0.309414	0.008748	0.364670	0.317168	CS pos: ?. Probable protein fragment    24
NZ_CP027599.1_112600	LIPO(Sec/SPII)	0.019138	0.003027	0.614657	0.363178	CS pos: 24-25. GTS-CQ. Pr: 0.6115    46
NZ_CP027599.1_112619	LIPO(Sec/SPII)	0.086752	0.012279	0.549355	0.351613	CS pos: 14-15. PSA-CC. Pr: 0.3136    31
NZ_CP027599.1_112631	LIPO(Sec/SPII)	0.050413	0.011770	0.526534	0.411283	CS pos: 14-15. LTA-CN. Pr: 0.5177    44
NZ_CP027599.1_112654	LIPO(Sec/SPII)	0.141244	0.008847	0.537666	0.312244	CS pos: 17-18. FVV-CS. Pr: 0.4508    30
NZ_CP027599.1_112657	LIPO(Sec/SPII)	0.269138	0.012709	0.420169	0.297984	CS pos: ?. Probable protein fragment    16
NZ_CP027599.1_112659	LIPO(Sec/SPII)	0.234281	0.030241	0.462234	0.273244	CS pos: 19-20. FPA-CH. Pr: 0.4340    32
NZ_CP027599.1_112682	SP(Sec/SPI)	0.479270	0.004362	0.389740	0.126628	CS pos: 19-20. ARS-IC. Pr: 0.3365    29
NZ_CP027599.1_112739	LIPO(Sec/SPII)	0.272606	0.037118	0.348403	0.341873	CS pos: ?. Probable protein fragment    15
NZ_CP027599.1_112749	LIPO(Sec/SPII)	0.161278	0.044573	0.421197	0.372952	CS pos: 22-23. KCG-CP. Pr: 0.2599    33
NZ_CP027599.1_112783	SP(Sec/SPI)	0.429724	0.050077	0.302614	0.217585	CS pos: 22-23. ALA-AG. Pr: 0.2911    34
NZ_CP027599.1_112796	LIPO(Sec/SPII)	0.343022	0.016626	0.411443	0.228909	CS pos: 17-18. PVV-CS. Pr: 0.2365    21
NZ_CP027599.1_112818	LIPO(Sec/SPII)	0.280153	0.011900	0.654958	0.052990	CS pos: 13-14. GTA-CC. Pr: 0.4407    26
NZ_CP027599.1_112822	LIPO(Sec/SPII)	0.127784	0.034498	0.575410	0.262308	CS pos: 14-15. QTA-CG. Pr: 0.5522    34
NZ_CP027599.1_112838	LIPO(Sec/SPII)	0.220881	0.024301	0.411342	0.343476	CS pos: ?. Probable protein fragment    15
NZ_CP027599.1_112839	TAT(Tat/SPI)	0.181052	0.335007	0.229661	0.254280	CS pos: 19-20. AKA-LI. Pr: 0.0878    25
NZ_CP027599.1_112862	LIPO(Sec/SPII)	0.272460	0.032162	0.415094	0.280285	CS pos: ?. Probable protein fragment    17
NZ_CP027599.1_112882	LIPO(Sec/SPII)	0.191655	0.018137	0.407093	0.383115	CS pos: 24-25. AYP-CS. Pr: 0.3823    29
NZ_CP027599.1_112883	LIPO(Sec/SPII)	0.060377	0.006441	0.686322	0.246860	CS pos: 20-21. SLT-CG. Pr: 0.5875    50
NZ_CP027599.1_112902	SP(Sec/SPI)	0.460338	0.027689	0.150775	0.361199	CS pos: 12-13. VHC-ED. Pr: 0.4018    19
NZ_CP027599.1_112905	LIPO(Sec/SPII)	0.346237	0.010620	0.570191	0.072953	CS pos: 14-15. MTP-CF. Pr: 0.2989    44
NZ_CP027599.1_112923	SP(Sec/SPI)	0.542541	0.077513	0.130019	0.249927	CS pos: 18-19. AVA-VE. Pr: 0.5004    22
NZ_CP027599.1_112941	TAT(Tat/SPI)	0.308248	0.403600	0.066329	0.221822	CS pos: 39-40. GAA-SP. Pr: 0.0776    41
NZ_CP027599.1_112951	SP(Sec/SPI)	0.979468	0.012330	0.003374	0.004828	CS pos: 19-20. AYA-EH. Pr: 0.9796    36
NZ_CP027599.1_112958	LIPO(Sec/SPII)	0.054911	0.064046	0.833105	0.047938	CS pos: 24-25. SSA-CS. Pr: 0.8301    40
NZ_CP027599.1_112973	SP(Sec/SPI)	0.466802	0.028425	0.164373	0.340400	CS pos: 25-26. VHS-TV. Pr: 0.3933    27
NZ_CP027599.1_112989	SP(Sec/SPI)	0.547908	0.066137	0.059051	0.326905	CS pos: 15-16. TTA-QE. Pr: 0.3076    27
NZ_CP027599.1_113027	LIPO(Sec/SPII)	0.245330	0.091187	0.398979	0.264505	CS pos: ?. Probable protein fragment    15
NZ_CP027599.1_113030	LIPO(Sec/SPII)	0.159908	0.036679	0.721252	0.082161	CS pos: 19-20. LSG-AS. Pr: 0.6815    36
NZ_CP027599.1_113038	SP(Sec/SPI)	0.531603	0.044553	0.084340	0.339504	CS pos: 18-19. TQA-KQ. Pr: 0.4653    28
NZ_CP027599.1_113061	LIPO(Sec/SPII)	0.113501	0.014040	0.514803	0.357656	CS pos: 24-25. WLA-CR. Pr: 0.4484    32
NZ_CP027599.1_113091	LIPO(Sec/SPII)	0.237311	0.016410	0.416932	0.329347	CS pos: 14-15. LVA-CL. Pr: 0.3356    26
NZ_CP027599.1_113131	LIPO(Sec/SPII)	0.356842	0.021320	0.414180	0.207659	CS pos: 25-26. LSA-ST. Pr: 0.3168    36
NZ_CP027599.1_113202	LIPO(Sec/SPII)	0.190132	0.013785	0.439765	0.356317	CS pos: 14-15. FNC-CF. Pr: 0.3202    26
NZ_CP027599.1_113213	SP(Sec/SPI)	0.479101	0.027141	0.300348	0.193410	CS pos: 21-22. VSA-RL. Pr: 0.4238    33
NZ_CP027599.1_113217	SP(Sec/SPI)	0.432585	0.092930	0.178827	0.295659	CS pos: 25-26. AFL-CR. Pr: 0.2461    36
NZ_CP027599.1_113352	LIPO(Sec/SPII)	0.359693	0.006534	0.504847	0.128926	CS pos: 22-23. VSL-CQ. Pr: 0.3905    29
NZ_CP027599.1_113355	LIPO(Sec/SPII)	0.296366	0.006826	0.420383	0.276424	CS pos: ?. Probable protein fragment    15
NZ_CP027599.1_113366	LIPO(Sec/SPII)	0.275495	0.051640	0.449025	0.223840	CS pos: 21-22. SQS-CS. Pr: 0.4293    40
NZ_CP027599.1_113369	LIPO(Sec/SPII)	0.070830	0.002405	0.516541	0.410223	CS pos: 19-20. LLS-CF. Pr: 0.4366    28
NZ_CP027599.1_113377	LIPO(Sec/SPII)	0.304853	0.028610	0.339824	0.326713	CS pos: ?. Probable protein fragment    18
NZ_CP027599.1_113378	LIPO(Sec/SPII)	0.007421	0.000355	0.929615	0.062609	CS pos: 16-17. LSA-CW. Pr: 0.9314    33
NZ_CP027599.1_113383	LIPO(Sec/SPII)	0.212074	0.012027	0.450241	0.325659	CS pos: ?. Probable protein fragment    17
NZ_CP027599.1_113395	LIPO(Sec/SPII)	0.269025	0.007589	0.498287	0.225100	CS pos: 15-16. KSG-CV. Pr: 0.1935    19
NZ_CP027599.1_113405	LIPO(Sec/SPII)	0.353417	0.011619	0.428798	0.206166	CS pos: 14-15. SSA-IV. Pr: 0.0209    17
NZ_CP027599.1_113406	SP(Sec/SPI)	0.500393	0.008430	0.370518	0.120659	CS pos: 26-27. TSG-LQ. Pr: 0.2382    46
NZ_CP027599.1_113460	SP(Sec/SPI)	0.921374	0.003794	0.032292	0.042540	CS pos: 19-20. SKA-RE. Pr: 0.8794    34
NZ_CP027599.1_113729	LIPO(Sec/SPII)	0.256250	0.033184	0.371936	0.338630	CS pos: ?. Probable protein fragment    17
NZ_CP027599.1_113743	LIPO(Sec/SPII)	0.308693	0.014682	0.411390	0.265234	CS pos: ?. Probable protein fragment    18
NZ_CP027599.1_113749	SP(Sec/SPI)	0.640851	0.027358	0.247454	0.084336	CS pos: 20-21. ALT-AS. Pr: 0.1751    31
NZ_CP027599.1_113785	LIPO(Sec/SPII)	0.013490	0.000702	0.565226	0.420582	CS pos: 24-25. MIG-CR. Pr: 0.5606    44
NZ_CP027599.1_113789	LIPO(Sec/SPII)	0.024730	0.003982	0.507887	0.463401	CS pos: 22-23. ETG-CH. Pr: 0.5003    37
NZ_CP027599.1_113792	LIPO(Sec/SPII)	0.313923	0.021477	0.366590	0.298010	CS pos: 15-16. SSP-CF. Pr: 0.1417    35
NZ_CP027599.1_113820	SP(Sec/SPI)	0.454967	0.101123	0.241624	0.202285	CS pos: 21-22. TRS-TN. Pr: 0.1279    29
NZ_CP027599.1_113826	SP(Sec/SPI)	0.418460	0.229509	0.044501	0.307530	CS pos: 27-28. AHS-RI. Pr: 0.2853    39
NZ_CP027599.1_113838	SP(Sec/SPI)	0.487182	0.071902	0.084600	0.356316	CS pos: 23-24. TRA-SP. Pr: 0.2609    37
NZ_CP027599.1_113850	LIPO(Sec/SPII)	0.187058	0.023009	0.509426	0.280507	CS pos: 21-22. ASA-CG. Pr: 0.5740    47
NZ_CP027599.1_113851	LIPO(Sec/SPII)	0.192620	0.132194	0.361222	0.313964	CS pos: 19-20. ARV-CG. Pr: 0.2999    48
NZ_CP027599.1_113854	LIPO(Sec/SPII)	0.249899	0.139771	0.421985	0.188344	CS pos: 21-22. AAG-CV. Pr: 0.3870    30
NZ_CP027599.1_113882	SP(Sec/SPI)	0.455180	0.037465	0.148027	0.359329	CS pos: 17-18. GVA-NG. Pr: 0.0685    37
NZ_CP027599.1_113887	LIPO(Sec/SPII)	0.133794	0.004273	0.633972	0.227961	CS pos: 27-28. ATA-CC. Pr: 0.5201    36
NZ_CP027599.1_113889	LIPO(Sec/SPII)	0.164340	0.140219	0.486510	0.208932	CS pos: ?. Probable protein fragment    17
NZ_CP027599.1_113893	LIPO(Sec/SPII)	0.210441	0.034539	0.605169	0.149851	CS pos: ?. Probable protein fragment    17
NZ_CP027599.1_113903	LIPO(Sec/SPII)	0.246276	0.018399	0.533000	0.202325	CS pos: 16-17. TTK-CG. Pr: 0.4344    20
NZ_CP027599.1_113941	SP(Sec/SPI)	0.416912	0.206438	0.049848	0.326802	CS pos: 22-23. ARA-ST. Pr: 0.3021    50
NZ_CP027599.1_113963	LIPO(Sec/SPII)	0.210007	0.043626	0.508517	0.237849	CS pos: 12-13. SAG-CF. Pr: 0.4723    17
NZ_CP027599.1_113969	SP(Sec/SPI)	0.428823	0.030050	0.138430	0.402697	CS pos: 23-24. ASA-TS. Pr: 0.2000    25
NZ_CP027599.1_113970	SP(Sec/SPI)	0.516406	0.143545	0.086171	0.253878	CS pos: 20-21. ASA-HR. Pr: 0.3252    32
NZ_CP027599.1_114001	LIPO(Sec/SPII)	0.321330	0.015400	0.398471	0.264798	CS pos: 22-23. VVY-CN. Pr: 0.3762    31
NZ_CP027599.1_114002	SP(Sec/SPI)	0.700572	0.002908	0.054681	0.241838	CS pos: 15-16. IQA-QV. Pr: 0.5848    32
NZ_CP027599.1_114022	SP(Sec/SPI)	0.504576	0.151540	0.051357	0.292527	CS pos: 8-9. AFA-AE. Pr: 0.2658    48
NZ_CP027599.1_114029	SP(Sec/SPI)	0.557487	0.012959	0.243536	0.186017	CS pos: 22-23. LPA-RH. Pr: 0.2761    43
NZ_CP027599.1_114036	SP(Sec/SPI)	0.607465	0.064444	0.100645	0.227445	CS pos: 25-26. NSA-KI. Pr: 0.2706    37
NZ_CP027599.1_114047	LIPO(Sec/SPII)	0.076649	0.006653	0.741585	0.175113	CS pos: ?. Probable protein fragment    32
NZ_CP027599.1_114067	SP(Sec/SPI)	0.515821	0.014450	0.356337	0.113392	CS pos: 22-23. TFS-SI. Pr: 0.2066    35
NZ_CP027599.1_114072	LIPO(Sec/SPII)	0.139521	0.003877	0.504712	0.351890	CS pos: 18-19. LQR-CM. Pr: 0.4756    24
NZ_CP027599.1_114102	LIPO(Sec/SPII)	0.131227	0.013251	0.491534	0.363988	CS pos: 14-15. LTG-AG. Pr: 0.4364    30
NZ_CP027599.1_114128	LIPO(Sec/SPII)	0.201422	0.221145	0.293213	0.284220	CS pos: ?. Probable protein fragment    15
NZ_CP027599.1_114132	LIPO(Sec/SPII)	0.270591	0.029497	0.350686	0.349227	CS pos: 13-14. LAA-TH. Pr: 0.0593    15
NZ_CP027599.1_114311	LIPO(Sec/SPII)	0.104866	0.006215	0.474019	0.414900	CS pos: 29-30. MIS-CQ. Pr: 0.3885    33
NZ_CP027599.1_114324	LIPO(Sec/SPII)	0.206305	0.000758	0.644424	0.148513	CS pos: 12-13. ATC-CL. Pr: 0.3669    29
NZ_CP027599.1_114372	LIPO(Sec/SPII)	0.265048	0.016556	0.414174	0.304222	CS pos: 14-15. IAL-CY. Pr: 0.1045    16
NZ_CP027599.1_114434	LIPO(Sec/SPII)	0.012261	0.000723	0.846582	0.140435	CS pos: 22-23. VTS-CV. Pr: 0.8462    37
NZ_CP027599.1_114453	LIPO(Sec/SPII)	0.154045	0.007013	0.667815	0.171128	CS pos: 17-18. FSK-CA. Pr: 0.6125    22
NZ_CP027599.1_114628	SP(Sec/SPI)	0.573258	0.040839	0.130613	0.255290	CS pos: ?. Probable protein fragment    17
NZ_CP027599.1_114836	LIPO(Sec/SPII)	0.150964	0.033472	0.424413	0.391151	CS pos: 16-17. VCV-CY. Pr: 0.1654    18
NZ_CP027599.1_114897	LIPO(Sec/SPII)	0.267181	0.016284	0.461017	0.255517	CS pos: ?. Probable protein fragment    18
NZ_CP027599.1_114898	SP(Sec/SPI)	0.626783	0.166605	0.021265	0.185347	CS pos: 22-23. AEA-GK. Pr: 0.5310    41
NZ_CP027599.1_114922	SP(Sec/SPI)	0.338219	0.032077	0.311318	0.318385	CS pos: ?. Probable protein fragment    15
NZ_CP027599.1_114925	LIPO(Sec/SPII)	0.198571	0.036690	0.498564	0.266175	CS pos: 17-18. GAS-CR. Pr: 0.3745    23
NZ_CP027599.1_114948	SP(Sec/SPI)	0.488522	0.118369	0.165099	0.228010	CS pos: 28-29. AQA-RR. Pr: 0.3909    36
NZ_CP027599.1_114950	TAT(Tat/SPI)	0.126612	0.528377	0.028805	0.316206	CS pos: 22-23. ATA-AP. Pr: 0.2428    39
NZ_CP027599.1_114957	LIPO(Sec/SPII)	0.182842	0.124267	0.463377	0.229513	CS pos: 19-20. SAS-CA. Pr: 0.3817    39
NZ_CP027599.1_114971	LIPO(Sec/SPII)	0.122365	0.009357	0.626795	0.241483	CS pos: 16-17. FAA-CF. Pr: 0.5514    18
NZ_CP027599.1_114979	TAT(Tat/SPI)	0.213806	0.620368	0.050963	0.114863	CS pos: 36-37. SRA-SS. Pr: 0.4923    38
NZ_CP027599.1_114981	LIPO(Sec/SPII)	0.055193	0.010594	0.829952	0.104262	CS pos: 17-18. GIS-CS. Pr: 0.8145    25
NZ_CP027599.1_114998	LIPO(Sec/SPII)	0.043816	0.005365	0.605409	0.345410	CS pos: 24-25. LCG-CI. Pr: 0.5991    45
NZ_CP027599.1_115044	LIPO(Sec/SPII)	0.002936	0.000260	0.990774	0.006030	CS pos: 14-15. LFS-CS. Pr: 0.9895    27
NZ_CP027599.1_115063	LIPO(Sec/SPII)	0.077766	0.006302	0.727568	0.188365	CS pos: 17-18. SIS-CS. Pr: 0.7022    25
NZ_CP027599.1_115069	SP(Sec/SPI)	0.373242	0.022893	0.322023	0.281842	CS pos: 24-25. VIS-GS. Pr: 0.0942    49
NZ_CP027599.1_115084	SP(Sec/SPI)	0.418456	0.005739	0.214577	0.361229	CS pos: 14-15. CKS-TT. Pr: 0.0688    37
NZ_CP027599.1_115098	LIPO(Sec/SPII)	0.262649	0.009524	0.363983	0.363844	CS pos: 21-22. GGL-CL. Pr: 0.1133    23
NZ_CP027599.1_115118	LIPO(Sec/SPII)	0.070270	0.004095	0.472396	0.453239	CS pos: 17-18. ISA-CI. Pr: 0.3620    27
NZ_CP027599.1_115130	SP(Sec/SPI)	0.422594	0.029413	0.282176	0.265816	CS pos: 18-19. CHA-LD. Pr: 0.1939    22
NZ_CP027599.1_115145	LIPO(Sec/SPII)	0.054434	0.006533	0.886148	0.052884	CS pos: 15-16. LTA-CQ. Pr: 0.8664    20
NZ_CP027599.1_115166	SP(Sec/SPI)	0.568223	0.015573	0.168832	0.247373	CS pos: 20-21. VSA-FK. Pr: 0.5520    35
NZ_CP027599.1_115184	SP(Sec/SPI)	0.686484	0.001987	0.284429	0.027100	CS pos: 22-23. TDA-AT. Pr: 0.6024    43
NZ_CP027599.1_115195	LIPO(Sec/SPII)	0.273935	0.026479	0.369770	0.329817	CS pos: ?. Probable protein fragment    15
NZ_CP027599.1_115227	SP(Sec/SPI)	0.851967	0.013048	0.047422	0.087563	CS pos: 17-18. SYA-KS. Pr: 0.8418    35
NZ_CP027599.1_115277	LIPO(Sec/SPII)	0.215945	0.059481	0.489332	0.235241	CS pos: 23-24. LQA-CP. Pr: 0.4697    26
NZ_CP027599.1_115324	LIPO(Sec/SPII)	0.045916	0.006417	0.864990	0.082676	CS pos: 24-25. QSG-CQ. Pr: 0.5635    33
NZ_CP027599.1_115325	SP(Sec/SPI)	0.411950	0.008146	0.171764	0.408140	CS pos: 19-20. VKS-GL. Pr: 0.1733    28
NZ_CP027599.1_115338	LIPO(Sec/SPII)	0.236166	0.007676	0.473612	0.282546	CS pos: 13-14. FPQ-CI. Pr: 0.0457    15
NZ_CP027599.1_115346	TAT(Tat/SPI)	0.162564	0.405265	0.067172	0.364999	CS pos: 28-29. TRS-SP. Pr: 0.1779    39
NZ_CP027599.1_115354	LIPO(Sec/SPII)	0.196418	0.014920	0.686766	0.101896	CS pos: 16-17. PVT-CS. Pr: 0.6140    32
NZ_CP027599.1_115363	SP(Sec/SPI)	0.542634	0.057019	0.169321	0.231026	CS pos: 13-14. VSA-AS. Pr: 0.1850    19
NZ_CP027599.1_115368	LIPO(Sec/SPII)	0.133778	0.029735	0.431571	0.404915	CS pos: 11-12. ATG-CG. Pr: 0.3000    30
NZ_CP027599.1_115414	LIPO(Sec/SPII)	0.263673	0.014697	0.444196	0.277434	CS pos: 14-15. LTP-LM. Pr: 0.0231    16
NZ_CP027599.1_115430	LIPO(Sec/SPII)	0.089116	0.003409	0.794848	0.112627	CS pos: 17-18. LNG-CF. Pr: 0.6557    21
NZ_CP027599.1_115447	LIPO(Sec/SPII)	0.329294	0.016325	0.385281	0.269100	CS pos: 14-15. LSS-FQ. Pr: 0.0848    16
NZ_CP027599.1_115465	LIPO(Sec/SPII)	0.236627	0.050501	0.471382	0.241490	CS pos: 16-17. LAA-CA. Pr: 0.4015    20
NZ_CP027599.1_115467	SP(Sec/SPI)	0.419185	0.012864	0.393815	0.174136	CS pos: 22-23. VLS-VQ. Pr: 0.2809    41
NZ_CP027599.1_115476	LIPO(Sec/SPII)	0.017178	0.000838	0.898932	0.083052	CS pos: 15-16. LLA-CN. Pr: 0.8968    32
NZ_CP027599.1_115480	SP(Sec/SPI)	0.556784	0.013514	0.198903	0.230799	CS pos: 19-20. SGA-LD. Pr: 0.3956    27
NZ_CP027599.1_115486	LIPO(Sec/SPII)	0.199283	0.263000	0.308538	0.229179	CS pos: 23-24. VAS-CR. Pr: 0.2908    36
NZ_CP027599.1_115530	LIPO(Sec/SPII)	0.216231	0.002977	0.492264	0.288528	CS pos: 19-20. MCL-CH. Pr: 0.3282    34
NZ_CP027599.1_115533	SP(Sec/SPI)	0.660533	0.026925	0.084242	0.228300	CS pos: 16-17. ANA-AM. Pr: 0.6108    26
NZ_CP027599.1_115538	LIPO(Sec/SPII)	0.204973	0.027001	0.390924	0.377102	CS pos: 16-17. IVF-CS. Pr: 0.2312    19
NZ_CP027599.1_115548	LIPO(Sec/SPII)	0.223355	0.013173	0.430911	0.332561	CS pos: 17-18. LNT-CS. Pr: 0.3137    35
NZ_CP027599.1_115644	LIPO(Sec/SPII)	0.039541	0.003287	0.792928	0.164243	CS pos: 17-18. TIG-CE. Pr: 0.7965    31
NZ_CP027599.1_115651	LIPO(Sec/SPII)	0.036707	0.019427	0.564017	0.379849	CS pos: 20-21. SPG-CS. Pr: 0.5589    36
NZ_CP027599.1_115718	SP(Sec/SPI)	0.650615	0.023553	0.081315	0.244517	CS pos: 23-24. TRA-VV. Pr: 0.5512    37
NZ_CP027599.1_115772	LIPO(Sec/SPII)	0.073518	0.003414	0.682119	0.240949	CS pos: 14-15. CAG-CI. Pr: 0.6566    48
NZ_CP027599.1_115812	LIPO(Sec/SPII)	0.059805	0.015162	0.496192	0.428841	CS pos: 26-27. TLS-CG. Pr: 0.4769    34
NZ_CP027599.1_115819	LIPO(Sec/SPII)	0.109495	0.033129	0.677314	0.180063	CS pos: 17-18. AAG-CR. Pr: 0.6675    29
NZ_CP027599.1_115834	LIPO(Sec/SPII)	0.168510	0.031025	0.506131	0.294335	CS pos: 19-20. LLT-CG. Pr: 0.2780    21
NZ_CP027599.1_115893	LIPO(Sec/SPII)	0.101732	0.016694	0.704652	0.176921	CS pos: 17-18. FAS-CW. Pr: 0.6764    26
NZ_CP027599.1_115894	LIPO(Sec/SPII)	0.237636	0.005588	0.708025	0.048751	CS pos: 21-22. RAG-CR. Pr: 0.5966    37
NZ_CP027599.1_115909	LIPO(Sec/SPII)	0.023385	0.000426	0.602504	0.373684	CS pos: 18-19. LMA-CV. Pr: 0.5603    35
NZ_CP027599.1_115919	LIPO(Sec/SPII)	0.089339	0.004424	0.868505	0.037732	CS pos: 13-14. TSQ-CS. Pr: 0.8502    39
NZ_CP027599.1_115922	SP(Sec/SPI)	0.425109	0.004563	0.205546	0.364783	CS pos: 14-15. ASG-NG. Pr: 0.1744    21
NZ_CP027599.1_116010	LIPO(Sec/SPII)	0.044747	0.003139	0.584854	0.367260	CS pos: 24-25. TSG-CE. Pr: 0.5893    43
NZ_CP027599.1_116014	SP(Sec/SPI)	0.590271	0.046803	0.164886	0.198040	CS pos: 19-20. PRA-LT. Pr: 0.2888    22
NZ_CP027599.1_116020	LIPO(Sec/SPII)	0.080539	0.068863	0.663564	0.187034	CS pos: 19-20. SSA-CL. Pr: 0.5667    43
NZ_CP027599.1_116031	LIPO(Sec/SPII)	0.073110	0.056745	0.708001	0.162144	CS pos: 19-20. LAS-CT. Pr: 0.6855    26
NZ_CP027599.1_116047	LIPO(Sec/SPII)	0.319988	0.027820	0.345727	0.306465	CS pos: ?. Probable protein fragment    18
NZ_CP027599.1_116092	LIPO(Sec/SPII)	0.051814	0.007063	0.870404	0.070718	CS pos: 17-18. TTG-CY. Pr: 0.8727    35
NZ_CP027599.1_116141	SP(Sec/SPI)	0.394635	0.188046	0.118542	0.298777	CS pos: 29-30. SSG-AS. Pr: 0.1759    39
NZ_CP027599.1_116160	SP(Sec/SPI)	0.584631	0.008723	0.338721	0.067925	CS pos: ?. Probable protein fragment    26
NZ_CP027599.1_116243	LIPO(Sec/SPII)	0.244960	0.080435	0.382345	0.292260	CS pos: 16-17. CLT-CS. Pr: 0.0783    18
NZ_CP027599.1_116279	LIPO(Sec/SPII)	0.148521	0.058243	0.409018	0.384217	CS pos: 14-15. LTS-CR. Pr: 0.3163    17
NZ_CP027599.1_116290	LIPO(Sec/SPII)	0.074867	0.004891	0.555077	0.365166	CS pos: 18-19. LVC-CI. Pr: 0.4158    24
NZ_CP027599.1_116311	LIPO(Sec/SPII)	0.332238	0.032422	0.377332	0.258009	CS pos: 11-12. VLS-CV. Pr: 0.1377    18
NZ_CP027599.1_116313	LIPO(Sec/SPII)	0.062674	0.034534	0.456095	0.446698	CS pos: 17-18. VPA-CF. Pr: 0.3641    39
NZ_CP027599.1_116394	LIPO(Sec/SPII)	0.048604	0.105022	0.591641	0.254733	CS pos: 18-19. VAG-CS. Pr: 0.5924    47
NZ_CP027599.1_116395	LIPO(Sec/SPII)	0.165671	0.009883	0.569489	0.254957	CS pos: 13-14. LFA-CC. Pr: 0.3836    21
NZ_CP027599.1_116397	LIPO(Sec/SPII)	0.100176	0.018110	0.735003	0.146711	CS pos: 24-25. LAA-CT. Pr: 0.7037    27
NZ_CP027599.1_116400	SP(Sec/SPI)	0.336112	0.031426	0.327938	0.304524	CS pos: 15-16. SES-AP. Pr: 0.1531    17
NZ_CP027599.1_116417	LIPO(Sec/SPII)	0.025278	0.001309	0.852285	0.121129	CS pos: 21-22. LLS-CP. Pr: 0.8245    30
NZ_CP027599.1_116431	LIPO(Sec/SPII)	0.235447	0.010717	0.395075	0.358761	CS pos: 13-14. PVL-CD. Pr: 0.0923    18
NZ_CP027599.1_116570	TAT(Tat/SPI)	0.130997	0.522176	0.276328	0.070499	CS pos: 30-31. SSA-ST. Pr: 0.2617    44
NZ_CP027599.1_116586	SP(Sec/SPI)	0.654162	0.037699	0.125379	0.182760	CS pos: 17-18. SFA-AG. Pr: 0.4283    26
NZ_CP027599.1_116590	LIPO(Sec/SPII)	0.092145	0.024281	0.670944	0.212631	CS pos: 16-17. ATS-CR. Pr: 0.6456    42
NZ_CP027599.1_116616	SP(Sec/SPI)	0.590705	0.099300	0.088750	0.221245	CS pos: 21-22. ATA-EG. Pr: 0.5476    30
NZ_CP027599.1_116633	SP(Sec/SPI)	0.692632	0.197227	0.050547	0.059594	CS pos: 19-20. SYA-DC. Pr: 0.7722    39
NZ_CP027599.1_116655	LIPO(Sec/SPII)	0.096619	0.005366	0.686590	0.211425	CS pos: 17-18. LSC-CH. Pr: 0.3475    31
NZ_CP027599.1_116667	SP(Sec/SPI)	0.444430	0.151981	0.092619	0.310969	CS pos: 26-27. AGA-AH. Pr: 0.3673    34
NZ_CP027599.1_116677	LIPO(Sec/SPII)	0.054356	0.003343	0.792836	0.149465	CS pos: 15-16. VTT-CG. Pr: 0.7489    36
NZ_CP027599.1_116690	SP(Sec/SPI)	0.389741	0.015709	0.364846	0.229704	CS pos: ?. Probable protein fragment    15
NZ_CP027599.1_116790	LIPO(Sec/SPII)	0.141726	0.100970	0.438280	0.319024	CS pos: 24-25. VCL-CW. Pr: 0.3506    50
NZ_CP027599.1_116924	SP(Sec/SPI)	0.637581	0.227929	0.039793	0.094697	CS pos: 26-27. ARS-FT. Pr: 0.7186    36
NZ_CP027599.1_116971	LIPO(Sec/SPII)	0.122208	0.005354	0.650843	0.221594	CS pos: 20-21. KVS-CQ. Pr: 0.6147    22
NZ_CP027599.1_117011	SP(Sec/SPI)	0.369460	0.017636	0.314096	0.298809	CS pos: 17-18. SQE-AP. Pr: 0.0861    23
NZ_CP027599.1_117018	LIPO(Sec/SPII)	0.243264	0.006912	0.470429	0.279395	CS pos: ?. Probable protein fragment    17
NZ_CP027599.1_117020	TAT(Tat/SPI)	0.084930	0.652909	0.026901	0.235260	CS pos: 32-33. ATA-GR. Pr: 0.4767    50
NZ_CP027599.1_117029	LIPO(Sec/SPII)	0.125924	0.001859	0.868105	0.004113	CS pos: 18-19. SAG-CP. Pr: 0.8568    22
NZ_CP027599.1_117034	SP(Sec/SPI)	0.357358	0.021104	0.282560	0.338978	CS pos: 18-19. CGA-TL. Pr: 0.1902    38
NZ_CP027599.1_117036	SP(Sec/SPI)	0.768216	0.073901	0.035759	0.122123	CS pos: 18-19. TRA-GA. Pr: 0.3793    47
NZ_CP027599.1_117087	SP(Sec/SPI)	0.371714	0.022341	0.240929	0.365016	CS pos: 17-18. VWA-EP. Pr: 0.2690    24
NZ_CP027599.1_117088	SP(Sec/SPI)	0.547574	0.226500	0.091059	0.134867	CS pos: 34-35. VMA-NG. Pr: 0.5682    40
NZ_CP027599.1_117108	LIPO(Sec/SPII)	0.124338	0.005365	0.485031	0.385266	CS pos: 22-23. LIC-CK. Pr: 0.1668    27
NZ_CP027599.1_117118	LIPO(Sec/SPII)	0.133670	0.008315	0.467916	0.390099	CS pos: 22-23. VQS-CH. Pr: 0.4293    31
NZ_CP027599.1_117132	LIPO(Sec/SPII)	0.223926	0.022843	0.426510	0.326721	CS pos: 19-20. AMG-CA. Pr: 0.2887    21
NZ_CP027599.1_117147	SP(Sec/SPI)	0.440012	0.163432	0.121625	0.274932	CS pos: 14-15. PSA-AP. Pr: 0.1394    28
NZ_CP027599.1_117169	LIPO(Sec/SPII)	0.078636	0.044218	0.591428	0.285718	CS pos: 32-33. VAA-CS. Pr: 0.5785    47
NZ_CP027599.1_117187	SP(Sec/SPI)	0.423365	0.003268	0.306293	0.267074	CS pos: 22-23. MLA-SI. Pr: 0.3214    29
NZ_CP027599.1_117202	LIPO(Sec/SPII)	0.349139	0.006059	0.396369	0.248433	CS pos: 16-17. LSA-AG. Pr: 0.3523    38
NZ_CP027599.1_117277	LIPO(Sec/SPII)	0.068576	0.002907	0.731506	0.197011	CS pos: 13-14. FSG-CT. Pr: 0.7112    47
NZ_CP027599.1_117306	SP(Sec/SPI)	0.566471	0.035233	0.124070	0.274226	CS pos: 19-20. STG-VP. Pr: 0.2247    31
NZ_CP027599.1_117324	LIPO(Sec/SPII)	0.142567	0.005042	0.555134	0.297257	CS pos: 13-14. GSG-CA. Pr: 0.3003    23
NZ_CP027599.1_117352	SP(Sec/SPI)	0.710229	0.004654	0.258479	0.026638	CS pos: 18-19. TRA-GG. Pr: 0.5976    41
NZ_CP027599.1_117358	LIPO(Sec/SPII)	0.169202	0.030973	0.468335	0.331490	CS pos: 17-18. CLG-CI. Pr: 0.3046    23
NZ_CP027599.1_117369	LIPO(Sec/SPII)	0.151612	0.006460	0.702363	0.139565	CS pos: 13-14. VIS-CQ. Pr: 0.5456    16
NZ_CP027599.1_117372	SP(Sec/SPI)	0.418070	0.014315	0.302087	0.265527	CS pos: 17-18. VRG-NP. Pr: 0.1470    29
NZ_CP027599.1_117392	TAT(Tat/SPI)	0.129234	0.583046	0.060116	0.227604	CS pos: 22-23. GSA-GS. Pr: 0.1223    43
NZ_CP027599.1_117394	LIPO(Sec/SPII)	0.160992	0.016159	0.423474	0.399375	CS pos: 35-36. ITA-CN. Pr: 0.3994    39
NZ_CP027599.1_117410	LIPO(Sec/SPII)	0.051779	0.002507	0.912702	0.033012	CS pos: 17-18. GAG-CD. Pr: 0.8873    24
NZ_CP027599.1_117459	LIPO(Sec/SPII)	0.245406	0.010823	0.437059	0.306713	CS pos: 16-17. ACW-CF. Pr: 0.0404    19
NZ_CP027599.1_117462	LIPO(Sec/SPII)	0.211797	0.016778	0.532111	0.239314	CS pos: 20-21. SLT-CR. Pr: 0.4023    25
NZ_CP027599.1_117475	LIPO(Sec/SPII)	0.133654	0.014130	0.762037	0.090179	CS pos: 19-20. TLA-CI. Pr: 0.7339    32
NZ_CP027599.1_117481	LIPO(Sec/SPII)	0.257655	0.022258	0.426354	0.293734	CS pos: ?. Probable protein fragment    20
NZ_CP027599.1_117483	TAT(Tat/SPI)	0.218831	0.370429	0.084671	0.326069	CS pos: 25-26. GVC-YR. Pr: 0.0451    32
NZ_CP027599.1_117509	SP(Sec/SPI)	0.442190	0.103902	0.071392	0.382516	CS pos: 23-24. VHA-GA. Pr: 0.3244    39
NZ_CP027599.1_117525	SP(Sec/SPI)	0.727373	0.058477	0.106854	0.107296	CS pos: 31-32. STA-AT. Pr: 0.3784    48
NZ_CP027599.1_117528	LIPO(Sec/SPII)	0.166189	0.222943	0.560266	0.050602	CS pos: 22-23. FSS-CC. Pr: 0.3648    47
NZ_CP027599.1_117529	SP(Sec/SPI)	0.542817	0.078604	0.177504	0.201075	CS pos: 19-20. ASS-AT. Pr: 0.1318    24
NZ_CP027599.1_117531	LIPO(Sec/SPII)	0.212529	0.107561	0.455444	0.224466	CS pos: ?. Probable protein fragment    30
NZ_CP027599.1_117567	LIPO(Sec/SPII)	0.091299	0.007223	0.493979	0.407498	CS pos: 17-18. LAG-DW. Pr: 0.4635    24
NZ_CP027599.1_117573	TAT(Tat/SPI)	0.181835	0.337803	0.143473	0.336888	CS pos: ?. Probable protein fragment    22
NZ_CP027599.1_117610	SP(Sec/SPI)	0.638682	0.094955	0.128305	0.138058	CS pos: 22-23. AAA-RS. Pr: 0.3028    32
NZ_CP027599.1_117629	SP(Sec/SPI)	0.561376	0.029609	0.101109	0.307906	CS pos: 15-16. ALA-TK. Pr: 0.4726    31
NZ_CP027599.1_117681	SP(Sec/SPI)	0.403355	0.050193	0.337898	0.208553	CS pos: 17-18. GLA-AS. Pr: 0.1477    20
NZ_CP027599.1_117690	LIPO(Sec/SPII)	0.094364	0.007985	0.471832	0.425819	CS pos: 22-23. IPT-CS. Pr: 0.4032    31
NZ_CP027599.1_117702	LIPO(Sec/SPII)	0.005418	0.000628	0.992316	0.001637	CS pos: 18-19. LSA-CR. Pr: 0.9914    32
NZ_CP027599.1_117712	LIPO(Sec/SPII)	0.097073	0.121495	0.413744	0.367688	CS pos: 21-22. TPG-CI. Pr: 0.3681    40
NZ_CP027599.1_117716	LIPO(Sec/SPII)	0.091374	0.022432	0.518849	0.367346	CS pos: 32-33. VCA-CR. Pr: 0.4669    38
NZ_CP027599.1_117738	SP(Sec/SPI)	0.455616	0.038869	0.189120	0.316395	CS pos: 9-10. TLA-GN. Pr: 0.1103    29
NZ_CP027599.1_117769	SP(Sec/SPI)	0.513760	0.032605	0.315867	0.137768	CS pos: 22-23. ISA-GC. Pr: 0.4510    44
NZ_CP027599.1_117770	LIPO(Sec/SPII)	0.218312	0.029152	0.394395	0.358141	CS pos: ?. Probable protein fragment    16
NZ_CP027599.1_117776	LIPO(Sec/SPII)	0.125511	0.030664	0.527805	0.316020	CS pos: 14-15. NCG-CS. Pr: 0.4726    33
NZ_CP027599.1_117786	LIPO(Sec/SPII)	0.207478	0.040097	0.459189	0.293237	CS pos: 20-21. AAS-CR. Pr: 0.3545    22
NZ_CP027599.1_117815	SP(Sec/SPI)	0.403862	0.229266	0.022519	0.344352	CS pos: 26-27. AKA-AE. Pr: 0.3477    46
NZ_CP027599.1_117817	SP(Sec/SPI)	0.374869	0.033383	0.302620	0.289128	CS pos: 15-16. AHA-GG. Pr: 0.1954    18
NZ_CP027599.1_117831	LIPO(Sec/SPII)	0.269786	0.053554	0.372940	0.303720	CS pos: ?. Probable protein fragment    15
NZ_CP027599.1_117836	TAT(Tat/SPI)	0.190920	0.503540	0.083652	0.221888	CS pos: 27-28. ALG-AD. Pr: 0.2989    37
NZ_CP027599.1_117837	LIPO(Sec/SPII)	0.275845	0.101188	0.354662	0.268305	CS pos: ?. Probable protein fragment    15
NZ_CP027599.1_117842	SP(Sec/SPI)	0.423856	0.028695	0.245116	0.302333	CS pos: 18-19. PLA-TL. Pr: 0.1139    28
NZ_CP027599.1_117846	SP(Sec/SPI)	0.445543	0.011654	0.107029	0.435774	CS pos: 24-25. VLA-GE. Pr: 0.3923    26
NZ_CP027599.1_117849	TAT(Tat/SPI)	0.094203	0.706676	0.017162	0.181959	CS pos: 26-27. ADA-QS. Pr: 0.4438    31
NZ_CP027599.1_117858	LIPO(Sec/SPII)	0.033196	0.008318	0.725250	0.233236	CS pos: 16-17. LPA-CQ. Pr: 0.7187    41
NZ_CP027599.1_117911	LIPO(Sec/SPII)	0.222378	0.022067	0.398123	0.357432	CS pos: ?. Probable protein fragment    15
NZ_CP027599.1_117924	TAT(Tat/SPI)	0.227685	0.432785	0.069663	0.269867	CS pos: 31-32. RSA-RE. Pr: 0.1405    36
NZ_CP027599.1_117933	LIPO(Sec/SPII)	0.111560	0.022644	0.691480	0.174315	CS pos: 26-27. LCG-CR. Pr: 0.6753    44
NZ_CP027599.1_117943	SP(Sec/SPI)	0.432840	0.130260	0.122511	0.314389	CS pos: 17-18. ASG-SR. Pr: 0.2480    33
NZ_CP027599.1_117948	TAT(Tat/SPI)	0.204639	0.781872	0.006720	0.006769	CS pos: 30-31. AAA-NV. Pr: 0.4751    49
NZ_CP027599.1_117969	TAT(Tat/SPI)	0.200455	0.379600	0.073612	0.346333	CS pos: 24-25. RKA-AR. Pr: 0.1235    47
NZ_CP027599.1_117990	SP(Sec/SPI)	0.565891	0.169922	0.073414	0.190773	CS pos: 12-13. AQA-AP. Pr: 0.4766    30
NZ_CP027599.1_118018	LIPO(Sec/SPII)	0.150888	0.201132	0.431399	0.216582	CS pos: 18-19. ASA-CS. Pr: 0.3923    21
NZ_CP027599.1_118031	LIPO(Sec/SPII)	0.074882	0.015903	0.610992	0.298222	CS pos: 24-25. FTT-CC. Pr: 0.3937    39
NZ_CP027599.1_118034	SP(Sec/SPI)	0.444965	0.018889	0.116556	0.419591	CS pos: 21-22. ANA-SV. Pr: 0.3236    30
NZ_CP027599.1_118036	LIPO(Sec/SPII)	0.191864	0.030576	0.434200	0.343360	CS pos: 25-26. SSS-CL. Pr: 0.3693    29
NZ_CP027599.1_118037	LIPO(Sec/SPII)	0.151486	0.015111	0.445287	0.388115	CS pos: 14-15. LTT-CN. Pr: 0.3538    20
NZ_CP027599.1_118049	LIPO(Sec/SPII)	0.182275	0.012543	0.514638	0.290543	CS pos: 15-16. VPA-CQ. Pr: 0.3228    22
NZ_CP027599.1_118055	LIPO(Sec/SPII)	0.123486	0.006591	0.760274	0.109649	CS pos: 15-16. LIS-CH. Pr: 0.7452    34
NZ_CP027599.1_118057	LIPO(Sec/SPII)	0.053747	0.011555	0.801945	0.132753	CS pos: 27-28. VGS-CS. Pr: 0.7420    44
NZ_CP027599.1_118064	SP(Sec/SPI)	0.679878	0.017922	0.228007	0.074193	CS pos: 22-23. VAG-SR. Pr: 0.3362    29
NZ_CP027599.1_118087	SP(Sec/SPI)	0.381891	0.049717	0.252593	0.315799	CS pos: 14-15. AQA-IK. Pr: 0.1044    35
NZ_CP027599.1_118127	LIPO(Sec/SPII)	0.065071	0.029490	0.763637	0.141801	CS pos: 19-20. VTG-CR. Pr: 0.6957    31
NZ_CP027599.1_118135	LIPO(Sec/SPII)	0.148300	0.044444	0.465315	0.341941	CS pos: 16-17. FSE-CN. Pr: 0.4370    22
NZ_CP027599.1_118151	SP(Sec/SPI)	0.534448	0.092833	0.107617	0.265102	CS pos: 17-18. AYA-VC. Pr: 0.1624    35
NZ_CP027599.1_118152	TAT(Tat/SPI)	0.239966	0.400944	0.064358	0.294732	CS pos: 23-24. AMA-TR. Pr: 0.0556    27
NZ_CP027599.1_118154	TAT(Tat/SPI)	0.158474	0.384918	0.101568	0.355040	CS pos: 34-35. TFS-NT. Pr: 0.1991    43
NZ_CP027599.1_118163	SP(Sec/SPI)	0.449605	0.030600	0.076776	0.443019	CS pos: 18-19. VSA-MK. Pr: 0.4181    37
NZ_CP027599.1_118177	LIPO(Sec/SPII)	0.067474	0.009386	0.885527	0.037613	CS pos: 14-15. FSA-CR. Pr: 0.8813    27
NZ_CP027599.1_118192	SP(Sec/SPI)	0.591336	0.073498	0.069319	0.265847	CS pos: 24-25. VSA-TD. Pr: 0.5931    32
NZ_CP027599.1_118195	LIPO(Sec/SPII)	0.046917	0.002753	0.624079	0.326251	CS pos: 21-22. VPA-CF. Pr: 0.5586    25
NZ_CP027599.1_118235	LIPO(Sec/SPII)	0.077933	0.009905	0.500988	0.411174	CS pos: 20-21. LSP-CG. Pr: 0.4496    36
NZ_CP027599.1_118265	LIPO(Sec/SPII)	0.248905	0.026479	0.534756	0.189861	CS pos: 14-15. LGG-CA. Pr: 0.2415    17
NZ_CP027599.1_118271	LIPO(Sec/SPII)	0.174946	0.126850	0.464507	0.233696	CS pos: ?. Probable protein fragment    16
NZ_CP027599.1_118326	TAT(Tat/SPI)	0.135170	0.396491	0.198910	0.269430	CS pos: 15-16. AIA-VT. Pr: 0.0276    17
NZ_CP027599.1_118336	LIPO(Sec/SPII)	0.326157	0.015777	0.360570	0.297496	CS pos: 16-17. FLK-CW. Pr: 0.2741    32
NZ_CP027599.1_118354	LIPO(Sec/SPII)	0.045414	0.037751	0.551410	0.365426	CS pos: 17-18. ATG-CS. Pr: 0.5439    34
NZ_CP027599.1_118365	LIPO(Sec/SPII)	0.162635	0.003243	0.524800	0.309322	CS pos: 17-18. NST-CN. Pr: 0.4292    28
NZ_CP027599.1_118389	LIPO(Sec/SPII)	0.372396	0.024223	0.397096	0.206285	CS pos: 13-14. STS-QL. Pr: 0.0471    15
NZ_CP027599.1_118403	LIPO(Sec/SPII)	0.071411	0.065070	0.816210	0.047309	CS pos: 15-16. IAA-CA. Pr: 0.4120    49
NZ_CP027599.1_118422	LIPO(Sec/SPII)	0.103770	0.012577	0.611898	0.271755	CS pos: 20-21. LPG-CA. Pr: 0.5737    24
NZ_CP027599.1_118500	SP(Sec/SPI)	0.628894	0.025660	0.051628	0.293817	CS pos: ?. Probable protein fragment    26
NZ_CP027599.1_118510	LIPO(Sec/SPII)	0.040543	0.004224	0.845817	0.109417	CS pos: 15-16. SFG-CD. Pr: 0.8414    21
NZ_CP027599.1_118566	LIPO(Sec/SPII)	0.135922	0.006459	0.720885	0.136733	CS pos: 15-16. LYA-CV. Pr: 0.6493    17
NZ_CP027599.1_118572	SP(Sec/SPI)	0.872554	0.016725	0.045534	0.065186	CS pos: 26-27. ASA-SE. Pr: 0.4371    28
NZ_CP027599.1_118651	LIPO(Sec/SPII)	0.260822	0.011214	0.420671	0.307293	CS pos: ?. Probable protein fragment    15
NZ_CP027599.1_118699	LIPO(Sec/SPII)	0.280488	0.017409	0.397049	0.305054	CS pos: ?. Probable protein fragment    15
NZ_CP027599.1_118752	LIPO(Sec/SPII)	0.188846	0.009706	0.673181	0.128266	CS pos: 16-17. SVA-CI. Pr: 0.5438    19
NZ_CP027599.1_118823	SP(Sec/SPI)	0.494138	0.075933	0.163776	0.266154	CS pos: 13-14. ISA-AP. Pr: 0.3272    24
NZ_CP027599.1_118891	TAT(Tat/SPI)	0.184260	0.555380	0.024484	0.235877	CS pos: 31-32. ARA-GR. Pr: 0.3473    46
NZ_CP027599.1_118906	SP(Sec/SPI)	0.572769	0.006988	0.253990	0.166254	CS pos: 16-17. ARS-GP. Pr: 0.3285    30
NZ_CP027599.1_118911	LIPO(Sec/SPII)	0.096367	0.014012	0.574142	0.315479	CS pos: 16-17. GSS-CG. Pr: 0.5246    25
NZ_CP027599.1_118915	SP(Sec/SPI)	0.658933	0.013773	0.165917	0.161378	CS pos: 20-21. SES-AL. Pr: 0.2563    41
NZ_CP027599.1_118974	SP(Sec/SPI)	0.364684	0.089510	0.203119	0.342687	CS pos: 22-23. VGG-GT. Pr: 0.0601    48
NZ_CP027599.1_118976	SP(Sec/SPI)	0.380072	0.014503	0.377106	0.228319	CS pos: ?. Probable protein fragment    19
NZ_CP027599.1_118982	SP(Sec/SPI)	0.669800	0.032627	0.038400	0.259173	CS pos: 18-19. TYA-QH. Pr: 0.6476    30
NZ_CP027599.1_118998	LIPO(Sec/SPII)	0.253873	0.047952	0.421199	0.276975	CS pos: ?. Probable protein fragment    16
NZ_CP027599.1_119003	LIPO(Sec/SPII)	0.268150	0.033034	0.381639	0.317177	CS pos: 15-16. TSF-CP. Pr: 0.0795    17
NZ_CP027599.1_119009	LIPO(Sec/SPII)	0.316817	0.036038	0.329866	0.317279	CS pos: 17-18. ISS-TH. Pr: 0.1696    30
NZ_CP027599.1_119018	LIPO(Sec/SPII)	0.236023	0.029676	0.370824	0.363476	CS pos: ?. Probable protein fragment    16
NZ_CP027599.1_119026	SP(Sec/SPI)	0.421187	0.018191	0.194347	0.366275	CS pos: 20-21. ANP-QF. Pr: 0.1730    25
NZ_CP027599.1_119027	SP(Sec/SPI)	0.731964	0.008926	0.138536	0.120574	CS pos: 17-18. SHP-AG. Pr: 0.2210    40
NZ_CP027599.1_119033	SP(Sec/SPI)	0.407928	0.018370	0.403527	0.170175	CS pos: 24-25. CQA-YS. Pr: 0.2226    32
NZ_CP027599.1_119042	SP(Sec/SPI)	0.695737	0.043411	0.059063	0.201789	CS pos: 26-27. ISA-LN. Pr: 0.5298    32
NZ_CP027599.1_119054	SP(Sec/SPI)	0.695664	0.021384	0.138566	0.144386	CS pos: 23-24. LLA-AS. Pr: 0.3926    37
NZ_CP027599.1_119071	LIPO(Sec/SPII)	0.050774	0.033346	0.874101	0.041779	CS pos: 21-22. PLS-CS. Pr: 0.8666    36
NZ_CP027599.1_119097	LIPO(Sec/SPII)	0.262426	0.013070	0.499383	0.225122	CS pos: 16-17. WNR-CG. Pr: 0.2371    19
NZ_CP027599.1_119105	LIPO(Sec/SPII)	0.267598	0.008493	0.484024	0.239885	CS pos: 17-18. QAG-CY. Pr: 0.4069    30
NZ_CP027599.1_119157	LIPO(Sec/SPII)	0.054673	0.002453	0.735935	0.206939	CS pos: 23-24. LTS-CI. Pr: 0.7291    48
NZ_CP027599.1_119175	LIPO(Sec/SPII)	0.188764	0.005525	0.543060	0.262650	CS pos: 16-17. VVH-CR. Pr: 0.4123    19
NZ_CP027599.1_119183	SP(Sec/SPI)	0.337242	0.258718	0.309258	0.094782	CS pos: 38-39. VHA-RT. Pr: 0.5230    47
NZ_CP027599.1_119186	SP(Sec/SPI)	0.429278	0.021556	0.389949	0.159217	CS pos: 15-16. SSG-NE. Pr: 0.2166    17
NZ_CP027599.1_119188	SP(Sec/SPI)	0.396457	0.240079	0.095541	0.267923	CS pos: 23-24. SSA-GL. Pr: 0.1428    30
NZ_CP027599.1_119196	LIPO(Sec/SPII)	0.292097	0.021651	0.387089	0.299163	CS pos: ?. Probable protein fragment    16
NZ_CP027599.1_119223	SP(Sec/SPI)	0.397688	0.133286	0.140048	0.328978	CS pos: 32-33. GSA-IN. Pr: 0.2071    41
NZ_CP027599.1_119245	LIPO(Sec/SPII)	0.178676	0.002304	0.697570	0.121450	CS pos: 14-15. LAY-CA. Pr: 0.6184    21
NZ_CP027599.1_119254	LIPO(Sec/SPII)	0.133649	0.017486	0.563205	0.285660	CS pos: 13-14. IAG-CV. Pr: 0.4828    18
NZ_CP027599.1_119275	SP(Sec/SPI)	0.366358	0.008614	0.362743	0.262285	CS pos: 19-20. AGA-AD. Pr: 0.2306    22
NZ_CP027599.1_119288	LIPO(Sec/SPII)	0.201180	0.029242	0.633995	0.135582	CS pos: 20-21. FTG-CI. Pr: 0.6100    37
NZ_CP027599.1_119305	SP(Sec/SPI)	0.641344	0.011346	0.178841	0.168468	CS pos: 25-26. LNS-AP. Pr: 0.3341    41
NZ_CP027599.1_119314	SP(Sec/SPI)	0.967756	0.002199	0.023444	0.006601	CS pos: 19-20. SEA-ST. Pr: 0.8802    47
NZ_CP027599.1_119322	LIPO(Sec/SPII)	0.274402	0.012279	0.386636	0.326683	CS pos: 15-16. CRC-CR. Pr: 0.0656    17
NZ_CP027599.1_119362	SP(Sec/SPI)	0.370650	0.192954	0.176790	0.259606	CS pos: 27-28. TNA-TR. Pr: 0.3742    40
NZ_CP027599.1_119407	SP(Sec/SPI)	0.377648	0.027588	0.362350	0.232413	CS pos: 22-23. VSG-FK. Pr: 0.2030    48
NZ_CP027599.1_119430	LIPO(Sec/SPII)	0.036573	0.001965	0.583033	0.378428	CS pos: 15-16. IYS-CI. Pr: 0.5755    39
NZ_CP027599.1_119434	LIPO(Sec/SPII)	0.226835	0.045236	0.366969	0.360961	CS pos: 13-14. IYS-CL. Pr: 0.2035    15
NZ_CP027599.1_119439	LIPO(Sec/SPII)	0.233278	0.050665	0.393505	0.322553	CS pos: ?. Probable protein fragment    15
NZ_CP027599.1_119454	SP(Sec/SPI)	0.443755	0.093697	0.111465	0.351084	CS pos: 15-16. AQA-GG. Pr: 0.3223    21
NZ_CP027599.1_119474	LIPO(Sec/SPII)	0.220212	0.015344	0.576356	0.188088	CS pos: 18-19. STS-CC. Pr: 0.4048    20
NZ_CP027599.1_119489	LIPO(Sec/SPII)	0.337034	0.016564	0.344624	0.301779	CS pos: 17-18. GAK-CR. Pr: 0.1833    25
NZ_CP027599.1_119500	LIPO(Sec/SPII)	0.224845	0.032861	0.425035	0.317259	CS pos: ?. Probable protein fragment    16
NZ_CP027599.1_119527	LIPO(Sec/SPII)	0.064664	0.005212	0.819382	0.110741	CS pos: 16-17. SLQ-CQ. Pr: 0.8073    34
NZ_CP027599.1_119529	LIPO(Sec/SPII)	0.157610	0.011290	0.462486	0.368614	CS pos: 15-16. LAG-GE. Pr: 0.3005    23
NZ_CP027599.1_119534	SP(Sec/SPI)	0.463706	0.068151	0.114474	0.353669	CS pos: 11-12. TQA-SI. Pr: 0.1655    27
NZ_CP027599.1_119539	SP(Sec/SPI)	0.420459	0.072448	0.096735	0.410358	CS pos: 14-15. TST-KW. Pr: 0.0951    27
NZ_CP027599.1_119553	LIPO(Sec/SPII)	0.224758	0.060996	0.437724	0.276522	CS pos: 25-26. TSV-CR. Pr: 0.3382    47
NZ_CP027599.1_119564	LIPO(Sec/SPII)	0.081456	0.006835	0.591010	0.320700	CS pos: 18-19. TNG-CV. Pr: 0.3981    37
NZ_CP027599.1_119566	LIPO(Sec/SPII)	0.236269	0.066439	0.439639	0.257653	CS pos: ?. Probable protein fragment    16
NZ_CP027599.1_119595	LIPO(Sec/SPII)	0.235905	0.011469	0.459303	0.293323	CS pos: ?. Probable protein fragment    22
NZ_CP027599.1_119597	LIPO(Sec/SPII)	0.318249	0.002553	0.605228	0.073970	CS pos: 13-14. PAA-CC. Pr: 0.1856    16
NZ_CP027599.1_119603	LIPO(Sec/SPII)	0.157212	0.042502	0.550794	0.249491	CS pos: 22-23. GVS-CR. Pr: 0.2848    48
NZ_CP027599.1_119651	TAT(Tat/SPI)	0.215044	0.545974	0.044435	0.194547	CS pos: 25-26. SKA-SQ. Pr: 0.4986    43
NZ_CP027599.1_119662	SP(Sec/SPI)	0.358509	0.048668	0.324690	0.268134	CS pos: 24-25. SNC-LN. Pr: 0.1654    41
NZ_CP027599.1_119694	LIPO(Sec/SPII)	0.176488	0.032315	0.451703	0.339494	CS pos: 16-17. LRA-CG. Pr: 0.3301    18
NZ_CP027599.1_119719	SP(Sec/SPI)	0.398315	0.168108	0.221037	0.212540	CS pos: 18-19. SMA-KS. Pr: 0.3497    29
NZ_CP027599.1_119730	SP(Sec/SPI)	0.415858	0.161265	0.231215	0.191663	CS pos: 18-19. FFA-AV. Pr: 0.2128    24
NZ_CP027599.1_119763	LIPO(Sec/SPII)	0.288850	0.015098	0.359257	0.336795	CS pos: ?. Probable protein fragment    16
NZ_CP027599.1_119795	TAT(Tat/SPI)	0.162922	0.354114	0.193991	0.288973	CS pos: ?. Probable protein fragment    15
NZ_CP027599.1_119838	LIPO(Sec/SPII)	0.174428	0.019546	0.448812	0.357214	CS pos: ?. Probable protein fragment    17
NZ_CP027599.1_119849	LIPO(Sec/SPII)	0.128790	0.008408	0.742929	0.119873	CS pos: 11-12. AMA-CV. Pr: 0.7316    29
NZ_CP027599.1_119865	LIPO(Sec/SPII)	0.047728	0.004099	0.794764	0.153409	CS pos: 26-27. LSV-CS. Pr: 0.7808    41
NZ_CP027599.1_119866	LIPO(Sec/SPII)	0.100968	0.013181	0.615933	0.269919	CS pos: 19-20. LST-CD. Pr: 0.5999    24
NZ_CP027599.1_119927	LIPO(Sec/SPII)	0.035087	0.003700	0.864373	0.096841	CS pos: 21-22. FVS-CS. Pr: 0.8478    30
NZ_CP027599.1_119951	SP(Sec/SPI)	0.352587	0.009220	0.327384	0.310809	CS pos: ?. Probable protein fragment    19
NZ_CP027599.1_120007	LIPO(Sec/SPII)	0.054275	0.007350	0.878765	0.059610	CS pos: 20-21. CAS-CA. Pr: 0.5407    48
NZ_CP027599.1_120037	TAT(Tat/SPI)	0.081315	0.465959	0.028946	0.423780	CS pos: 24-25. RLA-VP. Pr: 0.2625    28
NZ_CP027599.1_120117	SP(Sec/SPI)	0.514165	0.010368	0.162533	0.312933	CS pos: 20-21. AMA-LI. Pr: 0.4132    24
NZ_CP027599.1_120142	LIPO(Sec/SPII)	0.262872	0.015514	0.497692	0.223921	CS pos: 29-30. GSS-CC. Pr: 0.2766    33
NZ_CP027599.1_120146	SP(Sec/SPI)	0.433582	0.008404	0.316343	0.241671	CS pos: 20-21. SNG-TE. Pr: 0.3129    40
NZ_CP027599.1_120154	SP(Sec/SPI)	0.528379	0.049423	0.032109	0.390089	CS pos: 17-18. VYA-DS. Pr: 0.4922    35
NZ_CP027599.1_120174	LIPO(Sec/SPII)	0.306000	0.015443	0.388175	0.290382	CS pos: 15-16. IVY-CN. Pr: 0.2354    20
NZ_CP027599.1_120193	SP(Sec/SPI)	0.586774	0.027638	0.057903	0.327685	CS pos: 15-16. ALA-SG. Pr: 0.5116    26
NZ_CP027599.1_120715	SP(Sec/SPI)	0.664185	0.032790	0.110632	0.192394	CS pos: 21-22. TSA-IS. Pr: 0.4439    33
NZ_CP027599.1_120792	LIPO(Sec/SPII)	0.277195	0.033288	0.364584	0.324934	CS pos: 13-14. RSS-CL. Pr: 0.0564    16
NZ_CP027599.1_121177	LIPO(Sec/SPII)	0.452199	0.005790	0.463572	0.078438	CS pos: 19-20. VDA-CQ. Pr: 0.8705    27
NZ_CP027599.1_121193	LIPO(Sec/SPII)	0.049559	0.003377	0.517484	0.429580	CS pos: 15-16. PLS-CS. Pr: 0.2931    44
NZ_CP027599.1_121203	LIPO(Sec/SPII)	0.004152	0.000352	0.990688	0.004808	CS pos: 17-18. ISG-CQ. Pr: 0.9910    29
NZ_CP027599.1_121291	LIPO(Sec/SPII)	0.223205	0.008151	0.604009	0.164635	CS pos: 15-16. SAA-CF. Pr: 0.4615    17
NZ_CP027599.1_121320	LIPO(Sec/SPII)	0.280616	0.048566	0.384855	0.285962	CS pos: ?. Probable protein fragment    16
NZ_CP027599.1_121453	LIPO(Sec/SPII)	0.073091	0.007512	0.787377	0.132020	CS pos: 12-13. QLA-CL. Pr: 0.7524    19
NZ_CP027599.1_121726	LIPO(Sec/SPII)	0.076914	0.008083	0.740059	0.174944	CS pos: 19-20. FSS-CS. Pr: 0.6766    30
NZ_CP027599.1_121735	LIPO(Sec/SPII)	0.158937	0.024065	0.420708	0.396289	CS pos: 13-14. FNA-CK. Pr: 0.2813    19
NZ_CP027599.1_121739	SP(Sec/SPI)	0.697473	0.018378	0.114627	0.169522	CS pos: 26-27. SHS-WS. Pr: 0.3325    33
NZ_CP027599.1_121752	LIPO(Sec/SPII)	0.258298	0.034719	0.384728	0.322255	CS pos: ?. Probable protein fragment    15
NZ_CP027599.1_121774	LIPO(Sec/SPII)	0.094231	0.017043	0.531869	0.356858	CS pos: 25-26. TSG-CC. Pr: 0.4109    33
NZ_CP027599.1_121775	LIPO(Sec/SPII)	0.230855	0.028917	0.449381	0.290847	CS pos: 15-16. SIG-CC. Pr: 0.1103    17
NZ_CP027599.1_121789	LIPO(Sec/SPII)	0.173031	0.020263	0.506472	0.300234	CS pos: 18-19. SIP-CA. Pr: 0.4302    31
NZ_CP027599.1_121796	SP(Sec/SPI)	0.544088	0.066378	0.073748	0.315786	CS pos: 23-24. VAS-GG. Pr: 0.2384    39
NZ_CP027599.1_121843	LIPO(Sec/SPII)	0.082604	0.052014	0.572343	0.293038	CS pos: 20-21. FFT-CI. Pr: 0.5417    29
NZ_CP027599.1_121848	LIPO(Sec/SPII)	0.106584	0.022880	0.512700	0.357835	CS pos: 15-16. CSA-CA. Pr: 0.4792    37
NZ_CP027599.1_121884	LIPO(Sec/SPII)	0.243382	0.008137	0.390862	0.357619	CS pos: 19-20. TLL-CN. Pr: 0.2063    48
NZ_CP027599.1_121921	LIPO(Sec/SPII)	0.219328	0.040476	0.370411	0.369785	CS pos: 13-14. TFL-CN. Pr: 0.0869    16
NZ_CP027599.1_121951	SP(Sec/SPI)	0.487922	0.067901	0.062695	0.381482	CS pos: ?. Probable protein fragment    28
NZ_CP027599.1_122043	SP(Sec/SPI)	0.479958	0.051703	0.027444	0.440894	CS pos: 18-19. GSA-GD. Pr: 0.0732    45
NZ_CP027599.1_122081	LIPO(Sec/SPII)	0.068862	0.018251	0.670592	0.242295	CS pos: 29-30. TLG-CS. Pr: 0.6462    36
NZ_CP027599.1_122091	LIPO(Sec/SPII)	0.181091	0.007785	0.643716	0.167408	CS pos: ?. Probable protein fragment    18
NZ_CP027599.1_122132	SP(Sec/SPI)	0.513145	0.007975	0.173743	0.305137	CS pos: 15-16. VNS-NE. Pr: 0.2138    21
NZ_CP027599.1_122154	LIPO(Sec/SPII)	0.183800	0.005245	0.711220	0.099735	CS pos: 15-16. LSP-CH. Pr: 0.5227    17
NZ_CP027599.1_122161	LIPO(Sec/SPII)	0.201630	0.063948	0.442758	0.291664	CS pos: 22-23. FTP-CS. Pr: 0.3333    32
NZ_CP027599.1_122181	LIPO(Sec/SPII)	0.103998	0.101377	0.601362	0.193263	CS pos: 23-24. SSS-CQ. Pr: 0.5834    31
NZ_CP027599.1_122184	SP(Sec/SPI)	0.629876	0.050860	0.118911	0.200353	CS pos: 21-22. SHC-AV. Pr: 0.4812    44
NZ_CP027599.1_122186	LIPO(Sec/SPII)	0.134835	0.017181	0.433087	0.414897	CS pos: 17-18. LNK-CD. Pr: 0.2625    19
NZ_CP027599.1_122210	LIPO(Sec/SPII)	0.058724	0.003729	0.851725	0.085822	CS pos: 16-17. MVS-CV. Pr: 0.8358    25
NZ_CP027599.1_122215	LIPO(Sec/SPII)	0.217839	0.005061	0.402366	0.374734	CS pos: 19-20. VLH-CI. Pr: 0.3128    28
NZ_CP027599.1_122227	LIPO(Sec/SPII)	0.132986	0.013046	0.753483	0.100485	CS pos: 17-18. SVS-CR. Pr: 0.6987    20
NZ_CP027599.1_122244	LIPO(Sec/SPII)	0.294993	0.019352	0.357606	0.328049	CS pos: 16-17. ITA-AW. Pr: 0.1107    18
NZ_CP027599.1_122258	SP(Sec/SPI)	0.614112	0.067313	0.048090	0.270485	CS pos: 17-18. SWG-QP. Pr: 0.5210    36
NZ_CP027599.1_122280	LIPO(Sec/SPII)	0.142466	0.022772	0.527378	0.307384	CS pos: 19-20. CPG-CR. Pr: 0.3538    25
NZ_CP027599.1_122287	SP(Sec/SPI)	0.386988	0.160365	0.126561	0.326086	CS pos: 25-26. RLA-AD. Pr: 0.1793    34
NZ_CP027599.1_122303	SP(Sec/SPI)	0.582527	0.098576	0.104670	0.214227	CS pos: 22-23. RYA-SL. Pr: 0.3232    35
NZ_CP027599.1_122310	SP(Sec/SPI)	0.495021	0.029411	0.334229	0.141340	CS pos: 15-16. ASA-TW. Pr: 0.1661    21
NZ_CP027599.1_122494	LIPO(Sec/SPII)	0.104122	0.116901	0.412358	0.366618	CS pos: 24-25. LVA-CS. Pr: 0.4099    46
NZ_CP027599.1_122523	SP(Sec/SPI)	0.473125	0.039436	0.110546	0.376893	CS pos: 18-19. ADA-ES. Pr: 0.2794    23
NZ_CP027599.1_122574	LIPO(Sec/SPII)	0.310305	0.058758	0.324081	0.306857	CS pos: 19-20. NAG-CR. Pr: 0.2086    21
NZ_CP027599.1_122578	LIPO(Sec/SPII)	0.203522	0.015736	0.560790	0.219952	CS pos: 24-25. IAA-AG. Pr: 0.2387    45
NZ_CP027599.1_122595	LIPO(Sec/SPII)	0.120099	0.025793	0.594760	0.259348	CS pos: 14-15. AAS-CN. Pr: 0.5733    24
NZ_CP027599.1_122646	LIPO(Sec/SPII)	0.146399	0.027617	0.422838	0.403146	CS pos: 11-12. IAG-CC. Pr: 0.3118    16
NZ_CP027599.1_122681	SP(Sec/SPI)	0.392374	0.094850	0.268277	0.244498	CS pos: 23-24. IAG-KS. Pr: 0.2858    43
NZ_CP027599.1_122730	LIPO(Sec/SPII)	0.306676	0.004093	0.577828	0.111403	CS pos: 15-16. LQH-CF. Pr: 0.4048    18
NZ_CP027599.1_122789	LIPO(Sec/SPII)	0.118246	0.016482	0.748194	0.117078	CS pos: 17-18. IPG-CP. Pr: 0.7246    28
NZ_CP027599.1_122792	LIPO(Sec/SPII)	0.162495	0.023167	0.443911	0.370427	CS pos: 22-23. LSK-CS. Pr: 0.3666    38
NZ_CP027599.1_122802	SP(Sec/SPI)	0.370846	0.004077	0.255490	0.369587	CS pos: 14-15. LFA-DN. Pr: 0.4579    26
NZ_CP027599.1_122813	SP(Sec/SPI)	0.526403	0.044133	0.098282	0.331182	CS pos: 23-24. SLA-SG. Pr: 0.3393    27
NZ_CP027599.1_122877	SP(Sec/SPI)	0.383535	0.135880	0.123975	0.356611	CS pos: 18-19. VLS-SE. Pr: 0.1897    47
NZ_CP027599.1_122908	LIPO(Sec/SPII)	0.173533	0.005527	0.501853	0.319088	CS pos: 25-26. AIC-CK. Pr: 0.3395    29
NZ_CP027599.1_122964	SP(Sec/SPI)	0.434874	0.089993	0.256227	0.218906	CS pos: 18-19. LSA-TL. Pr: 0.1268    24
NZ_CP027599.1_122973	LIPO(Sec/SPII)	0.198428	0.010144	0.415892	0.375536	CS pos: 11-12. FVS-CC. Pr: 0.1814    23
NZ_CP027599.1_122994	SP(Sec/SPI)	0.375378	0.049424	0.214004	0.361195	CS pos: 22-23. IPA-ST. Pr: 0.1583    25
NZ_CP027599.1_123072	SP(Sec/SPI)	0.459770	0.048616	0.061589	0.430024	CS pos: 24-25. SFA-GE. Pr: 0.4261    27
NZ_CP027599.1_123083	SP(Sec/SPI)	0.465512	0.040088	0.118321	0.376080	CS pos: 9-10. VFA-AT. Pr: 0.2926    21
NZ_CP027599.1_123111	LIPO(Sec/SPII)	0.125510	0.007047	0.584174	0.283269	CS pos: ?. Probable protein fragment    16
NZ_CP027599.1_123166	LIPO(Sec/SPII)	0.365273	0.018100	0.372592	0.244035	CS pos: 14-15. MSA-FN. Pr: 0.0660    17
NZ_CP027599.1_123242	LIPO(Sec/SPII)	0.207273	0.029662	0.504755	0.258310	CS pos: 14-15. VKA-CS. Pr: 0.4998    17
NZ_CP027599.1_123273	LIPO(Sec/SPII)	0.017487	0.002871	0.503353	0.476290	CS pos: 28-29. VIG-CV. Pr: 0.5040    49
NZ_CP027599.1_123289	LIPO(Sec/SPII)	0.251743	0.045148	0.386189	0.316920	CS pos: ?. Probable protein fragment    15
NZ_CP027599.1_123290	SP(Sec/SPI)	0.343580	0.219254	0.103381	0.333785	CS pos: 22-23. IMA-AQ. Pr: 0.3185    33
NZ_CP027599.1_123316	LIPO(Sec/SPII)	0.128317	0.020530	0.440507	0.410646	CS pos: 32-33. SFG-CH. Pr: 0.3905    35
NZ_CP027599.1_123344	LIPO(Sec/SPII)	0.252809	0.025714	0.397624	0.323853	CS pos: 16-17. LLP-CL. Pr: 0.0284    19
NZ_CP027599.1_123348	LIPO(Sec/SPII)	0.184141	0.018883	0.544574	0.252402	CS pos: ?. Probable protein fragment    15
NZ_CP027599.1_123351	LIPO(Sec/SPII)	0.241360	0.005025	0.407875	0.345740	CS pos: 21-22. IWR-CS. Pr: 0.2243    25
NZ_CP027599.1_123363	LIPO(Sec/SPII)	0.214364	0.009034	0.664634	0.111969	CS pos: 19-20. KLC-CQ. Pr: 0.5036    37
NZ_CP027599.1_123412	SP(Sec/SPI)	0.476952	0.021193	0.182445	0.319411	CS pos: 17-18. VFP-AP. Pr: 0.2218    23
NZ_CP027599.1_123422	LIPO(Sec/SPII)	0.277596	0.015866	0.493313	0.213225	CS pos: 21-22. QCL-CG. Pr: 0.3590    35
NZ_CP027599.1_123450	LIPO(Sec/SPII)	0.250554	0.013085	0.545300	0.191062	CS pos: 17-18. SLP-CW. Pr: 0.4197    23
NZ_CP027599.1_123455	LIPO(Sec/SPII)	0.188722	0.093807	0.401086	0.316384	CS pos: ?. Probable protein fragment    17
NZ_CP027599.1_123477	LIPO(Sec/SPII)	0.055995	0.003133	0.713330	0.227543	CS pos: 16-17. LAG-CH. Pr: 0.6837    30
NZ_CP027599.1_123478	LIPO(Sec/SPII)	0.305845	0.021919	0.384721	0.287516	CS pos: ?. Probable protein fragment    17
NZ_CP027599.1_123499	LIPO(Sec/SPII)	0.008952	0.002935	0.907418	0.080695	CS pos: 18-19. LSA-CS. Pr: 0.9103    41
NZ_CP027599.1_123571	TAT(Tat/SPI)	0.091878	0.357503	0.197848	0.352771	CS pos: 22-23. VSC-YL. Pr: 0.0426    27
NZ_CP027599.1_123579	LIPO(Sec/SPII)	0.002713	0.000312	0.987268	0.009708	CS pos: 23-24. LAG-CM. Pr: 0.9855    39
NZ_CP027599.1_123617	SP(Sec/SPI)	0.415426	0.021102	0.252939	0.310533	CS pos: 19-20. TMS-KG. Pr: 0.2615    21
NZ_CP027599.1_123627	SP(Sec/SPI)	0.472299	0.032935	0.104097	0.390669	CS pos: 15-16. SNA-KL. Pr: 0.2634    29
NZ_CP027599.1_123643	SP(Sec/SPI)	0.509777	0.135555	0.071039	0.283629	CS pos: 25-26. ALA-KP. Pr: 0.3926    35
NZ_CP027599.1_123644	LIPO(Sec/SPII)	0.210985	0.015692	0.501124	0.272198	CS pos: 15-16. YNS-CY. Pr: 0.4848    29
NZ_CP027599.1_123664	LIPO(Sec/SPII)	0.305074	0.019237	0.464346	0.211343	CS pos: 19-20. LMQ-CK. Pr: 0.2972    29
NZ_CP027599.1_123681	SP(Sec/SPI)	0.418947	0.082249	0.268160	0.230644	CS pos: 13-14. IWA-QG. Pr: 0.1535    40
NZ_CP027599.1_123697	LIPO(Sec/SPII)	0.253591	0.013207	0.449376	0.283826	CS pos: 18-19. LPI-CI. Pr: 0.0207    20
NZ_CP027599.1_123718	LIPO(Sec/SPII)	0.148803	0.004689	0.746386	0.100122	CS pos: 18-19. MAQ-CS. Pr: 0.6977    33
NZ_CP027599.1_123727	LIPO(Sec/SPII)	0.467548	0.007884	0.478942	0.045626	CS pos: 23-24. SIS-CT. Pr: 0.4459    50
NZ_CP027599.1_123783	LIPO(Sec/SPII)	0.263556	0.032566	0.469611	0.234267	CS pos: ?. Probable protein fragment    17
NZ_CP027599.1_123811	LIPO(Sec/SPII)	0.036224	0.009378	0.650255	0.304143	CS pos: 22-23. MSA-CA. Pr: 0.6452    40
NZ_CP027599.1_123824	LIPO(Sec/SPII)	0.174389	0.082574	0.388798	0.354239	CS pos: ?. Probable protein fragment    16
NZ_CP027599.1_123832	SP(Sec/SPI)	0.430222	0.021999	0.153076	0.394703	CS pos: 19-20. SAS-EC. Pr: 0.1150    21
NZ_CP027599.1_123913	LIPO(Sec/SPII)	0.090975	0.001114	0.902207	0.005703	CS pos: 18-19. MCA-CE. Pr: 0.9030    27
NZ_CP027599.1_123918	SP(Sec/SPI)	0.386894	0.078793	0.235412	0.298902	CS pos: 21-22. SMA-YR. Pr: 0.3594    28
NZ_CP027599.1_123922	LIPO(Sec/SPII)	0.108837	0.008367	0.657798	0.224998	CS pos: 29-30. SAA-CG. Pr: 0.6397    31
NZ_CP027599.1_123924	SP(Sec/SPI)	0.477701	0.051950	0.099570	0.370779	CS pos: 21-22. AQA-PV. Pr: 0.2517    36
NZ_CP027599.1_123941	SP(Sec/SPI)	0.682439	0.032234	0.240803	0.044524	CS pos: 18-19. AAA-TA. Pr: 0.2136    25
NZ_CP027599.1_123953	TAT(Tat/SPI)	0.177483	0.351577	0.267249	0.203691	CS pos: ?. Probable protein fragment    19
NZ_CP027599.1_123973	SP(Sec/SPI)	0.588650	0.033595	0.136577	0.241178	CS pos: 17-18. VSA-AI. Pr: 0.3716    22
NZ_CP027599.1_123980	SP(Sec/SPI)	0.455676	0.180590	0.046711	0.317023	CS pos: 21-22. AQA-AL. Pr: 0.5042    33
NZ_CP027599.1_123996	TAT(Tat/SPI)	0.089097	0.476283	0.417082	0.017539	CS pos: 38-39. VKC-SI. Pr: 0.1335    44
NZ_CP027599.1_124008	LIPO(Sec/SPII)	0.374850	0.006024	0.591315	0.027811	CS pos: 15-16. TAM-CA. Pr: 0.4390    34
NZ_CP027599.1_124012	LIPO(Sec/SPII)	0.252024	0.025559	0.363653	0.358764	CS pos: ?. Probable protein fragment    15
NZ_CP027599.1_124041	LIPO(Sec/SPII)	0.096742	0.009990	0.836370	0.056898	CS pos: 19-20. QIA-CQ. Pr: 0.8272    24
NZ_CP027599.1_124044	SP(Sec/SPI)	0.518286	0.053141	0.076226	0.352347	CS pos: 15-16. VHA-EN. Pr: 0.4929    18
NZ_CP027599.1_124081	SP(Sec/SPI)	0.460908	0.013157	0.348016	0.177920	CS pos: 18-19. STG-EQ. Pr: 0.4224    39
NZ_CP027599.1_124087	LIPO(Sec/SPII)	0.109132	0.005844	0.480668	0.404356	CS pos: 21-22. MSA-CC. Pr: 0.3221    30
NZ_CP027599.1_124092	LIPO(Sec/SPII)	0.250854	0.016512	0.426700	0.305933	CS pos: ?. Probable protein fragment    17
NZ_CP027599.1_124094	LIPO(Sec/SPII)	0.196931	0.012086	0.448619	0.342364	CS pos: 19-20. YLP-CS. Pr: 0.2291    23
NZ_CP027599.1_124129	SP(Sec/SPI)	0.533703	0.096641	0.182850	0.186806	CS pos: 26-27. SRC-SP. Pr: 0.2090    30
NZ_CP027599.1_124166	LIPO(Sec/SPII)	0.206599	0.010237	0.582870	0.200293	CS pos: 16-17. INC-CF. Pr: 0.4406    31
NZ_CP027599.1_124175	LIPO(Sec/SPII)	0.037346	0.002918	0.806053	0.153683	CS pos: 21-22. NTS-CN. Pr: 0.7927    26
NZ_CP027599.1_124181	SP(Sec/SPI)	0.407148	0.234246	0.095391	0.263215	CS pos: 34-35. SSA-SV. Pr: 0.2625    38
NZ_CP027599.1_124188	LIPO(Sec/SPII)	0.310629	0.017153	0.365842	0.306376	CS pos: 21-22. VRG-CF. Pr: 0.4758    30
NZ_CP027599.1_124198	LIPO(Sec/SPII)	0.084646	0.033212	0.750569	0.131573	CS pos: 21-22. LAA-CR. Pr: 0.6958    37
NZ_CP027599.1_124221	SP(Sec/SPI)	0.400513	0.122503	0.335776	0.141207	CS pos: 24-25. PCA-YD. Pr: 0.1909    43
NZ_CP027599.1_124226	LIPO(Sec/SPII)	0.111958	0.034781	0.461755	0.391507	CS pos: 14-15. SAA-CV. Pr: 0.4507    38
NZ_CP027599.1_124257	LIPO(Sec/SPII)	0.037874	0.003466	0.822543	0.136117	CS pos: 25-26. VIG-CQ. Pr: 0.8179    37
NZ_CP027599.1_124267	SP(Sec/SPI)	0.504563	0.004587	0.301189	0.189661	CS pos: 28-29. SFA-FN. Pr: 0.1775    35
NZ_CP027599.1_124303	TAT(Tat/SPI)	0.057547	0.802482	0.026581	0.113389	CS pos: 36-37. TNA-AG. Pr: 0.6098    40
NZ_CP027599.1_124311	TAT(Tat/SPI)	0.329157	0.540765	0.020934	0.109144	CS pos: 33-34. TRA-MT. Pr: 0.6069    44
NZ_CP027599.1_124349	LIPO(Sec/SPII)	0.090014	0.038118	0.437971	0.433898	CS pos: 20-21. FTA-SD. Pr: 0.3808    46
NZ_CP027599.1_124398	SP(Sec/SPI)	0.555845	0.074546	0.127894	0.241716	CS pos: ?. Probable protein fragment    18
NZ_CP027599.1_124409	SP(Sec/SPI)	0.751718	0.029903	0.049009	0.169370	CS pos: 16-17. VSA-QP. Pr: 0.4166    39
NZ_CP027599.1_124411	LIPO(Sec/SPII)	0.155908	0.025600	0.528915	0.289578	CS pos: 21-22. VVS-CQ. Pr: 0.4559    23
NZ_CP027599.1_124412	LIPO(Sec/SPII)	0.289894	0.033944	0.383561	0.292601	CS pos: 13-14. CSS-VS. Pr: 0.0281    15
NZ_CP027599.1_124418	LIPO(Sec/SPII)	0.034144	0.231413	0.399438	0.335005	CS pos: 29-30. LIG-CT. Pr: 0.3929    49
NZ_CP027599.1_124443	LIPO(Sec/SPII)	0.174757	0.036679	0.440566	0.347998	CS pos: 16-17. VTA-CK. Pr: 0.4516    43
NZ_CP027599.1_124446	LIPO(Sec/SPII)	0.096215	0.033215	0.658164	0.212406	CS pos: 22-23. FIA-CG. Pr: 0.6151    26
NZ_CP027599.1_124450	LIPO(Sec/SPII)	0.172656	0.016041	0.406629	0.404675	CS pos: 16-17. VIM-CR. Pr: 0.1263    18
NZ_CP027599.1_124457	SP(Sec/SPI)	0.583976	0.168173	0.224691	0.023160	CS pos: 25-26. VNA-SG. Pr: 0.6063    34
NZ_CP027599.1_124462	LIPO(Sec/SPII)	0.269277	0.027435	0.384672	0.318617	CS pos: 13-14. ATS-TP. Pr: 0.0213    15
NZ_CP027599.1_124537	LIPO(Sec/SPII)	0.240069	0.045773	0.394494	0.319664	CS pos: 14-15. CMC-LF. Pr: 0.0223    16
NZ_CP027599.1_124543	SP(Sec/SPI)	0.483964	0.023210	0.323805	0.169022	CS pos: ?. Probable protein fragment    19
NZ_CP027599.1_124545	SP(Sec/SPI)	0.729291	0.015370	0.170839	0.084500	CS pos: 20-21. TNA-TG. Pr: 0.5028    25
NZ_CP027599.1_124609	LIPO(Sec/SPII)	0.087233	0.002919	0.829838	0.080011	CS pos: 12-13. VFS-CG. Pr: 0.7936    43
NZ_CP027599.1_124645	TAT(Tat/SPI)	0.055628	0.469643	0.012984	0.461745	CS pos: 41-42. LPA-QT. Pr: 0.2654    49
NZ_CP027599.1_124653	LIPO(Sec/SPII)	0.162617	0.043219	0.590781	0.203383	CS pos: 16-17. IFS-CS. Pr: 0.4664    18
NZ_CP027599.1_124658	LIPO(Sec/SPII)	0.378606	0.003719	0.491883	0.125792	CS pos: 15-16. ASV-CA. Pr: 0.2420    22
NZ_CP027599.1_124667	LIPO(Sec/SPII)	0.225504	0.031630	0.415879	0.326987	CS pos: 11-12. LVG-CQ. Pr: 0.1806    16
NZ_CP027599.1_124679	LIPO(Sec/SPII)	0.125373	0.003660	0.855068	0.015899	CS pos: 26-27. AAA-CS. Pr: 0.5699    46
NZ_CP027599.1_124766	TAT(Tat/SPI)	0.413819	0.511959	0.011007	0.063215	CS pos: 20-21. IHA-SP. Pr: 0.7577    35
NZ_CP027599.1_124773	LIPO(Sec/SPII)	0.410767	0.071850	0.430023	0.087361	CS pos: 14-15. TAS-CF. Pr: 0.3106    30
NZ_CP027599.1_124786	SP(Sec/SPI)	0.529501	0.034026	0.177854	0.258619	CS pos: ?. Probable protein fragment    24
NZ_CP027599.1_124842	SP(Sec/SPI)	0.413874	0.092783	0.093183	0.400160	CS pos: 18-19. GQS-LS. Pr: 0.2801    33
NZ_CP027599.1_124854	LIPO(Sec/SPII)	0.311577	0.044656	0.354754	0.289013	CS pos: ?. Probable protein fragment    15
NZ_CP027599.1_124858	LIPO(Sec/SPII)	0.179701	0.025808	0.426510	0.367980	CS pos: 18-19. ASL-CD. Pr: 0.3591    22
NZ_CP027599.1_124887	SP(Sec/SPI)	0.472072	0.067326	0.337698	0.122904	CS pos: 15-16. ASA-SS. Pr: 0.1353    18
NZ_CP027599.1_124895	LIPO(Sec/SPII)	0.135576	0.040123	0.625200	0.199101	CS pos: 21-22. SNA-CA. Pr: 0.5491    31
NZ_CP027599.1_124904	SP(Sec/SPI)	0.397473	0.136595	0.146203	0.319729	CS pos: 27-28. SLA-AK. Pr: 0.2373    45
NZ_CP027599.1_124908	LIPO(Sec/SPII)	0.289527	0.020581	0.441335	0.248558	CS pos: 15-16. AGQ-CR. Pr: 0.1421    17
NZ_CP027599.1_124963	SP(Sec/SPI)	0.552765	0.069130	0.077740	0.300365	CS pos: 20-21. ARS-GW. Pr: 0.4192    36
NZ_CP027599.1_124967	LIPO(Sec/SPII)	0.075493	0.005317	0.489706	0.429483	CS pos: 19-20. IAP-CP. Pr: 0.4325    36
NZ_CP027599.1_124971	LIPO(Sec/SPII)	0.263166	0.065594	0.386470	0.284771	CS pos: ?. Probable protein fragment    15
NZ_CP027599.1_124973	SP(Sec/SPI)	0.404222	0.066624	0.246929	0.282225	CS pos: 22-23. AFA-GL. Pr: 0.3514    28
NZ_CP027599.1_124994	SP(Sec/SPI)	0.539603	0.024790	0.123718	0.311889	CS pos: 16-17. TRA-RR. Pr: 0.1825    44
NZ_CP027599.1_125000	LIPO(Sec/SPII)	0.145623	0.018852	0.600114	0.235411	CS pos: 13-14. NHA-CG. Pr: 0.5681    17
NZ_CP027599.1_125009	TAT(Tat/SPI)	0.068165	0.476482	0.076200	0.379154	CS pos: 30-31. TRS-EQ. Pr: 0.1758    50
NZ_CP027599.1_125021	TAT(Tat/SPI)	0.121370	0.528771	0.097812	0.252047	CS pos: 20-21. MLS-VP. Pr: 0.0626    24
NZ_CP027599.1_125064	SP(Sec/SPI)	0.424970	0.017725	0.175978	0.381327	CS pos: 21-22. TKS-AP. Pr: 0.1838    27
NZ_CP027599.1_125085	SP(Sec/SPI)	0.517223	0.198609	0.080335	0.203832	CS pos: 27-28. INA-SS. Pr: 0.2963    29
NZ_CP027599.1_125092	SP(Sec/SPI)	0.802212	0.008456	0.027005	0.162327	CS pos: 20-21. ALA-GT. Pr: 0.7737    36
NZ_CP027599.1_125101	SP(Sec/SPI)	0.426288	0.081482	0.104275	0.387955	CS pos: 30-31. TFA-TV. Pr: 0.1924    34
NZ_CP027599.1_125126	LIPO(Sec/SPII)	0.114033	0.027367	0.548549	0.310051	CS pos: 13-14. LNS-CQ. Pr: 0.5058    21
NZ_CP027599.1_125166	LIPO(Sec/SPII)	0.136436	0.008231	0.559606	0.295727	CS pos: 12-13. FCG-CG. Pr: 0.2892    26
NZ_CP027599.1_125252	SP(Sec/SPI)	0.544466	0.065507	0.066667	0.323359	CS pos: 20-21. ARA-TS. Pr: 0.4039    43
NZ_CP027599.1_125253	SP(Sec/SPI)	0.507969	0.080103	0.124606	0.287322	CS pos: 21-22. VFS-AT. Pr: 0.2622    24
NZ_CP027599.1_125260	LIPO(Sec/SPII)	0.007341	0.000566	0.936852	0.055241	CS pos: 19-20. MLA-CM. Pr: 0.9337    40
NZ_CP027599.1_125311	LIPO(Sec/SPII)	0.299458	0.013595	0.406964	0.279983	CS pos: 18-19. NAI-CS. Pr: 0.2172    27
NZ_CP027599.1_125312	LIPO(Sec/SPII)	0.191603	0.004621	0.719873	0.083904	CS pos: 15-16. TTC-CL. Pr: 0.3610    23
NZ_CP027599.1_125349	LIPO(Sec/SPII)	0.021064	0.002760	0.916278	0.059898	CS pos: 21-22. ATS-CS. Pr: 0.8993    33
NZ_CP027599.1_125437	LIPO(Sec/SPII)	0.185488	0.030052	0.414491	0.369969	CS pos: ?. Probable protein fragment    15
NZ_CP027599.1_125479	LIPO(Sec/SPII)	0.337172	0.074197	0.392248	0.196382	CS pos: 25-26. LTS-CH. Pr: 0.3212    41
NZ_CP027599.1_125787	LIPO(Sec/SPII)	0.160791	0.030748	0.445841	0.362620	CS pos: 19-20. VIA-CI. Pr: 0.4246    23
NZ_CP027599.1_125819	LIPO(Sec/SPII)	0.362651	0.013525	0.375756	0.248068	CS pos: 12-13. PAL-CH. Pr: 0.1408    16
NZ_CP027599.1_125824	SP(Sec/SPI)	0.467125	0.109321	0.058485	0.365069	CS pos: 22-23. ALS-EY. Pr: 0.2073    37
NZ_CP027599.1_125894	SP(Sec/SPI)	0.506949	0.111991	0.108478	0.272582	CS pos: 35-36. IQS-NG. Pr: 0.1747    48
NZ_CP027599.1_125928	SP(Sec/SPI)	0.623102	0.030543	0.015048	0.331307	CS pos: 34-35. VRA-FI. Pr: 0.6131    45
NZ_CP027599.1_125953	LIPO(Sec/SPII)	0.028874	0.006440	0.954485	0.010201	CS pos: 17-18. NAS-CA. Pr: 0.9470    34
NZ_CP027599.1_125955	LIPO(Sec/SPII)	0.194890	0.024817	0.420639	0.359654	CS pos: 20-21. LTR-CA. Pr: 0.2942    24
NZ_CP027599.1_125971	LIPO(Sec/SPII)	0.226501	0.012611	0.463756	0.297132	CS pos: 19-20. HTK-CT. Pr: 0.3570    21
NZ_CP027599.1_125985	SP(Sec/SPI)	0.464375	0.014835	0.255390	0.265400	CS pos: 19-20. GKA-DC. Pr: 0.2706    23
NZ_CP027599.1_125992	LIPO(Sec/SPII)	0.292127	0.015243	0.354670	0.337960	CS pos: ?. Probable protein fragment    21
NZ_CP027599.1_126000	SP(Sec/SPI)	0.338907	0.038870	0.290526	0.331697	CS pos: 23-24. VRS-IL. Pr: 0.1865    37
NZ_CP027599.1_126004	LIPO(Sec/SPII)	0.129369	0.054466	0.515472	0.300693	CS pos: 17-18. SLA-CS. Pr: 0.5229    42
NZ_CP027599.1_126007	SP(Sec/SPI)	0.530327	0.016965	0.254314	0.198394	CS pos: 26-27. IAA-KV. Pr: 0.2987    32
NZ_CP027599.1_126063	LIPO(Sec/SPII)	0.134565	0.136108	0.424048	0.305280	CS pos: 28-29. VGG-CG. Pr: 0.3937    45
NZ_CP027599.1_126068	SP(Sec/SPI)	0.369172	0.029211	0.272922	0.328695	CS pos: 18-19. VEC-SS. Pr: 0.1117    28
NZ_CP027599.1_126069	LIPO(Sec/SPII)	0.145379	0.010820	0.433478	0.410323	CS pos: ?. Probable protein fragment    21
NZ_CP027599.1_126095	LIPO(Sec/SPII)	0.187848	0.025005	0.573414	0.213733	CS pos: 14-15. CGA-CC. Pr: 0.4266    25
NZ_CP027599.1_126099	LIPO(Sec/SPII)	0.109019	0.043029	0.469806	0.378147	CS pos: 24-25. VFA-CT. Pr: 0.4581    47
NZ_CP027599.1_126106	LIPO(Sec/SPII)	0.298198	0.032724	0.398731	0.270347	CS pos: ?. Probable protein fragment    15
NZ_CP027599.1_126114	LIPO(Sec/SPII)	0.272448	0.054941	0.495307	0.177305	CS pos: 14-15. SCS-CS. Pr: 0.2685    21
NZ_CP027599.1_126133	LIPO(Sec/SPII)	0.197010	0.110120	0.348888	0.343982	CS pos: 35-36. STP-CC. Pr: 0.1788    46
NZ_CP027599.1_126153	LIPO(Sec/SPII)	0.079150	0.103733	0.448192	0.368925	CS pos: 25-26. PAS-CP. Pr: 0.3312    47
NZ_CP027599.1_126192	LIPO(Sec/SPII)	0.213027	0.131335	0.331890	0.323748	CS pos: ?. Probable protein fragment    17
NZ_CP027599.1_126211	LIPO(Sec/SPII)	0.124623	0.002044	0.834830	0.038502	CS pos: 13-14. LDS-CN. Pr: 0.8189    28
NZ_CP027599.1_126293	LIPO(Sec/SPII)	0.293772	0.033214	0.356617	0.316398	CS pos: ?. Probable protein fragment    17
NZ_CP027599.1_126297	LIPO(Sec/SPII)	0.103257	0.012144	0.699264	0.185335	CS pos: 21-22. LAF-CT. Pr: 0.6850    42
NZ_CP027599.1_126330	LIPO(Sec/SPII)	0.130276	0.001704	0.738429	0.129591	CS pos: 26-27. AQG-CQ. Pr: 0.7101    29
NZ_CP027599.1_126344	TAT(Tat/SPI)	0.196776	0.465870	0.035360	0.301994	CS pos: 35-36. SRA-VS. Pr: 0.3944    48
NZ_CP027599.1_126352	LIPO(Sec/SPII)	0.247855	0.023339	0.385379	0.343427	CS pos: ?. Probable protein fragment    15
NZ_CP027599.1_126395	SP(Sec/SPI)	0.583030	0.001200	0.378665	0.037105	CS pos: 19-20. ANS-VC. Pr: 0.3611    26
NZ_CP027599.1_126418	LIPO(Sec/SPII)	0.118364	0.009937	0.763166	0.108532	CS pos: 25-26. FCA-CS. Pr: 0.6008    39
NZ_CP027599.1_126430	TAT(Tat/SPI)	0.135845	0.473079	0.059455	0.331621	CS pos: 29-30. SRA-VR. Pr: 0.2436    37
NZ_CP027599.1_126446	LIPO(Sec/SPII)	0.061361	0.021276	0.657700	0.259662	CS pos: 24-25. LRG-CR. Pr: 0.4326    39
NZ_CP027599.1_126448	LIPO(Sec/SPII)	0.085898	0.005754	0.906386	0.001961	CS pos: 15-16. LSA-CA. Pr: 0.8957    49
NZ_CP027599.1_126453	TAT(Tat/SPI)	0.308337	0.341307	0.055503	0.294853	CS pos: 18-19. ASA-GR. Pr: 0.2591    38
NZ_CP027599.1_126482	SP(Sec/SPI)	0.433336	0.009833	0.171105	0.385727	CS pos: 16-17. ASA-SY. Pr: 0.2736    35
NZ_CP027599.1_126503	LIPO(Sec/SPII)	0.111011	0.023785	0.616145	0.249059	CS pos: 21-22. FSS-CA. Pr: 0.5950    25
NZ_CP027599.1_126523	LIPO(Sec/SPII)	0.275984	0.003610	0.703786	0.016620	CS pos: 18-19. LLM-CG. Pr: 0.6055    49
NZ_CP027599.1_126537	SP(Sec/SPI)	0.564610	0.039274	0.219851	0.176266	CS pos: 22-23. GLA-IN. Pr: 0.3211    34
NZ_CP027599.1_126541	LIPO(Sec/SPII)	0.359626	0.017134	0.360305	0.262935	CS pos: ?. Probable protein fragment    19
NZ_CP027599.1_126543	TAT(Tat/SPI)	0.138287	0.638964	0.038333	0.184416	CS pos: 23-24. SSA-MP. Pr: 0.4863    39
NZ_CP027599.1_126563	SP(Sec/SPI)	0.387288	0.025139	0.295204	0.292369	CS pos: 17-18. ASA-II. Pr: 0.2373    25
NZ_CP027599.1_126602	LIPO(Sec/SPII)	0.196159	0.052931	0.433124	0.317786	CS pos: 21-22. TGG-QT. Pr: 0.2379    43
NZ_CP027599.1_126625	LIPO(Sec/SPII)	0.259055	0.029657	0.399997	0.311291	CS pos: 22-23. SGA-CS. Pr: 0.3656    24
NZ_CP027599.1_126643	LIPO(Sec/SPII)	0.151875	0.035183	0.451643	0.361299	CS pos: 19-20. SIS-CS. Pr: 0.3776    27
NZ_CP027599.1_126661	LIPO(Sec/SPII)	0.170928	0.078844	0.515312	0.234915	CS pos: 23-24. APS-CC. Pr: 0.3922    49
NZ_CP027599.1_126674	LIPO(Sec/SPII)	0.228059	0.027674	0.380482	0.363784	CS pos: 13-14. LIK-CG. Pr: 0.1151    15
NZ_CP027599.1_126677	LIPO(Sec/SPII)	0.193380	0.022031	0.470602	0.313987	CS pos: 13-14. TSL-CN. Pr: 0.2449    15
NZ_CP027599.1_126717	SP(Sec/SPI)	0.583078	0.022226	0.282125	0.112571	CS pos: 22-23. AFS-SA. Pr: 0.2520    25
NZ_CP027599.1_126745	LIPO(Sec/SPII)	0.261702	0.174439	0.343566	0.220293	CS pos: 16-17. STA-CA. Pr: 0.2837    27
NZ_CP027599.1_126760	SP(Sec/SPI)	0.434911	0.038510	0.194619	0.331960	CS pos: 20-21. AES-SY. Pr: 0.1041    41
NZ_CP027599.1_126762	LIPO(Sec/SPII)	0.241095	0.035073	0.607817	0.116015	CS pos: 13-14. VAS-CL. Pr: 0.4815    26
NZ_CP027599.1_126811	LIPO(Sec/SPII)	0.268618	0.009648	0.380104	0.341630	CS pos: 20-21. LFS-VP. Pr: 0.0206    22
NZ_CP027599.1_126812	LIPO(Sec/SPII)	0.143104	0.057457	0.783787	0.015652	CS pos: 20-21. LTA-CG. Pr: 0.7825    33
NZ_CP027599.1_126824	LIPO(Sec/SPII)	0.197173	0.016862	0.589707	0.196258	CS pos: 15-16. MMS-CC. Pr: 0.3714    31
NZ_CP027599.1_126838	LIPO(Sec/SPII)	0.255671	0.015767	0.413197	0.315365	CS pos: 13-14. RVC-CM. Pr: 0.0427    15
NZ_CP027599.1_126850	SP(Sec/SPI)	0.405431	0.042245	0.317377	0.234948	CS pos: 21-22. ANN-EP. Pr: 0.1294    30
NZ_CP027599.1_126863	SP(Sec/SPI)	0.427478	0.121245	0.296498	0.154780	CS pos: 26-27. ASA-GK. Pr: 0.2978    40
NZ_CP027599.1_126869	SP(Sec/SPI)	0.302903	0.257402	0.149456	0.290239	CS pos: 24-25. STA-AT. Pr: 0.1298    38
NZ_CP027599.1_126906	LIPO(Sec/SPII)	0.276054	0.000962	0.696706	0.026278	CS pos: 19-20. SIC-CV. Pr: 0.5246    36
NZ_CP027599.1_126909	LIPO(Sec/SPII)	0.282925	0.022108	0.423442	0.271526	CS pos: 13-14. QTP-CH. Pr: 0.1647    15
NZ_CP027599.1_126910	SP(Sec/SPI)	0.423495	0.159023	0.071910	0.345571	CS pos: 22-23. ANA-VP. Pr: 0.3590    46
NZ_CP027599.1_126914	SP(Sec/SPI)	0.656820	0.032793	0.125087	0.185301	CS pos: 22-23. CLA-NG. Pr: 0.5931    45
NZ_CP027599.1_126924	TAT(Tat/SPI)	0.210091	0.495172	0.031095	0.263641	CS pos: 33-34. ARA-DI. Pr: 0.5398    43
NZ_CP027599.1_126947	LIPO(Sec/SPII)	0.260140	0.021051	0.467662	0.251147	CS pos: ?. Probable protein fragment    16
NZ_CP027599.1_126955	LIPO(Sec/SPII)	0.228176	0.044813	0.449884	0.277127	CS pos: 16-17. ARS-CS. Pr: 0.3253    22
NZ_CP027599.1_127018	LIPO(Sec/SPII)	0.258337	0.020476	0.410062	0.311124	CS pos: ?. Probable protein fragment    16
NZ_CP027599.1_127019	SP(Sec/SPI)	0.380491	0.021433	0.301366	0.296710	CS pos: 15-16. ALS-DR. Pr: 0.1602    21
NZ_CP027599.1_127053	LIPO(Sec/SPII)	0.009059	0.000188	0.962322	0.028431	CS pos: 16-17. LTA-CE. Pr: 0.9613    27
NZ_CP027599.1_127065	TAT(Tat/SPI)	0.096424	0.603171	0.015280	0.285126	CS pos: 40-41. SRA-AV. Pr: 0.3489    50
NZ_CP027599.1_127077	TAT(Tat/SPI)	0.253700	0.536319	0.036978	0.173004	CS pos: 31-32. ARC-RN. Pr: 0.1545    43
NZ_CP027599.1_127090	LIPO(Sec/SPII)	0.253356	0.069643	0.442202	0.234799	CS pos: 21-22. AHF-CG. Pr: 0.2471    42
NZ_CP027599.1_127107	SP(Sec/SPI)	0.631416	0.022696	0.072141	0.273747	CS pos: 17-18. ANA-SQ. Pr: 0.5518    26
NZ_CP027599.1_127123	SP(Sec/SPI)	0.646985	0.038459	0.195844	0.118713	CS pos: 20-21. SLA-SM. Pr: 0.5023    26
NZ_CP027599.1_127172	LIPO(Sec/SPII)	0.220094	0.022638	0.395756	0.361513	CS pos: ?. Probable protein fragment    15
NZ_CP027599.1_127178	SP(Sec/SPI)	0.389135	0.027746	0.207472	0.375646	CS pos: 25-26. VAP-DR. Pr: 0.1040    28
NZ_CP027599.1_127194	TAT(Tat/SPI)	0.234887	0.449890	0.128788	0.186435	CS pos: ?. Probable protein fragment    28
NZ_CP027599.1_127199	SP(Sec/SPI)	0.553588	0.168851	0.026368	0.251193	CS pos: 29-30. ASA-IC. Pr: 0.4850    44
NZ_CP027599.1_127200	SP(Sec/SPI)	0.306802	0.290412	0.097175	0.305610	CS pos: 15-16. AYA-KK. Pr: 0.3814    23
NZ_CP027599.1_127202	LIPO(Sec/SPII)	0.059593	0.008483	0.790066	0.141858	CS pos: 16-17. IPG-CD. Pr: 0.7460    19
NZ_CP027599.1_127216	TAT(Tat/SPI)	0.050218	0.503278	0.039417	0.407087	CS pos: 29-30. TFS-TS. Pr: 0.1379    49
NZ_CP027599.1_127224	SP(Sec/SPI)	0.658939	0.013722	0.067266	0.260073	CS pos: 19-20. SDS-AI. Pr: 0.2471    42
NZ_CP027599.1_127228	SP(Sec/SPI)	0.487541	0.103680	0.197472	0.211308	CS pos: 23-24. VLA-AC. Pr: 0.5648    49
NZ_CP027599.1_127229	SP(Sec/SPI)	0.485487	0.030141	0.316411	0.167962	CS pos: 20-21. CSA-LF. Pr: 0.2632    34
NZ_CP027599.1_127242	LIPO(Sec/SPII)	0.228852	0.018613	0.399061	0.353474	CS pos: 17-18. LLA-CK. Pr: 0.2800    24
NZ_CP027599.1_127249	LIPO(Sec/SPII)	0.257731	0.020939	0.383193	0.338137	CS pos: ?. Probable protein fragment    17
NZ_CP027599.1_127250	LIPO(Sec/SPII)	0.256312	0.009839	0.403687	0.330162	CS pos: ?. Probable protein fragment    17
NZ_CP027599.1_127262	SP(Sec/SPI)	0.868610	0.018661	0.029429	0.083300	CS pos: 21-22. IFA-KN. Pr: 0.8125    37
NZ_CP027599.1_127290	TAT(Tat/SPI)	0.067389	0.718676	0.097575	0.116360	CS pos: ?. Probable protein fragment    27
NZ_CP027599.1_127298	SP(Sec/SPI)	0.406552	0.032072	0.170752	0.390625	CS pos: 20-21. LQA-TP. Pr: 0.1401    26
NZ_CP027599.1_127312	LIPO(Sec/SPII)	0.302514	0.052499	0.333468	0.311520	CS pos: 30-31. AIS-CA. Pr: 0.2557    33
NZ_CP027599.1_127313	LIPO(Sec/SPII)	0.243125	0.060441	0.358345	0.338089	CS pos: ?. Probable protein fragment    15
NZ_CP027599.1_127333	TAT(Tat/SPI)	0.150713	0.509731	0.032743	0.306813	CS pos: 41-42. LRA-EK. Pr: 0.1968    44
NZ_CP027599.1_127336	SP(Sec/SPI)	0.675279	0.122181	0.070108	0.132432	CS pos: 19-20. AAA-TS. Pr: 0.6008    32
NZ_CP027599.1_127337	LIPO(Sec/SPII)	0.301347	0.035678	0.369603	0.293372	CS pos: 17-18. STP-CT. Pr: 0.2414    24
NZ_CP027599.1_127347	SP(Sec/SPI)	0.473582	0.117301	0.048986	0.360131	CS pos: 18-19. AEA-GT. Pr: 0.4548    32
NZ_CP027599.1_127382	LIPO(Sec/SPII)	0.120756	0.002176	0.831372	0.045696	CS pos: 13-14. LAA-CT. Pr: 0.6736    19
NZ_CP027599.1_127445	LIPO(Sec/SPII)	0.178849	0.035061	0.408509	0.377581	CS pos: 15-16. LNG-CG. Pr: 0.3492    17
NZ_CP027599.1_127492	SP(Sec/SPI)	0.453580	0.075387	0.085335	0.385697	CS pos: 16-17. HYA-AP. Pr: 0.1386    36
NZ_CP027599.1_127496	LIPO(Sec/SPII)	0.094424	0.005349	0.805522	0.094705	CS pos: 20-21. CGA-CV. Pr: 0.4282    35
NZ_CP027599.1_127538	LIPO(Sec/SPII)	0.358615	0.007103	0.372692	0.261591	CS pos: 16-17. LSE-VA. Pr: 0.0803    18
NZ_CP027599.1_127556	LIPO(Sec/SPII)	0.126889	0.049321	0.432928	0.390862	CS pos: 25-26. QSG-CP. Pr: 0.4064    48
NZ_CP027599.1_127561	SP(Sec/SPI)	0.586545	0.004041	0.077807	0.331608	CS pos: 21-22. STG-HQ. Pr: 0.2038    38
NZ_CP027599.1_127563	LIPO(Sec/SPII)	0.079766	0.032298	0.847051	0.040885	CS pos: 19-20. ATA-CA. Pr: 0.4239    34
NZ_CP027599.1_127565	SP(Sec/SPI)	0.587294	0.123974	0.129420	0.159313	CS pos: 27-28. LSA-DK. Pr: 0.3577    37
NZ_CP027599.1_127578	LIPO(Sec/SPII)	0.131535	0.008699	0.454826	0.404939	CS pos: 23-24. SLS-CN. Pr: 0.4322    30
NZ_CP027599.1_127620	SP(Sec/SPI)	0.893170	0.000495	0.092351	0.013984	CS pos: 18-19. TYS-QS. Pr: 0.6465    31
NZ_CP027599.1_127645	LIPO(Sec/SPII)	0.085789	0.007546	0.497520	0.409145	CS pos: 19-20. TGG-CR. Pr: 0.4519    27
NZ_CP027599.1_127706	LIPO(Sec/SPII)	0.263668	0.018148	0.572109	0.146075	CS pos: 23-24. LTS-CH. Pr: 0.5519    35
NZ_CP027599.1_127727	LIPO(Sec/SPII)	0.238197	0.044958	0.367990	0.348855	CS pos: 12-13. AAT-CQ. Pr: 0.3601    47
NZ_CP027599.1_127837	LIPO(Sec/SPII)	0.233605	0.012994	0.392464	0.360937	CS pos: 14-15. IPC-CC. Pr: 0.1731    36
NZ_CP027599.1_127906	LIPO(Sec/SPII)	0.039047	0.002959	0.943011	0.014983	CS pos: 24-25. SGG-CS. Pr: 0.9361    35
NZ_CP027599.1_127992	LIPO(Sec/SPII)	0.156980	0.037065	0.518054	0.287900	CS pos: 22-23. SAG-CC. Pr: 0.4563    25
NZ_CP027599.1_128007	LIPO(Sec/SPII)	0.289262	0.020701	0.418972	0.271064	CS pos: 10-11. SIG-CF. Pr: 0.0287    15
NZ_CP027599.1_128154	SP(Sec/SPI)	0.440343	0.101020	0.036196	0.422442	CS pos: 28-29. SLA-QA. Pr: 0.2204    49
NZ_CP027599.1_128192	LIPO(Sec/SPII)	0.096615	0.013765	0.708542	0.181078	CS pos: 12-13. IGG-CD. Pr: 0.6280    16
NZ_CP027599.1_128214	LIPO(Sec/SPII)	0.047713	0.004621	0.934526	0.013140	CS pos: 21-22. LSG-CS. Pr: 0.9299    27
NZ_CP027599.1_128308	SP(Sec/SPI)	0.431510	0.094034	0.144405	0.330051	CS pos: 19-20. AYS-LK. Pr: 0.2794    44
NZ_CP027599.1_128326	SP(Sec/SPI)	0.823889	0.012697	0.080139	0.083275	CS pos: 18-19. STA-EM. Pr: 0.3588    30
NZ_CP027599.1_128330	LIPO(Sec/SPII)	0.174606	0.017711	0.507117	0.300566	CS pos: 16-17. CIA-CR. Pr: 0.3785    20
NZ_CP027599.1_128333	LIPO(Sec/SPII)	0.164351	0.006736	0.448553	0.380359	CS pos: 21-22. VPT-CA. Pr: 0.3848    28
NZ_CP027599.1_128348	LIPO(Sec/SPII)	0.151916	0.011247	0.645303	0.191535	CS pos: 13-14. SIS-CI. Pr: 0.4919    15
NZ_CP027599.1_128350	LIPO(Sec/SPII)	0.119418	0.006856	0.557812	0.315914	CS pos: 15-16. PFA-CV. Pr: 0.5396    34
NZ_CP027599.1_128358	SP(Sec/SPI)	0.883189	0.003092	0.076832	0.036887	CS pos: 21-22. SVS-QL. Pr: 0.2507    49
NZ_CP027599.1_128405	LIPO(Sec/SPII)	0.170019	0.004397	0.630870	0.194714	CS pos: 14-15. WCG-CL. Pr: 0.5444    27
NZ_CP027599.1_128416	LIPO(Sec/SPII)	0.237850	0.020505	0.524445	0.217200	CS pos: 17-18. AAV-CY. Pr: 0.2466    22
NZ_CP027599.1_128421	SP(Sec/SPI)	0.521837	0.041388	0.151540	0.285235	CS pos: 11-12. AMA-AT. Pr: 0.2793    21
NZ_CP027599.1_128444	LIPO(Sec/SPII)	0.271722	0.005084	0.638656	0.084538	CS pos: 22-23. TIP-CG. Pr: 0.4424    30
NZ_CP027599.1_128459	LIPO(Sec/SPII)	0.181888	0.019144	0.521163	0.277804	CS pos: 22-23. SVA-CF. Pr: 0.3948    28
NZ_CP027599.1_128476	LIPO(Sec/SPII)	0.209946	0.032672	0.531078	0.226304	CS pos: 16-17. VNS-CR. Pr: 0.4879    19
NZ_CP027599.1_128488	SP(Sec/SPI)	0.396392	0.132771	0.100768	0.370070	CS pos: 19-20. SIA-KR. Pr: 0.2769    34
NZ_CP027599.1_128497	SP(Sec/SPI)	0.370112	0.042342	0.241636	0.345910	CS pos: 16-17. LNA-IG. Pr: 0.1226    22
NZ_CP027599.1_128508	LIPO(Sec/SPII)	0.138073	0.004494	0.694752	0.162681	CS pos: 21-22. LPA-CS. Pr: 0.6116    24
NZ_CP027599.1_128530	LIPO(Sec/SPII)	0.043093	0.004196	0.910433	0.042277	CS pos: 15-16. MTA-CS. Pr: 0.9032    24
NZ_CP027599.1_128545	SP(Sec/SPI)	0.526788	0.015545	0.093274	0.364392	CS pos: 36-37. AFA-GV. Pr: 0.3947    45
NZ_CP027599.1_128546	SP(Sec/SPI)	0.560078	0.008271	0.139244	0.292406	CS pos: 32-33. LVA-NQ. Pr: 0.3423    34
NZ_CP027599.1_128557	TAT(Tat/SPI)	0.064946	0.477122	0.038318	0.419614	CS pos: 25-26. AFA-SS. Pr: 0.2624    38
NZ_CP027599.1_128580	SP(Sec/SPI)	0.369728	0.016442	0.255647	0.358183	CS pos: ?. Probable protein fragment    19
NZ_CP027599.1_128622	SP(Sec/SPI)	0.672243	0.067444	0.034109	0.226204	CS pos: 24-25. VQA-NA. Pr: 0.5879    36
NZ_CP027599.1_128632	LIPO(Sec/SPII)	0.084252	0.012394	0.864446	0.038907	CS pos: 16-17. FSA-CA. Pr: 0.8237    21
NZ_CP027599.1_128651	LIPO(Sec/SPII)	0.129621	0.002310	0.608696	0.259374	CS pos: 13-14. VCL-CQ. Pr: 0.5302    31
NZ_CP027599.1_128672	LIPO(Sec/SPII)	0.088970	0.013748	0.705730	0.191551	CS pos: 19-20. TIA-CR. Pr: 0.6835    25
NZ_CP027599.1_128686	SP(Sec/SPI)	0.782545	0.009207	0.144001	0.064248	CS pos: 23-24. ALA-VI. Pr: 0.6864    45
NZ_CP027599.1_128725	LIPO(Sec/SPII)	0.336467	0.019428	0.380019	0.264087	CS pos: ?. Probable protein fragment    16
NZ_CP027599.1_128726	SP(Sec/SPI)	0.440049	0.087224	0.068792	0.403935	CS pos: 17-18. ARA-NS. Pr: 0.4170    23
NZ_CP027599.1_128729	LIPO(Sec/SPII)	0.124037	0.015223	0.589425	0.271315	CS pos: 15-16. LSG-CV. Pr: 0.5120    23
NZ_CP027599.1_128730	TAT(Tat/SPI)	0.085077	0.822858	0.002098	0.089967	CS pos: 25-26. VRA-LN. Pr: 0.8848    42
NZ_CP027599.1_128740	SP(Sec/SPI)	0.402033	0.162375	0.071935	0.363657	CS pos: 20-21. AGA-GN. Pr: 0.1312    34
NZ_CP027599.1_128745	TAT(Tat/SPI)	0.096478	0.616249	0.026300	0.260973	CS pos: 23-24. IYS-TT. Pr: 0.2821    46
NZ_CP027599.1_128764	LIPO(Sec/SPII)	0.256017	0.041773	0.419850	0.282360	CS pos: ?. Probable protein fragment    17
NZ_CP027599.1_128788	SP(Sec/SPI)	0.485936	0.016013	0.291844	0.206207	CS pos: ?. Probable protein fragment    24
NZ_CP027599.1_128797	LIPO(Sec/SPII)	0.259230	0.024395	0.372244	0.344131	CS pos: ?. Probable protein fragment    16
NZ_CP027599.1_128823	LIPO(Sec/SPII)	0.264620	0.015039	0.522322	0.198018	CS pos: 13-14. AAS-CN. Pr: 0.3792    17
NZ_CP027599.1_128845	LIPO(Sec/SPII)	0.222683	0.015654	0.401837	0.359826	CS pos: 15-16. CLQ-CR. Pr: 0.0695    18
NZ_CP027599.1_128859	LIPO(Sec/SPII)	0.328239	0.005005	0.359840	0.306916	CS pos: ?. Probable protein fragment    25
NZ_CP027599.1_128863	SP(Sec/SPI)	0.530639	0.001868	0.084731	0.382762	CS pos: 16-17. GQS-QN. Pr: 0.4639    47
NZ_CP027599.1_128881	SP(Sec/SPI)	0.884956	0.049875	0.031744	0.033424	CS pos: 29-30. ADA-TV. Pr: 0.5073    50
NZ_CP027599.1_128894	SP(Sec/SPI)	0.646334	0.091294	0.176543	0.085829	CS pos: 21-22. VFA-AE. Pr: 0.6896    33
NZ_CP027599.1_128944	LIPO(Sec/SPII)	0.219873	0.041654	0.434817	0.303656	CS pos: 12-13. QSA-CY. Pr: 0.4014    16
NZ_CP027599.1_128957	LIPO(Sec/SPII)	0.194657	0.033267	0.398093	0.373983	CS pos: ?. Probable protein fragment    15
NZ_CP027599.1_128967	SP(Sec/SPI)	0.827445	0.008978	0.083961	0.079616	CS pos: 18-19. VHS-NT. Pr: 0.6277    23
NZ_CP027599.1_128968	TAT(Tat/SPI)	0.123311	0.524120	0.050806	0.301764	CS pos: 26-27. RQA-KF. Pr: 0.1875    28
NZ_CP027599.1_128972	TAT(Tat/SPI)	0.186717	0.424304	0.039113	0.349866	CS pos: 28-29. APA-IT. Pr: 0.1196    35
NZ_CP027599.1_128983	LIPO(Sec/SPII)	0.251974	0.028881	0.379656	0.339490	CS pos: ?. Probable protein fragment    15
NZ_CP027599.1_128985	LIPO(Sec/SPII)	0.225998	0.005949	0.499413	0.268640	CS pos: 13-14. CQS-CS. Pr: 0.4426    29
NZ_CP027599.1_128989	LIPO(Sec/SPII)	0.086155	0.050373	0.439275	0.424197	CS pos: 17-18. ISA-CR. Pr: 0.4163    37
NZ_CP027599.1_129020	LIPO(Sec/SPII)	0.198980	0.105469	0.467752	0.227798	CS pos: 26-27. SAA-CS. Pr: 0.3996    39
NZ_CP027599.1_129042	LIPO(Sec/SPII)	0.203849	0.035374	0.389717	0.371060	CS pos: 12-13. LIT-CQ. Pr: 0.2057    15
NZ_CP027599.1_129054	LIPO(Sec/SPII)	0.203883	0.009842	0.540518	0.245756	CS pos: 19-20. AGV-CL. Pr: 0.3393    42
NZ_CP027599.1_129058	LIPO(Sec/SPII)	0.223944	0.004296	0.701391	0.070369	CS pos: 15-16. LSP-CG. Pr: 0.3385    22
NZ_CP027599.1_129059	LIPO(Sec/SPII)	0.026519	0.003689	0.866111	0.103681	CS pos: 18-19. LSG-CL. Pr: 0.8596    26
NZ_CP027599.1_129117	LIPO(Sec/SPII)	0.077203	0.011920	0.585905	0.324972	CS pos: 15-16. LPS-CW. Pr: 0.5534    23
NZ_CP027599.1_129129	LIPO(Sec/SPII)	0.040816	0.025775	0.507160	0.426249	CS pos: 20-21. STS-CL. Pr: 0.4829    30
NZ_CP027599.1_129166	SP(Sec/SPI)	0.616960	0.085333	0.035136	0.262571	CS pos: 11-12. ANA-GL. Pr: 0.4355    31
NZ_CP027599.1_129184	LIPO(Sec/SPII)	0.169250	0.018809	0.617086	0.194854	CS pos: 14-15. TAS-CW. Pr: 0.5493    18
NZ_CP027599.1_129213	SP(Sec/SPI)	0.531510	0.076663	0.117378	0.274448	CS pos: 27-28. SRA-LI. Pr: 0.5114    42
NZ_CP027599.1_129226	LIPO(Sec/SPII)	0.022850	0.000594	0.799322	0.177234	CS pos: 22-23. VTA-CH. Pr: 0.8140    49
NZ_CP027599.1_129230	SP(Sec/SPI)	0.457687	0.077473	0.147897	0.316943	CS pos: 18-19. SLA-SH. Pr: 0.1315    21
NZ_CP027599.1_129251	LIPO(Sec/SPII)	0.139814	0.038542	0.467575	0.354068	CS pos: 16-17. VGS-CQ. Pr: 0.3855    20
NZ_CP027599.1_129253	SP(Sec/SPI)	0.442269	0.120210	0.173030	0.264491	CS pos: 23-24. ASA-KS. Pr: 0.2508    28
NZ_CP027599.1_129288	SP(Sec/SPI)	0.568095	0.104650	0.032844	0.294412	CS pos: 24-25. AMA-LC. Pr: 0.3094    46
NZ_CP027599.1_129290	SP(Sec/SPI)	0.918072	0.013465	0.020986	0.047477	CS pos: 18-19. AKA-SD. Pr: 0.8663    47
NZ_CP027599.1_129292	LIPO(Sec/SPII)	0.136600	0.012688	0.598169	0.252542	CS pos: 12-13. LHG-CH. Pr: 0.5308    20
NZ_CP027599.1_129304	SP(Sec/SPI)	0.449021	0.023735	0.211778	0.315467	CS pos: 13-14. STA-GD. Pr: 0.1547    19
NZ_CP027599.1_129313	LIPO(Sec/SPII)	0.078633	0.008665	0.465958	0.446744	CS pos: 14-15. TLG-CS. Pr: 0.3998    42
NZ_CP027599.1_129366	LIPO(Sec/SPII)	0.202195	0.003713	0.578214	0.215878	CS pos: 26-27. LAI-CN. Pr: 0.4671    39
NZ_CP027599.1_129372	TAT(Tat/SPI)	0.181695	0.319580	0.215051	0.283674	CS pos: ?. Probable protein fragment    19
NZ_CP027599.1_129373	SP(Sec/SPI)	0.635239	0.015853	0.155554	0.193354	CS pos: 20-21. VNS-SR. Pr: 0.5192    30
NZ_CP027599.1_129377	LIPO(Sec/SPII)	0.196802	0.025151	0.443404	0.334644	CS pos: 16-17. LSC-CD. Pr: 0.1501    20
NZ_CP027599.1_129408	LIPO(Sec/SPII)	0.259749	0.013686	0.406693	0.319872	CS pos: ?. Probable protein fragment    17
NZ_CP027599.1_129415	LIPO(Sec/SPII)	0.192791	0.063790	0.378279	0.365140	CS pos: 16-17. PGS-CS. Pr: 0.2995    21
NZ_CP027599.1_129454	SP(Sec/SPI)	0.351394	0.166121	0.234889	0.247597	CS pos: 31-32. IRS-EK. Pr: 0.2025    46
NZ_CP027599.1_129468	LIPO(Sec/SPII)	0.219931	0.025011	0.394352	0.360706	CS pos: ?. Probable protein fragment    17
NZ_CP027599.1_129471	LIPO(Sec/SPII)	0.221197	0.010510	0.611809	0.156484	CS pos: 18-19. HHA-CG. Pr: 0.5354    22
NZ_CP027599.1_129541	LIPO(Sec/SPII)	0.047727	0.000631	0.935187	0.016455	CS pos: 20-21. IPS-CN. Pr: 0.6751    43
NZ_CP027599.1_129547	LIPO(Sec/SPII)	0.045415	0.004321	0.792640	0.157624	CS pos: 11-12. LWG-CS. Pr: 0.7521    31
NZ_CP027599.1_129577	LIPO(Sec/SPII)	0.203281	0.016919	0.428632	0.351168	CS pos: 19-20. YVP-CH. Pr: 0.1909    25
NZ_CP027599.1_129583	LIPO(Sec/SPII)	0.058796	0.004224	0.599685	0.337295	CS pos: 24-25. LTG-CW. Pr: 0.5447    35
NZ_CP027599.1_129619	LIPO(Sec/SPII)	0.030743	0.011847	0.587269	0.370141	CS pos: 28-29. LAS-CS. Pr: 0.5699    42
NZ_CP027599.1_129629	SP(Sec/SPI)	0.448483	0.011101	0.427570	0.112846	CS pos: ?. Probable protein fragment    16
NZ_CP027599.1_129676	LIPO(Sec/SPII)	0.062826	0.009021	0.491303	0.436850	CS pos: 30-31. LAS-CS. Pr: 0.4735    40
NZ_CP027599.1_129695	LIPO(Sec/SPII)	0.224140	0.012576	0.440648	0.322636	CS pos: 15-16. VLP-CR. Pr: 0.3312    21
NZ_CP027599.1_129703	SP(Sec/SPI)	0.476112	0.051504	0.086526	0.385858	CS pos: 32-33. AFC-DG. Pr: 0.4446    35
NZ_CP027599.1_129806	LIPO(Sec/SPII)	0.167360	0.006755	0.722535	0.103350	CS pos: 18-19. LSP-CN. Pr: 0.6759    34
NZ_CP027599.1_129820	SP(Sec/SPI)	0.445692	0.026401	0.170164	0.357743	CS pos: 23-24. GFS-VP. Pr: 0.1213    30
NZ_CP027599.1_129827	SP(Sec/SPI)	0.378305	0.140205	0.110228	0.371262	CS pos: 21-22. SSA-AK. Pr: 0.1076    24
NZ_CP027599.1_129835	SP(Sec/SPI)	0.444997	0.064616	0.156685	0.333702	CS pos: ?. Probable protein fragment    22
NZ_CP027599.1_129838	LIPO(Sec/SPII)	0.405945	0.012519	0.407343	0.174193	CS pos: 17-18. SVK-CR. Pr: 0.2923    23
NZ_CP027599.1_129840	SP(Sec/SPI)	0.549486	0.049233	0.195555	0.205727	CS pos: 18-19. SLS-AD. Pr: 0.2802    21
NZ_CP027599.1_129849	LIPO(Sec/SPII)	0.171660	0.019207	0.416369	0.392764	CS pos: 19-20. AAG-KT. Pr: 0.2331    27
NZ_CP027599.1_129868	LIPO(Sec/SPII)	0.277510	0.041306	0.375501	0.305683	CS pos: 13-14. TFC-CF. Pr: 0.2780    23
NZ_CP027599.1_129882	TAT(Tat/SPI)	0.122794	0.447195	0.038393	0.391619	CS pos: 34-35. SVA-NW. Pr: 0.2334    42
NZ_CP027599.1_129886	LIPO(Sec/SPII)	0.132561	0.133656	0.470782	0.263001	CS pos: 18-19. GIA-CS. Pr: 0.4555    45
NZ_CP027599.1_129913	LIPO(Sec/SPII)	0.231980	0.063572	0.405006	0.299442	CS pos: 14-15. ATG-CD. Pr: 0.3936    45
NZ_CP027599.1_129923	LIPO(Sec/SPII)	0.281110	0.046937	0.408413	0.263541	CS pos: 17-18. YCA-CG. Pr: 0.2030    25
NZ_CP027599.1_129937	SP(Sec/SPI)	0.380536	0.063264	0.259438	0.296762	CS pos: 14-15. VSA-SS. Pr: 0.3098    37
NZ_CP027599.1_129947	LIPO(Sec/SPII)	0.062329	0.006630	0.695040	0.236000	CS pos: 17-18. TLS-CG. Pr: 0.6480    20
NZ_CP027599.1_129953	LIPO(Sec/SPII)	0.007202	0.000185	0.988471	0.004142	CS pos: 14-15. SFA-CS. Pr: 0.9874    29
NZ_CP027599.1_129956	SP(Sec/SPI)	0.700380	0.013736	0.159069	0.126815	CS pos: ?. Probable protein fragment    20
NZ_CP027599.1_129964	LIPO(Sec/SPII)	0.129039	0.007168	0.647250	0.216543	CS pos: 14-15. IFS-CL. Pr: 0.5389    21
NZ_CP027599.1_129980	LIPO(Sec/SPII)	0.204658	0.021937	0.398866	0.374539	CS pos: 15-16. LTG-RS. Pr: 0.2862    20
NZ_CP027599.1_129994	LIPO(Sec/SPII)	0.117041	0.009877	0.649474	0.223608	CS pos: 15-16. PSA-CI. Pr: 0.5907    22
NZ_CP027599.1_129998	SP(Sec/SPI)	0.400227	0.052985	0.218755	0.328033	CS pos: 19-20. ARS-YG. Pr: 0.2169    21
NZ_CP027599.1_130014	LIPO(Sec/SPII)	0.202303	0.006726	0.400981	0.389990	CS pos: 19-20. LYF-CR. Pr: 0.2320    32
NZ_CP027599.1_130018	LIPO(Sec/SPII)	0.123798	0.013923	0.455715	0.406564	CS pos: 21-22. LSR-CW. Pr: 0.4136    24
NZ_CP027599.1_130027	LIPO(Sec/SPII)	0.322736	0.153702	0.482079	0.041483	CS pos: 19-20. MAT-CA. Pr: 0.4752    48
NZ_CP027599.1_130065	LIPO(Sec/SPII)	0.231043	0.026310	0.399562	0.343086	CS pos: ?. Probable protein fragment    15
NZ_CP027599.1_130092	LIPO(Sec/SPII)	0.235062	0.019311	0.416213	0.329414	CS pos: 14-15. IYP-CS. Pr: 0.1750    18
NZ_CP027599.1_130124	LIPO(Sec/SPII)	0.174137	0.028974	0.628046	0.168843	CS pos: 18-19. NTG-CM. Pr: 0.5975    22
NZ_CP027599.1_130147	LIPO(Sec/SPII)	0.035675	0.124247	0.575088	0.264990	CS pos: 24-25. GSG-CR. Pr: 0.4346    48
NZ_CP027599.1_130182	LIPO(Sec/SPII)	0.211277	0.023972	0.410204	0.354547	CS pos: 17-18. NAG-CL. Pr: 0.2420    19
NZ_CP027599.1_130197	LIPO(Sec/SPII)	0.169907	0.035437	0.591315	0.203340	CS pos: 12-13. ASS-CT. Pr: 0.4967    43
NZ_CP027599.1_130219	SP(Sec/SPI)	0.384556	0.047810	0.266182	0.301452	CS pos: 24-25. SNA-DC. Pr: 0.1021    32
NZ_CP027599.1_130241	SP(Sec/SPI)	0.524840	0.002702	0.246225	0.226234	CS pos: 23-24. SHN-ID. Pr: 0.2127    35
NZ_CP027599.1_130266	LIPO(Sec/SPII)	0.023215	0.011300	0.938998	0.026487	CS pos: 19-20. ASS-CS. Pr: 0.9380    38
NZ_CP027599.1_130286	LIPO(Sec/SPII)	0.113179	0.005267	0.757900	0.123654	CS pos: 15-16. LEG-CF. Pr: 0.6501    21
NZ_CP027599.1_130299	SP(Sec/SPI)	0.415328	0.022191	0.162859	0.399622	CS pos: 21-22. PDA-HD. Pr: 0.1529    27
NZ_CP027599.1_130301	SP(Sec/SPI)	0.389655	0.037312	0.316690	0.256343	CS pos: 25-26. SRS-SN. Pr: 0.0977    27
NZ_CP027599.1_130326	SP(Sec/SPI)	0.407353	0.086906	0.142530	0.363212	CS pos: 20-21. AQA-IP. Pr: 0.2148    24
NZ_CP027599.1_130346	TAT(Tat/SPI)	0.077099	0.481120	0.238237	0.203544	CS pos: 33-34. VTS-QP. Pr: 0.1255    48
NZ_CP027599.1_130351	TAT(Tat/SPI)	0.054009	0.507004	0.015837	0.423149	CS pos: ?. Probable protein fragment    38
NZ_CP027599.1_130353	SP(Sec/SPI)	0.541768	0.092771	0.115499	0.249963	CS pos: 20-21. VAP-TG. Pr: 0.0756    31
NZ_CP027599.1_130419	LIPO(Sec/SPII)	0.105150	0.003488	0.806598	0.084764	CS pos: 21-22. LIA-CP. Pr: 0.4895    29
NZ_CP027599.1_130438	LIPO(Sec/SPII)	0.167844	0.003756	0.419855	0.408545	CS pos: 22-23. ICH-CN. Pr: 0.2328    29
NZ_CP027599.1_130459	SP(Sec/SPI)	0.473696	0.054209	0.052276	0.419820	CS pos: 24-25. VSS-AP. Pr: 0.2556    43
NZ_CP027599.1_130516	LIPO(Sec/SPII)	0.106356	0.014467	0.687802	0.191375	CS pos: 13-14. VTS-CR. Pr: 0.6147    17
NZ_CP027599.1_130562	LIPO(Sec/SPII)	0.129864	0.020346	0.466675	0.383115	CS pos: 16-17. FSG-QN. Pr: 0.4491    39
NZ_CP027599.1_130563	LIPO(Sec/SPII)	0.167699	0.007965	0.756060	0.068276	CS pos: 12-13. TLS-CR. Pr: 0.7288    29
NZ_CP027599.1_130578	LIPO(Sec/SPII)	0.224421	0.054137	0.368954	0.352487	CS pos: 12-13. HFA-CI. Pr: 0.0904    15
NZ_CP027599.1_130599	SP(Sec/SPI)	0.611949	0.055255	0.052066	0.280730	CS pos: 17-18. VLA-KS. Pr: 0.2668    33
NZ_CP027599.1_130600	LIPO(Sec/SPII)	0.290828	0.046290	0.381086	0.281796	CS pos: ?. Probable protein fragment    17
NZ_CP027599.1_130607	SP(Sec/SPI)	0.479040	0.062284	0.227201	0.231474	CS pos: 19-20. TTA-MP. Pr: 0.2486    24
NZ_CP027599.1_130631	SP(Sec/SPI)	0.448555	0.047995	0.156735	0.346715	CS pos: 15-16. NLA-TI. Pr: 0.0783    26
NZ_CP027599.1_130680	LIPO(Sec/SPII)	0.043706	0.001244	0.692177	0.262874	CS pos: 26-27. ITG-CI. Pr: 0.6805    41
NZ_CP027599.1_130685	LIPO(Sec/SPII)	0.214129	0.038327	0.381411	0.366133	CS pos: ?. Probable protein fragment    16
NZ_CP027599.1_130686	LIPO(Sec/SPII)	0.385704	0.013518	0.431945	0.168833	CS pos: 18-19. IAF-CA. Pr: 0.2750    29
NZ_CP027599.1_130694	SP(Sec/SPI)	0.447657	0.093942	0.143535	0.314866	CS pos: 20-21. VSA-SA. Pr: 0.1656    23
NZ_CP027599.1_130711	SP(Sec/SPI)	0.424386	0.053794	0.240124	0.281695	CS pos: 14-15. ALS-TP. Pr: 0.0798    22
NZ_CP027599.1_130716	LIPO(Sec/SPII)	0.098077	0.024178	0.443793	0.433952	CS pos: 22-23. FSA-CA. Pr: 0.4184    41
NZ_CP027599.1_130727	LIPO(Sec/SPII)	0.188545	0.005668	0.418944	0.386842	CS pos: 18-19. ITG-VD. Pr: 0.4115    26
NZ_CP027599.1_130729	LIPO(Sec/SPII)	0.176405	0.008184	0.654585	0.160826	CS pos: ?. Probable protein fragment    23
NZ_CP027599.1_130749	LIPO(Sec/SPII)	0.301697	0.051663	0.492884	0.153756	CS pos: 20-21. SVP-CN. Pr: 0.3197    22
NZ_CP027599.1_130753	SP(Sec/SPI)	0.664818	0.108695	0.070138	0.156349	CS pos: 21-22. ALA-RG. Pr: 0.2539    48
NZ_CP027599.1_130757	LIPO(Sec/SPII)	0.144840	0.038873	0.546063	0.270224	CS pos: 14-15. GCA-CH. Pr: 0.2962    24
NZ_CP027599.1_130773	SP(Sec/SPI)	0.449563	0.015411	0.143757	0.391270	CS pos: 20-21. SNG-KT. Pr: 0.2898    25
NZ_CP027599.1_130800	LIPO(Sec/SPII)	0.248704	0.123104	0.345476	0.282717	CS pos: 17-18. NAT-CG. Pr: 0.2595    22
NZ_CP027599.1_130814	SP(Sec/SPI)	0.506951	0.080785	0.086918	0.325347	CS pos: 17-18. AQA-GF. Pr: 0.3511    30
NZ_CP027599.1_130821	SP(Sec/SPI)	0.464501	0.198189	0.102465	0.234845	CS pos: 26-27. SRA-RI. Pr: 0.4428    31
NZ_CP027599.1_130833	SP(Sec/SPI)	0.832874	0.007422	0.076795	0.082909	CS pos: 18-19. TNA-IP. Pr: 0.7201    32
NZ_CP027599.1_130836	LIPO(Sec/SPII)	0.258748	0.048977	0.458509	0.233765	CS pos: 16-17. VCG-CT. Pr: 0.2930    18
NZ_CP027599.1_130844	SP(Sec/SPI)	0.457427	0.132575	0.090542	0.319456	CS pos: 14-15. SMA-QI. Pr: 0.2277    30
NZ_CP027599.1_130849	SP(Sec/SPI)	0.868983	0.105181	0.017334	0.008502	CS pos: 22-23. ATA-EA. Pr: 0.5156    29
NZ_CP027599.1_130857	LIPO(Sec/SPII)	0.208481	0.064592	0.603410	0.123516	CS pos: 20-21. SSG-CA. Pr: 0.5327    41
NZ_CP027599.1_130867	LIPO(Sec/SPII)	0.137737	0.031779	0.499209	0.331275	CS pos: 9-10. STA-CA. Pr: 0.4477    27
NZ_CP027599.1_130876	LIPO(Sec/SPII)	0.237926	0.043483	0.534605	0.183987	CS pos: 19-20. SAG-CV. Pr: 0.4979    37
NZ_CP027599.1_130887	SP(Sec/SPI)	0.573086	0.130885	0.127323	0.168706	CS pos: 20-21. VYS-RP. Pr: 0.3922    48
NZ_CP027599.1_130888	LIPO(Sec/SPII)	0.169718	0.018902	0.431880	0.379500	CS pos: 21-22. LTG-CC. Pr: 0.2827    25
NZ_CP027599.1_130896	SP(Sec/SPI)	0.478646	0.062143	0.131589	0.327622	CS pos: 23-24. SSA-MQ. Pr: 0.2691    37
NZ_CP027599.1_130908	SP(Sec/SPI)	0.657436	0.025288	0.178466	0.138810	CS pos: 27-28. ANA-HR. Pr: 0.5557    32
NZ_CP027599.1_130936	LIPO(Sec/SPII)	0.230245	0.012877	0.607911	0.148967	CS pos: 26-27. VAS-CG. Pr: 0.5486    50
NZ_CP027599.1_130945	TAT(Tat/SPI)	0.145644	0.495625	0.045935	0.312796	CS pos: 27-28. RSA-KS. Pr: 0.1202    33
NZ_CP027599.1_130947	SP(Sec/SPI)	0.498346	0.001233	0.341079	0.159342	CS pos: 19-20. SSG-QK. Pr: 0.4589    50
NZ_CP027599.1_131023	LIPO(Sec/SPII)	0.145196	0.032936	0.475559	0.346309	CS pos: 18-19. TVG-CY. Pr: 0.4151    32
NZ_CP027599.1_131044	LIPO(Sec/SPII)	0.143525	0.009956	0.478826	0.367693	CS pos: 23-24. GRG-CN. Pr: 0.4056    41
NZ_CP027599.1_131062	LIPO(Sec/SPII)	0.075314	0.010671	0.657703	0.256311	CS pos: 23-24. GSG-CR. Pr: 0.6431    46
NZ_CP027599.1_131079	SP(Sec/SPI)	0.487485	0.024705	0.265418	0.222392	CS pos: 13-14. AAA-LP. Pr: 0.1074    18
NZ_CP027599.1_131100	LIPO(Sec/SPII)	0.310145	0.010521	0.510450	0.168883	CS pos: 14-15. AIF-CA. Pr: 0.1534    18
NZ_CP027599.1_131141	LIPO(Sec/SPII)	0.257856	0.022397	0.367468	0.352279	CS pos: 15-16. QLV-CS. Pr: 0.0845    17
NZ_CP027599.1_131165	LIPO(Sec/SPII)	0.172115	0.037041	0.421994	0.368850	CS pos: 13-14. PIA-CI. Pr: 0.2323    15
NZ_CP027599.1_131176	SP(Sec/SPI)	0.440037	0.235124	0.156606	0.168232	CS pos: 27-28. SKA-KL. Pr: 0.5098    35
NZ_CP027599.1_131238	LIPO(Sec/SPII)	0.295129	0.051135	0.333518	0.320217	CS pos: 21-22. SAL-CA. Pr: 0.1543    34
NZ_CP027599.1_131239	SP(Sec/SPI)	0.450585	0.120971	0.118049	0.310396	CS pos: 27-28. RQA-AG. Pr: 0.1625    43
NZ_CP027599.1_131252	LIPO(Sec/SPII)	0.097307	0.006140	0.758554	0.137999	CS pos: ?. Probable protein fragment    17
NZ_CP027599.1_131283	SP(Sec/SPI)	0.388432	0.008282	0.225047	0.378239	CS pos: 24-25. ALS-SG. Pr: 0.1688    32
NZ_CP027599.1_131305	LIPO(Sec/SPII)	0.009326	0.000997	0.805760	0.183917	CS pos: 17-18. LLA-CT. Pr: 0.8053    47
NZ_CP027599.1_131323	LIPO(Sec/SPII)	0.184238	0.003772	0.436882	0.375108	CS pos: 13-14. LCG-AD. Pr: 0.3660    43
NZ_CP027599.1_131333	LIPO(Sec/SPII)	0.165041	0.005093	0.708058	0.121808	CS pos: 11-12. FYG-CH. Pr: 0.6601    22
NZ_CP027599.1_131371	SP(Sec/SPI)	0.432016	0.006299	0.373940	0.187744	CS pos: 18-19. LVA-DK. Pr: 0.4886    31
NZ_CP027599.1_131400	TAT(Tat/SPI)	0.255145	0.306046	0.140508	0.298300	CS pos: 23-24. VIG-VS. Pr: 0.1396    27
NZ_CP027599.1_131405	SP(Sec/SPI)	0.418465	0.024260	0.189916	0.367359	CS pos: 23-24. TAP-LR. Pr: 0.0745    25
NZ_CP027599.1_131421	SP(Sec/SPI)	0.910729	0.042613	0.011182	0.035475	CS pos: 20-21. AHA-RN. Pr: 0.9051    36
NZ_CP027599.1_131422	SP(Sec/SPI)	0.459875	0.014822	0.126029	0.399274	CS pos: 18-19. VFG-PG. Pr: 0.2884    30
NZ_CP027599.1_131425	LIPO(Sec/SPII)	0.096885	0.013810	0.558828	0.330477	CS pos: 18-19. FRS-CA. Pr: 0.5288    32
NZ_CP027599.1_131458	SP(Sec/SPI)	0.500153	0.200813	0.105954	0.193080	CS pos: 23-24. ILA-RP. Pr: 0.2661    37
NZ_CP027599.1_131484	LIPO(Sec/SPII)	0.038285	0.012824	0.861787	0.087105	CS pos: 21-22. STG-CG. Pr: 0.8552    30
NZ_CP027599.1_131542	LIPO(Sec/SPII)	0.175725	0.049847	0.454428	0.320000	CS pos: 13-14. LPG-CN. Pr: 0.4041    18
NZ_CP027599.1_131546	LIPO(Sec/SPII)	0.113915	0.023078	0.441635	0.421371	CS pos: 18-19. VMQ-CA. Pr: 0.3419    22
NZ_CP027599.1_131559	LIPO(Sec/SPII)	0.086376	0.046610	0.662289	0.204726	CS pos: 20-21. VTS-CP. Pr: 0.6429    35
NZ_CP027599.1_131565	SP(Sec/SPI)	0.461479	0.083738	0.165165	0.289618	CS pos: 37-38. ISA-NV. Pr: 0.1612    49
NZ_CP027599.1_131604	SP(Sec/SPI)	0.553884	0.025148	0.219549	0.201420	CS pos: 21-22. TSA-SG. Pr: 0.3008    40
NZ_CP027599.1_131608	LIPO(Sec/SPII)	0.075680	0.129564	0.441693	0.353062	CS pos: 23-24. ASA-CC. Pr: 0.3832    32
NZ_CP027599.1_131637	LIPO(Sec/SPII)	0.236863	0.006834	0.683183	0.073121	CS pos: 20-21. IIS-CY. Pr: 0.6692    27
NZ_CP027599.1_131666	SP(Sec/SPI)	0.429724	0.002571	0.313417	0.254288	CS pos: 24-25. VQS-PC. Pr: 0.0758    32
NZ_CP027599.1_131680	LIPO(Sec/SPII)	0.139332	0.006056	0.676887	0.177724	CS pos: 23-24. FNG-CC. Pr: 0.3338    33
NZ_CP027599.1_131715	LIPO(Sec/SPII)	0.256878	0.066129	0.350486	0.326507	CS pos: ?. Probable protein fragment    21
NZ_CP027599.1_131761	LIPO(Sec/SPII)	0.297698	0.008897	0.390095	0.303311	CS pos: ?. Probable protein fragment    20
NZ_CP027599.1_131763	LIPO(Sec/SPII)	0.118980	0.006889	0.708351	0.165781	CS pos: 18-19. VAS-CK. Pr: 0.6602    21
NZ_CP027599.1_131776	LIPO(Sec/SPII)	0.194968	0.005165	0.412113	0.387753	CS pos: 15-16. ILT-FH. Pr: 0.0168    17
NZ_CP027599.1_131781	LIPO(Sec/SPII)	0.126487	0.051695	0.492920	0.328898	CS pos: 24-25. IAA-CC. Pr: 0.3367    35
NZ_CP027599.1_131788	LIPO(Sec/SPII)	0.026375	0.000952	0.951839	0.020834	CS pos: 19-20. LLS-CR. Pr: 0.9449    35
NZ_CP027599.1_131791	SP(Sec/SPI)	0.318070	0.152012	0.248660	0.281258	CS pos: 23-24. GFA-RQ. Pr: 0.0841    44
NZ_CP027599.1_131854	LIPO(Sec/SPII)	0.161530	0.059374	0.458912	0.320184	CS pos: 16-17. TSP-CQ. Pr: 0.3930    33
NZ_CP027599.1_131857	SP(Sec/SPI)	0.427091	0.010694	0.374158	0.188057	CS pos: 17-18. LLQ-QS. Pr: 0.1382    29
NZ_CP027599.1_131858	SP(Sec/SPI)	0.373399	0.024151	0.248267	0.354184	CS pos: 18-19. VLA-PV. Pr: 0.1225    29
NZ_CP027599.1_131868	SP(Sec/SPI)	0.638252	0.186490	0.031194	0.144064	CS pos: 19-20. SFA-EP. Pr: 0.6089    28
NZ_CP027599.1_131869	SP(Sec/SPI)	0.783028	0.006811	0.186701	0.023461	CS pos: 21-22. AAA-RQ. Pr: 0.5793    48
NZ_CP027599.1_131884	SP(Sec/SPI)	0.610598	0.076599	0.068663	0.244139	CS pos: 22-23. SSA-IF. Pr: 0.2017    29
NZ_CP027599.1_131911	SP(Sec/SPI)	0.338807	0.066629	0.258186	0.336377	CS pos: ?. Probable protein fragment    24
NZ_CP027599.1_131914	TAT(Tat/SPI)	0.132692	0.426280	0.136051	0.304977	CS pos: ?. Probable protein fragment    18
NZ_CP027599.1_131918	LIPO(Sec/SPII)	0.264554	0.112201	0.522284	0.100961	CS pos: 16-17. STC-CS. Pr: 0.2396    38
NZ_CP027599.1_131942	LIPO(Sec/SPII)	0.207833	0.008585	0.493885	0.289697	CS pos: 13-14. VSA-CS. Pr: 0.3564    20
NZ_CP027599.1_131946	LIPO(Sec/SPII)	0.251315	0.013577	0.386520	0.348588	CS pos: ?. Probable protein fragment    18
NZ_CP027599.1_131955	LIPO(Sec/SPII)	0.158670	0.086814	0.572003	0.182513	CS pos: 23-24. LSG-CC. Pr: 0.4465    29
NZ_CP027599.1_131957	LIPO(Sec/SPII)	0.163714	0.005753	0.701590	0.128942	CS pos: 18-19. PYA-CS. Pr: 0.4980    24
NZ_CP027599.1_131964	SP(Sec/SPI)	0.429539	0.028915	0.182026	0.359520	CS pos: 20-21. SVA-RR. Pr: 0.2018    22
NZ_CP027599.1_131971	LIPO(Sec/SPII)	0.097200	0.008798	0.795524	0.098478	CS pos: 18-19. FTA-CR. Pr: 0.7568    20
NZ_CP027599.1_131976	SP(Sec/SPI)	0.556669	0.013563	0.072465	0.357304	CS pos: 19-20. GLT-AG. Pr: 0.1658    31
NZ_CP027599.1_132017	LIPO(Sec/SPII)	0.187841	0.045346	0.478938	0.287874	CS pos: 14-15. TFG-CL. Pr: 0.2756    17
NZ_CP027599.1_132051	SP(Sec/SPI)	0.844663	0.038776	0.059415	0.057146	CS pos: 19-20. VSA-SI. Pr: 0.6864    27
NZ_CP027599.1_132072	SP(Sec/SPI)	0.333930	0.025811	0.325663	0.314597	CS pos: 16-17. ASA-MV. Pr: 0.2068    19
NZ_CP027599.1_132464	SP(Sec/SPI)	0.404593	0.021879	0.211098	0.362431	CS pos: 22-23. VTA-GV. Pr: 0.2771    28
NZ_CP027599.1_132468	LIPO(Sec/SPII)	0.395806	0.014557	0.396883	0.192755	CS pos: 20-21. LLA-PG. Pr: 0.1690    36
NZ_CP027599.1_132484	SP(Sec/SPI)	0.435518	0.039054	0.114280	0.411148	CS pos: 19-20. VMP-AR. Pr: 0.1166    25
NZ_CP027599.1_132528	SP(Sec/SPI)	0.387851	0.065302	0.308613	0.238234	CS pos: 32-33. SLA-AC. Pr: 0.2546    35
NZ_CP027599.1_132607	SP(Sec/SPI)	0.581713	0.147734	0.117042	0.153511	CS pos: 31-32. IAA-KV. Pr: 0.4490    37
NZ_CP027599.1_132742	SP(Sec/SPI)	0.711225	0.061776	0.075387	0.151612	CS pos: 32-33. TTA-AN. Pr: 0.5891    44
NZ_CP027599.1_132772	LIPO(Sec/SPII)	0.082938	0.002454	0.845064	0.069544	CS pos: 14-15. FSA-CS. Pr: 0.8403    33
NZ_CP027599.1_132799	LIPO(Sec/SPII)	0.036800	0.001329	0.659407	0.302463	CS pos: 28-29. VSS-CL. Pr: 0.6141    35
NZ_CP027599.1_132824	LIPO(Sec/SPII)	0.180514	0.142340	0.409059	0.268087	CS pos: 13-14. TSS-CS. Pr: 0.3896    43
NZ_CP027599.1_132860	LIPO(Sec/SPII)	0.043949	0.002190	0.866384	0.087477	CS pos: 23-24. LRA-CE. Pr: 0.8495    45
NZ_CP027599.1_132873	LIPO(Sec/SPII)	0.147523	0.011398	0.668374	0.172705	CS pos: 16-17. MIS-CC. Pr: 0.4042    20
NZ_CP027599.1_132909	SP(Sec/SPI)	0.468990	0.004888	0.066159	0.459963	CS pos: 22-23. AYT-WY. Pr: 0.2137    39
NZ_CP027599.1_132949	LIPO(Sec/SPII)	0.270515	0.039544	0.383244	0.306698	CS pos: 12-13. LSC-CV. Pr: 0.0291    15
NZ_CP027599.1_132965	LIPO(Sec/SPII)	0.156254	0.021864	0.470784	0.351099	CS pos: 14-15. VVS-CN. Pr: 0.3865    18
NZ_CP027599.1_132984	LIPO(Sec/SPII)	0.038901	0.000700	0.761133	0.199266	CS pos: 18-19. FQV-CR. Pr: 0.7448    46
NZ_CP027599.1_133065	LIPO(Sec/SPII)	0.310436	0.013606	0.421735	0.254223	CS pos: ?. Probable protein fragment    17
NZ_CP027599.1_133106	LIPO(Sec/SPII)	0.248936	0.068527	0.367466	0.315071	CS pos: 17-18. ASA-CR. Pr: 0.3901    26
NZ_CP027599.1_133111	LIPO(Sec/SPII)	0.021352	0.001299	0.867769	0.109581	CS pos: 20-21. IFG-CT. Pr: 0.8690    34
NZ_CP027599.1_133117	LIPO(Sec/SPII)	0.249708	0.025742	0.375603	0.348948	CS pos: ?. Probable protein fragment    15
NZ_CP027599.1_133141	LIPO(Sec/SPII)	0.299714	0.006837	0.387693	0.305756	CS pos: 15-16. LAF-CA. Pr: 0.0914    20
NZ_CP027599.1_133150	LIPO(Sec/SPII)	0.018473	0.000579	0.835978	0.144970	CS pos: 20-21. VLA-CS. Pr: 0.8103    28
NZ_CP027599.1_133152	SP(Sec/SPI)	0.424557	0.033243	0.219881	0.322320	CS pos: 20-21. TPA-GQ. Pr: 0.1083    23
NZ_CP027599.1_133160	LIPO(Sec/SPII)	0.140092	0.001909	0.779481	0.078518	CS pos: 14-15. LSN-CR. Pr: 0.7061    18
NZ_CP027599.1_133203	LIPO(Sec/SPII)	0.079300	0.032781	0.642441	0.245478	CS pos: 14-15. FLA-CR. Pr: 0.6197    28
NZ_CP027599.1_133224	LIPO(Sec/SPII)	0.236544	0.034467	0.521769	0.207220	CS pos: 15-16. TYS-CT. Pr: 0.5417    39
NZ_CP027599.1_133264	LIPO(Sec/SPII)	0.390609	0.003249	0.408356	0.197786	CS pos: 18-19. WLF-CS. Pr: 0.1121    28
NZ_CP027599.1_133288	LIPO(Sec/SPII)	0.266701	0.018158	0.372793	0.342348	CS pos: 15-16. SIS-ME. Pr: 0.0328    17
NZ_CP027599.1_133291	LIPO(Sec/SPII)	0.210992	0.005460	0.567719	0.215829	CS pos: 16-17. NIS-CI. Pr: 0.2883    22
NZ_CP027599.1_133301	LIPO(Sec/SPII)	0.155711	0.066474	0.566615	0.211200	CS pos: 14-15. ASA-CG. Pr: 0.5615    45
NZ_CP027599.1_133316	LIPO(Sec/SPII)	0.126217	0.005071	0.691436	0.177275	CS pos: 16-17. MTN-CS. Pr: 0.4580    39
NZ_CP027599.1_133323	SP(Sec/SPI)	0.800656	0.114982	0.012799	0.071564	CS pos: 21-22. AFA-HP. Pr: 0.8028    48
NZ_CP027599.1_133330	LIPO(Sec/SPII)	0.126226	0.024933	0.484750	0.364092	CS pos: 20-21. QQS-CL. Pr: 0.4177    25
NZ_CP027599.1_133361	SP(Sec/SPI)	0.522936	0.158889	0.019047	0.299128	CS pos: 24-25. THA-SP. Pr: 0.5120    49
NZ_CP027599.1_133364	LIPO(Sec/SPII)	0.062234	0.053346	0.569453	0.314967	CS pos: 20-21. ATA-CH. Pr: 0.5546    42
NZ_CP027599.1_133384	LIPO(Sec/SPII)	0.066444	0.002525	0.607979	0.323052	CS pos: 20-21. IAS-CG. Pr: 0.5867    33
NZ_CP027599.1_133388	LIPO(Sec/SPII)	0.188299	0.043449	0.428166	0.340086	CS pos: 15-16. VIT-CG. Pr: 0.3206    18
NZ_CP027599.1_133395	SP(Sec/SPI)	0.590734	0.009021	0.036287	0.363959	CS pos: 17-18. SDA-LN. Pr: 0.5493    49
NZ_CP027599.1_133406	SP(Sec/SPI)	0.447342	0.033948	0.208134	0.310576	CS pos: 27-28. SGA-SQ. Pr: 0.1519    37
NZ_CP027599.1_133415	SP(Sec/SPI)	0.406890	0.022867	0.225347	0.344897	CS pos: 17-18. IAA-SV. Pr: 0.1199    32
NZ_CP027599.1_133429	SP(Sec/SPI)	0.413302	0.142152	0.088553	0.355993	CS pos: 18-19. ANA-GS. Pr: 0.2828    28
NZ_CP027599.1_133431	SP(Sec/SPI)	0.483248	0.015250	0.083337	0.418165	CS pos: 19-20. VYR-ER. Pr: 0.3257    27
NZ_CP027599.1_133434	SP(Sec/SPI)	0.539593	0.083731	0.060182	0.316494	CS pos: 18-19. VRS-VP. Pr: 0.2962    35
NZ_CP027599.1_133447	SP(Sec/SPI)	0.435188	0.026309	0.374692	0.163812	CS pos: 12-13. ATA-AP. Pr: 0.0868    17
NZ_CP027599.1_133465	LIPO(Sec/SPII)	0.256696	0.056316	0.385720	0.301268	CS pos: 15-16. TAI-CS. Pr: 0.0481    21
NZ_CP027599.1_133490	LIPO(Sec/SPII)	0.301006	0.009136	0.408270	0.281588	CS pos: 11-12. LHA-CI. Pr: 0.0918    17
NZ_CP027599.1_133493	SP(Sec/SPI)	0.870858	0.037039	0.067075	0.025029	CS pos: 21-22. ARS-SA. Pr: 0.3749    33
NZ_CP027599.1_133527	SP(Sec/SPI)	0.401358	0.147602	0.063027	0.388013	CS pos: 24-25. TVA-SP. Pr: 0.1298    43
NZ_CP027599.1_133561	SP(Sec/SPI)	0.358120	0.159820	0.308711	0.173348	CS pos: 15-16. ASA-MA. Pr: 0.0410    17
NZ_CP027599.1_133563	SP(Sec/SPI)	0.495495	0.082575	0.112375	0.309555	CS pos: 21-22. VAA-VN. Pr: 0.2494    27
NZ_CP027599.1_133585	SP(Sec/SPI)	0.426747	0.095106	0.126221	0.351926	CS pos: 16-17. SEA-FC. Pr: 0.2328    18
NZ_CP027599.1_133596	LIPO(Sec/SPII)	0.054742	0.000219	0.944650	0.000389	CS pos: 17-18. ISS-CQ. Pr: 0.9450    41
NZ_CP027599.1_133599	LIPO(Sec/SPII)	0.165619	0.013020	0.758588	0.062773	CS pos: 15-16. VLA-CN. Pr: 0.7384    29
NZ_CP027599.1_133600	SP(Sec/SPI)	0.415468	0.006736	0.392199	0.185596	CS pos: 19-20. IVA-KC. Pr: 0.2289    39
NZ_CP027599.1_133649	SP(Sec/SPI)	0.866108	0.029584	0.026282	0.078026	CS pos: 20-21. VTA-DG. Pr: 0.8056    31
NZ_CP027599.1_133668	SP(Sec/SPI)	0.853071	0.052180	0.063936	0.030813	CS pos: 21-22. SSA-AG. Pr: 0.3652    30
NZ_CP027599.1_133674	LIPO(Sec/SPII)	0.026928	0.002243	0.913777	0.057051	CS pos: 14-15. MTG-CS. Pr: 0.9045    20
NZ_CP027599.1_133677	LIPO(Sec/SPII)	0.122897	0.010904	0.573855	0.292344	CS pos: 21-22. DIS-CR. Pr: 0.5175    33
NZ_CP027599.1_133692	LIPO(Sec/SPII)	0.263449	0.032982	0.356178	0.347391	CS pos: ?. Probable protein fragment    20
NZ_CP027599.1_133739	LIPO(Sec/SPII)	0.123232	0.132536	0.652553	0.091679	CS pos: 18-19. ALS-CA. Pr: 0.5963    41
NZ_CP027599.1_133748	LIPO(Sec/SPII)	0.309440	0.013771	0.490877	0.185912	CS pos: 17-18. QSA-CG. Pr: 0.4899    48
NZ_CP027599.1_133750	LIPO(Sec/SPII)	0.355997	0.004975	0.503632	0.135395	CS pos: 19-20. ISS-QL. Pr: 0.1983    33
NZ_CP027599.1_133765	LIPO(Sec/SPII)	0.060597	0.039603	0.465155	0.434645	CS pos: 15-16. LFA-CN. Pr: 0.4486    39
NZ_CP027599.1_133785	LIPO(Sec/SPII)	0.149396	0.021291	0.421821	0.407492	CS pos: 19-20. STC-CI. Pr: 0.1936    27
NZ_CP027599.1_133807	LIPO(Sec/SPII)	0.227442	0.019189	0.454747	0.298622	CS pos: 20-21. ISQ-CL. Pr: 0.3225    26
NZ_CP027599.1_133890	LIPO(Sec/SPII)	0.084487	0.001754	0.536497	0.377262	CS pos: 19-20. VDG-CK. Pr: 0.5997    41
NZ_CP027599.1_133973	LIPO(Sec/SPII)	0.268093	0.001780	0.433784	0.296344	CS pos: 18-19. AVN-CY. Pr: 0.3944    28
NZ_CP027599.1_133989	LIPO(Sec/SPII)	0.108883	0.030862	0.571779	0.288476	CS pos: 9-10. STA-CT. Pr: 0.5495    25
NZ_CP027599.1_134002	SP(Sec/SPI)	0.320985	0.194752	0.217514	0.266749	CS pos: 17-18. ALA-RP. Pr: 0.1790    22
NZ_CP027599.1_134004	LIPO(Sec/SPII)	0.256603	0.004216	0.433935	0.305247	CS pos: ?. Probable protein fragment    22
NZ_CP027599.1_134026	LIPO(Sec/SPII)	0.157990	0.011342	0.774928	0.055740	CS pos: 17-18. VTQ-CT. Pr: 0.7517    40
NZ_CP027599.1_134083	LIPO(Sec/SPII)	0.297804	0.052393	0.369140	0.280662	CS pos: 10-11. TLA-CS. Pr: 0.2370    17
NZ_CP027599.1_134093	LIPO(Sec/SPII)	0.272300	0.035451	0.409797	0.282451	CS pos: 15-16. AAI-CS. Pr: 0.2353    20
NZ_CP027599.1_134096	LIPO(Sec/SPII)	0.169572	0.023745	0.466243	0.340440	CS pos: 16-17. VSA-CY. Pr: 0.5307    22
NZ_CP027599.1_134122	LIPO(Sec/SPII)	0.122022	0.034973	0.465443	0.377562	CS pos: 15-16. MPA-CN. Pr: 0.4332    21
NZ_CP027599.1_134127	SP(Sec/SPI)	0.387338	0.097358	0.243318	0.271987	CS pos: ?. Probable protein fragment    23
NZ_CP027599.1_134128	LIPO(Sec/SPII)	0.058897	0.009372	0.612211	0.319521	CS pos: 26-27. TSS-CR. Pr: 0.5753    38
NZ_CP027599.1_134134	LIPO(Sec/SPII)	0.336422	0.021692	0.408003	0.233883	CS pos: 14-15. AGY-CA. Pr: 0.0613    17
NZ_CP027599.1_134148	LIPO(Sec/SPII)	0.181420	0.001874	0.792273	0.024434	CS pos: 19-20. AAR-CH. Pr: 0.6630    40
NZ_CP027599.1_134162	LIPO(Sec/SPII)	0.330198	0.160416	0.433528	0.075858	CS pos: 21-22. TVS-CG. Pr: 0.3322    27
NZ_CP027599.1_134236	LIPO(Sec/SPII)	0.180717	0.016753	0.409904	0.392627	CS pos: 15-16. NQA-CH. Pr: 0.2610    23
NZ_CP027599.1_134256	LIPO(Sec/SPII)	0.456933	0.033093	0.460525	0.049450	CS pos: 20-21. AAA-CA. Pr: 0.4984    35
NZ_CP027599.1_134258	TAT(Tat/SPI)	0.289927	0.341862	0.076780	0.291431	CS pos: 23-24. SFA-SS. Pr: 0.2936    35
NZ_CP027599.1_134270	TAT(Tat/SPI)	0.219806	0.427396	0.051015	0.301782	CS pos: 32-33. APA-PS. Pr: 0.1581    40
NZ_CP027599.1_134273	SP(Sec/SPI)	0.471000	0.015099	0.049975	0.463926	CS pos: 22-23. ARA-FK. Pr: 0.4209    30
NZ_CP027599.1_134282	SP(Sec/SPI)	0.390333	0.057119	0.368961	0.183587	CS pos: ?. Probable protein fragment    34
NZ_CP027599.1_134284	SP(Sec/SPI)	0.492705	0.111875	0.313237	0.082183	CS pos: 25-26. ARS-NE. Pr: 0.2988    29
NZ_CP027599.1_134407	LIPO(Sec/SPII)	0.143288	0.034025	0.464642	0.358045	CS pos: 24-25. LMS-CV. Pr: 0.4106    28
NZ_CP027599.1_134434	SP(Sec/SPI)	0.491955	0.011521	0.171704	0.324820	CS pos: 19-20. IRS-KN. Pr: 0.3757    26
NZ_CP027599.1_134441	SP(Sec/SPI)	0.454746	0.010748	0.273095	0.261411	CS pos: 16-17. WHA-GQ. Pr: 0.1810    29
NZ_CP027599.1_134536	LIPO(Sec/SPII)	0.153888	0.053245	0.475872	0.316996	CS pos: 13-14. WLA-CA. Pr: 0.2211    36
NZ_CP027599.1_134551	SP(Sec/SPI)	0.428573	0.129206	0.312217	0.130003	CS pos: 23-24. VCA-TE. Pr: 0.2691    34
NZ_CP027599.1_134579	SP(Sec/SPI)	0.433830	0.022366	0.348262	0.195542	CS pos: 17-18. IYA-TM. Pr: 0.3693    28
NZ_CP027599.1_134601	LIPO(Sec/SPII)	0.153707	0.040590	0.665408	0.140295	CS pos: 17-18. ASA-CG. Pr: 0.6372    23
NZ_CP027599.1_134604	LIPO(Sec/SPII)	0.319923	0.100761	0.323417	0.255899	CS pos: 24-25. SAR-CG. Pr: 0.1991    31
NZ_CP027599.1_134605	TAT(Tat/SPI)	0.334482	0.363485	0.040390	0.261643	CS pos: 20-21. ARG-FS. Pr: 0.4314    37
NZ_CP027599.1_134611	LIPO(Sec/SPII)	0.086083	0.009724	0.589750	0.314442	CS pos: 27-28. LLG-CH. Pr: 0.5647    30
NZ_CP027599.1_134613	LIPO(Sec/SPII)	0.228444	0.009274	0.682798	0.079485	CS pos: 20-21. FSV-CW. Pr: 0.4496    29
NZ_CP027599.1_134617	SP(Sec/SPI)	0.541595	0.020815	0.323443	0.114146	CS pos: 16-17. AAA-KP. Pr: 0.4090    24
NZ_CP027599.1_134646	LIPO(Sec/SPII)	0.303568	0.024198	0.372839	0.299394	CS pos: ?. Probable protein fragment    16
NZ_CP027599.1_134651	LIPO(Sec/SPII)	0.107441	0.030188	0.466399	0.395972	CS pos: 15-16. LIA-CV. Pr: 0.4144    23
NZ_CP027599.1_134726	TAT(Tat/SPI)	0.072819	0.551105	0.027721	0.348355	CS pos: 27-28. AYA-AG. Pr: 0.3452    45
NZ_CP027599.1_134737	LIPO(Sec/SPII)	0.082813	0.011184	0.702102	0.203901	CS pos: 10-11. ASG-CC. Pr: 0.6113    27
NZ_CP027599.1_134743	SP(Sec/SPI)	0.523869	0.007633	0.309195	0.159303	CS pos: 25-26. CLA-AM. Pr: 0.3168    50
NZ_CP027599.1_134756	LIPO(Sec/SPII)	0.159092	0.021874	0.443578	0.375456	CS pos: 14-15. NMA-CG. Pr: 0.3797    29
NZ_CP027599.1_134758	SP(Sec/SPI)	0.378494	0.098149	0.234345	0.289012	CS pos: 18-19. AAG-ER. Pr: 0.1777    43
NZ_CP027599.1_134774	LIPO(Sec/SPII)	0.257791	0.013673	0.406818	0.321718	CS pos: 21-22. SLL-CG. Pr: 0.1663    29
NZ_CP027599.1_134782	LIPO(Sec/SPII)	0.097506	0.001074	0.667641	0.233779	CS pos: 22-23. LVN-CH. Pr: 0.5931    24
NZ_CP027599.1_134823	LIPO(Sec/SPII)	0.016386	0.002237	0.972651	0.008726	CS pos: 18-19. LLA-CS. Pr: 0.6466    30
NZ_CP027599.1_134833	LIPO(Sec/SPII)	0.027747	0.007816	0.868868	0.095569	CS pos: 20-21. FVS-CC. Pr: 0.6369    39
NZ_CP027599.1_134858	LIPO(Sec/SPII)	0.172423	0.007277	0.525131	0.295170	CS pos: 14-15. YLT-CR. Pr: 0.4189    22
NZ_CP027599.1_134871	TAT(Tat/SPI)	0.120416	0.486963	0.008313	0.384308	CS pos: 38-39. ADA-TP. Pr: 0.4442    43
NZ_CP027599.1_134872	SP(Sec/SPI)	0.961752	0.008963	0.025435	0.003849	CS pos: 17-18. ATA-AK. Pr: 0.8215    30
NZ_CP027599.1_134892	LIPO(Sec/SPII)	0.252046	0.002059	0.671617	0.074278	CS pos: 12-13. LAS-CG. Pr: 0.5281    19
NZ_CP027599.1_134965	LIPO(Sec/SPII)	0.114429	0.006291	0.581552	0.297729	CS pos: 27-28. GLC-CT. Pr: 0.3344    33
NZ_CP027599.1_134980	SP(Sec/SPI)	0.423166	0.138716	0.039486	0.398632	CS pos: 22-23. LNA-SD. Pr: 0.2989    50
NZ_CP027599.1_134989	LIPO(Sec/SPII)	0.200932	0.022614	0.407782	0.368671	CS pos: ?. Probable protein fragment    17
NZ_CP027599.1_135022	SP(Sec/SPI)	0.873904	0.044048	0.029079	0.052970	CS pos: 26-27. SFA-ET. Pr: 0.8612    31
NZ_CP027599.1_135054	SP(Sec/SPI)	0.536388	0.019753	0.079565	0.364293	CS pos: 23-24. PEA-VI. Pr: 0.1299    42
NZ_CP027599.1_135098	SP(Sec/SPI)	0.419926	0.064761	0.122866	0.392448	CS pos: 35-36. SLA-ED. Pr: 0.1958    39
NZ_CP027599.1_135104	SP(Sec/SPI)	0.409199	0.047231	0.363327	0.180244	CS pos: 16-17. AIA-IN. Pr: 0.2425    34
NZ_CP027599.1_135119	LIPO(Sec/SPII)	0.059978	0.004388	0.855726	0.079908	CS pos: 17-18. SLS-CP. Pr: 0.8512    28
NZ_CP027599.1_135123	SP(Sec/SPI)	0.383630	0.289926	0.240280	0.086164	CS pos: 27-28. VSG-AP. Pr: 0.3637    44
NZ_CP027599.1_135125	SP(Sec/SPI)	0.479569	0.067734	0.204155	0.248542	CS pos: 19-20. TSA-TI. Pr: 0.3478    26
NZ_CP027599.1_135127	SP(Sec/SPI)	0.545805	0.097255	0.079903	0.277036	CS pos: 13-14. AAA-IT. Pr: 0.2358    36
NZ_CP027599.1_135130	SP(Sec/SPI)	0.740420	0.075468	0.116423	0.067689	CS pos: 21-22. ASA-IP. Pr: 0.2841    39
NZ_CP027599.1_135133	LIPO(Sec/SPII)	0.070785	0.001109	0.920243	0.007864	CS pos: 17-18. GMA-CT. Pr: 0.9174    32
NZ_CP027599.1_135155	LIPO(Sec/SPII)	0.051287	0.034952	0.734071	0.179691	CS pos: 19-20. SMA-CF. Pr: 0.7512    40
NZ_CP027599.1_135166	LIPO(Sec/SPII)	0.044174	0.019423	0.871838	0.064565	CS pos: 17-18. FAS-CM. Pr: 0.8660    29
NZ_CP027599.1_135173	LIPO(Sec/SPII)	0.248777	0.022562	0.502980	0.225680	CS pos: ?. Probable protein fragment    16
NZ_CP027599.1_135180	LIPO(Sec/SPII)	0.306371	0.010145	0.481553	0.201930	CS pos: 17-18. LAG-AA. Pr: 0.0705    19
NZ_CP027599.1_135205	LIPO(Sec/SPII)	0.259958	0.037352	0.413925	0.288765	CS pos: 12-13. VTN-CR. Pr: 0.0841    15
NZ_CP027599.1_135256	SP(Sec/SPI)	0.360416	0.240575	0.173110	0.225899	CS pos: ?. Probable protein fragment    27
NZ_CP027599.1_135258	SP(Sec/SPI)	0.616246	0.056489	0.105406	0.221859	CS pos: 19-20. SAP-AP. Pr: 0.1121    30
NZ_CP027599.1_135271	LIPO(Sec/SPII)	0.158256	0.229569	0.368834	0.243340	CS pos: 19-20. RSA-CG. Pr: 0.3261    50
NZ_CP027599.1_135284	SP(Sec/SPI)	0.395509	0.050816	0.182282	0.371393	CS pos: 18-19. AMA-AS. Pr: 0.2583    36
NZ_CP027599.1_135292	SP(Sec/SPI)	0.433500	0.397511	0.040592	0.128398	CS pos: 29-30. ARA-AD. Pr: 0.6398    32
NZ_CP027599.1_135309	LIPO(Sec/SPII)	0.268521	0.022257	0.463437	0.245785	CS pos: ?. Probable protein fragment    20
NZ_CP027599.1_135310	SP(Sec/SPI)	0.633531	0.191850	0.038479	0.136140	CS pos: 16-17. ASA-AP. Pr: 0.5379    33
NZ_CP027599.1_135316	TAT(Tat/SPI)	0.265227	0.507356	0.019392	0.208026	CS pos: 42-43. AFA-WR. Pr: 0.4359    48
NZ_CP027599.1_135336	TAT(Tat/SPI)	0.256465	0.470071	0.029131	0.244333	CS pos: 25-26. AYA-RG. Pr: 0.4597    42
NZ_CP027599.1_135365	SP(Sec/SPI)	0.362605	0.052639	0.236298	0.348457	CS pos: 29-30. SRC-QL. Pr: 0.1087    39
NZ_CP027599.1_135379	LIPO(Sec/SPII)	0.100590	0.010300	0.640470	0.248640	CS pos: 31-32. CLG-CT. Pr: 0.5946    40
NZ_CP027599.1_135388	LIPO(Sec/SPII)	0.036496	0.010762	0.760520	0.192221	CS pos: 16-17. VTG-CR. Pr: 0.7391    28
NZ_CP027599.1_135391	LIPO(Sec/SPII)	0.038933	0.018494	0.871506	0.071067	CS pos: 19-20. TTS-CG. Pr: 0.8681    39
NZ_CP027599.1_135406	LIPO(Sec/SPII)	0.077465	0.007823	0.715581	0.199131	CS pos: 20-21. PVS-CD. Pr: 0.6727    23
NZ_CP027599.1_135409	LIPO(Sec/SPII)	0.069545	0.011120	0.483135	0.436199	CS pos: 21-22. YLS-CA. Pr: 0.4423    42
NZ_CP027599.1_135510	LIPO(Sec/SPII)	0.265926	0.027456	0.368959	0.337658	CS pos: ?. Probable protein fragment    16
NZ_CP027599.1_135557	SP(Sec/SPI)	0.416942	0.067216	0.126016	0.389826	CS pos: 17-18. TKS-II. Pr: 0.0846    23
NZ_CP027599.1_135581	SP(Sec/SPI)	0.422543	0.008735	0.289998	0.278724	CS pos: 19-20. SLA-DY. Pr: 0.1819    22
NZ_CP027599.1_135592	LIPO(Sec/SPII)	0.357262	0.031140	0.496017	0.115581	CS pos: 17-18. STL-CP. Pr: 0.2727    22
NZ_CP027599.1_135601	LIPO(Sec/SPII)	0.234117	0.028893	0.588113	0.148877	CS pos: 15-16. SAG-CA. Pr: 0.4918    24
NZ_CP027599.1_135631	TAT(Tat/SPI)	0.271240	0.463603	0.009969	0.255187	CS pos: 37-38. ARA-AP. Pr: 0.3746    50
NZ_CP027599.1_135644	SP(Sec/SPI)	0.378662	0.201472	0.110029	0.309837	CS pos: 25-26. SIA-AP. Pr: 0.2678    41
NZ_CP027599.1_135674	LIPO(Sec/SPII)	0.268763	0.017582	0.426995	0.286660	CS pos: ?. Probable protein fragment    15
NZ_CP027599.1_135686	LIPO(Sec/SPII)	0.196503	0.014359	0.512086	0.277052	CS pos: 16-17. PNC-CN. Pr: 0.4042    35
NZ_CP027599.1_135698	LIPO(Sec/SPII)	0.258156	0.024928	0.365891	0.351025	CS pos: ?. Probable protein fragment    17
NZ_CP027599.1_135718	SP(Sec/SPI)	0.581451	0.041308	0.058540	0.318700	CS pos: 24-25. SLS-DE. Pr: 0.3822    35
NZ_CP027599.1_135742	TAT(Tat/SPI)	0.239682	0.685081	0.028426	0.046810	CS pos: 32-33. SSA-EP. Pr: 0.5495    49
NZ_CP027599.1_135831	LIPO(Sec/SPII)	0.123490	0.013738	0.601609	0.261163	CS pos: 17-18. LIS-CV. Pr: 0.5042    19
NZ_CP027599.1_135837	SP(Sec/SPI)	0.416812	0.018787	0.305615	0.258785	CS pos: 17-18. TSG-GT. Pr: 0.1441    21
NZ_CP027599.1_136112	LIPO(Sec/SPII)	0.233536	0.028703	0.505851	0.231909	CS pos: 13-14. LSG-CL. Pr: 0.2780    18
NZ_CP027599.1_136140	SP(Sec/SPI)	0.416680	0.026005	0.155940	0.401375	CS pos: 22-23. VLQ-RR. Pr: 0.1743    24
NZ_CP027599.1_136162	SP(Sec/SPI)	0.736524	0.004036	0.189812	0.069628	CS pos: 19-20. ILA-ES. Pr: 0.7262    43
NZ_CP027599.1_136165	LIPO(Sec/SPII)	0.212785	0.046998	0.454494	0.285722	CS pos: 17-18. KTG-CG. Pr: 0.4059    25
NZ_CP027599.1_136185	LIPO(Sec/SPII)	0.141000	0.011851	0.518466	0.328682	CS pos: 19-20. IIN-CS. Pr: 0.5004    48
NZ_CP027599.1_136213	SP(Sec/SPI)	0.371475	0.006629	0.336422	0.285474	CS pos: ?. Probable protein fragment    19
NZ_CP027599.1_136224	LIPO(Sec/SPII)	0.033526	0.005098	0.842326	0.119050	CS pos: 17-18. LPG-CN. Pr: 0.8157    39
NZ_CP027599.1_136253	LIPO(Sec/SPII)	0.154935	0.021468	0.487770	0.335826	CS pos: ?. Probable protein fragment    28
NZ_CP027599.1_136264	LIPO(Sec/SPII)	0.278822	0.016238	0.391229	0.313711	CS pos: ?. Probable protein fragment    15
NZ_CP027599.1_136288	LIPO(Sec/SPII)	0.228019	0.033852	0.436443	0.301687	CS pos: 22-23. TNS-CT. Pr: 0.2434    27
NZ_CP027599.1_136291	TAT(Tat/SPI)	0.147023	0.547265	0.040179	0.265532	CS pos: 29-30. SES-QT. Pr: 0.1149    39
NZ_CP027599.1_136320	LIPO(Sec/SPII)	0.362314	0.006960	0.398020	0.232707	CS pos: 20-21. TFP-VW. Pr: 0.0311    22
NZ_CP027599.1_136344	SP(Sec/SPI)	0.448089	0.073589	0.106834	0.371488	CS pos: 16-17. SNA-SW. Pr: 0.3834    30
NZ_CP027599.1_136350	TAT(Tat/SPI)	0.254829	0.345669	0.070421	0.329081	CS pos: 31-32. MPA-ES. Pr: 0.0822    35
NZ_CP027599.1_136352	LIPO(Sec/SPII)	0.259573	0.044268	0.356781	0.339377	CS pos: ?. Probable protein fragment    17
NZ_CP027599.1_136386	LIPO(Sec/SPII)	0.255892	0.045851	0.412271	0.285986	CS pos: 12-13. GAG-CP. Pr: 0.1516    15
NZ_CP027599.1_136416	SP(Sec/SPI)	0.768932	0.141319	0.032568	0.057181	CS pos: 23-24. ANA-EN. Pr: 0.6875    28
NZ_CP027599.1_136462	TAT(Tat/SPI)	0.057382	0.394054	0.359079	0.189485	CS pos: 34-35. LDA-AT. Pr: 0.1761    37
NZ_CP027599.1_136474	LIPO(Sec/SPII)	0.017251	0.001549	0.890380	0.090820	CS pos: 13-14. LTG-CD. Pr: 0.8939    50
NZ_CP027599.1_136554	SP(Sec/SPI)	0.549737	0.023936	0.309509	0.116818	CS pos: 26-27. AMA-NV. Pr: 0.3019    28
NZ_CP027599.1_136561	LIPO(Sec/SPII)	0.202247	0.012862	0.430704	0.354187	CS pos: 17-18. TTR-CI. Pr: 0.1754    19
NZ_CP027599.1_136582	LIPO(Sec/SPII)	0.291286	0.000866	0.587312	0.120536	CS pos: 18-19. QIQ-CN. Pr: 0.5694    34
NZ_CP027599.1_136632	LIPO(Sec/SPII)	0.226390	0.016377	0.419920	0.337313	CS pos: ?. Probable protein fragment    17
NZ_CP027599.1_136663	LIPO(Sec/SPII)	0.078605	0.007197	0.619337	0.294862	CS pos: 16-17. NSS-CS. Pr: 0.6087    34
NZ_CP027599.1_136677	LIPO(Sec/SPII)	0.089511	0.008255	0.877459	0.024774	CS pos: 22-23. LSN-CA. Pr: 0.8598    36
NZ_CP027599.1_136678	LIPO(Sec/SPII)	0.118821	0.005536	0.442783	0.432860	CS pos: 15-16. LLR-CE. Pr: 0.3836    20
NZ_CP027599.1_136700	LIPO(Sec/SPII)	0.106726	0.007890	0.838286	0.047097	CS pos: 14-15. ISA-CS. Pr: 0.8126    18
NZ_CP027599.1_136715	SP(Sec/SPI)	0.394960	0.189854	0.190622	0.224565	CS pos: 20-21. TNG-LS. Pr: 0.1017    40
NZ_CP027599.1_136719	LIPO(Sec/SPII)	0.251338	0.131368	0.316684	0.300610	CS pos: 15-16. ISS-TM. Pr: 0.0278    18
NZ_CP027599.1_136731	SP(Sec/SPI)	0.513915	0.044168	0.172115	0.269802	CS pos: 14-15. THA-SS. Pr: 0.2566    18
NZ_CP027599.1_136751	TAT(Tat/SPI)	0.250362	0.459457	0.011815	0.278366	CS pos: 30-31. SFA-AV. Pr: 0.5964    38
NZ_CP027599.1_136761	SP(Sec/SPI)	0.488563	0.286227	0.067268	0.157941	CS pos: 22-23. VSA-TI. Pr: 0.6051    32
NZ_CP027599.1_136770	LIPO(Sec/SPII)	0.263878	0.157318	0.340734	0.238071	CS pos: 21-22. VFC-CA. Pr: 0.1084    29
NZ_CP027599.1_136776	LIPO(Sec/SPII)	0.214942	0.051767	0.390755	0.342537	CS pos: 15-16. QSA-CS. Pr: 0.3836    22
NZ_CP027599.1_136783	LIPO(Sec/SPII)	0.129915	0.083952	0.724799	0.061334	CS pos: 18-19. LLC-CF. Pr: 0.4451    41
NZ_CP027599.1_136788	LIPO(Sec/SPII)	0.283454	0.008847	0.544780	0.162918	CS pos: ?. Probable protein fragment    15
NZ_CP027599.1_136792	SP(Sec/SPI)	0.364878	0.191242	0.092994	0.350886	CS pos: 19-20. TNA-ST. Pr: 0.0840    44
NZ_CP027599.1_136815	SP(Sec/SPI)	0.438536	0.030251	0.179672	0.351541	CS pos: 18-19. ATA-TI. Pr: 0.2845    23
NZ_CP027599.1_136816	SP(Sec/SPI)	0.601598	0.127622	0.031074	0.239706	CS pos: 20-21. ARA-NA. Pr: 0.3765    24
NZ_CP027599.1_136824	TAT(Tat/SPI)	0.093461	0.649497	0.102257	0.154785	CS pos: 18-19. RQC-SN. Pr: 0.0957    22
NZ_CP027599.1_136851	LIPO(Sec/SPII)	0.121083	0.048940	0.661475	0.168502	CS pos: 21-22. TVS-CS. Pr: 0.6087    32
NZ_CP027599.1_136872	TAT(Tat/SPI)	0.293952	0.330849	0.077542	0.297657	CS pos: 21-22. SNA-AS. Pr: 0.2983    37
NZ_CP027599.1_136883	LIPO(Sec/SPII)	0.183427	0.064516	0.419519	0.332538	CS pos: 17-18. GAS-CP. Pr: 0.4074    49
NZ_CP027599.1_136887	SP(Sec/SPI)	0.601219	0.284891	0.026698	0.087192	CS pos: 26-27. SHA-GN. Pr: 0.7198    48
NZ_CP027599.1_136929	SP(Sec/SPI)	0.479616	0.090827	0.209654	0.219903	CS pos: 27-28. ASA-TT. Pr: 0.3785    34
NZ_CP027599.1_136965	TAT(Tat/SPI)	0.188833	0.365542	0.138177	0.307448	CS pos: 17-18. LAG-WE. Pr: 0.0564    19
NZ_CP027599.1_136984	SP(Sec/SPI)	0.668416	0.016902	0.151707	0.162974	CS pos: 15-16. AFC-HS. Pr: 0.4162    23
NZ_CP027599.1_136985	LIPO(Sec/SPII)	0.126791	0.009663	0.699430	0.164117	CS pos: 12-13. TTG-CW. Pr: 0.6351    17
NZ_CP027599.1_136988	LIPO(Sec/SPII)	0.053049	0.002727	0.897216	0.047009	CS pos: 21-22. FSS-CS. Pr: 0.8365    29
NZ_CP027599.1_136990	SP(Sec/SPI)	0.392182	0.239353	0.070277	0.298188	CS pos: 27-28. SLA-FS. Pr: 0.4126    33
NZ_CP027599.1_136999	LIPO(Sec/SPII)	0.230611	0.026617	0.374648	0.368124	CS pos: ?. Probable protein fragment    15
NZ_CP027599.1_137006	SP(Sec/SPI)	0.607370	0.138940	0.083785	0.169905	CS pos: 22-23. SPA-DS. Pr: 0.1978    29
NZ_CP027599.1_137043	SP(Sec/SPI)	0.437206	0.252189	0.041686	0.268919	CS pos: 25-26. SSA-TA. Pr: 0.1825    37
NZ_CP027599.1_137057	SP(Sec/SPI)	0.419915	0.195550	0.089744	0.294791	CS pos: 25-26. AQP-AG. Pr: 0.0725    49
NZ_CP027599.1_137075	LIPO(Sec/SPII)	0.171251	0.062119	0.662827	0.103803	CS pos: 19-20. TCA-CP. Pr: 0.3741    50
NZ_CP027599.1_137088	LIPO(Sec/SPII)	0.181267	0.012397	0.449411	0.356924	CS pos: 23-24. VKS-CG. Pr: 0.4026    25
NZ_CP027599.1_137092	TAT(Tat/SPI)	0.147797	0.443938	0.043840	0.364425	CS pos: 32-33. LHA-GT. Pr: 0.3071    41
NZ_CP027599.1_137097	TAT(Tat/SPI)	0.068973	0.495073	0.028174	0.407780	CS pos: 36-37. ILS-CG. Pr: 0.0632    50
NZ_CP027599.1_137103	TAT(Tat/SPI)	0.119835	0.511201	0.023710	0.345255	CS pos: 32-33. INA-AV. Pr: 0.3620    34
NZ_CP027599.1_137129	LIPO(Sec/SPII)	0.255707	0.011551	0.527501	0.205241	CS pos: ?. Probable protein fragment    18
NZ_CP027599.1_137133	LIPO(Sec/SPII)	0.142682	0.004106	0.467670	0.385541	CS pos: 22-23. GVA-CR. Pr: 0.4079    41
NZ_CP027599.1_137138	LIPO(Sec/SPII)	0.098104	0.021697	0.685222	0.194977	CS pos: 13-14. CSS-CM. Pr: 0.4218    42
NZ_CP027599.1_137140	LIPO(Sec/SPII)	0.318004	0.032514	0.373385	0.276097	CS pos: ?. Probable protein fragment    15
NZ_CP027599.1_137153	LIPO(Sec/SPII)	0.180471	0.007693	0.438718	0.373118	CS pos: 22-23. TAS-CR. Pr: 0.2842    25
NZ_CP027599.1_137160	LIPO(Sec/SPII)	0.295261	0.005407	0.536999	0.162333	CS pos: 17-18. APT-CR. Pr: 0.3040    21
NZ_CP027599.1_137165	LIPO(Sec/SPII)	0.067121	0.010312	0.696430	0.226137	CS pos: 17-18. FIA-CS. Pr: 0.6879    37
NZ_CP027599.1_137195	LIPO(Sec/SPII)	0.287967	0.012287	0.514551	0.185195	CS pos: 17-18. LSD-CQ. Pr: 0.3448    19
NZ_CP027599.1_137206	SP(Sec/SPI)	0.733562	0.013653	0.158818	0.093967	CS pos: 18-19. ISG-TP. Pr: 0.2400    21
NZ_CP027599.1_137217	LIPO(Sec/SPII)	0.280351	0.037036	0.381875	0.300738	CS pos: 16-17. SLS-CF. Pr: 0.3371    24
NZ_CP027599.1_137232	SP(Sec/SPI)	0.460955	0.446767	0.061614	0.030665	CS pos: 24-25. AWS-GK. Pr: 0.6563    35
NZ_CP027599.1_137235	LIPO(Sec/SPII)	0.144167	0.144903	0.381257	0.329672	CS pos: 22-23. AAA-CH. Pr: 0.3818    39
NZ_CP027599.1_137263	SP(Sec/SPI)	0.606464	0.076364	0.044089	0.273083	CS pos: 27-28. GGA-FP. Pr: 0.2704    49
NZ_CP027599.1_137267	SP(Sec/SPI)	0.488958	0.010810	0.223318	0.276914	CS pos: 20-21. VPA-IQ. Pr: 0.2191    29
NZ_CP027599.1_137272	SP(Sec/SPI)	0.343836	0.049270	0.315051	0.291843	CS pos: 24-25. CAA-AW. Pr: 0.1585    29
NZ_CP027599.1_137278	LIPO(Sec/SPII)	0.195719	0.006985	0.555200	0.242096	CS pos: ?. Probable protein fragment    21
NZ_CP027599.1_137280	LIPO(Sec/SPII)	0.168283	0.036565	0.421580	0.373571	CS pos: ?. Probable protein fragment    17
NZ_CP027599.1_137285	LIPO(Sec/SPII)	0.258720	0.066956	0.351794	0.322530	CS pos: ?. Probable protein fragment    19
NZ_CP027599.1_137309	LIPO(Sec/SPII)	0.036745	0.004858	0.690461	0.267935	CS pos: 18-19. LTG-CA. Pr: 0.6893    38
NZ_CP027599.1_137323	LIPO(Sec/SPII)	0.087144	0.068533	0.427347	0.416977	CS pos: 30-31. SVC-CR. Pr: 0.2151    42
NZ_CP027599.1_137347	SP(Sec/SPI)	0.324402	0.099842	0.313852	0.261903	CS pos: 21-22. TRC-YP. Pr: 0.1625    48
NZ_CP027599.1_137358	LIPO(Sec/SPII)	0.265975	0.039190	0.422202	0.272632	CS pos: 15-16. VFA-RL. Pr: 0.0388    17
NZ_CP027599.1_137360	LIPO(Sec/SPII)	0.036902	0.005310	0.800610	0.157179	CS pos: 20-21. VCG-CV. Pr: 0.7801    30
NZ_CP027599.1_137361	LIPO(Sec/SPII)	0.151872	0.030607	0.465506	0.352014	CS pos: 19-20. ASL-CS. Pr: 0.3567    27
NZ_CP027599.1_137378	SP(Sec/SPI)	0.406595	0.004252	0.285343	0.303810	CS pos: 24-25. VMN-ND. Pr: 0.1347    29
NZ_CP027599.1_137379	SP(Sec/SPI)	0.390770	0.026841	0.298244	0.284145	CS pos: 16-17. LPA-QQ. Pr: 0.1042    18
NZ_CP027599.1_137401	SP(Sec/SPI)	0.485491	0.027983	0.124501	0.362024	CS pos: 28-29. AHG-KW. Pr: 0.3340    30
NZ_CP027599.1_137421	LIPO(Sec/SPII)	0.256194	0.007316	0.456336	0.280154	CS pos: ?. Probable protein fragment    16
NZ_CP027599.1_137434	LIPO(Sec/SPII)	0.092286	0.048726	0.509230	0.349757	CS pos: 34-35. FPA-CA. Pr: 0.4802    50
NZ_CP027599.1_137485	SP(Sec/SPI)	0.554733	0.051887	0.063319	0.330061	CS pos: 21-22. IFA-AP. Pr: 0.5229    24
NZ_CP027599.1_137495	SP(Sec/SPI)	0.762232	0.012312	0.057398	0.168058	CS pos: 17-18. LNA-DP. Pr: 0.6887    50
NZ_CP027599.1_137501	LIPO(Sec/SPII)	0.214443	0.001245	0.718562	0.065750	CS pos: 17-18. LNV-CI. Pr: 0.7014    47
NZ_CP027599.1_137504	LIPO(Sec/SPII)	0.200442	0.021457	0.397213	0.380888	CS pos: 20-21. SQP-CA. Pr: 0.3113    23
NZ_CP027599.1_137551	SP(Sec/SPI)	0.418794	0.229547	0.055993	0.295666	CS pos: 23-24. IAA-AD. Pr: 0.2816    31
NZ_CP027599.1_137552	LIPO(Sec/SPII)	0.071988	0.010696	0.729896	0.187420	CS pos: 13-14. ISG-CC. Pr: 0.7085    50
NZ_CP027599.1_137556	SP(Sec/SPI)	0.508406	0.059138	0.182296	0.250160	CS pos: 25-26. SLA-IN. Pr: 0.2453    33
NZ_CP027599.1_137570	SP(Sec/SPI)	0.787573	0.047186	0.112212	0.053029	CS pos: 21-22. LPA-AD. Pr: 0.3105    25
NZ_CP027599.1_137575	LIPO(Sec/SPII)	0.298830	0.020607	0.449840	0.230723	CS pos: 14-15. WVM-CT. Pr: 0.1991    17
NZ_CP027599.1_137579	SP(Sec/SPI)	0.425948	0.342437	0.086573	0.145042	CS pos: 23-24. ARS-AT. Pr: 0.3722    43
NZ_CP027599.1_137585	LIPO(Sec/SPII)	0.151547	0.023111	0.535996	0.289346	CS pos: 12-13. LCA-CC. Pr: 0.2609    23
NZ_CP027599.1_137609	SP(Sec/SPI)	0.524654	0.035364	0.120462	0.319520	CS pos: 19-20. VAA-RW. Pr: 0.3656    23
NZ_CP027599.1_137613	LIPO(Sec/SPII)	0.198911	0.031972	0.530897	0.238221	CS pos: 13-14. LNA-CS. Pr: 0.5084    21
NZ_CP027599.1_137628	SP(Sec/SPI)	0.384958	0.021195	0.283937	0.309910	CS pos: 21-22. ANS-GW. Pr: 0.1403    26
NZ_CP027599.1_137634	LIPO(Sec/SPII)	0.104052	0.013323	0.622484	0.260141	CS pos: 15-16. VVS-CR. Pr: 0.5971    32
NZ_CP027599.1_137642	LIPO(Sec/SPII)	0.320710	0.030568	0.332004	0.316718	CS pos: ?. Probable protein fragment    18
NZ_CP027599.1_137676	LIPO(Sec/SPII)	0.218431	0.050093	0.586226	0.145250	CS pos: 16-17. TAS-CC. Pr: 0.3816    44
NZ_CP027599.1_137684	LIPO(Sec/SPII)	0.080198	0.009324	0.531242	0.379236	CS pos: 21-22. VCA-CS. Pr: 0.4931    41
NZ_CP027599.1_137699	SP(Sec/SPI)	0.407718	0.023753	0.250735	0.317794	CS pos: 16-17. CMA-RA. Pr: 0.1807    18
NZ_CP027599.1_137744	SP(Sec/SPI)	0.490255	0.001356	0.413024	0.095365	CS pos: 29-30. AFS-VM. Pr: 0.2025    44
NZ_CP027599.1_137747	LIPO(Sec/SPII)	0.244228	0.036022	0.421078	0.298671	CS pos: 13-14. LSG-CM. Pr: 0.1635    19
NZ_CP027599.1_137782	SP(Sec/SPI)	0.540339	0.047028	0.042923	0.369710	CS pos: 22-23. AKS-YF. Pr: 0.2767    36
NZ_CP027599.1_137805	LIPO(Sec/SPII)	0.057561	0.002040	0.902983	0.037415	CS pos: 17-18. LPS-CS. Pr: 0.8791    30
NZ_CP027599.1_137808	LIPO(Sec/SPII)	0.040289	0.000546	0.924340	0.034824	CS pos: 18-19. IFT-CC. Pr: 0.6969    37
NZ_CP027599.1_137832	SP(Sec/SPI)	0.338933	0.172464	0.243614	0.244989	CS pos: 24-25. LTG-EE. Pr: 0.3165    28
NZ_CP027599.1_137836	SP(Sec/SPI)	0.536262	0.017620	0.120107	0.326011	CS pos: 23-24. AVS-EE. Pr: 0.3731    32
NZ_CP027599.1_137849	SP(Sec/SPI)	0.445392	0.030060	0.097608	0.426940	CS pos: 26-27. TIA-LS. Pr: 0.2410    32
NZ_CP027599.1_137865	LIPO(Sec/SPII)	0.218629	0.014545	0.479144	0.287682	CS pos: 13-14. SLS-CT. Pr: 0.3173    27
NZ_CP027599.1_137873	LIPO(Sec/SPII)	0.058610	0.076600	0.562296	0.302494	CS pos: 27-28. STA-CS. Pr: 0.5523    50
NZ_CP027599.1_137878	LIPO(Sec/SPII)	0.008947	0.000824	0.985303	0.004926	CS pos: 20-21. LTA-CW. Pr: 0.9843    40
NZ_CP027599.1_137881	LIPO(Sec/SPII)	0.272577	0.038256	0.364584	0.324583	CS pos: 13-14. TNC-CA. Pr: 0.0807    15
NZ_CP027599.1_137930	SP(Sec/SPI)	0.533271	0.005126	0.201264	0.260340	CS pos: 19-20. AHG-SS. Pr: 0.1806    28
NZ_CP027599.1_137963	LIPO(Sec/SPII)	0.047842	0.014917	0.714135	0.223106	CS pos: 22-23. CLK-CS. Pr: 0.5970    34
NZ_CP027599.1_137991	LIPO(Sec/SPII)	0.182154	0.065951	0.395426	0.356469	CS pos: 21-22. FAS-CR. Pr: 0.2899    38
NZ_CP027599.1_138025	SP(Sec/SPI)	0.433655	0.065962	0.106394	0.393989	CS pos: 29-30. AIA-AS. Pr: 0.3258    33
NZ_CP027599.1_138036	SP(Sec/SPI)	0.445739	0.029847	0.168579	0.355835	CS pos: 19-20. TAG-RF. Pr: 0.0781    45
NZ_CP027599.1_138055	LIPO(Sec/SPII)	0.180933	0.161247	0.476356	0.181464	CS pos: 17-18. LTG-AT. Pr: 0.2803    43
NZ_CP027599.1_138058	TAT(Tat/SPI)	0.152205	0.549478	0.204283	0.094033	CS pos: 31-32. TRT-AG. Pr: 0.0995    47
NZ_CP027599.1_138062	SP(Sec/SPI)	0.545129	0.032435	0.102859	0.319577	CS pos: 20-21. VNA-LV. Pr: 0.4469    23
NZ_CP027599.1_138079	LIPO(Sec/SPII)	0.338581	0.017823	0.421750	0.221846	CS pos: 11-12. PAA-CA. Pr: 0.0927    16
NZ_CP027599.1_138097	LIPO(Sec/SPII)	0.211858	0.145472	0.335972	0.306699	CS pos: 14-15. CVG-TI. Pr: 0.0107    17
NZ_CP027599.1_138101	LIPO(Sec/SPII)	0.170169	0.012930	0.455017	0.361884	CS pos: 14-15. FLS-CW. Pr: 0.2739    18
NZ_CP027599.1_138102	LIPO(Sec/SPII)	0.115297	0.006413	0.722877	0.155414	CS pos: 22-23. LAA-VT. Pr: 0.5933    34
NZ_CP027599.1_138103	LIPO(Sec/SPII)	0.001878	0.000278	0.997119	0.000724	CS pos: 29-30. LAG-CG. Pr: 0.9980    50
NZ_CP027599.1_138136	LIPO(Sec/SPII)	0.143974	0.043964	0.481652	0.330409	CS pos: 22-23. LAR-CQ. Pr: 0.4595    30
NZ_CP027599.1_138197	SP(Sec/SPI)	0.588124	0.023980	0.367792	0.020104	CS pos: 24-25. ASV-AC. Pr: 0.1784    32
NZ_CP027599.1_138202	SP(Sec/SPI)	0.410510	0.007349	0.198040	0.384101	CS pos: 20-21. VIR-HT. Pr: 0.0653    23
NZ_CP027599.1_138207	SP(Sec/SPI)	0.403914	0.130753	0.121191	0.344142	CS pos: 35-36. ARA-TP. Pr: 0.0922    41
NZ_CP027599.1_138214	SP(Sec/SPI)	0.605785	0.023442	0.228828	0.141945	CS pos: 22-23. SRG-IW. Pr: 0.4542    38
NZ_CP027599.1_138215	SP(Sec/SPI)	0.448772	0.191607	0.049050	0.310571	CS pos: 22-23. SHG-KA. Pr: 0.1068    44
NZ_CP027599.1_138245	TAT(Tat/SPI)	0.107747	0.488813	0.154057	0.249382	CS pos: 37-38. QRA-QT. Pr: 0.1432    43
NZ_CP027599.1_138254	SP(Sec/SPI)	0.895115	0.007643	0.051656	0.045585	CS pos: 19-20. AYS-TL. Pr: 0.7909    37
NZ_CP027599.1_138261	SP(Sec/SPI)	0.338884	0.322630	0.061532	0.276954	CS pos: 24-25. PYA-AK. Pr: 0.3658    34
NZ_CP027599.1_138301	SP(Sec/SPI)	0.822881	0.034936	0.056970	0.085213	CS pos: 22-23. SRA-SS. Pr: 0.7557    46
NZ_CP027599.1_138340	SP(Sec/SPI)	0.582672	0.071913	0.026618	0.318797	CS pos: 20-21. AHA-AR. Pr: 0.5805    27
NZ_CP027599.1_138352	SP(Sec/SPI)	0.439924	0.156586	0.115373	0.288117	CS pos: 20-21. GFA-TP. Pr: 0.3880    44
NZ_CP027599.1_138372	SP(Sec/SPI)	0.424314	0.060067	0.168825	0.346793	CS pos: 43-44. GLA-HE. Pr: 0.1305    50
NZ_CP027599.1_138397	LIPO(Sec/SPII)	0.214933	0.032221	0.393016	0.359831	CS pos: 13-14. LLP-CY. Pr: 0.1609    16
NZ_CP027599.1_138442	LIPO(Sec/SPII)	0.052837	0.004010	0.902411	0.040741	CS pos: 13-14. SAG-CR. Pr: 0.8862    19
NZ_CP027599.1_138446	LIPO(Sec/SPII)	0.064175	0.014412	0.492605	0.428808	CS pos: 33-34. STS-CN. Pr: 0.4759    50
NZ_CP027599.1_138453	LIPO(Sec/SPII)	0.219587	0.192897	0.310310	0.277207	CS pos: ?. Probable protein fragment    21
NZ_CP027599.1_138475	LIPO(Sec/SPII)	0.184911	0.148812	0.444273	0.222004	CS pos: 13-14. IAG-CS. Pr: 0.3487    39
NZ_CP027599.1_138501	SP(Sec/SPI)	0.468909	0.054678	0.154894	0.321519	CS pos: 20-21. ASG-SV. Pr: 0.2753    25
NZ_CP027599.1_138523	TAT(Tat/SPI)	0.119036	0.466311	0.021202	0.393451	CS pos: 40-41. ASA-FT. Pr: 0.2462    50
NZ_CP027599.1_138531	LIPO(Sec/SPII)	0.272551	0.022289	0.372201	0.332959	CS pos: 14-15. NIA-CC. Pr: 0.1883    24
NZ_CP027599.1_138545	SP(Sec/SPI)	0.452457	0.101702	0.082009	0.363833	CS pos: 29-30. TVA-TE. Pr: 0.3429    34
NZ_CP027599.1_138568	SP(Sec/SPI)	0.585416	0.040288	0.217605	0.156691	CS pos: 23-24. TFA-VQ. Pr: 0.2872    33
NZ_CP027599.1_138581	LIPO(Sec/SPII)	0.243980	0.059787	0.491725	0.204508	CS pos: 13-14. SIS-CT. Pr: 0.4253    30
NZ_CP027599.1_138598	LIPO(Sec/SPII)	0.009975	0.010020	0.888380	0.091625	CS pos: 26-27. PTS-CN. Pr: 0.8869    42
NZ_CP027599.1_138622	SP(Sec/SPI)	0.518615	0.010643	0.180033	0.290709	CS pos: 18-19. FHS-QH. Pr: 0.2732    23
NZ_CP027599.1_138642	LIPO(Sec/SPII)	0.036095	0.150490	0.651916	0.161499	CS pos: 16-17. PSG-CQ. Pr: 0.6476    45
NZ_CP027599.1_138660	LIPO(Sec/SPII)	0.187897	0.081917	0.381148	0.349039	CS pos: 22-23. VPA-CN. Pr: 0.2863    24
NZ_CP027599.1_138667	LIPO(Sec/SPII)	0.160230	0.054632	0.691446	0.093692	CS pos: 17-18. STA-CS. Pr: 0.6834    26
NZ_CP027599.1_138675	LIPO(Sec/SPII)	0.237856	0.039445	0.541960	0.180739	CS pos: ?. Probable protein fragment    17
NZ_CP027599.1_138699	LIPO(Sec/SPII)	0.070396	0.003394	0.672013	0.254196	CS pos: 16-17. GCG-CN. Pr: 0.5375    49
NZ_CP027599.1_138702	SP(Sec/SPI)	0.528533	0.058229	0.046802	0.366436	CS pos: 12-13. STA-QY. Pr: 0.1835    27
NZ_CP027599.1_138706	LIPO(Sec/SPII)	0.243466	0.096510	0.343227	0.316798	CS pos: ?. Probable protein fragment    17
NZ_CP027599.1_138717	SP(Sec/SPI)	0.449051	0.106308	0.077670	0.366970	CS pos: 16-17. ANA-AD. Pr: 0.4183    22
NZ_CP027599.1_138738	TAT(Tat/SPI)	0.201307	0.469123	0.023496	0.306074	CS pos: 25-26. AYA-LP. Pr: 0.5588    39
NZ_CP027599.1_138745	LIPO(Sec/SPII)	0.100965	0.011031	0.817948	0.070056	CS pos: 13-14. VSS-CV. Pr: 0.7817    27
NZ_CP027599.1_138759	LIPO(Sec/SPII)	0.118620	0.045106	0.557869	0.278405	CS pos: 17-18. IAG-CN. Pr: 0.5481    20
NZ_CP027599.1_138792	LIPO(Sec/SPII)	0.068220	0.015226	0.503053	0.413501	CS pos: 18-19. KAS-CT. Pr: 0.4997    43
NZ_CP027599.1_138799	SP(Sec/SPI)	0.615222	0.005632	0.103118	0.276029	CS pos: 31-32. VLS-SN. Pr: 0.3956    35
NZ_CP027599.1_138859	SP(Sec/SPI)	0.480028	0.152556	0.114229	0.253187	CS pos: 17-18. ASA-AN. Pr: 0.3863    22
NZ_CP027599.1_138863	SP(Sec/SPI)	0.584523	0.013821	0.359430	0.042226	CS pos: 20-21. VNS-AS. Pr: 0.4477    44
NZ_CP027599.1_138874	LIPO(Sec/SPII)	0.055407	0.004406	0.825460	0.114727	CS pos: 12-13. ASG-CS. Pr: 0.7901    18
NZ_CP027599.1_138897	LIPO(Sec/SPII)	0.027000	0.005180	0.751931	0.215889	CS pos: 21-22. ASS-CN. Pr: 0.7448    41
NZ_CP027599.1_138912	SP(Sec/SPI)	0.530140	0.004429	0.191737	0.273694	CS pos: 18-19. VTS-QD. Pr: 0.5033    39
NZ_CP027599.1_138920	SP(Sec/SPI)	0.707306	0.022579	0.027463	0.242651	CS pos: 20-21. INA-QL. Pr: 0.6626    31
NZ_CP027599.1_138925	LIPO(Sec/SPII)	0.319622	0.010121	0.525421	0.144837	CS pos: 15-16. VYP-CR. Pr: 0.3169    17
NZ_CP027599.1_138989	LIPO(Sec/SPII)	0.208688	0.015900	0.639369	0.136043	CS pos: 21-22. VKA-CR. Pr: 0.5841    29
NZ_CP027599.1_138992	SP(Sec/SPI)	0.329897	0.223318	0.130394	0.316391	CS pos: 21-22. TRA-HA. Pr: 0.2086    44
NZ_CP027599.1_139003	SP(Sec/SPI)	0.427501	0.085901	0.091290	0.395308	CS pos: 13-14. ATA-GY. Pr: 0.2566    23
NZ_CP027599.1_139011	LIPO(Sec/SPII)	0.184591	0.018338	0.444209	0.352862	CS pos: 20-21. TSK-CS. Pr: 0.2093    40
NZ_CP027599.1_139014	SP(Sec/SPI)	0.609772	0.265493	0.071549	0.053186	CS pos: 23-24. SSA-TP. Pr: 0.5107    34
NZ_CP027599.1_139019	LIPO(Sec/SPII)	0.258020	0.011022	0.471456	0.259502	CS pos: 15-16. TPC-CW. Pr: 0.1082    17
NZ_CP027599.1_139033	LIPO(Sec/SPII)	0.136835	0.010100	0.523875	0.329190	CS pos: 14-15. SGG-CW. Pr: 0.3120    24
NZ_CP027599.1_139049	SP(Sec/SPI)	0.587249	0.004727	0.128817	0.279208	CS pos: 14-15. ALS-EN. Pr: 0.4693    22
NZ_CP027599.1_139051	SP(Sec/SPI)	0.519495	0.023583	0.212418	0.244504	CS pos: 16-17. TKA-TQ. Pr: 0.3070    19
NZ_CP027599.1_139052	LIPO(Sec/SPII)	0.156276	0.049114	0.550965	0.243646	CS pos: ?. Probable protein fragment    18
NZ_CP027599.1_139060	LIPO(Sec/SPII)	0.287881	0.019101	0.363339	0.329679	CS pos: 17-18. TTY-CD. Pr: 0.2871    25
NZ_CP027599.1_139062	SP(Sec/SPI)	0.401345	0.005684	0.215597	0.377373	CS pos: 22-23. LSA-RY. Pr: 0.2283    35
NZ_CP027599.1_139092	SP(Sec/SPI)	0.580011	0.162871	0.069352	0.187766	CS pos: 13-14. AAA-AN. Pr: 0.3508    34
NZ_CP027599.1_139098	TAT(Tat/SPI)	0.215595	0.372456	0.331361	0.080588	CS pos: 24-25. VRS-FS. Pr: 0.2040    50
NZ_CP027599.1_139104	LIPO(Sec/SPII)	0.083294	0.023381	0.545324	0.348001	CS pos: 28-29. PLS-CC. Pr: 0.4590    38
NZ_CP027599.1_139116	LIPO(Sec/SPII)	0.294499	0.021765	0.355341	0.328395	CS pos: 15-16. STS-QY. Pr: 0.0490    17
NZ_CP027599.1_139125	SP(Sec/SPI)	0.634693	0.007751	0.259042	0.098513	CS pos: 21-22. RKA-NG. Pr: 0.2183    23
NZ_CP027599.1_139154	LIPO(Sec/SPII)	0.280367	0.013907	0.456977	0.248749	CS pos: ?. Probable protein fragment    17
NZ_CP027599.1_139204	LIPO(Sec/SPII)	0.192609	0.024301	0.415416	0.367675	CS pos: 17-18. ATG-CN. Pr: 0.3442    21
NZ_CP027599.1_139347	LIPO(Sec/SPII)	0.114062	0.017670	0.439526	0.428741	CS pos: 17-18. FIC-CS. Pr: 0.3207    31
NZ_CP027599.1_139362	TAT(Tat/SPI)	0.230887	0.582311	0.043869	0.142932	CS pos: 30-31. AMP-TR. Pr: 0.1990    47
NZ_CP027599.1_139364	TAT(Tat/SPI)	0.053132	0.889102	0.042704	0.015063	CS pos: 30-31. AGA-CA. Pr: 0.3369    41
NZ_CP027599.1_139371	SP(Sec/SPI)	0.791683	0.036392	0.032699	0.139226	CS pos: 20-21. ASA-EP. Pr: 0.5850    47
NZ_CP027599.1_139439	LIPO(Sec/SPII)	0.095224	0.026675	0.686179	0.191922	CS pos: 16-17. VSA-CG. Pr: 0.6674    19
NZ_CP027599.1_139448	SP(Sec/SPI)	0.478486	0.112982	0.032835	0.375698	CS pos: 16-17. AHA-VP. Pr: 0.4756    38
NZ_CP027599.1_139462	LIPO(Sec/SPII)	0.102326	0.182420	0.388652	0.326602	CS pos: 26-27. ICH-CS. Pr: 0.2775    50
NZ_CP027599.1_139476	LIPO(Sec/SPII)	0.175918	0.016778	0.572592	0.234712	CS pos: 14-15. CAS-CS. Pr: 0.4898    39
NZ_CP027599.1_139482	TAT(Tat/SPI)	0.161481	0.403308	0.053739	0.381473	CS pos: 39-40. ASA-CS. Pr: 0.2650    44
NZ_CP027599.1_139524	LIPO(Sec/SPII)	0.079310	0.017384	0.595202	0.308104	CS pos: 28-29. TAS-CR. Pr: 0.5159    38
NZ_CP027599.1_139526	LIPO(Sec/SPII)	0.125010	0.065336	0.601297	0.208356	CS pos: 15-16. SAA-CG. Pr: 0.5684    45
NZ_CP027599.1_139539	SP(Sec/SPI)	0.510665	0.037637	0.098410	0.353288	CS pos: 25-26. ALP-SL. Pr: 0.2105    32
NZ_CP027599.1_139545	SP(Sec/SPI)	0.358168	0.019536	0.351328	0.270968	CS pos: 19-20. AFC-GV. Pr: 0.2734    21
NZ_CP027599.1_139557	SP(Sec/SPI)	0.352172	0.061893	0.289350	0.296585	CS pos: 16-17. GLA-GL. Pr: 0.0574    24
NZ_CP027599.1_139582	LIPO(Sec/SPII)	0.271730	0.022098	0.353331	0.352842	CS pos: ?. Probable protein fragment    18
NZ_CP027599.1_139584	SP(Sec/SPI)	0.463009	0.077537	0.213784	0.245670	CS pos: 15-16. ALA-TA. Pr: 0.0988    30
NZ_CP027599.1_139629	LIPO(Sec/SPII)	0.028456	0.000774	0.624573	0.346197	CS pos: 15-16. CCA-CY. Pr: 0.5479    50
NZ_CP027599.1_139640	LIPO(Sec/SPII)	0.065359	0.002514	0.533529	0.398598	CS pos: 19-20. STG-CL. Pr: 0.5323    46
NZ_CP027599.1_139663	LIPO(Sec/SPII)	0.208616	0.008604	0.497205	0.285575	CS pos: 16-17. VKV-CN. Pr: 0.1797    19
NZ_CP027599.1_139671	LIPO(Sec/SPII)	0.118200	0.028039	0.652265	0.201495	CS pos: 17-18. ISK-CS. Pr: 0.6149    37
NZ_CP027599.1_139690	SP(Sec/SPI)	0.395825	0.174434	0.225612	0.204130	CS pos: 17-18. ALP-AS. Pr: 0.1632    38
NZ_CP027599.1_139696	SP(Sec/SPI)	0.623842	0.129708	0.039444	0.207006	CS pos: 24-25. ALA-GS. Pr: 0.5795    33
NZ_CP027599.1_139709	LIPO(Sec/SPII)	0.049541	0.033926	0.635363	0.281170	CS pos: 21-22. AIS-CN. Pr: 0.5561    45
NZ_CP027599.1_139710	SP(Sec/SPI)	0.533475	0.239182	0.100927	0.126417	CS pos: 29-30. SRA-KK. Pr: 0.3411    50
NZ_CP027599.1_139711	LIPO(Sec/SPII)	0.142875	0.009862	0.509133	0.338129	CS pos: 22-23. KLT-CC. Pr: 0.2422    42
NZ_CP027599.1_139772	SP(Sec/SPI)	0.425815	0.157356	0.056175	0.360653	CS pos: 33-34. VRS-TS. Pr: 0.3242    44
NZ_CP027599.1_139779	SP(Sec/SPI)	0.512772	0.079341	0.061154	0.346733	CS pos: 11-12. ASA-AD. Pr: 0.4295    23
NZ_CP027599.1_139783	SP(Sec/SPI)	0.474409	0.019802	0.359765	0.146024	CS pos: 21-22. AEC-SA. Pr: 0.2211    45
NZ_CP027599.1_139787	LIPO(Sec/SPII)	0.196820	0.047120	0.385057	0.371003	CS pos: 16-17. FIG-CE. Pr: 0.2861    18
NZ_CP027599.1_139807	SP(Sec/SPI)	0.556701	0.092960	0.061011	0.289327	CS pos: 23-24. SLA-ET. Pr: 0.5332    28
NZ_CP027599.1_139839	SP(Sec/SPI)	0.595307	0.017901	0.069265	0.317527	CS pos: 14-15. TYS-QS. Pr: 0.3210    27
NZ_CP027599.1_140068	SP(Sec/SPI)	0.461483	0.223398	0.023215	0.291904	CS pos: 29-30. ARA-AS. Pr: 0.5789    34
NZ_CP027599.1_140088	SP(Sec/SPI)	0.674742	0.021359	0.231302	0.072596	CS pos: 25-26. ASV-AK. Pr: 0.1143    31
NZ_CP027599.1_140103	LIPO(Sec/SPII)	0.282488	0.085552	0.406885	0.225076	CS pos: 23-24. ASN-CT. Pr: 0.2727    48
NZ_CP027599.1_140152	TAT(Tat/SPI)	0.150130	0.388372	0.209485	0.252013	CS pos: 16-17. AIG-QT. Pr: 0.0462    18
NZ_CP027599.1_140232	SP(Sec/SPI)	0.838466	0.044853	0.017804	0.098877	CS pos: 19-20. SFA-TP. Pr: 0.8366    34
NZ_CP027599.1_140241	LIPO(Sec/SPII)	0.094586	0.006220	0.522546	0.376648	CS pos: 16-17. IPS-CE. Pr: 0.4920    29
NZ_CP027599.1_140368	LIPO(Sec/SPII)	0.101638	0.000605	0.890725	0.007032	CS pos: 20-21. GAS-CN. Pr: 0.8665    46
NZ_CP027599.1_140380	LIPO(Sec/SPII)	0.305996	0.039088	0.353092	0.301824	CS pos: ?. Probable protein fragment    17
NZ_CP027599.1_140413	LIPO(Sec/SPII)	0.245693	0.013188	0.375229	0.365889	CS pos: 15-16. GAT-CS. Pr: 0.2391    32
NZ_CP027599.1_140533	LIPO(Sec/SPII)	0.391025	0.026539	0.414912	0.167524	CS pos: 14-15. LLS-CA. Pr: 0.3002    36
NZ_CP027599.1_140547	LIPO(Sec/SPII)	0.208466	0.024406	0.559543	0.207585	CS pos: 13-14. SAA-CA. Pr: 0.3184    16
NZ_CP027599.1_140566	SP(Sec/SPI)	0.651553	0.061683	0.110615	0.176149	CS pos: 17-18. ANA-SR. Pr: 0.4902    20
NZ_CP027599.1_140574	SP(Sec/SPI)	0.450809	0.286340	0.077488	0.185363	CS pos: 23-24. ARA-RI. Pr: 0.4697    33
NZ_CP027599.1_140644	SP(Sec/SPI)	0.415361	0.057517	0.230012	0.297110	CS pos: ?. Probable protein fragment    22
NZ_CP027599.1_140646	LIPO(Sec/SPII)	0.142177	0.015285	0.544049	0.298489	CS pos: 18-19. MPG-CY. Pr: 0.3653    22
NZ_CP027599.1_140652	LIPO(Sec/SPII)	0.087481	0.008215	0.522896	0.381408	CS pos: 14-15. IFS-CN. Pr: 0.4915    30
NZ_CP027599.1_140682	LIPO(Sec/SPII)	0.121790	0.051122	0.417482	0.409606	CS pos: 18-19. PRA-CS. Pr: 0.3850    31
NZ_CP027599.1_140729	LIPO(Sec/SPII)	0.204824	0.005973	0.774629	0.014575	CS pos: 18-19. NMA-CR. Pr: 0.7463    24
NZ_CP027599.1_140734	LIPO(Sec/SPII)	0.182981	0.033422	0.498466	0.285131	CS pos: 13-14. PIA-CH. Pr: 0.1334    17
NZ_CP027599.1_140750	LIPO(Sec/SPII)	0.066144	0.010136	0.678946	0.244774	CS pos: 13-14. LPG-CD. Pr: 0.6468    22
NZ_CP027599.1_140766	LIPO(Sec/SPII)	0.190663	0.085031	0.583077	0.141229	CS pos: 21-22. SSA-CR. Pr: 0.5992    30
NZ_CP027599.1_140767	SP(Sec/SPI)	0.716506	0.089490	0.034698	0.159306	CS pos: 17-18. AHA-DR. Pr: 0.6957    30
NZ_CP027599.1_140774	LIPO(Sec/SPII)	0.170093	0.011412	0.483615	0.334880	CS pos: 28-29. VSS-CS. Pr: 0.2871    34
NZ_CP027599.1_140793	LIPO(Sec/SPII)	0.144963	0.042564	0.412487	0.399986	CS pos: 18-19. TTA-CC. Pr: 0.3352    27
NZ_CP027599.1_140816	TAT(Tat/SPI)	0.046075	0.633729	0.049530	0.270666	CS pos: 32-33. TRA-RS. Pr: 0.2995    43
NZ_CP027599.1_140825	LIPO(Sec/SPII)	0.274542	0.016723	0.487865	0.220870	CS pos: 23-24. ASL-CA. Pr: 0.1642    35
NZ_CP027599.1_140829	LIPO(Sec/SPII)	0.344823	0.008159	0.519271	0.127747	CS pos: 13-14. AVR-CN. Pr: 0.3458    16
NZ_CP027599.1_140845	LIPO(Sec/SPII)	0.101918	0.017766	0.474050	0.406266	CS pos: 17-18. PAG-CG. Pr: 0.4467    29
NZ_CP027599.1_140888	SP(Sec/SPI)	0.611577	0.232104	0.037606	0.118713	CS pos: 20-21. AVA-AA. Pr: 0.2203    43
NZ_CP027599.1_140912	LIPO(Sec/SPII)	0.006443	0.000905	0.843907	0.148744	CS pos: 24-25. ITG-CQ. Pr: 0.8468    48
NZ_CP027599.1_140983	LIPO(Sec/SPII)	0.271902	0.020590	0.437163	0.270345	CS pos: 15-16. VKA-CR. Pr: 0.5538    22
NZ_CP027599.1_140987	SP(Sec/SPI)	0.509138	0.012702	0.386621	0.091540	CS pos: 24-25. VHC-SN. Pr: 0.4300    36
NZ_CP027599.1_141005	SP(Sec/SPI)	0.519366	0.017483	0.358096	0.105055	CS pos: 23-24. VWH-GA. Pr: 0.1915    39
NZ_CP027599.1_141008	LIPO(Sec/SPII)	0.073750	0.001773	0.785595	0.138882	CS pos: 25-26. CSG-CW. Pr: 0.7549    33
NZ_CP027599.1_141018	SP(Sec/SPI)	0.374306	0.029472	0.234564	0.361658	CS pos: 18-19. CWS-YS. Pr: 0.0890    26
NZ_CP027599.1_141041	SP(Sec/SPI)	0.338857	0.130817	0.244953	0.285372	CS pos: 17-18. ATA-SQ. Pr: 0.2634    22
NZ_CP027599.1_141078	LIPO(Sec/SPII)	0.152452	0.063900	0.637368	0.146280	CS pos: 15-16. ATG-CL. Pr: 0.5891    37
NZ_CP027599.1_141086	LIPO(Sec/SPII)	0.179875	0.114251	0.359943	0.345931	CS pos: 23-24. PLC-CR. Pr: 0.2166    50
NZ_CP027599.1_141089	LIPO(Sec/SPII)	0.187869	0.043307	0.437950	0.330874	CS pos: 19-20. AVG-CN. Pr: 0.3384    21
NZ_CP027599.1_141102	SP(Sec/SPI)	0.400491	0.120568	0.120332	0.358610	CS pos: 15-16. AAP-TP. Pr: 0.0780    26
NZ_CP027599.1_141105	TAT(Tat/SPI)	0.272113	0.376694	0.046323	0.304870	CS pos: 20-21. ARA-FS. Pr: 0.3633    26
NZ_CP027599.1_141130	SP(Sec/SPI)	0.662148	0.049364	0.178321	0.110167	CS pos: 26-27. TFA-TK. Pr: 0.6375    31
NZ_CP027599.1_141154	SP(Sec/SPI)	0.444208	0.007953	0.114278	0.433561	CS pos: 19-20. SFA-TV. Pr: 0.3434    41
NZ_CP027599.1_141172	LIPO(Sec/SPII)	0.164283	0.018125	0.571169	0.246423	CS pos: ?. Probable protein fragment    18
NZ_CP027599.1_141177	LIPO(Sec/SPII)	0.049826	0.000909	0.726882	0.222383	CS pos: 19-20. LIR-CN. Pr: 0.7150    27
NZ_CP027599.1_141180	LIPO(Sec/SPII)	0.185702	0.010605	0.403303	0.400390	CS pos: ?. Probable protein fragment    21
NZ_CP027599.1_141247	SP(Sec/SPI)	0.449131	0.271189	0.121951	0.157729	CS pos: 18-19. ASS-SV. Pr: 0.1527    45
NZ_CP027599.1_141251	LIPO(Sec/SPII)	0.175671	0.037207	0.606259	0.180863	CS pos: 12-13. AAG-CM. Pr: 0.5400    18
NZ_CP027599.1_141256	SP(Sec/SPI)	0.391410	0.215600	0.168484	0.224506	CS pos: 26-27. ARS-SR. Pr: 0.2222    50
NZ_CP027599.1_141279	LIPO(Sec/SPII)	0.072713	0.067727	0.666338	0.193222	CS pos: 24-25. MYG-CG. Pr: 0.6571    45
NZ_CP027599.1_141286	SP(Sec/SPI)	0.556881	0.050598	0.053272	0.339248	CS pos: 23-24. KLA-AE. Pr: 0.3157    37
NZ_CP027599.1_141290	LIPO(Sec/SPII)	0.163814	0.097176	0.391625	0.347385	CS pos: 19-20. NSG-CF. Pr: 0.3371    23
NZ_CP027599.1_141291	SP(Sec/SPI)	0.573409	0.058770	0.151263	0.216558	CS pos: 22-23. SRA-LP. Pr: 0.3524    27
NZ_CP027599.1_141300	LIPO(Sec/SPII)	0.168647	0.038772	0.462244	0.330336	CS pos: 21-22. IYG-CN. Pr: 0.4177    30
NZ_CP027599.1_141321	SP(Sec/SPI)	0.412472	0.137260	0.062426	0.387842	CS pos: 19-20. AIA-WI. Pr: 0.2462    31
NZ_CP027599.1_141322	SP(Sec/SPI)	0.352355	0.093485	0.210590	0.343570	CS pos: 18-19. SKA-SV. Pr: 0.1031    23
NZ_CP027599.1_141327	SP(Sec/SPI)	0.792941	0.015397	0.119450	0.072213	CS pos: 17-18. AWS-AG. Pr: 0.4181    22
NZ_CP027599.1_141360	LIPO(Sec/SPII)	0.053799	0.078872	0.556697	0.310632	CS pos: 33-34. LTS-CS. Pr: 0.5505    47
NZ_CP027599.1_141376	SP(Sec/SPI)	0.621751	0.043369	0.043038	0.291842	CS pos: 24-25. FNA-LS. Pr: 0.4189    39
NZ_CP027599.1_141384	TAT(Tat/SPI)	0.106171	0.755375	0.007420	0.131034	CS pos: 41-42. TAA-RT. Pr: 0.2398    50
NZ_CP027599.1_141419	SP(Sec/SPI)	0.532160	0.049712	0.047069	0.371058	CS pos: 30-31. ASG-SV. Pr: 0.3508    36
NZ_CP027599.1_141420	LIPO(Sec/SPII)	0.271647	0.028169	0.376650	0.323535	CS pos: 12-13. IIS-CN. Pr: 0.3204    32
NZ_CP027599.1_141437	SP(Sec/SPI)	0.583383	0.081295	0.030462	0.304859	CS pos: 21-22. AVA-VL. Pr: 0.4660    44
NZ_CP027599.1_141440	SP(Sec/SPI)	0.430308	0.102653	0.046648	0.420391	CS pos: 13-14. ASA-TP. Pr: 0.1662    36
NZ_CP027599.1_141457	LIPO(Sec/SPII)	0.103870	0.241972	0.420644	0.233514	CS pos: 20-21. ASM-CS. Pr: 0.3976    49
NZ_CP027599.1_141481	SP(Sec/SPI)	0.336952	0.238534	0.111498	0.313016	CS pos: 21-22. SNA-VP. Pr: 0.2286    27
NZ_CP027599.1_141498	SP(Sec/SPI)	0.472732	0.043313	0.062527	0.421428	CS pos: 21-22. VNA-LT. Pr: 0.4404    27
NZ_CP027599.1_141500	SP(Sec/SPI)	0.370919	0.016092	0.349865	0.263123	CS pos: 21-22. SSS-TC. Pr: 0.1321    28
NZ_CP027599.1_141518	SP(Sec/SPI)	0.544076	0.330791	0.025766	0.099368	CS pos: 23-24. AHA-AF. Pr: 0.7711    38
NZ_CP027599.1_141522	LIPO(Sec/SPII)	0.088493	0.026667	0.527259	0.357581	CS pos: 21-22. LPA-CR. Pr: 0.4847    26
NZ_CP027599.1_141532	SP(Sec/SPI)	0.376626	0.027458	0.257129	0.338788	CS pos: 25-26. VRR-CS. Pr: 0.1576    27
NZ_CP027599.1_141535	TAT(Tat/SPI)	0.227073	0.311269	0.189880	0.271778	CS pos: ?. Probable protein fragment    17
NZ_CP027599.1_141547	LIPO(Sec/SPII)	0.194471	0.060541	0.428794	0.316194	CS pos: 26-27. FAL-CP. Pr: 0.3367    45
NZ_CP027599.1_141555	LIPO(Sec/SPII)	0.142835	0.015201	0.664675	0.177289	CS pos: 21-22. APG-CA. Pr: 0.5002    31
NZ_CP027599.1_141566	SP(Sec/SPI)	0.566838	0.045387	0.154213	0.233562	CS pos: 28-29. VMA-SA. Pr: 0.2767    39
NZ_CP027599.1_141568	LIPO(Sec/SPII)	0.216531	0.013971	0.456881	0.312617	CS pos: ?. Probable protein fragment    17
NZ_CP027599.1_141588	SP(Sec/SPI)	0.365572	0.323960	0.045057	0.265412	CS pos: 24-25. VSG-AF. Pr: 0.1025    50
NZ_CP027599.1_141603	SP(Sec/SPI)	0.373037	0.141702	0.115357	0.369904	CS pos: 19-20. ADA-WA. Pr: 0.1550    25
NZ_CP027599.1_141631	SP(Sec/SPI)	0.689172	0.016436	0.153530	0.140863	CS pos: 22-23. IWS-TN. Pr: 0.2354    29
NZ_CP027599.1_141639	TAT(Tat/SPI)	0.182314	0.387561	0.049079	0.381046	CS pos: 27-28. SGA-GR. Pr: 0.1133    29
NZ_CP027599.1_141677	SP(Sec/SPI)	0.404336	0.087892	0.159785	0.347987	CS pos: 26-27. TSA-VD. Pr: 0.2552    42
NZ_CP027599.1_141681	SP(Sec/SPI)	0.495488	0.033161	0.163736	0.307614	CS pos: 23-24. IAS-VT. Pr: 0.1866    33
NZ_CP027599.1_141684	LIPO(Sec/SPII)	0.244593	0.025583	0.372478	0.357346	CS pos: ?. Probable protein fragment    15
NZ_CP027599.1_141757	LIPO(Sec/SPII)	0.182447	0.034389	0.657953	0.125211	CS pos: 21-22. APS-CT. Pr: 0.5901    24
NZ_CP027599.1_141769	SP(Sec/SPI)	0.355692	0.157706	0.282836	0.203766	CS pos: 18-19. LVA-SR. Pr: 0.2054    49
NZ_CP027599.1_141790	LIPO(Sec/SPII)	0.222283	0.004411	0.460295	0.313010	CS pos: 18-19. LSG-CN. Pr: 0.4866    34
NZ_CP027599.1_141798	SP(Sec/SPI)	0.813131	0.060781	0.084642	0.041445	CS pos: 24-25. TLS-AT. Pr: 0.5123    36
NZ_CP027599.1_141805	SP(Sec/SPI)	0.562639	0.174140	0.036531	0.226691	CS pos: 23-24. ANA-ST. Pr: 0.4922    46
NZ_CP027599.1_141856	SP(Sec/SPI)	0.380698	0.127639	0.120755	0.370908	CS pos: 22-23. AIT-KP. Pr: 0.0418    26
NZ_CP027599.1_141887	LIPO(Sec/SPII)	0.130607	0.038681	0.531445	0.299268	CS pos: 27-28. VVG-CA. Pr: 0.5157    32
NZ_CP027599.1_141933	SP(Sec/SPI)	0.481541	0.033416	0.159065	0.325977	CS pos: ?. Probable protein fragment    22
NZ_CP027599.1_141979	SP(Sec/SPI)	0.560521	0.075685	0.134512	0.229282	CS pos: ?. Probable protein fragment    23
NZ_CP027599.1_142024	LIPO(Sec/SPII)	0.140537	0.007404	0.667483	0.184576	CS pos: 16-17. SYS-CT. Pr: 0.5776    38
NZ_CP027599.1_142029	SP(Sec/SPI)	0.453712	0.011096	0.159184	0.376008	CS pos: 20-21. RHS-SD. Pr: 0.2223    33
NZ_CP027599.1_142050	SP(Sec/SPI)	0.413900	0.104755	0.115031	0.366314	CS pos: 25-26. SFS-AP. Pr: 0.1275    36
NZ_CP027599.1_142057	LIPO(Sec/SPII)	0.090316	0.017081	0.449142	0.443460	CS pos: 23-24. NTA-CD. Pr: 0.4383    48
NZ_CP027599.1_142092	LIPO(Sec/SPII)	0.274943	0.011506	0.427767	0.285784	CS pos: ?. Probable protein fragment    22
NZ_CP027599.1_142103	SP(Sec/SPI)	0.579769	0.036914	0.143175	0.240142	CS pos: 18-19. ALQ-AV. Pr: 0.2651    21
NZ_CP027599.1_142116	LIPO(Sec/SPII)	0.100286	0.255511	0.341336	0.302867	CS pos: 18-19. PVA-CA. Pr: 0.3213    34
NZ_CP027599.1_142119	TAT(Tat/SPI)	0.142392	0.408755	0.065641	0.383212	CS pos: 45-46. SNA-GR. Pr: 0.1896    50
NZ_CP027599.1_142130	SP(Sec/SPI)	0.464175	0.104735	0.091550	0.339541	CS pos: 18-19. ASS-SP. Pr: 0.1765    32
NZ_CP027599.1_142153	LIPO(Sec/SPII)	0.110517	0.282359	0.444848	0.162276	CS pos: 18-19. AIS-CR. Pr: 0.4146    37
NZ_CP027599.1_142164	LIPO(Sec/SPII)	0.163136	0.024352	0.692772	0.119739	CS pos: 24-25. MAA-CP. Pr: 0.6974    37
NZ_CP027599.1_142182	LIPO(Sec/SPII)	0.143189	0.007624	0.620991	0.228196	CS pos: 20-21. PFT-CG. Pr: 0.4640    23
NZ_CP027599.1_142266	SP(Sec/SPI)	0.339838	0.039471	0.327832	0.292859	CS pos: 26-27. ASA-SC. Pr: 0.0964    29
NZ_CP027599.1_142277	SP(Sec/SPI)	0.388068	0.172024	0.056435	0.383473	CS pos: 28-29. ASA-TP. Pr: 0.1036    47
NZ_CP027599.1_142279	SP(Sec/SPI)	0.477154	0.033222	0.032895	0.456729	CS pos: 24-25. VFA-VP. Pr: 0.4521    33
NZ_CP027599.1_142283	LIPO(Sec/SPII)	0.053280	0.002142	0.843311	0.101266	CS pos: 25-26. CTG-CG. Pr: 0.8150    35
NZ_CP027599.1_142289	LIPO(Sec/SPII)	0.231841	0.021135	0.508230	0.238794	CS pos: 16-17. SGR-CS. Pr: 0.2565    20
NZ_CP027599.1_142312	LIPO(Sec/SPII)	0.056362	0.010553	0.741452	0.191634	CS pos: 17-18. LSA-CD. Pr: 0.7385    35
NZ_CP027599.1_142316	LIPO(Sec/SPII)	0.297219	0.017177	0.376612	0.308992	CS pos: 13-14. SYC-CS. Pr: 0.2360    35
NZ_CP027599.1_142331	SP(Sec/SPI)	0.815651	0.066295	0.021898	0.096156	CS pos: 21-22. AIA-YT. Pr: 0.7761    39
NZ_CP027599.1_142335	SP(Sec/SPI)	0.508743	0.040692	0.136091	0.314474	CS pos: 21-22. AIA-FS. Pr: 0.4121    43
NZ_CP027599.1_142357	SP(Sec/SPI)	0.710531	0.011669	0.126363	0.151436	CS pos: 25-26. VHS-DH. Pr: 0.6837    42
NZ_CP027599.1_142369	SP(Sec/SPI)	0.476768	0.175097	0.090666	0.257468	CS pos: 13-14. ASA-RS. Pr: 0.2464    29
NZ_CP027599.1_142384	SP(Sec/SPI)	0.521128	0.258672	0.046468	0.173732	CS pos: 22-23. GKA-QG. Pr: 0.2804    33
NZ_CP027599.1_142387	LIPO(Sec/SPII)	0.041152	0.213654	0.743016	0.002178	CS pos: 18-19. SVS-CT. Pr: 0.7367    41
NZ_CP027599.1_142440	LIPO(Sec/SPII)	0.079355	0.020092	0.483287	0.417266	CS pos: 18-19. LST-CT. Pr: 0.4664    43
NZ_CP027599.1_142444	SP(Sec/SPI)	0.410357	0.131076	0.085654	0.372913	CS pos: 16-17. PSA-TD. Pr: 0.0896    25
NZ_CP027599.1_142475	LIPO(Sec/SPII)	0.148553	0.011846	0.728690	0.110911	CS pos: 18-19. TTS-CA. Pr: 0.6849    20
NZ_CP027599.1_142476	LIPO(Sec/SPII)	0.086775	0.035500	0.759017	0.118707	CS pos: 15-16. FSS-CS. Pr: 0.7537    42
NZ_CP027599.1_142484	LIPO(Sec/SPII)	0.165866	0.010168	0.555221	0.268745	CS pos: 18-19. SAV-CA. Pr: 0.3425    26
NZ_CP027599.1_142485	SP(Sec/SPI)	0.636569	0.249232	0.083828	0.030371	CS pos: 32-33. SFA-TL. Pr: 0.3876    47
NZ_CP027599.1_142531	LIPO(Sec/SPII)	0.247046	0.039514	0.369935	0.343505	CS pos: 15-16. LAA-CL. Pr: 0.2260    18
NZ_CP027599.1_142549	LIPO(Sec/SPII)	0.048388	0.088874	0.480728	0.382010	CS pos: 17-18. VSA-CS. Pr: 0.4702    41
NZ_CP027599.1_142596	LIPO(Sec/SPII)	0.142193	0.024220	0.470170	0.363417	CS pos: 12-13. LSI-CL. Pr: 0.4328    41
NZ_CP027599.1_142691	SP(Sec/SPI)	0.567969	0.050876	0.250965	0.130190	CS pos: 23-24. AIA-FS. Pr: 0.2595    33
NZ_CP027599.1_142710	LIPO(Sec/SPII)	0.096235	0.000927	0.876781	0.026057	CS pos: 20-21. LAS-CH. Pr: 0.8695    34
NZ_CP027599.1_142729	LIPO(Sec/SPII)	0.356460	0.033291	0.390225	0.220024	CS pos: 23-24. SAQ-CT. Pr: 0.3280    33
NZ_CP027599.1_142769	LIPO(Sec/SPII)	0.133478	0.005305	0.496180	0.365038	CS pos: 13-14. SIQ-CW. Pr: 0.4464    20
NZ_CP027599.1_142794	LIPO(Sec/SPII)	0.245428	0.072167	0.348138	0.334267	CS pos: ?. Probable protein fragment    15
NZ_CP027599.1_142804	LIPO(Sec/SPII)	0.098193	0.004239	0.495743	0.401825	CS pos: 16-17. VVV-CH. Pr: 0.4583    29
NZ_CP027599.1_142805	LIPO(Sec/SPII)	0.302190	0.013264	0.580963	0.103583	CS pos: 23-24. LFC-CC. Pr: 0.3477    44
NZ_CP027599.1_142806	LIPO(Sec/SPII)	0.259500	0.067034	0.379873	0.293592	CS pos: 12-13. SGG-FS. Pr: 0.1680    35
NZ_CP027599.1_142811	LIPO(Sec/SPII)	0.162326	0.013681	0.626529	0.197463	CS pos: 17-18. SMT-CL. Pr: 0.5803    23
NZ_CP027599.1_142849	LIPO(Sec/SPII)	0.397778	0.029727	0.473661	0.098834	CS pos: 21-22. NSA-CG. Pr: 0.3015    38
NZ_CP027599.1_142951	LIPO(Sec/SPII)	0.069743	0.002699	0.625749	0.301809	CS pos: 14-15. WAE-CS. Pr: 0.6141    36
NZ_CP027599.1_142959	SP(Sec/SPI)	0.471943	0.080513	0.061989	0.385555	CS pos: 23-24. AKA-IT. Pr: 0.3615    38
NZ_CP027599.1_142969	LIPO(Sec/SPII)	0.107196	0.006195	0.521556	0.365052	CS pos: 24-25. CGG-CL. Pr: 0.2944    32
NZ_CP027599.1_142995	LIPO(Sec/SPII)	0.068400	0.024228	0.472277	0.435095	CS pos: 17-18. LTG-CS. Pr: 0.4356    21
NZ_CP027599.1_142997	LIPO(Sec/SPII)	0.064012	0.004472	0.650640	0.280876	CS pos: 19-20. VTA-CW. Pr: 0.6429    22
NZ_CP027599.1_143026	SP(Sec/SPI)	0.419780	0.019216	0.258020	0.302985	CS pos: 20-21. SAA-LK. Pr: 0.1444    33
NZ_CP027599.1_143047	LIPO(Sec/SPII)	0.185487	0.004233	0.732519	0.077760	CS pos: 16-17. LSR-CF. Pr: 0.7034    25
NZ_CP027599.1_143078	LIPO(Sec/SPII)	0.246578	0.014649	0.378095	0.360678	CS pos: 14-15. ACP-CL. Pr: 0.0547    19
NZ_CP027599.1_143105	SP(Sec/SPI)	0.381090	0.021337	0.304089	0.293484	CS pos: ?. Probable protein fragment    19
NZ_CP027599.1_143109	SP(Sec/SPI)	0.458565	0.008949	0.160411	0.372075	CS pos: 22-23. TMN-AP. Pr: 0.1846    40
NZ_CP027599.1_143135	LIPO(Sec/SPII)	0.241486	0.006779	0.472469	0.279267	CS pos: 13-14. LFC-CN. Pr: 0.2187    17
NZ_CP027599.1_143137	LIPO(Sec/SPII)	0.315528	0.012277	0.445142	0.227053	CS pos: 12-13. FGV-CQ. Pr: 0.0702    15
NZ_CP027599.1_143159	SP(Sec/SPI)	0.373843	0.031203	0.297431	0.297523	CS pos: 13-14. AFC-AK. Pr: 0.0467    18
NZ_CP027599.1_143178	LIPO(Sec/SPII)	0.222583	0.023082	0.423812	0.330524	CS pos: ?. Probable protein fragment    16
NZ_CP027599.1_143181	LIPO(Sec/SPII)	0.303186	0.018760	0.427585	0.250469	CS pos: ?. Probable protein fragment    16
NZ_CP027599.1_143185	SP(Sec/SPI)	0.440100	0.040224	0.083159	0.436516	CS pos: 27-28. TQG-VR. Pr: 0.3177    35
NZ_CP027599.1_143227	LIPO(Sec/SPII)	0.262531	0.025509	0.442897	0.269063	CS pos: 18-19. SVP-CA. Pr: 0.3354    22
NZ_CP027599.1_143238	LIPO(Sec/SPII)	0.332420	0.036028	0.406713	0.224840	CS pos: 13-14. AIG-DT. Pr: 0.0923    15
NZ_CP027599.1_143247	LIPO(Sec/SPII)	0.167682	0.029334	0.450057	0.352927	CS pos: 12-13. PTA-CD. Pr: 0.3617    44
NZ_CP027599.1_143250	LIPO(Sec/SPII)	0.164554	0.036882	0.427202	0.371363	CS pos: ?. Probable protein fragment    16
NZ_CP027599.1_143262	SP(Sec/SPI)	0.605202	0.024892	0.178967	0.190938	CS pos: 19-20. ASP-AS. Pr: 0.2086    22
NZ_CP027599.1_143286	LIPO(Sec/SPII)	0.188021	0.010051	0.667793	0.134135	CS pos: 21-22. VNA-CS. Pr: 0.5615    28
NZ_CP027599.1_143287	LIPO(Sec/SPII)	0.148546	0.094776	0.433000	0.323677	CS pos: 14-15. ASG-CG. Pr: 0.2844    17
NZ_CP027599.1_143292	LIPO(Sec/SPII)	0.067335	0.013470	0.794308	0.124888	CS pos: 26-27. FSG-CD. Pr: 0.7653    47
NZ_CP027599.1_143296	LIPO(Sec/SPII)	0.273174	0.015873	0.463033	0.247920	CS pos: 11-12. ASA-CA. Pr: 0.1898    18
NZ_CP027599.1_143297	LIPO(Sec/SPII)	0.248012	0.007006	0.567905	0.177076	CS pos: ?. Probable protein fragment    17
NZ_CP027599.1_143305	LIPO(Sec/SPII)	0.136735	0.075630	0.524354	0.263281	CS pos: 18-19. GVS-CC. Pr: 0.4275    36
NZ_CP027599.1_143307	SP(Sec/SPI)	0.575499	0.042612	0.145097	0.236792	CS pos: 21-22. SMS-SM. Pr: 0.2496    28
NZ_CP027599.1_143346	SP(Sec/SPI)	0.419133	0.090850	0.107435	0.382582	CS pos: 20-21. SSA-VK. Pr: 0.2845    25
NZ_CP027599.1_143364	LIPO(Sec/SPII)	0.024764	0.002274	0.489804	0.483159	CS pos: 22-23. AGG-CD. Pr: 0.3607    50
NZ_CP027599.1_143373	LIPO(Sec/SPII)	0.214177	0.021906	0.457581	0.306336	CS pos: 14-15. LSR-CS. Pr: 0.3044    17
NZ_CP027599.1_143397	LIPO(Sec/SPII)	0.131501	0.042567	0.513033	0.312898	CS pos: 14-15. GFG-CG. Pr: 0.4106    19
NZ_CP027599.1_143403	LIPO(Sec/SPII)	0.187912	0.014417	0.432740	0.364931	CS pos: 14-15. WQS-CC. Pr: 0.2097    16
NZ_CP027599.1_143427	LIPO(Sec/SPII)	0.072679	0.020696	0.775250	0.131375	CS pos: 18-19. SGS-CS. Pr: 0.7691    50
NZ_CP027599.1_143486	SP(Sec/SPI)	0.337089	0.024589	0.323403	0.314920	CS pos: ?. Probable protein fragment    20
NZ_CP027599.1_143492	SP(Sec/SPI)	0.348842	0.274660	0.037394	0.339104	CS pos: 31-32. AKA-DL. Pr: 0.5718    35
NZ_CP027599.1_143503	LIPO(Sec/SPII)	0.223654	0.035673	0.387528	0.353145	CS pos: 21-22. SDA-CQ. Pr: 0.3484    29
NZ_CP027599.1_143512	LIPO(Sec/SPII)	0.257987	0.060647	0.340906	0.340459	CS pos: ?. Probable protein fragment    16
NZ_CP027599.1_143529	TAT(Tat/SPI)	0.105703	0.451749	0.094941	0.347607	CS pos: 23-24. GES-GC. Pr: 0.1243    45
NZ_CP027599.1_143530	LIPO(Sec/SPII)	0.152479	0.000886	0.749944	0.096692	CS pos: 16-17. TTF-CH. Pr: 0.5088    39
NZ_CP027599.1_143549	SP(Sec/SPI)	0.527038	0.034815	0.100668	0.337480	CS pos: 18-19. ALS-EK. Pr: 0.4698    24
NZ_CP027599.1_143603	SP(Sec/SPI)	0.474842	0.031542	0.165557	0.328059	CS pos: 15-16. AST-YE. Pr: 0.1751    26
NZ_CP027599.1_143712	LIPO(Sec/SPII)	0.240014	0.007104	0.449290	0.303592	CS pos: 22-23. SGW-CR. Pr: 0.0918    34
NZ_CP027599.1_143731	SP(Sec/SPI)	0.453094	0.063098	0.102640	0.381168	CS pos: 18-19. SIA-RP. Pr: 0.2693    29
NZ_CP027599.1_143763	LIPO(Sec/SPII)	0.015105	0.001287	0.919879	0.063729	CS pos: 16-17. LYS-CN. Pr: 0.9174    26
NZ_CP027599.1_143786	SP(Sec/SPI)	0.344392	0.198169	0.292281	0.165158	CS pos: 18-19. SSA-RR. Pr: 0.1201    50
NZ_CP027599.1_143850	TAT(Tat/SPI)	0.229626	0.565530	0.089203	0.115641	CS pos: 31-32. VPG-CN. Pr: 0.1622    39
NZ_CP027599.1_143864	SP(Sec/SPI)	0.789684	0.047773	0.068946	0.093597	CS pos: 24-25. LRA-TF. Pr: 0.5713    45
NZ_CP027599.1_143911	SP(Sec/SPI)	0.482604	0.225116	0.058216	0.234065	CS pos: 28-29. TGA-AT. Pr: 0.4385    44
NZ_CP027599.1_143922	LIPO(Sec/SPII)	0.006672	0.000462	0.981056	0.011810	CS pos: 17-18. SLS-CN. Pr: 0.9803    39
NZ_CP027599.1_143941	LIPO(Sec/SPII)	0.047619	0.004320	0.616254	0.331807	CS pos: 16-17. FLT-CD. Pr: 0.6118    41
NZ_CP027599.1_143989	LIPO(Sec/SPII)	0.124565	0.012423	0.520716	0.342296	CS pos: 22-23. VFT-CT. Pr: 0.4809    31
NZ_CP027599.1_143996	LIPO(Sec/SPII)	0.185815	0.017308	0.421651	0.375226	CS pos: ?. Probable protein fragment    16
NZ_CP027599.1_144008	LIPO(Sec/SPII)	0.080010	0.007320	0.694858	0.217812	CS pos: 13-14. VLG-CE. Pr: 0.6924    24
NZ_CP027599.1_144161	SP(Sec/SPI)	0.448324	0.104894	0.110424	0.336359	CS pos: 29-30. LQA-LR. Pr: 0.2920    37
NZ_CP027599.1_144192	LIPO(Sec/SPII)	0.274308	0.003372	0.617656	0.104663	CS pos: 13-14. GWI-CG. Pr: 0.3063    29
NZ_CP027599.1_144201	LIPO(Sec/SPII)	0.212525	0.102595	0.381125	0.303755	CS pos: 20-21. RSG-CA. Pr: 0.3125    33
NZ_CP027599.1_144254	LIPO(Sec/SPII)	0.170611	0.007724	0.636141	0.185524	CS pos: 15-16. VPA-CR. Pr: 0.3773    17
NZ_CP027599.1_144278	LIPO(Sec/SPII)	0.213575	0.001735	0.651500	0.133190	CS pos: 18-19. SLV-CS. Pr: 0.5843    37
NZ_CP027599.1_144300	SP(Sec/SPI)	0.403797	0.003585	0.330821	0.261798	CS pos: 19-20. CWK-FN. Pr: 0.2053    35
NZ_CP027599.1_144318	LIPO(Sec/SPII)	0.180485	0.003071	0.671897	0.144548	CS pos: 19-20. LLP-CK. Pr: 0.5738    23
NZ_CP027599.1_144346	LIPO(Sec/SPII)	0.274561	0.017162	0.404067	0.304209	CS pos: ?. Probable protein fragment    17
NZ_CP027599.1_144389	LIPO(Sec/SPII)	0.250606	0.019993	0.431219	0.298182	CS pos: ?. Probable protein fragment    16
NZ_CP027599.1_144415	SP(Sec/SPI)	0.647521	0.028771	0.056650	0.267059	CS pos: 21-22. AAG-SM. Pr: 0.2666    33
NZ_CP027599.1_144416	LIPO(Sec/SPII)	0.032008	0.051178	0.738382	0.178432	CS pos: 28-29. FSS-CC. Pr: 0.7187    48
NZ_CP027599.1_144428	LIPO(Sec/SPII)	0.016520	0.001129	0.851486	0.130865	CS pos: 21-22. FAA-CG. Pr: 0.8505    34
NZ_CP027599.1_144444	LIPO(Sec/SPII)	0.376271	0.010554	0.408218	0.204957	CS pos: ?. Probable protein fragment    16
NZ_CP027599.1_144472	SP(Sec/SPI)	0.538437	0.031753	0.034762	0.395049	CS pos: 23-24. SQA-RY. Pr: 0.5302    32
NZ_CP027599.1_144521	LIPO(Sec/SPII)	0.299553	0.021805	0.448261	0.230381	CS pos: ?. Probable protein fragment    16
NZ_CP027599.1_144544	LIPO(Sec/SPII)	0.102188	0.089148	0.732376	0.076287	CS pos: 12-13. VSA-CF. Pr: 0.4206    48
NZ_CP027599.1_144547	LIPO(Sec/SPII)	0.136112	0.032892	0.613578	0.217418	CS pos: 15-16. SAA-CC. Pr: 0.4837    20
NZ_CP027599.1_144550	TAT(Tat/SPI)	0.283810	0.314426	0.143502	0.258262	CS pos: 24-25. ATA-VS. Pr: 0.2019    29
NZ_CP027599.1_144555	SP(Sec/SPI)	0.793131	0.047536	0.039972	0.119360	CS pos: 20-21. VKA-LS. Pr: 0.4988    47
NZ_CP027599.1_144560	LIPO(Sec/SPII)	0.242764	0.033673	0.376912	0.346651	CS pos: ?. Probable protein fragment    19
NZ_CP027599.1_144561	TAT(Tat/SPI)	0.114953	0.436922	0.094107	0.354018	CS pos: 21-22. AGA-KH. Pr: 0.2631    28
NZ_CP027599.1_144585	LIPO(Sec/SPII)	0.261844	0.058113	0.384994	0.295049	CS pos: ?. Probable protein fragment    15
NZ_CP027599.1_144589	LIPO(Sec/SPII)	0.312316	0.035824	0.378850	0.273009	CS pos: 17-18. LSS-SR. Pr: 0.1707    27
NZ_CP027599.1_144599	LIPO(Sec/SPII)	0.275748	0.021199	0.351908	0.351145	CS pos: 18-19. ASV-CA. Pr: 0.1981    21
NZ_CP027599.1_144600	LIPO(Sec/SPII)	0.338602	0.064502	0.380822	0.216073	CS pos: 21-22. TAG-CP. Pr: 0.3073    24
NZ_CP027599.1_144639	LIPO(Sec/SPII)	0.199047	0.026784	0.450740	0.323428	CS pos: 13-14. SSK-CS. Pr: 0.3265    16
NZ_CP027599.1_144640	TAT(Tat/SPI)	0.135756	0.474604	0.028915	0.360724	CS pos: 24-25. NSA-NL. Pr: 0.2336    34
NZ_CP027599.1_144654	SP(Sec/SPI)	0.371612	0.056273	0.206823	0.365291	CS pos: 14-15. SHA-AG. Pr: 0.1420    23
NZ_CP027599.1_144696	LIPO(Sec/SPII)	0.131757	0.014575	0.464468	0.389199	CS pos: 21-22. VSS-CF. Pr: 0.3270    28
NZ_CP027599.1_144731	LIPO(Sec/SPII)	0.114251	0.003325	0.686625	0.195799	CS pos: 19-20. LSK-CY. Pr: 0.6368    26
NZ_CP027599.1_144737	SP(Sec/SPI)	0.836490	0.097633	0.026272	0.039605	CS pos: 19-20. SRA-SW. Pr: 0.4955    30
NZ_CP027599.1_144747	LIPO(Sec/SPII)	0.127982	0.006805	0.438196	0.427017	CS pos: 33-34. ENA-CS. Pr: 0.3430    47
NZ_CP027599.1_144748	SP(Sec/SPI)	0.477991	0.081391	0.100589	0.340029	CS pos: 24-25. ALA-NQ. Pr: 0.3940    29
NZ_CP027599.1_144754	SP(Sec/SPI)	0.490945	0.056261	0.200856	0.251937	CS pos: 18-19. SVS-GP. Pr: 0.0780    31
NZ_CP027599.1_144791	LIPO(Sec/SPII)	0.179095	0.031767	0.402854	0.386284	CS pos: 18-19. SYS-CH. Pr: 0.3078    23
NZ_CP027599.1_144812	SP(Sec/SPI)	0.319132	0.241210	0.186949	0.252708	CS pos: ?. Probable protein fragment    20
NZ_CP027599.1_144813	SP(Sec/SPI)	0.482487	0.109648	0.159664	0.248201	CS pos: 21-22. TRS-AS. Pr: 0.2146    40
NZ_CP027599.1_144825	TAT(Tat/SPI)	0.124491	0.387012	0.141271	0.347225	CS pos: 32-33. VSS-IR. Pr: 0.1204    48
NZ_CP027599.1_144831	LIPO(Sec/SPII)	0.089655	0.010441	0.614433	0.285471	CS pos: 14-15. LTN-CA. Pr: 0.5801    42
NZ_CP027599.1_144847	SP(Sec/SPI)	0.418567	0.017875	0.197037	0.366522	CS pos: 17-18. VNA-AN. Pr: 0.1908    31
NZ_CP027599.1_144914	LIPO(Sec/SPII)	0.023572	0.002240	0.654559	0.319630	CS pos: 18-19. MNG-CN. Pr: 0.6583    32
NZ_CP027599.1_144921	SP(Sec/SPI)	0.453787	0.014950	0.177094	0.354169	CS pos: 17-18. FPA-VD. Pr: 0.1343    20
NZ_CP027599.1_144967	LIPO(Sec/SPII)	0.242839	0.007746	0.436701	0.312713	CS pos: 15-16. TVH-CA. Pr: 0.1887    20
NZ_CP027599.1_144979	LIPO(Sec/SPII)	0.142926	0.011152	0.438507	0.407415	CS pos: 16-17. IPS-CM. Pr: 0.1776    25
NZ_CP027599.1_144998	SP(Sec/SPI)	0.449709	0.013411	0.157909	0.378971	CS pos: 23-24. LLA-LI. Pr: 0.2788    32
NZ_CP027599.1_145020	LIPO(Sec/SPII)	0.389939	0.006816	0.511203	0.092041	CS pos: 13-14. VSA-CC. Pr: 0.3496    20
NZ_CP027599.1_145028	TAT(Tat/SPI)	0.167160	0.333608	0.167982	0.331251	CS pos: 26-27. SCA-IS. Pr: 0.1039    46
NZ_CP027599.1_145042	LIPO(Sec/SPII)	0.198451	0.066794	0.424769	0.309986	CS pos: 23-24. ALN-CS. Pr: 0.3818    34
NZ_CP027599.1_145045	SP(Sec/SPI)	0.474548	0.016821	0.237360	0.271271	CS pos: 13-14. ASA-SG. Pr: 0.1267    27
NZ_CP027599.1_145089	SP(Sec/SPI)	0.367645	0.056547	0.236317	0.339491	CS pos: 16-17. SWS-WV. Pr: 0.0793    30
NZ_CP027599.1_145090	TAT(Tat/SPI)	0.079709	0.787238	0.019530	0.113523	CS pos: 33-34. ARA-SA. Pr: 0.3598    47
NZ_CP027599.1_145127	LIPO(Sec/SPII)	0.099955	0.018941	0.744393	0.136711	CS pos: 16-17. AHC-CS. Pr: 0.4344    32
NZ_CP027599.1_145136	LIPO(Sec/SPII)	0.343460	0.013265	0.426747	0.216528	CS pos: ?. Probable protein fragment    18
NZ_CP027599.1_145142	LIPO(Sec/SPII)	0.302424	0.021974	0.386040	0.289562	CS pos: 12-13. MIF-CS. Pr: 0.1417    16
NZ_CP027599.1_145153	LIPO(Sec/SPII)	0.335061	0.013057	0.351752	0.300130	CS pos: 14-15. AVA-RR. Pr: 0.1399    17
NZ_CP027599.1_145173	LIPO(Sec/SPII)	0.268027	0.011555	0.481600	0.238819	CS pos: 22-23. IST-CC. Pr: 0.3787    24
NZ_CP027599.1_145187	LIPO(Sec/SPII)	0.050091	0.058715	0.764182	0.127012	CS pos: 22-23. IIC-CL. Pr: 0.6781    49
NZ_CP027599.1_145196	LIPO(Sec/SPII)	0.097304	0.023555	0.467328	0.411813	CS pos: 25-26. LSS-CC. Pr: 0.4001    35
NZ_CP027599.1_145203	LIPO(Sec/SPII)	0.208473	0.044383	0.474765	0.272379	CS pos: 20-21. AAV-CS. Pr: 0.3959    25
NZ_CP027599.1_145207	SP(Sec/SPI)	0.565836	0.042390	0.145923	0.245851	CS pos: 16-17. VSS-EG. Pr: 0.3944    31
NZ_CP027599.1_145257	SP(Sec/SPI)	0.344784	0.050687	0.326791	0.277737	CS pos: 21-22. AIS-KL. Pr: 0.1065    32
NZ_CP027599.1_145268	SP(Sec/SPI)	0.675867	0.010393	0.211902	0.101839	CS pos: 20-21. VVG-HP. Pr: 0.4589    27
NZ_CP027599.1_145269	LIPO(Sec/SPII)	0.279208	0.011066	0.417207	0.292520	CS pos: 21-22. NAG-CC. Pr: 0.3917    44
NZ_CP027599.1_145293	SP(Sec/SPI)	0.443213	0.086921	0.047037	0.422829	CS pos: 17-18. AHA-FQ. Pr: 0.4475    25
NZ_CP027599.1_145302	SP(Sec/SPI)	0.508986	0.093638	0.086097	0.311279	CS pos: 18-19. ADS-AE. Pr: 0.2453    26
NZ_CP027599.1_145306	SP(Sec/SPI)	0.382540	0.326247	0.069681	0.221532	CS pos: 22-23. ITA-SP. Pr: 0.3392    31
NZ_CP027599.1_145315	LIPO(Sec/SPII)	0.142460	0.032799	0.554203	0.270539	CS pos: 13-14. ATT-CP. Pr: 0.5122    42
NZ_CP027599.1_145335	TAT(Tat/SPI)	0.224320	0.505401	0.061192	0.209087	CS pos: 22-23. AFA-RP. Pr: 0.4006    33
NZ_CP027599.1_145357	LIPO(Sec/SPII)	0.197944	0.014809	0.565391	0.221856	CS pos: 19-20. FTT-CS. Pr: 0.4715    24
NZ_CP027599.1_145368	LIPO(Sec/SPII)	0.127214	0.091526	0.590286	0.190973	CS pos: 13-14. IIS-CT. Pr: 0.5751    46
NZ_CP027599.1_145392	LIPO(Sec/SPII)	0.072836	0.008383	0.688439	0.230342	CS pos: 23-24. STA-CV. Pr: 0.6660    30
NZ_CP027599.1_145411	SP(Sec/SPI)	0.371153	0.020573	0.253099	0.355175	CS pos: ?. Probable protein fragment    18
NZ_CP027599.1_145413	SP(Sec/SPI)	0.551397	0.097136	0.068121	0.283346	CS pos: 28-29. TDA-IG. Pr: 0.3426    33
NZ_CP027599.1_145423	LIPO(Sec/SPII)	0.205879	0.018116	0.555609	0.220396	CS pos: 17-18. RCA-CS. Pr: 0.3596    19
NZ_CP027599.1_145470	LIPO(Sec/SPII)	0.239623	0.047137	0.475458	0.237782	CS pos: 12-13. TTG-CV. Pr: 0.1236    17
NZ_CP027599.1_145493	SP(Sec/SPI)	0.346871	0.134528	0.194931	0.323670	CS pos: 17-18. VSA-VT. Pr: 0.3333    39
NZ_CP027599.1_145496	TAT(Tat/SPI)	0.183082	0.619188	0.023106	0.174623	CS pos: 42-43. IHA-VS. Pr: 0.2085    50
NZ_CP027599.1_145505	LIPO(Sec/SPII)	0.243317	0.115691	0.325246	0.315746	CS pos: 24-25. LNG-SS. Pr: 0.2476    42
NZ_CP027599.1_145519	LIPO(Sec/SPII)	0.217418	0.047447	0.390689	0.344446	CS pos: ?. Probable protein fragment    20
NZ_CP027599.1_145532	SP(Sec/SPI)	0.435901	0.083027	0.088949	0.392123	CS pos: 18-19. AQG-AS. Pr: 0.2731    23
NZ_CP027599.1_145566	LIPO(Sec/SPII)	0.078090	0.001469	0.881539	0.038903	CS pos: 13-14. LPG-CW. Pr: 0.6639    20
NZ_CP027599.1_145584	LIPO(Sec/SPII)	0.188955	0.001665	0.774747	0.034633	CS pos: 17-18. ICS-CK. Pr: 0.6824    24
NZ_CP027599.1_145590	LIPO(Sec/SPII)	0.271322	0.016640	0.377799	0.334239	CS pos: ?. Probable protein fragment    17
NZ_CP027599.1_145603	LIPO(Sec/SPII)	0.272193	0.013374	0.482420	0.232013	CS pos: 15-16. CSL-CW. Pr: 0.0879    23
NZ_CP027599.1_145604	LIPO(Sec/SPII)	0.147919	0.015674	0.452165	0.384243	CS pos: 22-23. AGS-CC. Pr: 0.2400    35
NZ_CP027599.1_145632	TAT(Tat/SPI)	0.279576	0.319825	0.085019	0.315579	CS pos: 27-28. TRA-GQ. Pr: 0.0812    33
NZ_CP027599.1_145642	SP(Sec/SPI)	0.412538	0.195522	0.135980	0.255960	CS pos: 31-32. INA-SC. Pr: 0.0998    48
NZ_CP027599.1_145649	TAT(Tat/SPI)	0.188818	0.341448	0.301517	0.168217	CS pos: 25-26. ACA-AS. Pr: 0.0584    29
NZ_CP027599.1_145655	SP(Sec/SPI)	0.418680	0.034158	0.212280	0.334882	CS pos: ?. Probable protein fragment    20
NZ_CP027599.1_145656	TAT(Tat/SPI)	0.368791	0.448703	0.033547	0.148958	CS pos: 25-26. TAA-VP. Pr: 0.5948    30
NZ_CP027599.1_145658	LIPO(Sec/SPII)	0.247663	0.023774	0.485369	0.243194	CS pos: 13-14. AIS-CC. Pr: 0.1614    20
NZ_CP027599.1_145701	TAT(Tat/SPI)	0.095795	0.410483	0.102484	0.391237	CS pos: 32-33. SLC-SP. Pr: 0.0821    43
NZ_CP027599.1_145704	LIPO(Sec/SPII)	0.280135	0.001096	0.709567	0.009203	CS pos: 17-18. FVG-CG. Pr: 0.6725    37
NZ_CP027599.1_145713	LIPO(Sec/SPII)	0.210070	0.038377	0.394801	0.356752	CS pos: ?. Probable protein fragment    25
NZ_CP027599.1_145755	LIPO(Sec/SPII)	0.033282	0.065159	0.847171	0.054388	CS pos: 22-23. GTG-CP. Pr: 0.8349    33
NZ_CP027599.1_145774	LIPO(Sec/SPII)	0.099253	0.003685	0.465976	0.431087	CS pos: 22-23. SIA-CM. Pr: 0.4434    32
NZ_CP027599.1_145795	LIPO(Sec/SPII)	0.103571	0.134462	0.443260	0.318707	CS pos: 14-15. LAG-CS. Pr: 0.3825    49
NZ_CP027599.1_145797	SP(Sec/SPI)	0.559443	0.125523	0.262796	0.052238	CS pos: 25-26. ARP-SP. Pr: 0.2809    39
NZ_CP027599.1_145802	LIPO(Sec/SPII)	0.140424	0.006020	0.782884	0.070673	CS pos: 16-17. AIS-CG. Pr: 0.7759    24
NZ_CP027599.1_145806	SP(Sec/SPI)	0.540879	0.088068	0.054872	0.316181	CS pos: 29-30. TGA-LC. Pr: 0.3236    39
NZ_CP027599.1_145810	LIPO(Sec/SPII)	0.050581	0.011779	0.737257	0.200383	CS pos: 28-29. AAG-CY. Pr: 0.7279    32
NZ_CP027599.1_145865	LIPO(Sec/SPII)	0.088410	0.002508	0.482814	0.426267	CS pos: 18-19. YTG-CI. Pr: 0.4305    30
NZ_CP027599.1_145883	SP(Sec/SPI)	0.417511	0.018371	0.241041	0.323077	CS pos: 19-20. RFA-AP. Pr: 0.3311    27
NZ_CP027599.1_145884	LIPO(Sec/SPII)	0.161478	0.009997	0.421498	0.407027	CS pos: ?. Probable protein fragment    19
NZ_CP027599.1_146003	SP(Sec/SPI)	0.409292	0.021299	0.320914	0.248494	CS pos: 24-25. ARR-LS. Pr: 0.1099    33
NZ_CP027599.1_146011	SP(Sec/SPI)	0.470383	0.033837	0.154643	0.341136	CS pos: 20-21. IKS-AS. Pr: 0.1845    24
NZ_CP027599.1_146027	LIPO(Sec/SPII)	0.264901	0.074955	0.332216	0.327927	CS pos: ?. Probable protein fragment    16
NZ_CP027599.1_146067	LIPO(Sec/SPII)	0.091395	0.217456	0.479931	0.211218	CS pos: 30-31. ING-CG. Pr: 0.4777    36
NZ_CP027599.1_146072	SP(Sec/SPI)	0.488417	0.009688	0.355528	0.146366	CS pos: 27-28. CHA-SI. Pr: 0.1370    29
NZ_CP027599.1_146103	SP(Sec/SPI)	0.369266	0.052613	0.281793	0.296328	CS pos: 27-28. CSA-ES. Pr: 0.3645    32
NZ_CP027599.1_146111	SP(Sec/SPI)	0.563210	0.024942	0.093301	0.318546	CS pos: 18-19. VHS-VG. Pr: 0.3891    27
NZ_CP027599.1_146124	SP(Sec/SPI)	0.700851	0.187982	0.019199	0.091967	CS pos: 31-32. VLA-AI. Pr: 0.7205    45
NZ_CP027599.1_146148	SP(Sec/SPI)	0.560697	0.051223	0.049139	0.338942	CS pos: 19-20. ASA-AM. Pr: 0.4620    43
NZ_CP027599.1_146169	LIPO(Sec/SPII)	0.159887	0.010717	0.595547	0.233848	CS pos: 18-19. LNT-CQ. Pr: 0.4390    23
NZ_CP027599.1_146173	SP(Sec/SPI)	0.391050	0.024554	0.361432	0.222963	CS pos: 19-20. LLS-SS. Pr: 0.1612    24
NZ_CP027599.1_146242	SP(Sec/SPI)	0.589420	0.049420	0.152643	0.208518	CS pos: 17-18. IQA-QP. Pr: 0.4907    19
NZ_CP027599.1_146281	LIPO(Sec/SPII)	0.188364	0.018098	0.504248	0.289291	CS pos: 18-19. CAA-CW. Pr: 0.2613    29
NZ_CP027599.1_146301	LIPO(Sec/SPII)	0.198241	0.010601	0.480462	0.310696	CS pos: 19-20. LTC-CS. Pr: 0.2614    44
NZ_CP027599.1_146321	LIPO(Sec/SPII)	0.169720	0.002055	0.814515	0.013710	CS pos: 21-22. GFA-CP. Pr: 0.8207    39
NZ_CP027599.1_146324	LIPO(Sec/SPII)	0.274613	0.019441	0.370127	0.335818	CS pos: 13-14. LHK-LQ. Pr: 0.0298    15
NZ_CP027599.1_146338	LIPO(Sec/SPII)	0.182886	0.008202	0.532387	0.276525	CS pos: 23-24. IAS-CS. Pr: 0.3984    26
NZ_CP027599.1_146342	SP(Sec/SPI)	0.500993	0.097643	0.153362	0.248003	CS pos: 25-26. TKA-SP. Pr: 0.2483    30
NZ_CP027599.1_146359	SP(Sec/SPI)	0.482662	0.171766	0.186469	0.159103	CS pos: 23-24. VAS-ST. Pr: 0.2290    28
NZ_CP027599.1_146380	LIPO(Sec/SPII)	0.102602	0.106086	0.558531	0.232781	CS pos: 24-25. VTV-CT. Pr: 0.4686    42
NZ_CP027599.1_146381	LIPO(Sec/SPII)	0.176947	0.033050	0.462082	0.327920	CS pos: 26-27. TAG-CS. Pr: 0.3761    29
NZ_CP027599.1_146419	SP(Sec/SPI)	0.772969	0.011223	0.024223	0.191584	CS pos: 20-21. IFA-AE. Pr: 0.7232    38
NZ_CP027599.1_146426	SP(Sec/SPI)	0.722587	0.018703	0.096167	0.162543	CS pos: ?. Probable protein fragment    18
NZ_CP027599.1_146433	SP(Sec/SPI)	0.414943	0.137386	0.090800	0.356870	CS pos: 17-18. SRA-TG. Pr: 0.1635    35
NZ_CP027599.1_146439	SP(Sec/SPI)	0.696852	0.092234	0.075752	0.135163	CS pos: 29-30. VAG-EP. Pr: 0.2759    39
NZ_CP027599.1_146443	LIPO(Sec/SPII)	0.204333	0.079329	0.526154	0.190183	CS pos: 20-21. AAA-CF. Pr: 0.5138    32
NZ_CP027599.1_146447	LIPO(Sec/SPII)	0.149205	0.081189	0.413320	0.356286	CS pos: 18-19. SIN-CD. Pr: 0.3920    43
NZ_CP027599.1_146486	SP(Sec/SPI)	0.457801	0.005924	0.233764	0.302510	CS pos: 20-21. STG-NQ. Pr: 0.2493    32
NZ_CP027599.1_146497	SP(Sec/SPI)	0.525301	0.012648	0.154525	0.307526	CS pos: ?. Probable protein fragment    25
NZ_CP027599.1_146521	SP(Sec/SPI)	0.560794	0.031259	0.109869	0.298078	CS pos: 17-18. VFG-EN. Pr: 0.2334    25
NZ_CP027599.1_146574	LIPO(Sec/SPII)	0.175340	0.017536	0.530316	0.276809	CS pos: 19-20. FTS-CS. Pr: 0.4749    35
NZ_CP027599.1_146592	SP(Sec/SPI)	0.639643	0.031713	0.039315	0.289329	CS pos: 31-32. VNS-EL. Pr: 0.5981    49
NZ_CP027599.1_146604	LIPO(Sec/SPII)	0.237380	0.034349	0.392360	0.335911	CS pos: ?. Probable protein fragment    15
NZ_CP027599.1_146615	SP(Sec/SPI)	0.569743	0.011258	0.082229	0.336770	CS pos: 22-23. GYS-DS. Pr: 0.4601    38
NZ_CP027599.1_146635	LIPO(Sec/SPII)	0.092979	0.037678	0.446246	0.423097	CS pos: 20-21. TTA-CQ. Pr: 0.4372    31
NZ_CP027599.1_146644	LIPO(Sec/SPII)	0.371403	0.011337	0.417872	0.199387	CS pos: 19-20. ATT-CR. Pr: 0.2711    29
NZ_CP027599.1_146663	LIPO(Sec/SPII)	0.157509	0.008960	0.637790	0.195742	CS pos: 19-20. VYG-CC. Pr: 0.4816    23
NZ_CP027599.1_146674	SP(Sec/SPI)	0.494957	0.051425	0.239785	0.213832	CS pos: 18-19. SSA-IC. Pr: 0.1274    26
NZ_CP027599.1_146677	LIPO(Sec/SPII)	0.192502	0.024379	0.475120	0.307999	CS pos: 15-16. VPS-CS. Pr: 0.2890    20
NZ_CP027599.1_146687	LIPO(Sec/SPII)	0.308968	0.026137	0.491540	0.173356	CS pos: 19-20. FCS-CA. Pr: 0.4034    30
NZ_CP027599.1_146979	SP(Sec/SPI)	0.724049	0.108697	0.055164	0.112091	CS pos: 25-26. AVA-AS. Pr: 0.6396    36
NZ_CP027599.1_147280	SP(Sec/SPI)	0.642224	0.055841	0.042506	0.259429	CS pos: 12-13. AEA-AD. Pr: 0.6195    19
NZ_CP027599.1_147348	SP(Sec/SPI)	0.515145	0.068181	0.052916	0.363758	CS pos: 20-21. SAA-TG. Pr: 0.2657    47
NZ_CP027599.1_147363	TAT(Tat/SPI)	0.058722	0.824405	0.108200	0.008673	CS pos: 28-29. AAA-FS. Pr: 0.5849    48
NZ_CP027599.1_147391	SP(Sec/SPI)	0.986781	0.002951	0.008455	0.001812	CS pos: 22-23. ASA-AS. Pr: 0.9342    43
NZ_CP027599.1_147427	LIPO(Sec/SPII)	0.046041	0.007472	0.752427	0.194059	CS pos: 23-24. AHG-CH. Pr: 0.7018    34
NZ_CP027599.1_147429	SP(Sec/SPI)	0.331864	0.149557	0.203747	0.314831	CS pos: ?. Probable protein fragment    20
NZ_CP027599.1_147461	TAT(Tat/SPI)	0.219292	0.412924	0.033190	0.334594	CS pos: 30-31. ARA-TE. Pr: 0.2938    46
NZ_CP027599.1_147470	SP(Sec/SPI)	0.625560	0.027982	0.175542	0.170916	CS pos: 17-18. GSA-EK. Pr: 0.4313    30
NZ_CP027599.1_147476	LIPO(Sec/SPII)	0.203849	0.164716	0.317126	0.314310	CS pos: ?. Probable protein fragment    16
NZ_CP027599.1_147500	LIPO(Sec/SPII)	0.151100	0.039171	0.435618	0.374111	CS pos: 22-23. LLS-CQ. Pr: 0.3620    25
NZ_CP027599.1_147505	LIPO(Sec/SPII)	0.141962	0.019404	0.561251	0.277384	CS pos: 14-15. TMG-CF. Pr: 0.4937    22
NZ_CP027599.1_147519	LIPO(Sec/SPII)	0.164515	0.054323	0.510075	0.271087	CS pos: 16-17. FSS-CT. Pr: 0.3865    20
NZ_CP027599.1_147520	LIPO(Sec/SPII)	0.033268	0.005014	0.934251	0.027467	CS pos: 17-18. VTG-CL. Pr: 0.9245    27
NZ_CP027599.1_147526	SP(Sec/SPI)	0.429783	0.188892	0.010484	0.370841	CS pos: 23-24. IHA-RL. Pr: 0.5752    36
NZ_CP027599.1_147527	LIPO(Sec/SPII)	0.393162	0.024184	0.399481	0.183173	CS pos: 11-12. FHG-CY. Pr: 0.3035    16
NZ_CP027599.1_147548	LIPO(Sec/SPII)	0.260089	0.019882	0.434655	0.285373	CS pos: ?. Probable protein fragment    19
NZ_CP027599.1_147553	SP(Sec/SPI)	0.639535	0.124309	0.072675	0.163481	CS pos: 24-25. SSA-AA. Pr: 0.3159    28
NZ_CP027599.1_147557	LIPO(Sec/SPII)	0.037539	0.002198	0.907739	0.052524	CS pos: 20-21. PAG-CI. Pr: 0.9001    37
NZ_CP027599.1_147560	SP(Sec/SPI)	0.454399	0.013538	0.365800	0.166263	CS pos: ?. Probable protein fragment    18
NZ_CP027599.1_147561	LIPO(Sec/SPII)	0.247224	0.010378	0.480324	0.262074	CS pos: 14-15. LVR-CF. Pr: 0.3354    18
NZ_CP027599.1_147562	SP(Sec/SPI)	0.415075	0.009426	0.347455	0.228044	CS pos: 26-27. LFS-QV. Pr: 0.2525    49
NZ_CP027599.1_147602	LIPO(Sec/SPII)	0.135726	0.036742	0.716923	0.110609	CS pos: 33-34. LIA-CS. Pr: 0.6839    48
NZ_CP027599.1_147604	TAT(Tat/SPI)	0.330922	0.425732	0.067926	0.175420	CS pos: 23-24. TRA-AS. Pr: 0.3674    40
NZ_CP027599.1_147622	TAT(Tat/SPI)	0.267743	0.356779	0.138752	0.236727	CS pos: 37-38. SNC-ST. Pr: 0.1002    41
NZ_CP027599.1_147623	LIPO(Sec/SPII)	0.134606	0.012159	0.599420	0.253814	CS pos: 18-19. AAS-CS. Pr: 0.5003    30
NZ_CP027599.1_147629	LIPO(Sec/SPII)	0.005607	0.004638	0.977677	0.012078	CS pos: 18-19. LIA-CA. Pr: 0.9723    43
NZ_CP027599.1_147630	SP(Sec/SPI)	0.661522	0.116396	0.140036	0.082047	CS pos: 27-28. AGA-PT. Pr: 0.2422    49
NZ_CP027599.1_147643	LIPO(Sec/SPII)	0.238438	0.026879	0.379795	0.354888	CS pos: ?. Probable protein fragment    18
NZ_CP027599.1_147647	LIPO(Sec/SPII)	0.248992	0.036920	0.465981	0.248107	CS pos: 10-11. SSA-CQ. Pr: 0.4071    15
NZ_CP027599.1_147674	LIPO(Sec/SPII)	0.221653	0.047076	0.552796	0.178475	CS pos: 14-15. VSS-CS. Pr: 0.2545    22
NZ_CP027599.1_147694	SP(Sec/SPI)	0.444511	0.076989	0.088562	0.389938	CS pos: 11-12. VRA-EY. Pr: 0.2745    25
NZ_CP027599.1_147707	SP(Sec/SPI)	0.619839	0.014272	0.119186	0.246703	CS pos: 23-24. ISA-KQ. Pr: 0.5539    36
NZ_CP027599.1_147713	SP(Sec/SPI)	0.427410	0.019323	0.221390	0.331877	CS pos: 24-25. NYA-SV. Pr: 0.2272    26
NZ_CP027599.1_147714	LIPO(Sec/SPII)	0.246733	0.065991	0.390890	0.296386	CS pos: 18-19. APA-CT. Pr: 0.3379    21
NZ_CP027599.1_147715	LIPO(Sec/SPII)	0.130314	0.095252	0.497687	0.276747	CS pos: 19-20. TAG-CA. Pr: 0.4745    39
NZ_CP027599.1_147723	SP(Sec/SPI)	0.623878	0.025517	0.198034	0.152572	CS pos: ?. Probable protein fragment    20
NZ_CP027599.1_147764	LIPO(Sec/SPII)	0.195664	0.027257	0.444953	0.332126	CS pos: 25-26. WMA-CW. Pr: 0.4366    43
NZ_CP027599.1_147772	LIPO(Sec/SPII)	0.291871	0.026369	0.395449	0.286311	CS pos: ?. Probable protein fragment    16
NZ_CP027599.1_147791	LIPO(Sec/SPII)	0.168611	0.027503	0.456849	0.347038	CS pos: 16-17. VAR-CT. Pr: 0.4418    41
NZ_CP027599.1_147868	LIPO(Sec/SPII)	0.218268	0.038445	0.547893	0.195394	CS pos: 17-18. VSA-CR. Pr: 0.4456    24
NZ_CP027599.1_147906	TAT(Tat/SPI)	0.100133	0.556137	0.041824	0.301905	CS pos: 30-31. ASC-GA. Pr: 0.1251    33
NZ_CP027599.1_147917	LIPO(Sec/SPII)	0.052706	0.002667	0.858129	0.086498	CS pos: 18-19. FSA-CA. Pr: 0.8167    24
NZ_CP027599.1_147919	SP(Sec/SPI)	0.759414	0.046937	0.132931	0.060718	CS pos: 20-21. ALA-TS. Pr: 0.6603    29
NZ_CP027599.1_147920	SP(Sec/SPI)	0.566375	0.089118	0.055060	0.289447	CS pos: 18-19. TLA-AD. Pr: 0.5498    42
NZ_CP027599.1_147955	LIPO(Sec/SPII)	0.172339	0.017504	0.671486	0.138671	CS pos: 16-17. FAT-CC. Pr: 0.3799    19
NZ_CP027599.1_147985	LIPO(Sec/SPII)	0.143830	0.037661	0.652934	0.165575	CS pos: 22-23. LAS-CS. Pr: 0.6036    29
NZ_CP027599.1_147992	LIPO(Sec/SPII)	0.126498	0.010506	0.687887	0.175109	CS pos: 18-19. LSG-CA. Pr: 0.6525    27
NZ_CP027599.1_147993	LIPO(Sec/SPII)	0.159558	0.004775	0.663783	0.171885	CS pos: 20-21. LVI-CS. Pr: 0.5619    26
NZ_CP027599.1_148002	SP(Sec/SPI)	0.502209	0.057675	0.316854	0.123262	CS pos: 14-15. ANA-AS. Pr: 0.2589    20
NZ_CP027599.1_148011	LIPO(Sec/SPII)	0.213086	0.033900	0.502343	0.250671	CS pos: 13-14. SLA-CW. Pr: 0.3399    18
NZ_CP027599.1_148022	LIPO(Sec/SPII)	0.302416	0.018092	0.388395	0.291098	CS pos: ?. Probable protein fragment    23
NZ_CP027599.1_148029	TAT(Tat/SPI)	0.287904	0.371496	0.026021	0.314579	CS pos: 30-31. AAA-AA. Pr: 0.3036    39
NZ_CP027599.1_148048	SP(Sec/SPI)	0.289571	0.206461	0.258928	0.245040	CS pos: 16-17. CAA-SR. Pr: 0.1210    25
NZ_CP027599.1_148060	SP(Sec/SPI)	0.407367	0.164441	0.065899	0.362293	CS pos: 22-23. SSA-LS. Pr: 0.2029    33
NZ_CP027599.1_148086	SP(Sec/SPI)	0.529340	0.012669	0.205441	0.252550	CS pos: 18-19. VYA-KC. Pr: 0.4463    45
NZ_CP027599.1_148089	SP(Sec/SPI)	0.395552	0.028372	0.293662	0.282415	CS pos: 19-20. LSG-HP. Pr: 0.1365    42
NZ_CP027599.1_148093	LIPO(Sec/SPII)	0.237907	0.013804	0.409636	0.338652	CS pos: 19-20. TPT-CW. Pr: 0.3715    31
NZ_CP027599.1_148099	LIPO(Sec/SPII)	0.109534	0.041665	0.647507	0.201294	CS pos: 20-21. PSA-CF. Pr: 0.6202    30
NZ_CP027599.1_148102	SP(Sec/SPI)	0.494228	0.022880	0.037499	0.445393	CS pos: 26-27. IRA-HF. Pr: 0.3746    38
NZ_CP027599.1_148116	LIPO(Sec/SPII)	0.104836	0.057787	0.513508	0.323869	CS pos: 19-20. TFS-CP. Pr: 0.3541    31
NZ_CP027599.1_148127	SP(Sec/SPI)	0.383910	0.007726	0.351400	0.256964	CS pos: ?. Probable protein fragment    21
NZ_CP027599.1_148175	LIPO(Sec/SPII)	0.192539	0.031754	0.605378	0.170329	CS pos: 16-17. AAR-CT. Pr: 0.5252    23
NZ_CP027599.1_148227	LIPO(Sec/SPII)	0.081160	0.015194	0.594462	0.309184	CS pos: 19-20. NDG-CS. Pr: 0.5337    38
NZ_CP027599.1_148228	LIPO(Sec/SPII)	0.124377	0.017579	0.534242	0.323802	CS pos: 16-17. IAG-CR. Pr: 0.4623    18
NZ_CP027599.1_148235	SP(Sec/SPI)	0.547643	0.049285	0.074006	0.329066	CS pos: 19-20. NST-AP. Pr: 0.1106    43
NZ_CP027599.1_148241	LIPO(Sec/SPII)	0.231351	0.081486	0.381522	0.305641	CS pos: 18-19. IAG-CT. Pr: 0.3760    30
NZ_CP027599.1_148245	SP(Sec/SPI)	0.414872	0.009187	0.199596	0.376345	CS pos: 15-16. LFG-ED. Pr: 0.3347    21
NZ_CP027599.1_148250	LIPO(Sec/SPII)	0.008395	0.002977	0.938236	0.050391	CS pos: 22-23. CSS-CT. Pr: 0.9211    40
NZ_CP027599.1_148265	SP(Sec/SPI)	0.598466	0.167298	0.054847	0.179389	CS pos: 22-23. SLA-DT. Pr: 0.5618    30
NZ_CP027599.1_148272	LIPO(Sec/SPII)	0.081242	0.009600	0.591136	0.318021	CS pos: 27-28. VNG-CN. Pr: 0.6180    49
NZ_CP027599.1_148286	SP(Sec/SPI)	0.487015	0.014130	0.202784	0.296071	CS pos: 17-18. ATA-AL. Pr: 0.3522    25
NZ_CP027599.1_148302	LIPO(Sec/SPII)	0.163045	0.062666	0.458318	0.315971	CS pos: 18-19. SAS-CW. Pr: 0.4136    20
NZ_CP027599.1_148324	LIPO(Sec/SPII)	0.125872	0.029422	0.747285	0.097421	CS pos: 15-16. GVA-CS. Pr: 0.7236    31
NZ_CP027599.1_148338	TAT(Tat/SPI)	0.338066	0.354648	0.158484	0.148802	CS pos: 26-27. SRA-AC. Pr: 0.1171    48
NZ_CP027599.1_148371	LIPO(Sec/SPII)	0.095837	0.010883	0.623019	0.270261	CS pos: 21-22. MSG-CD. Pr: 0.6078    26
NZ_CP027599.1_148436	SP(Sec/SPI)	0.458874	0.005909	0.313465	0.221752	CS pos: 22-23. GEC-AV. Pr: 0.3459    39
NZ_CP027599.1_148473	LIPO(Sec/SPII)	0.043482	0.002388	0.886017	0.068113	CS pos: 15-16. ITG-CC. Pr: 0.8430    17
NZ_CP027599.1_148543	SP(Sec/SPI)	0.596837	0.027365	0.252564	0.123234	CS pos: 17-18. ALA-CP. Pr: 0.6563    40
NZ_CP027599.1_148581	TAT(Tat/SPI)	0.119095	0.408303	0.091187	0.381415	CS pos: 24-25. TTG-RN. Pr: 0.0831    27
NZ_CP027599.1_148611	LIPO(Sec/SPII)	0.103390	0.009335	0.655591	0.231684	CS pos: 16-17. VIS-CL. Pr: 0.5452    19
NZ_CP027599.1_148638	SP(Sec/SPI)	0.395191	0.027172	0.248007	0.329630	CS pos: 14-15. CFA-VP. Pr: 0.1336    42
NZ_CP027599.1_148710	SP(Sec/SPI)	0.728676	0.120156	0.099897	0.051272	CS pos: 17-18. SFS-AS. Pr: 0.2179    40
NZ_CP027599.1_148712	TAT(Tat/SPI)	0.233054	0.386505	0.101923	0.278518	CS pos: 22-23. ITA-RP. Pr: 0.2338    27
NZ_CP027599.1_148715	LIPO(Sec/SPII)	0.157246	0.106587	0.511005	0.225162	CS pos: 24-25. SCA-CS. Pr: 0.3016    33
NZ_CP027599.1_148718	LIPO(Sec/SPII)	0.239325	0.046967	0.606879	0.106830	CS pos: 33-34. NAA-CT. Pr: 0.4512    38
NZ_CP027599.1_148737	SP(Sec/SPI)	0.885069	0.048938	0.008901	0.057093	CS pos: 23-24. VSA-EI. Pr: 0.8900    33
NZ_CP027599.1_148758	LIPO(Sec/SPII)	0.266601	0.007910	0.487286	0.238203	CS pos: 25-26. VAS-CC. Pr: 0.3954    31
NZ_CP027599.1_148787	SP(Sec/SPI)	0.593939	0.130991	0.064651	0.210420	CS pos: 23-24. SQA-AS. Pr: 0.4451    30
NZ_CP027599.1_148815	LIPO(Sec/SPII)	0.203096	0.018025	0.406869	0.372011	CS pos: 13-14. VCA-CS. Pr: 0.2680    16
NZ_CP027599.1_148818	LIPO(Sec/SPII)	0.255226	0.009210	0.454570	0.280993	CS pos: 31-32. VSG-CW. Pr: 0.4658    40
NZ_CP027599.1_148823	SP(Sec/SPI)	0.411039	0.149218	0.039245	0.400497	CS pos: 17-18. IKA-ES. Pr: 0.4024    37
NZ_CP027599.1_148825	SP(Sec/SPI)	0.473577	0.030497	0.267934	0.227991	CS pos: 31-32. LSS-TP. Pr: 0.1919    50
NZ_CP027599.1_148839	LIPO(Sec/SPII)	0.164625	0.026785	0.414076	0.394514	CS pos: 14-15. FSH-CN. Pr: 0.3198    18
NZ_CP027599.1_148852	LIPO(Sec/SPII)	0.257911	0.066562	0.426731	0.248797	CS pos: 15-16. SAA-TQ. Pr: 0.0272    19
NZ_CP027599.1_148863	SP(Sec/SPI)	0.432954	0.025374	0.423014	0.118659	CS pos: 26-27. AWN-AP. Pr: 0.1847    31
NZ_CP027599.1_148885	LIPO(Sec/SPII)	0.065027	0.009220	0.899456	0.026297	CS pos: 24-25. QTG-CA. Pr: 0.7628    50
NZ_CP027599.1_148895	LIPO(Sec/SPII)	0.437345	0.001393	0.519070	0.042192	CS pos: 22-23. VMV-CD. Pr: 0.3738    47
NZ_CP027599.1_148921	LIPO(Sec/SPII)	0.007811	0.000281	0.901836	0.090073	CS pos: 20-21. LCG-CE. Pr: 0.8993    37
NZ_CP027599.1_148937	LIPO(Sec/SPII)	0.290971	0.037948	0.399209	0.271871	CS pos: ?. Probable protein fragment    15
NZ_CP027599.1_148954	SP(Sec/SPI)	0.521113	0.105170	0.120618	0.253099	CS pos: 25-26. GLS-AN. Pr: 0.1574    35
NZ_CP027599.1_148985	LIPO(Sec/SPII)	0.054983	0.004100	0.574891	0.366026	CS pos: 25-26. LRS-CG. Pr: 0.5446    38
NZ_CP027599.1_149013	LIPO(Sec/SPII)	0.024602	0.003252	0.793657	0.178489	CS pos: 19-20. LSS-CC. Pr: 0.7052    48
NZ_CP027599.1_149020	SP(Sec/SPI)	0.384874	0.046546	0.263950	0.304630	CS pos: 13-14. VSA-ST. Pr: 0.0771    16
NZ_CP027599.1_149035	LIPO(Sec/SPII)	0.074283	0.010977	0.493422	0.421317	CS pos: 18-19. TLA-CI. Pr: 0.4719    30
NZ_CP027599.1_149042	LIPO(Sec/SPII)	0.269458	0.027069	0.407291	0.296181	CS pos: ?. Probable protein fragment    15
NZ_CP027599.1_149047	LIPO(Sec/SPII)	0.091020	0.008044	0.535093	0.365843	CS pos: 25-26. VSL-CN. Pr: 0.2175    33
NZ_CP027599.1_149101	LIPO(Sec/SPII)	0.193832	0.025262	0.456438	0.324468	CS pos: 16-17. IFS-CR. Pr: 0.2476    22
NZ_CP027599.1_149156	LIPO(Sec/SPII)	0.095388	0.008987	0.806406	0.089220	CS pos: 11-12. LSG-CR. Pr: 0.6252    30
NZ_CP027599.1_149159	LIPO(Sec/SPII)	0.134178	0.028953	0.485833	0.351037	CS pos: ?. Probable protein fragment    17
NZ_CP027599.1_149194	LIPO(Sec/SPII)	0.219865	0.013620	0.541639	0.224876	CS pos: 21-22. IMS-CT. Pr: 0.4532    26
NZ_CP027599.1_149225	LIPO(Sec/SPII)	0.042239	0.000948	0.944021	0.012792	CS pos: 16-17. LLA-CS. Pr: 0.9299    26
NZ_CP027599.1_149241	LIPO(Sec/SPII)	0.233704	0.100666	0.334361	0.331269	CS pos: 19-20. LSP-CS. Pr: 0.2443    31
NZ_CP027599.1_149340	LIPO(Sec/SPII)	0.150654	0.009276	0.517173	0.322896	CS pos: ?. Probable protein fragment    31
NZ_CP027599.1_149357	SP(Sec/SPI)	0.497598	0.024293	0.119097	0.359011	CS pos: 25-26. CHA-DN. Pr: 0.2762    38
NZ_CP027599.1_149365	LIPO(Sec/SPII)	0.095379	0.012130	0.481191	0.411301	CS pos: 18-19. LLG-CV. Pr: 0.3420    33
NZ_CP027599.1_149383	SP(Sec/SPI)	0.344971	0.309030	0.116472	0.229527	CS pos: 21-22. ASA-QC. Pr: 0.3750    32
NZ_CP027599.1_149385	SP(Sec/SPI)	0.473657	0.099252	0.156594	0.270498	CS pos: 18-19. AEA-SG. Pr: 0.1982    28
NZ_CP027599.1_149440	LIPO(Sec/SPII)	0.008174	0.000182	0.989050	0.002594	CS pos: 22-23. LVA-CE. Pr: 0.9886    30
NZ_CP027599.1_149493	SP(Sec/SPI)	0.787343	0.033952	0.088319	0.090386	CS pos: 17-18. VSA-SI. Pr: 0.5906    24
NZ_CP027599.1_149515	SP(Sec/SPI)	0.477860	0.010813	0.042015	0.469311	CS pos: 27-28. SMG-YP. Pr: 0.2609    50
NZ_CP027599.1_149532	LIPO(Sec/SPII)	0.101039	0.022162	0.585680	0.291119	CS pos: 19-20. NTG-CA. Pr: 0.5647    27
NZ_CP027599.1_149547	LIPO(Sec/SPII)	0.203650	0.021385	0.419205	0.355760	CS pos: ?. Probable protein fragment    15
NZ_CP027599.1_149584	LIPO(Sec/SPII)	0.019216	0.000319	0.598702	0.381762	CS pos: 19-20. LCS-CI. Pr: 0.5552    40
NZ_CP027599.1_149614	LIPO(Sec/SPII)	0.276003	0.007111	0.443132	0.273754	CS pos: 16-17. QSI-CI. Pr: 0.1542    20
NZ_CP027599.1_149689	SP(Sec/SPI)	0.791222	0.013870	0.040745	0.154163	CS pos: 15-16. AHA-GA. Pr: 0.6921    31
NZ_CP027599.1_149764	LIPO(Sec/SPII)	0.201546	0.088569	0.383180	0.326705	CS pos: ?. Probable protein fragment    17
NZ_CP027599.1_149982	LIPO(Sec/SPII)	0.231964	0.006675	0.540355	0.221006	CS pos: 26-27. FSL-CQ. Pr: 0.3632    30
NZ_CP027599.1_150005	LIPO(Sec/SPII)	0.094811	0.020696	0.870149	0.014344	CS pos: 13-14. FSA-CW. Pr: 0.8468    33
NZ_CP027599.1_150016	LIPO(Sec/SPII)	0.132909	0.038360	0.491243	0.337488	CS pos: 20-21. FTE-CR. Pr: 0.4446    31
NZ_CP027599.1_150039	LIPO(Sec/SPII)	0.133014	0.033993	0.478901	0.354092	CS pos: 16-17. AIS-CE. Pr: 0.4255    20
NZ_CP027599.1_150044	LIPO(Sec/SPII)	0.089827	0.092441	0.511788	0.305945	CS pos: 23-24. VFS-CG. Pr: 0.4690    39
NZ_CP027599.1_150047	TAT(Tat/SPI)	0.117839	0.484256	0.114602	0.283303	CS pos: 32-33. PFA-DC. Pr: 0.0850    41
NZ_CP027599.1_150051	TAT(Tat/SPI)	0.175985	0.635428	0.016399	0.172188	CS pos: 29-30. GNA-AI. Pr: 0.2633    48
NZ_CP027599.1_150112	LIPO(Sec/SPII)	0.244623	0.043297	0.494429	0.217652	CS pos: 21-22. LLQ-CR. Pr: 0.2644    39
NZ_CP027599.1_150118	SP(Sec/SPI)	0.429257	0.035810	0.139778	0.395155	CS pos: 23-24. NYA-NV. Pr: 0.2404    30
NZ_CP027599.1_150177	LIPO(Sec/SPII)	0.193898	0.011678	0.446221	0.348204	CS pos: 17-18. LGN-CK. Pr: 0.3815    21
NZ_CP027599.1_150225	LIPO(Sec/SPII)	0.225617	0.011357	0.509680	0.253345	CS pos: 19-20. LSL-CL. Pr: 0.2304    25
NZ_CP027599.1_150361	LIPO(Sec/SPII)	0.251955	0.009813	0.403891	0.334341	CS pos: ?. Probable protein fragment    16
NZ_CP027599.1_150385	SP(Sec/SPI)	0.386108	0.320898	0.011382	0.281613	CS pos: 31-32. ANA-FM. Pr: 0.6258    45
NZ_CP027599.1_150400	TAT(Tat/SPI)	0.130925	0.511977	0.011697	0.345401	CS pos: 31-32. SAA-SK. Pr: 0.4145    49
NZ_CP027599.1_150406	LIPO(Sec/SPII)	0.292272	0.020933	0.389683	0.297112	CS pos: 13-14. LAR-CT. Pr: 0.0861    16
NZ_CP027599.1_150409	TAT(Tat/SPI)	0.105555	0.511381	0.100095	0.282969	CS pos: ?. Probable protein fragment    23
NZ_CP027599.1_150426	LIPO(Sec/SPII)	0.405162	0.096133	0.447904	0.050801	CS pos: 17-18. AQV-CL. Pr: 0.3623    45
NZ_CP027599.1_150449	LIPO(Sec/SPII)	0.168855	0.031630	0.435568	0.363947	CS pos: 16-17. RCS-CT. Pr: 0.2354    21
NZ_CP027599.1_150458	SP(Sec/SPI)	0.526859	0.016457	0.110823	0.345861	CS pos: 18-19. AEA-GI. Pr: 0.3846    29
NZ_CP027599.1_150505	LIPO(Sec/SPII)	0.306609	0.020693	0.442528	0.230171	CS pos: ?. Probable protein fragment    21
NZ_CP027599.1_150515	LIPO(Sec/SPII)	0.082135	0.023374	0.478398	0.416093	CS pos: 17-18. MMA-CR. Pr: 0.4407    27
NZ_CP027599.1_150540	LIPO(Sec/SPII)	0.342089	0.034560	0.396484	0.226867	CS pos: 24-25. SLR-CL. Pr: 0.3246    50
NZ_CP027599.1_150560	LIPO(Sec/SPII)	0.048348	0.001087	0.944455	0.006110	CS pos: 19-20. VSG-CR. Pr: 0.9462    29
NZ_CP027599.1_150564	LIPO(Sec/SPII)	0.077839	0.015672	0.693914	0.212575	CS pos: 15-16. TTS-CN. Pr: 0.6497    31
NZ_CP027599.1_150582	SP(Sec/SPI)	0.467379	0.044237	0.174091	0.314293	CS pos: 22-23. LSA-QF. Pr: 0.2709    32
NZ_CP027599.1_150616	LIPO(Sec/SPII)	0.135940	0.078513	0.481634	0.303914	CS pos: 26-27. AVS-CS. Pr: 0.4221    30
NZ_CP027599.1_150619	LIPO(Sec/SPII)	0.173656	0.021306	0.575349	0.229690	CS pos: 17-18. FSA-CL. Pr: 0.3842    33
NZ_CP027599.1_150629	TAT(Tat/SPI)	0.196303	0.511318	0.026516	0.265862	CS pos: 24-25. ARA-SS. Pr: 0.5853    42
NZ_CP027599.1_150631	LIPO(Sec/SPII)	0.131572	0.019784	0.682112	0.166533	CS pos: 23-24. FSV-CK. Pr: 0.5901    35
NZ_CP027599.1_150639	LIPO(Sec/SPII)	0.138824	0.015471	0.621331	0.224373	CS pos: 23-24. APA-CG. Pr: 0.5569    25
NZ_CP027599.1_150640	LIPO(Sec/SPII)	0.230243	0.016014	0.526192	0.227551	CS pos: 24-25. RCA-CV. Pr: 0.1826    37
NZ_CP027599.1_150681	TAT(Tat/SPI)	0.184754	0.364598	0.234947	0.215701	CS pos: 24-25. GYS-SS. Pr: 0.1514    35
NZ_CP027599.1_150688	SP(Sec/SPI)	0.540781	0.015707	0.068818	0.374694	CS pos: 25-26. LYA-AD. Pr: 0.5019    46
NZ_CP027599.1_150699	LIPO(Sec/SPII)	0.203260	0.027197	0.435215	0.334328	CS pos: 18-19. SLL-CS. Pr: 0.2741    29
NZ_CP027599.1_150717	SP(Sec/SPI)	0.588855	0.224247	0.029655	0.157244	CS pos: 27-28. ASA-KS. Pr: 0.6090    44
NZ_CP027599.1_150719	SP(Sec/SPI)	0.627907	0.013694	0.042176	0.316222	CS pos: 20-21. SFA-LQ. Pr: 0.5971    28
NZ_CP027599.1_150760	LIPO(Sec/SPII)	0.318594	0.011293	0.426906	0.243206	CS pos: 14-15. ALS-II. Pr: 0.0218    16
NZ_CP027599.1_150768	SP(Sec/SPI)	0.510076	0.337841	0.083484	0.068599	CS pos: 18-19. ANA-AG. Pr: 0.2391    43
NZ_CP027599.1_150782	TAT(Tat/SPI)	0.216612	0.332810	0.136215	0.314362	CS pos: 27-28. AAS-LP. Pr: 0.1824    30
NZ_CP027599.1_150785	SP(Sec/SPI)	0.596714	0.094630	0.080184	0.228471	CS pos: 22-23. TNS-AV. Pr: 0.3570    33
NZ_CP027599.1_150824	SP(Sec/SPI)	0.398375	0.142777	0.064440	0.394407	CS pos: 16-17. AYA-SP. Pr: 0.4395    50
NZ_CP027599.1_150834	LIPO(Sec/SPII)	0.219629	0.076580	0.361899	0.341892	CS pos: 22-23. TAP-CC. Pr: 0.1813    41
NZ_CP027599.1_150857	LIPO(Sec/SPII)	0.050722	0.010065	0.863455	0.075758	CS pos: 12-13. LSG-CS. Pr: 0.8554    24
NZ_CP027599.1_150862	LIPO(Sec/SPII)	0.325577	0.026506	0.344657	0.303260	CS pos: 13-14. SSA-AG. Pr: 0.1197    15
NZ_CP027599.1_150878	LIPO(Sec/SPII)	0.362765	0.008766	0.400788	0.227682	CS pos: ?. Probable protein fragment    15
NZ_CP027599.1_150943	LIPO(Sec/SPII)	0.125288	0.051881	0.607525	0.215306	CS pos: 20-21. TSI-CS. Pr: 0.5468    42
NZ_CP027599.1_150945	LIPO(Sec/SPII)	0.267600	0.044370	0.375693	0.312336	CS pos: ?. Probable protein fragment    15
NZ_CP027599.1_150959	SP(Sec/SPI)	0.422048	0.203375	0.101382	0.273195	CS pos: 15-16. AAA-AE. Pr: 0.2740    23
NZ_CP027599.1_150988	SP(Sec/SPI)	0.390136	0.310853	0.067813	0.231198	CS pos: 24-25. ANA-GA. Pr: 0.1976    36
NZ_CP027599.1_150994	LIPO(Sec/SPII)	0.232589	0.013947	0.734165	0.019299	CS pos: 20-21. IAA-CN. Pr: 0.6554    31
NZ_CP027599.1_151103	LIPO(Sec/SPII)	0.254268	0.160756	0.298836	0.286140	CS pos: 21-22. RAT-CS. Pr: 0.1700    31
NZ_CP027599.1_151104	LIPO(Sec/SPII)	0.129177	0.192129	0.587305	0.091389	CS pos: 26-27. SAG-CS. Pr: 0.4476    36
NZ_CP027599.1_151115	SP(Sec/SPI)	0.375302	0.188168	0.092666	0.343864	CS pos: 28-29. APA-DK. Pr: 0.1426    37
NZ_CP027599.1_151118	LIPO(Sec/SPII)	0.274964	0.021752	0.677915	0.025369	CS pos: 15-16. AQC-CN. Pr: 0.3724    50
NZ_CP027599.1_151120	TAT(Tat/SPI)	0.405043	0.482335	0.017962	0.094660	CS pos: 29-30. ASA-KP. Pr: 0.7826    38
NZ_CP027599.1_151134	SP(Sec/SPI)	0.376726	0.077045	0.326079	0.220150	CS pos: 20-21. SAA-SD. Pr: 0.1893    26
NZ_CP027599.1_151153	LIPO(Sec/SPII)	0.272518	0.033146	0.356619	0.337718	CS pos: 14-15. GAG-CC. Pr: 0.2202    28
NZ_CP027599.1_151168	LIPO(Sec/SPII)	0.048849	0.022458	0.876032	0.052661	CS pos: 24-25. SCA-CA. Pr: 0.5049    38
NZ_CP027599.1_151180	LIPO(Sec/SPII)	0.128804	0.026787	0.476431	0.367977	CS pos: 28-29. IIA-CS. Pr: 0.4366    32
NZ_CP027599.1_151189	SP(Sec/SPI)	0.582933	0.110508	0.047142	0.259418	CS pos: 26-27. ARA-LL. Pr: 0.5052    48
NZ_CP027599.1_151196	SP(Sec/SPI)	0.908600	0.028683	0.025174	0.037544	CS pos: 26-27. SYA-RP. Pr: 0.6026    50
NZ_CP027599.1_151211	SP(Sec/SPI)	0.378923	0.171948	0.073525	0.375604	CS pos: 25-26. VSS-GG. Pr: 0.0453    31
NZ_CP027599.1_151223	SP(Sec/SPI)	0.472697	0.063988	0.040120	0.423195	CS pos: 24-25. ADG-DT. Pr: 0.2404    49
NZ_CP027599.1_151232	LIPO(Sec/SPII)	0.253378	0.011442	0.433421	0.301759	CS pos: 14-15. LPV-CM. Pr: 0.0133    17
NZ_CP027599.1_151274	LIPO(Sec/SPII)	0.170384	0.015662	0.486323	0.327630	CS pos: 18-19. FMN-CF. Pr: 0.4319    34
NZ_CP027599.1_151278	SP(Sec/SPI)	0.405420	0.028258	0.239624	0.326698	CS pos: 21-22. PRA-SS. Pr: 0.0597    23
NZ_CP027599.1_151381	SP(Sec/SPI)	0.496025	0.031267	0.117487	0.355220	CS pos: 26-27. LWA-QP. Pr: 0.3259    33
NZ_CP027599.1_151388	LIPO(Sec/SPII)	0.102194	0.017037	0.503761	0.377007	CS pos: 18-19. PVG-CS. Pr: 0.4599    29
NZ_CP027599.1_151393	LIPO(Sec/SPII)	0.036663	0.003360	0.919940	0.040037	CS pos: 19-20. FTA-CT. Pr: 0.9138    29
NZ_CP027599.1_151412	SP(Sec/SPI)	0.387669	0.121843	0.110104	0.380384	CS pos: 17-18. SLA-AR. Pr: 0.2227    21
NZ_CP027599.1_151431	LIPO(Sec/SPII)	0.038987	0.007279	0.876949	0.076785	CS pos: 26-27. FTS-CC. Pr: 0.7730    38
NZ_CP027599.1_151434	LIPO(Sec/SPII)	0.296574	0.012387	0.473333	0.217705	CS pos: ?. Probable protein fragment    15
NZ_CP027599.1_151448	SP(Sec/SPI)	0.502657	0.173269	0.084202	0.239871	CS pos: 28-29. ASA-FS. Pr: 0.1477    34
NZ_CP027599.1_151469	LIPO(Sec/SPII)	0.175901	0.165389	0.642893	0.015818	CS pos: 13-14. ACA-CA. Pr: 0.5713    46
NZ_CP027599.1_151484	LIPO(Sec/SPII)	0.167731	0.055491	0.484197	0.292580	CS pos: 24-25. TRG-CA. Pr: 0.3249    37
NZ_CP027599.1_151491	SP(Sec/SPI)	0.459487	0.014065	0.440571	0.085877	CS pos: 20-21. SLT-RV. Pr: 0.1361    22
NZ_CP027599.1_151540	LIPO(Sec/SPII)	0.118646	0.042869	0.464412	0.374072	CS pos: 22-23. ASS-CR. Pr: 0.4051    25
NZ_CP027599.1_151554	LIPO(Sec/SPII)	0.259316	0.053886	0.366164	0.320634	CS pos: 15-16. FGG-SD. Pr: 0.0510    17
NZ_CP027599.1_151599	LIPO(Sec/SPII)	0.245676	0.012638	0.494623	0.247063	CS pos: 13-14. SGP-CD. Pr: 0.4444    34
NZ_CP027599.1_151607	SP(Sec/SPI)	0.477338	0.028233	0.172184	0.322245	CS pos: 17-18. LSA-AS. Pr: 0.1623    25
NZ_CP027599.1_151653	LIPO(Sec/SPII)	0.262736	0.004748	0.427415	0.305100	CS pos: 14-15. AES-AN. Pr: 0.1715    41
NZ_CP027599.1_151662	SP(Sec/SPI)	0.466853	0.229747	0.062498	0.240901	CS pos: 19-20. AKA-AT. Pr: 0.5306    27
NZ_CP027599.1_151687	LIPO(Sec/SPII)	0.109089	0.014246	0.541412	0.335253	CS pos: 25-26. LAA-SG. Pr: 0.4503    42
NZ_CP027599.1_151694	LIPO(Sec/SPII)	0.361959	0.013231	0.431650	0.193159	CS pos: ?. Probable protein fragment    15
NZ_CP027599.1_151709	SP(Sec/SPI)	0.343343	0.249321	0.146260	0.261076	CS pos: 20-21. VHQ-AT. Pr: 0.1469    28
NZ_CP027599.1_151717	SP(Sec/SPI)	0.839052	0.117448	0.014291	0.029210	CS pos: 22-23. AYA-RV. Pr: 0.6898    46
NZ_CP027599.1_151725	TAT(Tat/SPI)	0.072094	0.708985	0.052101	0.166819	CS pos: 28-29. SRS-AC. Pr: 0.1129    43
NZ_CP027599.1_151731	TAT(Tat/SPI)	0.179089	0.422378	0.115753	0.282779	CS pos: 23-24. AGA-AD. Pr: 0.0599    25
NZ_CP027599.1_151736	LIPO(Sec/SPII)	0.267746	0.023037	0.414611	0.294606	CS pos: 13-14. SSK-CH. Pr: 0.2074    50
NZ_CP027599.1_151741	SP(Sec/SPI)	0.457527	0.048439	0.180009	0.314025	CS pos: 18-19. QQA-AD. Pr: 0.1911    20
NZ_CP027599.1_151817	SP(Sec/SPI)	0.483375	0.165079	0.083165	0.268381	CS pos: 23-24. AHA-LP. Pr: 0.4678    31
NZ_CP027599.1_151827	LIPO(Sec/SPII)	0.252755	0.018558	0.369289	0.359398	CS pos: 16-17. VTS-VI. Pr: 0.0255    18
NZ_CP027599.1_151841	LIPO(Sec/SPII)	0.022992	0.004414	0.602968	0.369626	CS pos: 24-25. ITA-CR. Pr: 0.6000    47
NZ_CP027599.1_151856	SP(Sec/SPI)	0.666235	0.004550	0.070851	0.258364	CS pos: 19-20. RYA-TQ. Pr: 0.5487    32
NZ_CP027599.1_151863	SP(Sec/SPI)	0.337296	0.018699	0.336859	0.307147	CS pos: ?. Probable protein fragment    21
NZ_CP027599.1_151877	SP(Sec/SPI)	0.485268	0.040219	0.116128	0.358385	CS pos: 21-22. VAA-VR. Pr: 0.2628    24
NZ_CP027599.1_151884	LIPO(Sec/SPII)	0.225465	0.002821	0.656011	0.115704	CS pos: 15-16. MCK-CL. Pr: 0.5864    48
NZ_CP027599.1_151894	LIPO(Sec/SPII)	0.138610	0.015164	0.447659	0.398567	CS pos: 18-19. LPT-CS. Pr: 0.4241    42
NZ_CP027599.1_151963	SP(Sec/SPI)	0.483876	0.165398	0.051308	0.299418	CS pos: 15-16. ASA-LE. Pr: 0.4185    22
NZ_CP027599.1_151987	SP(Sec/SPI)	0.373794	0.052507	0.210435	0.363264	CS pos: 21-22. GFA-SS. Pr: 0.1741    45
NZ_CP027599.1_151991	LIPO(Sec/SPII)	0.190458	0.055962	0.438290	0.315290	CS pos: 19-20. GIT-CT. Pr: 0.3237    25
NZ_CP027599.1_152002	LIPO(Sec/SPII)	0.210062	0.102405	0.526699	0.160834	CS pos: 24-25. TTA-CR. Pr: 0.5042    36
NZ_CP027599.1_152010	LIPO(Sec/SPII)	0.044638	0.001088	0.936749	0.017525	CS pos: 13-14. LMS-CN. Pr: 0.9341    36
NZ_CP027599.1_152023	LIPO(Sec/SPII)	0.157524	0.022400	0.594599	0.225478	CS pos: 17-18. LLN-CD. Pr: 0.5024    25
NZ_CP027599.1_152046	SP(Sec/SPI)	0.920621	0.054183	0.010652	0.014544	CS pos: 21-22. ARA-GS. Pr: 0.8937    45
NZ_CP027599.1_152088	SP(Sec/SPI)	0.404805	0.051558	0.355983	0.187654	CS pos: 19-20. STS-SP. Pr: 0.0824    30
NZ_CP027599.1_152114	TAT(Tat/SPI)	0.256830	0.319996	0.134093	0.289081	CS pos: 24-25. NSA-IT. Pr: 0.1390    41
NZ_CP027599.1_152134	LIPO(Sec/SPII)	0.260610	0.142970	0.305834	0.290585	CS pos: 13-14. ASA-SP. Pr: 0.0873    15
NZ_CP027599.1_152170	SP(Sec/SPI)	0.467751	0.005785	0.213803	0.312660	CS pos: 19-20. ASL-DN. Pr: 0.1961    34
NZ_CP027599.1_152175	SP(Sec/SPI)	0.389679	0.231530	0.017157	0.361634	CS pos: 35-36. AFA-GS. Pr: 0.4421    50
NZ_CP027599.1_152192	LIPO(Sec/SPII)	0.216375	0.102937	0.395971	0.284717	CS pos: 28-29. NCA-CI. Pr: 0.3262    34
NZ_CP027599.1_152195	LIPO(Sec/SPII)	0.124576	0.005938	0.677445	0.192041	CS pos: 14-15. AVA-CS. Pr: 0.6582    28
NZ_CP027599.1_152202	LIPO(Sec/SPII)	0.275290	0.011478	0.376289	0.336942	CS pos: 14-15. SGR-CM. Pr: 0.1507    20
NZ_CP027599.1_152216	LIPO(Sec/SPII)	0.182846	0.009850	0.727112	0.080192	CS pos: 18-19. LTS-CA. Pr: 0.6925    24
NZ_CP027599.1_152227	LIPO(Sec/SPII)	0.177014	0.004504	0.705742	0.112740	CS pos: 16-17. TGQ-CA. Pr: 0.5210    36
NZ_CP027599.1_152283	LIPO(Sec/SPII)	0.311297	0.014399	0.396378	0.277926	CS pos: ?. Probable protein fragment    16
NZ_CP027599.1_152287	LIPO(Sec/SPII)	0.149230	0.017403	0.456390	0.376977	CS pos: 15-16. LGT-CG. Pr: 0.4137    48
NZ_CP027599.1_152295	SP(Sec/SPI)	0.460106	0.243266	0.109396	0.187233	CS pos: 20-21. IMS-AS. Pr: 0.1218    47
NZ_CP027599.1_152338	LIPO(Sec/SPII)	0.098770	0.030973	0.440778	0.429479	CS pos: 25-26. CLT-CH. Pr: 0.3971    41
NZ_CP027599.1_152343	SP(Sec/SPI)	0.663911	0.121316	0.065314	0.149459	CS pos: 20-21. SVA-SH. Pr: 0.4486    31
NZ_CP027599.1_152366	TAT(Tat/SPI)	0.191491	0.452580	0.034073	0.321856	CS pos: 43-44. AAS-RS. Pr: 0.1407    46
NZ_CP027599.1_152413	TAT(Tat/SPI)	0.183832	0.386783	0.139751	0.289634	CS pos: ?. Probable protein fragment    21
NZ_CP027599.1_152417	SP(Sec/SPI)	0.759904	0.031276	0.168933	0.039887	CS pos: 23-24. AAA-HC. Pr: 0.2945    39
NZ_CP027599.1_152451	LIPO(Sec/SPII)	0.175276	0.040809	0.567559	0.216357	CS pos: 15-16. FFA-CQ. Pr: 0.4500    18
NZ_CP027599.1_152490	LIPO(Sec/SPII)	0.164600	0.044379	0.534762	0.256259	CS pos: 19-20. VSA-CC. Pr: 0.4312    43
NZ_CP027599.1_152508	TAT(Tat/SPI)	0.179033	0.447806	0.059987	0.313174	CS pos: 25-26. ARA-TS. Pr: 0.3954    39
NZ_CP027599.1_152579	LIPO(Sec/SPII)	0.201297	0.025860	0.401644	0.371199	CS pos: ?. Probable protein fragment    21
NZ_CP027599.1_152584	LIPO(Sec/SPII)	0.152956	0.017496	0.506152	0.323396	CS pos: 17-18. SKS-CQ. Pr: 0.4207    22
NZ_CP027599.1_152654	SP(Sec/SPI)	0.552255	0.046302	0.090105	0.311338	CS pos: 23-24. LSA-MV. Pr: 0.1767    37
NZ_CP027599.1_152669	LIPO(Sec/SPII)	0.215501	0.041433	0.446247	0.296819	CS pos: 14-15. LLA-CR. Pr: 0.2382    16
NZ_CP027599.1_152704	LIPO(Sec/SPII)	0.229518	0.061400	0.389655	0.319427	CS pos: ?. Probable protein fragment    18
NZ_CP027599.1_152707	LIPO(Sec/SPII)	0.084218	0.037728	0.543219	0.334835	CS pos: 23-24. NSG-CD. Pr: 0.5404    44
NZ_CP027599.1_152724	TAT(Tat/SPI)	0.116088	0.638776	0.056479	0.188657	CS pos: 27-28. RTA-SN. Pr: 0.2014    33
NZ_CP027599.1_152729	SP(Sec/SPI)	0.396160	0.106505	0.175163	0.322172	CS pos: 23-24. APA-AS. Pr: 0.1284    26
NZ_CP027599.1_152733	LIPO(Sec/SPII)	0.035501	0.013582	0.803055	0.147862	CS pos: 17-18. IAG-CV. Pr: 0.8014    28
NZ_CP027599.1_152755	SP(Sec/SPI)	0.425122	0.091956	0.146264	0.336658	CS pos: 21-22. ASA-RA. Pr: 0.1747    23
NZ_CP027599.1_152757	SP(Sec/SPI)	0.418058	0.090094	0.209265	0.282584	CS pos: 12-13. AAA-DA. Pr: 0.1686    18
NZ_CP027599.1_152810	SP(Sec/SPI)	0.589707	0.080652	0.190006	0.139635	CS pos: 28-29. LSA-SS. Pr: 0.3071    33
NZ_CP027599.1_152836	LIPO(Sec/SPII)	0.233676	0.037128	0.537131	0.192065	CS pos: 24-25. NGA-CQ. Pr: 0.3204    48
NZ_CP027599.1_152861	SP(Sec/SPI)	0.419517	0.071193	0.259025	0.250265	CS pos: 25-26. TQA-ES. Pr: 0.3339    36
NZ_CP027599.1_152869	LIPO(Sec/SPII)	0.194975	0.015395	0.503562	0.286068	CS pos: 14-15. EST-CA. Pr: 0.2688    16
NZ_CP027599.1_152874	LIPO(Sec/SPII)	0.215121	0.082372	0.540505	0.162002	CS pos: 12-13. LAG-CF. Pr: 0.3605    17
NZ_CP027599.1_152882	SP(Sec/SPI)	0.580479	0.039481	0.009012	0.371028	CS pos: 21-22. FHA-ET. Pr: 0.5612    44
NZ_CP027599.1_152921	TAT(Tat/SPI)	0.020391	0.810411	0.016805	0.152393	CS pos: 39-40. SFA-FQ. Pr: 0.4125    46
NZ_CP027599.1_152922	TAT(Tat/SPI)	0.272280	0.476182	0.041877	0.209662	CS pos: 20-21. SRA-GS. Pr: 0.4510    26
NZ_CP027599.1_152940	LIPO(Sec/SPII)	0.144538	0.012516	0.645854	0.197091	CS pos: 16-17. CIT-CN. Pr: 0.5728    24
NZ_CP027599.1_152964	SP(Sec/SPI)	0.366523	0.009153	0.347089	0.277234	CS pos: ?. Probable protein fragment    25
NZ_CP027599.1_152990	SP(Sec/SPI)	0.591267	0.093639	0.089963	0.225130	CS pos: 15-16. ANS-AP. Pr: 0.2567    34
NZ_CP027599.1_153006	LIPO(Sec/SPII)	0.304378	0.038505	0.567917	0.089201	CS pos: 18-19. VLS-CS. Pr: 0.4641    27
NZ_CP027599.1_153011	SP(Sec/SPI)	0.671488	0.207643	0.039279	0.081590	CS pos: 20-21. ASA-NE. Pr: 0.6488    31
NZ_CP027599.1_153068	LIPO(Sec/SPII)	0.007646	0.000292	0.917397	0.074665	CS pos: 21-22. IAS-CW. Pr: 0.9104    35
NZ_CP027599.1_153111	SP(Sec/SPI)	0.837693	0.007564	0.032702	0.122041	CS pos: 17-18. SFA-IN. Pr: 0.7843    31
NZ_CP027599.1_153127	LIPO(Sec/SPII)	0.140301	0.009851	0.460225	0.389623	CS pos: 27-28. VFA-CA. Pr: 0.2840    44
NZ_CP027599.1_153137	SP(Sec/SPI)	0.404903	0.155340	0.087814	0.351943	CS pos: 23-24. ARA-FC. Pr: 0.1983    30
NZ_CP027599.1_153141	SP(Sec/SPI)	0.433515	0.136608	0.074966	0.354911	CS pos: 19-20. INA-FT. Pr: 0.2223    30
NZ_CP027599.1_153151	LIPO(Sec/SPII)	0.388743	0.010778	0.445167	0.155312	CS pos: ?. Probable protein fragment    17
NZ_CP027599.1_153215	LIPO(Sec/SPII)	0.163850	0.004489	0.462042	0.369620	CS pos: 22-23. FLH-CR. Pr: 0.2239    28
NZ_CP027599.1_153251	LIPO(Sec/SPII)	0.116586	0.019075	0.454578	0.409761	CS pos: 15-16. VIS-CS. Pr: 0.4156    21
NZ_CP027599.1_153295	LIPO(Sec/SPII)	0.048271	0.001674	0.927596	0.022459	CS pos: 24-25. AMS-CN. Pr: 0.9525    34
NZ_CP027599.1_153331	LIPO(Sec/SPII)	0.253779	0.016490	0.452127	0.277604	CS pos: ?. Probable protein fragment    15
NZ_CP027599.1_153333	LIPO(Sec/SPII)	0.248071	0.012007	0.463823	0.276099	CS pos: ?. Probable protein fragment    15
NZ_CP027599.1_153354	LIPO(Sec/SPII)	0.301951	0.012342	0.488891	0.196816	CS pos: 19-20. SLA-CC. Pr: 0.4557    21
NZ_CP027599.1_153381	LIPO(Sec/SPII)	0.045926	0.000325	0.483191	0.470558	CS pos: 23-24. FFQ-CL. Pr: 0.4431    46
NZ_CP027599.1_153416	SP(Sec/SPI)	0.682692	0.033483	0.093341	0.190484	CS pos: 20-21. NLS-SE. Pr: 0.2951    27
NZ_CP027599.1_153435	SP(Sec/SPI)	0.431871	0.048422	0.181235	0.338472	CS pos: 19-20. AKA-FS. Pr: 0.3238    24
NZ_CP027599.1_153456	SP(Sec/SPI)	0.581219	0.006705	0.043351	0.368725	CS pos: 15-16. AYA-GS. Pr: 0.5286    39
NZ_CP027599.1_153493	SP(Sec/SPI)	0.710741	0.033084	0.003384	0.252791	CS pos: 24-25. IWA-ND. Pr: 0.7270    44
NZ_CP027599.1_153511	LIPO(Sec/SPII)	0.088551	0.027521	0.598102	0.285826	CS pos: 26-27. SIA-CI. Pr: 0.5666    32
NZ_CP027599.1_153548	LIPO(Sec/SPII)	0.020972	0.000693	0.946872	0.031463	CS pos: 20-21. LTG-CP. Pr: 0.9321    33
NZ_CP027599.1_153552	LIPO(Sec/SPII)	0.155749	0.049477	0.501662	0.293112	CS pos: 15-16. HQS-CS. Pr: 0.3447    29
NZ_CP027599.1_153556	SP(Sec/SPI)	0.518285	0.165407	0.036992	0.279316	CS pos: 20-21. ARA-SN. Pr: 0.6027    36
NZ_CP027599.1_153630	LIPO(Sec/SPII)	0.297287	0.014950	0.471493	0.216270	CS pos: 14-15. SLA-CL. Pr: 0.2550    17
NZ_CP027599.1_153648	LIPO(Sec/SPII)	0.153735	0.028433	0.448198	0.369634	CS pos: 22-23. LLT-CS. Pr: 0.3773    25
NZ_CP027599.1_153659	SP(Sec/SPI)	0.426203	0.001631	0.200242	0.371925	CS pos: 23-24. GQC-FR. Pr: 0.1880    32
NZ_CP027599.1_153667	LIPO(Sec/SPII)	0.069281	0.015146	0.740434	0.175139	CS pos: 11-12. YTG-CE. Pr: 0.7163    26
NZ_CP027599.1_153680	LIPO(Sec/SPII)	0.229608	0.032282	0.396491	0.341619	CS pos: ?. Probable protein fragment    19
NZ_CP027599.1_153691	LIPO(Sec/SPII)	0.275074	0.025802	0.361706	0.337418	CS pos: ?. Probable protein fragment    15
NZ_CP027599.1_153705	LIPO(Sec/SPII)	0.043356	0.052498	0.757307	0.146840	CS pos: 24-25. ILA-CT. Pr: 0.6335    39
NZ_CP027599.1_153707	SP(Sec/SPI)	0.395714	0.037404	0.173309	0.393574	CS pos: 20-21. LRL-KA. Pr: 0.0840    36
NZ_CP027599.1_153716	SP(Sec/SPI)	0.379650	0.359346	0.060201	0.200803	CS pos: 18-19. VRA-AP. Pr: 0.4712    30
NZ_CP027599.1_153736	LIPO(Sec/SPII)	0.296180	0.030282	0.364777	0.308761	CS pos: ?. Probable protein fragment    16
NZ_CP027599.1_153758	LIPO(Sec/SPII)	0.190118	0.013759	0.491851	0.304272	CS pos: 17-18. IRS-CI. Pr: 0.3794    45
NZ_CP027599.1_153796	LIPO(Sec/SPII)	0.206646	0.008106	0.405722	0.379527	CS pos: ?. Probable protein fragment    17
NZ_CP027599.1_153808	SP(Sec/SPI)	0.459381	0.008364	0.420093	0.112161	CS pos: 25-26. SFC-FS. Pr: 0.3858    39
NZ_CP027599.1_153832	LIPO(Sec/SPII)	0.271999	0.030307	0.515297	0.182396	CS pos: 19-20. SFS-CY. Pr: 0.5016    47
NZ_CP027599.1_153847	LIPO(Sec/SPII)	0.287555	0.006442	0.538549	0.167454	CS pos: ?. Probable protein fragment    17
NZ_CP027599.1_153848	LIPO(Sec/SPII)	0.130901	0.008745	0.706605	0.153749	CS pos: 15-16. VVG-CC. Pr: 0.5970    27
NZ_CP027599.1_153876	LIPO(Sec/SPII)	0.330956	0.022435	0.343428	0.303181	CS pos: 15-16. FQA-TR. Pr: 0.0985    17
NZ_CP027599.1_153882	SP(Sec/SPI)	0.632562	0.010121	0.161796	0.195520	CS pos: 16-17. SSA-KP. Pr: 0.4476    33
NZ_CP027599.1_153912	LIPO(Sec/SPII)	0.249003	0.011594	0.527927	0.211476	CS pos: 16-17. LFT-CA. Pr: 0.1935    20
NZ_CP027599.1_153925	SP(Sec/SPI)	0.576212	0.076594	0.065298	0.281896	CS pos: 22-23. ATA-AN. Pr: 0.4913    33
NZ_CP027599.1_153936	SP(Sec/SPI)	0.785362	0.020492	0.089936	0.104209	CS pos: 17-18. NVA-DQ. Pr: 0.2914    40
NZ_CP027599.1_153978	SP(Sec/SPI)	0.400317	0.018615	0.196219	0.384848	CS pos: 22-23. TIA-QQ. Pr: 0.1521    48
NZ_CP027599.1_154003	LIPO(Sec/SPII)	0.144137	0.024577	0.425393	0.405893	CS pos: 20-21. AIA-CC. Pr: 0.3248    23
NZ_CP027599.1_154026	SP(Sec/SPI)	0.675510	0.079879	0.052469	0.192142	CS pos: 26-27. IEA-RL. Pr: 0.4581    44
NZ_CP027599.1_154034	LIPO(Sec/SPII)	0.244229	0.009724	0.487379	0.258668	CS pos: ?. Probable protein fragment    16
NZ_CP027599.1_154038	SP(Sec/SPI)	0.647797	0.008197	0.079744	0.264263	CS pos: 19-20. GIA-VK. Pr: 0.2385    44
NZ_CP027599.1_154047	SP(Sec/SPI)	0.580627	0.014849	0.034000	0.370524	CS pos: 19-20. AQA-TP. Pr: 0.4906    44
NZ_CP027599.1_154079	LIPO(Sec/SPII)	0.351821	0.015663	0.378713	0.253803	CS pos: 13-14. LKA-TP. Pr: 0.0549    16
NZ_CP027599.1_154127	LIPO(Sec/SPII)	0.215714	0.030114	0.454795	0.299377	CS pos: 17-18. SIA-CH. Pr: 0.3103    19
NZ_CP027599.1_154132	SP(Sec/SPI)	0.439535	0.066627	0.185563	0.308274	CS pos: 27-28. PDA-ST. Pr: 0.2096    48
NZ_CP027599.1_154140	SP(Sec/SPI)	0.395295	0.060482	0.160263	0.383959	CS pos: 18-19. ITT-SW. Pr: 0.0833    24
NZ_CP027599.1_154143	LIPO(Sec/SPII)	0.204684	0.048615	0.435310	0.311391	CS pos: 26-27. AIS-CG. Pr: 0.2858    34
NZ_CP027599.1_154155	LIPO(Sec/SPII)	0.320183	0.024767	0.470088	0.184962	CS pos: 22-23. STS-CC. Pr: 0.3692    27
NZ_CP027599.1_154161	LIPO(Sec/SPII)	0.136959	0.033028	0.515040	0.314972	CS pos: 11-12. LSS-CE. Pr: 0.4735    20
NZ_CP027599.1_154250	LIPO(Sec/SPII)	0.219655	0.073019	0.382802	0.324524	CS pos: ?. Probable protein fragment    19
NZ_CP027599.1_154285	LIPO(Sec/SPII)	0.080611	0.197866	0.514388	0.207136	CS pos: 22-23. PLS-CR. Pr: 0.4838    36
NZ_CP027599.1_154323	LIPO(Sec/SPII)	0.288511	0.002814	0.420556	0.288120	CS pos: ?. Probable protein fragment    18
NZ_CP027599.1_154333	SP(Sec/SPI)	0.392624	0.008649	0.342102	0.256625	CS pos: 21-22. TNA-TN. Pr: 0.2532    30
NZ_CP027599.1_154340	LIPO(Sec/SPII)	0.095823	0.003766	0.679930	0.220481	CS pos: 24-25. VSA-CF. Pr: 0.6699    28
NZ_CP027599.1_154352	LIPO(Sec/SPII)	0.204839	0.029247	0.383313	0.382601	CS pos: 21-22. CVP-CS. Pr: 0.2290    25
NZ_CP027599.1_154385	LIPO(Sec/SPII)	0.258075	0.027157	0.358018	0.356750	CS pos: ?. Probable protein fragment    16
NZ_CP027599.1_154406	LIPO(Sec/SPII)	0.192502	0.022836	0.499441	0.285220	CS pos: 13-14. FAG-CV. Pr: 0.3498    18
NZ_CP027599.1_154414	LIPO(Sec/SPII)	0.073551	0.009075	0.644777	0.272596	CS pos: 20-21. LYS-CH. Pr: 0.6118    23
NZ_CP027599.1_154449	LIPO(Sec/SPII)	0.088045	0.004563	0.531115	0.376278	CS pos: 17-18. SIA-CF. Pr: 0.4532    29
NZ_CP027599.1_154452	LIPO(Sec/SPII)	0.235168	0.219478	0.289074	0.256280	CS pos: 16-17. ISS-ST. Pr: 0.0302    20
NZ_CP027599.1_154504	SP(Sec/SPI)	0.421871	0.075568	0.101062	0.401499	CS pos: 20-21. PVA-YN. Pr: 0.0807    34
NZ_CP027599.1_154518	SP(Sec/SPI)	0.426254	0.050540	0.207688	0.315519	CS pos: 21-22. ASG-SS. Pr: 0.3201    37
NZ_CP027599.1_154523	SP(Sec/SPI)	0.418415	0.113916	0.081116	0.386553	CS pos: 12-13. ANA-RP. Pr: 0.2521    24
NZ_CP027599.1_154535	SP(Sec/SPI)	0.885208	0.001022	0.023717	0.090053	CS pos: 21-22. SNS-GL. Pr: 0.6514    48
NZ_CP027599.1_154568	LIPO(Sec/SPII)	0.203272	0.006429	0.673025	0.117275	CS pos: 18-19. CSA-CF. Pr: 0.4961    39
NZ_CP027599.1_154594	LIPO(Sec/SPII)	0.199948	0.009121	0.564809	0.226122	CS pos: 26-27. AWG-CS. Pr: 0.4772    29
NZ_CP027599.1_154595	LIPO(Sec/SPII)	0.115315	0.090625	0.499497	0.294563	CS pos: 17-18. SSA-CP. Pr: 0.4197    44
NZ_CP027599.1_154602	SP(Sec/SPI)	0.541024	0.046918	0.076909	0.335149	CS pos: 22-23. TNA-LP. Pr: 0.4265    41
NZ_CP027599.1_154603	SP(Sec/SPI)	0.487795	0.122978	0.068435	0.320791	CS pos: 27-28. GFA-DN. Pr: 0.4294    29
NZ_CP027599.1_154610	TAT(Tat/SPI)	0.084343	0.743350	0.043663	0.128645	CS pos: 31-32. AHS-AT. Pr: 0.1296    36
NZ_CP027599.1_154612	TAT(Tat/SPI)	0.148086	0.371564	0.169538	0.310812	CS pos: 26-27. IHS-CA. Pr: 0.1710    48
NZ_CP027599.1_154614	LIPO(Sec/SPII)	0.163806	0.021297	0.626343	0.188554	CS pos: 17-18. SCG-CT. Pr: 0.5295    21
NZ_CP027599.1_154636	SP(Sec/SPI)	0.888219	0.034390	0.066682	0.010708	CS pos: 23-24. VAG-AP. Pr: 0.3628    32
NZ_CP027599.1_154658	SP(Sec/SPI)	0.450299	0.014923	0.336500	0.198278	CS pos: 14-15. SFA-SR. Pr: 0.2016    16
NZ_CP027599.1_154690	SP(Sec/SPI)	0.420662	0.154482	0.083554	0.341301	CS pos: 23-24. SNA-NS. Pr: 0.2983    42
NZ_CP027599.1_154713	LIPO(Sec/SPII)	0.280875	0.064045	0.468745	0.186336	CS pos: 22-23. LPG-CI. Pr: 0.3795    29
NZ_CP027599.1_154718	LIPO(Sec/SPII)	0.062212	0.059563	0.826442	0.051783	CS pos: 24-25. SFG-CV. Pr: 0.8202    33
NZ_CP027599.1_154720	LIPO(Sec/SPII)	0.237834	0.034895	0.488100	0.239171	CS pos: 20-21. RSA-CA. Pr: 0.3942    24
NZ_CP027599.1_154729	LIPO(Sec/SPII)	0.159639	0.023998	0.621494	0.194869	CS pos: 19-20. VFG-CC. Pr: 0.4822    24
NZ_CP027599.1_154745	SP(Sec/SPI)	0.580784	0.101111	0.037498	0.280607	CS pos: 30-31. VRA-LP. Pr: 0.5448    41
NZ_CP027599.1_154760	LIPO(Sec/SPII)	0.450063	0.057902	0.482362	0.009672	CS pos: 15-16. FIA-CS. Pr: 0.4116    32
NZ_CP027599.1_154862	LIPO(Sec/SPII)	0.335143	0.010629	0.370853	0.283375	CS pos: ?. Probable protein fragment    17
NZ_CP027599.1_154871	SP(Sec/SPI)	0.493744	0.049666	0.128630	0.327961	CS pos: 22-23. AAA-KW. Pr: 0.1313    29
NZ_CP027599.1_154873	LIPO(Sec/SPII)	0.074577	0.037756	0.599087	0.288580	CS pos: 22-23. ALC-CV. Pr: 0.4635    42
NZ_CP027599.1_154885	LIPO(Sec/SPII)	0.265443	0.011323	0.423879	0.299356	CS pos: 17-18. ITA-RN. Pr: 0.3712    27
NZ_CP027599.1_154901	SP(Sec/SPI)	0.461168	0.019539	0.081264	0.438029	CS pos: 18-19. ISG-KG. Pr: 0.1205    41
NZ_CP027599.1_154946	LIPO(Sec/SPII)	0.259221	0.035938	0.487665	0.217176	CS pos: 16-17. AAG-CV. Pr: 0.2430    19
NZ_CP027599.1_154958	SP(Sec/SPI)	0.658190	0.047917	0.235640	0.058253	CS pos: 23-24. ATA-GS. Pr: 0.4750    41
NZ_CP027599.1_155004	LIPO(Sec/SPII)	0.222968	0.074936	0.386891	0.315206	CS pos: ?. Probable protein fragment    15
NZ_CP027599.1_155016	TAT(Tat/SPI)	0.150654	0.473436	0.070004	0.305906	CS pos: 26-27. AES-GF. Pr: 0.2068    28
NZ_CP027599.1_155021	LIPO(Sec/SPII)	0.313834	0.011588	0.455802	0.218776	CS pos: 10-11. FLS-CG. Pr: 0.2170    22
NZ_CP027599.1_155031	SP(Sec/SPI)	0.488528	0.163448	0.021798	0.326226	CS pos: 28-29. KRA-SD. Pr: 0.3759    44
NZ_CP027599.1_155033	SP(Sec/SPI)	0.727992	0.030815	0.093642	0.147551	CS pos: 21-22. SSA-NP. Pr: 0.3961    31
NZ_CP027599.1_155043	SP(Sec/SPI)	0.772015	0.114088	0.015670	0.098226	CS pos: 19-20. AQA-EI. Pr: 0.7006    34
NZ_CP027599.1_155056	SP(Sec/SPI)	0.459900	0.127682	0.069392	0.343026	CS pos: 12-13. AHA-SS. Pr: 0.2893    27
NZ_CP027599.1_155073	SP(Sec/SPI)	0.672845	0.021445	0.014750	0.290960	CS pos: 22-23. VIA-KD. Pr: 0.6434    46
NZ_CP027599.1_155093	SP(Sec/SPI)	0.524226	0.078165	0.035516	0.362093	CS pos: 10-11. ASA-AE. Pr: 0.4440    26
NZ_CP027599.1_155112	LIPO(Sec/SPII)	0.194943	0.028708	0.391185	0.385165	CS pos: 14-15. VRS-CC. Pr: 0.1843    19
NZ_CP027599.1_155119	SP(Sec/SPI)	0.936354	0.008468	0.052070	0.003108	CS pos: 23-24. AFA-SK. Pr: 0.7935    43
NZ_CP027599.1_155127	SP(Sec/SPI)	0.804489	0.125042	0.031462	0.039007	CS pos: 27-28. ALA-IP. Pr: 0.8556    42
NZ_CP027599.1_155151	LIPO(Sec/SPII)	0.126698	0.028445	0.492714	0.352143	CS pos: 18-19. MTA-CP. Pr: 0.4269    21
NZ_CP027599.1_155157	LIPO(Sec/SPII)	0.009211	0.017261	0.955716	0.017812	CS pos: 18-19. LSS-CQ. Pr: 0.9569    46
NZ_CP027599.1_155160	SP(Sec/SPI)	0.478498	0.276292	0.035976	0.209234	CS pos: 43-44. AEA-QE. Pr: 0.4252    47
NZ_CP027599.1_155181	SP(Sec/SPI)	0.556719	0.064569	0.121534	0.257178	CS pos: 23-24. TKT-AT. Pr: 0.2616    36
NZ_CP027599.1_155190	TAT(Tat/SPI)	0.071616	0.626861	0.044779	0.256743	CS pos: 33-34. SSA-SS. Pr: 0.2049    48
NZ_CP027599.1_155244	SP(Sec/SPI)	0.364580	0.197424	0.096351	0.341645	CS pos: 16-17. TSA-AP. Pr: 0.2429    22
NZ_CP027599.1_155291	SP(Sec/SPI)	0.609157	0.086008	0.153979	0.150856	CS pos: 21-22. NSA-FE. Pr: 0.2214    33
NZ_CP027599.1_155292	SP(Sec/SPI)	0.487017	0.102072	0.076855	0.334055	CS pos: 27-28. VRP-NE. Pr: 0.1925    39
NZ_CP027599.1_155299	LIPO(Sec/SPII)	0.010981	0.000499	0.981182	0.007338	CS pos: 15-16. ATS-CM. Pr: 0.9808    45
NZ_CP027599.1_155311	LIPO(Sec/SPII)	0.220098	0.011424	0.396225	0.372254	CS pos: 23-24. FLT-CR. Pr: 0.2350    41
NZ_CP027599.1_155320	LIPO(Sec/SPII)	0.265746	0.055702	0.344282	0.334270	CS pos: ?. Probable protein fragment    17
NZ_CP027599.1_155321	LIPO(Sec/SPII)	0.103940	0.044279	0.539808	0.311974	CS pos: 15-16. MLS-CF. Pr: 0.5077    33
NZ_CP027599.1_155333	LIPO(Sec/SPII)	0.087947	0.006985	0.610549	0.294519	CS pos: 17-18. FHS-CY. Pr: 0.5677    23
NZ_CP027599.1_155344	LIPO(Sec/SPII)	0.151760	0.125219	0.417134	0.305887	CS pos: 23-24. LCG-CA. Pr: 0.3493    27
NZ_CP027599.1_155347	SP(Sec/SPI)	0.538139	0.060023	0.142864	0.258975	CS pos: 21-22. VHG-AG. Pr: 0.4422    26
NZ_CP027599.1_155357	LIPO(Sec/SPII)	0.180747	0.061311	0.498232	0.259711	CS pos: 16-17. CAA-CG. Pr: 0.4860    25
NZ_CP027599.1_155370	SP(Sec/SPI)	0.846462	0.068143	0.044404	0.040991	CS pos: 17-18. AKA-ST. Pr: 0.7457    23
NZ_CP027599.1_155382	LIPO(Sec/SPII)	0.003612	0.006200	0.975764	0.014424	CS pos: 22-23. VTG-CR. Pr: 0.9771    42
NZ_CP027599.1_155395	SP(Sec/SPI)	0.474931	0.209598	0.127345	0.188126	CS pos: 22-23. AYS-AG. Pr: 0.4363    37
NZ_CP027599.1_155434	LIPO(Sec/SPII)	0.049145	0.006099	0.711753	0.233003	CS pos: 20-21. ASG-CS. Pr: 0.6938    35
NZ_CP027599.1_155462	SP(Sec/SPI)	0.427276	0.149729	0.033383	0.389613	CS pos: 30-31. ALA-TT. Pr: 0.1330    42
NZ_CP027599.1_155480	SP(Sec/SPI)	0.409243	0.015529	0.251901	0.323327	CS pos: 26-27. FLC-EK. Pr: 0.2689    31
NZ_CP027599.1_155511	LIPO(Sec/SPII)	0.257965	0.038509	0.386077	0.317449	CS pos: ?. Probable protein fragment    16
NZ_CP027599.1_155519	SP(Sec/SPI)	0.545761	0.067313	0.123270	0.263656	CS pos: 26-27. SLA-AA. Pr: 0.4205    28
NZ_CP027599.1_155528	SP(Sec/SPI)	0.691977	0.037657	0.018187	0.252179	CS pos: 15-16. AQA-LP. Pr: 0.5775    47
NZ_CP027599.1_155531	LIPO(Sec/SPII)	0.125909	0.005465	0.829911	0.038715	CS pos: 17-18. RAS-CS. Pr: 0.8089    44
NZ_CP027599.1_155541	LIPO(Sec/SPII)	0.268056	0.017511	0.390243	0.324191	CS pos: 21-22. RFG-CG. Pr: 0.3040    34
NZ_CP027599.1_155584	SP(Sec/SPI)	0.380523	0.143970	0.204649	0.270857	CS pos: 22-23. ALA-RR. Pr: 0.3287    27
NZ_CP027599.1_155612	LIPO(Sec/SPII)	0.139045	0.022308	0.647318	0.191329	CS pos: 16-17. LSR-CS. Pr: 0.6076    31
NZ_CP027599.1_155614	SP(Sec/SPI)	0.475506	0.114345	0.071312	0.338837	CS pos: 26-27. VSG-AP. Pr: 0.3677    37
NZ_CP027599.1_155651	LIPO(Sec/SPII)	0.178091	0.019177	0.439657	0.363075	CS pos: 27-28. STA-CS. Pr: 0.4365    36
NZ_CP027599.1_155653	SP(Sec/SPI)	0.469366	0.171609	0.222542	0.136483	CS pos: 28-29. VKS-VS. Pr: 0.3147    37
NZ_CP027599.1_155662	SP(Sec/SPI)	0.504186	0.050758	0.113546	0.331510	CS pos: 22-23. AFS-AH. Pr: 0.1601    37
NZ_CP027599.1_155704	SP(Sec/SPI)	0.567497	0.027341	0.096867	0.308295	CS pos: 16-17. SRA-TE. Pr: 0.4587    19
NZ_CP027599.1_155750	SP(Sec/SPI)	0.787022	0.044531	0.056081	0.112365	CS pos: 25-26. AVS-AP. Pr: 0.3722    44
NZ_CP027599.1_155759	LIPO(Sec/SPII)	0.124487	0.002035	0.692414	0.181064	CS pos: 16-17. VNV-CS. Pr: 0.6615    31
NZ_CP027599.1_155767	SP(Sec/SPI)	0.389836	0.056692	0.203358	0.350114	CS pos: 27-28. SRC-VS. Pr: 0.1196    33
NZ_CP027599.1_155816	SP(Sec/SPI)	0.624374	0.132256	0.065890	0.177480	CS pos: 17-18. SVA-AI. Pr: 0.1797    42
NZ_CP027599.1_155843	LIPO(Sec/SPII)	0.109399	0.016058	0.735273	0.139271	CS pos: 17-18. HSG-CG. Pr: 0.7104    21
NZ_CP027599.1_155876	LIPO(Sec/SPII)	0.009671	0.002541	0.962220	0.025567	CS pos: 20-21. MAS-CR. Pr: 0.9614    50
NZ_CP027599.1_155879	SP(Sec/SPI)	0.532106	0.354595	0.041400	0.071899	CS pos: 27-28. ARA-VI. Pr: 0.6105    35
NZ_CP027599.1_155906	LIPO(Sec/SPII)	0.068185	0.055231	0.700771	0.175814	CS pos: 24-25. LIG-CR. Pr: 0.6786    30
NZ_CP027599.1_155926	SP(Sec/SPI)	0.773028	0.058628	0.130625	0.037719	CS pos: 22-23. ASA-AP. Pr: 0.7783    41
NZ_CP027599.1_155951	LIPO(Sec/SPII)	0.232258	0.016472	0.375690	0.375580	CS pos: 15-16. CNG-LN. Pr: 0.0440    17
NZ_CP027599.1_155958	LIPO(Sec/SPII)	0.314997	0.021099	0.418821	0.245083	CS pos: 14-15. SIT-CS. Pr: 0.3461    24
NZ_CP027599.1_155961	SP(Sec/SPI)	0.431629	0.156614	0.094191	0.317566	CS pos: 22-23. RRA-IP. Pr: 0.2609    39
NZ_CP027599.1_155962	TAT(Tat/SPI)	0.098657	0.575020	0.033747	0.292575	CS pos: 31-32. SRA-LL. Pr: 0.5026    49
NZ_CP027599.1_155973	LIPO(Sec/SPII)	0.180600	0.008972	0.675907	0.134521	CS pos: 17-18. ALR-CS. Pr: 0.5977    33
NZ_CP027599.1_156385	LIPO(Sec/SPII)	0.145562	0.041153	0.414894	0.398391	CS pos: 18-19. PAS-CS. Pr: 0.3448    24
NZ_CP027599.1_156428	SP(Sec/SPI)	0.428871	0.090058	0.204461	0.276610	CS pos: 20-21. NFA-SS. Pr: 0.2268    44
NZ_CP027599.1_156430	TAT(Tat/SPI)	0.078262	0.435268	0.171017	0.315452	CS pos: 31-32. SSA-SR. Pr: 0.2347    50
NZ_CP027599.1_156464	LIPO(Sec/SPII)	0.255667	0.016414	0.425529	0.302391	CS pos: 19-20. RCF-CY. Pr: 0.0888    21
NZ_CP027599.1_156473	LIPO(Sec/SPII)	0.276256	0.022278	0.443626	0.257840	CS pos: 15-16. FLC-CS. Pr: 0.0311    20
NZ_CP027599.1_156495	LIPO(Sec/SPII)	0.204589	0.082425	0.361764	0.351223	CS pos: 18-19. RWA-CM. Pr: 0.2080    20
NZ_CP027599.1_156500	SP(Sec/SPI)	0.667992	0.052464	0.089854	0.189690	CS pos: 21-22. HQA-QR. Pr: 0.2483    30
NZ_CP027599.1_156546	SP(Sec/SPI)	0.405736	0.026424	0.243188	0.324652	CS pos: 24-25. SEA-AR. Pr: 0.2018    34
NZ_CP027599.1_156559	LIPO(Sec/SPII)	0.123743	0.035044	0.678094	0.163119	CS pos: 20-21. PLA-CL. Pr: 0.6412    29
NZ_CP027599.1_156572	LIPO(Sec/SPII)	0.274944	0.010597	0.375887	0.338572	CS pos: 19-20. STW-CR. Pr: 0.2718    30
NZ_CP027599.1_156594	LIPO(Sec/SPII)	0.289154	0.119379	0.336076	0.255391	CS pos: 27-28. FAN-CG. Pr: 0.3061    41
NZ_CP027599.1_156626	SP(Sec/SPI)	0.634801	0.055220	0.062951	0.247029	CS pos: 11-12. VDA-AG. Pr: 0.3488    31
NZ_CP027599.1_156658	LIPO(Sec/SPII)	0.199110	0.004358	0.715027	0.081505	CS pos: 14-15. ISS-CS. Pr: 0.6376    22
NZ_CP027599.1_156666	LIPO(Sec/SPII)	0.264432	0.011849	0.510224	0.213496	CS pos: 22-23. LTG-QR. Pr: 0.3698    26
NZ_CP027599.1_156671	LIPO(Sec/SPII)	0.318487	0.015772	0.396417	0.269324	CS pos: ?. Probable protein fragment    20
NZ_CP027599.1_156707	SP(Sec/SPI)	0.369970	0.072789	0.216117	0.341125	CS pos: 15-16. ATG-VP. Pr: 0.0868    22
NZ_CP027599.1_156713	LIPO(Sec/SPII)	0.204775	0.007739	0.591474	0.196012	CS pos: 18-19. RIS-CN. Pr: 0.5421    23
NZ_CP027599.1_156716	LIPO(Sec/SPII)	0.154370	0.029573	0.579077	0.236980	CS pos: 13-14. LPA-CC. Pr: 0.2998    31
NZ_CP027599.1_156728	SP(Sec/SPI)	0.494537	0.137659	0.085771	0.282033	CS pos: 21-22. LPA-AV. Pr: 0.1001    32
NZ_CP027599.1_156732	SP(Sec/SPI)	0.602496	0.077066	0.195754	0.124684	CS pos: 32-33. SAA-RT. Pr: 0.1894    38
NZ_CP027599.1_156780	LIPO(Sec/SPII)	0.028634	0.005056	0.537500	0.428810	CS pos: 13-14. LSA-CV. Pr: 0.5352    44
NZ_CP027599.1_156781	LIPO(Sec/SPII)	0.196613	0.035281	0.413834	0.354272	CS pos: 15-16. IFS-CL. Pr: 0.2283    20
NZ_CP027599.1_156785	SP(Sec/SPI)	0.420685	0.155391	0.076815	0.347110	CS pos: 15-16. AAA-FD. Pr: 0.2372    21
NZ_CP027599.1_156786	LIPO(Sec/SPII)	0.186232	0.040264	0.621587	0.151917	CS pos: 20-21. STC-CC. Pr: 0.2653    32
NZ_CP027599.1_156799	LIPO(Sec/SPII)	0.375100	0.019350	0.519400	0.086150	CS pos: 23-24. VNT-CS. Pr: 0.4962    31
NZ_CP027599.1_156806	LIPO(Sec/SPII)	0.239880	0.036010	0.493774	0.230337	CS pos: 12-13. STA-CA. Pr: 0.1843    15
NZ_CP027599.1_156828	LIPO(Sec/SPII)	0.287323	0.030763	0.350316	0.331598	CS pos: ?. Probable protein fragment    16
NZ_CP027599.1_156853	LIPO(Sec/SPII)	0.259440	0.050416	0.366738	0.323406	CS pos: 16-17. HSA-LH. Pr: 0.0324    18
NZ_CP027599.1_156860	LIPO(Sec/SPII)	0.092739	0.022977	0.517907	0.366377	CS pos: 19-20. SSG-CA. Pr: 0.4887    26
NZ_CP027599.1_156914	LIPO(Sec/SPII)	0.248240	0.039289	0.374439	0.338032	CS pos: ?. Probable protein fragment    18
NZ_CP027599.1_156925	LIPO(Sec/SPII)	0.190722	0.015125	0.639854	0.154299	CS pos: 18-19. AMS-CP. Pr: 0.6980    33
NZ_CP027599.1_156948	SP(Sec/SPI)	0.403428	0.024192	0.241925	0.330454	CS pos: 19-20. IMA-AS. Pr: 0.3152    35
NZ_CP027599.1_156956	LIPO(Sec/SPII)	0.393852	0.028931	0.419296	0.157921	CS pos: 14-15. QPA-CS. Pr: 0.2799    34
NZ_CP027599.1_156972	LIPO(Sec/SPII)	0.301627	0.010560	0.439008	0.248805	CS pos: 11-12. VSM-CG. Pr: 0.0909    17
NZ_CP027599.1_156995	SP(Sec/SPI)	0.422430	0.150531	0.056647	0.370392	CS pos: 20-21. AFG-DI. Pr: 0.2972    50
NZ_CP027599.1_157001	LIPO(Sec/SPII)	0.059632	0.003048	0.891741	0.045579	CS pos: 15-16. NSA-CT. Pr: 0.8653    31
NZ_CP027599.1_157010	TAT(Tat/SPI)	0.188263	0.427559	0.083225	0.300953	CS pos: 36-37. AVA-QC. Pr: 0.3839    50
NZ_CP027599.1_157011	SP(Sec/SPI)	0.451689	0.143239	0.044536	0.360536	CS pos: 21-22. TAA-QD. Pr: 0.4464    39
NZ_CP027599.1_157032	TAT(Tat/SPI)	0.163722	0.467205	0.060132	0.308941	CS pos: 46-47. TRA-PE. Pr: 0.1672    49
NZ_CP027599.1_157050	LIPO(Sec/SPII)	0.030301	0.015136	0.639104	0.315458	CS pos: 15-16. SAA-CS. Pr: 0.6410    43
NZ_CP027599.1_157068	SP(Sec/SPI)	0.709675	0.016277	0.064131	0.209918	CS pos: 19-20. LLA-AN. Pr: 0.4738    33
NZ_CP027599.1_157076	LIPO(Sec/SPII)	0.054239	0.035638	0.645136	0.264987	CS pos: 17-18. VTS-CS. Pr: 0.6258    32
NZ_CP027599.1_157117	SP(Sec/SPI)	0.433145	0.156262	0.152194	0.258399	CS pos: 24-25. ATT-MS. Pr: 0.0819    38
NZ_CP027599.1_157125	LIPO(Sec/SPII)	0.319140	0.017383	0.413383	0.250094	CS pos: ?. Probable protein fragment    17
NZ_CP027599.1_157131	LIPO(Sec/SPII)	0.072121	0.034951	0.454503	0.438424	CS pos: 21-22. ATS-CG. Pr: 0.4475    47
NZ_CP027599.1_157134	LIPO(Sec/SPII)	0.066348	0.025824	0.651870	0.255958	CS pos: 19-20. EIS-CT. Pr: 0.3876    46
NZ_CP027599.1_157161	LIPO(Sec/SPII)	0.293918	0.069742	0.348781	0.287559	CS pos: 14-15. AAR-CR. Pr: 0.2236    42
NZ_CP027599.1_157227	SP(Sec/SPI)	0.496030	0.016276	0.260615	0.227079	CS pos: 20-21. SHP-LF. Pr: 0.1106    22
NZ_CP027599.1_157246	LIPO(Sec/SPII)	0.247783	0.016159	0.422364	0.313694	CS pos: ?. Probable protein fragment    17
NZ_CP027599.1_157249	LIPO(Sec/SPII)	0.051354	0.012059	0.881700	0.054886	CS pos: 23-24. IGS-CP. Pr: 0.8660    36
NZ_CP027599.1_157259	LIPO(Sec/SPII)	0.066368	0.001159	0.731663	0.200811	CS pos: 26-27. WTA-CC. Pr: 0.5960    35
NZ_CP027599.1_157266	LIPO(Sec/SPII)	0.075735	0.007218	0.566968	0.350079	CS pos: 25-26. LFG-CL. Pr: 0.5116    32
NZ_CP027599.1_157272	LIPO(Sec/SPII)	0.195477	0.007431	0.419604	0.377488	CS pos: 20-21. APS-CH. Pr: 0.3125    24
NZ_CP027599.1_157292	LIPO(Sec/SPII)	0.216208	0.027507	0.381880	0.374406	CS pos: ?. Probable protein fragment    15
NZ_CP027599.1_157296	LIPO(Sec/SPII)	0.229222	0.015837	0.610041	0.144899	CS pos: 14-15. LFT-CK. Pr: 0.2461    19
NZ_CP027599.1_157303	LIPO(Sec/SPII)	0.227779	0.009414	0.422825	0.339982	CS pos: 17-18. VSL-CR. Pr: 0.1184    19
NZ_CP027599.1_157365	SP(Sec/SPI)	0.397321	0.009273	0.243783	0.349623	CS pos: 16-17. CSA-FK. Pr: 0.3573    31
NZ_CP027599.1_157428	LIPO(Sec/SPII)	0.076428	0.117083	0.768885	0.037603	CS pos: 23-24. MSF-CA. Pr: 0.4467    43
NZ_CP027599.1_157438	SP(Sec/SPI)	0.381281	0.095542	0.205672	0.317505	CS pos: 16-17. AAA-MR. Pr: 0.1502    25
NZ_CP027599.1_157486	SP(Sec/SPI)	0.394264	0.022067	0.310741	0.272928	CS pos: 14-15. LLS-FH. Pr: 0.0688    18
NZ_CP027599.1_157496	LIPO(Sec/SPII)	0.088751	0.111884	0.580998	0.218367	CS pos: 22-23. PSS-CN. Pr: 0.3045    45
NZ_CP027599.1_157528	SP(Sec/SPI)	0.760379	0.057912	0.046506	0.135203	CS pos: 18-19. SHA-IS. Pr: 0.6356    34
NZ_CP027599.1_157532	LIPO(Sec/SPII)	0.061930	0.010645	0.914870	0.012556	CS pos: 18-19. FAA-CV. Pr: 0.6923    47
NZ_CP027599.1_157557	LIPO(Sec/SPII)	0.095316	0.103978	0.406287	0.394419	CS pos: 26-27. LAS-CK. Pr: 0.3543    48
NZ_CP027599.1_157573	LIPO(Sec/SPII)	0.137001	0.003281	0.486546	0.373172	CS pos: 26-27. LMC-CT. Pr: 0.3401    31
NZ_CP027599.1_157586	TAT(Tat/SPI)	0.072559	0.508978	0.028776	0.389687	CS pos: 21-22. RLA-LT. Pr: 0.2226    34
NZ_CP027599.1_157588	SP(Sec/SPI)	0.472365	0.180716	0.085906	0.261014	CS pos: 18-19. ASS-ID. Pr: 0.1773    26
NZ_CP027599.1_157603	TAT(Tat/SPI)	0.094548	0.700357	0.050438	0.154658	CS pos: 26-27. LLS-DQ. Pr: 0.2820    31
NZ_CP027599.1_157619	SP(Sec/SPI)	0.446627	0.091050	0.032632	0.429691	CS pos: 29-30. VQA-AM. Pr: 0.3797    43
NZ_CP027599.1_157647	LIPO(Sec/SPII)	0.156522	0.023589	0.608362	0.211527	CS pos: 22-23. STA-CA. Pr: 0.5469    25
NZ_CP027599.1_157660	LIPO(Sec/SPII)	0.262839	0.018646	0.457583	0.260931	CS pos: ?. Probable protein fragment    15
NZ_CP027599.1_157675	SP(Sec/SPI)	0.711599	0.049999	0.023209	0.215193	CS pos: 23-24. AKA-DE. Pr: 0.6664    41
NZ_CP027599.1_157680	LIPO(Sec/SPII)	0.151624	0.054360	0.431655	0.362361	CS pos: 18-19. CSS-CA. Pr: 0.2268    32
NZ_CP027599.1_157682	TAT(Tat/SPI)	0.209131	0.483554	0.150233	0.157083	CS pos: 29-30. RSA-GI. Pr: 0.1713    39
NZ_CP027599.1_157717	SP(Sec/SPI)	0.667246	0.053748	0.163045	0.115961	CS pos: 25-26. SVA-RV. Pr: 0.2125    31
NZ_CP027599.1_157725	LIPO(Sec/SPII)	0.053728	0.012634	0.689379	0.244260	CS pos: 19-20. LTS-CQ. Pr: 0.6662    31
NZ_CP027599.1_157746	SP(Sec/SPI)	0.333115	0.103743	0.234252	0.328890	CS pos: 22-23. ASA-YW. Pr: 0.2388    40
NZ_CP027599.1_157749	LIPO(Sec/SPII)	0.058693	0.006374	0.661147	0.273786	CS pos: 17-18. TST-CT. Pr: 0.6553    46
NZ_CP027599.1_157777	LIPO(Sec/SPII)	0.244818	0.013931	0.372865	0.368386	CS pos: 21-22. ISK-CA. Pr: 0.2544    33
NZ_CP027599.1_157810	LIPO(Sec/SPII)	0.324181	0.032370	0.332235	0.311214	CS pos: 11-12. VWC-CS. Pr: 0.2379    36
NZ_CP027599.1_157856	SP(Sec/SPI)	0.553982	0.017796	0.305899	0.122323	CS pos: 12-13. AMA-AT. Pr: 0.2389    28
NZ_CP027599.1_157881	LIPO(Sec/SPII)	0.062500	0.007732	0.871038	0.058730	CS pos: 18-19. ATG-CD. Pr: 0.8690    22
NZ_CP027599.1_157912	LIPO(Sec/SPII)	0.214087	0.044553	0.463841	0.277520	CS pos: 30-31. VSA-CC. Pr: 0.4076    33
NZ_CP027599.1_157927	LIPO(Sec/SPII)	0.298890	0.021890	0.381316	0.297904	CS pos: 15-16. CRA-AS. Pr: 0.0732    17
NZ_CP027599.1_157930	SP(Sec/SPI)	0.504047	0.046560	0.367100	0.082292	CS pos: 24-25. SLS-ST. Pr: 0.2401    30
NZ_CP027599.1_157935	SP(Sec/SPI)	0.353428	0.038226	0.348371	0.259975	CS pos: ?. Probable protein fragment    18
NZ_CP027599.1_157955	LIPO(Sec/SPII)	0.304858	0.020573	0.383318	0.291250	CS pos: ?. Probable protein fragment    18
NZ_CP027599.1_157970	LIPO(Sec/SPII)	0.113008	0.027640	0.578623	0.280728	CS pos: 23-24. LST-CC. Pr: 0.3006    34
NZ_CP027599.1_158023	LIPO(Sec/SPII)	0.153826	0.015932	0.420188	0.410054	CS pos: 12-13. SSS-CC. Pr: 0.2358    19
NZ_CP027599.1_158026	TAT(Tat/SPI)	0.243816	0.277548	0.230184	0.248452	CS pos: ?. Probable protein fragment    26
NZ_CP027599.1_158028	SP(Sec/SPI)	0.613968	0.026677	0.250201	0.109155	CS pos: 21-22. AIS-AN. Pr: 0.2343    24
NZ_CP027599.1_158033	TAT(Tat/SPI)	0.252116	0.344473	0.117870	0.285541	CS pos: 22-23. AGA-SP. Pr: 0.2456    41
NZ_CP027599.1_158067	LIPO(Sec/SPII)	0.137746	0.009018	0.768621	0.084616	CS pos: 23-24. VVT-CR. Pr: 0.6759    33
NZ_CP027599.1_158068	SP(Sec/SPI)	0.499616	0.016180	0.323948	0.160256	CS pos: 19-20. VWC-EP. Pr: 0.3893    25
NZ_CP027599.1_158073	SP(Sec/SPI)	0.428604	0.062962	0.226584	0.281851	CS pos: 26-27. ASA-RC. Pr: 0.3543    37
NZ_CP027599.1_158087	LIPO(Sec/SPII)	0.285422	0.042183	0.362972	0.309423	CS pos: ?. Probable protein fragment    15
NZ_CP027599.1_158090	LIPO(Sec/SPII)	0.200279	0.046077	0.387089	0.366555	CS pos: 16-17. ARS-CC. Pr: 0.1500    19
NZ_CP027599.1_158164	LIPO(Sec/SPII)	0.174428	0.024940	0.515998	0.284634	CS pos: ?. Probable protein fragment    19
NZ_CP027599.1_158188	LIPO(Sec/SPII)	0.331908	0.018540	0.466811	0.182740	CS pos: 21-22. PRS-CY. Pr: 0.1378    44
NZ_CP027599.1_158205	SP(Sec/SPI)	0.706017	0.011452	0.159593	0.122938	CS pos: 20-21. TAA-DD. Pr: 0.5804    29
NZ_CP027599.1_158206	LIPO(Sec/SPII)	0.124384	0.002006	0.817946	0.055664	CS pos: 17-18. LWS-CY. Pr: 0.8079    40
NZ_CP027599.1_158248	LIPO(Sec/SPII)	0.247192	0.016185	0.368818	0.367806	CS pos: 16-17. LIQ-CM. Pr: 0.1384    18
NZ_CP027599.1_158258	LIPO(Sec/SPII)	0.127512	0.041472	0.744959	0.086057	CS pos: 19-20. SAA-CT. Pr: 0.7332    33
NZ_CP027599.1_158266	LIPO(Sec/SPII)	0.141212	0.008592	0.632603	0.217594	CS pos: 16-17. STG-CL. Pr: 0.5555    19
NZ_CP027599.1_158274	LIPO(Sec/SPII)	0.216386	0.115263	0.460104	0.208247	CS pos: 17-18. SSS-CT. Pr: 0.4378    48
NZ_CP027599.1_158301	SP(Sec/SPI)	0.577373	0.141578	0.068144	0.212905	CS pos: 22-23. AHS-AD. Pr: 0.4169    32
NZ_CP027599.1_158314	SP(Sec/SPI)	0.508949	0.121673	0.050373	0.319005	CS pos: 22-23. THA-AP. Pr: 0.3481    41
NZ_CP027599.1_158391	LIPO(Sec/SPII)	0.105618	0.016588	0.445288	0.432507	CS pos: 14-15. PNG-CS. Pr: 0.4163    40
NZ_CP027599.1_158401	LIPO(Sec/SPII)	0.330364	0.023137	0.423014	0.223485	CS pos: 17-18. LVG-LA. Pr: 0.2110    46
NZ_CP027599.1_158436	SP(Sec/SPI)	0.555961	0.008793	0.389674	0.045571	CS pos: 18-19. TMS-ST. Pr: 0.2484    26
NZ_CP027599.1_158507	LIPO(Sec/SPII)	0.294708	0.016873	0.384249	0.304170	CS pos: ?. Probable protein fragment    17
NZ_CP027599.1_158526	SP(Sec/SPI)	0.980860	0.003950	0.009299	0.005891	CS pos: 21-22. ANA-DN. Pr: 0.9656    35
NZ_CP027599.1_158538	SP(Sec/SPI)	0.611176	0.079063	0.113709	0.196053	CS pos: 23-24. ANT-AS. Pr: 0.2238    38
NZ_CP027599.1_158542	SP(Sec/SPI)	0.579640	0.095865	0.028792	0.295703	CS pos: 30-31. VTA-KL. Pr: 0.4578    43
NZ_CP027599.1_158549	SP(Sec/SPI)	0.408092	0.160707	0.119039	0.312162	CS pos: 39-40. VLP-AS. Pr: 0.0818    46
NZ_CP027599.1_158551	SP(Sec/SPI)	0.481830	0.011028	0.293699	0.213443	CS pos: 17-18. QYS-AP. Pr: 0.2225    20
NZ_CP027599.1_158552	SP(Sec/SPI)	0.567846	0.042040	0.074596	0.315518	CS pos: 16-17. VSA-SD. Pr: 0.3197    28
NZ_CP027599.1_158557	SP(Sec/SPI)	0.675217	0.052395	0.087986	0.184403	CS pos: 19-20. ALA-VD. Pr: 0.2623    44
NZ_CP027599.1_158582	SP(Sec/SPI)	0.557893	0.022578	0.171112	0.248417	CS pos: 20-21. STT-AP. Pr: 0.0949    36
NZ_CP027599.1_158593	SP(Sec/SPI)	0.774835	0.008323	0.022783	0.194060	CS pos: 24-25. TYA-DF. Pr: 0.7682    48
NZ_CP027599.1_158603	TAT(Tat/SPI)	0.238295	0.411108	0.057358	0.293238	CS pos: 31-32. THA-AT. Pr: 0.2260    49
NZ_CP027599.1_158632	LIPO(Sec/SPII)	0.036301	0.006268	0.730074	0.227357	CS pos: 14-15. FSG-CR. Pr: 0.7292    43
NZ_CP027599.1_158639	LIPO(Sec/SPII)	0.286431	0.012902	0.374458	0.326209	CS pos: ?. Probable protein fragment    18
NZ_CP027599.1_158647	SP(Sec/SPI)	0.430096	0.012277	0.420927	0.136700	CS pos: 25-26. TDG-ST. Pr: 0.2791    39
NZ_CP027599.1_158656	SP(Sec/SPI)	0.355855	0.036538	0.268619	0.338988	CS pos: ?. Probable protein fragment    15
NZ_CP027599.1_158693	LIPO(Sec/SPII)	0.089530	0.002482	0.903943	0.004045	CS pos: 17-18. ALS-CL. Pr: 0.8963    37
NZ_CP027599.1_158699	LIPO(Sec/SPII)	0.138642	0.003431	0.564108	0.293820	CS pos: 29-30. LAG-CT. Pr: 0.2974    36
NZ_CP027599.1_158700	LIPO(Sec/SPII)	0.086260	0.004956	0.857371	0.051412	CS pos: 15-16. SAA-CS. Pr: 0.8544    22
NZ_CP027599.1_158779	LIPO(Sec/SPII)	0.103954	0.001823	0.772975	0.121248	CS pos: 17-18. VLA-CC. Pr: 0.5539    21
NZ_CP027599.1_158781	SP(Sec/SPI)	0.354566	0.029952	0.311915	0.303567	CS pos: 14-15. AAA-SE. Pr: 0.0901    17
NZ_CP027599.1_158793	LIPO(Sec/SPII)	0.185140	0.019782	0.499003	0.296075	CS pos: 16-17. SCS-CW. Pr: 0.2587    32
NZ_CP027599.1_158839	SP(Sec/SPI)	0.469557	0.014374	0.093999	0.422071	CS pos: 21-22. TWA-SK. Pr: 0.3470    24
NZ_CP027599.1_158877	LIPO(Sec/SPII)	0.092229	0.157227	0.585009	0.165535	CS pos: 15-16. SSA-CS. Pr: 0.5750    34
NZ_CP027599.1_158966	LIPO(Sec/SPII)	0.226605	0.033810	0.692362	0.047223	CS pos: 17-18. SIC-CA. Pr: 0.5177    33
NZ_CP027599.1_158972	LIPO(Sec/SPII)	0.048476	0.006527	0.737255	0.207742	CS pos: 20-21. HGS-CT. Pr: 0.7159    27
NZ_CP027599.1_159005	LIPO(Sec/SPII)	0.137585	0.166517	0.444960	0.250938	CS pos: 22-23. AAG-CR. Pr: 0.3923    44
NZ_CP027599.1_159007	LIPO(Sec/SPII)	0.207501	0.044528	0.409722	0.338249	CS pos: 18-19. SAA-CA. Pr: 0.3166    32
NZ_CP027599.1_159010	TAT(Tat/SPI)	0.012685	0.908911	0.021258	0.057146	CS pos: 31-32. RSA-DR. Pr: 0.4715    47
NZ_CP027599.1_159024	SP(Sec/SPI)	0.392642	0.022727	0.246450	0.338180	CS pos: 11-12. TGG-GW. Pr: 0.0737    21
NZ_CP027599.1_159106	LIPO(Sec/SPII)	0.173795	0.150773	0.594045	0.081387	CS pos: 30-31. TSA-CV. Pr: 0.5700    41
NZ_CP027599.1_159110	LIPO(Sec/SPII)	0.053216	0.420335	0.468571	0.057878	CS pos: 23-24. GSG-CQ. Pr: 0.4546    40
NZ_CP027599.1_159128	LIPO(Sec/SPII)	0.275691	0.018724	0.371178	0.334407	CS pos: ?. Probable protein fragment    21
NZ_CP027599.1_159132	LIPO(Sec/SPII)	0.021474	0.000703	0.928127	0.049696	CS pos: 15-16. VAT-CY. Pr: 0.9187    46
NZ_CP027599.1_159142	LIPO(Sec/SPII)	0.161986	0.083086	0.383545	0.371383	CS pos: 14-15. DIP-CD. Pr: 0.3320    43
NZ_CP027599.1_159145	SP(Sec/SPI)	0.434574	0.163114	0.172365	0.229946	CS pos: 30-31. AGA-SL. Pr: 0.0647    38
NZ_CP027599.1_159160	TAT(Tat/SPI)	0.249857	0.396176	0.070643	0.283324	CS pos: 23-24. AAG-TP. Pr: 0.2205    42
NZ_CP027599.1_159180	LIPO(Sec/SPII)	0.153201	0.059430	0.454246	0.333123	CS pos: 18-19. PLS-CE. Pr: 0.4087    25
NZ_CP027599.1_159210	LIPO(Sec/SPII)	0.274693	0.035077	0.377318	0.312911	CS pos: ?. Probable protein fragment    16
NZ_CP027599.1_159225	SP(Sec/SPI)	0.513081	0.304151	0.010401	0.172367	CS pos: 29-30. AFA-AV. Pr: 0.7318    40
NZ_CP027599.1_159231	LIPO(Sec/SPII)	0.098602	0.002940	0.745951	0.152508	CS pos: 14-15. CNA-CD. Pr: 0.7310    28
NZ_CP027599.1_159233	SP(Sec/SPI)	0.466122	0.034068	0.128631	0.371178	CS pos: 22-23. ADC-EL. Pr: 0.2102    28
NZ_CP027599.1_159238	LIPO(Sec/SPII)	0.228347	0.004410	0.447066	0.320176	CS pos: 12-13. AST-CG. Pr: 0.3667    37
NZ_CP027599.1_159276	LIPO(Sec/SPII)	0.164524	0.080961	0.409358	0.345156	CS pos: 30-31. AST-CK. Pr: 0.3305    48
NZ_CP027599.1_159294	SP(Sec/SPI)	0.720467	0.015580	0.167559	0.096394	CS pos: 16-17. AQA-RL. Pr: 0.5564    48
NZ_CP027599.1_159375	LIPO(Sec/SPII)	0.110357	0.012472	0.619484	0.257687	CS pos: 23-24. INA-CK. Pr: 0.5583    25
NZ_CP027599.1_159379	LIPO(Sec/SPII)	0.055298	0.036636	0.651029	0.257037	CS pos: 16-17. SSA-CT. Pr: 0.6429    44
NZ_CP027599.1_159409	LIPO(Sec/SPII)	0.242095	0.029664	0.373777	0.354463	CS pos: ?. Probable protein fragment    21
NZ_CP027599.1_159489	LIPO(Sec/SPII)	0.358035	0.014327	0.478339	0.149299	CS pos: ?. Probable protein fragment    19
NZ_CP027599.1_159495	LIPO(Sec/SPII)	0.047030	0.002570	0.827374	0.123026	CS pos: 25-26. LSS-CW. Pr: 0.8096    31
NZ_CP027599.1_159505	SP(Sec/SPI)	0.428796	0.018703	0.150756	0.401744	CS pos: 16-17. TQA-AH. Pr: 0.2926    26
NZ_CP027599.1_159515	SP(Sec/SPI)	0.561459	0.010995	0.319086	0.108459	CS pos: 23-24. SLS-LP. Pr: 0.2590    31
NZ_CP027599.1_159543	SP(Sec/SPI)	0.682641	0.069898	0.209687	0.037773	CS pos: 27-28. ARA-AV. Pr: 0.6425    48
NZ_CP027599.1_159545	SP(Sec/SPI)	0.518114	0.016959	0.160993	0.303934	CS pos: 22-23. VNV-AV. Pr: 0.1529    24
NZ_CP027599.1_159553	SP(Sec/SPI)	0.433863	0.012238	0.311574	0.242325	CS pos: 19-20. PLM-TP. Pr: 0.0537    23
NZ_CP027599.1_159560	SP(Sec/SPI)	0.551459	0.035278	0.142670	0.270593	CS pos: 33-34. LSA-AI. Pr: 0.1963    41
NZ_CP027599.1_159571	LIPO(Sec/SPII)	0.298023	0.020563	0.531179	0.150236	CS pos: 16-17. MAA-CC. Pr: 0.4157    42
NZ_CP027599.1_159585	LIPO(Sec/SPII)	0.219012	0.047276	0.585569	0.148143	CS pos: 22-23. SLT-CA. Pr: 0.3075    37
NZ_CP027599.1_159632	LIPO(Sec/SPII)	0.083422	0.012437	0.737757	0.166384	CS pos: 15-16. LTA-CG. Pr: 0.7269    25
NZ_CP027599.1_159659	SP(Sec/SPI)	0.409235	0.056397	0.334468	0.199900	CS pos: ?. Probable protein fragment    17
NZ_CP027599.1_159663	LIPO(Sec/SPII)	0.213713	0.190590	0.434853	0.160844	CS pos: 18-19. KVS-CS. Pr: 0.4001    31
NZ_CP027599.1_159671	SP(Sec/SPI)	0.662962	0.180718	0.028172	0.128149	CS pos: 21-22. ASA-SN. Pr: 0.6738    37
NZ_CP027599.1_159678	SP(Sec/SPI)	0.474061	0.029648	0.332893	0.163398	CS pos: ?. Probable protein fragment    27
NZ_CP027599.1_159687	SP(Sec/SPI)	0.376370	0.009439	0.351996	0.262195	CS pos: ?. Probable protein fragment    19
NZ_CP027599.1_159699	TAT(Tat/SPI)	0.073494	0.493822	0.072554	0.360130	CS pos: 23-24. AGA-RL. Pr: 0.1759    39
NZ_CP027599.1_159701	SP(Sec/SPI)	0.717549	0.154160	0.051627	0.076664	CS pos: 21-22. AAA-LK. Pr: 0.6321    40
NZ_CP027599.1_159702	LIPO(Sec/SPII)	0.173125	0.029077	0.716513	0.081285	CS pos: 15-16. SGS-CG. Pr: 0.6893    33
NZ_CP027599.1_159748	LIPO(Sec/SPII)	0.126111	0.004924	0.752419	0.116546	CS pos: 15-16. SCA-CR. Pr: 0.4670    21
NZ_CP027599.1_159762	LIPO(Sec/SPII)	0.232845	0.090506	0.478235	0.198413	CS pos: 15-16. ISQ-CA. Pr: 0.3994    41
NZ_CP027599.1_159780	SP(Sec/SPI)	0.441451	0.055600	0.219865	0.283083	CS pos: 18-19. ANC-DP. Pr: 0.2762    22
NZ_CP027599.1_159811	LIPO(Sec/SPII)	0.349242	0.141153	0.372235	0.137371	CS pos: 26-27. APA-CA. Pr: 0.3191    35
NZ_CP027599.1_159853	LIPO(Sec/SPII)	0.210538	0.050288	0.537281	0.201893	CS pos: 17-18. SVA-CS. Pr: 0.4577    21
NZ_CP027599.1_159917	LIPO(Sec/SPII)	0.339977	0.017404	0.386693	0.255926	CS pos: ?. Probable protein fragment    17
NZ_CP027599.1_159962	LIPO(Sec/SPII)	0.264537	0.020465	0.402230	0.312768	CS pos: 13-14. CAS-VI. Pr: 0.0249    17
NZ_CP027599.1_160070	LIPO(Sec/SPII)	0.279443	0.044111	0.424312	0.252134	CS pos: 19-20. DIA-CT. Pr: 0.2947    38
NZ_CP027599.1_160086	LIPO(Sec/SPII)	0.145217	0.033515	0.453298	0.367971	CS pos: 18-19. LAR-CQ. Pr: 0.4201    41
NZ_CP027599.1_160100	TAT(Tat/SPI)	0.150244	0.411576	0.028818	0.409363	CS pos: 41-42. VAA-TR. Pr: 0.0775    46
NZ_CP027599.1_160127	SP(Sec/SPI)	0.322946	0.091364	0.287711	0.297980	CS pos: 15-16. FYC-LP. Pr: 0.0542    19
NZ_CP027599.1_160156	SP(Sec/SPI)	0.529549	0.043457	0.119258	0.307736	CS pos: 18-19. TSA-SE. Pr: 0.3918    35
NZ_CP027599.1_160159	SP(Sec/SPI)	0.813016	0.077564	0.047004	0.062416	CS pos: 16-17. ASA-AR. Pr: 0.6686    28
NZ_CP027599.1_160166	TAT(Tat/SPI)	0.282574	0.310385	0.115087	0.291953	CS pos: 25-26. ASA-SS. Pr: 0.1344    30
NZ_CP027599.1_160172	LIPO(Sec/SPII)	0.256534	0.030049	0.361206	0.352211	CS pos: 22-23. FTT-CT. Pr: 0.2579    29
NZ_CP027599.1_160196	SP(Sec/SPI)	0.441854	0.074121	0.044902	0.439123	CS pos: 12-13. AQA-VE. Pr: 0.3000    20
NZ_CP027599.1_160197	LIPO(Sec/SPII)	0.296988	0.150125	0.381719	0.171168	CS pos: 32-33. VVG-CC. Pr: 0.2585    37
NZ_CP027599.1_160220	LIPO(Sec/SPII)	0.044067	0.010653	0.807001	0.138279	CS pos: 15-16. SSG-CE. Pr: 0.8074    30
NZ_CP027599.1_160225	SP(Sec/SPI)	0.763148	0.026853	0.040237	0.169761	CS pos: 19-20. ANA-EN. Pr: 0.6925    29
NZ_CP027599.1_160235	TAT(Tat/SPI)	0.311998	0.383487	0.149676	0.154839	CS pos: 29-30. APA-VR. Pr: 0.0690    36
NZ_CP027599.1_160286	LIPO(Sec/SPII)	0.247039	0.030102	0.376913	0.345945	CS pos: ?. Probable protein fragment    15
NZ_CP027599.1_160371	LIPO(Sec/SPII)	0.300171	0.014003	0.406052	0.279775	CS pos: 20-21. ASS-CR. Pr: 0.2747    22
NZ_CP027599.1_160372	LIPO(Sec/SPII)	0.204000	0.024537	0.449625	0.321838	CS pos: ?. Probable protein fragment    17
NZ_CP027599.1_160375	LIPO(Sec/SPII)	0.075823	0.007174	0.763944	0.153059	CS pos: 11-12. LTS-CI. Pr: 0.7506    29
NZ_CP027599.1_160377	SP(Sec/SPI)	0.398420	0.024473	0.194417	0.382691	CS pos: 18-19. INT-VP. Pr: 0.1343    20
NZ_CP027599.1_160407	LIPO(Sec/SPII)	0.118818	0.017073	0.579986	0.284122	CS pos: 23-24. FAG-CI. Pr: 0.5444    25
NZ_CP027599.1_160422	LIPO(Sec/SPII)	0.149509	0.004165	0.757896	0.088430	CS pos: 14-15. FSA-CF. Pr: 0.5835    19
NZ_CP027599.1_160468	LIPO(Sec/SPII)	0.151392	0.015786	0.544286	0.288536	CS pos: ?. Probable protein fragment    19
NZ_CP027599.1_160469	LIPO(Sec/SPII)	0.270217	0.015060	0.417487	0.297236	CS pos: ?. Probable protein fragment    16
NZ_CP027599.1_160485	LIPO(Sec/SPII)	0.139393	0.018274	0.539231	0.303102	CS pos: 17-18. LCA-CN. Pr: 0.4788    25
NZ_CP027599.1_160501	LIPO(Sec/SPII)	0.062218	0.026806	0.474111	0.436866	CS pos: 38-39. LNS-CA. Pr: 0.4763    49
NZ_CP027599.1_160519	LIPO(Sec/SPII)	0.253811	0.028849	0.369310	0.348030	CS pos: 12-13. STG-CL. Pr: 0.0925    15
NZ_CP027599.1_160521	SP(Sec/SPI)	0.736314	0.177622	0.028748	0.057316	CS pos: 23-24. VAS-SG. Pr: 0.4946    45
NZ_CP027599.1_160532	LIPO(Sec/SPII)	0.069293	0.002979	0.638574	0.289154	CS pos: 16-17. YIS-CQ. Pr: 0.6046    27
NZ_CP027599.1_160583	SP(Sec/SPI)	0.426537	0.093407	0.085892	0.394165	CS pos: 17-18. AVA-AA. Pr: 0.1046    28
NZ_CP027599.1_160612	SP(Sec/SPI)	0.613075	0.018821	0.116615	0.251489	CS pos: 17-18. MKA-GQ. Pr: 0.4338    29
NZ_CP027599.1_160670	SP(Sec/SPI)	0.405995	0.034683	0.182933	0.376389	CS pos: 19-20. QFA-RT. Pr: 0.2000    28
NZ_CP027599.1_160824	LIPO(Sec/SPII)	0.212862	0.028619	0.654709	0.103811	CS pos: 28-29. SSV-CS. Pr: 0.5150    33
NZ_CP027599.1_160842	SP(Sec/SPI)	0.424001	0.246390	0.060116	0.269493	CS pos: 26-27. TLA-RS. Pr: 0.2118    37
NZ_CP027599.1_160870	LIPO(Sec/SPII)	0.017702	0.000931	0.947057	0.034310	CS pos: 35-36. SLA-CS. Pr: 0.8618    49
NZ_CP027599.1_160874	SP(Sec/SPI)	0.565033	0.004457	0.369689	0.060821	CS pos: 24-25. CHA-GA. Pr: 0.3873    43
NZ_CP027599.1_160891	LIPO(Sec/SPII)	0.138961	0.009643	0.622480	0.228916	CS pos: ?. Probable protein fragment    16
NZ_CP027599.1_160918	SP(Sec/SPI)	0.650742	0.021729	0.047114	0.280415	CS pos: 18-19. ALS-AE. Pr: 0.5033    41
NZ_CP027599.1_160963	SP(Sec/SPI)	0.652983	0.019356	0.116175	0.211486	CS pos: 22-23. SKA-RR. Pr: 0.3416    28
NZ_CP027599.1_161011	SP(Sec/SPI)	0.403275	0.020071	0.349931	0.226723	CS pos: ?. Probable protein fragment    22
NZ_CP027599.1_161034	SP(Sec/SPI)	0.445641	0.261906	0.049653	0.242799	CS pos: 20-21. AIA-SP. Pr: 0.4995    40
NZ_CP027599.1_161069	SP(Sec/SPI)	0.394609	0.109299	0.114406	0.381686	CS pos: 29-30. ASA-GQ. Pr: 0.2628    31
NZ_CP027599.1_161106	LIPO(Sec/SPII)	0.052616	0.010720	0.687407	0.249258	CS pos: 18-19. FMG-CK. Pr: 0.6525    25
NZ_CP027599.1_161108	LIPO(Sec/SPII)	0.045718	0.004232	0.605142	0.344908	CS pos: 18-19. SMA-CY. Pr: 0.6265    43
NZ_CP027599.1_161149	LIPO(Sec/SPII)	0.274600	0.051340	0.364661	0.309399	CS pos: 14-15. AGT-CR. Pr: 0.1673    16
NZ_CP027599.1_161159	SP(Sec/SPI)	0.487930	0.071559	0.088222	0.352289	CS pos: 20-21. ASA-EN. Pr: 0.4128    28
NZ_CP027599.1_161169	LIPO(Sec/SPII)	0.193517	0.010880	0.411403	0.384200	CS pos: 14-15. ASM-CA. Pr: 0.2452    22
NZ_CP027599.1_161203	LIPO(Sec/SPII)	0.129458	0.006112	0.815557	0.048874	CS pos: 14-15. ISA-CA. Pr: 0.7033    17
NZ_CP027599.1_161204	SP(Sec/SPI)	0.529779	0.021132	0.075807	0.373283	CS pos: 18-19. TMA-KR. Pr: 0.4084    31
NZ_CP027599.1_161234	LIPO(Sec/SPII)	0.074244	0.011911	0.540747	0.373098	CS pos: 14-15. VSS-CS. Pr: 0.5140    44
NZ_CP027599.1_161263	SP(Sec/SPI)	0.419586	0.148812	0.107302	0.324300	CS pos: 15-16. ATA-WS. Pr: 0.1165    41
NZ_CP027599.1_161268	LIPO(Sec/SPII)	0.196868	0.045591	0.392018	0.365523	CS pos: 21-22. QSK-CS. Pr: 0.3681    42
NZ_CP027599.1_161277	SP(Sec/SPI)	0.687288	0.021056	0.158163	0.133492	CS pos: 20-21. RFA-TE. Pr: 0.5218    23
NZ_CP027599.1_161283	SP(Sec/SPI)	0.299679	0.209951	0.223570	0.266800	CS pos: 26-27. TLG-RK. Pr: 0.2657    45
NZ_CP027599.1_161285	TAT(Tat/SPI)	0.131556	0.818300	0.017079	0.033065	CS pos: 30-31. ASG-AG. Pr: 0.1769    35
NZ_CP027599.1_161303	TAT(Tat/SPI)	0.145215	0.618768	0.098078	0.137940	CS pos: 20-21. AGA-GT. Pr: 0.0795    25
NZ_CP027599.1_161306	TAT(Tat/SPI)	0.180829	0.380798	0.095985	0.342388	CS pos: 31-32. AAA-RR. Pr: 0.1303    35
NZ_CP027599.1_161315	SP(Sec/SPI)	0.347444	0.185672	0.125894	0.340990	CS pos: 21-22. ALA-IV. Pr: 0.2813    36
NZ_CP027599.1_161329	TAT(Tat/SPI)	0.105733	0.541534	0.032054	0.320678	CS pos: 30-31. YYA-AQ. Pr: 0.1634    45
NZ_CP027599.1_161354	SP(Sec/SPI)	0.334345	0.094437	0.313701	0.257517	CS pos: ?. Probable protein fragment    21
NZ_CP027599.1_161372	SP(Sec/SPI)	0.467849	0.061337	0.167468	0.303346	CS pos: 14-15. ANA-GK. Pr: 0.2103    19
NZ_CP027599.1_161377	TAT(Tat/SPI)	0.339575	0.433755	0.042172	0.184498	CS pos: 21-22. AQA-RG. Pr: 0.3844    26
NZ_CP027599.1_161426	LIPO(Sec/SPII)	0.357680	0.036085	0.360127	0.246108	CS pos: 16-17. LRR-CA. Pr: 0.0856    23
NZ_CP027599.1_161443	TAT(Tat/SPI)	0.225729	0.376532	0.025728	0.372011	CS pos: 42-43. ANA-VP. Pr: 0.1769    50
NZ_CP027599.1_161452	LIPO(Sec/SPII)	0.151561	0.014064	0.517626	0.316749	CS pos: 23-24. TAT-CC. Pr: 0.3140    28
NZ_CP027599.1_161484	LIPO(Sec/SPII)	0.075727	0.019760	0.745892	0.158621	CS pos: 22-23. LHA-CR. Pr: 0.7341    47
NZ_CP027599.1_161496	LIPO(Sec/SPII)	0.381966	0.012625	0.396479	0.208931	CS pos: 23-24. SSG-CG. Pr: 0.3054    27
NZ_CP027599.1_161512	SP(Sec/SPI)	0.706578	0.127083	0.063794	0.102545	CS pos: 15-16. ANA-RD. Pr: 0.7249    42
NZ_CP027599.1_161535	LIPO(Sec/SPII)	0.299504	0.011564	0.374568	0.314365	CS pos: ?. Probable protein fragment    16
NZ_CP027599.1_161543	TAT(Tat/SPI)	0.279171	0.460478	0.037112	0.223240	CS pos: 26-27. AGA-GD. Pr: 0.5885    40
NZ_CP027599.1_161559	TAT(Tat/SPI)	0.103369	0.537695	0.023189	0.335747	CS pos: 26-27. VRA-NG. Pr: 0.3648    43
NZ_CP027599.1_161576	SP(Sec/SPI)	0.543734	0.027501	0.130895	0.297870	CS pos: 22-23. AYS-RD. Pr: 0.2353    37
NZ_CP027599.1_161580	LIPO(Sec/SPII)	0.323539	0.027806	0.414297	0.234357	CS pos: ?. Probable protein fragment    16
NZ_CP027599.1_161599	LIPO(Sec/SPII)	0.236003	0.022767	0.615285	0.125945	CS pos: 16-17. ASG-CC. Pr: 0.4709    49
NZ_CP027599.1_161608	LIPO(Sec/SPII)	0.118134	0.014975	0.748117	0.118774	CS pos: 19-20. AIF-CT. Pr: 0.6756    30
NZ_CP027599.1_161630	LIPO(Sec/SPII)	0.257888	0.007279	0.498023	0.236811	CS pos: 20-21. CSR-CK. Pr: 0.2495    43
NZ_CP027599.1_161647	LIPO(Sec/SPII)	0.027667	0.011468	0.748894	0.211971	CS pos: 16-17. AVG-CV. Pr: 0.7485    40
NZ_CP027599.1_161649	SP(Sec/SPI)	0.585134	0.096504	0.110712	0.207649	CS pos: 18-19. TPA-SY. Pr: 0.1314    32
NZ_CP027599.1_161661	LIPO(Sec/SPII)	0.223157	0.011297	0.431148	0.334398	CS pos: 21-22. PPG-CG. Pr: 0.1913    24
NZ_CP027599.1_161665	LIPO(Sec/SPII)	0.320095	0.105291	0.393446	0.181168	CS pos: 18-19. GSG-CD. Pr: 0.3496    33
NZ_CP027599.1_161669	LIPO(Sec/SPII)	0.161520	0.029418	0.417722	0.391339	CS pos: 23-24. AAG-CS. Pr: 0.3980    33
NZ_CP027599.1_161725	LIPO(Sec/SPII)	0.113302	0.030235	0.580030	0.276433	CS pos: 20-21. LIS-CS. Pr: 0.5457    32
NZ_CP027599.1_161748	SP(Sec/SPI)	0.480498	0.054686	0.044987	0.419828	CS pos: 21-22. RDA-LP. Pr: 0.0988    47
NZ_CP027599.1_161755	TAT(Tat/SPI)	0.182404	0.371412	0.156576	0.289608	CS pos: 21-22. LNS-SI. Pr: 0.0614    23
NZ_CP027599.1_161837	LIPO(Sec/SPII)	0.285903	0.009959	0.410912	0.293225	CS pos: 15-16. PRV-CL. Pr: 0.0634    17
NZ_CP027599.1_161887	SP(Sec/SPI)	0.790932	0.008231	0.012291	0.188546	CS pos: 18-19. TLA-DS. Pr: 0.7493    44
NZ_CP027599.1_161888	LIPO(Sec/SPII)	0.110412	0.020849	0.719904	0.148835	CS pos: 22-23. LTT-CG. Pr: 0.7085    48
NZ_CP027599.1_161898	SP(Sec/SPI)	0.517667	0.012353	0.030621	0.439360	CS pos: 35-36. GYA-AE. Pr: 0.3154    49
NZ_CP027599.1_161912	SP(Sec/SPI)	0.507971	0.057485	0.072243	0.362301	CS pos: 18-19. SHS-HD. Pr: 0.4053    26
NZ_CP027599.1_161928	SP(Sec/SPI)	0.378509	0.061273	0.187178	0.373040	CS pos: 16-17. SRA-KS. Pr: 0.1392    20
NZ_CP027599.1_161940	LIPO(Sec/SPII)	0.199946	0.033013	0.385936	0.381105	CS pos: 18-19. WRA-CR. Pr: 0.2609    28
NZ_CP027599.1_161990	LIPO(Sec/SPII)	0.254143	0.025854	0.634485	0.085518	CS pos: 23-24. ATT-CC. Pr: 0.4491    33
NZ_CP027599.1_162021	TAT(Tat/SPI)	0.077619	0.451386	0.215757	0.255238	CS pos: 30-31. SYA-RT. Pr: 0.4509    49
NZ_CP027599.1_162057	LIPO(Sec/SPII)	0.154129	0.049448	0.413703	0.382720	CS pos: 24-25. ISA-CA. Pr: 0.3383    26
NZ_CP027599.1_162105	SP(Sec/SPI)	0.660677	0.038931	0.051710	0.248682	CS pos: 24-25. GLA-DY. Pr: 0.6221    36
NZ_CP027599.1_162132	LIPO(Sec/SPII)	0.280035	0.016830	0.423150	0.279985	CS pos: 22-23. PMC-CG. Pr: 0.1996    25
NZ_CP027599.1_162164	LIPO(Sec/SPII)	0.185169	0.019955	0.460658	0.334218	CS pos: 9-10. SAG-CR. Pr: 0.3814    20
NZ_CP027599.1_162195	LIPO(Sec/SPII)	0.111500	0.046389	0.574508	0.267603	CS pos: 17-18. SSG-CS. Pr: 0.5177    29
NZ_CP027599.1_162207	SP(Sec/SPI)	0.349369	0.201486	0.133241	0.315905	CS pos: 23-24. ATA-TR. Pr: 0.1874    30
NZ_CP027599.1_162212	LIPO(Sec/SPII)	0.195648	0.044808	0.471661	0.287883	CS pos: 13-14. SNA-CG. Pr: 0.3564    16
NZ_CP027599.1_162215	SP(Sec/SPI)	0.444101	0.120992	0.132718	0.302190	CS pos: 20-21. SAA-SY. Pr: 0.3624    40
NZ_CP027599.1_162235	LIPO(Sec/SPII)	0.170634	0.086404	0.379742	0.363221	CS pos: 12-13. MPC-CS. Pr: 0.1817    46
NZ_CP027599.1_162258	LIPO(Sec/SPII)	0.175881	0.014596	0.502316	0.307207	CS pos: 14-15. VSA-CW. Pr: 0.4876    28
NZ_CP027599.1_162269	LIPO(Sec/SPII)	0.152522	0.037702	0.555566	0.254210	CS pos: 18-19. IAN-CR. Pr: 0.3194    39
NZ_CP027599.1_162270	SP(Sec/SPI)	0.474815	0.090486	0.043674	0.391025	CS pos: 22-23. ANA-KP. Pr: 0.4234    30
NZ_CP027599.1_162277	SP(Sec/SPI)	0.555867	0.043285	0.085860	0.314988	CS pos: 11-12. ATA-SV. Pr: 0.2784    25
NZ_CP027599.1_162297	SP(Sec/SPI)	0.425320	0.202246	0.072302	0.300132	CS pos: 28-29. TSA-SL. Pr: 0.2369    40
NZ_CP027599.1_162318	SP(Sec/SPI)	0.648221	0.026333	0.233559	0.091888	CS pos: 27-28. VSA-GR. Pr: 0.2638    42
NZ_CP027599.1_162362	LIPO(Sec/SPII)	0.256750	0.046227	0.379053	0.317971	CS pos: ?. Probable protein fragment    15
NZ_CP027599.1_162369	LIPO(Sec/SPII)	0.115359	0.327062	0.364388	0.193192	CS pos: 22-23. TVA-CA. Pr: 0.3459    44
NZ_CP027599.1_162372	LIPO(Sec/SPII)	0.163876	0.007058	0.637374	0.191693	CS pos: 16-17. APA-CR. Pr: 0.6170    30
NZ_CP027599.1_162383	LIPO(Sec/SPII)	0.113333	0.008839	0.857334	0.020494	CS pos: 17-18. TAS-CC. Pr: 0.7152    25
NZ_CP027599.1_162402	LIPO(Sec/SPII)	0.218021	0.027138	0.446029	0.308812	CS pos: 15-16. SIA-CR. Pr: 0.3911    24
NZ_CP027599.1_162437	LIPO(Sec/SPII)	0.178283	0.034291	0.442356	0.345070	CS pos: 16-17. ARS-CG. Pr: 0.4041    21
NZ_CP027599.1_162451	LIPO(Sec/SPII)	0.105221	0.004069	0.716831	0.173879	CS pos: 18-19. TIA-CP. Pr: 0.6846    26
NZ_CP027599.1_162467	LIPO(Sec/SPII)	0.087733	0.006955	0.484045	0.421267	CS pos: 18-19. TFS-CW. Pr: 0.4695    34
NZ_CP027599.1_162517	LIPO(Sec/SPII)	0.137883	0.038799	0.555886	0.267432	CS pos: 25-26. ILC-CA. Pr: 0.4206    45
NZ_CP027599.1_162535	SP(Sec/SPI)	0.350133	0.261917	0.141208	0.246742	CS pos: 23-24. SSA-VM. Pr: 0.1723    30
NZ_CP027599.1_162546	SP(Sec/SPI)	0.405237	0.024484	0.290740	0.279539	CS pos: ?. Probable protein fragment    20
NZ_CP027599.1_162547	SP(Sec/SPI)	0.519174	0.055512	0.023993	0.401321	CS pos: 12-13. VNA-DD. Pr: 0.4864    40
NZ_CP027599.1_162552	LIPO(Sec/SPII)	0.079927	0.018350	0.531112	0.370610	CS pos: 27-28. TSS-CD. Pr: 0.5160    37
NZ_CP027599.1_162575	LIPO(Sec/SPII)	0.075888	0.005492	0.704602	0.214018	CS pos: 28-29. TSG-CD. Pr: 0.6936    34
NZ_CP027599.1_162581	LIPO(Sec/SPII)	0.216038	0.021679	0.449004	0.313279	CS pos: 15-16. LTG-AA. Pr: 0.2483    24
NZ_CP027599.1_162585	LIPO(Sec/SPII)	0.366894	0.020529	0.462901	0.149676	CS pos: 21-22. WSA-CR. Pr: 0.3822    23
NZ_CP027599.1_162591	LIPO(Sec/SPII)	0.057035	0.025357	0.738145	0.179463	CS pos: 15-16. LVG-CN. Pr: 0.7345    27
NZ_CP027599.1_162610	LIPO(Sec/SPII)	0.069782	0.006469	0.628673	0.295077	CS pos: 13-14. LSS-CY. Pr: 0.6073    28
NZ_CP027599.1_162725	LIPO(Sec/SPII)	0.288249	0.041025	0.368942	0.301784	CS pos: 11-12. ASA-TF. Pr: 0.0114    15
NZ_CP027599.1_162727	LIPO(Sec/SPII)	0.080519	0.276608	0.376478	0.266396	CS pos: 20-21. AGV-CS. Pr: 0.3403    50
NZ_CP027599.1_162753	SP(Sec/SPI)	0.461251	0.204259	0.059547	0.274943	CS pos: 20-21. ANA-AQ. Pr: 0.4932    32
NZ_CP027599.1_162830	LIPO(Sec/SPII)	0.337956	0.021687	0.377719	0.262638	CS pos: 19-20. ASG-VP. Pr: 0.1276    21
NZ_CP027599.1_162836	TAT(Tat/SPI)	0.197927	0.400384	0.076637	0.325052	CS pos: 22-23. AAG-SS. Pr: 0.3023    45
NZ_CP027599.1_162843	TAT(Tat/SPI)	0.025350	0.972174	0.001358	0.001118	CS pos: 27-28. ADA-RS. Pr: 0.6991    44
NZ_CP027599.1_162866	LIPO(Sec/SPII)	0.185286	0.009362	0.430173	0.375179	CS pos: 19-20. ITA-CM. Pr: 0.4232    36
NZ_CP027599.1_162890	LIPO(Sec/SPII)	0.044807	0.004004	0.932419	0.018769	CS pos: 18-19. ATA-CF. Pr: 0.9308    47
NZ_CP027599.1_162893	LIPO(Sec/SPII)	0.249805	0.015475	0.474131	0.260589	CS pos: ?. Probable protein fragment    15
NZ_CP027599.1_162939	LIPO(Sec/SPII)	0.117754	0.018106	0.805854	0.058286	CS pos: 22-23. MQA-CE. Pr: 0.8319    24
NZ_CP027599.1_162948	SP(Sec/SPI)	0.460395	0.117095	0.322479	0.100031	CS pos: 21-22. ISS-AP. Pr: 0.2077    40
NZ_CP027599.1_162949	SP(Sec/SPI)	0.451458	0.087428	0.167744	0.293370	CS pos: 19-20. AAA-SS. Pr: 0.2338    27
NZ_CP027599.1_162961	SP(Sec/SPI)	0.472088	0.133704	0.060467	0.333741	CS pos: 16-17. SSA-AD. Pr: 0.3184    39
NZ_CP027599.1_162965	LIPO(Sec/SPII)	0.147129	0.023925	0.517894	0.311052	CS pos: 19-20. CSA-CL. Pr: 0.4359    24
NZ_CP027599.1_162982	LIPO(Sec/SPII)	0.239436	0.254552	0.313736	0.192276	CS pos: 22-23. ALC-CG. Pr: 0.1873    28
NZ_CP027599.1_163006	SP(Sec/SPI)	0.411405	0.261182	0.058215	0.269198	CS pos: 31-32. AIA-GK. Pr: 0.0756    45
NZ_CP027599.1_163089	LIPO(Sec/SPII)	0.204687	0.009052	0.419611	0.366650	CS pos: 23-24. SEC-CS. Pr: 0.3075    38
NZ_CP027599.1_163093	SP(Sec/SPI)	0.334135	0.036553	0.301608	0.327705	CS pos: 15-16. GWG-WS. Pr: 0.0619    17
NZ_CP027599.1_163095	LIPO(Sec/SPII)	0.388003	0.007908	0.445757	0.158332	CS pos: 17-18. SAH-CF. Pr: 0.2564    19
NZ_CP027599.1_163143	LIPO(Sec/SPII)	0.250564	0.053183	0.383287	0.312966	CS pos: 13-14. WLA-CS. Pr: 0.0491    18
NZ_CP027599.1_163152	TAT(Tat/SPI)	0.214273	0.360662	0.069672	0.355393	CS pos: 24-25. TRA-AP. Pr: 0.4113    43
NZ_CP027599.1_163167	SP(Sec/SPI)	0.365416	0.079826	0.209386	0.345371	CS pos: ?. Probable protein fragment    16
NZ_CP027599.1_163170	LIPO(Sec/SPII)	0.280350	0.034516	0.385314	0.299819	CS pos: ?. Probable protein fragment    20
NZ_CP027599.1_163180	LIPO(Sec/SPII)	0.140261	0.005708	0.836902	0.017129	CS pos: 19-20. SAA-CG. Pr: 0.8904    47
NZ_CP027599.1_163231	SP(Sec/SPI)	0.562408	0.004125	0.075472	0.357995	CS pos: 23-24. THG-RS. Pr: 0.4543    31
NZ_CP027599.1_163268	SP(Sec/SPI)	0.541963	0.041910	0.039038	0.377089	CS pos: 22-23. SSA-MV. Pr: 0.4484    47
NZ_CP027599.1_163270	TAT(Tat/SPI)	0.229251	0.396975	0.037808	0.335967	CS pos: 34-35. VAA-LN. Pr: 0.1391    41
NZ_CP027599.1_163290	LIPO(Sec/SPII)	0.296397	0.016988	0.467996	0.218619	CS pos: 21-22. ATS-CN. Pr: 0.2849    31
NZ_CP027599.1_163294	SP(Sec/SPI)	0.438651	0.207231	0.057923	0.296194	CS pos: 17-18. APA-SN. Pr: 0.2485    34
NZ_CP027599.1_163295	LIPO(Sec/SPII)	0.444692	0.014793	0.448736	0.091778	CS pos: 23-24. AAS-CK. Pr: 0.3407    25
NZ_CP027599.1_163326	LIPO(Sec/SPII)	0.268130	0.033942	0.369988	0.327940	CS pos: ?. Probable protein fragment    15
NZ_CP027599.1_163364	LIPO(Sec/SPII)	0.205020	0.021615	0.449132	0.324233	CS pos: ?. Probable protein fragment    15
NZ_CP027599.1_163386	SP(Sec/SPI)	0.393743	0.014688	0.206181	0.385387	CS pos: 25-26. IRS-FT. Pr: 0.2375    28
NZ_CP027599.1_163418	LIPO(Sec/SPII)	0.141790	0.072414	0.639052	0.146744	CS pos: 18-19. ISA-CW. Pr: 0.5519    47
NZ_CP027599.1_163480	LIPO(Sec/SPII)	0.060338	0.045030	0.659442	0.235190	CS pos: 13-14. VTA-CL. Pr: 0.6438    49
NZ_CP027599.1_163491	SP(Sec/SPI)	0.430100	0.028545	0.351085	0.190270	CS pos: 18-19. TFA-SG. Pr: 0.1225    22
NZ_CP027599.1_163493	LIPO(Sec/SPII)	0.330716	0.007375	0.504713	0.157196	CS pos: 14-15. FCL-CG. Pr: 0.2988    21
NZ_CP027599.1_163513	SP(Sec/SPI)	0.411719	0.025237	0.325444	0.237599	CS pos: ?. Probable protein fragment    20
NZ_CP027599.1_163536	SP(Sec/SPI)	0.475576	0.210914	0.064039	0.249471	CS pos: 13-14. AAA-AV. Pr: 0.2007    30
NZ_CP027599.1_163553	LIPO(Sec/SPII)	0.255288	0.154310	0.355711	0.234691	CS pos: 23-24. WTK-CC. Pr: 0.2739    31
NZ_CP027599.1_163556	SP(Sec/SPI)	0.909251	0.014186	0.041769	0.034794	CS pos: 22-23. AEA-ES. Pr: 0.5865    37
NZ_CP027599.1_163584	SP(Sec/SPI)	0.548827	0.054753	0.132737	0.263682	CS pos: 13-14. AFA-NT. Pr: 0.3967    17
NZ_CP027599.1_163589	LIPO(Sec/SPII)	0.124531	0.019708	0.768184	0.087577	CS pos: 15-16. ITA-CG. Pr: 0.7510    33
NZ_CP027599.1_163593	LIPO(Sec/SPII)	0.032533	0.009247	0.614548	0.343672	CS pos: 20-21. YSG-CT. Pr: 0.6051    28
NZ_CP027599.1_163601	LIPO(Sec/SPII)	0.076521	0.021292	0.490186	0.412001	CS pos: 22-23. YVG-CD. Pr: 0.4844    41
NZ_CP027599.1_163658	SP(Sec/SPI)	0.459992	0.032651	0.154181	0.353176	CS pos: 23-24. NRA-GV. Pr: 0.1379    32
NZ_CP027599.1_163659	LIPO(Sec/SPII)	0.028143	0.001648	0.939208	0.031001	CS pos: 16-17. GLG-CA. Pr: 0.8586    29
NZ_CP027599.1_163667	SP(Sec/SPI)	0.606901	0.061668	0.104035	0.227396	CS pos: 18-19. SMA-VT. Pr: 0.3195    37
NZ_CP027599.1_163680	SP(Sec/SPI)	0.734379	0.014495	0.131142	0.119983	CS pos: 22-23. AFA-FP. Pr: 0.6617    26
NZ_CP027599.1_163685	SP(Sec/SPI)	0.478722	0.021311	0.242223	0.257744	CS pos: 22-23. SLL-LD. Pr: 0.1444    27
NZ_CP027599.1_163696	LIPO(Sec/SPII)	0.080345	0.021655	0.526835	0.371165	CS pos: 18-19. SSG-CC. Pr: 0.4292    31
NZ_CP027599.1_163748	LIPO(Sec/SPII)	0.203867	0.008192	0.630343	0.157597	CS pos: 16-17. CLA-CT. Pr: 0.4877    21
NZ_CP027599.1_163753	SP(Sec/SPI)	0.461291	0.033733	0.339817	0.165158	CS pos: ?. Probable protein fragment    18
NZ_CP027599.1_163771	TAT(Tat/SPI)	0.027882	0.580524	0.165573	0.226021	CS pos: 25-26. GSC-TV. Pr: 0.2026    42
NZ_CP027599.1_163849	SP(Sec/SPI)	0.557371	0.037390	0.236499	0.168740	CS pos: 20-21. ISS-QD. Pr: 0.4708    36
NZ_CP027599.1_163853	LIPO(Sec/SPII)	0.109625	0.025178	0.594660	0.270537	CS pos: 20-21. GMG-CT. Pr: 0.4993    35
NZ_CP027599.1_163854	SP(Sec/SPI)	0.384691	0.102783	0.155616	0.356910	CS pos: 16-17. ARS-SS. Pr: 0.0751    28
NZ_CP027599.1_163877	LIPO(Sec/SPII)	0.050222	0.009695	0.915344	0.024739	CS pos: 23-24. TSG-CR. Pr: 0.8975    39
NZ_CP027599.1_163879	SP(Sec/SPI)	0.419188	0.015064	0.205755	0.359992	CS pos: 14-15. AGA-GG. Pr: 0.2507    28
NZ_CP027599.1_163924	LIPO(Sec/SPII)	0.148936	0.006320	0.786200	0.058545	CS pos: ?. Probable protein fragment    18
NZ_CP027599.1_163926	SP(Sec/SPI)	0.631654	0.063622	0.264325	0.040400	CS pos: 21-22. ASG-AF. Pr: 0.1867    48
NZ_CP027599.1_163935	LIPO(Sec/SPII)	0.149691	0.054385	0.571847	0.224076	CS pos: 20-21. SGG-CR. Pr: 0.5155    30
NZ_CP027599.1_163944	LIPO(Sec/SPII)	0.237895	0.002341	0.423068	0.336696	CS pos: 21-22. SAI-CY. Pr: 0.3332    32
NZ_CP027599.1_163948	LIPO(Sec/SPII)	0.050823	0.056841	0.729486	0.162850	CS pos: 22-23. MFA-CR. Pr: 0.3927    40
NZ_CP027599.1_163956	LIPO(Sec/SPII)	0.237563	0.030253	0.390751	0.341432	CS pos: 15-16. QPG-CR. Pr: 0.1629    21
NZ_CP027599.1_163975	SP(Sec/SPI)	0.412817	0.132502	0.109745	0.344936	CS pos: 21-22. VFA-AP. Pr: 0.3587    31
NZ_CP027599.1_164007	LIPO(Sec/SPII)	0.133539	0.028086	0.823305	0.015069	CS pos: 17-18. TSG-CT. Pr: 0.8231    36
NZ_CP027599.1_164008	LIPO(Sec/SPII)	0.168843	0.028626	0.453979	0.348551	CS pos: 17-18. PFG-CS. Pr: 0.4205    29
NZ_CP027599.1_164009	SP(Sec/SPI)	0.766383	0.124553	0.022680	0.086384	CS pos: 21-22. ADA-DP. Pr: 0.6106    32
NZ_CP027599.1_164016	LIPO(Sec/SPII)	0.351580	0.026771	0.423386	0.198263	CS pos: 10-11. STG-CF. Pr: 0.2007    18
NZ_CP027599.1_164021	SP(Sec/SPI)	0.470029	0.040651	0.078818	0.410501	CS pos: ?. Probable protein fragment    21
NZ_CP027599.1_164041	SP(Sec/SPI)	0.373533	0.181465	0.071513	0.373489	CS pos: 19-20. AYA-AA. Pr: 0.3076    40
NZ_CP027599.1_164057	LIPO(Sec/SPII)	0.091582	0.006879	0.817978	0.083561	CS pos: 16-17. CIS-CS. Pr: 0.7035    46
NZ_CP027599.1_164111	LIPO(Sec/SPII)	0.034067	0.034110	0.685348	0.246475	CS pos: 16-17. ASA-CC. Pr: 0.6388    35
NZ_CP027599.1_164116	SP(Sec/SPI)	0.719079	0.055490	0.152787	0.072644	CS pos: 22-23. ARA-FS. Pr: 0.6112    35
NZ_CP027599.1_164127	SP(Sec/SPI)	0.277710	0.266163	0.181859	0.274268	CS pos: 21-22. SSS-RY. Pr: 0.1080    46
NZ_CP027599.1_164138	SP(Sec/SPI)	0.978089	0.014627	0.004609	0.002676	CS pos: 21-22. SLA-KN. Pr: 0.9603    47
NZ_CP027599.1_164155	SP(Sec/SPI)	0.610309	0.065378	0.092993	0.231321	CS pos: 18-19. AAA-GG. Pr: 0.2908    28
NZ_CP027599.1_164163	LIPO(Sec/SPII)	0.270004	0.013196	0.389246	0.327554	CS pos: ?. Probable protein fragment    17
NZ_CP027599.1_164168	LIPO(Sec/SPII)	0.132279	0.014602	0.598543	0.254576	CS pos: 16-17. AMA-CI. Pr: 0.5757    20
NZ_CP027599.1_164203	TAT(Tat/SPI)	0.225246	0.500294	0.088096	0.186364	CS pos: 28-29. CLA-AR. Pr: 0.2619    38
NZ_CP027599.1_164205	SP(Sec/SPI)	0.420371	0.053858	0.119401	0.406370	CS pos: 13-14. TKA-GK. Pr: 0.1947    27
NZ_CP027599.1_164206	LIPO(Sec/SPII)	0.155344	0.036365	0.555672	0.252620	CS pos: ?. Probable protein fragment    18
NZ_CP027599.1_164208	LIPO(Sec/SPII)	0.356353	0.025883	0.413087	0.204677	CS pos: ?. Probable protein fragment    16
NZ_CP027599.1_164238	LIPO(Sec/SPII)	0.215769	0.018681	0.405990	0.359560	CS pos: 20-21. LPC-CQ. Pr: 0.1053    22
NZ_CP027599.1_164252	SP(Sec/SPI)	0.424119	0.030850	0.383438	0.161593	CS pos: 19-20. CRS-AL. Pr: 0.1916    35
NZ_CP027599.1_164282	LIPO(Sec/SPII)	0.095995	0.001653	0.857279	0.045074	CS pos: 11-12. LFG-CK. Pr: 0.8305    40
NZ_CP027599.1_164303	TAT(Tat/SPI)	0.092584	0.467408	0.134144	0.305863	CS pos: 35-36. RSA-DD. Pr: 0.1802    40
NZ_CP027599.1_164312	LIPO(Sec/SPII)	0.166776	0.019919	0.549506	0.263800	CS pos: 19-20. CGS-CL. Pr: 0.1588    27
NZ_CP027599.1_164330	TAT(Tat/SPI)	0.108169	0.454117	0.034470	0.403243	CS pos: 40-41. APA-AD. Pr: 0.1132    47
NZ_CP027599.1_164336	LIPO(Sec/SPII)	0.051188	0.005271	0.611549	0.331992	CS pos: 21-22. SVT-CD. Pr: 0.5999    30
NZ_CP027599.1_164346	LIPO(Sec/SPII)	0.162116	0.018116	0.552627	0.267141	CS pos: 17-18. ASS-CA. Pr: 0.4523    19
NZ_CP027599.1_164382	LIPO(Sec/SPII)	0.195238	0.001885	0.446065	0.356812	CS pos: 20-21. LTL-CS. Pr: 0.3959    47
NZ_CP027599.1_164392	LIPO(Sec/SPII)	0.278115	0.083849	0.494350	0.143685	CS pos: 21-22. SLQ-CR. Pr: 0.4126    42
NZ_CP027599.1_164424	SP(Sec/SPI)	0.490625	0.148593	0.036540	0.324242	CS pos: 23-24. IGA-QT. Pr: 0.4914    50
NZ_CP027599.1_164474	LIPO(Sec/SPII)	0.068576	0.042550	0.636884	0.251990	CS pos: 23-24. NAS-CS. Pr: 0.6226    46
NZ_CP027599.1_164476	LIPO(Sec/SPII)	0.184042	0.097450	0.522077	0.196431	CS pos: 18-19. LTT-CP. Pr: 0.4969    44
NZ_CP027599.1_164579	LIPO(Sec/SPII)	0.097877	0.004025	0.791223	0.106875	CS pos: 15-16. NGA-CL. Pr: 0.7282    26
NZ_CP027599.1_164584	LIPO(Sec/SPII)	0.264394	0.021675	0.412208	0.301723	CS pos: ?. Probable protein fragment    18
NZ_CP027599.1_164616	TAT(Tat/SPI)	0.276204	0.293903	0.158608	0.271286	CS pos: ?. Probable protein fragment    28
NZ_CP027599.1_164639	LIPO(Sec/SPII)	0.060545	0.004659	0.688044	0.246753	CS pos: 15-16. SLA-CC. Pr: 0.4933    30
NZ_CP027599.1_164642	LIPO(Sec/SPII)	0.188636	0.013586	0.563638	0.234140	CS pos: 18-19. ING-CN. Pr: 0.5494    32
NZ_CP027599.1_164644	LIPO(Sec/SPII)	0.179648	0.035697	0.556211	0.228444	CS pos: 19-20. ASA-CN. Pr: 0.5239    46
NZ_CP027599.1_164664	SP(Sec/SPI)	0.577843	0.006274	0.157191	0.258693	CS pos: 22-23. SNR-LI. Pr: 0.2298    39
NZ_CP027599.1_164680	LIPO(Sec/SPII)	0.234803	0.019737	0.456920	0.288541	CS pos: 18-19. PAP-CV. Pr: 0.3943    27
NZ_CP027599.1_164682	LIPO(Sec/SPII)	0.195730	0.014506	0.410050	0.379713	CS pos: 15-16. FSV-CL. Pr: 0.2833    21
NZ_CP027599.1_164695	LIPO(Sec/SPII)	0.085067	0.014199	0.674243	0.226491	CS pos: 19-20. ALQ-CR. Pr: 0.6288    30
NZ_CP027599.1_164697	LIPO(Sec/SPII)	0.113411	0.001829	0.797985	0.086774	CS pos: 29-30. WSG-CE. Pr: 0.7638    40
NZ_CP027599.1_164700	LIPO(Sec/SPII)	0.171472	0.044225	0.447079	0.337224	CS pos: 19-20. FSY-CS. Pr: 0.2218    35
NZ_CP027599.1_164755	LIPO(Sec/SPII)	0.099768	0.019809	0.798803	0.081620	CS pos: 22-23. PQA-CT. Pr: 0.7690    32
NZ_CP027599.1_164761	LIPO(Sec/SPII)	0.017875	0.001703	0.718010	0.262412	CS pos: 21-22. ATA-CD. Pr: 0.6997    37
NZ_CP027599.1_164770	LIPO(Sec/SPII)	0.090142	0.008989	0.746595	0.154274	CS pos: 19-20. LTS-CR. Pr: 0.7178    23
NZ_CP027599.1_164781	LIPO(Sec/SPII)	0.338961	0.046058	0.450388	0.164594	CS pos: 15-16. VTT-CV. Pr: 0.4055    34
NZ_CP027599.1_164796	LIPO(Sec/SPII)	0.198301	0.016468	0.564186	0.221046	CS pos: ?. Probable protein fragment    19
NZ_CP027599.1_164855	SP(Sec/SPI)	0.875139	0.004764	0.035619	0.084478	CS pos: 17-18. NQA-AN. Pr: 0.6206    45
NZ_CP027599.1_164874	LIPO(Sec/SPII)	0.122726	0.030419	0.433480	0.413375	CS pos: 17-18. VLS-CI. Pr: 0.2930    50
NZ_CP027599.1_164915	LIPO(Sec/SPII)	0.338230	0.004846	0.595259	0.061665	CS pos: 14-15. TIK-CW. Pr: 0.5345    40
NZ_CP027599.1_164932	SP(Sec/SPI)	0.439578	0.111845	0.241022	0.207555	CS pos: 15-16. ALS-SP. Pr: 0.1589    27
NZ_CP027599.1_164964	LIPO(Sec/SPII)	0.107178	0.084409	0.575042	0.233372	CS pos: 24-25. TTG-CA. Pr: 0.5650    49
NZ_CP027599.1_164983	LIPO(Sec/SPII)	0.217965	0.011451	0.528118	0.242466	CS pos: 18-19. PVL-CL. Pr: 0.0536    20
NZ_CP027599.1_164989	LIPO(Sec/SPII)	0.257862	0.001976	0.613054	0.127108	CS pos: 20-21. GHC-CC. Pr: 0.3366    26
NZ_CP027599.1_164993	LIPO(Sec/SPII)	0.138183	0.019004	0.553208	0.289605	CS pos: 14-15. TSA-CW. Pr: 0.4986    18
NZ_CP027599.1_165002	SP(Sec/SPI)	0.398771	0.062316	0.354852	0.184061	CS pos: ?. Probable protein fragment    22
NZ_CP027599.1_165017	LIPO(Sec/SPII)	0.279599	0.038702	0.352862	0.328837	CS pos: ?. Probable protein fragment    19
NZ_CP027599.1_165030	SP(Sec/SPI)	0.723073	0.044896	0.076935	0.155097	CS pos: 21-22. APG-SK. Pr: 0.2005    30
NZ_CP027599.1_165044	LIPO(Sec/SPII)	0.184414	0.018931	0.563352	0.233303	CS pos: 20-21. LLT-CR. Pr: 0.3426    28
NZ_CP027599.1_165048	SP(Sec/SPI)	0.657908	0.011973	0.163702	0.166417	CS pos: 28-29. RYA-SE. Pr: 0.5590    34
NZ_CP027599.1_165062	LIPO(Sec/SPII)	0.202959	0.130461	0.591950	0.074630	CS pos: 22-23. AAP-CD. Pr: 0.3938    30
NZ_CP027599.1_165065	LIPO(Sec/SPII)	0.144862	0.023008	0.529496	0.302634	CS pos: 18-19. RCA-CE. Pr: 0.4211    29
NZ_CP027599.1_165070	SP(Sec/SPI)	0.700441	0.077610	0.076701	0.145249	CS pos: 34-35. ALA-IN. Pr: 0.7026    50
NZ_CP027599.1_165074	LIPO(Sec/SPII)	0.202296	0.025579	0.500840	0.271284	CS pos: 15-16. LSS-CC. Pr: 0.3408    19
NZ_CP027599.1_165099	SP(Sec/SPI)	0.439214	0.085351	0.065117	0.410318	CS pos: 18-19. MVA-IT. Pr: 0.1324    36
NZ_CP027599.1_165101	SP(Sec/SPI)	0.429960	0.233564	0.068472	0.268003	CS pos: 22-23. GRA-LN. Pr: 0.3826    39
NZ_CP027599.1_165104	LIPO(Sec/SPII)	0.131597	0.035266	0.425890	0.407246	CS pos: 19-20. SAS-CA. Pr: 0.3586    26
NZ_CP027599.1_165105	SP(Sec/SPI)	0.464023	0.015791	0.144091	0.376096	CS pos: 19-20. CSA-AD. Pr: 0.2203    30
NZ_CP027599.1_165108	LIPO(Sec/SPII)	0.255364	0.050112	0.360369	0.334155	CS pos: ?. Probable protein fragment    15
NZ_CP027599.1_165115	SP(Sec/SPI)	0.413131	0.013611	0.247771	0.325487	CS pos: 30-31. VTC-GT. Pr: 0.2215    49
NZ_CP027599.1_165165	LIPO(Sec/SPII)	0.038240	0.014307	0.855208	0.092244	CS pos: 27-28. IGS-CG. Pr: 0.8523    37
NZ_CP027599.1_165185	TAT(Tat/SPI)	0.148313	0.473802	0.137963	0.239922	CS pos: 25-26. GNA-IR. Pr: 0.1049    42
NZ_CP027599.1_165191	TAT(Tat/SPI)	0.207823	0.427776	0.090834	0.273568	CS pos: 19-20. AYG-FE. Pr: 0.1478    27
NZ_CP027599.1_165192	SP(Sec/SPI)	0.683333	0.059506	0.015588	0.241573	CS pos: 23-24. VHA-SV. Pr: 0.6954    46
NZ_CP027599.1_165195	SP(Sec/SPI)	0.461982	0.263252	0.067029	0.207738	CS pos: 24-25. ASA-KP. Pr: 0.4215    34
NZ_CP027599.1_165196	LIPO(Sec/SPII)	0.159712	0.320666	0.383269	0.136353	CS pos: 27-28. PVS-CK. Pr: 0.3665    50
NZ_CP027599.1_165302	LIPO(Sec/SPII)	0.296644	0.013692	0.377976	0.311688	CS pos: ?. Probable protein fragment    15
NZ_CP027599.1_165305	LIPO(Sec/SPII)	0.073798	0.296061	0.510059	0.120082	CS pos: 23-24. IAA-CR. Pr: 0.5024    47
NZ_CP027599.1_165315	LIPO(Sec/SPII)	0.101542	0.004528	0.515632	0.378298	CS pos: 15-16. LVN-CM. Pr: 0.3652    20
NZ_CP027599.1_165336	LIPO(Sec/SPII)	0.229457	0.009582	0.514205	0.246756	CS pos: 17-18. TLH-CD. Pr: 0.2896    20
NZ_CP027599.1_165355	LIPO(Sec/SPII)	0.069422	0.050552	0.450387	0.429638	CS pos: 21-22. SVS-CA. Pr: 0.3346    37
NZ_CP027599.1_165361	LIPO(Sec/SPII)	0.104548	0.186714	0.510446	0.198292	CS pos: 20-21. AFS-CD. Pr: 0.5147    34
NZ_CP027599.1_165364	SP(Sec/SPI)	0.394645	0.010726	0.357259	0.237371	CS pos: 17-18. GLA-AR. Pr: 0.1774    23
NZ_CP027599.1_165377	LIPO(Sec/SPII)	0.333849	0.044403	0.351910	0.269839	CS pos: ?. Probable protein fragment    16
NZ_CP027599.1_165380	SP(Sec/SPI)	0.517720	0.011238	0.110670	0.360372	CS pos: 28-29. LRA-VR. Pr: 0.3032    47
NZ_CP027599.1_165384	LIPO(Sec/SPII)	0.248404	0.029872	0.380997	0.340726	CS pos: ?. Probable protein fragment    15
NZ_CP027599.1_165400	LIPO(Sec/SPII)	0.213039	0.001133	0.717120	0.068707	CS pos: 17-18. SVN-CW. Pr: 0.6939    25
NZ_CP027599.1_165424	LIPO(Sec/SPII)	0.299811	0.019943	0.402450	0.277796	CS pos: 14-15. IFL-CV. Pr: 0.0268    16
NZ_CP027599.1_165427	LIPO(Sec/SPII)	0.074066	0.009424	0.855518	0.060993	CS pos: 17-18. STG-CA. Pr: 0.8466    27
NZ_CP027599.1_165456	LIPO(Sec/SPII)	0.346144	0.014813	0.481532	0.157510	CS pos: ?. Probable protein fragment    15
NZ_CP027599.1_165484	LIPO(Sec/SPII)	0.338494	0.010632	0.366059	0.284815	CS pos: 18-19. MVA-SR. Pr: 0.1468    22
NZ_CP027599.1_165517	SP(Sec/SPI)	0.401708	0.006966	0.393928	0.197398	CS pos: 16-17. ANC-SV. Pr: 0.2499    33
NZ_CP027599.1_165523	SP(Sec/SPI)	0.844230	0.029386	0.064788	0.061596	CS pos: 19-20. VLA-TL. Pr: 0.7176    36
NZ_CP027599.1_165525	SP(Sec/SPI)	0.629681	0.014529	0.071233	0.284557	CS pos: 23-24. TTA-SH. Pr: 0.5056    39
NZ_CP027599.1_165527	SP(Sec/SPI)	0.603630	0.126778	0.040049	0.229543	CS pos: 28-29. VVA-TA. Pr: 0.3153    47
NZ_CP027599.1_165568	LIPO(Sec/SPII)	0.347017	0.018313	0.376780	0.257890	CS pos: 15-16. LSN-TA. Pr: 0.0505    17
NZ_CP027599.1_165578	LIPO(Sec/SPII)	0.095627	0.024846	0.528453	0.351074	CS pos: 25-26. ITS-CC. Pr: 0.3889    41
NZ_CP027599.1_165594	LIPO(Sec/SPII)	0.116241	0.016090	0.590134	0.277535	CS pos: 18-19. LMS-CV. Pr: 0.5035    20
NZ_CP027599.1_165595	LIPO(Sec/SPII)	0.102860	0.005453	0.580121	0.311566	CS pos: 14-15. VLS-CM. Pr: 0.5406    25
NZ_CP027599.1_165596	SP(Sec/SPI)	0.377209	0.012835	0.286663	0.323293	CS pos: 22-23. VCA-GN. Pr: 0.0735    31
NZ_CP027599.1_165618	LIPO(Sec/SPII)	0.299305	0.029319	0.425041	0.246335	CS pos: ?. Probable protein fragment    15
NZ_CP027599.1_165620	SP(Sec/SPI)	0.568334	0.015958	0.115079	0.300628	CS pos: 27-28. SSS-HD. Pr: 0.2105    35
NZ_CP027599.1_165623	LIPO(Sec/SPII)	0.143891	0.058351	0.451072	0.346686	CS pos: 29-30. VLA-CT. Pr: 0.3699    32
NZ_CP027599.1_165636	LIPO(Sec/SPII)	0.271503	0.003555	0.364196	0.360745	CS pos: 16-17. SDM-CR. Pr: 0.0903    30
NZ_CP027599.1_165658	LIPO(Sec/SPII)	0.195989	0.021972	0.440272	0.341767	CS pos: ?. Probable protein fragment    17
NZ_CP027599.1_165659	SP(Sec/SPI)	0.556756	0.037552	0.119774	0.285918	CS pos: 22-23. AYT-AT. Pr: 0.4715    31
NZ_CP027599.1_165745	LIPO(Sec/SPII)	0.019840	0.003577	0.969763	0.006820	CS pos: 18-19. ISA-CC. Pr: 0.9044    44
NZ_CP027599.1_165795	LIPO(Sec/SPII)	0.272002	0.170867	0.448377	0.108753	CS pos: 26-27. MYA-CS. Pr: 0.2254    34
NZ_CP027599.1_165798	SP(Sec/SPI)	0.314508	0.070846	0.301869	0.312777	CS pos: 20-21. AVA-GE. Pr: 0.1103    24
NZ_CP027599.1_165832	LIPO(Sec/SPII)	0.250451	0.034778	0.411333	0.303438	CS pos: ?. Probable protein fragment    15
NZ_CP027599.1_165839	SP(Sec/SPI)	0.488174	0.024947	0.113017	0.373862	CS pos: ?. Probable protein fragment    23
NZ_CP027599.1_165862	SP(Sec/SPI)	0.429706	0.017243	0.271642	0.281408	CS pos: 23-24. SNA-LC. Pr: 0.3271    32
NZ_CP027599.1_165876	LIPO(Sec/SPII)	0.295497	0.009780	0.421356	0.273366	CS pos: 15-16. LTA-FL. Pr: 0.0599    17
NZ_CP027599.1_165936	LIPO(Sec/SPII)	0.008952	0.000375	0.987427	0.003246	CS pos: 21-22. ASA-CD. Pr: 0.9920    49
NZ_CP027599.1_165954	SP(Sec/SPI)	0.493887	0.030974	0.071231	0.403908	CS pos: 16-17. SLA-AI. Pr: 0.3220    32
NZ_CP027599.1_165961	LIPO(Sec/SPII)	0.034668	0.003271	0.954033	0.008028	CS pos: 15-16. ISS-CV. Pr: 0.9134    30
NZ_CP027599.1_165963	LIPO(Sec/SPII)	0.038499	0.014497	0.664372	0.282632	CS pos: 16-17. STG-CS. Pr: 0.6588    33
NZ_CP027599.1_166040	LIPO(Sec/SPII)	0.122176	0.027751	0.675840	0.174233	CS pos: 14-15. TWS-CF. Pr: 0.5416    33
NZ_CP027599.1_166061	SP(Sec/SPI)	0.491618	0.061278	0.287346	0.159758	CS pos: 18-19. GSA-QP. Pr: 0.1888    22
NZ_CP027599.1_166100	SP(Sec/SPI)	0.602507	0.025856	0.069393	0.302245	CS pos: 31-32. TYA-SE. Pr: 0.3104    33
NZ_CP027599.1_166155	LIPO(Sec/SPII)	0.147425	0.014785	0.613410	0.224380	CS pos: 16-17. TGG-CM. Pr: 0.4842    20
NZ_CP027599.1_166188	SP(Sec/SPI)	0.523806	0.030689	0.135115	0.310390	CS pos: 14-15. VRA-QP. Pr: 0.3460    20
NZ_CP027599.1_166207	LIPO(Sec/SPII)	0.288665	0.008724	0.374674	0.327938	CS pos: 19-20. LVR-CR. Pr: 0.2312    21
NZ_CP027599.1_166222	LIPO(Sec/SPII)	0.130408	0.023010	0.491593	0.354990	CS pos: 17-18. CIA-CT. Pr: 0.2292    25
NZ_CP027599.1_166241	LIPO(Sec/SPII)	0.284730	0.034559	0.459554	0.221157	CS pos: ?. Probable protein fragment    15
NZ_CP027599.1_166268	LIPO(Sec/SPII)	0.015445	0.001186	0.980350	0.003018	CS pos: 16-17. LTA-CT. Pr: 0.9759    21
NZ_CP027599.1_166284	SP(Sec/SPI)	0.651787	0.027642	0.251077	0.069494	CS pos: 21-22. SSA-SA. Pr: 0.1186    23
NZ_CP027599.1_166311	LIPO(Sec/SPII)	0.185329	0.093182	0.496713	0.224776	CS pos: 17-18. GVC-CC. Pr: 0.2504    20
NZ_CP027599.1_166438	LIPO(Sec/SPII)	0.263356	0.096724	0.322030	0.317889	CS pos: 30-31. SSG-CG. Pr: 0.2529    35
NZ_CP027599.1_166449	LIPO(Sec/SPII)	0.212165	0.021908	0.409686	0.356242	CS pos: ?. Probable protein fragment    16
NZ_CP027599.1_166462	LIPO(Sec/SPII)	0.047238	0.005278	0.847352	0.100131	CS pos: 16-17. FSS-CQ. Pr: 0.8489    42
NZ_CP027599.1_166481	SP(Sec/SPI)	0.402923	0.011223	0.208386	0.377467	CS pos: 15-16. PGA-DT. Pr: 0.1337    30
NZ_CP027599.1_166490	LIPO(Sec/SPII)	0.154216	0.008092	0.658711	0.178981	CS pos: 20-21. LST-CI. Pr: 0.4126    32
NZ_CP027599.1_166491	SP(Sec/SPI)	0.642948	0.045584	0.026141	0.285328	CS pos: 17-18. TQA-AP. Pr: 0.3052    39
NZ_CP027599.1_166503	LIPO(Sec/SPII)	0.249016	0.021716	0.461373	0.267895	CS pos: ?. Probable protein fragment    15
NZ_CP027599.1_166574	SP(Sec/SPI)	0.607192	0.005168	0.026345	0.361296	CS pos: 15-16. SHA-NN. Pr: 0.5587    35
NZ_CP027599.1_166584	LIPO(Sec/SPII)	0.286895	0.048043	0.338188	0.326874	CS pos: ?. Probable protein fragment    18
NZ_CP027599.1_166590	LIPO(Sec/SPII)	0.242464	0.021659	0.374800	0.361076	CS pos: ?. Probable protein fragment    18
NZ_CP027599.1_166614	LIPO(Sec/SPII)	0.286765	0.014213	0.374075	0.324947	CS pos: 27-28. SSR-CS. Pr: 0.2263    29
NZ_CP027599.1_166657	SP(Sec/SPI)	0.551931	0.005939	0.409529	0.032601	CS pos: 21-22. GLC-AS. Pr: 0.2708    27
NZ_CP027599.1_166659	LIPO(Sec/SPII)	0.140416	0.027707	0.574370	0.257508	CS pos: 12-13. LTG-CS. Pr: 0.3115    17
NZ_CP027599.1_166664	SP(Sec/SPI)	0.669848	0.085638	0.049965	0.194549	CS pos: 19-20. VRA-HG. Pr: 0.5276    26
NZ_CP027599.1_166676	LIPO(Sec/SPII)	0.262944	0.007605	0.427725	0.301726	CS pos: ?. Probable protein fragment    16
NZ_CP027599.1_166691	SP(Sec/SPI)	0.614406	0.081345	0.144770	0.159478	CS pos: 21-22. VPA-AL. Pr: 0.3422    32
NZ_CP027599.1_166712	LIPO(Sec/SPII)	0.260745	0.024229	0.400041	0.314985	CS pos: ?. Probable protein fragment    17
NZ_CP027599.1_166743	LIPO(Sec/SPII)	0.256013	0.014181	0.403524	0.326282	CS pos: ?. Probable protein fragment    15
NZ_CP027599.1_166766	SP(Sec/SPI)	0.468190	0.012911	0.141691	0.377208	CS pos: 22-23. SYS-TG. Pr: 0.2833    37
NZ_CP027599.1_166773	SP(Sec/SPI)	0.590136	0.011015	0.206089	0.192760	CS pos: 17-18. ATS-VI. Pr: 0.2529    32
NZ_CP027599.1_166780	LIPO(Sec/SPII)	0.386863	0.001731	0.470461	0.140945	CS pos: 22-23. FGI-CH. Pr: 0.4328    38
NZ_CP027599.1_166788	LIPO(Sec/SPII)	0.083615	0.003054	0.838299	0.075033	CS pos: 19-20. LCS-CI. Pr: 0.7040    21
NZ_CP027599.1_166861	LIPO(Sec/SPII)	0.025437	0.010121	0.840594	0.123848	CS pos: 20-21. FLG-CS. Pr: 0.8098    26
NZ_CP027599.1_166945	TAT(Tat/SPI)	0.036196	0.708533	0.055174	0.200097	CS pos: 27-28. TRA-AR. Pr: 0.5169    39
NZ_CP027599.1_166990	SP(Sec/SPI)	0.692442	0.244284	0.026795	0.036480	CS pos: 34-35. AAA-ST. Pr: 0.6531    50
NZ_CP027599.1_167001	LIPO(Sec/SPII)	0.231018	0.013306	0.439884	0.315792	CS pos: 17-18. NAS-CP. Pr: 0.3128    19
NZ_CP027599.1_167092	SP(Sec/SPI)	0.582995	0.029668	0.090868	0.296469	CS pos: ?. Probable protein fragment    19
NZ_CP027599.1_167119	LIPO(Sec/SPII)	0.159967	0.026102	0.550391	0.263540	CS pos: 14-15. VSS-CC. Pr: 0.4551    16
NZ_CP027599.1_167143	LIPO(Sec/SPII)	0.314092	0.064444	0.428655	0.192809	CS pos: ?. Probable protein fragment    20
NZ_CP027599.1_167144	LIPO(Sec/SPII)	0.026094	0.001891	0.941209	0.030806	CS pos: 18-19. PIA-CF. Pr: 0.9309    42
NZ_CP027599.1_167199	LIPO(Sec/SPII)	0.071108	0.005698	0.475913	0.447281	CS pos: 17-18. FLS-CF. Pr: 0.4441    29
NZ_CP027599.1_167237	LIPO(Sec/SPII)	0.268069	0.011307	0.565294	0.155330	CS pos: 19-20. APA-CA. Pr: 0.3569    26
NZ_CP027599.1_167247	LIPO(Sec/SPII)	0.002237	0.000192	0.947553	0.050017	CS pos: 21-22. LSG-CI. Pr: 0.9494    49
NZ_CP027599.1_167257	LIPO(Sec/SPII)	0.035425	0.002017	0.530037	0.432521	CS pos: 36-37. VSA-CF. Pr: 0.5121    42
NZ_CP027599.1_167260	TAT(Tat/SPI)	0.128725	0.455440	0.033024	0.382811	CS pos: 30-31. SGA-TM. Pr: 0.2014    38
NZ_CP027599.1_167265	LIPO(Sec/SPII)	0.190579	0.012405	0.442883	0.354133	CS pos: ?. Probable protein fragment    23
NZ_CP027599.1_167281	SP(Sec/SPI)	0.376264	0.068563	0.289953	0.265220	CS pos: 19-20. GSC-AP. Pr: 0.1243    28
NZ_CP027599.1_167287	LIPO(Sec/SPII)	0.210358	0.022762	0.384735	0.382145	CS pos: ?. Probable protein fragment    16
NZ_CP027599.1_167309	TAT(Tat/SPI)	0.199771	0.512390	0.075779	0.212059	CS pos: 22-23. AWS-AT. Pr: 0.3303    45
NZ_CP027599.1_167323	SP(Sec/SPI)	0.362139	0.089225	0.211522	0.337114	CS pos: 38-39. TCA-AF. Pr: 0.1111    50
NZ_CP027599.1_167382	SP(Sec/SPI)	0.797426	0.048875	0.057239	0.096460	CS pos: 22-23. TAA-TP. Pr: 0.6281    42
NZ_CP027599.1_167385	SP(Sec/SPI)	0.354153	0.239930	0.122524	0.283393	CS pos: 25-26. ARS-ES. Pr: 0.1027    45
NZ_CP027599.1_167408	SP(Sec/SPI)	0.399481	0.258431	0.016439	0.325649	CS pos: 22-23. AAA-MP. Pr: 0.4605    45
NZ_CP027599.1_167434	LIPO(Sec/SPII)	0.248935	0.034756	0.417063	0.299247	CS pos: 16-17. SAP-CQ. Pr: 0.3262    19
NZ_CP027599.1_167451	SP(Sec/SPI)	0.526575	0.041091	0.090140	0.342194	CS pos: 15-16. VFA-AP. Pr: 0.4437    22
NZ_CP027599.1_167458	SP(Sec/SPI)	0.463457	0.048896	0.068120	0.419528	CS pos: 14-15. TQA-AT. Pr: 0.2356    21
NZ_CP027599.1_167459	SP(Sec/SPI)	0.397032	0.111712	0.131767	0.359490	CS pos: 19-20. CKS-AT. Pr: 0.0711    46
NZ_CP027599.1_167463	LIPO(Sec/SPII)	0.128708	0.028924	0.474472	0.367896	CS pos: 14-15. IAQ-CG. Pr: 0.3944    20
NZ_CP027599.1_167469	LIPO(Sec/SPII)	0.283466	0.017560	0.441134	0.257841	CS pos: ?. Probable protein fragment    15
NZ_CP027599.1_167475	SP(Sec/SPI)	0.480438	0.001908	0.215551	0.302103	CS pos: 16-17. IQA-QL. Pr: 0.5813    34
NZ_CP027599.1_167483	SP(Sec/SPI)	0.520996	0.043481	0.157506	0.278017	CS pos: 14-15. AGA-AS. Pr: 0.1236    24
NZ_CP027599.1_167496	LIPO(Sec/SPII)	0.150394	0.017767	0.586716	0.245123	CS pos: ?. Probable protein fragment    21
NZ_CP027599.1_167506	SP(Sec/SPI)	0.426970	0.077609	0.271180	0.224240	CS pos: 21-22. SSA-SM. Pr: 0.0950    24
NZ_CP027599.1_167529	LIPO(Sec/SPII)	0.296986	0.010035	0.469063	0.223916	CS pos: ?. Probable protein fragment    16
NZ_CP027599.1_167604	SP(Sec/SPI)	0.350894	0.040358	0.349848	0.258900	CS pos: ?. Probable protein fragment    31
NZ_CP027599.1_167605	SP(Sec/SPI)	0.486920	0.061200	0.022140	0.429740	CS pos: 20-21. ALA-TE. Pr: 0.4304    37
NZ_CP027599.1_167615	LIPO(Sec/SPII)	0.137762	0.086532	0.657994	0.117712	CS pos: 21-22. ITS-CR. Pr: 0.6129    28
NZ_CP027599.1_167624	SP(Sec/SPI)	0.378079	0.020595	0.339709	0.261617	CS pos: 18-19. VDA-SR. Pr: 0.2034    22
NZ_CP027599.1_167695	LIPO(Sec/SPII)	0.320854	0.031920	0.443599	0.203628	CS pos: 15-16. APA-CL. Pr: 0.4175    40
NZ_CP027599.1_167706	SP(Sec/SPI)	0.423591	0.168881	0.064392	0.343136	CS pos: 24-25. ATA-IA. Pr: 0.2554    28
NZ_CP027599.1_167788	LIPO(Sec/SPII)	0.160355	0.086403	0.455805	0.297437	CS pos: 23-24. AAA-CC. Pr: 0.3916    35
NZ_CP027599.1_167799	LIPO(Sec/SPII)	0.160753	0.012567	0.612363	0.214316	CS pos: 18-19. LSA-CT. Pr: 0.5192    29
NZ_CP027599.1_167806	LIPO(Sec/SPII)	0.046263	0.108818	0.469807	0.375112	CS pos: 27-28. FAA-CW. Pr: 0.4661    45
NZ_CP027599.1_167814	SP(Sec/SPI)	0.533136	0.026514	0.123586	0.316765	CS pos: 22-23. HNA-AT. Pr: 0.1605    25
NZ_CP027599.1_167823	LIPO(Sec/SPII)	0.245217	0.024932	0.373426	0.356426	CS pos: ?. Probable protein fragment    17
NZ_CP027599.1_167824	LIPO(Sec/SPII)	0.145112	0.005048	0.628067	0.221773	CS pos: 17-18. SLR-CS. Pr: 0.5966    38
NZ_CP027599.1_167827	SP(Sec/SPI)	0.445469	0.018325	0.298232	0.237975	CS pos: 24-25. VTG-KP. Pr: 0.3059    31
NZ_CP027599.1_167837	LIPO(Sec/SPII)	0.399955	0.014823	0.489396	0.095826	CS pos: 14-15. AAF-CT. Pr: 0.2952    20
NZ_CP027599.1_167844	SP(Sec/SPI)	0.403380	0.112941	0.241428	0.242251	CS pos: 24-25. GRL-VP. Pr: 0.1755    29
NZ_CP027599.1_167865	SP(Sec/SPI)	0.837316	0.019710	0.077742	0.065231	CS pos: 22-23. SNA-SP. Pr: 0.4899    46
NZ_CP027599.1_167872	LIPO(Sec/SPII)	0.287686	0.052653	0.330282	0.329379	CS pos: 11-12. LCP-CR. Pr: 0.1824    38
NZ_CP027599.1_167875	SP(Sec/SPI)	0.459466	0.020926	0.122724	0.396885	CS pos: 18-19. TNA-LM. Pr: 0.3751    23
NZ_CP027599.1_167902	LIPO(Sec/SPII)	0.195295	0.010048	0.663822	0.130835	CS pos: 12-13. VPG-CW. Pr: 0.4223    15
NZ_CP027599.1_167917	LIPO(Sec/SPII)	0.093067	0.014722	0.737456	0.154755	CS pos: 16-17. PTA-CS. Pr: 0.6544    19
NZ_CP027600.1_11	LIPO(Sec/SPII)	0.258093	0.192076	0.355046	0.194785	CS pos: 21-22. ARC-CP. Pr: 0.1135    31
NZ_CP027600.1_29	LIPO(Sec/SPII)	0.221113	0.144866	0.410466	0.223556	CS pos: 10-11. TVS-CG. Pr: 0.0569    18
NZ_CP027600.1_46	LIPO(Sec/SPII)	0.135616	0.166946	0.682234	0.015204	CS pos: 27-28. SAS-CA. Pr: 0.5817    36
NZ_CP027600.1_48	SP(Sec/SPI)	0.454501	0.057109	0.047042	0.441348	CS pos: 26-27. VEA-SP. Pr: 0.4180    33
NZ_CP027600.1_66	SP(Sec/SPI)	0.518262	0.015060	0.117482	0.349196	CS pos: 25-26. AFA-QN. Pr: 0.4933    34
NZ_CP027600.1_70	TAT(Tat/SPI)	0.067502	0.826109	0.008912	0.097477	CS pos: 34-35. VHA-EA. Pr: 0.5151    42
NZ_CP027600.1_89	SP(Sec/SPI)	0.510432	0.203574	0.065418	0.220576	CS pos: 19-20. NHA-HT. Pr: 0.1776    44
NZ_CP027600.1_98	LIPO(Sec/SPII)	0.224704	0.019879	0.395345	0.360072	CS pos: 18-19. VFT-CA. Pr: 0.2528    25
NZ_CP027600.1_100	LIPO(Sec/SPII)	0.072414	0.013478	0.480336	0.433772	CS pos: 20-21. TTT-CH. Pr: 0.3094    40
NZ_CP027600.1_127	LIPO(Sec/SPII)	0.231501	0.040489	0.469130	0.258881	CS pos: ?. Probable protein fragment    15
NZ_CP027600.1_160	SP(Sec/SPI)	0.368429	0.115288	0.180437	0.335845	CS pos: 21-22. AQG-VY. Pr: 0.2468    33
NZ_CP027600.1_161	SP(Sec/SPI)	0.503371	0.040717	0.061493	0.394420	CS pos: 14-15. AGA-DQ. Pr: 0.2123    32
NZ_CP027600.1_179	LIPO(Sec/SPII)	0.137146	0.008294	0.444492	0.410068	CS pos: 17-18. LFS-CI. Pr: 0.4170    30
NZ_CP027600.1_199	SP(Sec/SPI)	0.462818	0.211315	0.050601	0.275266	CS pos: 21-22. VSA-KV. Pr: 0.2718    29
NZ_CP027600.1_243	SP(Sec/SPI)	0.600552	0.021733	0.265647	0.112068	CS pos: 25-26. ASA-VI. Pr: 0.5216    36
NZ_CP027600.1_259	LIPO(Sec/SPII)	0.111020	0.002817	0.724570	0.161593	CS pos: 13-14. FPG-CR. Pr: 0.5630    15
NZ_CP027600.1_265	LIPO(Sec/SPII)	0.236759	0.046989	0.407123	0.309129	CS pos: ?. Probable protein fragment    15
NZ_CP027600.1_300	LIPO(Sec/SPII)	0.101933	0.011423	0.528529	0.358114	CS pos: 17-18. VCS-CK. Pr: 0.4117    27
NZ_CP027600.1_302	LIPO(Sec/SPII)	0.073821	0.008264	0.650778	0.267136	CS pos: 29-30. ISG-CP. Pr: 0.4038    41
NZ_CP027600.1_316	LIPO(Sec/SPII)	0.232019	0.012527	0.486687	0.268768	CS pos: ?. Probable protein fragment    22
NZ_CP027600.1_380	SP(Sec/SPI)	0.461226	0.007719	0.318090	0.212965	CS pos: 20-21. CMA-KT. Pr: 0.3646    32
NZ_CP027600.1_383	SP(Sec/SPI)	0.774488	0.008036	0.054735	0.162741	CS pos: 20-21. TMA-EF. Pr: 0.5858    28
NZ_CP027600.1_390	SP(Sec/SPI)	0.921588	0.006185	0.027341	0.044886	CS pos: 23-24. VQT-AP. Pr: 0.8549    41
NZ_CP027600.1_431	LIPO(Sec/SPII)	0.186896	0.013092	0.511356	0.288655	CS pos: 14-15. RNA-CG. Pr: 0.4156    23
NZ_CP027600.1_451	LIPO(Sec/SPII)	0.300317	0.017324	0.408968	0.273391	CS pos: ?. Probable protein fragment    15
NZ_CP027600.1_511	SP(Sec/SPI)	0.901227	0.027893	0.037608	0.033272	CS pos: 17-18. AEA-GE. Pr: 0.8725    33
NZ_CP027600.1_518	SP(Sec/SPI)	0.435272	0.223819	0.108505	0.232405	CS pos: 22-23. TYA-AP. Pr: 0.5338    33
NZ_CP027600.1_569	SP(Sec/SPI)	0.332894	0.030248	0.307671	0.329188	CS pos: 16-17. SLS-AS. Pr: 0.0797    27
NZ_CP027600.1_585	SP(Sec/SPI)	0.660428	0.012623	0.144675	0.182273	CS pos: 19-20. REA-EV. Pr: 0.2697    38
NZ_CP027600.1_592	LIPO(Sec/SPII)	0.266970	0.028010	0.416601	0.288418	CS pos: 14-15. GHQ-CS. Pr: 0.1368    18
NZ_CP027600.1_637	SP(Sec/SPI)	0.368034	0.190175	0.097677	0.344114	CS pos: 22-23. ARG-SR. Pr: 0.2717    26
NZ_CP027600.1_657	SP(Sec/SPI)	0.481826	0.367514	0.030376	0.120285	CS pos: 34-35. SVA-DI. Pr: 0.3969    40
NZ_CP027600.1_674	LIPO(Sec/SPII)	0.413839	0.004159	0.428101	0.153901	CS pos: 21-22. SSR-CC. Pr: 0.2439    23
NZ_CP027600.1_676	SP(Sec/SPI)	0.372076	0.036709	0.343829	0.247386	CS pos: 17-18. VAT-LC. Pr: 0.1007    28
NZ_CP027600.1_690	SP(Sec/SPI)	0.783344	0.001943	0.191851	0.022862	CS pos: 18-19. GSA-GE. Pr: 0.5116    35
NZ_CP027600.1_713	LIPO(Sec/SPII)	0.320645	0.009403	0.546419	0.123533	CS pos: 12-13. TGS-CF. Pr: 0.1031    15
NZ_CP027600.1_719	LIPO(Sec/SPII)	0.137946	0.039525	0.448094	0.374435	CS pos: 20-21. AVA-CT. Pr: 0.4038    22
NZ_CP027600.1_724	SP(Sec/SPI)	0.374603	0.043223	0.267716	0.314458	CS pos: 18-19. VRP-DP. Pr: 0.1268    35
NZ_CP027600.1_740	LIPO(Sec/SPII)	0.254615	0.012647	0.409562	0.323176	CS pos: 15-16. LTG-TA. Pr: 0.0287    17
NZ_CP027600.1_745	LIPO(Sec/SPII)	0.084741	0.052348	0.449698	0.413213	CS pos: 29-30. QTS-CA. Pr: 0.2209    42
NZ_CP027600.1_756	LIPO(Sec/SPII)	0.140234	0.005709	0.504746	0.349312	CS pos: 15-16. QSF-CS. Pr: 0.3627    21
NZ_CP027600.1_784	LIPO(Sec/SPII)	0.269764	0.018355	0.381198	0.330683	CS pos: ?. Probable protein fragment    17
NZ_CP027600.1_808	TAT(Tat/SPI)	0.161091	0.376291	0.186825	0.275794	CS pos: 26-27. TES-KV. Pr: 0.1317    29
NZ_CP027600.1_817	LIPO(Sec/SPII)	0.175765	0.004336	0.721883	0.098016	CS pos: 16-17. VAG-RQ. Pr: 0.5058    25
NZ_CP027600.1_823	SP(Sec/SPI)	0.420138	0.079366	0.209230	0.291266	CS pos: 28-29. VRA-GC. Pr: 0.3618    49
NZ_CP027600.1_836	LIPO(Sec/SPII)	0.021518	0.000372	0.975569	0.002540	CS pos: 19-20. SSA-CE. Pr: 0.9841    35
NZ_CP027600.1_867	LIPO(Sec/SPII)	0.096676	0.008316	0.865373	0.029635	CS pos: 20-21. VAS-CL. Pr: 0.8557    39
NZ_CP027600.1_879	LIPO(Sec/SPII)	0.157949	0.016395	0.663904	0.161752	CS pos: 20-21. SFS-CI. Pr: 0.4493    23
NZ_CP027600.1_903	TAT(Tat/SPI)	0.120500	0.419427	0.076391	0.383681	CS pos: ?. Probable protein fragment    30
NZ_CP027600.1_905	SP(Sec/SPI)	0.572767	0.032452	0.020644	0.374136	CS pos: 24-25. SDA-LP. Pr: 0.3444    42
NZ_CP027600.1_911	SP(Sec/SPI)	0.518128	0.033944	0.110671	0.337257	CS pos: 19-20. CRA-EQ. Pr: 0.4206    27
NZ_CP027600.1_921	SP(Sec/SPI)	0.318270	0.298379	0.146934	0.236417	CS pos: 26-27. VAA-TG. Pr: 0.2121    32
NZ_CP027600.1_924	SP(Sec/SPI)	0.779728	0.012187	0.188982	0.019103	CS pos: 24-25. AEA-DV. Pr: 0.4531    31
NZ_CP027600.1_927	LIPO(Sec/SPII)	0.226128	0.031965	0.393853	0.348053	CS pos: ?. Probable protein fragment    17
NZ_CP027600.1_947	SP(Sec/SPI)	0.729700	0.148956	0.049573	0.071770	CS pos: 23-24. AWA-RT. Pr: 0.6367    35
NZ_CP027600.1_974	TAT(Tat/SPI)	0.050908	0.770879	0.039460	0.138753	CS pos: 30-31. GFS-WD. Pr: 0.1930    39
NZ_CP027600.1_1008	SP(Sec/SPI)	0.744721	0.083312	0.089781	0.082186	CS pos: 18-19. AYA-AG. Pr: 0.5156    26
NZ_CP027600.1_1028	SP(Sec/SPI)	0.327733	0.126338	0.220710	0.325219	CS pos: 24-25. AGA-AS. Pr: 0.0529    27
NZ_CP027600.1_1045	LIPO(Sec/SPII)	0.185455	0.181368	0.343056	0.290120	CS pos: 15-16. AVG-CT. Pr: 0.3111    34
NZ_CP027600.1_1053	LIPO(Sec/SPII)	0.288174	0.013318	0.424768	0.273740	CS pos: ?. Probable protein fragment    19
NZ_CP027600.1_1066	LIPO(Sec/SPII)	0.021705	0.000562	0.596969	0.380764	CS pos: 26-27. FMG-CS. Pr: 0.5538    35
NZ_CP027600.1_1087	SP(Sec/SPI)	0.485548	0.013567	0.270300	0.230586	CS pos: 22-23. LLA-VR. Pr: 0.3324    46
NZ_CP027600.1_1093	SP(Sec/SPI)	0.775871	0.086386	0.024469	0.113273	CS pos: 14-15. AHA-DI. Pr: 0.7818    31
NZ_CP027600.1_1098	SP(Sec/SPI)	0.453738	0.138774	0.240432	0.167057	CS pos: 25-26. LSA-KE. Pr: 0.4525    50
NZ_CP027600.1_1103	SP(Sec/SPI)	0.446385	0.163356	0.077272	0.312987	CS pos: 33-34. ASA-TR. Pr: 0.3028    37
NZ_CP027600.1_1106	SP(Sec/SPI)	0.458136	0.129718	0.140600	0.271546	CS pos: 19-20. TGA-TK. Pr: 0.1830    32
NZ_CP027600.1_1108	SP(Sec/SPI)	0.346925	0.231191	0.098773	0.323111	CS pos: 26-27. ARS-AS. Pr: 0.1390    37
NZ_CP027600.1_1181	LIPO(Sec/SPII)	0.139538	0.001249	0.542935	0.316277	CS pos: 24-25. LVQ-CN. Pr: 0.5230    33
NZ_CP027600.1_1207	TAT(Tat/SPI)	0.211265	0.388526	0.021942	0.378266	CS pos: 36-37. ALA-IM. Pr: 0.0975    43
NZ_CP027600.1_1237	TAT(Tat/SPI)	0.223643	0.293929	0.282301	0.200126	CS pos: 32-33. RSA-NG. Pr: 0.0548    36
NZ_CP027600.1_1239	LIPO(Sec/SPII)	0.156196	0.103195	0.500538	0.240071	CS pos: 18-19. GAA-CP. Pr: 0.4312    31
NZ_CP027600.1_1268	SP(Sec/SPI)	0.407245	0.064860	0.187992	0.339903	CS pos: 19-20. AFA-VA. Pr: 0.1636    23
NZ_CP027600.1_1274	LIPO(Sec/SPII)	0.106061	0.004752	0.843439	0.045747	CS pos: 14-15. WAS-CD. Pr: 0.8061    18
NZ_CP027600.1_1296	LIPO(Sec/SPII)	0.178316	0.025033	0.533715	0.262936	CS pos: 16-17. LHA-CT. Pr: 0.5373    20
NZ_CP027600.1_1356	LIPO(Sec/SPII)	0.156028	0.101880	0.546834	0.195257	CS pos: 13-14. STA-CC. Pr: 0.3242    39
NZ_CP027600.1_1358	LIPO(Sec/SPII)	0.205857	0.151088	0.363607	0.279447	CS pos: 12-13. TTS-CA. Pr: 0.2954    27
NZ_CP027600.1_1360	SP(Sec/SPI)	0.412729	0.309845	0.155035	0.122390	CS pos: 30-31. SSA-TG. Pr: 0.2043    38
NZ_CP027600.1_1379	SP(Sec/SPI)	0.463980	0.113683	0.044987	0.377350	CS pos: 20-21. RHA-GN. Pr: 0.2062    40
NZ_CP027600.1_1387	LIPO(Sec/SPII)	0.057519	0.004019	0.890661	0.047801	CS pos: 17-18. LLS-CT. Pr: 0.8126    21
NZ_CP027600.1_1429	LIPO(Sec/SPII)	0.110175	0.126910	0.420995	0.341921	CS pos: 22-23. RLS-CV. Pr: 0.3995    35
NZ_CP027600.1_1442	LIPO(Sec/SPII)	0.224379	0.027669	0.590481	0.157471	CS pos: 16-17. PAS-CV. Pr: 0.5414    21
NZ_CP027600.1_1465	TAT(Tat/SPI)	0.163435	0.380647	0.159694	0.296223	CS pos: ?. Probable protein fragment    20
NZ_CP027600.1_1468	TAT(Tat/SPI)	0.369830	0.405131	0.100908	0.124131	CS pos: 19-20. SLA-IK. Pr: 0.6147    41
NZ_CP027600.1_1489	SP(Sec/SPI)	0.543006	0.003936	0.227266	0.225791	CS pos: 20-21. IFC-MP. Pr: 0.4064    32
NZ_CP027600.1_1490	LIPO(Sec/SPII)	0.191158	0.028755	0.595662	0.184425	CS pos: 18-19. FSV-CR. Pr: 0.5270    34
NZ_CP027600.1_1523	LIPO(Sec/SPII)	0.085357	0.017895	0.804045	0.092703	CS pos: 16-17. ASA-CS. Pr: 0.8028    27
NZ_CP027600.1_1525	LIPO(Sec/SPII)	0.120311	0.019949	0.659474	0.200266	CS pos: 26-27. LCG-CP. Pr: 0.5270    30
NZ_CP027600.1_1547	SP(Sec/SPI)	0.485239	0.379763	0.023486	0.111512	CS pos: 27-28. AYG-KD. Pr: 0.6711    43
NZ_CP027600.1_1559	TAT(Tat/SPI)	0.199924	0.583690	0.035535	0.180850	CS pos: 31-32. ALA-TS. Pr: 0.2844    44
NZ_CP027600.1_1582	LIPO(Sec/SPII)	0.213563	0.024722	0.420198	0.341517	CS pos: 18-19. SFA-CH. Pr: 0.3349    20
NZ_CP027600.1_1605	LIPO(Sec/SPII)	0.022763	0.000703	0.722094	0.254439	CS pos: 17-18. LLS-CY. Pr: 0.6442    21
NZ_CP027600.1_1607	LIPO(Sec/SPII)	0.259647	0.024306	0.430561	0.285487	CS pos: ?. Probable protein fragment    17
NZ_CP027600.1_1610	SP(Sec/SPI)	0.374316	0.012576	0.297255	0.315853	CS pos: 19-20. VIA-QK. Pr: 0.1996    25
NZ_CP027600.1_1639	LIPO(Sec/SPII)	0.216332	0.019959	0.400414	0.363294	CS pos: 15-16. FYS-LL. Pr: 0.0246    17
NZ_CP027600.1_1640	SP(Sec/SPI)	0.435212	0.007618	0.152215	0.404955	CS pos: 19-20. MDA-SC. Pr: 0.3796    37
NZ_CP027600.1_1652	SP(Sec/SPI)	0.552835	0.009692	0.141607	0.295866	CS pos: 22-23. NLG-SP. Pr: 0.2290    29
NZ_CP027600.1_1678	SP(Sec/SPI)	0.405377	0.074890	0.196819	0.322914	CS pos: 12-13. ANA-LP. Pr: 0.2197    21
NZ_CP027600.1_1685	TAT(Tat/SPI)	0.052963	0.396031	0.193682	0.357324	CS pos: 38-39. CRA-GS. Pr: 0.1780    43
NZ_CP027600.1_1713	TAT(Tat/SPI)	0.152420	0.597527	0.030685	0.219367	CS pos: 23-24. ASA-AA. Pr: 0.3257    39
NZ_CP027600.1_1725	LIPO(Sec/SPII)	0.152232	0.015578	0.472977	0.359213	CS pos: 15-16. NQG-CA. Pr: 0.3269    20
NZ_CP027600.1_1765	LIPO(Sec/SPII)	0.275381	0.151286	0.335691	0.237642	CS pos: 22-23. PSA-CA. Pr: 0.2389    39
NZ_CP027600.1_1774	SP(Sec/SPI)	0.430054	0.083243	0.174899	0.311804	CS pos: 38-39. TSA-LG. Pr: 0.1778    43
NZ_CP027600.1_1775	TAT(Tat/SPI)	0.233577	0.387492	0.066644	0.312287	CS pos: 33-34. TMA-AS. Pr: 0.3162    45
NZ_CP027600.1_1791	LIPO(Sec/SPII)	0.238305	0.048693	0.380743	0.332258	CS pos: 13-14. LQQ-CR. Pr: 0.1480    15
NZ_CP027600.1_1800	SP(Sec/SPI)	0.397915	0.290260	0.110408	0.201417	CS pos: 34-35. ASA-AS. Pr: 0.2662    38
NZ_CP027600.1_1805	LIPO(Sec/SPII)	0.296980	0.286039	0.369772	0.047209	CS pos: 18-19. WTR-CG. Pr: 0.2855    47
NZ_CP027600.1_1806	LIPO(Sec/SPII)	0.095347	0.070202	0.542880	0.291571	CS pos: 23-24. ASG-CA. Pr: 0.5188    37
NZ_CP027600.1_1808	LIPO(Sec/SPII)	0.287489	0.028383	0.386169	0.297959	CS pos: 15-16. FPA-NW. Pr: 0.0676    17
NZ_CP027600.1_1812	SP(Sec/SPI)	0.475106	0.041324	0.112365	0.371205	CS pos: 16-17. APA-AN. Pr: 0.2040    37
NZ_CP027600.1_1816	TAT(Tat/SPI)	0.050501	0.619786	0.027256	0.302457	CS pos: 26-27. AFG-AR. Pr: 0.2290    49
NZ_CP027600.1_1819	TAT(Tat/SPI)	0.365246	0.479328	0.067160	0.088266	CS pos: 22-23. ARA-HR. Pr: 0.7620    46
NZ_CP027600.1_1835	LIPO(Sec/SPII)	0.267178	0.026508	0.473881	0.232433	CS pos: 18-19. KTS-CS. Pr: 0.4227    26
NZ_CP027600.1_1858	LIPO(Sec/SPII)	0.209693	0.004922	0.428472	0.356913	CS pos: 20-21. MHG-YS. Pr: 0.4356    34
NZ_CP027600.1_1904	SP(Sec/SPI)	0.375328	0.050009	0.326537	0.248126	CS pos: 16-17. VLG-SS. Pr: 0.1720    29
NZ_CP027600.1_1980	SP(Sec/SPI)	0.573994	0.078249	0.117339	0.230419	CS pos: 21-22. ILS-YN. Pr: 0.2244    28
NZ_CP027600.1_1984	LIPO(Sec/SPII)	0.276848	0.014171	0.366393	0.342588	CS pos: ?. Probable protein fragment    15
NZ_CP027600.1_1997	SP(Sec/SPI)	0.798443	0.060655	0.070885	0.070018	CS pos: 21-22. AEA-SG. Pr: 0.6777    35
NZ_CP027600.1_2001	SP(Sec/SPI)	0.432623	0.085848	0.086380	0.395150	CS pos: 22-23. APA-QT. Pr: 0.1354    33
NZ_CP027600.1_2022	SP(Sec/SPI)	0.616279	0.077136	0.067267	0.239319	CS pos: 21-22. AKT-AN. Pr: 0.4460    39
NZ_CP027600.1_2033	SP(Sec/SPI)	0.662871	0.015520	0.160448	0.161160	CS pos: 17-18. VST-MP. Pr: 0.4071    24
NZ_CP027600.1_2040	LIPO(Sec/SPII)	0.200847	0.049677	0.380346	0.369130	CS pos: 14-15. VIS-CS. Pr: 0.1833    16
NZ_CP027600.1_2048	LIPO(Sec/SPII)	0.007655	0.001814	0.987817	0.002714	CS pos: 22-23. LSG-CH. Pr: 0.9874    48
NZ_CP027600.1_2053	LIPO(Sec/SPII)	0.390134	0.005595	0.513603	0.090669	CS pos: 13-14. LSP-CS. Pr: 0.4983    32
NZ_CP027600.1_2095	LIPO(Sec/SPII)	0.090766	0.004716	0.828884	0.075635	CS pos: 16-17. MAG-CT. Pr: 0.8083    23
NZ_CP027600.1_2112	SP(Sec/SPI)	0.416201	0.019747	0.197011	0.367041	CS pos: 22-23. ADC-WT. Pr: 0.2593    36
NZ_CP027600.1_2161	LIPO(Sec/SPII)	0.201793	0.115994	0.409320	0.272893	CS pos: 27-28. AVS-CN. Pr: 0.2950    48
NZ_CP027600.1_2188	LIPO(Sec/SPII)	0.205487	0.023841	0.386205	0.384468	CS pos: ?. Probable protein fragment    21
NZ_CP027600.1_2213	LIPO(Sec/SPII)	0.107313	0.006659	0.632301	0.253727	CS pos: 25-26. GFS-CY. Pr: 0.4963    29
NZ_CP027600.1_2230	LIPO(Sec/SPII)	0.126997	0.009883	0.483999	0.379121	CS pos: 21-22. GVS-CR. Pr: 0.4128    47
NZ_CP027600.1_2257	LIPO(Sec/SPII)	0.315778	0.041313	0.373483	0.269425	CS pos: 15-16. SAV-CS. Pr: 0.1935    21
NZ_CP027600.1_2269	LIPO(Sec/SPII)	0.203400	0.034848	0.473887	0.287865	CS pos: 15-16. TIT-CS. Pr: 0.2111    19
NZ_CP027600.1_2270	LIPO(Sec/SPII)	0.181668	0.009890	0.654886	0.153556	CS pos: ?. Probable protein fragment    16
NZ_CP027600.1_2275	LIPO(Sec/SPII)	0.184988	0.021195	0.452175	0.341642	CS pos: 14-15. SLS-CY. Pr: 0.3437    17
NZ_CP027600.1_2286	LIPO(Sec/SPII)	0.032754	0.019289	0.831094	0.116863	CS pos: 18-19. TAS-CS. Pr: 0.8221    37
NZ_CP027600.1_2291	SP(Sec/SPI)	0.499901	0.016776	0.181959	0.301363	CS pos: 20-21. TNS-QI. Pr: 0.2863    23
NZ_CP027600.1_2327	TAT(Tat/SPI)	0.215816	0.533398	0.216081	0.034705	CS pos: 24-25. SGA-SV. Pr: 0.3237    39
NZ_CP027600.1_2328	SP(Sec/SPI)	0.546168	0.052896	0.141395	0.259541	CS pos: 33-34. ATA-AS. Pr: 0.1893    47
NZ_CP027600.1_2331	SP(Sec/SPI)	0.482668	0.007741	0.198972	0.310619	CS pos: 15-16. LQA-VP. Pr: 0.1766    26
NZ_CP027600.1_2360	TAT(Tat/SPI)	0.127698	0.492044	0.065542	0.314716	CS pos: ?. Probable protein fragment    30
NZ_CP027600.1_2459	LIPO(Sec/SPII)	0.132410	0.008034	0.551048	0.308508	CS pos: 22-23. STS-CD. Pr: 0.4757    29
NZ_CP027600.1_2520	LIPO(Sec/SPII)	0.062305	0.018410	0.479342	0.439943	CS pos: 19-20. SCT-CW. Pr: 0.3010    49
NZ_CP027600.1_2529	SP(Sec/SPI)	0.461719	0.024483	0.420932	0.092865	CS pos: 21-22. SRC-VP. Pr: 0.1478    40
NZ_CP027600.1_2531	LIPO(Sec/SPII)	0.077136	0.022366	0.799838	0.100660	CS pos: 24-25. TGS-CP. Pr: 0.7435    31
NZ_CP027600.1_2540	LIPO(Sec/SPII)	0.049538	0.026373	0.590135	0.333954	CS pos: 29-30. LSG-CR. Pr: 0.5703    46
NZ_CP027600.1_2555	LIPO(Sec/SPII)	0.100059	0.010504	0.600114	0.289323	CS pos: 24-25. VAG-CS. Pr: 0.5807    32
NZ_CP027600.1_2564	SP(Sec/SPI)	0.431391	0.182734	0.036597	0.349278	CS pos: 18-19. TRA-MS. Pr: 0.2734    33
NZ_CP027600.1_2609	LIPO(Sec/SPII)	0.224521	0.032809	0.439710	0.302960	CS pos: ?. Probable protein fragment    15
NZ_CP027600.1_2643	SP(Sec/SPI)	0.416668	0.015761	0.207063	0.360508	CS pos: 17-18. GTS-YP. Pr: 0.1159    25
NZ_CP027600.1_2652	LIPO(Sec/SPII)	0.104802	0.210739	0.409484	0.274976	CS pos: 33-34. SVS-CC. Pr: 0.3903    39
NZ_CP027600.1_2689	SP(Sec/SPI)	0.431915	0.070324	0.136380	0.361381	CS pos: 15-16. VFA-SQ. Pr: 0.3158    20
NZ_CP027600.1_2748	SP(Sec/SPI)	0.699436	0.030352	0.046650	0.223561	CS pos: 21-22. QSA-SE. Pr: 0.3412    44
NZ_CP027600.1_2752	LIPO(Sec/SPII)	0.262258	0.030350	0.364226	0.343166	CS pos: ?. Probable protein fragment    15
NZ_CP027600.1_2760	LIPO(Sec/SPII)	0.193979	0.033536	0.386343	0.386143	CS pos: 17-18. PLS-CH. Pr: 0.1732    19
NZ_CP027600.1_2768	SP(Sec/SPI)	0.533689	0.025412	0.176786	0.264113	CS pos: 20-21. SSS-HP. Pr: 0.1331    24
NZ_CP027600.1_2770	LIPO(Sec/SPII)	0.294798	0.023444	0.352100	0.329659	CS pos: 15-16. VTG-KE. Pr: 0.3028    21
NZ_CP027600.1_2781	SP(Sec/SPI)	0.444207	0.037289	0.203512	0.314991	CS pos: 14-15. ASA-SP. Pr: 0.1688    29
NZ_CP027600.1_2805	SP(Sec/SPI)	0.421728	0.369550	0.104394	0.104328	CS pos: 25-26. ASA-SW. Pr: 0.6827    33
NZ_CP027600.1_2815	SP(Sec/SPI)	0.720862	0.022938	0.091414	0.164786	CS pos: 19-20. TSA-EC. Pr: 0.4841    28
NZ_CP027600.1_2823	SP(Sec/SPI)	0.434636	0.134797	0.321307	0.109259	CS pos: 20-21. VLA-VP. Pr: 0.3175    37
NZ_CP027600.1_2875	SP(Sec/SPI)	0.616029	0.031242	0.201411	0.151319	CS pos: 29-30. ISA-NT. Pr: 0.3631    35
NZ_CP027600.1_2883	LIPO(Sec/SPII)	0.152357	0.034523	0.434821	0.378299	CS pos: 26-27. ISA-CI. Pr: 0.3961    35
NZ_CP027600.1_2894	SP(Sec/SPI)	0.402501	0.031051	0.172021	0.394427	CS pos: 23-24. FMA-SG. Pr: 0.1150    26
NZ_CP027600.1_2898	SP(Sec/SPI)	0.421881	0.072570	0.354607	0.150942	CS pos: 29-30. VHA-QS. Pr: 0.4519    40
NZ_CP027600.1_2937	LIPO(Sec/SPII)	0.080728	0.003111	0.854638	0.061522	CS pos: 18-19. LPS-CL. Pr: 0.8209    31
NZ_CP027600.1_2944	LIPO(Sec/SPII)	0.280736	0.019780	0.443672	0.255812	CS pos: ?. Probable protein fragment    19
NZ_CP027600.1_2957	SP(Sec/SPI)	0.422650	0.115010	0.081972	0.380368	CS pos: 22-23. SRA-SL. Pr: 0.3964    33
NZ_CP027600.1_2960	LIPO(Sec/SPII)	0.231512	0.021828	0.412814	0.333846	CS pos: ?. Probable protein fragment    16
NZ_CP027600.1_2977	SP(Sec/SPI)	0.685047	0.004915	0.276528	0.033510	CS pos: 18-19. SSG-SL. Pr: 0.2305    37
NZ_CP027600.1_2982	LIPO(Sec/SPII)	0.340855	0.093963	0.548949	0.016234	CS pos: 14-15. MAA-CC. Pr: 0.3952    40
NZ_CP027600.1_2983	SP(Sec/SPI)	0.605284	0.031889	0.237255	0.125572	CS pos: 22-23. SVA-AS. Pr: 0.1899    27
NZ_CP027600.1_2990	TAT(Tat/SPI)	0.072570	0.395583	0.384245	0.147602	CS pos: 20-21. SRA-CE. Pr: 0.4613    46
NZ_CP027601.1_7	SP(Sec/SPI)	0.423348	0.042477	0.249746	0.284429	CS pos: ?. Probable protein fragment    20
NZ_CP027601.1_12	LIPO(Sec/SPII)	0.265379	0.015287	0.401470	0.317864	CS pos: 13-14. FAM-CL. Pr: 0.1623    16
NZ_CP027601.1_112	LIPO(Sec/SPII)	0.232902	0.018794	0.589333	0.158971	CS pos: 23-24. GAS-CY. Pr: 0.5435    39
NZ_CP027601.1_215	LIPO(Sec/SPII)	0.127170	0.007028	0.576810	0.288992	CS pos: 22-23. IIA-CY. Pr: 0.4910    28
NZ_CP027601.1_237	TAT(Tat/SPI)	0.189397	0.418292	0.102726	0.289585	CS pos: 30-31. TES-VT. Pr: 0.3405    37
NZ_CP027601.1_255	LIPO(Sec/SPII)	0.207879	0.072706	0.444977	0.274439	CS pos: 12-13. ISS-CA. Pr: 0.2949    16
NZ_CP027601.1_269	LIPO(Sec/SPII)	0.271746	0.091558	0.337386	0.299310	CS pos: 17-18. CRA-CR. Pr: 0.3019    33
NZ_CP027601.1_272	TAT(Tat/SPI)	0.073750	0.515930	0.019228	0.391092	CS pos: 34-35. MEA-RH. Pr: 0.1751    46
NZ_CP027601.1_279	SP(Sec/SPI)	0.574474	0.057730	0.275442	0.092353	CS pos: 34-35. VAA-AD. Pr: 0.3378    47
NZ_CP027601.1_298	SP(Sec/SPI)	0.640825	0.027592	0.192672	0.138911	CS pos: 14-15. IHG-LP. Pr: 0.3621    41
NZ_CP027601.1_370	LIPO(Sec/SPII)	0.235842	0.013490	0.433366	0.317303	CS pos: ?. Probable protein fragment    21
NZ_CP027601.1_401	LIPO(Sec/SPII)	0.082435	0.003386	0.616443	0.297736	CS pos: 17-18. ISG-YS. Pr: 0.5567    25
NZ_CP027601.1_474	SP(Sec/SPI)	0.358708	0.201824	0.091501	0.347967	CS pos: 21-22. RGA-AP. Pr: 0.1864    30
NZ_CP027601.1_494	LIPO(Sec/SPII)	0.324458	0.021841	0.378262	0.275439	CS pos: 10-11. AAA-CH. Pr: 0.2133    18
NZ_CP027601.1_496	SP(Sec/SPI)	0.555803	0.026909	0.149251	0.268038	CS pos: 28-29. SAA-QT. Pr: 0.3379    30
NZ_CP027601.1_530	LIPO(Sec/SPII)	0.178730	0.057291	0.426960	0.337018	CS pos: 11-12. ATA-CS. Pr: 0.3947    32
NZ_CP027601.1_533	LIPO(Sec/SPII)	0.212233	0.064947	0.373755	0.349065	CS pos: 12-13. SSA-CT. Pr: 0.2994    20
NZ_CP027601.1_561	LIPO(Sec/SPII)	0.128746	0.011070	0.738574	0.121610	CS pos: 19-20. QCS-CA. Pr: 0.5663    35
NZ_CP027601.1_567	SP(Sec/SPI)	0.388707	0.004893	0.373243	0.233157	CS pos: 16-17. VNT-FS. Pr: 0.0778    18
NZ_CP027601.1_629	LIPO(Sec/SPII)	0.160111	0.012698	0.513012	0.314180	CS pos: 20-21. LYG-CL. Pr: 0.3769    25
NZ_CP027601.1_649	LIPO(Sec/SPII)	0.152397	0.070788	0.413901	0.362914	CS pos: 25-26. GTG-CS. Pr: 0.3811    38
NZ_CP027601.1_674	SP(Sec/SPI)	0.392147	0.008140	0.317432	0.282281	CS pos: 16-17. APA-TQ. Pr: 0.1342    28
NZ_CP027601.1_675	SP(Sec/SPI)	0.738426	0.032968	0.010679	0.217926	CS pos: 25-26. VQA-RL. Pr: 0.7403    41
NZ_CP027601.1_677	LIPO(Sec/SPII)	0.122831	0.024329	0.462081	0.390758	CS pos: 18-19. LPS-CD. Pr: 0.3696    21
NZ_CP027601.1_680	LIPO(Sec/SPII)	0.143264	0.037551	0.473759	0.345426	CS pos: 22-23. NVS-CF. Pr: 0.3889    24
NZ_CP027601.1_685	LIPO(Sec/SPII)	0.333658	0.006616	0.425778	0.233948	CS pos: 17-18. QQR-CF. Pr: 0.2396    19
NZ_CP027601.1_692	LIPO(Sec/SPII)	0.194204	0.024036	0.513742	0.268018	CS pos: 12-13. LTT-CV. Pr: 0.2106    15
NZ_CP027601.1_707	LIPO(Sec/SPII)	0.215200	0.004899	0.422879	0.357022	CS pos: 18-19. PCH-CN. Pr: 0.3351    43
NZ_CP027601.1_736	LIPO(Sec/SPII)	0.026762	0.001037	0.902783	0.069417	CS pos: 17-18. ASS-CQ. Pr: 0.9001    36
NZ_CP027601.1_748	LIPO(Sec/SPII)	0.185727	0.013535	0.582968	0.217769	CS pos: 18-19. SSQ-CC. Pr: 0.1997    31
NZ_CP027601.1_802	LIPO(Sec/SPII)	0.236349	0.013371	0.463463	0.286817	CS pos: ?. Probable protein fragment    16
NZ_CP027601.1_805	LIPO(Sec/SPII)	0.073337	0.001151	0.584862	0.340650	CS pos: 23-24. ITA-CS. Pr: 0.3303    38
NZ_CP027601.1_843	SP(Sec/SPI)	0.687275	0.015935	0.181090	0.115700	CS pos: 27-28. PSA-TE. Pr: 0.2391    36
NZ_CP027601.1_857	LIPO(Sec/SPII)	0.191038	0.044770	0.484322	0.279870	CS pos: 13-14. AGG-CV. Pr: 0.2638    35
NZ_CP027601.1_867	LIPO(Sec/SPII)	0.246205	0.009063	0.460470	0.284262	CS pos: ?. Probable protein fragment    19
NZ_CP027601.1_871	LIPO(Sec/SPII)	0.250065	0.010397	0.548313	0.191225	CS pos: ?. Probable protein fragment    21
NZ_CP027601.1_929	LIPO(Sec/SPII)	0.348700	0.007192	0.400491	0.243617	CS pos: 15-16. SVA-QT. Pr: 0.1322    17
NZ_CP027601.1_952	LIPO(Sec/SPII)	0.059595	0.004987	0.530626	0.404792	CS pos: 17-18. QMT-CG. Pr: 0.4518    34
NZ_CP027601.1_1042	LIPO(Sec/SPII)	0.225269	0.021722	0.534204	0.218805	CS pos: 14-15. GCR-CT. Pr: 0.1603    17
NZ_CP027601.1_1077	LIPO(Sec/SPII)	0.078504	0.004353	0.735342	0.181801	CS pos: 15-16. PAS-CT. Pr: 0.6985    27
NZ_CP027601.1_1133	LIPO(Sec/SPII)	0.163892	0.005036	0.441715	0.389357	CS pos: 16-17. SIK-CP. Pr: 0.3851    25
NZ_CP027601.1_1168	SP(Sec/SPI)	0.406759	0.208389	0.042080	0.342772	CS pos: 21-22. VQA-DA. Pr: 0.3865    25
NZ_CP027601.1_1300	LIPO(Sec/SPII)	0.076614	0.007882	0.864273	0.051231	CS pos: 18-19. QSG-CA. Pr: 0.8526    30
NZ_CP027601.1_1334	LIPO(Sec/SPII)	0.116153	0.003569	0.575283	0.304996	CS pos: 14-15. YLS-CY. Pr: 0.3541    22
NZ_CP027601.1_1342	LIPO(Sec/SPII)	0.303229	0.019064	0.375046	0.302661	CS pos: ?. Probable protein fragment    15
NZ_CP027601.1_1374	LIPO(Sec/SPII)	0.237156	0.030479	0.390516	0.341850	CS pos: ?. Probable protein fragment    16
NZ_CP027601.1_1407	LIPO(Sec/SPII)	0.137124	0.003417	0.452005	0.407454	CS pos: 18-19. YHS-CI. Pr: 0.4411    40
NZ_CP027601.1_1505	LIPO(Sec/SPII)	0.036594	0.006413	0.905758	0.051235	CS pos: 23-24. LAS-CK. Pr: 0.8815    26
NZ_CP027601.1_1515	LIPO(Sec/SPII)	0.140418	0.037666	0.464061	0.357855	CS pos: 10-11. SSA-CM. Pr: 0.4371    25
NZ_CP027601.1_1523	SP(Sec/SPI)	0.620542	0.026785	0.297668	0.055006	CS pos: 21-22. IHA-AT. Pr: 0.5829    32
NZ_CP027601.1_1531	TAT(Tat/SPI)	0.245428	0.390946	0.029508	0.334119	CS pos: 21-22. ASA-EH. Pr: 0.3553    38
NZ_CP027601.1_1537	LIPO(Sec/SPII)	0.085341	0.015365	0.688245	0.211050	CS pos: 11-12. GTA-CS. Pr: 0.6793    41
NZ_CP027601.1_1541	SP(Sec/SPI)	0.401499	0.010639	0.271824	0.316038	CS pos: 16-17. AEP-WL. Pr: 0.1253    25
NZ_CP027601.1_1571	SP(Sec/SPI)	0.503657	0.099099	0.040495	0.356748	CS pos: 19-20. AVA-QT. Pr: 0.3303    43
NZ_CP027601.1_1607	LIPO(Sec/SPII)	0.005307	0.001601	0.988605	0.004487	CS pos: 19-20. TTG-CG. Pr: 0.9882    31
NZ_CP027601.1_1621	TAT(Tat/SPI)	0.106361	0.490009	0.115548	0.288082	CS pos: 24-25. TRS-GY. Pr: 0.1355    35
NZ_CP027601.1_1686	LIPO(Sec/SPII)	0.243085	0.020962	0.390367	0.345587	CS pos: 20-21. FGA-GS. Pr: 0.1397    44
NZ_CP027601.1_1689	SP(Sec/SPI)	0.868391	0.012919	0.108345	0.010345	CS pos: 17-18. ATA-AS. Pr: 0.6125    30
NZ_CP027601.1_1706	LIPO(Sec/SPII)	0.233593	0.029345	0.369110	0.367952	CS pos: ?. Probable protein fragment    17
NZ_CP027601.1_1724	SP(Sec/SPI)	0.546800	0.053786	0.173867	0.225547	CS pos: 28-29. LQA-SK. Pr: 0.4409    36
NZ_CP027601.1_1727	SP(Sec/SPI)	0.352060	0.035546	0.294712	0.317681	CS pos: 23-24. LFG-AD. Pr: 0.2295    29
NZ_CP027601.1_1755	LIPO(Sec/SPII)	0.251245	0.050179	0.352786	0.345789	CS pos: 12-13. TAL-CN. Pr: 0.0251    15
NZ_CP027601.1_1793	LIPO(Sec/SPII)	0.278179	0.041789	0.340751	0.339280	CS pos: ?. Probable protein fragment    15
NZ_CP027601.1_1807	LIPO(Sec/SPII)	0.252380	0.011419	0.405597	0.330604	CS pos: ?. Probable protein fragment    16
NZ_CP027601.1_1809	LIPO(Sec/SPII)	0.089438	0.006266	0.476616	0.427680	CS pos: 24-25. WAG-CC. Pr: 0.4016    42
NZ_CP027601.1_1813	SP(Sec/SPI)	0.461962	0.000491	0.082980	0.454568	CS pos: 22-23. NLS-EL. Pr: 0.1422    36
NZ_CP027601.1_1819	LIPO(Sec/SPII)	0.284168	0.030300	0.459316	0.226216	CS pos: ?. Probable protein fragment    15
NZ_CP027601.1_1820	LIPO(Sec/SPII)	0.261889	0.008713	0.412983	0.316415	CS pos: 13-14. LVS-MQ. Pr: 0.0893    15
NZ_CP027601.1_1827	LIPO(Sec/SPII)	0.275941	0.028053	0.426738	0.269268	CS pos: 14-15. RSI-CW. Pr: 0.0488    16
NZ_CP027601.1_1833	LIPO(Sec/SPII)	0.274360	0.017060	0.372834	0.335747	CS pos: 16-17. MMS-MG. Pr: 0.0416    18
NZ_CP027601.1_1844	LIPO(Sec/SPII)	0.138235	0.004681	0.624520	0.232564	CS pos: 21-22. FSG-CN. Pr: 0.5470    24
NZ_CP027601.1_1900	SP(Sec/SPI)	0.821817	0.003169	0.135124	0.039890	CS pos: 21-22. VTA-SD. Pr: 0.8032    43
NZ_CP027601.1_1915	LIPO(Sec/SPII)	0.032461	0.002762	0.541265	0.423512	CS pos: 16-17. ITS-CR. Pr: 0.5437    48
NZ_CP027601.1_1926	LIPO(Sec/SPII)	0.200655	0.013318	0.713485	0.072542	CS pos: 14-15. RSS-CV. Pr: 0.6520    22
NZ_CP027601.1_2052	LIPO(Sec/SPII)	0.187534	0.021482	0.487752	0.303233	CS pos: 22-23. SAA-CG. Pr: 0.2856    24
NZ_CP027601.1_2053	LIPO(Sec/SPII)	0.048585	0.002768	0.756178	0.192468	CS pos: 22-23. LQC-CL. Pr: 0.4498    40
NZ_CP027601.1_2097	TAT(Tat/SPI)	0.078724	0.343266	0.309292	0.268718	CS pos: 34-35. GSA-CN. Pr: 0.1170    36
NZ_CP027601.1_2136	LIPO(Sec/SPII)	0.022204	0.001330	0.880626	0.095840	CS pos: 14-15. GIS-CC. Pr: 0.6277    30
NZ_CP027601.1_2154	LIPO(Sec/SPII)	0.123366	0.016122	0.585492	0.275020	CS pos: 13-14. SSS-CG. Pr: 0.5259    20
NZ_CP027601.1_2177	LIPO(Sec/SPII)	0.276215	0.019456	0.391982	0.312347	CS pos: ?. Probable protein fragment    17
NZ_CP027601.1_2195	LIPO(Sec/SPII)	0.181475	0.048797	0.407423	0.362305	CS pos: 18-19. STS-CG. Pr: 0.3452    20
NZ_CP027601.1_2199	LIPO(Sec/SPII)	0.269727	0.023055	0.393089	0.314129	CS pos: ?. Probable protein fragment    16
NZ_CP027601.1_2202	LIPO(Sec/SPII)	0.150736	0.004541	0.751689	0.093035	CS pos: 13-14. LGS-CQ. Pr: 0.7170    20
NZ_CP027601.1_2260	SP(Sec/SPI)	0.425408	0.116229	0.083418	0.374944	CS pos: 18-19. VWP-AG. Pr: 0.2763    31
NZ_CP027601.1_2300	LIPO(Sec/SPII)	0.146072	0.012726	0.784828	0.056374	CS pos: 16-17. RAG-CG. Pr: 0.7572    26
NZ_CP027601.1_2310	LIPO(Sec/SPII)	0.242154	0.023193	0.447627	0.287025	CS pos: ?. Probable protein fragment    15
NZ_CP027601.1_2336	LIPO(Sec/SPII)	0.230702	0.011363	0.594387	0.163547	CS pos: 12-13. LLA-CA. Pr: 0.4614    19
NZ_CP027601.1_2369	LIPO(Sec/SPII)	0.086196	0.008404	0.542742	0.362659	CS pos: 17-18. FVS-CW. Pr: 0.4671    23
NZ_CP027601.1_2370	LIPO(Sec/SPII)	0.023527	0.003361	0.793584	0.179528	CS pos: 27-28. VVG-CA. Pr: 0.7911    35
NZ_CP027601.1_2373	SP(Sec/SPI)	0.903263	0.064800	0.012888	0.019049	CS pos: 23-24. SFA-RD. Pr: 0.9341    33
NZ_CP027601.1_2476	LIPO(Sec/SPII)	0.312829	0.035242	0.326667	0.325262	CS pos: 13-14. SVF-CI. Pr: 0.0789    18
NZ_CP027601.1_2478	LIPO(Sec/SPII)	0.045223	0.003502	0.504846	0.446429	CS pos: 25-26. LHS-CN. Pr: 0.4338    39
NZ_CP027601.1_2487	SP(Sec/SPI)	0.440695	0.049899	0.165811	0.343595	CS pos: 29-30. VKS-SP. Pr: 0.1835    34
NZ_CP027601.1_2509	LIPO(Sec/SPII)	0.314377	0.012437	0.441516	0.231670	CS pos: ?. Probable protein fragment    18
NZ_CP027601.1_2513	TAT(Tat/SPI)	0.262918	0.321000	0.173688	0.242394	CS pos: 29-30. RHG-SS. Pr: 0.0909    49
